<SEC-DOCUMENT>0000816956-21-000008.txt : 20210429
<SEC-HEADER>0000816956-21-000008.hdr.sgml : 20210429
<ACCEPTANCE-DATETIME>20210429101610
ACCESSION NUMBER:		0000816956-21-000008
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		70
CONFORMED PERIOD OF REPORT:	20210331
FILED AS OF DATE:		20210429
DATE AS OF CHANGE:		20210429

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CONMED Corp
		CENTRAL INDEX KEY:			0000816956
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				160977505
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39218
		FILM NUMBER:		21867689

	BUSINESS ADDRESS:	
		STREET 1:		11311 CONCEPT BOULEVARD
		CITY:			LARGO
		STATE:			FL
		ZIP:			33773
		BUSINESS PHONE:		727-214-2974

	MAIL ADDRESS:	
		STREET 1:		11311 CONCEPT BOULEVARD
		CITY:			LARGO
		STATE:			FL
		ZIP:			33773

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CONMED CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>cnmd-20210331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:4a71bfc6-7922-4305-aa8d-7a5d2323cf49,g:a58de70d-c080-4226-99f2-d632a7268b2f,d:60ea575d4ae7456fa9ff06ec4f3488e0--><html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:cnmd="http://www.conmed.com/20210331" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cnmd-20210331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80L2ZyYWc6ZTc0MTVmMTFkMDI3NGY1YWFjYmI4MDdiYWVmZmM3MzYvdGFibGU6ZTBhN2VlNzkxMjI2NDljODllOTBkOTMyODFhNzYyOGQvdGFibGVyYW5nZTplMGE3ZWU3OTEyMjY0OWM4OWU5MGQ5MzI4MWE3NjI4ZF8xLTEtMS0xLTA_283974ac-c3fb-404d-8e53-5af219b06b23">0000816956</ix:nonNumeric><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80L2ZyYWc6ZTc0MTVmMTFkMDI3NGY1YWFjYmI4MDdiYWVmZmM3MzYvdGFibGU6ZTBhN2VlNzkxMjI2NDljODllOTBkOTMyODFhNzYyOGQvdGFibGVyYW5nZTplMGE3ZWU3OTEyMjY0OWM4OWU5MGQ5MzI4MWE3NjI4ZF8yLTEtMS0xLTA_5a08a772-76bf-4136-82f3-bdf0425bc6d1">12/31</ix:nonNumeric><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80L2ZyYWc6ZTc0MTVmMTFkMDI3NGY1YWFjYmI4MDdiYWVmZmM3MzYvdGFibGU6ZTBhN2VlNzkxMjI2NDljODllOTBkOTMyODFhNzYyOGQvdGFibGVyYW5nZTplMGE3ZWU3OTEyMjY0OWM4OWU5MGQ5MzI4MWE3NjI4ZF8zLTEtMS0xLTA_764b1f00-458c-4c45-9b10-ffe1e0e3b2bd">2021</ix:nonNumeric><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80L2ZyYWc6ZTc0MTVmMTFkMDI3NGY1YWFjYmI4MDdiYWVmZmM3MzYvdGFibGU6ZTBhN2VlNzkxMjI2NDljODllOTBkOTMyODFhNzYyOGQvdGFibGVyYW5nZTplMGE3ZWU3OTEyMjY0OWM4OWU5MGQ5MzI4MWE3NjI4ZF80LTEtMS0xLTA_606142de-ad57-46c6-8225-b03ce03a707c">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" format="ixt:booleanfalse" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80L2ZyYWc6ZTc0MTVmMTFkMDI3NGY1YWFjYmI4MDdiYWVmZmM3MzYvdGFibGU6ZTBhN2VlNzkxMjI2NDljODllOTBkOTMyODFhNzYyOGQvdGFibGVyYW5nZTplMGE3ZWU3OTEyMjY0OWM4OWU5MGQ5MzI4MWE3NjI4ZF81LTEtMS0xLTA_7c60f7d6-1752-496d-b994-75e6d4836c07">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cnmd-20210331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ia8dfbbe9d1c145d5bb72b02ea4fac60c_I20210426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46ba6599130f4eb1a4d6fe042999e135_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae012f3fcd9f41fd9bc6e05669f51454_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8d0268193f046989c7a7367bc639b32_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27c15051984d44e6b5c9858e676ca33c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i151d90f96de242678881f597e8015d38_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2905d9021abd4b9ea314e60814616d57_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3676449ae5744b184ad5f60ae92544f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie64010a164eb46af89de3193d71e8fba_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96387733ca074ff7b4010cdd9df409b6_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if474f87feaa54dc0a8fcf5d08a768e3e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id31031a486b14a38af8dea7f3155fcb8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibac6966a355949378bb6c2fc42834ec1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8f8f0e52b974b4e95f209ba842d8bb6_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i029f793cce2d4474856e032865f1f946_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33ed66e8daf34fa8b10ccb54d98510cf_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e2c39713f4b45bf83812220f02bcfce_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieebf93936a0b4946a4cebd127f100d98_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b008cae44884d848870e03a18000ab9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cb501558a20431db8401ff4a527404c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba78700e77d54679bf93d6b9acf74fae_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e86d4601a4b4430ba15cc2ae32a9336_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc2b6de697384224975fbf30994d9a87_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72ed1085bea54a3ca02ccafd38fb3dca_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44890b61b4e54cd6a45ec9fe485dffab_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95bc22c9cff4438ba21e7d9b6141399c_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cc29bb8dbaa42239d37e7bb08963171_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc96afc7d3fb40a98303297d7f214b0e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cef9bc34cee464192cc0b9012143d3f_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ec34830172747ee92a710ad30795223_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i120ee47c2d2c46e08a15d763a7767f75_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c56f028fc084321a0e30cfeaea79a64_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie62997345e524027a79ecf64d5ed0611_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fd2671e438a474faa38d3e9a2c3f250_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4190bedf816e408ca9d02bfd966a3366_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb19adcd1a5d48da93ca6e4fe100bba2_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i775199af495945bf86d1df93013e716d_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8caf0668d2a043b99300c2d015a59f5e_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d5cbd26c2e34fcca879ebd88ed26bbc_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c4dbcab20b64473a815fafab7bb519b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacc6728071cc42afac66a950fd77c7ec_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id693351de21b454f9ad10a807a5dd52f_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb2a8238876248f585425eb5051bb474_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29730944e6d14730a59d95854830ef68_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bf13cfe5c8b4c3c98489e1e906361e1_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8985ce744656405e85a504c9d31badd8_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbade5dec7f741f6a1a4d181a6fd7c0a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe2d2ede0d054d3ea31d7f38ad84c165_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4d5dfe5f1934d3982cae7661c4cf533_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4c14268949c4a94b1580a7aeb78ecbb_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bbfa0455ef7435a9f76aa8e63565ef5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cnmd:AmericasexcludingtheUnitedStatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68905b6fbdec4d4cb2932ea45ef02924_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cnmd:AmericasexcludingtheUnitedStatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb1d2f66658942c69084f7e2616e914f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cnmd:AmericasexcludingtheUnitedStatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c75aafd2b4c449c95acdba707112745_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cnmd:AmericasexcludingtheUnitedStatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76d7ef8d98cb4ff19a021ad02e67da31_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cnmd:AmericasexcludingtheUnitedStatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cdefd0b0a3045d49ceeadee9e6bb36b_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cnmd:AmericasexcludingtheUnitedStatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia86b4262c6984bb6ad658ce074db008e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id802a374e8af403cb3d3822bd10d7c08_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9557a8db05ee41ffaa88a992a0b82938_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a7ac877916a4014a3fb26b999be79af_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if94e1dc3dd564aaebe0c764b728d2713_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfadd8f8b84b4fdf903364c77b8920f3_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f20b36e15fb425494acd84a048f7177_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11161ef39ae1485b8d27a2ae4c22875d_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i782cd02ea1ba4cd78b680a524b6ca850_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a74e7f2ffa04fa0814e8231216941c4_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib20f23593d444604b32c771d7959b0ca_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d4311b6e8044c8894a8f3e8bba1645c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e128db3c81e4e588034d3c0247dee80_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7057925e589d42faa6a4fb3ddf23bbd6_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if74b6b7e82ac4212bba27824114d47b4_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12d7e0dffb5e4869af8c81221b0c0a7f_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01ec3e073702455c9e537fe9a5385abb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b7ea3f8782943fcbc4ba9d0d76b3ec1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1adb37865c4441248b72947844ddca28_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d3af65fad6f44f0b3d057bbf55a6a78_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad15f0679e6b4c0d9ac7119db78f9c33_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1dc7178d7a640169fb15973f1266566_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8245a6aa10f94c0bbcc41d1b62a19629_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c348cefc0004f5a84965d0ccc163ea3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07bd77a73b3545aa8a2104efd8e434fd_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fab3fd5ae6d4130a6074da5f6e613ae_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide5c2d5254674b079e19ce03c1af6597_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3260d253c3314cdda5a4ade16ecbac96_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i539165515ff54031a19c7afae85ae40a_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib283f3bae1b7414e9448c28a5baa9aff_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2aa32ba1223944909a381ed581c46123_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48e8d40f4b764e66a575ca1ee4752691_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied165b7d8f6347aaa83ef46fd509ac16_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib74665bfb6b541e48986d00dea4ca711_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c2b490080b54ee293093cabd55cf92f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2efe3e302ba4492a9b14126b56757fe7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf6b5979fbd34dcbae2c42f8e0d6aed2_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacdfcde17fac4a0eb431ce68961ed713_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1e08f06254d472fa74789af8e1cd878_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99806f4ebd244f5e87a9fa07d01115f6_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e47fc121f8545dbb0463f80ac04eab2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">cnmd:RevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa13b87841fb46f9971920ec855139e0_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">cnmd:RevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4cfe412f15e40679fed8fb1ab50ff59_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if891372cb88f49d1ad8cf68161f49100_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id18f74481683457cb6b00dae1d5691a4_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6331111f415a4d5ea9e8cd727632eeee_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35307b95062445a3a39801d79634cee9_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d3efa96f76c423a828baa29d94dcb15_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67d105aa68f347b8a414ade6ce5542bc_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic235813d62984ee3b72d058a569b0a54_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9abfdfe4a61a4a60ab8b291e94a8244d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a133038947642198d9059759b25062b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd85c1ac785d48edbf3dd0030c518099_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic248ae873ff841ffbe0200170d941d8d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="id748c1bbe2b3409b9e97ffd239dcc0f0_I20190129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2.625PercentConvertibleNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4166a58e42b343bfb5ae40145fb70764_D20190129-20190129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cnmd:IndexedTransactionTypeAxis">cnmd:HedgeTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2.625PercentConvertibleNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-29</xbrli:startDate><xbrli:endDate>2019-01-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf721ab99d84490dbfa3d3cec7d8e799_D20190129-20190129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2.625PercentConvertibleNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cnmd:IndexedTransactionTypeAxis">cnmd:WarrantTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-29</xbrli:startDate><xbrli:endDate>2019-01-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieced3d585af14a18830b4dd4d45722c5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnmd:CustomerandDistributorRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i845a4163284f443481a7a9c2d614d09a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnmd:CustomerandDistributorRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ee91ad444274cc2a46852ceb1cbe07b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnmd:CustomerandDistributorRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i764a3b1ff7c841b1ba858429acbdb036_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnmd:SalesrepresentationmarketingandpromotionalrightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67e28dd28d264c5ca16a46ab1364c8bc_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnmd:SalesrepresentationmarketingandpromotionalrightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if46896d334d94c639ad7dd9fe363f7ff_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnmd:SalesrepresentationmarketingandpromotionalrightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4827d1b693224030887c79b6d7a4ac8a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id22fbed2f4c849639e7b4e6618063e83_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7cce587c6664fba92238d523270294d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic619fc4d993649a0aa3de013bce24ac7_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnmd:PatentsAndOtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c573b67931c49ae94806ae92e81066f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnmd:PatentsAndOtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8660d403bca94922a95c5e1926714e31_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnmd:PatentsAndOtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fbb390301fb48f0a30356e63cdebb22_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16f265525a594e4196ee9d5387895783_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie71bc8ca5147459e9fc9a708d695e3d8_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f228fccaaf945268b8dcbd31bed8868_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">cnmd:ExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cfc55d543ed45c79d4721e64e912827_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">cnmd:ReductionofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i824ceb82e4874235bfdf7c0af561e38c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d478e70dcec4899b2e2962f31e3f914_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d8fccab0a15481582a37233de37abbf_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc48b5a1f090411da72a4fabcf8ba3c5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99821198665d4c33ba7a5fc053af58b5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b2868e4273945968f65bc7567ca9021_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida498aa346244a73997d7daf728c9420_I20190207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:AmendedAndRestatedSeniorCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7729e32eb8ce41c089d19b2205b89c39_I20190207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:AmendedAndRestatedSeniorCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9eaf4f751cfe4066b7c97b065a34e247_I20190207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2.625PercentConvertibleNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28142c61de0544568e9a171dfbb1187c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cnmd:VariableRateBasisAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:AmendedAndRestatedSeniorCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e5c081b73e84195a5fcd7003f17de71_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cnmd:VariableRateBasisAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:AmendedAndRestatedSeniorCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied43b21a44b44e51b34956e8f380ca38_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:AmendedAndRestatedSeniorCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib605253e0a9f4dfba2ff9d30ac708b49_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cnmd:VariableRateBasisAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:AmendedAndRestatedSeniorCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d7a728e16414d51a3ab40885ff60574_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:AmendedAndRestatedSeniorCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee99b7a3a16541f8b5be3bf158edab1d_D20190129-20190129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2.625PercentConvertibleNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-29</xbrli:startDate><xbrli:endDate>2019-01-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5c0fe7cdde24d5ab7b9a921af59a0d9_I20190129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2.625PercentConvertibleNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:CallOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf80fee48fa74ab4b9051fb83cdd995b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2.625PercentConvertibleNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i296a43d7781e4424a01be9d77422618e_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2.625PercentConvertibleNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c05d83ea1e6498489016ad7d59cf236_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e04b4ea73e04184933b0223f3525651_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id854f60e596745a88a6555bfb8baa9c8_D20170118-20170118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cnmd:EndoDynamixInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cnmd:LitigationDamagesAxis">cnmd:LiquidatedDamagesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-18</xbrli:startDate><xbrli:endDate>2017-01-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82aee7908b334a16816b4969f87ddeaa_D20170118-20170118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cnmd:EndoDynamixInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cnmd:LitigationDamagesAxis">cnmd:AdditionalDamagesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-18</xbrli:startDate><xbrli:endDate>2017-01-18</xbrli:endDate></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNC03LTEtMS0w_7d609658-4f9f-4a30-a5c9-fcb8abb16924 id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNC01LTEtMS0w_1846a0b4-0c4b-442c-8e88-61f74f76dd73 id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNC0zLTEtMS0w_e2eaf120-37e1-465c-b2ed-24e267ffb15d id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNC0xLTEtMS0w_767c56ac-23ad-4d12-b20f-2d598b83b31f id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNC0xLTEtMS0w_e5da9a35-d40d-4807-a614-2a0192f2d59f id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNC0zLTEtMS0w_605e62c1-18c1-4300-86b4-c5e62ec335ce id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNC03LTEtMS0w_8a1edb82-783b-40f1-9075-643fba61b055 id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNC01LTEtMS0w_47619acf-92fc-44be-89a1-4a998a5d3dcf" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RleHRyZWdpb246ZjhhOTI2NTdlY2MyNDJjOTk4ZGQ2ZmQwMTllN2U1MTRfNDg1_0cde947c-56e3-469d-922e-df5586b6f6bc" order="1"></ix:relationship></ix:resources></ix:header></div><div id="i60ea575d4ae7456fa9ff06ec4f3488e0_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Washington, D.C. 20549</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGV4dHJlZ2lvbjoyMWZiZTlmZWY1ZDc0ZmFmYWRiZmQ2YjMyNzViYTQ0ZF8yMTM4_a69dd2f9-c26b-447b-a0e6-8763d3d05c11">10-Q</ix:nonNumeric> </span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGV4dHJlZ2lvbjoyMWZiZTlmZWY1ZDc0ZmFmYWRiZmQ2YjMyNzViYTQ0ZF8yMTQ2_97882b7b-8462-43f7-b944-462940621b85">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">or</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGV4dHJlZ2lvbjoyMWZiZTlmZWY1ZDc0ZmFmYWRiZmQ2YjMyNzViYTQ0ZF8yMTM5_dfef0ffe-fe46-4cc2-82dd-bff5aaa36834">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">For the quarterly period ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commission File Number</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGFibGU6MmVkYmNiODdjNzFlNGEyNzhkNWFlNjlmN2JkZWFlMTIvdGFibGVyYW5nZToyZWRiY2I4N2M3MWU0YTI3OGQ1YWU2OWY3YmRlYWUxMl8xLTAtMS0xLTA_7b5cd5a5-b7b6-464c-9075-d406715d002f">March 31, 2021</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGFibGU6MmVkYmNiODdjNzFlNGEyNzhkNWFlNjlmN2JkZWFlMTIvdGFibGVyYW5nZToyZWRiY2I4N2M3MWU0YTI3OGQ1YWU2OWY3YmRlYWUxMl8xLTEtMS0xLTA_51a3fa38-eabf-4394-ad99-55fa746a72f2">001-39218</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGV4dHJlZ2lvbjoyMWZiZTlmZWY1ZDc0ZmFmYWRiZmQ2YjMyNzViYTQ0ZF8yMTQ3_841d157e-3c40-4814-a0f9-bf15fe188afc">CONMED CORPORATION</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Exact name of the registrant as specified in its charter)</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.912%"><tr><td style="width:1.0%"></td><td style="width:26.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.493%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.704%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.536%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGFibGU6MGFmNzNiM2NmYzkxNGM3N2I1MGJhMDhhOTQxZDc1ZjEvdGFibGVyYW5nZTowYWY3M2IzY2ZjOTE0Yzc3YjUwYmEwOGE5NDFkNzVmMV8wLTAtMS0xLTA_34c622ac-4154-43ea-9f89-b149c100ec48">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGFibGU6MGFmNzNiM2NmYzkxNGM3N2I1MGJhMDhhOTQxZDc1ZjEvdGFibGVyYW5nZTowYWY3M2IzY2ZjOTE0Yzc3YjUwYmEwOGE5NDFkNzVmMV8wLTMtMS0xLTA_865442e2-afcd-4f19-88a2-80af2daf2b8c">16-0977505</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGFibGU6MGFmNzNiM2NmYzkxNGM3N2I1MGJhMDhhOTQxZDc1ZjEvdGFibGVyYW5nZTowYWY3M2IzY2ZjOTE0Yzc3YjUwYmEwOGE5NDFkNzVmMV8zLTAtMS0xLTA_157963d2-d850-44cf-919a-d46d0ffb2370">11311 Concept Blvd</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGFibGU6MGFmNzNiM2NmYzkxNGM3N2I1MGJhMDhhOTQxZDc1ZjEvdGFibGVyYW5nZTowYWY3M2IzY2ZjOTE0Yzc3YjUwYmEwOGE5NDFkNzVmMV8zLTEtMS0xLTA_74a74e78-d7cb-4dd3-af81-3015dc259f05">Largo,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGFibGU6MGFmNzNiM2NmYzkxNGM3N2I1MGJhMDhhOTQxZDc1ZjEvdGFibGVyYW5nZTowYWY3M2IzY2ZjOTE0Yzc3YjUwYmEwOGE5NDFkNzVmMV8zLTItMS0xLTA_29587e19-77d5-4033-ad94-0364caef33f7">Florida</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGFibGU6MGFmNzNiM2NmYzkxNGM3N2I1MGJhMDhhOTQxZDc1ZjEvdGFibGVyYW5nZTowYWY3M2IzY2ZjOTE0Yzc3YjUwYmEwOGE5NDFkNzVmMV8zLTMtMS0xLTA_d4ea6799-9d85-40a3-894d-e8b67a692afc">33773</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGV4dHJlZ2lvbjoyMWZiZTlmZWY1ZDc0ZmFmYWRiZmQ2YjMyNzViYTQ0ZF8yMTQ4_05dd89dc-1da5-4e09-a774-c2e95c1a847c">727</ix:nonNumeric>) <ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGV4dHJlZ2lvbjoyMWZiZTlmZWY1ZDc0ZmFmYWRiZmQ2YjMyNzViYTQ0ZF8yMTQw_c2c0a758-2dc8-468e-b650-ff7a19558705">392-6464</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Registrant's telephone number, including area code)</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.283%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Trading Symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGFibGU6YzliOGFlMjhmOGVjNGRjNWEwOWMwOTI1MjlhODEyNTAvdGFibGVyYW5nZTpjOWI4YWUyOGY4ZWM0ZGM1YTA5YzA5MjUyOWE4MTI1MF8xLTAtMS0xLTA_0b1ab7bc-9400-484a-8b8c-9e08686175ff">Common Stock, $0.01 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGFibGU6YzliOGFlMjhmOGVjNGRjNWEwOWMwOTI1MjlhODEyNTAvdGFibGVyYW5nZTpjOWI4YWUyOGY4ZWM0ZGM1YTA5YzA5MjUyOWE4MTI1MF8xLTEtMS0xLTA_08766dba-b4ff-4347-9a34-83e62aa0b396">CNMD</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGFibGU6YzliOGFlMjhmOGVjNGRjNWEwOWMwOTI1MjlhODEyNTAvdGFibGVyYW5nZTpjOWI4YWUyOGY4ZWM0ZGM1YTA5YzA5MjUyOWE4MTI1MF8xLTItMS0xLTA_13dc3c57-c685-4ade-bcc4-57bd85445242">NYSE</ix:nonNumeric></span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGV4dHJlZ2lvbjoyMWZiZTlmZWY1ZDc0ZmFmYWRiZmQ2YjMyNzViYTQ0ZF8yMTQx_ccc1fcf3-5598-40a3-af47-7c2544f9eeb9">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGV4dHJlZ2lvbjoyMWZiZTlmZWY1ZDc0ZmFmYWRiZmQ2YjMyNzViYTQ0ZF8yMTM2_f8f558b3-e4cf-4c0a-8801-bfde58b1315f">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company.&#160;&#160;See the definitions of "large accelerated filer", "accelerated filer", "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act (Check one).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGV4dHJlZ2lvbjoyMWZiZTlmZWY1ZDc0ZmFmYWRiZmQ2YjMyNzViYTQ0ZF8yMTM3_8655cdc8-6b8a-438f-ab37-cc8f154cdad2">Large accelerated filer</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Accelerated filer </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Non-accelerated filer </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Smaller reporting company </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGV4dHJlZ2lvbjoyMWZiZTlmZWY1ZDc0ZmFmYWRiZmQ2YjMyNzViYTQ0ZF8yMTQy_3a0b264f-1078-475b-8f3a-c491e920a7c4">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Emerging growth company </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGV4dHJlZ2lvbjoyMWZiZTlmZWY1ZDc0ZmFmYWRiZmQ2YjMyNzViYTQ0ZF8yMTQz_39d2ae9f-3a62-48db-b9f6-53830dd55101">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGV4dHJlZ2lvbjoyMWZiZTlmZWY1ZDc0ZmFmYWRiZmQ2YjMyNzViYTQ0ZF8yMTQ1_d273ec38-3494-497f-9390-9253a407de99">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The number of shares outstanding of registrant's common stock, as of April&#160;26, 2021 is <ix:nonFraction unitRef="shares" contextRef="ia8dfbbe9d1c145d5bb72b02ea4fac60c_I20210426" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGV4dHJlZ2lvbjoyMWZiZTlmZWY1ZDc0ZmFmYWRiZmQ2YjMyNzViYTQ0ZF8yMTI3_f962c370-52b7-4477-9265-43f07fcca8c0">29,092,141</ix:nonFraction> shares.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i60ea575d4ae7456fa9ff06ec4f3488e0_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONMED CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUARTERLY REPORT ON FORM 10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE QUARTER ENDED MARCH&#160;31, 2021 </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:12.065%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.189%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I FINANCIAL INFORMATION</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_13">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_13">Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_16">&#8211; Consolidated Condensed Statements of Comprehensive Income (Loss) for the three months ended March 31, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_16">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_19">&#8211; Consolidated Condensed Balance Sheets as of March 31, 2021 and December 31, 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_19">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_22">&#8211; Consolidated Condensed Statements of Shareholders' Equity for the three months ended March 31, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_22">3</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_25">&#8211;  Consolidated Condensed Statements of Cash Flows for the three months ended March 31, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_25">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_28">&#8211; Notes to Consolidated Condensed Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_28">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_85">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_85">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_85">19</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_94">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_94">Quantitative and Qualitative Disclosures About Market Risk&#160;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_94">25</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_97">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_97">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_97">25</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART II OTHER INFORMATION</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_103">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_103">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_103">25</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_109">Item 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_109">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_109">26</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_112">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_112">27</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i60ea575d4ae7456fa9ff06ec4f3488e0_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I&#160;FINANCIAL INFORMATION</span></div><div id="i60ea575d4ae7456fa9ff06ec4f3488e0_13"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.</span></div><div id="i60ea575d4ae7456fa9ff06ec4f3488e0_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONMED CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</span></div><div style="text-align:center;text-indent:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited, in thousands except per share amounts)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.259%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMy0xLTEtMS0w_1f9028fe-ff19-4c21-b052-2faf7667e2a2">232,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMy0zLTEtMS0w_08918b4b-d3fc-447b-b7d4-3c487e93d984">214,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfNS0xLTEtMS0w_527b43f8-fa9c-4af1-accd-214bd9654a19">104,228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfNS0zLTEtMS0w_0efad7e6-1d98-40d6-b4d5-09b27be8cbdc">94,851</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfNy0xLTEtMS0w_201eb49c-8eec-4856-87dd-7d63e0ef0035">128,449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfNy0zLTEtMS0w_acfbd39a-5fb8-430a-b233-7ab36519fc89">119,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfOS0xLTEtMS0w_396e71f3-994a-4507-98a5-69c065075e38">98,340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfOS0zLTEtMS0w_c6ef80c7-c91e-4ab6-9424-7654bace8814">95,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMTEtMS0xLTEtMA_0d54384c-a8bf-4fbd-8131-f0791a207f84">10,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMTEtMy0xLTEtMA_f3a6287b-35b5-4d39-8b60-780e8cd2d612">10,120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;   Operating expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMTMtMS0xLTEtMA_df91f349-53cf-481e-8291-9a817b56b944">108,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMTMtMy0xLTEtMA_3b877e2e-41c5-4155-9148-58fc5b190173">105,987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMTUtMS0xLTEtMA_eab0561b-f98d-4b09-b3ea-4428d55de910">20,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMTUtMy0xLTEtMA_1ad5344e-4e6d-4af8-8044-d0754fc6f0a8">13,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMTctMS0xLTEtMA_f352ff02-d347-4ebc-b122-0f2aa90bb84a">10,351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMTctMy0xLTEtMA_a8a41ab2-2dd6-4a32-a5d4-33e7b8eb07d8">9,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherNonoperatingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMTktMS0xLTEtMA_4970c99f-37b2-49ba-a540-7f73307aedf9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" name="us-gaap:OtherNonoperatingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMTktMy0xLTEtMA_0823f6e2-a85a-4de4-8709-af8eaa0448e3">89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMjEtMS0xLTEtMA_2f967235-4140-400c-9c76-e4832d29327b">9,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMjEtMy0xLTEtMA_cf5b8a3a-2bc8-485e-86f1-f1ee71ff7c86">3,491</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit from income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMjMtMS0xLTEtMA_2c7ef6b8-1216-45eb-a465-3803b546ba49">129</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMjMtMy0xLTEtMA_cdace072-fa47-41e0-b611-7b1a4e6654a7">2,436</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMjUtMS0xLTEtMA_531667d9-77cd-4d45-bdda-e77cd158e532">9,860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMjUtMy0xLTEtMA_98893cad-29f8-4137-8fd3-04cc836b7e51">5,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMjctMS0xLTEtMA_63a3b3cc-0600-4722-a0c3-c1f87d0a43bb">10,743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMjctMy0xLTEtMA_db90a39b-37e1-4653-a2d9-6a4c79953f7a">1,121</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Per share data:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMzMtMS0xLTEtMA_0ed89bf5-3567-47c8-b679-0b511fb97af3">0.34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMzMtMy0xLTEtMA_885470f5-180a-427a-a941-0fdfade38d8b">0.21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMzQtMS0xLTEtMA_4aec4ddc-dd57-45f3-b212-6c92389816de">0.31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMzQtMy0xLTEtMA_7c005e7d-0e4f-4726-9a74-1e8e3c9e9957">0.20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMzctMS0xLTEtMA_5d3b43fc-9775-4685-bc06-32fdcede2797">28,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMzctMy0xLTEtMA_08441aa9-8dcf-4d8f-9ee3-78bc03aeefc1">28,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMzgtMS0xLTEtMA_06695938-77eb-409b-99af-ebe309777927">31,378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMzgtMy0xLTEtMA_c7dfb1f3-1c19-4850-a621-c69704da79f3">29,707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;See notes to consolidated condensed financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i60ea575d4ae7456fa9ff06ec4f3488e0_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONMED CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED CONDENSED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited, in thousands except share and per share amounts)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMy0xLTEtMS0w_63f1bfce-4d53-49cd-af3d-898d0c946ef0">36,769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMy0zLTEtMS0w_f4d91063-bdd8-4e49-a6dd-f813ddcff3a8">27,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfNC0xLTEtMS0w_5426556c-3b1b-4cb9-bdb9-95df9a2a5c33">163,954</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfNC0zLTEtMS0w_f69e3df6-1ef8-43c5-883b-1b8df69e594f">177,152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfNS0xLTEtMS0w_a1ca8e74-b6f4-43e1-8047-6354719abffe">205,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfNS0zLTEtMS0w_6a6e6df9-2675-4d90-971a-a481aa5a7c93">194,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfNi0xLTEtMS0w_46818817-8438-4201-ad0b-1332f5e685db">17,849</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfNi0zLTEtMS0w_f9f27dd9-e11c-41c9-80eb-efa0547e7b88">17,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfNy0xLTEtMS0w_56883c1b-8ec2-48e1-be6d-60be85849a33">424,369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfNy0zLTEtMS0w_fbf93c65-eb30-4c1d-b9cf-71823c390574">416,654</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfOC0xLTEtMS0w_f62b1dab-b53c-4659-a325-d8de7c29854d">109,379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfOC0zLTEtMS0w_ff9dbb88-7796-47dc-b002-c63c321dd5e0">111,407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfOS0xLTEtMS0w_48ff962f-b4b4-42ae-9604-f913a653cd46">618,104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfOS0zLTEtMS0w_ad5acd04-e5d4-489c-8457-78fa119c2c6d">618,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMTAtMS0xLTEtMA_638ff893-eec2-45f4-811e-805baea991dc">493,905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMTAtMy0xLTEtMA_0a1851f8-f1ba-408c-a2d2-1728cfa3fc60">501,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMTEtMS0xLTEtMA_e1d0962c-017d-4a45-8732-eb4d27e6572f">100,855</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMTEtMy0xLTEtMA_41de55ad-e0e8-421d-ad5d-a14ad8f9cb25">103,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMTItMS0xLTEtMA_c74b4d53-bf6a-4858-a41d-11dd1474a292">1,746,612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMTItMy0xLTEtMA_7d2d3dce-be10-4f6b-b3e9-6f2209341470">1,751,673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND SHAREHOLDERS' EQUITY</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMTktMS0xLTEtMA_31b7d62a-d9e9-4018-babd-a464efed8adb">20,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMTktMy0xLTEtMA_f6910fa5-1bb7-4a66-909e-b1496f19deb2">18,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMjAtMS0xLTEtMA_ec8052a4-8b68-4ef7-9084-92d823d3c3da">55,780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMjAtMy0xLTEtMA_f4578e49-e035-4d29-900f-f92d68e6a0b1">53,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMjEtMS0xLTEtMA_c6612d23-b5ef-406c-a5d9-c9355599c9be">40,908</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMjEtMy0xLTEtMA_6523420f-dce3-4d6c-88e8-a960f891cfcd">50,171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMjItMS0xLTEtMA_9cb7d58b-89f0-4d7d-9c64-c967101ebc2d">65,391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMjItMy0xLTEtMA_341fc990-e252-49d9-98d2-5ef129dbf417">68,305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMjMtMS0xLTEtMA_327d81bb-4040-46de-9aeb-6597b761ffe8">182,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMjMtMy0xLTEtMA_d4762602-47b9-4011-b116-fafabb02db26">190,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMjUtMS0xLTEtMA_802b2bfd-c102-4b94-a769-e8b1df2abd43">725,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMjUtMy0xLTEtMA_500ddf7f-c938-4c81-92db-c7598b925491">735,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMjYtMS0xLTEtMA_819ad34a-f404-4d84-9302-96b3e765dc0b">56,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMjYtMy0xLTEtMA_9e536d12-8637-41fd-bacf-57a68006aac7">57,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMjctMS0xLTEtMA_259bee1d-a536-4745-8f55-d6f6d8f84fba">56,974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMjctMy0xLTEtMA_e318d582-82b8-4564-b4cd-d6ed117c2699">59,338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMjgtMS0xLTEtMA_2ca5b9e7-6f3b-403c-857d-af5015bddc31">1,021,042</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMjgtMy0xLTEtMA_22b683ef-f28d-4c6d-a58f-89e1924fbbf8">1,042,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzAtMS0xLTEtMA_455f556a-c679-4936-ad88-73216076a84a"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzAtMy0xLTEtMA_a09df9c4-307a-43be-a647-4d5389dc5aeb"></ix:nonFraction></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders' equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmE5M2RkZmZhYjEwNjRjODFiOWYxNDhmY2FiZjUxNDBkXzMx_5ac8beb5-e818-490b-80af-05dea52442b0"><ix:nonFraction unitRef="usdPerShare" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmE5M2RkZmZhYjEwNjRjODFiOWYxNDhmY2FiZjUxNDBkXzMx_9b9d731a-e755-4bef-9490-5af5183d9ea1">0.01</ix:nonFraction></ix:nonFraction> per share;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">authorized <ix:nonFraction unitRef="shares" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmYzNTcxODE0MmMzNDQ3OGM5MTdjNThhMzQ4MTFjNzg2XzE1_0fc341c2-44f7-431b-b2b6-03f2b322e801"><ix:nonFraction unitRef="shares" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmYzNTcxODE0MmMzNDQ3OGM5MTdjNThhMzQ4MTFjNzg2XzE1_b6b924f6-835a-42ed-ab27-d483e9ce3bf2">500,000</ix:nonFraction></ix:nonFraction> shares; <ix:nonFraction unitRef="shares" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmYzNTcxODE0MmMzNDQ3OGM5MTdjNThhMzQ4MTFjNzg2XzI2_0a6147cd-ef92-4f24-9f39-68bffddf9050"><ix:nonFraction unitRef="shares" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmYzNTcxODE0MmMzNDQ3OGM5MTdjNThhMzQ4MTFjNzg2XzI2_728cf6cc-ed73-444c-a0c8-af155ff95728">none</ix:nonFraction></ix:nonFraction> outstanding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzQtMS0xLTEtMA_82951dee-7e81-4f2f-8c1f-73def463a9d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzQtMy0xLTEtMA_7d61d0c8-8974-4764-8ac1-c12f8e708ced">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjFjNDNhYzczMDU1ZDRlYzM5MjQyNzAxMzU4NTRiYTQ4XzI4_4b455b76-c1c8-4e57-a2f3-f80790d596f9"><ix:nonFraction unitRef="usdPerShare" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjFjNDNhYzczMDU1ZDRlYzM5MjQyNzAxMzU4NTRiYTQ4XzI4_db6893bb-6e26-433b-93d4-584fadbb01ad">0.01</ix:nonFraction></ix:nonFraction> per share;</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjFjNDNhYzczMDU1ZDRlYzM5MjQyNzAxMzU4NTRiYTQ4XzQy_6a3e4577-13a2-43f3-9cbd-9630626c659d"><ix:nonFraction unitRef="shares" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjFjNDNhYzczMDU1ZDRlYzM5MjQyNzAxMzU4NTRiYTQ4XzQy_91608040-0d72-43d3-91d3-e440f3384b88">100,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjFjNDNhYzczMDU1ZDRlYzM5MjQyNzAxMzU4NTRiYTQ4XzY0_513eeb1f-f367-47af-92f2-9b3d71811e4d"><ix:nonFraction unitRef="shares" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjFjNDNhYzczMDU1ZDRlYzM5MjQyNzAxMzU4NTRiYTQ4XzY0_88240086-ecea-4785-9322-8ff61c5b199f">31,299,194</ix:nonFraction></ix:nonFraction> shares</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">issued in 2021 and 2020, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzUtMS0xLTEtMA_76273220-bc55-43f6-b709-fdc5627ebde9">313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzUtMy0xLTEtMA_1a56d710-caa5-4c89-a0e5-a4165bda91e2">313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzYtMS0xLTEtMA_718f9986-e631-4a79-a358-0e0ce80bedce">388,959</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzYtMy0xLTEtMA_90adca62-d635-4594-8e64-3bf88c1ce64f">382,628</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzctMS0xLTEtMA_7ebbc5eb-7c45-466b-bd2a-645de7ec8ad7">461,464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzctMy0xLTEtMA_7ab39a61-a00a-4042-8f48-c434cd0267b6">457,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzgtMS0xLTEtMA_954c7040-127d-4522-ab04-36ab557cc884">62,798</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzgtMy0xLTEtMA_a6615b53-65d2-4415-ad65-8d9e91b76d2c">63,681</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: <ix:nonFraction unitRef="shares" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzktMC0xLTEtMC90ZXh0cmVnaW9uOjdjZDY0NDU3Yjg1YjQ3M2I5YmRmNTIzMGY4MWI4MDk4XzEw_a6100a3c-706f-4f06-8f18-7537000304ac">2,222,233</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzktMC0xLTEtMC90ZXh0cmVnaW9uOjdjZDY0NDU3Yjg1YjQ3M2I5YmRmNTIzMGY4MWI4MDk4XzE3_0eea2ad4-0b6d-4472-8135-1f9f8f34cc28">2,410,045</ix:nonFraction> shares of common stock </span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">in treasury, at cost in 2021 and 2020, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzktMS0xLTEtMA_8f2eff83-e12b-4969-8d8c-4e5b41a17216">62,368</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzktMy0xLTEtMA_8bbf71b1-c26b-438e-9948-7246cc8f80cc">67,639</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfNDAtMS0xLTEtMA_328881ea-3793-4601-9be4-b4980928fa86">725,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfNDAtMy0xLTEtMA_53cbe7ab-17e8-47f0-b282-3ce9b09a1839">709,038</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfNDEtMS0xLTEtMA_b359e4a8-077f-4dd9-927b-b83e65b953c0">1,746,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfNDEtMy0xLTEtMA_d4a3f045-030d-47f7-97dd-2274f5755da4">1,751,673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;See notes to consolidated condensed financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i60ea575d4ae7456fa9ff06ec4f3488e0_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_7">Table of Contents</a></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONMED CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED CONDENSED STATEMENTS OF SHAREHOLDERS' EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited, in thousands except per share amounts)</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:35.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.046%"></td><td style="width:0.1%"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Paid-in<br/>Capital</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Treasury<br/>Stock</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Shareholders&#8217;<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iae012f3fcd9f41fd9bc6e05669f51454_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMi0xLTEtMS0w_922c66b2-ba19-439c-b4aa-fc3fa6df3533">31,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae012f3fcd9f41fd9bc6e05669f51454_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMi0yLTEtMS0w_347a464b-73e8-4251-864f-9198f536d9e4">313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8d0268193f046989c7a7367bc639b32_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMi0zLTEtMS0w_c633f2a3-f4ca-4bd2-aaf7-539e4154007e">382,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c15051984d44e6b5c9858e676ca33c_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMi00LTEtMS0w_d7539c50-715c-4c07-b56e-f69d380cb25f">457,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i151d90f96de242678881f597e8015d38_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMi01LTEtMS0w_c6600e42-d9b8-424a-9736-0176a639efec">63,681</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2905d9021abd4b9ea314e60814616d57_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMi02LTEtMS0w_ecb55ae8-7253-4450-ae4f-bde112e1d764">67,639</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMi03LTEtMS0w_483612c8-3a58-4cd1-b404-103de33b3eca">709,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Common stock issued under employee plans</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3676449ae5744b184ad5f60ae92544f_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMy0zLTEtMS0w_80df5b52-022c-4c7f-9a2b-b68afd9fc9f2">2,944</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie64010a164eb46af89de3193d71e8fba_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMy02LTEtMS0w_18981237-e3ed-4b5f-8ad2-b7dbf4caa16f">5,271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMy03LTEtMS0w_6d575a2c-1464-4a3c-8ae5-b38fc4f9a18e">8,215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3676449ae5744b184ad5f60ae92544f_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfNC0zLTEtMS0w_3948cd91-3d87-4d61-ad73-1b7bf1eca3c2">3,387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfNC03LTEtMS0w_9aa183d4-5ab7-4e60-bc35-4b9f6ec2fbef">3,387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Dividends on common stock ($<ix:nonFraction unitRef="usdPerShare" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfNS0wLTEtMS0wL3RleHRyZWdpb246MjVmM2RmNjk1ODc4NDJkOGFjMDQ0YmE2MjNmMzYyYzNfMzE_3872687a-beb6-48d6-b475-a441f5967129">0.20</ix:nonFraction> per share)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96387733ca074ff7b4010cdd9df409b6_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStockCash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfNS00LTEtMS0w_836344cf-ad38-496d-a17d-8842cde1a6f8">5,813</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStockCash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfNS03LTEtMS0w_49d62c1d-6ebf-4928-a324-ab2040d7523e">5,813</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Comprehensive income (loss):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Cash flow hedging gain, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if474f87feaa54dc0a8fcf5d08a768e3e_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMTAtNS0xLTEtMTYxOQ_4d4ea368-ef73-46ea-9815-76d5eb8337b6">3,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Pension liability, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if474f87feaa54dc0a8fcf5d08a768e3e_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMTAtNS0xLTEtMA_0257a9e9-a247-470d-8234-177cd02fda93">631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if474f87feaa54dc0a8fcf5d08a768e3e_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMTEtNS0xLTEtMA_e2aec636-c26a-4753-969b-593414afadeb">3,674</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96387733ca074ff7b4010cdd9df409b6_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMTMtNC0xLTEtMA_7e0035ac-59cf-401b-a04b-fb37a4cd5e5e">9,860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Total comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMTQtNy0xLTEtMA_fb35efe1-9844-41a0-845d-17eca7e6d295">10,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Balance at March&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id31031a486b14a38af8dea7f3155fcb8_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMTUtMS0xLTEtMA_b41c486e-2431-47be-9252-760b276472e6">31,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id31031a486b14a38af8dea7f3155fcb8_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMTUtMi0xLTEtMA_43e1494e-ecc9-46c2-b39d-3b3a4f0385c2">313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibac6966a355949378bb6c2fc42834ec1_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMTUtMy0xLTEtMA_d6d0a09f-a8fe-42ec-a075-e1cc32abaee1">388,959</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8f8f0e52b974b4e95f209ba842d8bb6_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMTUtNC0xLTEtMA_c013d483-2202-4e49-ad5c-a9fdb6f1b262">461,464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i029f793cce2d4474856e032865f1f946_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMTUtNS0xLTEtMA_6a394405-e5b8-4fbc-8ff6-af9f346a06bd">62,798</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33ed66e8daf34fa8b10ccb54d98510cf_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMTUtNi0xLTEtMA_94900616-b3b1-4acf-a5f6-13eac8da48da">62,368</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMTUtNy0xLTEtMA_8e963bc8-c219-4cea-b94f-a8821e855538">725,570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:35.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.046%"></td><td style="width:0.1%"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Paid-in<br/>Capital</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Treasury<br/>Stock</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Shareholders&#8217;<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5e2c39713f4b45bf83812220f02bcfce_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMi0xLTEtMS0w_bffdd09c-a6ae-4dbf-b6bb-2a60b627e64c">31,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e2c39713f4b45bf83812220f02bcfce_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMi0yLTEtMS0w_39608a8c-194a-4b81-9e60-125155e066ae">313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieebf93936a0b4946a4cebd127f100d98_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMi0zLTEtMS0w_2e71c061-2734-4163-ba67-d6a98e68de86">379,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b008cae44884d848870e03a18000ab9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMi00LTEtMS0w_d6c95a5b-b1d2-4e23-8154-2ec4becb7dc1">470,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6cb501558a20431db8401ff4a527404c_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMi01LTEtMS0w_72878d06-d3f1-4c64-8428-68054cdd4bb8">59,277</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba78700e77d54679bf93d6b9acf74fae_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMi02LTEtMS0w_38314b01-90b2-4279-9896-b5ed0aa76b2f">80,737</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e86d4601a4b4430ba15cc2ae32a9336_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMi03LTEtMS0w_355f0e58-88a9-412d-ab37-0eb781ee87a5">710,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Common stock issued under employee plans</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc2b6de697384224975fbf30994d9a87_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMy0zLTEtMS0w_cb8e3b77-aa45-4fe2-8e6e-b91217bf3bec">7,736</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72ed1085bea54a3ca02ccafd38fb3dca_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMy02LTEtMS0w_32996bb3-ccef-4133-a695-d8392ff9cd98">2,696</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMy03LTEtMS0w_f2a8bdd6-ba73-480d-8f45-20241535a423">5,040</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc2b6de697384224975fbf30994d9a87_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfNC0zLTEtMS0w_3ae4ffee-ea01-4455-aa2e-c5d47fb0e683">3,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfNC03LTEtMS0w_9ac8c79a-4187-462d-8b43-9c5dac83ea25">3,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Dividends on common stock ($<ix:nonFraction unitRef="usdPerShare" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfNS0wLTEtMS0wL3RleHRyZWdpb246YjcxMWMwZTVhNjE3NDBhMzkwYTdiOWFmOTQ0NDMxMDVfMzE_9d3b70c3-3546-41a4-92ba-cc25b02f112b">0.20</ix:nonFraction> per share)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i44890b61b4e54cd6a45ec9fe485dffab_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStockCash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfNS00LTEtMS0w_9e79e860-fb6b-46b8-b878-1501222f3e17">5,703</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStockCash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfNS03LTEtMS0w_24f28d54-9d26-4878-9df1-d252eb58903a">5,703</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Comprehensive income (loss):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Cash flow hedging gain, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95bc22c9cff4438ba21e7d9b6141399c_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfNy01LTEtMS0xNjM3_4dbcf823-04df-4a09-a2fd-59ede34301a3">2,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Pension liability, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95bc22c9cff4438ba21e7d9b6141399c_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfOC01LTEtMS0xNjQw_9018268d-ae97-4594-813b-ac50d643e926">535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95bc22c9cff4438ba21e7d9b6141399c_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMTAtNS0xLTEtMA_422c3c7a-c8b5-481f-aee7-5a24470ecc6e">9,988</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44890b61b4e54cd6a45ec9fe485dffab_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMTMtNC0xLTEtMA_9cdab457-8b06-42fe-9348-8983ba7b999c">5,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Total comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMTQtNy0xLTEtMA_41705093-ea5b-4ec9-8b4b-9bc9c6aada26">1,121</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Balance at March&#160;31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1cc29bb8dbaa42239d37e7bb08963171_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMTYtMS0xLTEtMA_f81b583e-2187-4243-beb1-281be7c0f9f3">31,299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cc29bb8dbaa42239d37e7bb08963171_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMTYtMi0xLTEtMA_47381749-24db-45a9-824f-74787675d9da">313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc96afc7d3fb40a98303297d7f214b0e_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMTYtMy0xLTEtMA_bad5c2c5-fba1-4d4e-a9a5-86770f6898af">374,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cef9bc34cee464192cc0b9012143d3f_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMTYtNC0xLTEtMA_f7917abb-8709-46df-b468-a8e9b973be7e">471,068</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ec34830172747ee92a710ad30795223_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMTYtNS0xLTEtMA_a49e542e-a304-4196-affa-7b45a9b442a1">66,325</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i120ee47c2d2c46e08a15d763a7767f75_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMTYtNi0xLTEtMA_ff4b42d7-73bb-4cd8-aa2d-8d1b479dcbd6">78,041</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c56f028fc084321a0e30cfeaea79a64_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMTYtNy0xLTEtMA_2cbfdeb8-7685-48bc-beac-c76c33a074a6">701,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to consolidated condensed financial statements.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i60ea575d4ae7456fa9ff06ec4f3488e0_25"></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONMED CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited, in thousands)</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:77.808%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.076%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.079%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNC0xLTEtMS0w_e61f8bf8-b4c1-498d-be31-539883fe6c98">9,860</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNC0zLTEtMS0w_618f0824-0fc3-413c-94a6-5e3e4aa1dd0d">5,927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNi0xLTEtMS0w_8fe6d92b-dcc4-43d9-a706-3663313d747c">4,757</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNi0zLTEtMS0w_9692ac0c-7b3e-408e-bcf4-9be196f3d884">4,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNy0xLTEtMS0w_df75bb64-92ff-4203-b85d-5ed9a637efe8">2,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNy0zLTEtMS0w_1a4e994c-3e9e-49ff-8fd0-075c3ef60199">2,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfOC0xLTEtMS0w_c2186d39-a4da-4ec4-8256-a2911ea6a61e">1,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfOC0zLTEtMS0w_43b09bc4-9073-44db-b954-bc17c9657def">819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAmortizationOfDeferredCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfOS0xLTEtMS0w_63719d48-f2ca-4e2d-88e5-fac151b71383">13,519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAmortizationOfDeferredCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfOS0zLTEtMS0w_b455ca26-834e-4a37-9d27-c9333a6de9a1">13,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMTAtMS0xLTEtMA_f6f360ad-1afd-4c3c-81a3-23dc5d6277b5">3,387</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMTAtMy0xLTEtMA_c144293a-a0d2-4348-902e-8f8be6a02f4e">3,032</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMTItMS0xLTEtMA_ebdb5ffd-a331-499b-81ec-32392d199dbf">2,688</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMTItMy0xLTEtMA_6042f334-c80e-4c08-bb55-bf4374b6c100">2,742</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) in cash flows from changes in assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMTUtMS0xLTEtMA_f1e36026-7bf7-49cb-8e2e-c13c0f2fd18e">11,957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMTUtMy0xLTEtMA_09fb31c0-42d6-4f4c-aa96-07ef251a70d7">19,057</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMTYtMS0xLTEtMA_e3a62e0d-7248-4755-ba81-76a424aa4e46">11,638</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMTYtMy0xLTEtMA_308c593b-4573-4093-b4c6-25e44ed5bc6b">12,313</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMTctMS0xLTEtMA_50844257-dbe8-4b51-8c62-7313c426d704">2,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMTctMy0xLTEtMA_37dc19b3-0f8c-4c6a-99af-f04f1aeaafb3">1,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMTgtMS0xLTEtMA_cbc596ce-f0b6-47ed-b9a9-20a42ee4c42f">8,955</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMTgtMy0xLTEtMA_5938e52f-3fba-4b4e-a7f2-a1cc595e2cd8">18,397</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMTktMS0xLTEtMA_1cb08e62-a697-4aa2-802c-a6e6870a842d">6,002</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMTktMy0xLTEtMA_ab7a630e-a9bc-4b54-8436-fccb72f81eb2">7,260</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMjAtMS0xLTEtMA_b980b22f-8f05-4997-8301-b1d435b10eda">1,782</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMjAtMy0xLTEtMA_86451596-8a43-4664-9f13-b0603ae3ee88">6,793</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMjItMS0xLTEtMA_9c4b667c-5fe7-427b-8470-8db26d27a9d7">22,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMjItMy0xLTEtMA_c2333a52-09a9-4f02-94f2-67c47c4e3de3">3,721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMjYtMS0xLTEtMA_aa0ad3e5-9fc9-4c3a-9d57-76ee874582a5">3,109</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMjYtMy0xLTEtMA_22d7ed1d-06ea-4c4e-8e44-4cc3fac169e0">2,825</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments related to business and asset acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="cnmd:Paymentsrelatedtobusinessacquisitionsandassetacquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMjctMS0xLTEtMA_a1bd0b0b-62ce-40e3-9443-5c257ffe652e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="cnmd:Paymentsrelatedtobusinessacquisitionsandassetacquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMjctMy0xLTEtMA_8e41ad81-4f28-4402-abda-ecfcd613e357">3,852</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMjgtMS0xLTEtMA_b68f4c0a-c791-4f2f-b58b-3cdee1eed681">3,109</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMjgtMy0xLTEtMA_05579990-47cc-4e69-8a79-212330703b3f">6,677</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments on term loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMzEtMS0xLTEtMA_92121dc5-a157-4f89-9308-fb6915030004">3,313</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMzEtMy0xLTEtMA_a557660f-71b1-4d2d-a559-ec6a6223f817">3,313</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments on revolving line of credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMzQtMS0xLTEtMA_94a72845-e399-49d8-97c4-e2558cb7b4aa">72,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMzQtMy0xLTEtMA_84eb4bd9-7395-4005-b8a7-12e356e4782b">41,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from revolving line of credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMzUtMS0xLTEtMA_e6287a5c-ba12-4489-8851-5b1c36c88c24">64,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMzUtMy0xLTEtMA_e95f7f0d-d7dd-4072-9aeb-ed81161ffaae">59,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments related to contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="cnmd:PaymentsForContingentConsideration" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMzctMS0xLTEtMA_c0e0a39d-9f0d-462d-a03f-7d2b0f667fc9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="cnmd:PaymentsForContingentConsideration" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMzctMy0xLTEtMA_f98b1198-2993-49c1-9868-1f11451a31fc">1,133</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid on common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDividendsCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMzktMS0xLTEtMA_eb291e8d-0bc0-4617-943a-13f0e176ba50">5,775</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDividendsCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMzktMy0xLTEtMA_dd840db3-cc7e-4d94-9524-c4a77567c878">5,683</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNDItMS0xLTEtMA_d38854de-a4bc-4b6d-a554-aa376454cfb4">8,216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNDItMy0xLTEtMA_98051a94-8537-49b3-ae05-108641e3b085">5,132</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNDMtMS0xLTEtMA_4672aa22-545e-4467-8fc1-584fc15598cf">8,872</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNDMtMy0xLTEtMA_9421a34b-db7c-4ddf-8128-70a649b83e0d">2,739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNDUtMS0xLTEtMA_a875f7fc-9ce9-464a-b6a3-897874d6f98e">950</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNDUtMy0xLTEtMA_a8729a41-6530-4d1e-baea-e541c9720db7">1,330</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNDctMS0xLTEtMA_636ad000-66a0-4a89-a811-92f99c32dcfd">9,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNDctMy0xLTEtMA_7cfce18d-c4ad-4edd-8cc4-d71856749ef6">1,547</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNDktMS0xLTEtMA_a8c65645-86f4-482d-a044-889185e67236">27,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e86d4601a4b4430ba15cc2ae32a9336_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNDktMy0xLTEtMA_305c503b-1e1b-45e0-9240-a366b5cbaaa3">25,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNTEtMS0xLTEtMA_1cead05f-f3c8-4587-8474-af3ba5bac8e2">36,769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c56f028fc084321a0e30cfeaea79a64_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNTEtMy0xLTEtMA_dee1aa4a-57d1-4d51-a0c4-a1d740b8adcf">24,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Dividends payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DividendsPayableCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNTQtMS0xLTEtMA_e5a021aa-ff79-4035-bf56-b8dff1e718ce">5,813</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c56f028fc084321a0e30cfeaea79a64_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DividendsPayableCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNTQtMy0xLTEtMA_5fe156ae-7764-4900-997d-fe70e33d6001">5,703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to consolidated condensed financial statements.</span></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i60ea575d4ae7456fa9ff06ec4f3488e0_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONMED CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited, in thousands except per share amounts)</span></div><div><span><br/></span></div><div id="i60ea575d4ae7456fa9ff06ec4f3488e0_31"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 1 &#8211; <ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8zMS9mcmFnOjMxMTFmZTMyY2VkYzRmNmI4YjJlNDJmMGNiODVjZTcwL3RleHRyZWdpb246MzExMWZlMzJjZWRjNGY2YjhiMmU0MmYwY2I4NWNlNzBfMzk2_f44ddd58-b5d3-419e-8565-86456c6de7e2" continuedAt="i43b60b8e18cb4500b9f359062b510e99" escape="true">Operations</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i43b60b8e18cb4500b9f359062b510e99">CONMED Corporation (&#8220;CONMED&#8221;, the &#8220;Company&#8221;, &#8220;we&#8221; or &#8220;us&#8221;) is a medical technology company that provides surgical devices and equipment for minimally invasive procedures.&#160;&#160;The Company&#8217;s products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology.</ix:continuation></span></div><div><span><br/></span></div><div id="i60ea575d4ae7456fa9ff06ec4f3488e0_34"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 2 - <ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8zNC9mcmFnOjM5MGQzNGRhNmU2MTQ2NjE4ZjkwN2U1YzdhZjFkZGE5L3RleHRyZWdpb246MzkwZDM0ZGE2ZTYxNDY2MThmOTA3ZTVjN2FmMWRkYTlfMjEzOQ_74d4ae1c-0d73-4063-9193-e4a1c7c543ec" continuedAt="i52f492abac8e4547872d7148dfa7db81" escape="true">Interim Financial Information</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i52f492abac8e4547872d7148dfa7db81"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited consolidated condensed financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for annual financial statements.  The information herein reflects all normal recurring material adjustments, which are, in the opinion of management, necessary to fairly present the results for the periods presented.  The consolidated condensed financial statements herein consist of all wholly-owned domestic and foreign subsidiaries with all significant intercompany transactions eliminated.  Results for the period ended March&#160;31, 2021 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2021.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated condensed financial statements and notes thereto should be read in conjunction with the consolidated financial statements and notes for the year ended December&#160;31, 2020 included in our Annual Report on Form 10-K.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8zNC9mcmFnOjM5MGQzNGRhNmU2MTQ2NjE4ZjkwN2U1YzdhZjFkZGE5L3RleHRyZWdpb246MzkwZDM0ZGE2ZTYxNDY2MThmOTA3ZTVjN2FmMWRkYTlfMjE0MQ_7c91d408-89e4-4afd-bef5-61bd7607be3c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preparation of the consolidated condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated condensed financial statements and the reported amounts of revenue and expenses during the reporting period.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the COVID-19 pandemic, there has been uncertainty and disruption in the global economy and financial markets. We are not aware of any specific event or circumstance that would require an update to our estimates or judgments or a revision of the carrying value of our assets or liabilities as of&#160;April&#160;29, 2021, the date of issuance of this Quarterly Report on Form 10-Q.  These estimates may change, as new events occur and additional information is obtained. Actual results could differ materially from these estimates under different assumptions or conditions.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i60ea575d4ae7456fa9ff06ec4f3488e0_40"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 3 - <ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RleHRyZWdpb246NWMzMDgwYmQ4M2RmNDU4ZWEwMjUxMjRiZTI0YjMxZjlfNTEz_4597fe73-8c69-49b1-97e6-24dab47afba6" continuedAt="i27a24b6abb3f407bbc2d021e0c6cbc2d" escape="true">Revenues</ix:nonNumeric></span></div><ix:continuation id="i27a24b6abb3f407bbc2d021e0c6cbc2d"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RleHRyZWdpb246NWMzMDgwYmQ4M2RmNDU4ZWEwMjUxMjRiZTI0YjMxZjlfNTE1_dd553447-a4c8-44ff-98d1-88178b8fb2fd" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present revenue disaggregated by primary geographic market where the products are sold, by product line and timing of revenue recognition: </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:33.458%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.316%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Orthopedic Surgery</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">General Surgery</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Orthopedic Surgery</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">General Surgery</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Primary Geographic Markets</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie62997345e524027a79ecf64d5ed0611_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNC0xLTEtMS0w_e0695ac9-d494-4888-b97f-2b1fed4545a3">37,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fd2671e438a474faa38d3e9a2c3f250_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNC0zLTEtMS0w_0bcad251-9bd7-47cf-923b-8eb01e3ab3ca">86,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4190bedf816e408ca9d02bfd966a3366_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNC01LTEtMS0w_b9d46602-3e8e-465d-b7ce-30faef35c20c">123,943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb19adcd1a5d48da93ca6e4fe100bba2_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNC03LTEtMS0w_3375d9fc-6454-44cc-be8d-069428f9e325">37,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i775199af495945bf86d1df93013e716d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNC05LTEtMS0w_a1d3d103-da52-46af-a5a2-5abc4f603c5f">81,808</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8caf0668d2a043b99300c2d015a59f5e_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNC0xMS0xLTEtMA_f17d902f-d8e1-4bd2-b013-941b3a1520b5">118,847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, Middle East &amp; Africa</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d5cbd26c2e34fcca879ebd88ed26bbc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNS0xLTEtMS0xNTkx_a7a0065d-130e-4f5c-bb2f-9fe72aaac79f">26,052</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c4dbcab20b64473a815fafab7bb519b_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNS0zLTEtMS0xNTkx_11b2d194-d98e-4b04-8775-253dad78bc5a">18,544</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacc6728071cc42afac66a950fd77c7ec_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNS01LTEtMS0xNTkx_40b020ba-3d08-4ec0-9b1f-b4b4536780cb">44,596</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id693351de21b454f9ad10a807a5dd52f_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNS03LTEtMS0xNTkx_3df5c877-6da5-426c-a6b0-6f314142c84a">25,907</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb2a8238876248f585425eb5051bb474_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNS05LTEtMS0xNTkx_93e7d693-0de4-452c-912c-b0d0ecc2be8a">16,615</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29730944e6d14730a59d95854830ef68_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNS0xMS0xLTEtMTU5MQ_be6f3b4b-554f-4015-90a8-fbeb2c86f671">42,522</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf13cfe5c8b4c3c98489e1e906361e1_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNS0xLTEtMS0w_4252253f-113d-4cd2-863f-0fefa39a2d06">26,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8985ce744656405e85a504c9d31badd8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNS0zLTEtMS0w_6afc4c87-bb8d-4064-b8c7-77de3c1cb23b">12,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbade5dec7f741f6a1a4d181a6fd7c0a_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNS01LTEtMS0w_49b3498a-447d-4fcc-b2cc-cb32132a0c3e">39,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe2d2ede0d054d3ea31d7f38ad84c165_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNS03LTEtMS0w_9397b88c-cc61-4f01-88c5-142f899d4c65">20,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4d5dfe5f1934d3982cae7661c4cf533_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNS05LTEtMS0w_487efac1-a1d9-46c1-88b1-bf33f131dc02">8,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4c14268949c4a94b1580a7aeb78ecbb_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNS0xMS0xLTEtMA_6cd5dc4b-752b-416e-998b-26fdf0b1ce1f">28,860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas (excluding the United States)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bbfa0455ef7435a9f76aa8e63565ef5_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNy0xLTEtMS0w_c8cc3de9-58e5-4533-b9c5-985477cc4f74">17,381</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68905b6fbdec4d4cb2932ea45ef02924_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNy0zLTEtMS0w_64da8ad0-fef2-49b8-9b6f-408b3f47b910">7,493</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb1d2f66658942c69084f7e2616e914f_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNy01LTEtMS0w_f836649a-ec47-4a24-8a6b-eb23eb727d11">24,874</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c75aafd2b4c449c95acdba707112745_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNy03LTEtMS0w_fb1053a2-fb7c-410e-8b59-cd8ca8f3f736">15,802</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76d7ef8d98cb4ff19a021ad02e67da31_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNy05LTEtMS0w_6bf50ca6-7020-400a-a88a-8eca558ea1cf">7,979</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cdefd0b0a3045d49ceeadee9e6bb36b_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNy0xMS0xLTEtMA_c530b156-1f2e-47df-b3d5-a5b39397dac2">23,781</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total sales from contracts with customers</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia86b4262c6984bb6ad658ce074db008e_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfOC0xLTEtMS0w_eda337a8-b8d1-4a1a-bbe2-df52684c8d3d">107,166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id802a374e8af403cb3d3822bd10d7c08_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfOC0zLTEtMS0w_1b597b1b-8bbb-49fa-ac71-059fffed260c">125,511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfOC01LTEtMS0w_96e19e1d-2546-4967-8161-d29370ca5949">232,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9557a8db05ee41ffaa88a992a0b82938_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfOC03LTEtMS0w_0e2c0c87-a6af-4a6a-bcb9-a914063fc4e8">99,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a7ac877916a4014a3fb26b999be79af_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfOC05LTEtMS0w_9bbe9e98-7907-43d4-8bc6-257f06066179">114,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfOC0xMS0xLTEtMA_1173c061-7ebe-4af5-838a-5806f935f280">214,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Timing of Revenue Recognition</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goods transferred at a point in time</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if94e1dc3dd564aaebe0c764b728d2713_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfMTEtMS0xLTEtMA_f55b75a3-7448-4df2-96ff-c5a9c1d0dfaa">97,690</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfadd8f8b84b4fdf903364c77b8920f3_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfMTEtMy0xLTEtMA_e7c2cc7b-b099-438a-b960-630067fd9068">124,394</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f20b36e15fb425494acd84a048f7177_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfMTEtNS0xLTEtMA_eac9e0db-d788-4875-a77d-2c8ed9b78eb8">222,084</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11161ef39ae1485b8d27a2ae4c22875d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfMTEtNy0xLTEtMA_544582d2-04e3-4334-bc09-1be310058ffb">90,553</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i782cd02ea1ba4cd78b680a524b6ca850_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfMTEtOS0xLTEtMA_2a7b348b-32d1-40b7-b87a-916c8a91872a">113,901</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a74e7f2ffa04fa0814e8231216941c4_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfMTEtMTEtMS0xLTA_eeb301bb-191e-4cd6-926c-9a281a60a53b">204,454</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services transferred over time</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib20f23593d444604b32c771d7959b0ca_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfMTItMS0xLTEtMA_77eb4287-b7cf-4f69-ae0e-b0a407b0326e">9,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d4311b6e8044c8894a8f3e8bba1645c_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfMTItMy0xLTEtMA_7586f0aa-85ee-4804-96f7-38f440cf89d0">1,117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e128db3c81e4e588034d3c0247dee80_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfMTItNS0xLTEtMA_adefd34c-6833-4454-93f8-1bcca9a0499e">10,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7057925e589d42faa6a4fb3ddf23bbd6_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfMTItNy0xLTEtMA_a4313292-f842-447d-9b9e-7fd13e80cc41">8,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if74b6b7e82ac4212bba27824114d47b4_D20200101-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfMTItOS0xLTEtMA_6253eef3-1dca-4ba8-90e2-7e00fd7ab27a">826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12d7e0dffb5e4869af8c81221b0c0a7f_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfMTItMTEtMS0xLTA_31a6912d-ead8-4a2b-9b68-ae03858f8d11">9,556</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total sales from contracts with customers</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia86b4262c6984bb6ad658ce074db008e_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfMTMtMS0xLTEtMA_b917d1b8-81dd-422f-af4f-fa17d0e43f40">107,166</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id802a374e8af403cb3d3822bd10d7c08_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfMTMtMy0xLTEtMA_d40c3cc2-9be1-49c6-b119-2b49775818c5">125,511</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfMTMtNS0xLTEtMA_419c81d4-b5c4-498d-b092-5cf2e5587ad2">232,677</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9557a8db05ee41ffaa88a992a0b82938_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfMTMtNy0xLTEtMA_4f329020-b9ae-48d9-b7fa-e6fe253ff19c">99,283</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a7ac877916a4014a3fb26b999be79af_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfMTMtOS0xLTEtMA_6d74c1e5-2dcd-4369-a2c6-75a8a44c1bdf">114,727</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfMTMtMTEtMS0xLTA_b36da887-54ae-40bb-8383-49eaeb572e71">214,010</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.209%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.581%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RleHRyZWdpb246NWMzMDgwYmQ4M2RmNDU4ZWEwMjUxMjRiZTI0YjMxZjlfNTIz_5fc2fec6-e35a-4c30-a8ea-4e8487eb5bd3" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liability balances related to the sale of extended warranties to customers are as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:58.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.401%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.826%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.403%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOjhmMTUyMmI1OGVkODQzMTg5ZDhhMDdjZjhmM2NmYzRkL3RhYmxlcmFuZ2U6OGYxNTIyYjU4ZWQ4NDMxODlkOGEwN2NmOGYzY2ZjNGRfMi0xLTEtMS0w_02e7eecb-2952-41dc-860b-86e88722b434">15,231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOjhmMTUyMmI1OGVkODQzMTg5ZDhhMDdjZjhmM2NmYzRkL3RhYmxlcmFuZ2U6OGYxNTIyYjU4ZWQ4NDMxODlkOGEwN2NmOGYzY2ZjNGRfMi0zLTEtMS0w_7d82a2cf-6c00-43da-a08d-7e5be3fa92d1">13,666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized during the three months ended March&#160;31, 2021 and March&#160;31, 2020 from amounts included in contract liabilities at the beginning of the period were $<ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RleHRyZWdpb246NWMzMDgwYmQ4M2RmNDU4ZWEwMjUxMjRiZTI0YjMxZjlfNDMw_986fe9e3-b20f-4d1a-8013-4b585de0c0b8">3.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RleHRyZWdpb246NWMzMDgwYmQ4M2RmNDU4ZWEwMjUxMjRiZTI0YjMxZjlfNDM3_3da55bbc-5f5b-4325-be67-fc49164a9543">3.0</ix:nonFraction> million, respectively.  There were no material contract assets as of March&#160;31, 2021 and December&#160;31, 2020.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i60ea575d4ae7456fa9ff06ec4f3488e0_43"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 4 &#8211; <ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RleHRyZWdpb246ZjhhOTI2NTdlY2MyNDJjOTk4ZGQ2ZmQwMTllN2U1MTRfNDgw_5d46a1a8-8a45-4ae5-97fd-d68dd5abd294" continuedAt="i727969bcc8d443f6ab4f851bffee3401" escape="true">Comprehensive Income (Loss)</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i727969bcc8d443f6ab4f851bffee3401"><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RleHRyZWdpb246ZjhhOTI2NTdlY2MyNDJjOTk4ZGQ2ZmQwMTllN2U1MTRfNDU3_1e5e6280-f17f-4b96-be1f-94f7965c5a08" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) consists of the following:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.113%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOmQ3NWQ0MzliM2I1NDQ0N2Q4MjllZjY4NGZhOTY1Zjk5L3RhYmxlcmFuZ2U6ZDc1ZDQzOWIzYjU0NDQ3ZDgyOWVmNjg0ZmE5NjVmOTlfMi0xLTEtMS0w_41305769-9f00-4fa4-9a6d-ca00cb8120f1">9,860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOmQ3NWQ0MzliM2I1NDQ0N2Q4MjllZjY4NGZhOTY1Zjk5L3RhYmxlcmFuZ2U6ZDc1ZDQzOWIzYjU0NDQ3ZDgyOWVmNjg0ZmE5NjVmOTlfMi0zLTEtMS0w_103d19d3-f2a5-46f0-a818-6517c155725d">5,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedging gain, net of income tax (income tax expense of $<ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOmQ3NWQ0MzliM2I1NDQ0N2Q4MjllZjY4NGZhOTY1Zjk5L3RhYmxlcmFuZ2U6ZDc1ZDQzOWIzYjU0NDQ3ZDgyOWVmNjg0ZmE5NjVmOTlfNS0wLTEtMS0xNjQ1L3RleHRyZWdpb246YmJhODNmYmE5YTMwNDRlNWFjNjAxNDdhMTMwZWYxZjRfODY_4a13dce7-a45a-439d-9166-52e15b74e6b6">1,250</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOmQ3NWQ0MzliM2I1NDQ0N2Q4MjllZjY4NGZhOTY1Zjk5L3RhYmxlcmFuZ2U6ZDc1ZDQzOWIzYjU0NDQ3ZDgyOWVmNjg0ZmE5NjVmOTlfNS0wLTEtMS0xNjQ1L3RleHRyZWdpb246YmJhODNmYmE5YTMwNDRlNWFjNjAxNDdhMTMwZWYxZjRfOTM_45dfcc09-5fc5-4bb6-8f83-97b4d87b77fc">766</ix:nonFraction> for the three months ended March 31, 2021 and 2020, respectively)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOmQ3NWQ0MzliM2I1NDQ0N2Q4MjllZjY4NGZhOTY1Zjk5L3RhYmxlcmFuZ2U6ZDc1ZDQzOWIzYjU0NDQ3ZDgyOWVmNjg0ZmE5NjVmOTlfNS0xLTEtMS0xNjQ1_126eb743-cae8-4e68-bfbd-912fe30d5428">3,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOmQ3NWQ0MzliM2I1NDQ0N2Q4MjllZjY4NGZhOTY1Zjk5L3RhYmxlcmFuZ2U6ZDc1ZDQzOWIzYjU0NDQ3ZDgyOWVmNjg0ZmE5NjVmOTlfNS0zLTEtMS0xNjQ1_ab05c4dc-5c8a-4f92-aedf-ff0c390aefa2">2,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension liability, net of income tax (income tax expense of $<ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOmQ3NWQ0MzliM2I1NDQ0N2Q4MjllZjY4NGZhOTY1Zjk5L3RhYmxlcmFuZ2U6ZDc1ZDQzOWIzYjU0NDQ3ZDgyOWVmNjg0ZmE5NjVmOTlfNi0wLTEtMS0wL3RleHRyZWdpb246MmY0MThiMTQ1Y2ZiNDU5NzlhNWJiNTY3MWVjZWNlM2JfNjQ_9cf8cd84-bf37-4dd7-a4e5-42baaa0eb316">201</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOmQ3NWQ0MzliM2I1NDQ0N2Q4MjllZjY4NGZhOTY1Zjk5L3RhYmxlcmFuZ2U6ZDc1ZDQzOWIzYjU0NDQ3ZDgyOWVmNjg0ZmE5NjVmOTlfNi0wLTEtMS0wL3RleHRyZWdpb246MmY0MThiMTQ1Y2ZiNDU5NzlhNWJiNTY3MWVjZWNlM2JfNzE_b950b559-2fca-4454-be35-66b125416b29">170</ix:nonFraction> for the three months ended March 31, 2021 and 2020, respectively)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOmQ3NWQ0MzliM2I1NDQ0N2Q4MjllZjY4NGZhOTY1Zjk5L3RhYmxlcmFuZ2U6ZDc1ZDQzOWIzYjU0NDQ3ZDgyOWVmNjg0ZmE5NjVmOTlfNi0xLTEtMS0w_330d2b2f-c3f3-45f2-be00-ece95168a8d2">631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOmQ3NWQ0MzliM2I1NDQ0N2Q4MjllZjY4NGZhOTY1Zjk5L3RhYmxlcmFuZ2U6ZDc1ZDQzOWIzYjU0NDQ3ZDgyOWVmNjg0ZmE5NjVmOTlfNi0zLTEtMS0w_0a60f6c3-083d-4c3a-bbc0-153c0b31e676">535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOmQ3NWQ0MzliM2I1NDQ0N2Q4MjllZjY4NGZhOTY1Zjk5L3RhYmxlcmFuZ2U6ZDc1ZDQzOWIzYjU0NDQ3ZDgyOWVmNjg0ZmE5NjVmOTlfOC0xLTEtMS0xNDk4_890e3f3b-367e-443e-9fea-0c8803ab5bc5"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOmQ3NWQ0MzliM2I1NDQ0N2Q4MjllZjY4NGZhOTY1Zjk5L3RhYmxlcmFuZ2U6ZDc1ZDQzOWIzYjU0NDQ3ZDgyOWVmNjg0ZmE5NjVmOTlfOC0xLTEtMS0xNDk4_e0e45703-df24-46b3-a7a7-8143a062db3c">3,674</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOmQ3NWQ0MzliM2I1NDQ0N2Q4MjllZjY4NGZhOTY1Zjk5L3RhYmxlcmFuZ2U6ZDc1ZDQzOWIzYjU0NDQ3ZDgyOWVmNjg0ZmE5NjVmOTlfOC0zLTEtMS0xNTA0_af205491-1d5e-4780-9fd3-85b63eeabb93">9,988</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOmQ3NWQ0MzliM2I1NDQ0N2Q4MjllZjY4NGZhOTY1Zjk5L3RhYmxlcmFuZ2U6ZDc1ZDQzOWIzYjU0NDQ3ZDgyOWVmNjg0ZmE5NjVmOTlfOS0xLTEtMS0w_9365023c-1d04-45af-b0be-65eea173e5b2">10,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOmQ3NWQ0MzliM2I1NDQ0N2Q4MjllZjY4NGZhOTY1Zjk5L3RhYmxlcmFuZ2U6ZDc1ZDQzOWIzYjU0NDQ3ZDgyOWVmNjg0ZmE5NjVmOTlfOS0zLTEtMS0w_969ed10b-3e4a-44b2-9f80-a7d62359a5d7">1,121</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RleHRyZWdpb246ZjhhOTI2NTdlY2MyNDJjOTk4ZGQ2ZmQwMTllN2U1MTRfNDUy_67f301d7-2294-47e3-9c68-a7bc784a1d97" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss consists of the following:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.526%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flow<br/>Hedging<br/>Gain (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension<br/>Liability</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cumulative<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01ec3e073702455c9e537fe9a5385abb_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfMS0xLTEtMS0w_c6bc204e-f383-4710-b358-7f7426d0ad29">5,945</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7ea3f8782943fcbc4ba9d0d76b3ec1_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfMS0zLTEtMS0w_5c155b28-50d5-4d36-bc06-ab6e876180cd">36,620</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1adb37865c4441248b72947844ddca28_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfMS01LTEtMS0w_75f842d2-a151-4941-b67b-ab2b66774cb6">21,116</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i151d90f96de242678881f597e8015d38_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfMS03LTEtMS0w_87a84f53-da1c-4886-9c27-ce3931c904ae">63,681</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d3af65fad6f44f0b3d057bbf55a6a78_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfMy0xLTEtMS0w_49b50a6c-0683-409a-ac9c-d842d7fd81de">2,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad15f0679e6b4c0d9ac7119db78f9c33_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfMy0zLTEtMS0w_9cd5a6c1-4456-4c12-b839-70ebb5772bf2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1dc7178d7a640169fb15973f1266566_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfMy01LTEtMS0w_1086cf77-672e-42c4-a67f-32f181a78aba">3,674</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if474f87feaa54dc0a8fcf5d08a768e3e_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfMy03LTEtMS0w_d4db72e5-7afb-43e8-aa54-38681ab728fa">949</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss) before tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">a</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d3af65fad6f44f0b3d057bbf55a6a78_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNC0xLTEtMS0w_e5da9a35-d40d-4807-a614-2a0192f2d59f">1,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad15f0679e6b4c0d9ac7119db78f9c33_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNC0zLTEtMS0w_e2eaf120-37e1-465c-b2ed-24e267ffb15d">832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1dc7178d7a640169fb15973f1266566_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNC01LTEtMS0w_1846a0b4-0c4b-442c-8e88-61f74f76dd73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if474f87feaa54dc0a8fcf5d08a768e3e_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNC03LTEtMS0w_7d609658-4f9f-4a30-a5c9-fcb8abb16924">2,416</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d3af65fad6f44f0b3d057bbf55a6a78_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNS0xLTEtMS0w_70cf523c-2a18-4116-879a-96bf775cf50b">383</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad15f0679e6b4c0d9ac7119db78f9c33_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNS0zLTEtMS0w_f16d15a2-982e-4678-94e0-380e2007b043">201</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1dc7178d7a640169fb15973f1266566_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNS01LTEtMS0w_0041e0de-12fd-486b-a42a-0ba79d882842">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if474f87feaa54dc0a8fcf5d08a768e3e_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNS03LTEtMS0w_e5bcbb4e-50a8-4b6f-8ff8-00d950e08250">584</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d3af65fad6f44f0b3d057bbf55a6a78_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNy0xLTEtMS0w_9bf094b1-fb34-4408-b295-358c28ef71b2">3,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad15f0679e6b4c0d9ac7119db78f9c33_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNy0zLTEtMS0w_b620c6de-a539-4c48-9a0a-ac72236be37f">631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1dc7178d7a640169fb15973f1266566_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNy01LTEtMS0w_faeea029-6e8a-4728-9649-b7a3d89526e5">3,674</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if474f87feaa54dc0a8fcf5d08a768e3e_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNy03LTEtMS0w_2394f9a0-2499-4ccb-aef6-ccc5218cce03">883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8245a6aa10f94c0bbcc41d1b62a19629_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfOS0xLTEtMS0w_98658507-75ae-498e-a019-8cd6790feed5">2,019</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c348cefc0004f5a84965d0ccc163ea3_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfOS0zLTEtMS0w_584b7976-4bdc-48ae-80bf-dec885660ae3">35,989</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07bd77a73b3545aa8a2104efd8e434fd_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfOS01LTEtMS0w_cdafc7f2-5024-4456-b136-2b159b391930">24,790</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i029f793cce2d4474856e032865f1f946_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfOS03LTEtMS0w_91dbe9c5-6643-49a4-b060-dfa60155192a">62,798</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.526%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flow<br/>Hedging<br/>Gain (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension<br/>Liability</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cumulative<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fab3fd5ae6d4130a6074da5f6e613ae_I20191231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfMS0xLTEtMS0w_63e10b35-1f66-4c80-ba8f-9f0eae28d856">493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide5c2d5254674b079e19ce03c1af6597_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfMS0zLTEtMS0w_07996af9-1d8a-4e20-9704-38cbd8c8167c">31,691</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3260d253c3314cdda5a4ade16ecbac96_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfMS01LTEtMS0w_8d100270-f494-464e-a35c-e900dcfd816c">28,079</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6cb501558a20431db8401ff4a527404c_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfMS03LTEtMS0w_d541b8ce-c129-4072-918e-96d6b569df25">59,277</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i539165515ff54031a19c7afae85ae40a_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfMy0xLTEtMS0w_76d137b2-77aa-4988-b814-5b350b8382c1">3,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib283f3bae1b7414e9448c28a5baa9aff_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfMy0zLTEtMS0w_72d1e703-cfea-495d-9ee9-ba6481cf6614">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2aa32ba1223944909a381ed581c46123_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfMy01LTEtMS0w_707e08d9-7dd7-482c-8c1a-1ab3bc2752bc">9,988</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95bc22c9cff4438ba21e7d9b6141399c_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfMy03LTEtMS0w_9e302967-624e-4d11-aab3-866ccceb3d2e">6,731</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss) before tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">a</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i539165515ff54031a19c7afae85ae40a_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNC0xLTEtMS0w_767c56ac-23ad-4d12-b20f-2d598b83b31f">1,124</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib283f3bae1b7414e9448c28a5baa9aff_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNC0zLTEtMS0w_605e62c1-18c1-4300-86b4-c5e62ec335ce">705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2aa32ba1223944909a381ed581c46123_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNC01LTEtMS0w_47619acf-92fc-44be-89a1-4a998a5d3dcf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95bc22c9cff4438ba21e7d9b6141399c_D20200101-20200331" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNC03LTEtMS0w_8a1edb82-783b-40f1-9075-643fba61b055">419</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i539165515ff54031a19c7afae85ae40a_D20200101-20200331" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNS0xLTEtMS0w_d5940b06-4aaa-461e-bc84-9f8a76abf7d8">272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib283f3bae1b7414e9448c28a5baa9aff_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNS0zLTEtMS0w_04f29630-9cd5-421a-8340-cabf287fa2db">170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2aa32ba1223944909a381ed581c46123_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNS01LTEtMS0w_8e0833cf-d8a7-4266-a981-c35239ea585d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95bc22c9cff4438ba21e7d9b6141399c_D20200101-20200331" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNS03LTEtMS0w_b1607e06-f358-44d7-b148-205e8bc91eda">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i539165515ff54031a19c7afae85ae40a_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNy0xLTEtMS0w_f57fb1e2-0af6-4fc9-91fd-f11a76557578">2,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib283f3bae1b7414e9448c28a5baa9aff_D20200101-20200331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNy0zLTEtMS0w_46e9e850-d9e0-4f7d-8a5a-b0a257e96956">535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2aa32ba1223944909a381ed581c46123_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNy01LTEtMS0w_dffb5009-f75f-4d5c-9595-24d5c0230630">9,988</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95bc22c9cff4438ba21e7d9b6141399c_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNy03LTEtMS0w_d90c380a-4d04-4bd9-9e04-6f239ac22832">7,048</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48e8d40f4b764e66a575ca1ee4752691_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfOS0xLTEtMS0w_8f3b785b-7a3a-41ef-a1ad-f13ae322d53a">2,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied165b7d8f6347aaa83ef46fd509ac16_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfOS0zLTEtMS0w_142a1119-d423-4084-b871-62ed5312f2c4">31,156</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib74665bfb6b541e48986d00dea4ca711_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfOS01LTEtMS0w_b6cc6856-ba54-45cb-a4a2-1d75862afb85">38,067</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ec34830172747ee92a710ad30795223_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfOS03LTEtMS0w_549725e2-e9d8-474d-9bb6-a93a78605d62">66,325</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)  <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RleHRyZWdpb246ZjhhOTI2NTdlY2MyNDJjOTk4ZGQ2ZmQwMTllN2U1MTRfNDg1_0cde947c-56e3-469d-922e-df5586b6f6bc" footnoteRole="http://www.xbrl.org/2003/role/footnote">The cash flow hedging gain (loss) and pension liability accumulated other comprehensive income (loss) components are included in sales or cost of sales and as a component of net periodic pension cost, respectively.  Refer to Note 5 and Note 11, respectively, for further details.</ix:footnote></span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i60ea575d4ae7456fa9ff06ec4f3488e0_46"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 5 &#8211; <ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="us-gaap:DerivativesAndFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RleHRyZWdpb246NzdiODQ5ODUwNmU1NGIyNDkzYzAxNTkwYjY3Nzk5ODVfNTYyNg_45be4c28-d24b-4153-9689-1a06f6b09c7b" continuedAt="id56fbf099a444cb283c143e075af9b62" escape="true">Fair Value of Financial Instruments</ix:nonNumeric></span></div><ix:continuation id="id56fbf099a444cb283c143e075af9b62" continuedAt="i5b0ec482f4424d0a9b181d2be77e91ad"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into derivative instruments for risk management purposes only.  We operate internationally and, in the normal course of business, are exposed to fluctuations in interest rates, foreign exchange rates and commodity prices.  These fluctuations can increase the costs of financing, investing and operating the business.  We use forward contracts, a type of derivative instrument, to manage certain foreign currency exposures.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By nature, all financial instruments involve market and credit risks.  We enter into forward contracts with major investment grade financial institutions and have policies to monitor the credit risk of those counterparties.  While there can be no assurance, we do not anticipate any material non-performance by any of these counterparties.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Forward Contracts.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hedge forecasted intercompany sales denominated in foreign currencies through the use of forward contracts.&#160;&#160;We account for these forward contracts as cash flow hedges.&#160;&#160;To the extent these forward contracts meet hedge accounting criteria, changes in their fair value are not included in current earnings but are included in accumulated other comprehensive loss.&#160;&#160;These changes in fair value will be recognized into earnings as a component of sales or cost of sales when the forecasted transaction occurs.&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also enter into forward contracts to exchange foreign currencies for United States dollars in order to hedge our currency transaction exposures on intercompany receivables designated in foreign currencies.&#160;&#160;These forward contracts settle each month at month-end, at which time we enter into new forward contracts.&#160;&#160;We have not designated these forward contracts as hedges and have not applied hedge accounting to them.&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RleHRyZWdpb246NzdiODQ5ODUwNmU1NGIyNDkzYzAxNTkwYjY3Nzk5ODVfNTYzNg_864732d6-0c29-4d94-ac99-5a6e6769cfec" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the notional contract amounts for forward contracts outstanding:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:38.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.401%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.401%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.403%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c2b490080b54ee293093cabd55cf92f_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFkOTVhNjdjOTU1MjQ2ZjFiM2FkMTA3ZTBhOGU3NTBmL3RhYmxlcmFuZ2U6YWQ5NWE2N2M5NTUyNDZmMWIzYWQxMDdlMGE4ZTc1MGZfMi0zLTEtMS0w_faed0d11-27d0-440e-8f99-75e0d1b426d0">164,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2efe3e302ba4492a9b14126b56757fe7_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFkOTVhNjdjOTU1MjQ2ZjFiM2FkMTA3ZTBhOGU3NTBmL3RhYmxlcmFuZ2U6YWQ5NWE2N2M5NTUyNDZmMWIzYWQxMDdlMGE4ZTc1MGZfMi01LTEtMS0w_076c49ab-a824-4ea4-b550-53932ca40e5f">154,504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf6b5979fbd34dcbae2c42f8e0d6aed2_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFkOTVhNjdjOTU1MjQ2ZjFiM2FkMTA3ZTBhOGU3NTBmL3RhYmxlcmFuZ2U6YWQ5NWE2N2M5NTUyNDZmMWIzYWQxMDdlMGE4ZTc1MGZfMy0zLTEtMS0w_da357639-61a9-45e7-a682-7fca38489ee1">45,545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacdfcde17fac4a0eb431ce68961ed713_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFkOTVhNjdjOTU1MjQ2ZjFiM2FkMTA3ZTBhOGU3NTBmL3RhYmxlcmFuZ2U6YWQ5NWE2N2M5NTUyNDZmMWIzYWQxMDdlMGE4ZTc1MGZfMy01LTEtMS0w_786e4830-d227-4149-8709-33bfdbc0ac31">42,380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining time to maturity as of March&#160;31, 2021 is within <ix:nonNumeric contextRef="ib1e08f06254d472fa74789af8e1cd878_D20210101-20210331" format="ixt-sec:durwordsen" name="us-gaap:MaximumLengthOfTimeHedgedInCashFlowHedge1" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RleHRyZWdpb246NzdiODQ5ODUwNmU1NGIyNDkzYzAxNTkwYjY3Nzk5ODVfMTk1Mw_0c1d9584-9898-4bb7-ac60-52c4223a4b25">two years</ix:nonNumeric> for hedge designated foreign exchange contracts and approximately <ix:nonNumeric contextRef="i99806f4ebd244f5e87a9fa07d01115f6_D20210101-20210331" format="ixt-sec:durwordsen" name="us-gaap:MaximumLengthOfTimeHedgedInCashFlowHedge1" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RleHRyZWdpb246NzdiODQ5ODUwNmU1NGIyNDkzYzAxNTkwYjY3Nzk5ODVfMjAyMg_06f51eac-3565-440e-ae21-d0919ed6d169">one month</ix:nonNumeric> for non-hedge designated forward exchange contracts.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_7">Table of Contents</a></span></div></div><ix:continuation id="i5b0ec482f4424d0a9b181d2be77e91ad" continuedAt="i0f10b3c15a614917a8e640797c45d1ac"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Statement of comprehensive income (loss) presentation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives designated as cash flow hedges</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RleHRyZWdpb246NzdiODQ5ODUwNmU1NGIyNDkzYzAxNTkwYjY3Nzk5ODVfNTY0Ng_c361de3e-1f48-41b5-a444-7c4c9b1a174b" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign exchange contracts designated as cash flow hedges had the following effects on accumulated other comprehensive income (loss) and net earnings on our consolidated condensed statements of comprehensive income (loss) and our consolidated condensed balance sheets:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:28.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.582%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in AOCI</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Condensed Statements  of Comprehensive Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Reclassified from AOCI</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="36" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Amount of Line Item Presented</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Instrument</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of amount reclassified</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfNS0yLTEtMS0w_c0e9918b-f94b-4a43-a286-25a2dd1e0e70">3,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfNS00LTEtMS0w_56d7f305-6294-469f-a0af-3e5c3bdb70e2">4,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfNS04LTEtMS0w_1f9028fe-ff19-4c21-b052-2faf7667e2a2">232,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfNS05LTEtMS0w_08918b4b-d3fc-447b-b7d4-3c487e93d984">214,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e47fc121f8545dbb0463f80ac04eab2_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfNS0xMS0xLTEtMA_31149520-be77-4ac4-a8ae-48f17f032095">1,849</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa13b87841fb46f9971920ec855139e0_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfNS0xMy0xLTEtMA_b2e1ddbc-1b30-4028-ac6b-41c242a08415">1,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of Sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfNi04LTEtMS0w_527b43f8-fa9c-4af1-accd-214bd9654a19">104,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfNi05LTEtMS0w_0efad7e6-1d98-40d6-b4d5-09b27be8cbdc">94,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4cfe412f15e40679fed8fb1ab50ff59_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfNi0xMS0xLTEtMA_13fdf3c4-8817-447c-8c77-7eb6200cb519">265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if891372cb88f49d1ad8cf68161f49100_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfNi0xMy0xLTEtMA_48659db7-bf24-4bf2-899f-e540780790ec">77</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax gain (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfNy0yLTEtMS0w_01724a77-822b-454c-9f82-c392458d75d5">3,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfNy00LTEtMS0w_b7eec16b-12d8-4e8d-81e6-6cb2276be004">4,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfNy0xMS0xLTEtMA_54b66bef-78b2-4fbf-b82b-f4b7b93e3792">1,584</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfNy0xMy0xLTEtMA_fb396c0a-07ca-4ac4-a985-12c31536ade7">1,124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax expense (benefit)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfOC0yLTEtMS0w_fd25959c-af3e-48b1-8825-2b4118c8dec5">868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfOC00LTEtMS0w_a8761297-f222-4f3e-9423-af2271c1ff36">1,038</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfOC0xMS0xLTEtMA_3d1a59ad-ec95-45b7-8c6a-ee4a0b8a5fce">383</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfOC0xMy0xLTEtMA_4f3acd5d-e593-41ea-b12f-704959c0b765">272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfOS0yLTEtMS0w_21a98419-e793-404a-80e0-91c417a47c5f">2,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfOS00LTEtMS0w_31d1ccd9-1946-4292-82fd-32d111c93e60">3,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfOS0xMS0xLTEtMA_823fac13-0436-4c2a-85a6-a30cf1326020">1,201</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfOS0xMy0xLTEtMA_064fede4-cefe-44f7-bcc3-277d61eea219">852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:28.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.582%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2021, $<ix:nonFraction unitRef="usd" contextRef="i6c2b490080b54ee293093cabd55cf92f_I20210331" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RleHRyZWdpb246NzdiODQ5ODUwNmU1NGIyNDkzYzAxNTkwYjY3Nzk5ODVfMjQ2Mw_26493120-8272-40a1-9b18-e5f063542ee3">2.3</ix:nonFraction> million of net unrealized losses on forward contracts accounted for as cash flow hedges, and included in accumulated other comprehensive loss, are expected to be recognized in earnings in the next twelve months.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives not designated as cash flow hedges</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RleHRyZWdpb246NzdiODQ5ODUwNmU1NGIyNDkzYzAxNTkwYjY3Nzk5ODVfNTYyNw_66327c90-228f-4120-90ba-c681e5872611" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains and losses from derivative instruments not accounted for as hedges and gains and losses on our intercompany receivables on our consolidated condensed statements of comprehensive income (loss) were:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.145%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.091%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Instrument</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Condensed Statements of Comprehensive Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id18f74481683457cb6b00dae1d5691a4_D20210101-20210331" decimals="-3" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRjYTY5ZGM2Yzc4MzQ0YzZhNGRhZDI5N2M4NTcyYTU0L3RhYmxlcmFuZ2U6ZGNhNjlkYzZjNzgzNDRjNmE0ZGFkMjk3Yzg1NzJhNTRfMy00LTEtMS0w_3dbb85f4-9426-4b98-a5e9-73b28bee3a2b">458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6331111f415a4d5ea9e8cd727632eeee_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRjYTY5ZGM2Yzc4MzQ0YzZhNGRhZDI5N2M4NTcyYTU0L3RhYmxlcmFuZ2U6ZGNhNjlkYzZjNzgzNDRjNmE0ZGFkMjk3Yzg1NzJhNTRfMy02LTEtMS0w_11580119-78c0-4acc-8815-df041ef65d58">245</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss on currency transaction exposures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRjYTY5ZGM2Yzc4MzQ0YzZhNGRhZDI5N2M4NTcyYTU0L3RhYmxlcmFuZ2U6ZGNhNjlkYzZjNzgzNDRjNmE0ZGFkMjk3Yzg1NzJhNTRfNC00LTEtMS0w_7271f7d8-9544-48ad-9c42-dcc5112c7587">1,123</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRjYTY5ZGM2Yzc4MzQ0YzZhNGRhZDI5N2M4NTcyYTU0L3RhYmxlcmFuZ2U6ZGNhNjlkYzZjNzgzNDRjNmE0ZGFkMjk3Yzg1NzJhNTRfNC02LTEtMS0w_e36a90a6-6a86-4489-b42e-5be025a17c18">191</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_7">Table of Contents</a></span></div></div><ix:continuation id="i0f10b3c15a614917a8e640797c45d1ac" continuedAt="i27401ee178104010a8e81c8d3ee6f2c4"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Balance sheet presentation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record these forward foreign exchange contracts at fair value.  <ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RleHRyZWdpb246NzdiODQ5ODUwNmU1NGIyNDkzYzAxNTkwYjY3Nzk5ODVfNTYxOA_91ff426f-deb0-4f82-af6e-9aac55ecd7c7" continuedAt="i78c19bd7f04e471f9781f945bc71c640" escape="true">The following tables summarize the fair value for forward foreign exchange contracts outstanding at March&#160;31, 2021 and December&#160;31, 2020: </ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:continuation id="i78c19bd7f04e471f9781f945bc71c640"><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:33.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.033%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.399%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.944%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.944%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.950%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Condensed Balance Sheet</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net<br/>Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedged instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35307b95062445a3a39801d79634cee9_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFmMTZhYmY0ZmQ4MjQxYmJhYThhODgyNDVhMmM1MWU2L3RhYmxlcmFuZ2U6YWYxNmFiZjRmZDgyNDFiYmFhOGE4ODI0NWEyYzUxZTZfMi0yLTEtMS0w_b9380026-ed18-4712-84e1-7c36e74a797e">1,557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35307b95062445a3a39801d79634cee9_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFmMTZhYmY0ZmQ4MjQxYmJhYThhODgyNDVhMmM1MWU2L3RhYmxlcmFuZ2U6YWYxNmFiZjRmZDgyNDFiYmFhOGE4ODI0NWEyYzUxZTZfMi00LTEtMS0w_6ec362ee-5f72-42e9-a9ff-017ced7cd5a2">4,592</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35307b95062445a3a39801d79634cee9_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFmMTZhYmY0ZmQ4MjQxYmJhYThhODgyNDVhMmM1MWU2L3RhYmxlcmFuZ2U6YWYxNmFiZjRmZDgyNDFiYmFhOGE4ODI0NWEyYzUxZTZfMi02LTEtMS0w_238c9484-27d8-4907-8cdf-e0be7f9e41d2">3,035</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d3efa96f76c423a828baa29d94dcb15_I20210331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFmMTZhYmY0ZmQ4MjQxYmJhYThhODgyNDVhMmM1MWU2L3RhYmxlcmFuZ2U6YWYxNmFiZjRmZDgyNDFiYmFhOGE4ODI0NWEyYzUxZTZfMy0yLTEtMS0w_82cd3118-044d-475e-ae44-2dc84e29a142">709</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d3efa96f76c423a828baa29d94dcb15_I20210331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFmMTZhYmY0ZmQ4MjQxYmJhYThhODgyNDVhMmM1MWU2L3RhYmxlcmFuZ2U6YWYxNmFiZjRmZDgyNDFiYmFhOGE4ODI0NWEyYzUxZTZfMy00LTEtMS0w_06aa2881-795d-4b1d-8eae-16e4e27a66a1">337</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d3efa96f76c423a828baa29d94dcb15_I20210331" decimals="-3" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFmMTZhYmY0ZmQ4MjQxYmJhYThhODgyNDVhMmM1MWU2L3RhYmxlcmFuZ2U6YWYxNmFiZjRmZDgyNDFiYmFhOGE4ODI0NWEyYzUxZTZfMy02LTEtMS0w_6c855029-4d90-40d7-b1b8-5c64a15534a4">372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67d105aa68f347b8a414ade6ce5542bc_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFmMTZhYmY0ZmQ4MjQxYmJhYThhODgyNDVhMmM1MWU2L3RhYmxlcmFuZ2U6YWYxNmFiZjRmZDgyNDFiYmFhOGE4ODI0NWEyYzUxZTZfNC0yLTEtMS0w_9dacdb0b-4b34-41c9-9e0b-d44d1ec9d3e6">2,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67d105aa68f347b8a414ade6ce5542bc_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFmMTZhYmY0ZmQ4MjQxYmJhYThhODgyNDVhMmM1MWU2L3RhYmxlcmFuZ2U6YWYxNmFiZjRmZDgyNDFiYmFhOGE4ODI0NWEyYzUxZTZfNC00LTEtMS0w_bd7251db-edfc-49b5-983f-269d7deade8a">4,929</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67d105aa68f347b8a414ade6ce5542bc_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFmMTZhYmY0ZmQ4MjQxYmJhYThhODgyNDVhMmM1MWU2L3RhYmxlcmFuZ2U6YWYxNmFiZjRmZDgyNDFiYmFhOGE4ODI0NWEyYzUxZTZfNC02LTEtMS0w_7bbf3ebc-e40e-4b23-83c6-169a3e0ef7f0">2,663</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic235813d62984ee3b72d058a569b0a54_I20210331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFmMTZhYmY0ZmQ4MjQxYmJhYThhODgyNDVhMmM1MWU2L3RhYmxlcmFuZ2U6YWYxNmFiZjRmZDgyNDFiYmFhOGE4ODI0NWEyYzUxZTZfNy0yLTEtMS0w_902b792b-92c3-4500-a824-4c8651861ca0">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic235813d62984ee3b72d058a569b0a54_I20210331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFmMTZhYmY0ZmQ4MjQxYmJhYThhODgyNDVhMmM1MWU2L3RhYmxlcmFuZ2U6YWYxNmFiZjRmZDgyNDFiYmFhOGE4ODI0NWEyYzUxZTZfNy00LTEtMS0w_3bc8ed0e-1539-4b8a-b7e6-88d692e8261c">179</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic235813d62984ee3b72d058a569b0a54_I20210331" decimals="-3" sign="-" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFmMTZhYmY0ZmQ4MjQxYmJhYThhODgyNDVhMmM1MWU2L3RhYmxlcmFuZ2U6YWYxNmFiZjRmZDgyNDFiYmFhOGE4ODI0NWEyYzUxZTZfNy02LTEtMS0w_1ccb5444-40e7-49da-a745-9057afad2a17">171</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFmMTZhYmY0ZmQ4MjQxYmJhYThhODgyNDVhMmM1MWU2L3RhYmxlcmFuZ2U6YWYxNmFiZjRmZDgyNDFiYmFhOGE4ODI0NWEyYzUxZTZfOS0yLTEtMS0w_c3b2a859-0e7c-4207-80f5-fd5b5029d33f">2,274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFmMTZhYmY0ZmQ4MjQxYmJhYThhODgyNDVhMmM1MWU2L3RhYmxlcmFuZ2U6YWYxNmFiZjRmZDgyNDFiYmFhOGE4ODI0NWEyYzUxZTZfOS00LTEtMS0w_ad4afa43-7cd0-4412-b1aa-6cc6754bbf64">5,108</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFmMTZhYmY0ZmQ4MjQxYmJhYThhODgyNDVhMmM1MWU2L3RhYmxlcmFuZ2U6YWYxNmFiZjRmZDgyNDFiYmFhOGE4ODI0NWEyYzUxZTZfOS02LTEtMS0w_0d03f739-e660-47c4-9bff-6f5415392de0">2,834</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:33.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.033%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.399%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.944%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.944%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.950%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Condensed Balance Sheet</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net<br/>Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedged instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9abfdfe4a61a4a60ab8b291e94a8244d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRkZjkzYjNmNGI1MTQ2ZTY5MmI4MzNhY2I5Y2UwYjg0L3RhYmxlcmFuZ2U6ZGRmOTNiM2Y0YjUxNDZlNjkyYjgzM2FjYjljZTBiODRfMi0yLTEtMS0w_c247d310-0e4e-423c-bbde-87f39a47416c">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9abfdfe4a61a4a60ab8b291e94a8244d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRkZjkzYjNmNGI1MTQ2ZTY5MmI4MzNhY2I5Y2UwYjg0L3RhYmxlcmFuZ2U6ZGRmOTNiM2Y0YjUxNDZlNjkyYjgzM2FjYjljZTBiODRfMi00LTEtMS0w_4a6c6697-7f21-4a09-855f-eacc663eec71">8,826</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9abfdfe4a61a4a60ab8b291e94a8244d_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRkZjkzYjNmNGI1MTQ2ZTY5MmI4MzNhY2I5Y2UwYjg0L3RhYmxlcmFuZ2U6ZGRmOTNiM2Y0YjUxNDZlNjkyYjgzM2FjYjljZTBiODRfMi02LTEtMS0w_16b418d5-976a-430a-a81b-92afc4fa1f91">7,326</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a133038947642198d9059759b25062b_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRkZjkzYjNmNGI1MTQ2ZTY5MmI4MzNhY2I5Y2UwYjg0L3RhYmxlcmFuZ2U6ZGRmOTNiM2Y0YjUxNDZlNjkyYjgzM2FjYjljZTBiODRfMy0yLTEtMS0w_6fc4692c-6c4d-41b8-90ea-1136a5ec9bf6">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a133038947642198d9059759b25062b_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRkZjkzYjNmNGI1MTQ2ZTY5MmI4MzNhY2I5Y2UwYjg0L3RhYmxlcmFuZ2U6ZGRmOTNiM2Y0YjUxNDZlNjkyYjgzM2FjYjljZTBiODRfMy00LTEtMS0w_f2ad0753-e1dd-4ed7-9930-538c2648016e">535</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a133038947642198d9059759b25062b_I20201231" decimals="-3" sign="-" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRkZjkzYjNmNGI1MTQ2ZTY5MmI4MzNhY2I5Y2UwYjg0L3RhYmxlcmFuZ2U6ZGRmOTNiM2Y0YjUxNDZlNjkyYjgzM2FjYjljZTBiODRfMy02LTEtMS0w_91f57abd-d41b-4008-901b-4b61c99887a4">512</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd85c1ac785d48edbf3dd0030c518099_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRkZjkzYjNmNGI1MTQ2ZTY5MmI4MzNhY2I5Y2UwYjg0L3RhYmxlcmFuZ2U6ZGRmOTNiM2Y0YjUxNDZlNjkyYjgzM2FjYjljZTBiODRfNC0yLTEtMS0w_29f441fe-c1c9-49be-ae77-55581c9f9181">1,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd85c1ac785d48edbf3dd0030c518099_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRkZjkzYjNmNGI1MTQ2ZTY5MmI4MzNhY2I5Y2UwYjg0L3RhYmxlcmFuZ2U6ZGRmOTNiM2Y0YjUxNDZlNjkyYjgzM2FjYjljZTBiODRfNC00LTEtMS0w_f7adb3dd-3155-450a-8ab0-fcf2a70833ce">9,361</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd85c1ac785d48edbf3dd0030c518099_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRkZjkzYjNmNGI1MTQ2ZTY5MmI4MzNhY2I5Y2UwYjg0L3RhYmxlcmFuZ2U6ZGRmOTNiM2Y0YjUxNDZlNjkyYjgzM2FjYjljZTBiODRfNC02LTEtMS0w_16bae2e5-9fc2-41d7-bc56-cff3a6619db2">7,838</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic248ae873ff841ffbe0200170d941d8d_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRkZjkzYjNmNGI1MTQ2ZTY5MmI4MzNhY2I5Y2UwYjg0L3RhYmxlcmFuZ2U6ZGRmOTNiM2Y0YjUxNDZlNjkyYjgzM2FjYjljZTBiODRfNy0yLTEtMS0w_879bbac2-1c01-4cad-85a8-dc1f20647503">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic248ae873ff841ffbe0200170d941d8d_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRkZjkzYjNmNGI1MTQ2ZTY5MmI4MzNhY2I5Y2UwYjg0L3RhYmxlcmFuZ2U6ZGRmOTNiM2Y0YjUxNDZlNjkyYjgzM2FjYjljZTBiODRfNy00LTEtMS0w_7ac8280d-492e-4406-9fde-0dd4019ec7dd">150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic248ae873ff841ffbe0200170d941d8d_I20201231" decimals="-3" sign="-" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRkZjkzYjNmNGI1MTQ2ZTY5MmI4MzNhY2I5Y2UwYjg0L3RhYmxlcmFuZ2U6ZGRmOTNiM2Y0YjUxNDZlNjkyYjgzM2FjYjljZTBiODRfNy02LTEtMS0w_d37346dc-1631-46a3-a2bd-5d454966121f">125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRkZjkzYjNmNGI1MTQ2ZTY5MmI4MzNhY2I5Y2UwYjg0L3RhYmxlcmFuZ2U6ZGRmOTNiM2Y0YjUxNDZlNjkyYjgzM2FjYjljZTBiODRfOS0yLTEtMS0w_68690ae8-e045-4026-b9cc-8003d7c18575">1,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRkZjkzYjNmNGI1MTQ2ZTY5MmI4MzNhY2I5Y2UwYjg0L3RhYmxlcmFuZ2U6ZGRmOTNiM2Y0YjUxNDZlNjkyYjgzM2FjYjljZTBiODRfOS00LTEtMS0w_183dd3e9-36b8-418a-9c05-00496ff7684b">9,511</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRkZjkzYjNmNGI1MTQ2ZTY5MmI4MzNhY2I5Y2UwYjg0L3RhYmxlcmFuZ2U6ZGRmOTNiM2Y0YjUxNDZlNjkyYjgzM2FjYjljZTBiODRfOS02LTEtMS0w_6fb472a0-7f92-4602-8611-eb41513e5f34">7,963</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our forward foreign exchange contracts are subject to a master netting agreement and qualify for netting in the consolidated condensed balance sheets. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Disclosure.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  FASB guidance defines fair value and establishes a framework for measuring fair value and related disclosure requirements.  This guidance applies when fair value measurements are required or permitted.  The guidance indicates, among other things, that a fair value measurement assumes that the transaction to sell an asset or transfer a liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market for the asset or liability.  Fair value is defined based upon an exit price model.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Valuation Hierarchy. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A valuation hierarchy was established for disclosure of the inputs to the valuations used to measure fair value.  This hierarchy prioritizes the inputs into three broad levels as follows.  Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities.  Level 2 inputs are quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in markets that are not active, inputs other than quoted prices that are observable for the asset or liability, including interest rates, yield curves and credit risks, or inputs that are derived principally from or corroborated by observable market data through correlation.  Level 3 inputs are unobservable inputs based on our own assumptions used to measure assets and liabilities at fair value.  A financial asset or liability&#8217;s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement.  There have been no significant changes in the assumptions.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_7">Table of Contents</a></span></div></div><ix:continuation id="i27401ee178104010a8e81c8d3ee6f2c4" continuedAt="i8e09e9b757c646a59ca9d6006a71e749"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Valuation Techniques. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Assets and liabilities carried at fair value and measured on a recurring basis as of March&#160;31, 2021 consist of forward foreign exchange contracts.  The Company values its forward foreign exchange contracts using quoted prices for similar assets.  The most significant assumption is quoted currency rates.  The value of the forward foreign exchange contract assets and liabilities were valued using Level 2 inputs and are listed in the table above.&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8e09e9b757c646a59ca9d6006a71e749">The carrying amounts reported in our consolidated condensed balance sheets for cash and cash equivalents, accounts receivable, accounts payable and long-term debt approximate fair value.</ix:continuation>&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div id="i60ea575d4ae7456fa9ff06ec4f3488e0_49"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 6 - <ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80OS9mcmFnOjNiNjdjMzBhZTFiNzQ2M2I4YjhjYzg2YTVjODMwYWIzL3RleHRyZWdpb246M2I2N2MzMGFlMWI3NDYzYjhiOGNjODZhNWM4MzBhYjNfODM_7cfb338c-d23e-45be-bf6f-998cf057ec50" continuedAt="i3b9aa391cd73405088b4be63498dbb10" escape="true">Inventories</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i3b9aa391cd73405088b4be63498dbb10"><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80OS9mcmFnOjNiNjdjMzBhZTFiNzQ2M2I4YjhjYzg2YTVjODMwYWIzL3RleHRyZWdpb246M2I2N2MzMGFlMWI3NDYzYjhiOGNjODZhNWM4MzBhYjNfODc_73c8fa25-b907-49f5-9cdd-e575fd2f77c5" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of the following:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.225%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80OS9mcmFnOjNiNjdjMzBhZTFiNzQ2M2I4YjhjYzg2YTVjODMwYWIzL3RhYmxlOmFjMDIxMTBlMWMwOTQzOThiMDk0MzVmYTJjYjJkMDgxL3RhYmxlcmFuZ2U6YWMwMjExMGUxYzA5NDM5OGIwOTQzNWZhMmNiMmQwODFfMS0xLTEtMS0w_05ee549a-a015-4038-a237-2bd3cf1e1081">73,654</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80OS9mcmFnOjNiNjdjMzBhZTFiNzQ2M2I4YjhjYzg2YTVjODMwYWIzL3RhYmxlOmFjMDIxMTBlMWMwOTQzOThiMDk0MzVmYTJjYjJkMDgxL3RhYmxlcmFuZ2U6YWMwMjExMGUxYzA5NDM5OGIwOTQzNWZhMmNiMmQwODFfMS0zLTEtMS0w_e9d5a8be-b64b-47a6-9474-f299f939c7b1">71,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80OS9mcmFnOjNiNjdjMzBhZTFiNzQ2M2I4YjhjYzg2YTVjODMwYWIzL3RhYmxlOmFjMDIxMTBlMWMwOTQzOThiMDk0MzVmYTJjYjJkMDgxL3RhYmxlcmFuZ2U6YWMwMjExMGUxYzA5NDM5OGIwOTQzNWZhMmNiMmQwODFfMi0xLTEtMS0w_df677fcd-4996-4a0c-bb68-ac7c15570636">18,429</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80OS9mcmFnOjNiNjdjMzBhZTFiNzQ2M2I4YjhjYzg2YTVjODMwYWIzL3RhYmxlOmFjMDIxMTBlMWMwOTQzOThiMDk0MzVmYTJjYjJkMDgxL3RhYmxlcmFuZ2U6YWMwMjExMGUxYzA5NDM5OGIwOTQzNWZhMmNiMmQwODFfMi0zLTEtMS0w_72e88d8b-821d-4ae1-b282-ac9cc785547a">15,864</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80OS9mcmFnOjNiNjdjMzBhZTFiNzQ2M2I4YjhjYzg2YTVjODMwYWIzL3RhYmxlOmFjMDIxMTBlMWMwOTQzOThiMDk0MzVmYTJjYjJkMDgxL3RhYmxlcmFuZ2U6YWMwMjExMGUxYzA5NDM5OGIwOTQzNWZhMmNiMmQwODFfMy0xLTEtMS0w_ca6c9543-f16f-4645-91f2-d4c1e517858b">113,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80OS9mcmFnOjNiNjdjMzBhZTFiNzQ2M2I4YjhjYzg2YTVjODMwYWIzL3RhYmxlOmFjMDIxMTBlMWMwOTQzOThiMDk0MzVmYTJjYjJkMDgxL3RhYmxlcmFuZ2U6YWMwMjExMGUxYzA5NDM5OGIwOTQzNWZhMmNiMmQwODFfMy0zLTEtMS0w_702cdab0-c3bb-4aa0-b615-f3023b0be562">107,197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80OS9mcmFnOjNiNjdjMzBhZTFiNzQ2M2I4YjhjYzg2YTVjODMwYWIzL3RhYmxlOmFjMDIxMTBlMWMwOTQzOThiMDk0MzVmYTJjYjJkMDgxL3RhYmxlcmFuZ2U6YWMwMjExMGUxYzA5NDM5OGIwOTQzNWZhMmNiMmQwODFfNC0xLTEtMS0w_8ef49eee-9145-4f66-97e4-488d75921bfb">205,797</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80OS9mcmFnOjNiNjdjMzBhZTFiNzQ2M2I4YjhjYzg2YTVjODMwYWIzL3RhYmxlOmFjMDIxMTBlMWMwOTQzOThiMDk0MzVmYTJjYjJkMDgxL3RhYmxlcmFuZ2U6YWMwMjExMGUxYzA5NDM5OGIwOTQzNWZhMmNiMmQwODFfNC0zLTEtMS0w_528737b7-bdd0-409c-8d77-25bdb72ec447">194,868</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i60ea575d4ae7456fa9ff06ec4f3488e0_52"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 7 &#8211; <ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RleHRyZWdpb246N2MwZWEzOGVkODVjNDZmZTk2MGJlNDAxNzk3YjNjZGZfMjMyMA_ea51827f-e37d-4e71-86cd-c7cfa077942c" continuedAt="i6c7cbc66638c4088b123d58488442b9f" escape="true">Earnings Per Share</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i6c7cbc66638c4088b123d58488442b9f" continuedAt="ia53bb27cf60e4c3da2d4e654463ce717"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share (&#8220;basic EPS&#8221;) is computed by dividing net income by the weighted average number of common shares outstanding for the reporting period.  Diluted earnings per share (&#8220;diluted EPS&#8221;) gives effect to all dilutive potential shares outstanding resulting from employee stock options, restricted stock units, performance share units and stock appreciation rights ("SARs") as well as the Notes and related hedge transactions during the period.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RleHRyZWdpb246N2MwZWEzOGVkODVjNDZmZTk2MGJlNDAxNzk3YjNjZGZfMjMwNQ_f57f1783-d744-4ab3-81f6-68a9bc10c483" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted earnings per share for the three months ended March 31, 2021 and 2020:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.113%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RhYmxlOjQyMGRkNmI3ZGFlNzQ0ZTBhMDg4ZDkzNjc5OThmZWI3L3RhYmxlcmFuZ2U6NDIwZGQ2YjdkYWU3NDRlMGEwODhkOTM2Nzk5OGZlYjdfMi0xLTEtMS0w_41305769-9f00-4fa4-9a6d-ca00cb8120f1">9,860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RhYmxlOjQyMGRkNmI3ZGFlNzQ0ZTBhMDg4ZDkzNjc5OThmZWI3L3RhYmxlcmFuZ2U6NDIwZGQ2YjdkYWU3NDRlMGEwODhkOTM2Nzk5OGZlYjdfMi0zLTEtMS0w_103d19d3-f2a5-46f0-a818-6517c155725d">5,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic &#8211; weighted average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RhYmxlOjQyMGRkNmI3ZGFlNzQ0ZTBhMDg4ZDkzNjc5OThmZWI3L3RhYmxlcmFuZ2U6NDIwZGQ2YjdkYWU3NDRlMGEwODhkOTM2Nzk5OGZlYjdfNC0xLTEtMS0w_5d3b43fc-9775-4685-bc06-32fdcede2797">28,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RhYmxlOjQyMGRkNmI3ZGFlNzQ0ZTBhMDg4ZDkzNjc5OThmZWI3L3RhYmxlcmFuZ2U6NDIwZGQ2YjdkYWU3NDRlMGEwODhkOTM2Nzk5OGZlYjdfNC0zLTEtMS0w_08441aa9-8dcf-4d8f-9ee3-78bc03aeefc1">28,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive potential securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RhYmxlOjQyMGRkNmI3ZGFlNzQ0ZTBhMDg4ZDkzNjc5OThmZWI3L3RhYmxlcmFuZ2U6NDIwZGQ2YjdkYWU3NDRlMGEwODhkOTM2Nzk5OGZlYjdfNi0xLTEtMS0w_e46c40b9-ac64-4b4d-bb62-091cbb4d4537">2,406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RhYmxlOjQyMGRkNmI3ZGFlNzQ0ZTBhMDg4ZDkzNjc5OThmZWI3L3RhYmxlcmFuZ2U6NDIwZGQ2YjdkYWU3NDRlMGEwODhkOTM2Nzk5OGZlYjdfNi0zLTEtMS0w_5a2cfa00-30c5-4084-984a-b79b0faef41f">1,229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted &#8211; weighted average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RhYmxlOjQyMGRkNmI3ZGFlNzQ0ZTBhMDg4ZDkzNjc5OThmZWI3L3RhYmxlcmFuZ2U6NDIwZGQ2YjdkYWU3NDRlMGEwODhkOTM2Nzk5OGZlYjdfOC0xLTEtMS0w_06695938-77eb-409b-99af-ebe309777927">31,378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RhYmxlOjQyMGRkNmI3ZGFlNzQ0ZTBhMDg4ZDkzNjc5OThmZWI3L3RhYmxlcmFuZ2U6NDIwZGQ2YjdkYWU3NDRlMGEwODhkOTM2Nzk5OGZlYjdfOC0zLTEtMS0w_c7dfb1f3-1c19-4850-a621-c69704da79f3">29,707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (per share)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RhYmxlOjQyMGRkNmI3ZGFlNzQ0ZTBhMDg4ZDkzNjc5OThmZWI3L3RhYmxlcmFuZ2U6NDIwZGQ2YjdkYWU3NDRlMGEwODhkOTM2Nzk5OGZlYjdfMTEtMS0xLTEtMA_0ed89bf5-3567-47c8-b679-0b511fb97af3">0.34</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RhYmxlOjQyMGRkNmI3ZGFlNzQ0ZTBhMDg4ZDkzNjc5OThmZWI3L3RhYmxlcmFuZ2U6NDIwZGQ2YjdkYWU3NDRlMGEwODhkOTM2Nzk5OGZlYjdfMTEtMy0xLTEtMA_885470f5-180a-427a-a941-0fdfade38d8b">0.21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RhYmxlOjQyMGRkNmI3ZGFlNzQ0ZTBhMDg4ZDkzNjc5OThmZWI3L3RhYmxlcmFuZ2U6NDIwZGQ2YjdkYWU3NDRlMGEwODhkOTM2Nzk5OGZlYjdfMTItMS0xLTEtMA_4aec4ddc-dd57-45f3-b212-6c92389816de">0.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RhYmxlOjQyMGRkNmI3ZGFlNzQ0ZTBhMDg4ZDkzNjc5OThmZWI3L3RhYmxlcmFuZ2U6NDIwZGQ2YjdkYWU3NDRlMGEwODhkOTM2Nzk5OGZlYjdfMTItMy0xLTEtMA_7c005e7d-0e4f-4726-9a74-1e8e3c9e9957">0.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shares used in the calculation of diluted EPS exclude options and SARs to purchase shares where the exercise price was greater than the average market price of common shares for the period and the effect of the inclusion would be anti-dilutive.  Such shares aggregated approximately <ix:nonFraction unitRef="shares" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RleHRyZWdpb246N2MwZWEzOGVkODVjNDZmZTk2MGJlNDAxNzk3YjNjZGZfODc0_09f080b9-1359-429c-8179-15f242b63819">0.3</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RleHRyZWdpb246N2MwZWEzOGVkODVjNDZmZTk2MGJlNDAxNzk3YjNjZGZfMTA5OTUxMTYzMDY4Nw_a2a78478-14f7-4219-aeb5-24ea78b8701c">1.1</ix:nonFraction> million for the three months ended March&#160;31, 2021 and 2020, respectively.  Our <ix:nonFraction unitRef="number" contextRef="id748c1bbe2b3409b9e97ffd239dcc0f0_I20190129" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RleHRyZWdpb246N2MwZWEzOGVkODVjNDZmZTk2MGJlNDAxNzk3YjNjZGZfMTAzMw_4b151355-2264-482d-948e-413a8a1fdbe8">2.625</ix:nonFraction>% convertible notes due in 2024 (the &#8220;Notes&#8221;) are convertible under certain circumstances, as defined in the indenture, into a combination of cash and CONMED common stock.&#160; </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is intended to describe the impact of the Notes and related hedge transactions on the calculation of diluted EPS.  Additional shares to be issued pursuant to the terms of the Notes and related hedge transactions, if any, would occur at maturity.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:continuation id="ia53bb27cf60e4c3da2d4e654463ce717" continuedAt="i9a07bdf142dc49e093b527e07579ddc2"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of diluted EPS includes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">potential diluted shares upon conversion of the Notes when the average market price per share of our common stock for the period is greater than the conversion price of the Notes of $<ix:nonFraction unitRef="usdPerShare" contextRef="id748c1bbe2b3409b9e97ffd239dcc0f0_I20190129" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RleHRyZWdpb246N2MwZWEzOGVkODVjNDZmZTk2MGJlNDAxNzk3YjNjZGZfMTQzNQ_7488fc20-c2c5-4385-90e6-1dc3c601e0b8">88.80</ix:nonFraction>.  We intend to settle in cash the principal outstanding and use the treasury stock method when calculating their potential dilutive effect, if any.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2021 and 2020, our average share price exceeded the conversion price of the Notes and we included in our diluted share count <ix:nonFraction unitRef="shares" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RleHRyZWdpb246N2MwZWEzOGVkODVjNDZmZTk2MGJlNDAxNzk3YjNjZGZfMTA5OTUxMTYzMDQ0OQ_cfed98f1-47f4-42ba-9997-b9e983f1173e">1.0</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="shares" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RleHRyZWdpb246N2MwZWEzOGVkODVjNDZmZTk2MGJlNDAxNzk3YjNjZGZfMTc5Nw_cd66234c-10d8-4074-b4c0-cebcedfd4e74">0.1</ix:nonFraction>&#160;million shares, respectively, assumed to be issued if the Notes were converted.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We previously entered into convertible notes hedge transactions to increase the effective conversion price of the Notes to $<ix:nonFraction unitRef="usdPerShare" contextRef="i4166a58e42b343bfb5ae40145fb70764_D20190129-20190129" decimals="2" name="us-gaap:OptionIndexedToIssuersEquityStrikePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RleHRyZWdpb246N2MwZWEzOGVkODVjNDZmZTk2MGJlNDAxNzk3YjNjZGZfMTA5OTUxMTYzNTUzMQ_9737693d-7ccb-4cb8-91e8-0843e0ad1652">114.92</ix:nonFraction>.&#160; However, our convertible notes hedges are not included when calculating potential dilutive shares since their effect is always anti-dilutive.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concurrently with entering into the hedge transactions, we also previously entered into warrant transactions under which we agreed to sell shares of our common stock at $<ix:nonFraction unitRef="usdPerShare" contextRef="idf721ab99d84490dbfa3d3cec7d8e799_D20190129-20190129" decimals="2" name="us-gaap:OptionIndexedToIssuersEquityStrikePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RleHRyZWdpb246N2MwZWEzOGVkODVjNDZmZTk2MGJlNDAxNzk3YjNjZGZfMTA5OTUxMTYzNTUzNQ_9253a793-70b2-423f-833e-7645b6b34251">114.92</ix:nonFraction>.  </span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><ix:continuation id="i9a07bdf142dc49e093b527e07579ddc2" continuedAt="id129e346f52b43df9ed3b60c2c89c998"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of diluted EPS also includes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id129e346f52b43df9ed3b60c2c89c998">potential diluted shares to be issued under the warrants when the average market price per share of our common stock for the period is greater than $<ix:nonFraction unitRef="usdPerShare" contextRef="idf721ab99d84490dbfa3d3cec7d8e799_D20190129-20190129" decimals="2" name="us-gaap:OptionIndexedToIssuersEquityStrikePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RleHRyZWdpb246N2MwZWEzOGVkODVjNDZmZTk2MGJlNDAxNzk3YjNjZGZfMTA5OTUxMTYzNTU0Mw_9253a793-70b2-423f-833e-7645b6b34251">114.92</ix:nonFraction>.  During the three months ended March&#160;31, 2021, our average share price exceeded $<ix:nonFraction unitRef="usdPerShare" contextRef="idf721ab99d84490dbfa3d3cec7d8e799_D20190129-20190129" decimals="2" name="us-gaap:OptionIndexedToIssuersEquityStrikePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RleHRyZWdpb246N2MwZWEzOGVkODVjNDZmZTk2MGJlNDAxNzk3YjNjZGZfMTA5OTUxMTYzNTUzOQ_9253a793-70b2-423f-833e-7645b6b34251">114.92</ix:nonFraction> and we therefore included in our diluted share count an additional <ix:nonFraction unitRef="shares" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RleHRyZWdpb246N2MwZWEzOGVkODVjNDZmZTk2MGJlNDAxNzk3YjNjZGZfMjE5OTAyMzI1OTk5NQ_9c0e4256-8fee-4fb2-ae40-0eabd94c7ad3">0.2</ix:nonFraction>&#160;million shares assumed to be issued under the warrants.</ix:continuation>  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i60ea575d4ae7456fa9ff06ec4f3488e0_55"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 8 &#8211; <ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RleHRyZWdpb246MWIzNmViMjUwOTRkNDUzZGFlYjdjZDYzYjUyN2M2OWZfMTc3Nw_8e6f3f39-d07f-4bea-a791-c264376234c2" continuedAt="if41d88d5d8304c12aba774ecf2b3563e" escape="true">Goodwill and Other Intangible Assets</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="if41d88d5d8304c12aba774ecf2b3563e" continuedAt="ia41638cff58141dcbb6d8522c4c1c5d1"><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RleHRyZWdpb246MWIzNmViMjUwOTRkNDUzZGFlYjdjZDYzYjUyN2M2OWZfMTc2Nw_0cf0f43b-17d3-4fe7-b366-40899c27ad7a" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the net carrying amount of goodwill for the three months ended March&#160;31, 2021 are as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:84.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOmZmZGM0ZDA2OGNkYjQ4NDg4ZWM2ZmFiYjRiMzFkNWFmL3RhYmxlcmFuZ2U6ZmZkYzRkMDY4Y2RiNDg0ODhlYzZmYWJiNGIzMWQ1YWZfMC0xLTEtMS0w_9b84263e-4c78-4b05-8747-287ddd0fc363">618,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOmZmZGM0ZDA2OGNkYjQ4NDg4ZWM2ZmFiYjRiMzFkNWFmL3RhYmxlcmFuZ2U6ZmZkYzRkMDY4Y2RiNDg0ODhlYzZmYWJiNGIzMWQ1YWZfNC0xLTEtMS0w_8a444b98-c0b1-4cfe-85ed-917f2ce98ea8">336</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOmZmZGM0ZDA2OGNkYjQ4NDg4ZWM2ZmFiYjRiMzFkNWFmL3RhYmxlcmFuZ2U6ZmZkYzRkMDY4Y2RiNDg0ODhlYzZmYWJiNGIzMWQ1YWZfNi0xLTEtMS0w_b2df201f-bc91-4849-983c-1c7fe36d1149">618,104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities of acquired businesses are recorded at their estimated fair values as of the date of acquisition.&#160;&#160;Goodwill represents costs in excess of fair values assigned to the underlying net assets of acquired businesses.&#160; </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_7">Table of Contents</a></span></div></div><ix:continuation id="ia41638cff58141dcbb6d8522c4c1c5d1"><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RleHRyZWdpb246MWIzNmViMjUwOTRkNDUzZGFlYjdjZDYzYjUyN2M2OWZfMTc2NA_d1eaf1dd-580c-4f95-be95-116c3dd77ebc" escape="true"><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RleHRyZWdpb246MWIzNmViMjUwOTRkNDUzZGFlYjdjZDYzYjUyN2M2OWZfMzI5ODUzNDg4NTY5MA_1b2372b6-3193-4a62-a0a1-72a2a4a40d46" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets consist of the following:</span></div><div style="text-align:justify;text-indent:15.75pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:36.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.365%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Amortization Period (Years)</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets with definite lives:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer and distributor relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ieced3d585af14a18830b4dd4d45722c5_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfNC0xLTEtMS0w_45952025-ff4c-4915-b916-394cba6204c0">24</ix:nonNumeric></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845a4163284f443481a7a9c2d614d09a_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfNC0yLTEtMS0w_ea226ccb-1304-47e3-b050-b847416c9a88">342,531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i845a4163284f443481a7a9c2d614d09a_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfNC00LTEtMS0w_a4ab01cd-464a-45f4-8a34-879f063785c9">139,243</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee91ad444274cc2a46852ceb1cbe07b_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfNC02LTEtMS0w_6eaff69c-2eab-4040-a201-16f8741fa9cc">342,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ee91ad444274cc2a46852ceb1cbe07b_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfNC04LTEtMS0w_c5c68b33-80d7-48b6-b412-e7dc3b720683">134,555</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales representation, marketing and promotional rights</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i764a3b1ff7c841b1ba858429acbdb036_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfNi0xLTEtMS0w_8ac6504e-f156-4696-b1f4-76b0d4a23a2d">25</ix:nonNumeric></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67e28dd28d264c5ca16a46ab1364c8bc_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfNi0yLTEtMS0w_37425b1e-7409-4d40-9413-25921a01cbf8">149,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67e28dd28d264c5ca16a46ab1364c8bc_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfNi00LTEtMS0w_713c1f97-3f46-4e98-ba7a-e5426005c2fc">55,500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if46896d334d94c639ad7dd9fe363f7ff_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfNi02LTEtMS0w_609ab1c1-bfe8-4be8-8f73-44a4b69ce876">149,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if46896d334d94c639ad7dd9fe363f7ff_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfNi04LTEtMS0w_2710c6e1-6244-4dd4-a1e1-6e13c3c43a91">54,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4827d1b693224030887c79b6d7a4ac8a_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfOC0xLTEtMS0w_368be12e-fa78-4543-9d21-562958382b29">16</ix:nonNumeric></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id22fbed2f4c849639e7b4e6618063e83_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfOC0yLTEtMS0w_599cf894-0ad1-490c-92f6-1e40966e0806">106,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id22fbed2f4c849639e7b4e6618063e83_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfOC00LTEtMS0w_b7604673-f751-40d4-ac1b-e6c625230a96">21,358</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7cce587c6664fba92238d523270294d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfOC02LTEtMS0w_d9949dbf-6498-4bc2-a973-d8252d6e206c">106,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7cce587c6664fba92238d523270294d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfOC04LTEtMS0w_ab6b4d4f-8662-4d35-9d8f-787b31e65833">19,705</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and other intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic619fc4d993649a0aa3de013bce24ac7_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfMTAtMS0xLTEtMA_961f9369-f54a-4e69-ba74-733affa23767">16</ix:nonNumeric></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c573b67931c49ae94806ae92e81066f_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfMTAtMi0xLTEtMA_05cfd50d-9078-4fef-b02a-e5aa49b1f873">74,307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c573b67931c49ae94806ae92e81066f_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfMTAtNC0xLTEtMA_02552650-4dd3-44be-9768-7c4d1b7e1d52">49,356</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8660d403bca94922a95c5e1926714e31_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfMTAtNi0xLTEtMA_590b0133-5af9-4949-a6d6-e65d3892f128">73,516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8660d403bca94922a95c5e1926714e31_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfMTAtOC0xLTEtMA_9e68a6de-3cc3-429c-a509-b3215854f329">48,882</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets with indefinite lives:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and tradenames</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fbb390301fb48f0a30356e63cdebb22_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfMTQtMi0xLTEtMA_6e647e0b-cd89-4103-90a4-29cb417aeee7">86,544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f265525a594e4196ee9d5387895783_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfMTQtNi0xLTEtMA_86a39316-8159-40a8-8dde-6af8c7ec7a03">86,544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie71bc8ca5147459e9fc9a708d695e3d8_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfMTYtMS0xLTEtMA_81604fc0-8192-4e48-bce1-4f1ef7a98a38">22</ix:nonNumeric></span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfMTYtMi0xLTEtMA_3ed955d7-fab7-40b8-9b86-dff519123cb0">759,362</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfMTYtNC0xLTEtMA_8f0c0532-56ed-4351-9d08-552e94d228a9">265,457</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfMTYtNi0xLTEtMA_db653d60-73f2-4f92-af90-23fc27f985db">758,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfMTYtOC0xLTEtMA_0cd25eed-1b9e-41b0-9a24-e4d89247348f">257,142</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer and distributor relationships, trademarks and tradenames, developed technology and patents and other intangible assets primarily represent allocations of purchase price to identifiable intangible assets of acquired businesses.  Sales representation, marketing and promotional rights represent intangible assets created under our agreement with Musculoskeletal Transplant Foundation (&#8220;MTF&#8221;).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense related to intangible assets which are subject to amortization totaled $<ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RleHRyZWdpb246MWIzNmViMjUwOTRkNDUzZGFlYjdjZDYzYjUyN2M2OWZfMTA1MQ_67e43ee1-8acb-4f21-9282-dc38b1b54b78">8.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RleHRyZWdpb246MWIzNmViMjUwOTRkNDUzZGFlYjdjZDYzYjUyN2M2OWZfMTA1OA_e6a72452-6261-431d-80ff-bcff041a0a87">8.5</ix:nonFraction> million in the three months ended March 31, 2021 and 2020, respectively, and is included as a reduction of revenue (for amortization related to our sales representation, marketing and promotional rights) and in selling and administrative expense (for all other intangible assets) in the consolidated condensed statements of comprehensive income (loss).  Included in developed technology is $<ix:nonFraction unitRef="usd" contextRef="id22fbed2f4c849639e7b4e6618063e83_I20210331" decimals="-5" format="ixt:numdotdecimal" name="cnmd:AssetAcquisitionContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RleHRyZWdpb246MWIzNmViMjUwOTRkNDUzZGFlYjdjZDYzYjUyN2M2OWZfMTQ0OA_f44bfe9a-ccbe-4351-afac-f8ee85e0533e">6.0</ix:nonFraction> million of earn-out consideration that is considered probable as of March&#160;31, 2021 associated with a prior asset acquisition.  This is recorded in other current and other long-term liabilities at March&#160;31, 2021. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RleHRyZWdpb246MWIzNmViMjUwOTRkNDUzZGFlYjdjZDYzYjUyN2M2OWZfMTc5Nw_0d97864c-b6d9-4f24-b6d4-9fcabfcdbbf1" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated intangible asset amortization expense remaining for the year ending December&#160;31, 2021 and for each of the five succeeding years is as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:57.025%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.374%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization included in expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization recorded as a reduction of revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining, 2021</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f228fccaaf945268b8dcbd31bed8868_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjMwNDI3ZDk3ZjgzYjQ0Nzk5NmJhMTJkNzRkYTk5ZTMyL3RhYmxlcmFuZ2U6MzA0MjdkOTdmODNiNDQ3OTk2YmExMmQ3NGRhOTllMzJfMS0xLTEtMS0w_a9a856ca-e9de-4f0b-9639-c83fc977351e">20,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cfc55d543ed45c79d4721e64e912827_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjMwNDI3ZDk3ZjgzYjQ0Nzk5NmJhMTJkNzRkYTk5ZTMyL3RhYmxlcmFuZ2U6MzA0MjdkOTdmODNiNDQ3OTk2YmExMmQ3NGRhOTllMzJfMS0zLTEtMS0w_11b16ceb-350f-47de-82cc-9a84d21fc4e6">4,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjMwNDI3ZDk3ZjgzYjQ0Nzk5NmJhMTJkNzRkYTk5ZTMyL3RhYmxlcmFuZ2U6MzA0MjdkOTdmODNiNDQ3OTk2YmExMmQ3NGRhOTllMzJfMS01LTEtMS0w_a50b27a1-8d9e-42ac-88c3-592eaa5a4b77">25,120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f228fccaaf945268b8dcbd31bed8868_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjMwNDI3ZDk3ZjgzYjQ0Nzk5NmJhMTJkNzRkYTk5ZTMyL3RhYmxlcmFuZ2U6MzA0MjdkOTdmODNiNDQ3OTk2YmExMmQ3NGRhOTllMzJfMi0xLTEtMS0w_8a705c38-df39-4cb0-b16a-70ad8fd60c04">26,426</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cfc55d543ed45c79d4721e64e912827_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjMwNDI3ZDk3ZjgzYjQ0Nzk5NmJhMTJkNzRkYTk5ZTMyL3RhYmxlcmFuZ2U6MzA0MjdkOTdmODNiNDQ3OTk2YmExMmQ3NGRhOTllMzJfMi0zLTEtMS0w_56ffcb99-5e0e-455b-9e1c-43cb3d6def22">6,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjMwNDI3ZDk3ZjgzYjQ0Nzk5NmJhMTJkNzRkYTk5ZTMyL3RhYmxlcmFuZ2U6MzA0MjdkOTdmODNiNDQ3OTk2YmExMmQ3NGRhOTllMzJfMi01LTEtMS0w_fe8b0a86-43f1-45e2-a339-c5299bf0ccf9">32,426</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f228fccaaf945268b8dcbd31bed8868_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjMwNDI3ZDk3ZjgzYjQ0Nzk5NmJhMTJkNzRkYTk5ZTMyL3RhYmxlcmFuZ2U6MzA0MjdkOTdmODNiNDQ3OTk2YmExMmQ3NGRhOTllMzJfMy0xLTEtMS0w_14672ee8-d2cc-4f19-a8bf-6019a8266db8">25,646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cfc55d543ed45c79d4721e64e912827_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjMwNDI3ZDk3ZjgzYjQ0Nzk5NmJhMTJkNzRkYTk5ZTMyL3RhYmxlcmFuZ2U6MzA0MjdkOTdmODNiNDQ3OTk2YmExMmQ3NGRhOTllMzJfMy0zLTEtMS0w_c6481f76-e217-49fd-8341-9ad6e91edd29">6,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjMwNDI3ZDk3ZjgzYjQ0Nzk5NmJhMTJkNzRkYTk5ZTMyL3RhYmxlcmFuZ2U6MzA0MjdkOTdmODNiNDQ3OTk2YmExMmQ3NGRhOTllMzJfMy01LTEtMS0w_0db53078-c296-4869-9cc4-ac43d12970bc">31,646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f228fccaaf945268b8dcbd31bed8868_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjMwNDI3ZDk3ZjgzYjQ0Nzk5NmJhMTJkNzRkYTk5ZTMyL3RhYmxlcmFuZ2U6MzA0MjdkOTdmODNiNDQ3OTk2YmExMmQ3NGRhOTllMzJfNC0xLTEtMS0w_8e6de201-5d45-4daf-984a-4b7fe6b7c1ee">24,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cfc55d543ed45c79d4721e64e912827_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjMwNDI3ZDk3ZjgzYjQ0Nzk5NmJhMTJkNzRkYTk5ZTMyL3RhYmxlcmFuZ2U6MzA0MjdkOTdmODNiNDQ3OTk2YmExMmQ3NGRhOTllMzJfNC0zLTEtMS0w_227db3fc-0c44-425a-b5e3-0f444b2f8f2c">6,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjMwNDI3ZDk3ZjgzYjQ0Nzk5NmJhMTJkNzRkYTk5ZTMyL3RhYmxlcmFuZ2U6MzA0MjdkOTdmODNiNDQ3OTk2YmExMmQ3NGRhOTllMzJfNC01LTEtMS0w_8e31e9d6-0c4e-44cf-9893-4c4935b53082">30,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f228fccaaf945268b8dcbd31bed8868_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjMwNDI3ZDk3ZjgzYjQ0Nzk5NmJhMTJkNzRkYTk5ZTMyL3RhYmxlcmFuZ2U6MzA0MjdkOTdmODNiNDQ3OTk2YmExMmQ3NGRhOTllMzJfNS0xLTEtMS0w_60963e8a-ce37-4931-aee1-ee7ff9a5d2b9">25,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cfc55d543ed45c79d4721e64e912827_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjMwNDI3ZDk3ZjgzYjQ0Nzk5NmJhMTJkNzRkYTk5ZTMyL3RhYmxlcmFuZ2U6MzA0MjdkOTdmODNiNDQ3OTk2YmExMmQ3NGRhOTllMzJfNS0zLTEtMS0w_ae8b810d-66f1-4c1e-96ba-b73fd9fb864b">6,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjMwNDI3ZDk3ZjgzYjQ0Nzk5NmJhMTJkNzRkYTk5ZTMyL3RhYmxlcmFuZ2U6MzA0MjdkOTdmODNiNDQ3OTk2YmExMmQ3NGRhOTllMzJfNS01LTEtMS0w_2ba56bf6-1129-43dd-8cd7-d0617966bcb6">31,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f228fccaaf945268b8dcbd31bed8868_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjMwNDI3ZDk3ZjgzYjQ0Nzk5NmJhMTJkNzRkYTk5ZTMyL3RhYmxlcmFuZ2U6MzA0MjdkOTdmODNiNDQ3OTk2YmExMmQ3NGRhOTllMzJfNi0xLTEtMS0w_074a3466-5fd3-468b-912c-a0097e034d9f">24,529</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cfc55d543ed45c79d4721e64e912827_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjMwNDI3ZDk3ZjgzYjQ0Nzk5NmJhMTJkNzRkYTk5ZTMyL3RhYmxlcmFuZ2U6MzA0MjdkOTdmODNiNDQ3OTk2YmExMmQ3NGRhOTllMzJfNi0zLTEtMS0w_1daecece-43f0-4d3c-9a95-2ff42b195969">6,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjMwNDI3ZDk3ZjgzYjQ0Nzk5NmJhMTJkNzRkYTk5ZTMyL3RhYmxlcmFuZ2U6MzA0MjdkOTdmODNiNDQ3OTk2YmExMmQ3NGRhOTllMzJfNi01LTEtMS0w_19767385-998a-4036-91e8-3bfe67fb69bc">30,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="i60ea575d4ae7456fa9ff06ec4f3488e0_58"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 9 - <ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfNjcxMQ_271f4461-2608-4d2d-b0e7-2d81e6162f0b" continuedAt="i2700a92a8de64046940ba1fecb1ada44" escape="true">Long-Term Debt</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i2700a92a8de64046940ba1fecb1ada44" continuedAt="i4aed26b0b0604940a9a61d8d6cc3d85c"><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfNjcwNA_7cab6c70-b395-4211-853f-f3e24848ec46" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consists of the following:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:72.360%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.804%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving line of credit</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i824ceb82e4874235bfdf7c0af561e38c_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfMS0xLTEtMS0w_d6758f28-557d-4fc8-9e22-ce2bb68af9c7">199,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d478e70dcec4899b2e2962f31e3f914_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfMS0zLTEtMS0w_984d1ed9-c918-409a-b648-661de8c494d5">207,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan, net of deferred debt issuance costs of $<ix:nonFraction unitRef="usd" contextRef="i3d8fccab0a15481582a37233de37abbf_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfMi0wLTEtMS0wL3RleHRyZWdpb246NjI0MTM2NDQ2ZTIzNGE5MGE1NmU0NzI2MGRiZDY2NjdfNTQ_92be8098-ae6b-43a4-9f4e-3da201f79f8d">1,520</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="idc48b5a1f090411da72a4fabcf8ba3c5_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfMi0wLTEtMS0wL3RleHRyZWdpb246NjI0MTM2NDQ2ZTIzNGE5MGE1NmU0NzI2MGRiZDY2NjdfNjE_8db901c9-05e6-42bb-895d-a543bd3e4ff2">1,668</ix:nonFraction> in 2021 and 2020, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d8fccab0a15481582a37233de37abbf_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfMi0xLTEtMS0w_6216b605-c515-4697-86e8-ccc6a2fb1433">236,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc48b5a1f090411da72a4fabcf8ba3c5_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfMi0zLTEtMS0w_295cbe8b-5236-4c5a-9ca3-40789bc13802">240,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id748c1bbe2b3409b9e97ffd239dcc0f0_I20190129" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfMy0wLTEtMS0wL3RleHRyZWdpb246ZTdjNTY0M2ZlMTVjNGQ0MmI0YjliN2Y2OWZhNmY2MjZfNA_4b151355-2264-482d-948e-413a8a1fdbe8">2.625</ix:nonFraction>% convertible notes, net of deferred debt issuance costs of $<ix:nonFraction unitRef="usd" contextRef="i99821198665d4c33ba7a5fc053af58b5_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfMy0wLTEtMS0wL3RleHRyZWdpb246ZTdjNTY0M2ZlMTVjNGQ0MmI0YjliN2Y2OWZhNmY2MjZfNjU_eb95ccce-9351-48d4-baa6-5f76e1e37dc3">5,031</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i0b2868e4273945968f65bc7567ca9021_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfMy0wLTEtMS0wL3RleHRyZWdpb246ZTdjNTY0M2ZlMTVjNGQ0MmI0YjliN2Y2OWZhNmY2MjZfNzI_b3944a2a-5548-409f-b6f7-041e231d3a46">5,475</ix:nonFraction> in 2021 and 2020, respectively, and unamortized discount of $<ix:nonFraction unitRef="usd" contextRef="i99821198665d4c33ba7a5fc053af58b5_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfMy0wLTEtMS0wL3RleHRyZWdpb246ZTdjNTY0M2ZlMTVjNGQ0MmI0YjliN2Y2OWZhNmY2MjZfMTMx_01efc9dc-0bd8-40e8-817a-86ec912570b8">31,117</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i0b2868e4273945968f65bc7567ca9021_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfMy0wLTEtMS0wL3RleHRyZWdpb246ZTdjNTY0M2ZlMTVjNGQ0MmI0YjliN2Y2OWZhNmY2MjZfMTM4_8c8a049e-d3ad-4fa0-8f69-46f15065d183">33,620</ix:nonFraction> in 2021 and 2020, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99821198665d4c33ba7a5fc053af58b5_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfMy0xLTEtMS0w_ce7fb3e7-8ba6-4565-99dd-5bc760db5979">308,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b2868e4273945968f65bc7567ca9021_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfMy0zLTEtMS0w_18e007b6-a9c8-4ee4-97cd-9ba20faf077d">305,904</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" name="us-gaap:FinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfNC0xLTEtMS0w_bc21e3cb-ef95-4cbe-bdfb-ac53d513ad56">566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" name="us-gaap:FinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfNC0zLTEtMS0w_6438ee1f-eb65-48ac-b21b-102d9dcf2d1f">587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfNS0xLTEtMS0w_79f50cc9-8ffb-43f0-a778-4d10142acd1e">745,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfNS0zLTEtMS0w_7a126a21-26f3-4358-a7bd-d0931b357a55">753,636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:&#160;&#160;Current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfNi0xLTEtMS0w_4f6f13b5-d4f3-4de3-8199-5f0be8dc3e2a">20,076</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfNi0zLTEtMS0w_3db1f42e-8143-47a0-a915-94a300d8bd64">18,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfNy0xLTEtMS0w_360aa65c-c001-403d-9398-96144b846176">725,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfNy0zLTEtMS0w_9c033519-d075-4845-ad69-ec20fbaeb32e">735,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;7, 2019 we entered into a sixth amended and restated senior credit agreement consisting of: (a) a $<ix:nonFraction unitRef="usd" contextRef="ida498aa346244a73997d7daf728c9420_I20190207" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfMTg5_fb24c343-29c7-4a1b-b7c7-4d8138287d28">265.0</ix:nonFraction> million term loan facility and (b) a $<ix:nonFraction unitRef="usd" contextRef="i7729e32eb8ce41c089d19b2205b89c39_I20190207" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfMjIx_f76c9d53-af64-41b0-a20b-d597b82cf53f">585.0</ix:nonFraction> million revolving credit facility.   The revolving credit facility will terminate and the loans outstanding under the term loan facility will mature on the earlier of (i)&#160;February&#160;7, 2024 or (ii) 91 days prior to the earliest scheduled maturity date of the <ix:nonFraction unitRef="number" contextRef="id748c1bbe2b3409b9e97ffd239dcc0f0_I20190129" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfNDcz_4b151355-2264-482d-948e-413a8a1fdbe8">2.625</ix:nonFraction>% convertible notes due in 2024 described below, (if, as of such date, more than $<ix:nonFraction unitRef="usd" contextRef="i9eaf4f751cfe4066b7c97b065a34e247_I20190207" decimals="INF" format="ixt:numdotdecimal" name="cnmd:CreditAgreementExpirationTriggerRequirementConvertibleNoteOutstandingBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfNTU1_624baf66-34b8-47b7-8000-3cbfe8283e42">150.0</ix:nonFraction> million in aggregate principal amount of such convertible notes (or any refinancing thereof) remains outstanding).  The term loan facility is payable in quarterly installments increasing over the term of the facility.  Proceeds from the term loan facility and borrowings under the revolving credit facility were used to repay the then existing senior credit agreement and in part to finance the acquisition of Buffalo Filter.  On April&#160;17, 2020, we amended our sixth amended and restated senior credit agreement to suspend our required leverage ratios for up to four quarters as a result of the potential impact from the COVID-19 pandemic.  On November&#160;20, 2020, we entered into a third amendment under our senior credit agreement to lower the applicable margin on the loans and lower the interest floor on Eurocurrency loans agreed upon in April 2020.  On April&#160;15, 2021, we terminated the suspension period, thus reinstating our required leverage ratios.  Interest rates are  adjusted so that the applicable margin for base rate loans is <ix:nonFraction unitRef="number" contextRef="i28142c61de0544568e9a171dfbb1187c_D20210101-20210331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfMTQxNQ_0d4a0bfa-efa5-4b4b-bd82-bcd4c4af08de">2.00</ix:nonFraction>% per annum and for Eurocurrency rate loans is <ix:nonFraction unitRef="number" contextRef="i6e5c081b73e84195a5fcd7003f17de71_D20210101-20210331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfMTQ2Mw_48aea068-a17c-4cac-81d9-032f3589eb18">3.00</ix:nonFraction>% per annum, and the applicable commitment fee rate for the revolving credit facility is <ix:nonFraction unitRef="number" contextRef="ied43b21a44b44e51b34956e8f380ca38_D20210101-20210331" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfMTU1Mw_60194f48-3d74-466e-9dac-955ec7b8357a">0.50</ix:nonFraction>%.  Following the suspension period, the applicable margin will depend upon CONMED&#8217;s consolidated senior secured leverage ratio, using the pricing grid set forth in the amendment.  Interest rates were at LIBOR (subject to <ix:nonFraction unitRef="number" contextRef="ied43b21a44b44e51b34956e8f380ca38_D20210101-20210331" decimals="INF" name="cnmd:LIBORInterestRateFloor" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfMTc3Ng_3cd84ef4-94df-4abb-a67d-f92ed6c89b42">0.50</ix:nonFraction>% floor) plus an interest rate margin of <ix:nonFraction unitRef="number" contextRef="ib605253e0a9f4dfba2ff9d30ac708b49_D20210101-20210331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfMTgxOA_ec0485a9-38c3-47bb-87f3-f0a19067e5c9">3.00</ix:nonFraction>% (<ix:nonFraction unitRef="number" contextRef="i3d7a728e16414d51a3ab40885ff60574_I20210331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfMTgyMg_c50d1b19-2a67-4959-a431-d49409774b69">3.50</ix:nonFraction>% at March&#160;31, 2021).</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were $<ix:nonFraction unitRef="usd" contextRef="i3d8fccab0a15481582a37233de37abbf_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfMTg0NQ_1b616e2d-bb50-4762-9761-f008e5b1af64">238.5</ix:nonFraction> million in borrowings outstanding on the term loan facility as of March&#160;31, 2021.  There were $<ix:nonFraction unitRef="usd" contextRef="i824ceb82e4874235bfdf7c0af561e38c_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfMTkyMg_d6758f28-557d-4fc8-9e22-ce2bb68af9c7">199.0</ix:nonFraction> million in borrowings outstanding under the revolving credit facility as of March&#160;31, 2021.  Our available borrowings on the revolving credit facility at March&#160;31, 2021 were $<ix:nonFraction unitRef="usd" contextRef="i824ceb82e4874235bfdf7c0af561e38c_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfMjA2Nw_fa28d650-85ab-43a0-a204-c18b3bb66eed">383.4</ix:nonFraction> million with approximately $<ix:nonFraction unitRef="usd" contextRef="i824ceb82e4874235bfdf7c0af561e38c_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfMjA4OQ_d5fbcf9e-e99a-4ee1-95ab-7a60bae187a9">2.6</ix:nonFraction> million of the facility set aside for outstanding letters of credit.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sixth amended and restated senior credit agreement is collateralized by substantially all of our personal property and assets.  The sixth amended and restated senior credit agreement contains covenants and restrictions which, among other things, require the maintenance of certain financial ratios and restrict dividend payments and the incurrence of certain indebtedness and other activities, including acquisitions and dispositions.  We were in full compliance with these covenants and restrictions as of March&#160;31, 2021.  We are also required, under certain circumstances, to make mandatory prepayments from net cash proceeds from any issuance of equity and asset sales.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 29, 2019, we issued $<ix:nonFraction unitRef="usd" contextRef="id748c1bbe2b3409b9e97ffd239dcc0f0_I20190129" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfMjg1Mg_f01c285b-cfa6-4cdb-9a14-d14738e2ce1c">345.0</ix:nonFraction> million in <ix:nonFraction unitRef="number" contextRef="id748c1bbe2b3409b9e97ffd239dcc0f0_I20190129" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfMjg1OA_4b151355-2264-482d-948e-413a8a1fdbe8">2.625</ix:nonFraction>% convertible notes due in 2024 (the "Notes").  Interest is payable semi-annually in arrears on February 1 and August 1 of each year, commencing August 1, 2019.  The Notes will mature on February 1, 2024, unless earlier repurchased or converted.  The Notes represent subordinated unsecured obligations and are convertible under certain circumstances, as defined in the indenture, into a combination of cash and CONMED common stock.&#160;&#160;The Notes may be converted at an initial conversion rate of <ix:nonFraction unitRef="number" contextRef="iee99b7a3a16541f8b5be3bf158edab1d_D20190129-20190129" decimals="4" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfMzM1Mg_3c52b533-4f32-4e39-bf70-cfb629057e12">11.2608</ix:nonFraction> shares of our common stock per $1,000 principal amount of Notes (equivalent to an initial conversion price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="id748c1bbe2b3409b9e97ffd239dcc0f0_I20190129" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfMzQ3NQ_7488fc20-c2c5-4385-90e6-1dc3c601e0b8">88.80</ix:nonFraction> per share of common stock).  Holders of the Notes may convert the Notes at their option at any time on or after November 1, 2023 through the second scheduled trading day preceding the maturity date.  Holders of the Notes will also have the right to convert the Notes prior to November 1, 2023, but only upon the occurrence of specified events.  The conversion rate is subject to anti-dilution adjustments if certain events occur.  A portion of the net proceeds from the offering of the Notes were used as part of the financing for the Buffalo Filter acquisition </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_7">Table of Contents</a></span></div></div><ix:continuation id="i4aed26b0b0604940a9a61d8d6cc3d85c"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $<ix:nonFraction unitRef="usd" contextRef="ie5c0fe7cdde24d5ab7b9a921af59a0d9_I20190129" decimals="-5" format="ixt:numdotdecimal" name="cnmd:Hedgeandwarranttransactionsnetcashpaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfNDA0NA_96787fcf-bb5f-42f6-95cc-8081184de058">21.0</ix:nonFraction> million were used to pay the cost of certain convertible notes hedge transactions as further described below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective borrowing rate for nonconvertible debt at the time of issuance of the Notes was estimated to be <ix:nonFraction unitRef="number" contextRef="id748c1bbe2b3409b9e97ffd239dcc0f0_I20190129" decimals="INF" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfNDI2MA_5ec888cf-349a-4203-8bf5-3911d38f5aa7">6.14</ix:nonFraction>%, which resulted in $<ix:nonFraction unitRef="usd" contextRef="id748c1bbe2b3409b9e97ffd239dcc0f0_I20190129" decimals="-5" format="ixt:numdotdecimal" name="cnmd:DebtInstrumentConvertibleGrossAmountofEquityComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfNDI4Mg_dbcedafc-e6b5-4b37-bd82-33ec1aef9340">51.6</ix:nonFraction> million of the $<ix:nonFraction unitRef="usd" contextRef="id748c1bbe2b3409b9e97ffd239dcc0f0_I20190129" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfNDI5Mg_f01c285b-cfa6-4cdb-9a14-d14738e2ce1c">345.0</ix:nonFraction> million aggregate principal amount of Notes issued, or $<ix:nonFraction unitRef="usd" contextRef="id748c1bbe2b3409b9e97ffd239dcc0f0_I20190129" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfNDM0Mg_6650c33d-e643-461f-b3cb-6d6dae785a43">39.1</ix:nonFraction> million after taxes, being attributable to equity.&#160;&#160;For the three months ended March 31, 2021 and 2020, we have recorded interest expense related to the amortization of debt discount on the Notes of $<ix:nonFraction unitRef="usd" contextRef="ibf80fee48fa74ab4b9051fb83cdd995b_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfNDQ5OQ_0fb106a8-1758-449b-b0be-c201f3981497">2.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i296a43d7781e4424a01be9d77422618e_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfNDUwNg_ae154320-3949-4348-8d02-e25bb25c5e7e">2.3</ix:nonFraction> million, respectively, at the effective interest rate of <ix:nonFraction unitRef="number" contextRef="id748c1bbe2b3409b9e97ffd239dcc0f0_I20190129" decimals="INF" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfNDY5Nw_5ec888cf-349a-4203-8bf5-3911d38f5aa7">6.14</ix:nonFraction>%.&#160;&#160;The debt discount on the Notes is being amortized through February 2024.&#160;&#160;For both the three months ended March 31, 2021 and 2020, we have recorded interest expense on the Notes of  $<ix:nonFraction unitRef="usd" contextRef="ibf80fee48fa74ab4b9051fb83cdd995b_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfNDg0Nw_3c73347e-4a10-4e59-b4a8-df2dbaa2def3"><ix:nonFraction unitRef="usd" contextRef="i296a43d7781e4424a01be9d77422618e_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfNDg0Nw_559e6b73-8d70-48dc-ac93-ff6aeb9f9e51">2.3</ix:nonFraction></ix:nonFraction> million at the contractual coupon rate of <ix:nonFraction unitRef="number" contextRef="id748c1bbe2b3409b9e97ffd239dcc0f0_I20190129" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfNDk3OA_4b151355-2264-482d-948e-413a8a1fdbe8">2.625</ix:nonFraction>%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the offering of the Notes, we entered into convertible note hedge transactions with a number of financial institutions (each, an &#8220;option counterparty&#8221;).  The convertible note hedge transactions cover, subject to anti-dilution adjustments substantially similar to those applicable to the Notes, the number of shares of our common stock underlying the Notes.  Concurrently with entering into the convertible note hedge transactions, we also entered into separate warrant transactions with each option counterparty whereby we sold to such option counterparty warrants to purchase, subject to customary anti-dilution adjustments, the same number of shares of our common stock.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The convertible note hedge transactions are expected generally to reduce the potential dilution upon conversion of the Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted Notes, as the case may be, in the event that the market price per share of our common stock, as measured under the terms of the convertible note hedge transactions, is greater than the strike price ($<ix:nonFraction unitRef="usdPerShare" contextRef="i4166a58e42b343bfb5ae40145fb70764_D20190129-20190129" decimals="2" name="us-gaap:OptionIndexedToIssuersEquityStrikePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfNjEwMw_d31c1a4c-81ef-4de2-b086-18a0a9401ebb">114.92</ix:nonFraction>) of the convertible note hedge transactions, which initially corresponds to the conversion price of the Notes and is subject to anti-dilution adjustments substantially similar to those applicable to the conversion rate of the Notes.  If, however, the market price per share of our common stock, as measured under the terms of the warrant transactions, exceeds the strike price of the warrants, there would nevertheless be dilution to the extent that such market price exceeds the strike price of the warrants as noted in Note 7, unless we elect to settle the warrants in cash.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfNjcwMA_9ba8ca6d-7cb7-4d3c-ab8d-b347b9011737" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scheduled&#160;maturities&#160;of&#160;long-term&#160;debt outstanding at March&#160;31, 2021 are as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:85.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjY2NzE4YjFmYjFiYTQyNGNhNDA3NGExZDU2YWZlYmRmL3RhYmxlcmFuZ2U6NjY3MThiMWZiMWJhNDI0Y2E0MDc0YTFkNTZhZmViZGZfMC0xLTEtMS0w_377a2307-5ba7-4e64-8cd8-cab2af0aa54b">14,906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjY2NzE4YjFmYjFiYTQyNGNhNDA3NGExZDU2YWZlYmRmL3RhYmxlcmFuZ2U6NjY3MThiMWZiMWJhNDI0Y2E0MDc0YTFkNTZhZmViZGZfMS0xLTEtMS0w_e668b26e-9a75-421c-9a0b-754aacea178b">24,844</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjY2NzE4YjFmYjFiYTQyNGNhNDA3NGExZDU2YWZlYmRmL3RhYmxlcmFuZ2U6NjY3MThiMWZiMWJhNDI0Y2E0MDc0YTFkNTZhZmViZGZfMi0xLTEtMS0w_eed5b040-e3a4-489c-8410-0fb889a54de4">397,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjY2NzE4YjFmYjFiYTQyNGNhNDA3NGExZDU2YWZlYmRmL3RhYmxlcmFuZ2U6NjY3MThiMWZiMWJhNDI0Y2E0MDc0YTFkNTZhZmViZGZfMy0xLTEtMS0w_eb1e6448-7a1f-46e5-a8d1-2589c68a28ee">345,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjY2NzE4YjFmYjFiYTQyNGNhNDA3NGExZDU2YWZlYmRmL3RhYmxlcmFuZ2U6NjY3MThiMWZiMWJhNDI0Y2E0MDc0YTFkNTZhZmViZGZfNC0xLTEtMS0w_6aa94137-4580-4b0b-8334-c3243ff55b1a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The above amounts exclude debt discount, deferred debt issuance costs and financing leases.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div id="i60ea575d4ae7456fa9ff06ec4f3488e0_61"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 10 &#8211; <ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="us-gaap:ProductWarrantyDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82MS9mcmFnOjBjNDg5NDdkMGNkMTRiNTU5MWVlODIwZDQ4OWIxNzA4L3RleHRyZWdpb246MGM0ODk0N2QwY2QxNGI1NTkxZWU4MjBkNDg5YjE3MDhfNjYy_01a38578-6d06-4747-9092-6f547b82b357" continuedAt="i15b1d4f3b0d2438ba3c97bef20831a47" escape="true">Guarantees</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i15b1d4f3b0d2438ba3c97bef20831a47"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide warranties on certain of our products at the time of sale and sell extended warranties.  The standard warranty period for our capital equipment is generally <ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" format="ixt-sec:durwordsen" name="cnmd:ProductWarrantyAccrualTerm" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82MS9mcmFnOjBjNDg5NDdkMGNkMTRiNTU5MWVlODIwZDQ4OWIxNzA4L3RleHRyZWdpb246MGM0ODk0N2QwY2QxNGI1NTkxZWU4MjBkNDg5YjE3MDhfMTk1_2113ed90-c865-4e95-8266-466d6e55294e">one year</ix:nonNumeric> and our extended warranties typically vary from one to three years.  Liability under warranty policies is based upon a review of historical claim experience.  Adjustments are made to accruals as claim data and historical experience warrant.</span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82MS9mcmFnOjBjNDg5NDdkMGNkMTRiNTU5MWVlODIwZDQ4OWIxNzA4L3RleHRyZWdpb246MGM0ODk0N2QwY2QxNGI1NTkxZWU4MjBkNDg5YjE3MDhfNjY5_c9c60c64-ca37-4ad1-ac8d-b1827b7c0f77" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the liability for standard warranties for the three months ended March 31, are as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:77.932%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.018%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1,</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StandardProductWarrantyAccrual" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82MS9mcmFnOjBjNDg5NDdkMGNkMTRiNTU5MWVlODIwZDQ4OWIxNzA4L3RhYmxlOjI4OTViMGIxYmMyNTQyMWQ5YmMxOGQyYzdlM2EzZWVjL3RhYmxlcmFuZ2U6Mjg5NWIwYjFiYzI1NDIxZDliYzE4ZDJjN2UzYTNlZWNfMS0xLTEtMS0w_9d3b3f40-fd89-4314-b6ee-7a1386817b68">1,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e86d4601a4b4430ba15cc2ae32a9336_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StandardProductWarrantyAccrual" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82MS9mcmFnOjBjNDg5NDdkMGNkMTRiNTU5MWVlODIwZDQ4OWIxNzA4L3RhYmxlOjI4OTViMGIxYmMyNTQyMWQ5YmMxOGQyYzdlM2EzZWVjL3RhYmxlcmFuZ2U6Mjg5NWIwYjFiYzI1NDIxZDliYzE4ZDJjN2UzYTNlZWNfMS0zLTEtMS0w_c5b710c5-58fe-4fda-a318-b638821e8461">2,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for warranties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" name="us-gaap:StandardProductWarrantyAccrualWarrantiesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82MS9mcmFnOjBjNDg5NDdkMGNkMTRiNTU5MWVlODIwZDQ4OWIxNzA4L3RhYmxlOjI4OTViMGIxYmMyNTQyMWQ5YmMxOGQyYzdlM2EzZWVjL3RhYmxlcmFuZ2U6Mjg5NWIwYjFiYzI1NDIxZDliYzE4ZDJjN2UzYTNlZWNfMy0xLTEtMS0w_9676ef6f-524f-4caf-823b-50dbbcb5f3c1">291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" name="us-gaap:StandardProductWarrantyAccrualWarrantiesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82MS9mcmFnOjBjNDg5NDdkMGNkMTRiNTU5MWVlODIwZDQ4OWIxNzA4L3RhYmxlOjI4OTViMGIxYmMyNTQyMWQ5YmMxOGQyYzdlM2EzZWVjL3RhYmxlcmFuZ2U6Mjg5NWIwYjFiYzI1NDIxZDliYzE4ZDJjN2UzYTNlZWNfMy0zLTEtMS0w_53e62340-2819-4355-af7c-940e8d39c3f9">355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims made</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" name="us-gaap:StandardProductWarrantyAccrualPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82MS9mcmFnOjBjNDg5NDdkMGNkMTRiNTU5MWVlODIwZDQ4OWIxNzA4L3RhYmxlOjI4OTViMGIxYmMyNTQyMWQ5YmMxOGQyYzdlM2EzZWVjL3RhYmxlcmFuZ2U6Mjg5NWIwYjFiYzI1NDIxZDliYzE4ZDJjN2UzYTNlZWNfNC0xLTEtMS0w_1a1c30b3-85cb-46ed-942f-471ecb62c6b3">206</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" name="us-gaap:StandardProductWarrantyAccrualPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82MS9mcmFnOjBjNDg5NDdkMGNkMTRiNTU5MWVlODIwZDQ4OWIxNzA4L3RhYmxlOjI4OTViMGIxYmMyNTQyMWQ5YmMxOGQyYzdlM2EzZWVjL3RhYmxlcmFuZ2U6Mjg5NWIwYjFiYzI1NDIxZDliYzE4ZDJjN2UzYTNlZWNfNC0zLTEtMS0w_b1814f32-4674-43e5-857b-113db1831a6f">363</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31,</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StandardProductWarrantyAccrual" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82MS9mcmFnOjBjNDg5NDdkMGNkMTRiNTU5MWVlODIwZDQ4OWIxNzA4L3RhYmxlOjI4OTViMGIxYmMyNTQyMWQ5YmMxOGQyYzdlM2EzZWVjL3RhYmxlcmFuZ2U6Mjg5NWIwYjFiYzI1NDIxZDliYzE4ZDJjN2UzYTNlZWNfNi0xLTEtMS0w_0278ce44-fea5-40f5-b65c-bf0bc5bb08ca">1,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c56f028fc084321a0e30cfeaea79a64_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StandardProductWarrantyAccrual" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82MS9mcmFnOjBjNDg5NDdkMGNkMTRiNTU5MWVlODIwZDQ4OWIxNzA4L3RhYmxlOjI4OTViMGIxYmMyNTQyMWQ5YmMxOGQyYzdlM2EzZWVjL3RhYmxlcmFuZ2U6Mjg5NWIwYjFiYzI1NDIxZDliYzE4ZDJjN2UzYTNlZWNfNi0zLTEtMS0w_79f7f61d-2d06-4f66-a540-5afdcf66c884">2,178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs associated with extended warranty repairs are recorded as incurred and amounted to $<ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProductWarrantyExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82MS9mcmFnOjBjNDg5NDdkMGNkMTRiNTU5MWVlODIwZDQ4OWIxNzA4L3RleHRyZWdpb246MGM0ODk0N2QwY2QxNGI1NTkxZWU4MjBkNDg5YjE3MDhfNjE1_aaa64afb-732e-41f7-925c-ef1898de559f">1.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProductWarrantyExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82MS9mcmFnOjBjNDg5NDdkMGNkMTRiNTU5MWVlODIwZDQ4OWIxNzA4L3RleHRyZWdpb246MGM0ODk0N2QwY2QxNGI1NTkxZWU4MjBkNDg5YjE3MDhfNjIy_6f86f920-20ef-403e-824f-50fde9420e11">1.5</ix:nonFraction> million for the three months ended March 31, 2021 and 2020, respectively.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div id="i60ea575d4ae7456fa9ff06ec4f3488e0_64"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 11 &#8211; <ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82NC9mcmFnOjNmYjJmYzI3NjljNzQ1MTU4ZmZjNzljZTM3ZGE1MjZjL3RleHRyZWdpb246M2ZiMmZjMjc2OWM3NDUxNThmZmM3OWNlMzdkYTUyNmNfMzg4_e406ec6f-f076-40ec-a69f-ff1cd247cac6" continuedAt="i0d173c470da24e249ed84d8a14d3b378" escape="true">Pension Plan</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i0d173c470da24e249ed84d8a14d3b378" continuedAt="i0640b52b23f742c3a58a58df35ab3735"><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82NC9mcmFnOjNmYjJmYzI3NjljNzQ1MTU4ZmZjNzljZTM3ZGE1MjZjL3RleHRyZWdpb246M2ZiMmZjMjc2OWM3NDUxNThmZmM3OWNlMzdkYTUyNmNfMzg1_3f745c93-a837-4e40-9722-6c2fbc2d7d7a" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic pension cost consists of the following:&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.990%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82NC9mcmFnOjNmYjJmYzI3NjljNzQ1MTU4ZmZjNzljZTM3ZGE1MjZjL3RhYmxlOjk1YThiMDU0MjllZjRkYjE5OWRiOWJhMmUyNzhlZDJmL3RhYmxlcmFuZ2U6OTVhOGIwNTQyOWVmNGRiMTk5ZGI5YmEyZTI3OGVkMmZfMi0xLTEtMS0w_a86b2ce1-7b5b-4f7b-8c0c-ca0a59e17fd1">248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82NC9mcmFnOjNmYjJmYzI3NjljNzQ1MTU4ZmZjNzljZTM3ZGE1MjZjL3RhYmxlOjk1YThiMDU0MjllZjRkYjE5OWRiOWJhMmUyNzhlZDJmL3RhYmxlcmFuZ2U6OTVhOGIwNTQyOWVmNGRiMTk5ZGI5YmEyZTI3OGVkMmZfMi0zLTEtMS0w_a3ff53ce-aadd-4c22-af4b-b6a5ab316c38">179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on projected benefit obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82NC9mcmFnOjNmYjJmYzI3NjljNzQ1MTU4ZmZjNzljZTM3ZGE1MjZjL3RhYmxlOjk1YThiMDU0MjllZjRkYjE5OWRiOWJhMmUyNzhlZDJmL3RhYmxlcmFuZ2U6OTVhOGIwNTQyOWVmNGRiMTk5ZGI5YmEyZTI3OGVkMmZfNC0xLTEtMS0w_975acdf2-92aa-4a2e-9009-d8a213269975">451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82NC9mcmFnOjNmYjJmYzI3NjljNzQ1MTU4ZmZjNzljZTM3ZGE1MjZjL3RhYmxlOjk1YThiMDU0MjllZjRkYjE5OWRiOWJhMmUyNzhlZDJmL3RhYmxlcmFuZ2U6OTVhOGIwNTQyOWVmNGRiMTk5ZGI5YmEyZTI3OGVkMmZfNC0zLTEtMS0w_80f33fdf-b7ef-46d9-8840-5024318f5605">639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82NC9mcmFnOjNmYjJmYzI3NjljNzQ1MTU4ZmZjNzljZTM3ZGE1MjZjL3RhYmxlOjk1YThiMDU0MjllZjRkYjE5OWRiOWJhMmUyNzhlZDJmL3RhYmxlcmFuZ2U6OTVhOGIwNTQyOWVmNGRiMTk5ZGI5YmEyZTI3OGVkMmZfNi0xLTEtMS0w_9f971663-8181-46db-9edc-818f980fd7f8">1,289</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82NC9mcmFnOjNmYjJmYzI3NjljNzQ1MTU4ZmZjNzljZTM3ZGE1MjZjL3RhYmxlOjk1YThiMDU0MjllZjRkYjE5OWRiOWJhMmUyNzhlZDJmL3RhYmxlcmFuZ2U6OTVhOGIwNTQyOWVmNGRiMTk5ZGI5YmEyZTI3OGVkMmZfNi0zLTEtMS0w_060cd1ee-d40f-4561-a513-c2bad445d8d1">1,255</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amortization and deferral</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82NC9mcmFnOjNmYjJmYzI3NjljNzQ1MTU4ZmZjNzljZTM3ZGE1MjZjL3RhYmxlOjk1YThiMDU0MjllZjRkYjE5OWRiOWJhMmUyNzhlZDJmL3RhYmxlcmFuZ2U6OTVhOGIwNTQyOWVmNGRiMTk5ZGI5YmEyZTI3OGVkMmZfOC0xLTEtMS0w_d9f90f36-36c9-44bf-8f1b-7815ab9c4967">832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82NC9mcmFnOjNmYjJmYzI3NjljNzQ1MTU4ZmZjNzljZTM3ZGE1MjZjL3RhYmxlOjk1YThiMDU0MjllZjRkYjE5OWRiOWJhMmUyNzhlZDJmL3RhYmxlcmFuZ2U6OTVhOGIwNTQyOWVmNGRiMTk5ZGI5YmEyZTI3OGVkMmZfOC0zLTEtMS0w_ee646c38-d5e0-4b50-835d-719fdba02be2">705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82NC9mcmFnOjNmYjJmYzI3NjljNzQ1MTU4ZmZjNzljZTM3ZGE1MjZjL3RhYmxlOjk1YThiMDU0MjllZjRkYjE5OWRiOWJhMmUyNzhlZDJmL3RhYmxlcmFuZ2U6OTVhOGIwNTQyOWVmNGRiMTk5ZGI5YmEyZTI3OGVkMmZfMTAtMS0xLTEtMA_5927a122-9d86-4e87-b0df-2d6c9cd25d68">242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82NC9mcmFnOjNmYjJmYzI3NjljNzQ1MTU4ZmZjNzljZTM3ZGE1MjZjL3RhYmxlOjk1YThiMDU0MjllZjRkYjE5OWRiOWJhMmUyNzhlZDJmL3RhYmxlcmFuZ2U6OTVhOGIwNTQyOWVmNGRiMTk5ZGI5YmEyZTI3OGVkMmZfMTAtMy0xLTEtMA_5304d9ba-dd03-4371-ac68-9ed3b25b9e65">268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0640b52b23f742c3a58a58df35ab3735">We do not expect to make any pension contributions during 2021.  Non-service cost of $<ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="cnmd:DefinedBenefitPlanNonServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82NC9mcmFnOjNmYjJmYzI3NjljNzQ1MTU4ZmZjNzljZTM3ZGE1MjZjL3RleHRyZWdpb246M2ZiMmZjMjc2OWM3NDUxNThmZmM3OWNlMzdkYTUyNmNfMTc5_e96d5d2e-3e20-4fb0-8b62-3f3cfea68928">0.1</ix:nonFraction> million for the three months ended March&#160;31, 2020 is included in other expense in the consolidated condensed statements of comprehensive income (loss).  Non-service pension cost was immaterial for the three months ended March&#160;31, 2021.</ix:continuation> </span></div><div><span><br/></span></div><div id="i60ea575d4ae7456fa9ff06ec4f3488e0_67"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 12 &#8211; <ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="cnmd:AcquisitionandOtherExpenseTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82Ny9mcmFnOmNjYmNmMDU0MjFiNTQ0YmZhMjIzMDAxZTBiMWEwYTJlL3RleHRyZWdpb246Y2NiY2YwNTQyMWI1NDRiZmEyMjMwMDFlMGIxYTBhMmVfMzk0Nw_408f17fb-784d-4e89-ae79-16b525b52d14" continuedAt="i4a3d5507ed694c7eab3490e6afbb4576" escape="true">Acquisition and Other Expense</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:continuation id="i4a3d5507ed694c7eab3490e6afbb4576" continuedAt="i7a0e2886cc1d4488ade55c1e7142bd6e"><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="cnmd:ScheduleOfAcquisitionAndOtherOperatingExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82Ny9mcmFnOmNjYmNmMDU0MjFiNTQ0YmZhMjIzMDAxZTBiMWEwYTJlL3RleHRyZWdpb246Y2NiY2YwNTQyMWI1NDRiZmEyMjMwMDFlMGIxYTBhMmVfMzk1NA_2ab5096f-0345-4aa4-9f01-2a1bed634828" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Acquisition and other expense consist of the following, which are included in cost of sales or selling and administrative expense depending on the nature of the charge:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:80.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing consolidation costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4cfe412f15e40679fed8fb1ab50ff59_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="cnmd:Manufacturingconsolidationcosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82Ny9mcmFnOmNjYmNmMDU0MjFiNTQ0YmZhMjIzMDAxZTBiMWEwYTJlL3RhYmxlOjU4MWU5NWM0ZGEzODRhMjE4YTEzYjNiMjczYjgyMzk0L3RhYmxlcmFuZ2U6NTgxZTk1YzRkYTM4NGEyMThhMTNiM2IyNzNiODIzOTRfNy0xLTEtMS0w_016c0be1-c23e-4e52-aab7-0e4c5f539232">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if891372cb88f49d1ad8cf68161f49100_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="cnmd:Manufacturingconsolidationcosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82Ny9mcmFnOmNjYmNmMDU0MjFiNTQ0YmZhMjIzMDAxZTBiMWEwYTJlL3RhYmxlOjU4MWU5NWM0ZGEzODRhMjE4YTEzYjNiMjczYjgyMzk0L3RhYmxlcmFuZ2U6NTgxZTk1YzRkYTM4NGEyMThhMTNiM2IyNzNiODIzOTRfNy0zLTEtMS0w_1faf3101-f835-4cd6-a045-7a1703e0ff69">1,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4cfe412f15e40679fed8fb1ab50ff59_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82Ny9mcmFnOmNjYmNmMDU0MjFiNTQ0YmZhMjIzMDAxZTBiMWEwYTJlL3RhYmxlOjU4MWU5NWM0ZGEzODRhMjE4YTEzYjNiMjczYjgyMzk0L3RhYmxlcmFuZ2U6NTgxZTk1YzRkYTM4NGEyMThhMTNiM2IyNzNiODIzOTRfOC0xLTEtMS0w_8b7831a4-d4a2-439e-8216-7cdcfcc30dd4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if891372cb88f49d1ad8cf68161f49100_D20200101-20200331" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82Ny9mcmFnOmNjYmNmMDU0MjFiNTQ0YmZhMjIzMDAxZTBiMWEwYTJlL3RhYmxlOjU4MWU5NWM0ZGEzODRhMjE4YTEzYjNiMjczYjgyMzk0L3RhYmxlcmFuZ2U6NTgxZTk1YzRkYTM4NGEyMThhMTNiM2IyNzNiODIzOTRfOC0zLTEtMS0w_2ee8c869-1906-4ea6-a2d9-24f9a09fc1af">805</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and other expense included in cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4cfe412f15e40679fed8fb1ab50ff59_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherCostAndExpenseOperating" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82Ny9mcmFnOmNjYmNmMDU0MjFiNTQ0YmZhMjIzMDAxZTBiMWEwYTJlL3RhYmxlOjU4MWU5NWM0ZGEzODRhMjE4YTEzYjNiMjczYjgyMzk0L3RhYmxlcmFuZ2U6NTgxZTk1YzRkYTM4NGEyMThhMTNiM2IyNzNiODIzOTRfOS0xLTEtMS0w_c62fb990-d46c-4776-9539-b9ea96ac9285">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if891372cb88f49d1ad8cf68161f49100_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherCostAndExpenseOperating" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82Ny9mcmFnOmNjYmNmMDU0MjFiNTQ0YmZhMjIzMDAxZTBiMWEwYTJlL3RhYmxlOjU4MWU5NWM0ZGEzODRhMjE4YTEzYjNiMjczYjgyMzk0L3RhYmxlcmFuZ2U6NTgxZTk1YzRkYTM4NGEyMThhMTNiM2IyNzNiODIzOTRfOS0zLTEtMS0w_f39e3e4d-a9e0-4a2d-96f2-e2ad47916a78">2,590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and related costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c05d83ea1e6498489016ad7d59cf236_D20210101-20210331" decimals="-3" name="cnmd:RestructuringAndRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82Ny9mcmFnOmNjYmNmMDU0MjFiNTQ0YmZhMjIzMDAxZTBiMWEwYTJlL3RhYmxlOjU4MWU5NWM0ZGEzODRhMjE4YTEzYjNiMjczYjgyMzk0L3RhYmxlcmFuZ2U6NTgxZTk1YzRkYTM4NGEyMThhMTNiM2IyNzNiODIzOTRfMTItMS0xLTEtMA_30e9070a-797c-46fa-9917-3b844e0fae9f">414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e04b4ea73e04184933b0223f3525651_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="cnmd:RestructuringAndRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82Ny9mcmFnOmNjYmNmMDU0MjFiNTQ0YmZhMjIzMDAxZTBiMWEwYTJlL3RhYmxlOjU4MWU5NWM0ZGEzODRhMjE4YTEzYjNiMjczYjgyMzk0L3RhYmxlcmFuZ2U6NTgxZTk1YzRkYTM4NGEyMThhMTNiM2IyNzNiODIzOTRfMTItMy0xLTEtMA_61abfb27-dd5d-4a68-8244-ee442ee754fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration costs </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c05d83ea1e6498489016ad7d59cf236_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82Ny9mcmFnOmNjYmNmMDU0MjFiNTQ0YmZhMjIzMDAxZTBiMWEwYTJlL3RhYmxlOjU4MWU5NWM0ZGEzODRhMjE4YTEzYjNiMjczYjgyMzk0L3RhYmxlcmFuZ2U6NTgxZTk1YzRkYTM4NGEyMThhMTNiM2IyNzNiODIzOTRfMTQtMS0xLTEtMA_b24e6308-c058-4366-be01-0e0f35230e2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e04b4ea73e04184933b0223f3525651_D20200101-20200331" decimals="-3" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82Ny9mcmFnOmNjYmNmMDU0MjFiNTQ0YmZhMjIzMDAxZTBiMWEwYTJlL3RhYmxlOjU4MWU5NWM0ZGEzODRhMjE4YTEzYjNiMjczYjgyMzk0L3RhYmxlcmFuZ2U6NTgxZTk1YzRkYTM4NGEyMThhMTNiM2IyNzNiODIzOTRfMTQtMy0xLTEtMA_8f836247-8ea7-4d99-a5db-a9815fc3aa18">754</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and other expense included in selling and administrative expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c05d83ea1e6498489016ad7d59cf236_D20210101-20210331" decimals="-3" name="us-gaap:OtherCostAndExpenseOperating" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82Ny9mcmFnOmNjYmNmMDU0MjFiNTQ0YmZhMjIzMDAxZTBiMWEwYTJlL3RhYmxlOjU4MWU5NWM0ZGEzODRhMjE4YTEzYjNiMjczYjgyMzk0L3RhYmxlcmFuZ2U6NTgxZTk1YzRkYTM4NGEyMThhMTNiM2IyNzNiODIzOTRfMTUtMS0xLTEtMA_b49dbcf3-c3d8-43bd-8ea6-b7428a1448f9">414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e04b4ea73e04184933b0223f3525651_D20200101-20200331" decimals="-3" name="us-gaap:OtherCostAndExpenseOperating" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82Ny9mcmFnOmNjYmNmMDU0MjFiNTQ0YmZhMjIzMDAxZTBiMWEwYTJlL3RhYmxlOjU4MWU5NWM0ZGEzODRhMjE4YTEzYjNiMjczYjgyMzk0L3RhYmxlcmFuZ2U6NTgxZTk1YzRkYTM4NGEyMThhMTNiM2IyNzNiODIzOTRfMTUtMy0xLTEtMA_ce78d048-b5e0-4620-87d4-31bbaeddbfbd">754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2020, we incurred $<ix:nonFraction unitRef="usd" contextRef="if891372cb88f49d1ad8cf68161f49100_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="cnmd:Manufacturingconsolidationcosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82Ny9mcmFnOmNjYmNmMDU0MjFiNTQ0YmZhMjIzMDAxZTBiMWEwYTJlL3RleHRyZWdpb246Y2NiY2YwNTQyMWI1NDRiZmEyMjMwMDFlMGIxYTBhMmVfMTA5OTUxMTYzODg0NQ_c495f97c-3305-439b-a894-0788224789af">1.8</ix:nonFraction>&#160;million in costs related to the consolidation of certain manufacturing operations which were charged to cost of sales.  These costs related to winding down operations at certain locations and moving production lines to other facilities. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2020, we incurred costs for inventory step-up adjustments and other costs of $<ix:nonFraction unitRef="usd" contextRef="if891372cb88f49d1ad8cf68161f49100_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82Ny9mcmFnOmNjYmNmMDU0MjFiNTQ0YmZhMjIzMDAxZTBiMWEwYTJlL3RleHRyZWdpb246Y2NiY2YwNTQyMWI1NDRiZmEyMjMwMDFlMGIxYTBhMmVfMTA5OTUxMTYzOTU4OA_0ce8baad-5285-4493-964d-706f559baf58">0.8</ix:nonFraction> million related to a previous acquisition, which were charged to cost of sales.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2020, we incurred $<ix:nonFraction unitRef="usd" contextRef="i7e04b4ea73e04184933b0223f3525651_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82Ny9mcmFnOmNjYmNmMDU0MjFiNTQ0YmZhMjIzMDAxZTBiMWEwYTJlL3RleHRyZWdpb246Y2NiY2YwNTQyMWI1NDRiZmEyMjMwMDFlMGIxYTBhMmVfMTA5OTUxMTYzOTYwNQ_ff629d44-fd81-4c6a-868c-60d9dd9b542a">0.8</ix:nonFraction> million in severance and integration costs mainly related to the Buffalo Filter acquisition, which were included in selling and administrative expense.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2021, we recorded a charge of $<ix:nonFraction unitRef="usd" contextRef="i1c05d83ea1e6498489016ad7d59cf236_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="cnmd:RestructuringAndRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82Ny9mcmFnOmNjYmNmMDU0MjFiNTQ0YmZhMjIzMDAxZTBiMWEwYTJlL3RleHRyZWdpb246Y2NiY2YwNTQyMWI1NDRiZmEyMjMwMDFlMGIxYTBhMmVfMjE5OTAyMzI4NzI4MQ_0f845c75-c764-4c55-a1a3-1bc9f4d410b7">0.4</ix:nonFraction> million related to the restructuring of our sales force which was charged to selling and administrative expense.  The charges for sales force restructuring consisted </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7a0e2886cc1d4488ade55c1e7142bd6e">primarily of termination payments to Orthopedic distributors made in exchange for ongoing assistance to transition to employee-based sales representatives and severance.</ix:continuation></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i60ea575d4ae7456fa9ff06ec4f3488e0_70"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 13 &#8212; <ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF83MC9mcmFnOmZmNTc2N2Y0ZjRkYzQzNTBhZDk3MjRkNjY2OGMwNWQ4L3RleHRyZWdpb246ZmY1NzY3ZjRmNGRjNDM1MGFkOTcyNGQ2NjY4YzA1ZDhfMTI0Nw_dac0adee-72c5-42f9-88e2-1f1018728096" continuedAt="ib598b09b386c4769b67bc44d320a9457" escape="true">Business Segment</ix:nonNumeric></span></div><ix:continuation id="ib598b09b386c4769b67bc44d320a9457"><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are accounting and reporting for our business as a single operating segment entity engaged in the development, manufacturing and sale on a global basis of surgical devices and related equipment.  Our chief operating decision maker (the CEO) evaluates the various global product portfolios on a net sales basis and evaluates profitability, investment, cash flow metrics and allocates resources on a consolidated worldwide basis due to shared infrastructure and resources.  Our product lines consist of orthopedic surgery and general surgery.  Orthopedic surgery consists of sports medicine instrumentation and small bone, large bone and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures including 2DHD vision technologies and fees related to the sales representation, promotion and marketing of sports medicine allograft tissue.  General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.  <ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF83MC9mcmFnOmZmNTc2N2Y0ZjRkYzQzNTBhZDk3MjRkNjY2OGMwNWQ4L3RleHRyZWdpb246ZmY1NzY3ZjRmNGRjNDM1MGFkOTcyNGQ2NjY4YzA1ZDhfMTI0NQ_4798febe-987f-4e03-85f9-df5c5dd3ee30" continuedAt="i65945c501a254e7f801a551b9f4b372a" escape="true">These product lines' net sales are as follows:</ix:nonNumeric></span></div><div style="margin-top:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><ix:continuation id="i65945c501a254e7f801a551b9f4b372a"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.113%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orthopedic surgery</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia86b4262c6984bb6ad658ce074db008e_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF83MC9mcmFnOmZmNTc2N2Y0ZjRkYzQzNTBhZDk3MjRkNjY2OGMwNWQ4L3RhYmxlOjY0YjBmNTMwNTg3ZjQ3MjM5NjllNTgzZTNiZjk1YWU4L3RhYmxlcmFuZ2U6NjRiMGY1MzA1ODdmNDcyMzk2OWU1ODNlM2JmOTVhZThfMi0xLTEtMS0w_c78cb339-44db-4c4f-ab34-513784e5bea7">107,166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9557a8db05ee41ffaa88a992a0b82938_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF83MC9mcmFnOmZmNTc2N2Y0ZjRkYzQzNTBhZDk3MjRkNjY2OGMwNWQ4L3RhYmxlOjY0YjBmNTMwNTg3ZjQ3MjM5NjllNTgzZTNiZjk1YWU4L3RhYmxlcmFuZ2U6NjRiMGY1MzA1ODdmNDcyMzk2OWU1ODNlM2JmOTVhZThfMi0zLTEtMS0w_ea6cd1d3-9a21-4e24-8032-53dc699729df">99,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General surgery</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id802a374e8af403cb3d3822bd10d7c08_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF83MC9mcmFnOmZmNTc2N2Y0ZjRkYzQzNTBhZDk3MjRkNjY2OGMwNWQ4L3RhYmxlOjY0YjBmNTMwNTg3ZjQ3MjM5NjllNTgzZTNiZjk1YWU4L3RhYmxlcmFuZ2U6NjRiMGY1MzA1ODdmNDcyMzk2OWU1ODNlM2JmOTVhZThfMy0xLTEtMS0w_5dcbfaf8-8b0d-4672-bd4b-009b9a6781e0">125,511</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a7ac877916a4014a3fb26b999be79af_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF83MC9mcmFnOmZmNTc2N2Y0ZjRkYzQzNTBhZDk3MjRkNjY2OGMwNWQ4L3RhYmxlOjY0YjBmNTMwNTg3ZjQ3MjM5NjllNTgzZTNiZjk1YWU4L3RhYmxlcmFuZ2U6NjRiMGY1MzA1ODdmNDcyMzk2OWU1ODNlM2JmOTVhZThfMy0zLTEtMS0w_bd6a029b-92a4-43e1-bf95-4fea556f6c9f">114,727</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF83MC9mcmFnOmZmNTc2N2Y0ZjRkYzQzNTBhZDk3MjRkNjY2OGMwNWQ4L3RhYmxlOjY0YjBmNTMwNTg3ZjQ3MjM5NjllNTgzZTNiZjk1YWU4L3RhYmxlcmFuZ2U6NjRiMGY1MzA1ODdmNDcyMzk2OWU1ODNlM2JmOTVhZThfNC0xLTEtMS0w_6af0d646-a0c6-4e1a-adcd-bff49c5599c1">232,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF83MC9mcmFnOmZmNTc2N2Y0ZjRkYzQzNTBhZDk3MjRkNjY2OGMwNWQ4L3RhYmxlOjY0YjBmNTMwNTg3ZjQ3MjM5NjllNTgzZTNiZjk1YWU4L3RhYmxlcmFuZ2U6NjRiMGY1MzA1ODdmNDcyMzk2OWU1ODNlM2JmOTVhZThfNC0zLTEtMS0w_ba3c4551-8ebc-42af-adb5-67eff33cb5ad">214,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div id="i60ea575d4ae7456fa9ff06ec4f3488e0_73"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 14 &#8211; <ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="us-gaap:LegalMattersAndContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF83My9mcmFnOjM3Nzg0ZWYzNTIwZDQ2OGM4MTA3YzI5MTg5NjZmMDMyL3RleHRyZWdpb246Mzc3ODRlZjM1MjBkNDY4YzgxMDdjMjkxODk2NmYwMzJfODA2OA_fe57294b-fd9b-4e4f-a44c-d406c2998681" continuedAt="i0441cea7fadd46c19a507a9a91876e19" escape="true">Legal Proceedings</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i0441cea7fadd46c19a507a9a91876e19" continuedAt="if70b2d3eb07d42768bd44220375bc5cc"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company may receive an information request, subpoena or warrant from a government agency such as the Securities and Exchange Commission, Department of Justice, Equal Employment Opportunity Commission, the Occupational Safety and Health Administration, the United States Food and Drug Administration, the Department of Labor, the Treasury Department or other federal and state agencies or foreign governments or government agencies.  These information requests, subpoenas or warrants may or may not be routine inquiries, or may begin as routine inquiries and over time develop into enforcement actions of various types.  Likewise, if we receive reports of alleged misconduct from employees and third parties, we investigate as appropriate.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturers of medical devices have been the subject of various enforcement actions relating to interactions with health care providers domestically or internationally whereby companies are claimed to have provided health care providers with inappropriate incentives to purchase their products.  Similarly, the Foreign Corrupt Practices Act ("FCPA") imposes obligations on manufacturers with respect to interactions with health care providers who may be considered government officials based on their affiliation with public hospitals.  The FCPA also requires publicly listed manufacturers to maintain accurate books and records, and maintain internal accounting controls sufficient to provide assurance that transactions are accurately recorded, lawful and in accordance with management's authorization.  The FCPA poses unique challenges both because manufacturers operate in foreign cultures in which conduct illegal under the FCPA may not be illegal in local jurisdictions, and because, in some cases, a United States manufacturer may face risks under the FCPA based on the conduct of third parties over whom the manufacturer may not have complete control.  While CONMED has not experienced any material enforcement action to date, there can be no assurance that the Company will not be subject to a material enforcement action in the future, or that the Company will not incur costs including, in the form of fees for lawyers and other consultants, that are material to the Company&#8217;s results of operations in the course of responding to a future inquiry or investigation.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturers of medical products may face exposure to significant product liability claims, as well as patent infringement and other claims incurred in the ordinary course of business.  To date, we have not experienced any claims that have been material to our financial statements or financial condition, but any such claims arising in the future could have a material adverse effect on our business, results of operations or cash flows.  We currently maintain commercial product liability insurance of $<ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-6" format="ixt:numdotdecimal" name="cnmd:ProductLiabilityContingencyInsuranceAmountPerIncident" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF83My9mcmFnOjM3Nzg0ZWYzNTIwZDQ2OGM4MTA3YzI5MTg5NjZmMDMyL3RleHRyZWdpb246Mzc3ODRlZjM1MjBkNDY4YzgxMDdjMjkxODk2NmYwMzJfMjg4MQ_7e934365-0aca-4bd1-baea-15131b457b1e">30</ix:nonFraction> million per incident and $<ix:nonFraction unitRef="usd" contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331" decimals="-6" format="ixt:numdotdecimal" name="cnmd:ProductLiabilityContingencyInsuranceAggregateAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF83My9mcmFnOjM3Nzg0ZWYzNTIwZDQ2OGM4MTA3YzI5MTg5NjZmMDMyL3RleHRyZWdpb246Mzc3ODRlZjM1MjBkNDY4YzgxMDdjMjkxODk2NmYwMzJfMjkwMQ_49f6fd9d-b7df-4ed2-981b-cb2294a3398d">30</ix:nonFraction> million in the aggregate annually, which we believe is adequate.  This coverage is on a claims-made basis.  There can be no assurance that claims will not exceed insurance coverage, that the carriers will be solvent or that such insurance will be available to us in the future at a reasonable cost.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations are subject, and in the past have been subject, to a number of environmental laws and regulations governing, among other things, air emissions; wastewater discharges; the use, handling and disposal of hazardous substances </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_7">Table of Contents</a></span></div></div><ix:continuation id="if70b2d3eb07d42768bd44220375bc5cc"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and wastes; soil and groundwater remediation and employee health and safety.  Likewise, the operations of our suppliers and sterilizers are subject to similar environmental laws and regulations.  In some jurisdictions, environmental requirements may be expected to become more stringent in the future.  In the United States, certain environmental laws can impose liability for the entire cost of site restoration upon each of the parties that may have contributed to conditions at the site regardless of fault or the lawfulness of the party&#8217;s activities.  While we do not believe that the present costs of environmental compliance and remediation are material, there can be no assurance that future compliance or remedial obligations would not have a material adverse effect on our financial condition, results of operations or cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2014, the Company acquired EndoDynamix, Inc.  The agreement governing the terms of the acquisition provides that, if various conditions are met, certain contingent payments relating to the first commercial sale of the products (the milestone payment), as well as royalties based on sales (the revenue based payments), are due to the seller.  In 2016, we notified the seller that there was a need to redesign the product, and that, as a consequence, the first commercial sale had been delayed.  Consequently, the payment of contingent milestone and revenue-based payments were delayed.  On January 18, 2017, the seller provided notice ("the Notice") seeking $<ix:nonFraction unitRef="usd" contextRef="id854f60e596745a88a6555bfb8baa9c8_D20170118-20170118" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesSoughtValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF83My9mcmFnOjM3Nzg0ZWYzNTIwZDQ2OGM4MTA3YzI5MTg5NjZmMDMyL3RleHRyZWdpb246Mzc3ODRlZjM1MjBkNDY4YzgxMDdjMjkxODk2NmYwMzJfNDkzNA_ca8049a3-56fd-4185-8cc6-82ecd38b8699">12.7</ix:nonFraction> million under a liquidated damages clause, which essentially represents the seller's view as to the sum of the projected contingent milestone and revenue-based payments on an accelerated basis.  CONMED responded to the Notice denying that there was any basis for acceleration of the payments due under the acquisition agreement.  On February 22, 2017, the representative of the former shareholders of EndoDynamix filed a complaint in Delaware Chancery Court claiming breach of contract with respect to the duty to commercialize the product and seeking the contingent payments on an accelerated basis.  We believe that there was a substantive contractual basis to support the Company's decision to redesign the product, such that there was no legitimate basis for seeking the liquidated damages.  In the third quarter of 2018, the Company decided to halt the development of the EndoDynamix clip applier.  We previously recorded a charge to write off assets and released a previously accrued contingent consideration liability.  In a pre-trial filing the Plaintiffs claim to seek liquidated damages, as well as additional damages up to $<ix:nonFraction unitRef="usd" contextRef="i82aee7908b334a16816b4969f87ddeaa_D20170118-20170118" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesSoughtValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF83My9mcmFnOjM3Nzg0ZWYzNTIwZDQ2OGM4MTA3YzI5MTg5NjZmMDMyL3RleHRyZWdpb246Mzc3ODRlZjM1MjBkNDY4YzgxMDdjMjkxODk2NmYwMzJfMTA5OTUxMTYzNjA3Mw_4fdc6779-2d0f-4735-b85a-c9cf4c4903a5">24.8</ix:nonFraction>&#160;million.  A non-jury trial in the Delaware Chancery Court commenced on March 18, 2021, and testimony concluded on April 7, 2021.  We expect the parties to submit post-trial briefs in the second quarter of 2021, with the Court to hear oral arguments at a hearing scheduled for July 22, 2021, and the Court to issue a ruling at some point thereafter.  The Company has not recorded any expense related to potential damages in connection with this matter because the Company does not believe any potential loss is probable.  We expect to defend the claims asserted by the sellers of EndoDynamix,  although there can be no assurance that we will prevail in the trial and/or any resulting appeals. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record reserves sufficient to cover probable and estimable losses associated with any such pending claims.  We do not expect that the resolution of any pending claims, investigations or reports of alleged misconduct will have a material adverse effect on our financial condition, results of operations or cash flows.  There can be no assurance, however, that future claims or investigations, or the costs associated with responding to such claims, investigations or reports of misconduct, especially claims and investigations not covered by insurance, will not have a material adverse effect on our financial condition, results of operations or cash flows.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i60ea575d4ae7456fa9ff06ec4f3488e0_76"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 15 &#8211; <ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF83Ni9mcmFnOjRiOTUyN2IyNGI2ZTQ3MmZiYzhlMDVlNmIwOGViMmVhL3RleHRyZWdpb246NGI5NTI3YjI0YjZlNDcyZmJjOGUwNWU2YjA4ZWIyZWFfNDU1MA_458366d5-5bc8-4039-82e5-6851c614abfb" continuedAt="i7d5aac67c1624c83b82f54588d906284" escape="true"><ix:nonNumeric contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF83Ni9mcmFnOjRiOTUyN2IyNGI2ZTQ3MmZiYzhlMDVlNmIwOGViMmVhL3RleHRyZWdpb246NGI5NTI3YjI0YjZlNDcyZmJjOGUwNWU2YjA4ZWIyZWFfNDU1Mw_c5cd72dd-5f5f-4218-8f94-eb84852f6239" continuedAt="i8eaa12ad007545bc9ed8583d2b389589" escape="true">New Accounting Pronouncements</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i7d5aac67c1624c83b82f54588d906284"><ix:continuation id="i8eaa12ad007545bc9ed8583d2b389589"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Standards, Not Yet Adopted</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional guidance if certain criteria are met for entities that have contracts, hedging relationships, and other transactions that reference LIBOR or other reference rates expected to be discontinued as a result of reference rate reform.  This ASU is effective as of March 12, 2020 through December 31, 2022.  The Company has not adopted this ASU as of March&#160;31, 2021, however will continue to monitor the impact of reference rates and will elect to apply this guidance in our consolidated financial statements in the event that we are impacted by reference rate reform.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity, which simplifies the accounting for convertible instruments by removing certain separation models requiring separate accounting for embedded conversion features which will result in more convertible debt instruments accounted for as a single liability.  The ASU eliminates certain settlement conditions that are required for equity classification to qualify for the derivative scope exception.  The ASU addresses how convertible instruments are accounted for in the calculation of diluted earnings per share by using the if-converted method.  The ASU is effective for fiscal years beginning after December 15, 2021, with early adoption permitted no earlier than fiscal years beginning after December 15, 2020.  The Company is currently assessing the impact of this guidance on our consolidated financial statements.</span></div></ix:continuation></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="i60ea575d4ae7456fa9ff06ec4f3488e0_85"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:19.837%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:57.025%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION<br/>&#160;AND RESULTS OF OPERATIONS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this Report on Form 10-Q, we make forward-looking statements about our financial condition, results of operations and business.  Forward-looking statements are statements made by us concerning events that may or may not occur in the future.  These statements may be made directly in this document or may be &#8220;incorporated by reference&#8221; from other documents.  Such statements may be identified by the use of words such as &#8220;anticipates&#8221;, &#8220;expects&#8221;, &#8220;estimates&#8221;, &#8220;intends&#8221; and &#8220;believes&#8221; and variations thereof and other terms of similar meaning.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements are not Guarantees of Future Performance</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements involve known and unknown risks, uncertainties and other factors, including those that may cause our actual results, performance or achievements or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.  Such factors include those identified under &#8220;Risk Factors&#8221; in our Annual Report on Form 10-K for the year-ended December&#160;31, 2020 and the following, among others:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic and business conditions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">compliance with and changes in regulatory requirements;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">COVID-19 global pandemic poses significant risks to our business, financial condition and results of operations, which may be heightened if the pandemic, and various government responses to it, continue for an extended period of time;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.15pt">environmental compliance risks, including lack of availability of sterilization with Ethylene Oxide (&#8220;EtO&#8221;) or other compliance costs associated with the use of EtO; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the possibility that United States or foreign regulatory and/or administrative agencies may initiate enforcement actions against us or our distributors;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competition;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in customer preferences;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in technology;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the introduction and acceptance of new products;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the availability and cost of materials;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the risk of an information security breach, including a cybersecurity breach;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">cyclical customer purchasing patterns due to budgetary and other constraints;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the quality of our management and business abilities and the judgment of our personnel;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the availability, terms and deployment of capital;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">future levels of indebtedness and capital spending;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in foreign exchange and interest rates;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability to evaluate, finance and integrate acquired businesses, products and companies;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in business strategy;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the risk of a lack of allograft tissues due to reduced donations of such tissues or due to tissues not meeting the appropriate high standards for screening and/or processing of such tissues; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability to defend and enforce intellectual property</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> including the risks related to theft or compromise of intellectual property in connection with our international operations;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the risk of patent, product and other litigation, as well as the cost associated with such litigation; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">trade protection measures, tariffs and other border taxes, and import or export licensing requirements.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; below and &#8220;Risk Factors&#8221; and &#8220;Business&#8221; in our Annual Report on Form 10-K for the year-ended December&#160;31, 2020 for a further discussion of these factors.  You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.  We do not undertake any obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date of this Quarterly Report on Form 10-Q or to reflect the occurrence of unanticipated events.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONMED Corporation (&#8220;CONMED&#8221;, the &#8220;Company&#8221;, &#8220;we&#8221; or &#8220;us&#8221;) is a medical technology company that provides surgical devices and equipment for minimally invasive procedures.  The Company&#8217;s products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our product lines consist of orthopedic surgery and general surgery.  Orthopedic surgery consists of sports medicine instrumentation and small bone, large bone and specialty powered surgical instruments as well as, imaging systems for use in minimally invasive surgery procedures including 2DHD vision technologies and service fees related to the promotion and marketing of sports medicine allograft tissue.  General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.  These product lines as a percentage of consolidated net sales are as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.113%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orthopedic surgery</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General surgery</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant amount of our products are used in surgical procedures with approximately 81% of our revenues derived from the sale of single-use products.  Our capital equipment offerings also facilitate the ongoing sale of related single-use products and accessories, thus providing us with a recurring revenue stream.  We manufacture substantially all of our products in facilities located in the United States and Mexico.  We market our products both domestically and internationally directly to customers and through distributors.  International sales approximated 47% and 44% during the three months ended March 31, 2021 and 2020, respectively.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Environment </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business has been significantly impacted by the emergence of the COVID-19 pandemic, first in the Asia Pacific geography and later in the United States, Europe and elsewhere as temporary closures occurred and hospitals and surgery centers postponed many non-urgent surgical procedures in order to minimize the risk of infection.&#160; In compliance with various governmental orders, beginning in March 2020 we restricted access to our main facilities to only essential personnel required to be onsite while maintaining production and distribution.&#160; During the first quarter of 2021, revenues increased compared to the first quarter of 2020.  We have seen and believe we will continue to experience geographic disparities in the recovery efforts associated with the COVID-19 pandemic.   We expect general surgery to rebound faster than orthopedic surgery due to the nature of the products.  However, the extent and duration of the adverse impact of COVID-19 on our business are still uncertain, rapidly changing and are subject to factors outside of our control.  See additional discussion in Liquidity and Capital Resources below.&#160; </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preparation of our financial statements requires us to make estimates and assumptions which affect the reported amounts of assets, liabilities, revenues and expenses.  Note 1 to the Consolidated Financial Statements in our Annual Report on Form 10-K for the year-ended December&#160;31, 2020 describes the significant accounting policies used in preparation of the Consolidated Financial Statements.  On an ongoing basis, we evaluate the critical accounting policies used to prepare our consolidated financial statements, including, but not limited to, those related to goodwill and intangible assets and our pension benefit obligation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i60ea575d4ae7456fa9ff06ec4f3488e0_88"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Results of Operations</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents, as a percentage of net sales, certain categories included in our consolidated condensed statements of income for the periods indicated:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.113%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit from income taxes </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:22.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Sales</span></div><div style="margin-top:9pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents net sales by product line for the three months ended March 31, 2021 and 2020:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:40.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.060%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.060%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.060%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.060%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Impact of Foreign Currency</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Constant Currency</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orthopedic surgery</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-2.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General surgery</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-1.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-1.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Single-use products</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital products</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-2.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-1.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales increased 8.7% in the three months ended March&#160;31, 2021 compared to the same period a year ago driven by increases in both our orthopedic surgery and general surgery product lines. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Orthopedic surgery sales increased 7.9% in the three months ended March&#160;31, 2021 mainly driven by higher capital sales in our power and visualization products as well as an increase in our single-use products as hospitals and surgery centers increased the number of non-urgent surgeries.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">General surgery sales increased 9.4% in the three months ended March&#160;31, 2021 mainly driven by continued growth in our advanced surgical products, including in our Buffalo Filter and AirSeal products.  We believe the deferral of non-urgent procedures has had a lesser impact on our general surgery products as a result of the nature of the products and procedures in which they are used.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cost of Sales </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales increased to $104.2 million in the three months ended March&#160;31, 2021 as compared to $94.9 million in the three months ended March&#160;31, 2020.  Gross profit margins decreased 50 basis points to 55.2% in the three months ended March&#160;31, 2021 as compared to 55.7% in the three months ended March&#160;31, 2020.  The decrease in gross profit margin of 50 basis points was primarily a result of unfavorable production variances recognized during the first quarter of 2021.  Offsetting this decrease in gross profit margins was the absence in 2021 of certain costs incurred in 2020 including $1.8&#160;million in charges related to manufacturing consolidation costs and $0.8&#160;million in charges related to inventory adjustments and other costs related to a prior acquisition as more fully described in Note 12.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Selling and Administrative Expense</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling and administrative expense increased to $98.3 million in the three months ended March&#160;31, 2021 as compared to $95.9 million in the three months ended March&#160;31, 2020.  Selling and administrative expense as a percentage of net sales decreased to 42.3% in the three months ended March&#160;31, 2021 compared to 44.8% in the three months ended March&#160;31, 2020.  The decrease in selling and administrative expense as a percentage of net sales for the three months ended March&#160;31, 2021 was driven mainly by actions taken to reduce expenses in response to the COVID-19 pandemic.  During 2021, we experienced reduced travel due to safety measures put in place and reduced trade show costs as shows were cancelled.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development Expense</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense remained relatively flat at $10.0 million in the three months ended March&#160;31, 2021 as compared to $10.1 million in the three months ended March&#160;31, 2020.  As a percentage of net sales, research and development expense decreased 40 basis points to 4.3% in the three months ended March&#160;31, 2021 as compared to 4.7% in the three months ended  March&#160;31, 2020.  The lower spend as a percentage of sales is driven by higher sales in 2021.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Expense</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense increased to $10.4 million in the three months ended March&#160;31, 2021 from $9.6 million in the three months ended March&#160;31, 2020.  The weighted average interest rates on our borrowings increased to 3.37% in the three months ended March&#160;31, 2021 as compared to 3.12% in the three months ended March&#160;31, 2020.  The increase in interest expense during the three months ended March&#160;31, 2021 was due to higher interest rates as compared to the prior period resulting from the amendments to our senior credit facility during 2020 as more fully described in Note 9.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Expense</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense in the three months ended March&#160;31, 2020 is related to non-service pension costs as further described in Note 11.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Benefit from Income Taxes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Income tax benefit has been recorded at an effective tax rate of (1.3)% for the three months ended March&#160;31, 2021 compared to (69.8)% for the three months ended March&#160;31, 2020.  The higher effective tax rate for the three months ended March&#160;31, 2021 as compared to the same period a year ago was primarily the result of higher income in 2021.  The increased income generated more tax expense for the quarter and reduced the discrete tax benefit as a percentage of income.  Federal tax deductions relating to stock option exercises and federal tax benefit relating to the issuance of tax regulations regarding US tax of foreign earnings at different rates provided a discrete tax benefit which decreased the effective rate by 28.1% for the three months ended March&#160;31, 2021 as compared to discrete income tax benefit associated with stock options and settlements with tax authorities which decreased the effective tax rate by 79.9% for the three months ended March&#160;31, 2020.  A reconciliation of the United States statutory income tax rate to our effective tax rate is included in our Annual Report on Form 10-K for the year ended December&#160;31, 2020, under Note 8 to the consolidated financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales on a "constant currency" basis is a non-GAAP measure.  The Company analyzes net sales on a constant currency basis to better measure the comparability of results between periods.  To measure percentage sales growth in constant currency, the Company removes the impact of changes in foreign currency exchange rates that affect the comparability and trend of net sales. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because non-GAAP financial measures are not standardized, it may not be possible to compare this financial measure with other companies' non-GAAP financial measures having the same or similar names.  This adjusted financial measure should not be considered in isolation or as a substitute for reported net sales growth, the most directly comparable GAAP financial measure.  This non-GAAP financial measure is an additional way of viewing net sales that, when viewed with our GAAP results, provides a more complete understanding of our business.  The Company strongly encourages investors and shareholders to review our financial statements and publicly-filed reports in their entirety and not to rely on any single financial measure.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i60ea575d4ae7456fa9ff06ec4f3488e0_91"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our liquidity needs arise primarily from capital investments, working capital requirements and payments on indebtedness under the sixth amended and restated senior credit agreement, described below.  We have historically met these liquidity requirements with funds generated from operations and borrowings under our revolving credit facility.  In addition, we have historically used term borrowings, including borrowings under the sixth amended and restated senior credit agreement, and borrowings under separate loan facilities, in the case of real property purchases, to finance our acquisitions.  We also have the ability to raise funds through the sale of stock or we may issue debt through a private placement or public offering.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the COVID-19 pandemic, we experienced lower sales in 2020.  On April&#160;17, 2020 we amended our senior credit agreement to suspend our required leverage ratios for up to four quarters.  We continued to have certain minimum liquidity and fixed charge coverage ratio requirements with which we were in full compliance with as of March&#160;31, 2021.  On November&#160;20, 2020, we entered into a third amendment under our senior credit agreement to lower the applicable margin on loans and lower the interest floor on Eurocurrency loans agreed upon in April 2020.    On April&#160;15, 2021, we terminated the suspension period, thus reinstating our required leverage ratios.  Management believes that cash flow from operations, including cash and cash equivalents on hand and available borrowing capacity under our revolving credit facility, will be adequate to meet our liquidity needs for the foreseeable future.  We continue to monitor our spending and expenses in light of our expectation that our revenues will continue to be impacted by the pandemic. While we expect that we will be well positioned when surgeries return to their pre-pandemic levels, we are unable to predict with certainty how long the COVID-19 pandemic will last, or how severe its economic impact will be. Even after the COVID-19 pandemic and government responses thereto have subsided, residual economic and other effects may have an impact on the demand for post-pandemic surgery levels that are difficult to predict. If the downturn is more severe and prolonged than we currently expect, we may need to take further steps to reduce our costs, or to refinance our debt.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating cash flows</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net working capital position was $242.2 million at March&#160;31, 2021.&#160;&#160;Net cash provided by operating activities was $22.3 million and $3.7 million in the three months ended March 31, 2021 and 2020, respectively, generated on net income of $9.9 million and $5.9 million for the three months ended March 31, 2021 and 2020, respectively.  The increase in cash provided by operating activities in 2021 as compared to 2020 was mainly driven by higher net income and lower incentive compensation payments in the first quarter of 2021 compared to the same period a year ago. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investing cash flows</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities in the three months ended March&#160;31, 2021 decreased $3.6 million from the same period a year ago due to $3.9 million in payments mainly related to the acquisition of a distributor in 2020.  Capital expenditures were  $3.1 million in the three months ended March&#160;31, 2021 compared to $2.8 million in the same period a year ago.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financing cash flows</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities in the three months ended March&#160;31, 2021 was $8.9 million compared to cash provided by financing activities of $2.7 million during 2020.  Below is a summary of the significant financing activities impacting the change during the three months ended March&#160;31, 2021 compared to 2020:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We had net payments on our revolving line of credit of $8.0 million compared to $18.0 million in net borrowings during the three months ended March&#160;31, 2020.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We had net cash proceeds of $9.7 million related to stock issued under employee plans for the three months ended March&#160;31, 2021 compared to $1.2 million in the same period a year ago.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We paid $1.1 million in contingent consideration related to a prior acquisition during the three months ended March&#160;31, 2020.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;7, 2019 we entered into a sixth amended and restated senior credit agreement consisting of: (a) a $265.0 million term loan facility and (b) a $585.0 million revolving credit facility.   The revolving credit facility will terminate and the loans outstanding under the term loan facility will mature on the earlier of (i)&#160;February&#160;7, 2024 or (ii) 91 days prior to the earliest scheduled maturity date of the 2.625% convertible notes due in 2024 described below, (if, as of such date, more than $150.0 million in aggregate principal amount of such convertible notes (or any refinancing thereof) remains outstanding).  The term loan facility is payable in quarterly installments increasing over the term of the facility.  Proceeds from the term loan facility and borrowings under the revolving credit facility were used to repay the then existing senior credit agreement and in part to finance the acquisition of Buffalo Filter.  As noted above, on April&#160;17, 2020 we amended our sixth amended and restated senior credit agreement to suspend our required leverage ratios for up to four quarters.  We continued to have certain minimum liquidity and fixed charge coverage ratio requirements.  On November 20, 2020, we entered into a third amendment under our senior credit agreement to lower the applicable margin on the loans and lower the interest floor on Eurocurrency loans agreed upon in April 2020.  On April&#160;15, 2021, we terminated the suspension period, thus reinstating our required leverage ratios.  Interest rates are adjusted so that the applicable margin for base rate loans is 2.00% per annum and for Eurocurrency rate loans is 3.00% per annum, and the applicable commitment fee rate for the revolving credit facility is 0.50%.  Following the suspension period, the applicable margin will depend upon CONMED&#8217;s consolidated senior secured leverage ratio, using the pricing grid set forth in the November 2020 amendment.&#160; Interest rates were at LIBOR (subject to 0.50% floor) plus an interest rate margin of 3.00% (3.50% at March&#160;31, 2021).  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were $238.5 million in borrowings outstanding on the term loan facility as of March&#160;31, 2021.  There were $199.0 million in borrowings outstanding under the revolving credit facility as of March&#160;31, 2021.  Our available borrowings on the revolving credit facility at March&#160;31, 2021 were $383.4 million with approximately $2.6 million of the facility set aside for outstanding letters of credit.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sixth amended and restated senior credit agreement is collateralized by substantially all of our personal property and assets.  The sixth amended and restated senior credit agreement contains covenants and restrictions which, among other things, require the maintenance of certain financial ratios and restrict dividend payments and the incurrence of certain indebtedness and other activities, including acquisitions and dispositions.  We were in full compliance with these covenants and restrictions as of March&#160;31, 2021.  We are also required, under certain circumstances, to make mandatory prepayments from net cash proceeds from any issuance of equity and asset sales.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 29, 2019, we issued $345.0 million in 2.625% convertible notes due in 2024 (the "Notes").  Interest is payable semi-annually in arrears on February 1 and August 1 of each year, commencing August 1, 2019.  The Notes will mature on February 1, 2024, unless earlier repurchased or converted.  The Notes represent subordinated unsecured obligations and are convertible under certain circumstances, as defined in the indenture, into a combination of cash and CONMED common stock.&#160;&#160;The Notes may be converted at an initial conversion rate of 11.2608 shares of our common stock per $1,000 principal amount of Notes (equivalent to an initial conversion price of approximately $88.80 per share of common stock).  Holders of the Notes may convert the Notes at their option at any time on or after November 1, 2023 through the second scheduled trading day preceding the maturity date.  Holders of the Notes will also have the right to convert the Notes prior to November 1, 2023, but only upon the occurrence of specified events.  The conversion rate is subject to anti-dilution adjustments if certain events occur.  A portion of the net proceeds from the offering of the Notes were used as part of the financing for the Buffalo Filter acquisition and $21.0 million were used to pay the cost of certain convertible notes hedge transactions as further described below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the offering of the Notes, we entered into convertible note hedge transactions with a number of financial institutions (each, an &#8220;option counterparty&#8221;).  The convertible note hedge transactions cover, subject to anti-dilution adjustments substantially similar to those applicable to the Notes, the number of shares of our common stock underlying the Notes.  Concurrently with entering into the convertible note hedge transactions, we also entered into separate warrant transactions with each option counterparty whereby we sold to such option counterparty warrants to purchase, subject to customary anti-dilution adjustments, the same number of shares of our common stock.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The convertible note hedge transactions are expected generally to reduce the potential dilution upon conversion of the Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted Notes, as the case may be, in the event that the market price per share of our common stock, as measured under the terms of the convertible note hedge transactions, is greater than the strike price ($114.92) of the convertible note hedge transactions, which initially corresponds to the conversion price of the Notes and is subject to anti-dilution adjustments substantially similar to those applicable to the conversion rate of the Notes.  If, however, the market price per share of our common stock, as measured under the terms of the warrant transactions, exceeds the strike price of the warrants, there would nevertheless be dilution to the extent that such market price exceeds the strike price of the warrants as noted in Note 7, unless we elect to settle the warrants in cash.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors has authorized a $200.0 million share repurchase program.  Through March&#160;31, 2021, we have repurchased a total of 6.1 million shares of common stock aggregating $162.6 million under this authorization and have $37.4 million remaining available for share repurchases.  The repurchase program calls for shares to be purchased in the open market or in private transactions from time to time.  We may suspend or discontinue the share repurchase program at any time.  We have not purchased any shares of common stock under the share repurchase program during 2021.  We have financed the repurchases and may finance additional repurchases through operating cash flow and from available borrowings under our revolving credit facility.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management believes that cash flow from operations, including cash and cash equivalents on hand and available borrowing capacity under our sixth amended and restated senior credit agreement, will be adequate to meet our anticipated operating working capital requirements, debt service, funding of capital expenditures, dividend payments and common stock repurchases in the foreseeable future. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New accounting pronouncements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 15 to the consolidated condensed financial statements for a discussion of new accounting pronouncements.</span></div><div><span><br/></span></div><div id="i60ea575d4ae7456fa9ff06ec4f3488e0_94"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures About Market Risk</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no significant changes in our primary market risk exposures or in how these exposures are managed during the three months ended March&#160;31, 2021.&#160;&#160;Reference is made to Item 7A. of our Annual Report on Form 10-K for the year ended December&#160;31, 2020 for a description of Qualitative and Quantitative Disclosures About Market Risk.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i60ea575d4ae7456fa9ff06ec4f3488e0_97"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;Controls and Procedures</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the end of the period covered by this report, an evaluation was carried out by CONMED Corporation&#8217;s management, with the participation of our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934).&#160;&#160;Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that these disclosure controls and procedures were effective as of the end of the period covered by this report.&#160;&#160;In addition, no change in our internal control over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934) occurred during the quarter ended March&#160;31, 2021 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span><br/></span></div><div id="i60ea575d4ae7456fa9ff06ec4f3488e0_100"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II OTHER INFORMATION</span></div><div><span><br/></span></div><div id="i60ea575d4ae7456fa9ff06ec4f3488e0_103"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Legal Proceedings</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reference is made to Item 3 of the Company&#8217;s Annual Report on Form 10-K for the year-ended December&#160;31, 2020 and to Note 14 of the Notes to Consolidated Condensed Financial Statements included in Part I of this Report for a description of certain legal matters.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i60ea575d4ae7456fa9ff06ec4f3488e0_106"></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><div id="i60ea575d4ae7456fa9ff06ec4f3488e0_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.  Exhibits</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.748%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit Index</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Description of Exhibit</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="cnmd33121ex311.htm">Certification of Curt R. Hartman pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="cnmd33121ex312.htm">Certification of Todd W. Garner pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="cnmd33121ex321.htm">Certifications of Curt R. Hartman and Todd W. Garner pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page - Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document (included in Exhibit 101)</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="i60ea575d4ae7456fa9ff06ec4f3488e0_112"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i60ea575d4ae7456fa9ff06ec4f3488e0_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on the date indicated below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:58.197%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.893%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CONMED CORPORATION</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">By: /s/ Todd W. Garner</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Todd W. Garner</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:&#160;&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 29, 2021</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>cnmd33121ex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="iaed03b44f6d744d9b92f16054fdd0eb3_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Curt R. Hartman, certify that&#58;</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this quarterly report on Form 10-Q of CONMED Corporation&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;29, 2021 </font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.228%"><tr><td style="width:1.0%"></td><td style="width:54.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.971%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Curt R. Hartman</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curt R. Hartman</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair of the Board, President &#38; Chief Executive Officer</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>cnmd33121ex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i691351855fd2405ea7d876b7946238ec_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Todd W. Garner, certify that&#58;</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this quarterly report on Form 10-Q of CONMED Corporation&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;29, 2021 </font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.228%"><tr><td style="width:1.0%"></td><td style="width:54.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.971%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Todd W. Garner</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Todd W. Garner</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>cnmd33121ex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i3e5fba56e8ee4ea8ab363d79c6a41fb5_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(SUBSECTIONS (a) AND (b) OF SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE)</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of CONMED Corporation, a Delaware corporation (the &#8220;Corporation&#8221;), does hereby certify that&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Quarterly Report on Form 10-Q for the quarter ended March&#160;31, 2021 (the &#8220;Form 10-Q&#8221;) of the Corporation fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Corporation.</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:72.215%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 29, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Curt R. Hartman</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curt R. Hartman</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair of the Board, President &#38; <br>Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 29, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Todd W. Garner</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Todd W. Garner</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>cnmd-20210331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:4a71bfc6-7922-4305-aa8d-7a5d2323cf49,g:a58de70d-c080-4226-99f2-d632a7268b2f-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cnmd="http://www.conmed.com/20210331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:num="http://www.xbrl.org/dtr/type/numeric" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.conmed.com/20210331">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cnmd-20210331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cnmd-20210331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cnmd-20210331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cnmd-20210331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformation" roleURI="http://www.conmed.com/role/DocumentandEntityInformation">
        <link:definition>0001001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited" roleURI="http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited">
        <link:definition>1001002 - Statement - Consolidated Condensed Statements of Comprehensive Income (Loss) (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedCondensedBalanceSheetsUnaudited" roleURI="http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited">
        <link:definition>1002003 - Statement - Consolidated Condensed Balance Sheets (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedCondensedBalanceSheetsUnauditedParenthetical" roleURI="http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical">
        <link:definition>1003004 - Statement - Consolidated Condensed Balance Sheets (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedCondensedStatementsofShareholdersEquityUnaudited" roleURI="http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited">
        <link:definition>1004005 - Statement - Consolidated Condensed Statements of Shareholders' Equity (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedCondensedStatementsofShareholdersEquityUnauditedParenthetical" roleURI="http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnauditedParenthetical">
        <link:definition>1005006 - Statement - Consolidated Condensed Statements of Shareholders' Equity (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedCondensedStatementsofCashFlowsUnaudited" roleURI="http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited">
        <link:definition>1006007 - Statement - Consolidated Condensed Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Operations" roleURI="http://www.conmed.com/role/Operations">
        <link:definition>2101101 - Disclosure - Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InterimFinancialInformation" roleURI="http://www.conmed.com/role/InterimFinancialInformation">
        <link:definition>2102102 - Disclosure - Interim Financial Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InterimReportingPolicies" roleURI="http://www.conmed.com/role/InterimReportingPolicies">
        <link:definition>2203201 - Disclosure - Interim Reporting (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenues" roleURI="http://www.conmed.com/role/Revenues">
        <link:definition>2104103 - Disclosure - Revenues</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesTables" roleURI="http://www.conmed.com/role/RevenuesTables">
        <link:definition>2305301 - Disclosure - Revenues (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesDisaggregatedRevenuesDetails" roleURI="http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails">
        <link:definition>2406401 - Disclosure - Revenues (Disaggregated Revenues) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesCustomerLiabilityDetails" roleURI="http://www.conmed.com/role/RevenuesCustomerLiabilityDetails">
        <link:definition>2407402 - Disclosure - Revenues (Customer Liability) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComprehensiveIncomeLoss" roleURI="http://www.conmed.com/role/ComprehensiveIncomeLoss">
        <link:definition>2108104 - Disclosure - Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComprehensiveIncomeLossTables" roleURI="http://www.conmed.com/role/ComprehensiveIncomeLossTables">
        <link:definition>2309302 - Disclosure - Comprehensive Income (Loss) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComprehensiveIncomeLossDetails" roleURI="http://www.conmed.com/role/ComprehensiveIncomeLossDetails">
        <link:definition>2410403 - Disclosure - Comprehensive Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails" roleURI="http://www.conmed.com/role/ComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails">
        <link:definition>2411404 - Disclosure - Comprehensive Income (Loss) (Accumulated Other Comprehensive Income (Loss)) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstruments" roleURI="http://www.conmed.com/role/FairValueofFinancialInstruments">
        <link:definition>2112105 - Disclosure - Fair Value of Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstrumentsTables" roleURI="http://www.conmed.com/role/FairValueofFinancialInstrumentsTables">
        <link:definition>2313303 - Disclosure - Fair Value of Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails" roleURI="http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails">
        <link:definition>2414405 - Disclosure - Fair Value of Financial Instruments (Amounts Recorded In and Reclassified From AOCI) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails" roleURI="http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails">
        <link:definition>2415406 - Disclosure - Fair Value of Financial Instruments (Foreign Currency Forward Contracts) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventories" roleURI="http://www.conmed.com/role/Inventories">
        <link:definition>2116106 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesTables" roleURI="http://www.conmed.com/role/InventoriesTables">
        <link:definition>2317304 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesDetails" roleURI="http://www.conmed.com/role/InventoriesDetails">
        <link:definition>2418407 - Disclosure - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.conmed.com/role/EarningsPerShare">
        <link:definition>2119107 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.conmed.com/role/EarningsPerShareTables">
        <link:definition>2320305 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareDetails" roleURI="http://www.conmed.com/role/EarningsPerShareDetails">
        <link:definition>2421408 - Disclosure - Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareConvertibleNotesDetails" roleURI="http://www.conmed.com/role/EarningsPerShareConvertibleNotesDetails">
        <link:definition>2422409 - Disclosure - Earnings Per Share - Convertible Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssets" roleURI="http://www.conmed.com/role/GoodwillandOtherIntangibleAssets">
        <link:definition>2123108 - Disclosure - Goodwill and Other Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsTables" roleURI="http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsTables">
        <link:definition>2324306 - Disclosure - Goodwill and Other Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsGoodwillDetails" roleURI="http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails">
        <link:definition>2425410 - Disclosure - Goodwill and Other Intangible Assets (Goodwill) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails" roleURI="http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails">
        <link:definition>2426411 - Disclosure - Goodwill and Other Intangible Assets (Intangible Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebt" roleURI="http://www.conmed.com/role/LongTermDebt">
        <link:definition>2127109 - Disclosure - Long Term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTables" roleURI="http://www.conmed.com/role/LongTermDebtTables">
        <link:definition>2328307 - Disclosure - Long Term Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtDetails" roleURI="http://www.conmed.com/role/LongTermDebtDetails">
        <link:definition>2429412 - Disclosure - Long Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtAdditionalInformationDetails" roleURI="http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails">
        <link:definition>2430413 - Disclosure - Long Term Debt Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtMaturitiesofLongTermDebtDetails" roleURI="http://www.conmed.com/role/LongTermDebtMaturitiesofLongTermDebtDetails">
        <link:definition>2431414 - Disclosure - Long Term Debt Maturities of Long Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Guarantees" roleURI="http://www.conmed.com/role/Guarantees">
        <link:definition>2132110 - Disclosure - Guarantees</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GuaranteesTables" roleURI="http://www.conmed.com/role/GuaranteesTables">
        <link:definition>2333308 - Disclosure - Guarantees (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GuaranteesDetails" roleURI="http://www.conmed.com/role/GuaranteesDetails">
        <link:definition>2434415 - Disclosure - Guarantees (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionPlan" roleURI="http://www.conmed.com/role/PensionPlan">
        <link:definition>2135111 - Disclosure - Pension Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionPlanTables" roleURI="http://www.conmed.com/role/PensionPlanTables">
        <link:definition>2336309 - Disclosure - Pension Plan (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionPlanDetails" roleURI="http://www.conmed.com/role/PensionPlanDetails">
        <link:definition>2437416 - Disclosure - Pension Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionandOtherExpense" roleURI="http://www.conmed.com/role/AcquisitionandOtherExpense">
        <link:definition>2138112 - Disclosure - Acquisition and Other Expense</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionandOtherExpenseTables" roleURI="http://www.conmed.com/role/AcquisitionandOtherExpenseTables">
        <link:definition>2339310 - Disclosure - Acquisition and Other Expense (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionandOtherExpenseDetails" roleURI="http://www.conmed.com/role/AcquisitionandOtherExpenseDetails">
        <link:definition>2440417 - Disclosure - Acquisition and Other Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegment" roleURI="http://www.conmed.com/role/BusinessSegment">
        <link:definition>2141113 - Disclosure - Business Segment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentTables" roleURI="http://www.conmed.com/role/BusinessSegmentTables">
        <link:definition>2342311 - Disclosure - Business Segment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentDetails" roleURI="http://www.conmed.com/role/BusinessSegmentDetails">
        <link:definition>2443418 - Disclosure - Business Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LegalProceedings" roleURI="http://www.conmed.com/role/LegalProceedings">
        <link:definition>2144114 - Disclosure - Legal Proceedings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LegalProceedingsDetails" roleURI="http://www.conmed.com/role/LegalProceedingsDetails">
        <link:definition>2445419 - Disclosure - Legal Proceedings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingPronouncements" roleURI="http://www.conmed.com/role/NewAccountingPronouncements">
        <link:definition>2146115 - Disclosure - New Accounting Pronouncements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingPronouncementsPolicies" roleURI="http://www.conmed.com/role/NewAccountingPronouncementsPolicies">
        <link:definition>2247202 - Disclosure - New Accounting Pronouncements (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="cnmd_CustomerandDistributorRelationshipsMember" abstract="true" name="CustomerandDistributorRelationshipsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cnmd_OtherExpensesTable" abstract="true" name="OtherExpensesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="cnmd_Manufacturingconsolidationcosts" abstract="false" name="Manufacturingconsolidationcosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnmd_FairValueofFinancialInstrumentsAbstract" abstract="true" name="FairValueofFinancialInstrumentsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cnmd_LitigationDamagesAxis" abstract="true" name="LitigationDamagesAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cnmd_GeneralSurgeryMember" abstract="true" name="GeneralSurgeryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cnmd_VariableRateBasisDomain" abstract="true" name="VariableRateBasisDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cnmd_Paymentsrelatedtobusinessacquisitionsandassetacquisitions" abstract="false" name="Paymentsrelatedtobusinessacquisitionsandassetacquisitions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnmd_ProductWarrantyAccrualTerm" abstract="false" name="ProductWarrantyAccrualTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cnmd_AdditionalDamagesMember" abstract="true" name="AdditionalDamagesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cnmd_VariableRateBasisAxis" abstract="true" name="VariableRateBasisAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cnmd_AcquisitionandOtherExpenseAbstract" abstract="true" name="AcquisitionandOtherExpenseAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cnmd_ReductionofRevenueMember" abstract="true" name="ReductionofRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cnmd_Hedgeandwarranttransactionsnetcashpaid" abstract="false" name="Hedgeandwarranttransactionsnetcashpaid" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnmd_LiquidatedDamagesMember" abstract="true" name="LiquidatedDamagesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cnmd_LitigationDamagesDomain" abstract="true" name="LitigationDamagesDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cnmd_ScheduleOfAcquisitionAndOtherOperatingExpenseTableTextBlock" abstract="false" name="ScheduleOfAcquisitionAndOtherOperatingExpenseTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="cnmd_PatentsAndOtherIntangibleAssetsMember" abstract="true" name="PatentsAndOtherIntangibleAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cnmd_AcquisitionandOtherExpenseTextBlock" abstract="false" name="AcquisitionandOtherExpenseTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="cnmd_DebtInstrumentConvertibleGrossAmountofEquityComponent" abstract="false" name="DebtInstrumentConvertibleGrossAmountofEquityComponent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnmd_LIBORInterestRateFloor" abstract="false" name="LIBORInterestRateFloor" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="cnmd_RestructuringAndRelatedCosts" abstract="false" name="RestructuringAndRelatedCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnmd_A2.625PercentConvertibleNotesDue2024Member" abstract="true" name="A2.625PercentConvertibleNotesDue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount" abstract="false" name="ProductLiabilityContingencyInsuranceAggregateAnnualAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnmd_AmendedAndRestatedSeniorCreditAgreementMember" abstract="true" name="AmendedAndRestatedSeniorCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cnmd_EndoDynamixInc.Member" abstract="true" name="EndoDynamixInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cnmd_HedgeTransactionsMember" abstract="true" name="HedgeTransactionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cnmd_AssetAcquisitionContingentConsiderationLiability" abstract="false" name="AssetAcquisitionContingentConsiderationLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnmd_AcquisitionandOtherExpenseLineItems" abstract="true" name="AcquisitionandOtherExpenseLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cnmd_DefinedBenefitPlanNonServiceCost" abstract="false" name="DefinedBenefitPlanNonServiceCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnmd_WarrantTransactionsMember" abstract="true" name="WarrantTransactionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cnmd_IndexedTransactionTypeAxis" abstract="true" name="IndexedTransactionTypeAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident" abstract="false" name="ProductLiabilityContingencyInsuranceAmountPerIncident" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable" abstract="true" name="ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="cnmd_OrthopedicSurgeryMember" abstract="true" name="OrthopedicSurgeryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cnmd_AmericasexcludingtheUnitedStatesMember" abstract="true" name="AmericasexcludingtheUnitedStatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cnmd_RevenuesMember" abstract="true" name="RevenuesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cnmd_CreditAgreementExpirationTriggerRequirementConvertibleNoteOutstandingBalance" abstract="false" name="CreditAgreementExpirationTriggerRequirementConvertibleNoteOutstandingBalance" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnmd_IndexedTransactionTypeDomain" abstract="true" name="IndexedTransactionTypeDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cnmd_PaymentsForContingentConsideration" abstract="false" name="PaymentsForContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnmd_ExpenseMember" abstract="true" name="ExpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems" abstract="true" name="ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cnmd_SalesrepresentationmarketingandpromotionalrightsMember" abstract="true" name="SalesrepresentationmarketingandpromotionalrightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>cnmd-20210331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:4a71bfc6-7922-4305-aa8d-7a5d2323cf49,g:a58de70d-c080-4226-99f2-d632a7268b2f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.conmed.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="cnmd-20210331.xsd#DocumentandEntityInformation"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/DocumentandEntityInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited" xlink:type="simple" xlink:href="cnmd-20210331.xsd#ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_df369e18-7055-40e1-8c0c-b5656a1e3b4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_bf08cf71-2cb7-4298-b2b5-90830302b0b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_df369e18-7055-40e1-8c0c-b5656a1e3b4e" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_bf08cf71-2cb7-4298-b2b5-90830302b0b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_bd96ed75-b93d-4cd3-b8b6-fc16efedc905" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_df369e18-7055-40e1-8c0c-b5656a1e3b4e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_bd96ed75-b93d-4cd3-b8b6-fc16efedc905" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_f3569f2f-ba95-43c8-add0-77fa4f5fd517" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e78cf19e-09c8-42d1-96a0-a0b1752a795f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_f3569f2f-ba95-43c8-add0-77fa4f5fd517" xlink:to="loc_us-gaap_OperatingIncomeLoss_e78cf19e-09c8-42d1-96a0-a0b1752a795f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_08c242d0-870c-4af7-848f-54ad3e188bb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_f3569f2f-ba95-43c8-add0-77fa4f5fd517" xlink:to="loc_us-gaap_InterestExpense_08c242d0-870c-4af7-848f-54ad3e188bb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingExpense_8ffeb633-2600-4a3c-a9b5-ec83e5f56791" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_f3569f2f-ba95-43c8-add0-77fa4f5fd517" xlink:to="loc_us-gaap_OtherNonoperatingExpense_8ffeb633-2600-4a3c-a9b5-ec83e5f56791" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_aea5dab2-5875-4f83-99f4-55c5d424b71a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2189f962-544b-4a11-8b6c-410ea8eadf1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_aea5dab2-5875-4f83-99f4-55c5d424b71a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2189f962-544b-4a11-8b6c-410ea8eadf1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d9f9c895-af41-4c8f-918e-3fdb43b8ef27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_aea5dab2-5875-4f83-99f4-55c5d424b71a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d9f9c895-af41-4c8f-918e-3fdb43b8ef27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e3e5dbb0-7659-46b1-a155-4cc24b5aa19e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_0e2d6915-10e8-43a6-b092-91de7e75b376" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_e3e5dbb0-7659-46b1-a155-4cc24b5aa19e" xlink:to="loc_us-gaap_GrossProfit_0e2d6915-10e8-43a6-b092-91de7e75b376" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_6dfdec2e-7cef-45e8-83c4-840e4e798563" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_e3e5dbb0-7659-46b1-a155-4cc24b5aa19e" xlink:to="loc_us-gaap_OperatingExpenses_6dfdec2e-7cef-45e8-83c4-840e4e798563" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_ca1a3570-3c49-4be5-9b57-bd33c531159f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_eb667702-a845-466d-a690-93292630382c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_ca1a3570-3c49-4be5-9b57-bd33c531159f" xlink:to="loc_us-gaap_Revenues_eb667702-a845-466d-a690-93292630382c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_d5db836e-4732-4a27-8761-17f10e48c1eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_ca1a3570-3c49-4be5-9b57-bd33c531159f" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_d5db836e-4732-4a27-8761-17f10e48c1eb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="cnmd-20210331.xsd#ConsolidatedCondensedBalanceSheetsUnaudited"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0b69e03f-6f27-4cf7-a667-d34a7e962275" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_f4035ffc-0295-4a0e-86a1-e143828d56fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0b69e03f-6f27-4cf7-a667-d34a7e962275" xlink:to="loc_us-gaap_PreferredStockValue_f4035ffc-0295-4a0e-86a1-e143828d56fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_a52f79c7-2a33-431f-b985-e86cc7a163f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0b69e03f-6f27-4cf7-a667-d34a7e962275" xlink:to="loc_us-gaap_CommonStockValue_a52f79c7-2a33-431f-b985-e86cc7a163f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_21aecb1a-a03b-4e24-b7c9-4b1cf195a26c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0b69e03f-6f27-4cf7-a667-d34a7e962275" xlink:to="loc_us-gaap_AdditionalPaidInCapital_21aecb1a-a03b-4e24-b7c9-4b1cf195a26c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_42da66f7-c46d-4906-92dc-d932e17eb432" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0b69e03f-6f27-4cf7-a667-d34a7e962275" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_42da66f7-c46d-4906-92dc-d932e17eb432" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5ad914d5-1e70-477d-abf2-6e477b1f8a28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0b69e03f-6f27-4cf7-a667-d34a7e962275" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5ad914d5-1e70-477d-abf2-6e477b1f8a28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_07c59de3-a1e9-499e-9932-9ecef2a86fa9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0b69e03f-6f27-4cf7-a667-d34a7e962275" xlink:to="loc_us-gaap_TreasuryStockValue_07c59de3-a1e9-499e-9932-9ecef2a86fa9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_599eb9e6-4a50-4d78-b01c-a8cdaefa07ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3e78a1bc-2a32-4fc3-8f8b-0611ad2b4ec6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_599eb9e6-4a50-4d78-b01c-a8cdaefa07ac" xlink:to="loc_us-gaap_AssetsCurrent_3e78a1bc-2a32-4fc3-8f8b-0611ad2b4ec6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_958bd16a-8726-4b46-95c9-b7915a8e78ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_599eb9e6-4a50-4d78-b01c-a8cdaefa07ac" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_958bd16a-8726-4b46-95c9-b7915a8e78ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_46fb6bd9-65f8-46d9-9238-afab6b712335" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_599eb9e6-4a50-4d78-b01c-a8cdaefa07ac" xlink:to="loc_us-gaap_Goodwill_46fb6bd9-65f8-46d9-9238-afab6b712335" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3a2fd056-50c8-4a25-a697-e0adc3e3db00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_599eb9e6-4a50-4d78-b01c-a8cdaefa07ac" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3a2fd056-50c8-4a25-a697-e0adc3e3db00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_1ec71b03-bc47-44fc-9510-31779eccdd07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_599eb9e6-4a50-4d78-b01c-a8cdaefa07ac" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_1ec71b03-bc47-44fc-9510-31779eccdd07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_2116ce62-f662-458b-a57a-328a7a7517bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_610fa9b1-15bb-41e6-8246-6e40a022b8ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2116ce62-f662-458b-a57a-328a7a7517bc" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_610fa9b1-15bb-41e6-8246-6e40a022b8ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_21995e58-4a09-43ef-aba5-756d70a0d20f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2116ce62-f662-458b-a57a-328a7a7517bc" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_21995e58-4a09-43ef-aba5-756d70a0d20f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_b10c6497-ab39-4f14-8fe6-81833e6b32ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2116ce62-f662-458b-a57a-328a7a7517bc" xlink:to="loc_us-gaap_InventoryNet_b10c6497-ab39-4f14-8fe6-81833e6b32ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_64e10233-881d-42b5-88a7-f977679a6c6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2116ce62-f662-458b-a57a-328a7a7517bc" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_64e10233-881d-42b5-88a7-f977679a6c6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_5ba6fcd5-b832-454c-8033-59c21fc176e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_4186e822-4274-4693-bca6-88332ad2910a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_5ba6fcd5-b832-454c-8033-59c21fc176e3" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_4186e822-4274-4693-bca6-88332ad2910a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_7b3491ad-6ce0-42ed-b12b-9d076054e484" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_5ba6fcd5-b832-454c-8033-59c21fc176e3" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_7b3491ad-6ce0-42ed-b12b-9d076054e484" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_d4805b64-c73c-44ff-a75d-8c1c5f67a8bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_5ba6fcd5-b832-454c-8033-59c21fc176e3" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_d4805b64-c73c-44ff-a75d-8c1c5f67a8bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_6d01fc54-3343-4b47-96b8-54c72ffc0acf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_5ba6fcd5-b832-454c-8033-59c21fc176e3" xlink:to="loc_us-gaap_LiabilitiesCurrent_6d01fc54-3343-4b47-96b8-54c72ffc0acf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_73c5d9a5-109e-4ccc-8c9a-538f5e2c4e46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_cfd8d4da-d384-48f1-a767-55fb05e9d701" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_73c5d9a5-109e-4ccc-8c9a-538f5e2c4e46" xlink:to="loc_us-gaap_Liabilities_cfd8d4da-d384-48f1-a767-55fb05e9d701" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ebb3c03e-fee8-4523-bee4-3e8069fec27c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_73c5d9a5-109e-4ccc-8c9a-538f5e2c4e46" xlink:to="loc_us-gaap_StockholdersEquity_ebb3c03e-fee8-4523-bee4-3e8069fec27c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_89bdf981-2208-4be2-8343-4c38c2c37cea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_73c5d9a5-109e-4ccc-8c9a-538f5e2c4e46" xlink:to="loc_us-gaap_CommitmentsAndContingencies_89bdf981-2208-4be2-8343-4c38c2c37cea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_8471c53c-6008-4c5c-b70d-c50a8b20abdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_81d4593f-583b-4fb2-a8a1-f33230826db9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_8471c53c-6008-4c5c-b70d-c50a8b20abdd" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_81d4593f-583b-4fb2-a8a1-f33230826db9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_21c3ec1d-ad9a-4317-9d4d-c9c800facedd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_8471c53c-6008-4c5c-b70d-c50a8b20abdd" xlink:to="loc_us-gaap_AccountsPayableCurrent_21c3ec1d-ad9a-4317-9d4d-c9c800facedd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_f1f4362b-d5e5-408e-bf7c-aab6665d9f27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_8471c53c-6008-4c5c-b70d-c50a8b20abdd" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_f1f4362b-d5e5-408e-bf7c-aab6665d9f27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_f457d171-c5b1-449c-bc83-7a9e17233196" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_8471c53c-6008-4c5c-b70d-c50a8b20abdd" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_f457d171-c5b1-449c-bc83-7a9e17233196" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical" xlink:type="simple" xlink:href="cnmd-20210331.xsd#ConsolidatedCondensedBalanceSheetsUnauditedParenthetical"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited" xlink:type="simple" xlink:href="cnmd-20210331.xsd#ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnauditedParenthetical" xlink:type="simple" xlink:href="cnmd-20210331.xsd#ConsolidatedCondensedStatementsofShareholdersEquityUnauditedParenthetical"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnauditedParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="cnmd-20210331.xsd#ConsolidatedCondensedStatementsofCashFlowsUnaudited"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_26921a7a-cda8-4086-870f-994a0f454ddd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_75f7ff4c-71b9-45c4-b421-ded77ce608bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_26921a7a-cda8-4086-870f-994a0f454ddd" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_75f7ff4c-71b9-45c4-b421-ded77ce608bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_660015f3-b9d0-4622-b2fc-bfb4e71df9d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_26921a7a-cda8-4086-870f-994a0f454ddd" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_660015f3-b9d0-4622-b2fc-bfb4e71df9d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_9d34ce03-3341-47d7-9791-f0703c014519" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_26921a7a-cda8-4086-870f-994a0f454ddd" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_9d34ce03-3341-47d7-9791-f0703c014519" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_PaymentsForContingentConsideration_e319b4b3-e450-49a9-9a60-a915ef341c97" xlink:href="cnmd-20210331.xsd#cnmd_PaymentsForContingentConsideration"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_26921a7a-cda8-4086-870f-994a0f454ddd" xlink:to="loc_cnmd_PaymentsForContingentConsideration_e319b4b3-e450-49a9-9a60-a915ef341c97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_20a7b8d7-717d-415a-931e-5e69e851df93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_26921a7a-cda8-4086-870f-994a0f454ddd" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_20a7b8d7-717d-415a-931e-5e69e851df93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_8c0fdd4c-c525-42ac-bedb-88d840d7cc2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_26921a7a-cda8-4086-870f-994a0f454ddd" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_8c0fdd4c-c525-42ac-bedb-88d840d7cc2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ada6fdc0-fba5-4352-8d86-56823f8ab450" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_561cf08b-6936-4c5e-aa92-036269ae0283" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ada6fdc0-fba5-4352-8d86-56823f8ab450" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_561cf08b-6936-4c5e-aa92-036269ae0283" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_Paymentsrelatedtobusinessacquisitionsandassetacquisitions_dedace97-7a4e-4540-85d9-10ee50695360" xlink:href="cnmd-20210331.xsd#cnmd_Paymentsrelatedtobusinessacquisitionsandassetacquisitions"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ada6fdc0-fba5-4352-8d86-56823f8ab450" xlink:to="loc_cnmd_Paymentsrelatedtobusinessacquisitionsandassetacquisitions_dedace97-7a4e-4540-85d9-10ee50695360" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0f343bd8-b11b-466f-ac88-51d2d436010a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_eb3d0ab1-238a-4ac7-b55d-8545d96434d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0f343bd8-b11b-466f-ac88-51d2d436010a" xlink:to="loc_us-gaap_NetIncomeLoss_eb3d0ab1-238a-4ac7-b55d-8545d96434d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_9c62ed71-c994-4ea4-bf13-18ec0bc8bf48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0f343bd8-b11b-466f-ac88-51d2d436010a" xlink:to="loc_us-gaap_Depreciation_9c62ed71-c994-4ea4-bf13-18ec0bc8bf48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_786c6ee1-9973-4c0b-bb74-2459d4bb9fcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0f343bd8-b11b-466f-ac88-51d2d436010a" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_786c6ee1-9973-4c0b-bb74-2459d4bb9fcb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_8c79cd21-48d6-4d4f-88bc-019368b9c880" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0f343bd8-b11b-466f-ac88-51d2d436010a" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_8c79cd21-48d6-4d4f-88bc-019368b9c880" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges_8b259ebf-b671-4a41-987f-f2d47adf95c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAmortizationOfDeferredCharges"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0f343bd8-b11b-466f-ac88-51d2d436010a" xlink:to="loc_us-gaap_OtherAmortizationOfDeferredCharges_8b259ebf-b671-4a41-987f-f2d47adf95c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_b6deee63-d47f-404f-95a6-8bb57c8f528b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0f343bd8-b11b-466f-ac88-51d2d436010a" xlink:to="loc_us-gaap_ShareBasedCompensation_b6deee63-d47f-404f-95a6-8bb57c8f528b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c1ff9091-5f66-474a-a0b4-3c55f1714160" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0f343bd8-b11b-466f-ac88-51d2d436010a" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c1ff9091-5f66-474a-a0b4-3c55f1714160" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_8c3f2a9c-a361-4251-b69c-f7e7d89d57bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0f343bd8-b11b-466f-ac88-51d2d436010a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_8c3f2a9c-a361-4251-b69c-f7e7d89d57bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_d4037440-b92f-4075-b2fa-9526bf7fcfef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0f343bd8-b11b-466f-ac88-51d2d436010a" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_d4037440-b92f-4075-b2fa-9526bf7fcfef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_73adc5f5-f6fa-4fb8-9720-0b62cc05e9cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0f343bd8-b11b-466f-ac88-51d2d436010a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_73adc5f5-f6fa-4fb8-9720-0b62cc05e9cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_bb6809ff-de30-4fbc-96f1-9adf61ee5e41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0f343bd8-b11b-466f-ac88-51d2d436010a" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_bb6809ff-de30-4fbc-96f1-9adf61ee5e41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_c9085b95-a7e1-4e16-b3e3-732baa735bef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0f343bd8-b11b-466f-ac88-51d2d436010a" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_c9085b95-a7e1-4e16-b3e3-732baa735bef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_77fb6ac2-6878-4723-99fb-8a14633b9400" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0f343bd8-b11b-466f-ac88-51d2d436010a" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_77fb6ac2-6878-4723-99fb-8a14633b9400" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2e90717d-bf8a-4570-9363-939ba7e340a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_ad035d72-90cd-4dab-9bdd-8b555d535d4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2e90717d-bf8a-4570-9363-939ba7e340a7" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_ad035d72-90cd-4dab-9bdd-8b555d535d4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_418d92ac-0fd8-496f-b98a-d85916eebeea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2e90717d-bf8a-4570-9363-939ba7e340a7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_418d92ac-0fd8-496f-b98a-d85916eebeea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_169893fd-3194-49fa-9a83-91d0cc9a8164" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2e90717d-bf8a-4570-9363-939ba7e340a7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_169893fd-3194-49fa-9a83-91d0cc9a8164" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_01950a81-f224-4940-9d1a-b94cb57f563c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2e90717d-bf8a-4570-9363-939ba7e340a7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_01950a81-f224-4940-9d1a-b94cb57f563c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/Operations" xlink:type="simple" xlink:href="cnmd-20210331.xsd#Operations"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/Operations" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/InterimFinancialInformation" xlink:type="simple" xlink:href="cnmd-20210331.xsd#InterimFinancialInformation"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/InterimFinancialInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/InterimReportingPolicies" xlink:type="simple" xlink:href="cnmd-20210331.xsd#InterimReportingPolicies"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/InterimReportingPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/Revenues" xlink:type="simple" xlink:href="cnmd-20210331.xsd#Revenues"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/Revenues" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/RevenuesTables" xlink:type="simple" xlink:href="cnmd-20210331.xsd#RevenuesTables"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/RevenuesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#RevenuesDisaggregatedRevenuesDetails"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/RevenuesCustomerLiabilityDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#RevenuesCustomerLiabilityDetails"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/RevenuesCustomerLiabilityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/ComprehensiveIncomeLoss" xlink:type="simple" xlink:href="cnmd-20210331.xsd#ComprehensiveIncomeLoss"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/ComprehensiveIncomeLoss" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/ComprehensiveIncomeLossTables" xlink:type="simple" xlink:href="cnmd-20210331.xsd#ComprehensiveIncomeLossTables"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/ComprehensiveIncomeLossTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/ComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#ComprehensiveIncomeLossDetails"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/ComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c7d07865-a32d-446c-a5c2-ca369b29fc15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_bf32dd29-b341-437c-898b-c0773e60d00f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c7d07865-a32d-446c-a5c2-ca369b29fc15" xlink:to="loc_us-gaap_NetIncomeLoss_bf32dd29-b341-437c-898b-c0773e60d00f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_9d99bdc7-02ac-49fd-8933-bd3e8b8b91a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c7d07865-a32d-446c-a5c2-ca369b29fc15" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_9d99bdc7-02ac-49fd-8933-bd3e8b8b91a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_6ec2afbb-3b27-4bd4-a894-7213ce8214f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c7d07865-a32d-446c-a5c2-ca369b29fc15" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_6ec2afbb-3b27-4bd4-a894-7213ce8214f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7fe639e1-b5af-4252-a7d0-cde9af9416fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c7d07865-a32d-446c-a5c2-ca369b29fc15" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7fe639e1-b5af-4252-a7d0-cde9af9416fd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/ComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#ComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/ComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d919b183-f2eb-4a3d-84dc-0ffbc21749ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_eeb622e0-2897-41e2-adde-45cc96520e6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d919b183-f2eb-4a3d-84dc-0ffbc21749ee" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_eeb622e0-2897-41e2-adde-45cc96520e6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_d3c23a87-1dbb-436c-a078-6626fef9db38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d919b183-f2eb-4a3d-84dc-0ffbc21749ee" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_d3c23a87-1dbb-436c-a078-6626fef9db38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_b17c7c0c-e091-4b03-b31c-cd0c6d351e3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d919b183-f2eb-4a3d-84dc-0ffbc21749ee" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_b17c7c0c-e091-4b03-b31c-cd0c6d351e3e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/FairValueofFinancialInstruments" xlink:type="simple" xlink:href="cnmd-20210331.xsd#FairValueofFinancialInstruments"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/FairValueofFinancialInstruments" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/FairValueofFinancialInstrumentsTables" xlink:type="simple" xlink:href="cnmd-20210331.xsd#FairValueofFinancialInstrumentsTables"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/FairValueofFinancialInstrumentsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_04ce552f-f472-4025-bc4d-20c57e0a8278" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_79ec7b52-24ba-4efb-ac97-3d5bd909782e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_04ce552f-f472-4025-bc4d-20c57e0a8278" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_79ec7b52-24ba-4efb-ac97-3d5bd909782e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_6a25147e-751b-45be-9c58-d676d2ff4b07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_04ce552f-f472-4025-bc4d-20c57e0a8278" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_6a25147e-751b-45be-9c58-d676d2ff4b07" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/Inventories" xlink:type="simple" xlink:href="cnmd-20210331.xsd#Inventories"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/Inventories" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/InventoriesTables" xlink:type="simple" xlink:href="cnmd-20210331.xsd#InventoriesTables"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/InventoriesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/InventoriesDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#InventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_2855ef1a-82d1-4f24-bddb-bbf683005229" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_223301d1-e595-45b6-9e43-e389a1034e0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_2855ef1a-82d1-4f24-bddb-bbf683005229" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_223301d1-e595-45b6-9e43-e389a1034e0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_378a66bf-8321-4f5e-ac64-ea4c9779c535" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_2855ef1a-82d1-4f24-bddb-bbf683005229" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_378a66bf-8321-4f5e-ac64-ea4c9779c535" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_9ae9c4dc-0564-4f16-ad0f-aa45133c72fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_2855ef1a-82d1-4f24-bddb-bbf683005229" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_9ae9c4dc-0564-4f16-ad0f-aa45133c72fd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/EarningsPerShare" xlink:type="simple" xlink:href="cnmd-20210331.xsd#EarningsPerShare"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/EarningsPerShare" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="cnmd-20210331.xsd#EarningsPerShareTables"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/EarningsPerShareTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#EarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/EarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d972d17c-ead2-42da-a4d1-78eb513bf3d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2cca91a0-d811-4ae0-bb0c-46923ac50977" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d972d17c-ead2-42da-a4d1-78eb513bf3d1" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2cca91a0-d811-4ae0-bb0c-46923ac50977" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_f1899ce4-4d7c-40f6-a1d3-e58ea24bfdcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d972d17c-ead2-42da-a4d1-78eb513bf3d1" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_f1899ce4-4d7c-40f6-a1d3-e58ea24bfdcb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/EarningsPerShareConvertibleNotesDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#EarningsPerShareConvertibleNotesDetails"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/EarningsPerShareConvertibleNotesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="cnmd-20210331.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="simple" xlink:href="cnmd-20210331.xsd#GoodwillandOtherIntangibleAssetsTables"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#GoodwillandOtherIntangibleAssetsGoodwillDetails"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_a75805a0-22a2-412a-b609-ded23e60dc5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_547aa761-2fc0-41f4-bcff-1adb405a71b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_a75805a0-22a2-412a-b609-ded23e60dc5f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_547aa761-2fc0-41f4-bcff-1adb405a71b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_91ef7478-8040-4f04-aab8-6d1471e41caf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_a75805a0-22a2-412a-b609-ded23e60dc5f" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_91ef7478-8040-4f04-aab8-6d1471e41caf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/LongTermDebt" xlink:type="simple" xlink:href="cnmd-20210331.xsd#LongTermDebt"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/LongTermDebt" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="cnmd-20210331.xsd#LongTermDebtTables"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/LongTermDebtTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/LongTermDebtDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#LongTermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/LongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_1038d2cd-e160-4ee2-81dc-b98a74b8f4f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_8f713fc1-fd42-4ddd-bdc0-3da8d273addc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_1038d2cd-e160-4ee2-81dc-b98a74b8f4f3" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_8f713fc1-fd42-4ddd-bdc0-3da8d273addc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_b7276ea8-6048-4e90-91b2-d5a985bbaf6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_1038d2cd-e160-4ee2-81dc-b98a74b8f4f3" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_b7276ea8-6048-4e90-91b2-d5a985bbaf6f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#LongTermDebtAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/LongTermDebtMaturitiesofLongTermDebtDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#LongTermDebtMaturitiesofLongTermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/LongTermDebtMaturitiesofLongTermDebtDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/Guarantees" xlink:type="simple" xlink:href="cnmd-20210331.xsd#Guarantees"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/Guarantees" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/GuaranteesTables" xlink:type="simple" xlink:href="cnmd-20210331.xsd#GuaranteesTables"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/GuaranteesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/GuaranteesDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#GuaranteesDetails"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/GuaranteesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/PensionPlan" xlink:type="simple" xlink:href="cnmd-20210331.xsd#PensionPlan"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/PensionPlan" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/PensionPlanTables" xlink:type="simple" xlink:href="cnmd-20210331.xsd#PensionPlanTables"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/PensionPlanTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/PensionPlanDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#PensionPlanDetails"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/PensionPlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3cb82c19-81c9-4872-94d2-598ff3720a58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_735791a7-ce57-4cc4-86a0-11c0de856e66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3cb82c19-81c9-4872-94d2-598ff3720a58" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_735791a7-ce57-4cc4-86a0-11c0de856e66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_39f7e1fe-8984-49e3-99e9-92caede506ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3cb82c19-81c9-4872-94d2-598ff3720a58" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_39f7e1fe-8984-49e3-99e9-92caede506ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_c6088bdd-8fab-4e5d-8c0a-adddd280a21d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3cb82c19-81c9-4872-94d2-598ff3720a58" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_c6088bdd-8fab-4e5d-8c0a-adddd280a21d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_ee761538-6784-4ce1-b52e-c118bbd2232b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3cb82c19-81c9-4872-94d2-598ff3720a58" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_ee761538-6784-4ce1-b52e-c118bbd2232b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/AcquisitionandOtherExpense" xlink:type="simple" xlink:href="cnmd-20210331.xsd#AcquisitionandOtherExpense"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/AcquisitionandOtherExpense" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/AcquisitionandOtherExpenseTables" xlink:type="simple" xlink:href="cnmd-20210331.xsd#AcquisitionandOtherExpenseTables"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/AcquisitionandOtherExpenseTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/AcquisitionandOtherExpenseDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#AcquisitionandOtherExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/AcquisitionandOtherExpenseDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/BusinessSegment" xlink:type="simple" xlink:href="cnmd-20210331.xsd#BusinessSegment"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/BusinessSegment" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/BusinessSegmentTables" xlink:type="simple" xlink:href="cnmd-20210331.xsd#BusinessSegmentTables"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/BusinessSegmentTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/BusinessSegmentDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#BusinessSegmentDetails"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/BusinessSegmentDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/LegalProceedings" xlink:type="simple" xlink:href="cnmd-20210331.xsd#LegalProceedings"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/LegalProceedings" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/LegalProceedingsDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#LegalProceedingsDetails"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/LegalProceedingsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/NewAccountingPronouncements" xlink:type="simple" xlink:href="cnmd-20210331.xsd#NewAccountingPronouncements"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/NewAccountingPronouncements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.conmed.com/role/NewAccountingPronouncementsPolicies" xlink:type="simple" xlink:href="cnmd-20210331.xsd#NewAccountingPronouncementsPolicies"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/NewAccountingPronouncementsPolicies" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>cnmd-20210331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:4a71bfc6-7922-4305-aa8d-7a5d2323cf49,g:a58de70d-c080-4226-99f2-d632a7268b2f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.conmed.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="cnmd-20210331.xsd#DocumentandEntityInformation"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/DocumentandEntityInformation" xlink:type="extended" id="i6090a23c224f41999b81209353aeddc0_DocumentandEntityInformation"/>
  <link:roleRef roleURI="http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited" xlink:type="simple" xlink:href="cnmd-20210331.xsd#ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited" xlink:type="extended" id="i856a27432ae04ba993e720c45cc84143_ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited"/>
  <link:roleRef roleURI="http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="cnmd-20210331.xsd#ConsolidatedCondensedBalanceSheetsUnaudited"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited" xlink:type="extended" id="i4ad53ed3741941a0bfc05db1354e5e8e_ConsolidatedCondensedBalanceSheetsUnaudited"/>
  <link:roleRef roleURI="http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical" xlink:type="simple" xlink:href="cnmd-20210331.xsd#ConsolidatedCondensedBalanceSheetsUnauditedParenthetical"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical" xlink:type="extended" id="i7416872610484018a84cbd5d8d64c601_ConsolidatedCondensedBalanceSheetsUnauditedParenthetical"/>
  <link:roleRef roleURI="http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited" xlink:type="simple" xlink:href="cnmd-20210331.xsd#ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited" xlink:type="extended" id="i07b8eee6bb304828a7db58b61c3f2d66_ConsolidatedCondensedStatementsofShareholdersEquityUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2c24b86d-c20b-41c9-8393-1168edbf4b16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_57f61161-da97-49da-ad1f-dbe0207b3870" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2c24b86d-c20b-41c9-8393-1168edbf4b16" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_57f61161-da97-49da-ad1f-dbe0207b3870" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_3d7b428f-6895-429a-94e0-427e3dfcf8ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_57f61161-da97-49da-ad1f-dbe0207b3870" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_3d7b428f-6895-429a-94e0-427e3dfcf8ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0d9961c6-2aa8-43c5-a9c2-84d3698ee0fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_57f61161-da97-49da-ad1f-dbe0207b3870" xlink:to="loc_us-gaap_StockholdersEquity_0d9961c6-2aa8-43c5-a9c2-84d3698ee0fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_099102d9-e7a0-4301-9cff-6d8263651d42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_57f61161-da97-49da-ad1f-dbe0207b3870" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_099102d9-e7a0-4301-9cff-6d8263651d42" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_47ef6f86-8ea1-4859-87ad-5c66850b2ce4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_57f61161-da97-49da-ad1f-dbe0207b3870" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_47ef6f86-8ea1-4859-87ad-5c66850b2ce4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_470967b1-99fd-4062-937b-a1cc2dc4a5b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_57f61161-da97-49da-ad1f-dbe0207b3870" xlink:to="loc_us-gaap_DividendsCommonStockCash_470967b1-99fd-4062-937b-a1cc2dc4a5b6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2513b942-cf09-48e7-83db-4909c442aabd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_57f61161-da97-49da-ad1f-dbe0207b3870" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2513b942-cf09-48e7-83db-4909c442aabd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_993aeadd-2bf8-45db-b7de-ccddd6a3ec09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2513b942-cf09-48e7-83db-4909c442aabd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_993aeadd-2bf8-45db-b7de-ccddd6a3ec09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_c3be278d-fbc3-48c0-93e1-d9b66247d710" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2513b942-cf09-48e7-83db-4909c442aabd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_c3be278d-fbc3-48c0-93e1-d9b66247d710" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_04f2f0a6-4389-4043-af78-51d64694c193" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2513b942-cf09-48e7-83db-4909c442aabd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_04f2f0a6-4389-4043-af78-51d64694c193" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_03e99b82-0c30-4acf-85f3-18dab8700a0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2513b942-cf09-48e7-83db-4909c442aabd" xlink:to="loc_us-gaap_NetIncomeLoss_03e99b82-0c30-4acf-85f3-18dab8700a0a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e798053d-6eb9-4eee-b998-1e9e1a6bd983" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2513b942-cf09-48e7-83db-4909c442aabd" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e798053d-6eb9-4eee-b998-1e9e1a6bd983" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_6660fea2-4fcc-4ef4-8d92-064196be8c70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_398ab99a-c250-4c97-9ce4-6d3aec3c99f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f402893e-5c5a-462b-b4db-cd651192d594" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_2c24b86d-c20b-41c9-8393-1168edbf4b16" xlink:to="loc_us-gaap_StatementTable_f402893e-5c5a-462b-b4db-cd651192d594" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_89ff4660-88db-43d8-99fc-f7791551c3ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f402893e-5c5a-462b-b4db-cd651192d594" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_89ff4660-88db-43d8-99fc-f7791551c3ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_89ff4660-88db-43d8-99fc-f7791551c3ab_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_89ff4660-88db-43d8-99fc-f7791551c3ab" xlink:to="loc_us-gaap_TypeOfAdoptionMember_89ff4660-88db-43d8-99fc-f7791551c3ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_0c78ac35-7ab2-4647-a8b5-e1b23d2e95c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_89ff4660-88db-43d8-99fc-f7791551c3ab" xlink:to="loc_us-gaap_TypeOfAdoptionMember_0c78ac35-7ab2-4647-a8b5-e1b23d2e95c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_779b42e6-89f5-4138-8660-c5d446cc3502" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f402893e-5c5a-462b-b4db-cd651192d594" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_779b42e6-89f5-4138-8660-c5d446cc3502" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_779b42e6-89f5-4138-8660-c5d446cc3502_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_779b42e6-89f5-4138-8660-c5d446cc3502" xlink:to="loc_us-gaap_EquityComponentDomain_779b42e6-89f5-4138-8660-c5d446cc3502_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e620911c-580d-48c1-8f2b-e5d79529cf07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_779b42e6-89f5-4138-8660-c5d446cc3502" xlink:to="loc_us-gaap_EquityComponentDomain_e620911c-580d-48c1-8f2b-e5d79529cf07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_772ef7e6-0f9d-4a52-a738-a2d2727e0924" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e620911c-580d-48c1-8f2b-e5d79529cf07" xlink:to="loc_us-gaap_CommonStockMember_772ef7e6-0f9d-4a52-a738-a2d2727e0924" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_f7dc161a-cbb0-4022-bfc2-c61eb852ea6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e620911c-580d-48c1-8f2b-e5d79529cf07" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_f7dc161a-cbb0-4022-bfc2-c61eb852ea6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_746521d1-2dc6-4437-a266-7e5ca710f411" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e620911c-580d-48c1-8f2b-e5d79529cf07" xlink:to="loc_us-gaap_RetainedEarningsMember_746521d1-2dc6-4437-a266-7e5ca710f411" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2cbd493d-066a-4ee7-835e-919e9827f72c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e620911c-580d-48c1-8f2b-e5d79529cf07" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2cbd493d-066a-4ee7-835e-919e9827f72c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_7703c5b6-1bcf-4d51-88a3-248599a10171" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e620911c-580d-48c1-8f2b-e5d79529cf07" xlink:to="loc_us-gaap_TreasuryStockMember_7703c5b6-1bcf-4d51-88a3-248599a10171" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnauditedParenthetical" xlink:type="simple" xlink:href="cnmd-20210331.xsd#ConsolidatedCondensedStatementsofShareholdersEquityUnauditedParenthetical"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnauditedParenthetical" xlink:type="extended" id="i801cdb6309664af4a39ec29320a1a9bb_ConsolidatedCondensedStatementsofShareholdersEquityUnauditedParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a2d2a3b5-ea1c-4263-b169-a92f6b1c094b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_b21bb05e-0777-4d95-968f-3d326d4f6fc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a2d2a3b5-ea1c-4263-b169-a92f6b1c094b" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_b21bb05e-0777-4d95-968f-3d326d4f6fc0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ff8865af-b5a7-49af-9ba3-d01400f68df1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_a2d2a3b5-ea1c-4263-b169-a92f6b1c094b" xlink:to="loc_us-gaap_StatementTable_ff8865af-b5a7-49af-9ba3-d01400f68df1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9586cc58-5040-4f9e-9835-96efd53b5e84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ff8865af-b5a7-49af-9ba3-d01400f68df1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9586cc58-5040-4f9e-9835-96efd53b5e84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9586cc58-5040-4f9e-9835-96efd53b5e84_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9586cc58-5040-4f9e-9835-96efd53b5e84" xlink:to="loc_us-gaap_EquityComponentDomain_9586cc58-5040-4f9e-9835-96efd53b5e84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e0c818ef-5209-479f-9ee6-03b56ba762d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9586cc58-5040-4f9e-9835-96efd53b5e84" xlink:to="loc_us-gaap_EquityComponentDomain_e0c818ef-5209-479f-9ee6-03b56ba762d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_5aba9c0f-c9d8-4191-8edd-85b9af385328" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e0c818ef-5209-479f-9ee6-03b56ba762d8" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_5aba9c0f-c9d8-4191-8edd-85b9af385328" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="cnmd-20210331.xsd#ConsolidatedCondensedStatementsofCashFlowsUnaudited"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" xlink:type="extended" id="i4ed04a316aa540f9b4848c2393b7f320_ConsolidatedCondensedStatementsofCashFlowsUnaudited"/>
  <link:roleRef roleURI="http://www.conmed.com/role/Operations" xlink:type="simple" xlink:href="cnmd-20210331.xsd#Operations"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/Operations" xlink:type="extended" id="i5a7e69b199ce4261ac5cac15d2f20a22_Operations"/>
  <link:roleRef roleURI="http://www.conmed.com/role/InterimFinancialInformation" xlink:type="simple" xlink:href="cnmd-20210331.xsd#InterimFinancialInformation"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/InterimFinancialInformation" xlink:type="extended" id="ifc9d009c04a04a04b4c223fdece19f1a_InterimFinancialInformation"/>
  <link:roleRef roleURI="http://www.conmed.com/role/InterimReportingPolicies" xlink:type="simple" xlink:href="cnmd-20210331.xsd#InterimReportingPolicies"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/InterimReportingPolicies" xlink:type="extended" id="i4b61c9db01a34850b4dc19649f2af331_InterimReportingPolicies"/>
  <link:roleRef roleURI="http://www.conmed.com/role/Revenues" xlink:type="simple" xlink:href="cnmd-20210331.xsd#Revenues"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/Revenues" xlink:type="extended" id="i0cab937a7cea47a8af770c5ed3a61607_Revenues"/>
  <link:roleRef roleURI="http://www.conmed.com/role/RevenuesTables" xlink:type="simple" xlink:href="cnmd-20210331.xsd#RevenuesTables"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/RevenuesTables" xlink:type="extended" id="i0726d5ea94b44c62b587e43252f8a964_RevenuesTables"/>
  <link:roleRef roleURI="http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#RevenuesDisaggregatedRevenuesDetails"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails" xlink:type="extended" id="i922db1472c304464a17a296b330f9536_RevenuesDisaggregatedRevenuesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_1c7bc1ea-ef99-4ddc-8d9e-b312a31a4d74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_cdbb9a60-687e-4686-b55b-c3eb3c708aa0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1c7bc1ea-ef99-4ddc-8d9e-b312a31a4d74" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_cdbb9a60-687e-4686-b55b-c3eb3c708aa0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_2e0a1495-002b-496c-94c9-4b1929044ade" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1c7bc1ea-ef99-4ddc-8d9e-b312a31a4d74" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_2e0a1495-002b-496c-94c9-4b1929044ade" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_505b0e6e-f67a-4c51-8431-31de3b7e58be" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2e0a1495-002b-496c-94c9-4b1929044ade" xlink:to="loc_srt_StatementGeographicalAxis_505b0e6e-f67a-4c51-8431-31de3b7e58be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_505b0e6e-f67a-4c51-8431-31de3b7e58be_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_505b0e6e-f67a-4c51-8431-31de3b7e58be" xlink:to="loc_srt_SegmentGeographicalDomain_505b0e6e-f67a-4c51-8431-31de3b7e58be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3921faff-b4d7-401b-814f-d96e3244931e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_505b0e6e-f67a-4c51-8431-31de3b7e58be" xlink:to="loc_srt_SegmentGeographicalDomain_3921faff-b4d7-401b-814f-d96e3244931e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_eca92f3f-4590-4aca-9441-1feb540bfd38" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3921faff-b4d7-401b-814f-d96e3244931e" xlink:to="loc_country_US_eca92f3f-4590-4aca-9441-1feb540bfd38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AmericasexcludingtheUnitedStatesMember_da58f81c-363d-4765-88a5-46e0ae3beec4" xlink:href="cnmd-20210331.xsd#cnmd_AmericasexcludingtheUnitedStatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3921faff-b4d7-401b-814f-d96e3244931e" xlink:to="loc_cnmd_AmericasexcludingtheUnitedStatesMember_da58f81c-363d-4765-88a5-46e0ae3beec4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_edc84081-df28-4705-a469-e6add8ab0186" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EMEAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3921faff-b4d7-401b-814f-d96e3244931e" xlink:to="loc_us-gaap_EMEAMember_edc84081-df28-4705-a469-e6add8ab0186" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_13402e14-8ed7-488c-b5d4-cb4572cb4fdb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3921faff-b4d7-401b-814f-d96e3244931e" xlink:to="loc_srt_AsiaPacificMember_13402e14-8ed7-488c-b5d4-cb4572cb4fdb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_bbb75cb8-f1e0-4e38-a6da-d34dc9be0748" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2e0a1495-002b-496c-94c9-4b1929044ade" xlink:to="loc_srt_ProductOrServiceAxis_bbb75cb8-f1e0-4e38-a6da-d34dc9be0748" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_bbb75cb8-f1e0-4e38-a6da-d34dc9be0748_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_bbb75cb8-f1e0-4e38-a6da-d34dc9be0748" xlink:to="loc_srt_ProductsAndServicesDomain_bbb75cb8-f1e0-4e38-a6da-d34dc9be0748_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_908b15bd-cc15-4b16-890a-e16377333101" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_bbb75cb8-f1e0-4e38-a6da-d34dc9be0748" xlink:to="loc_srt_ProductsAndServicesDomain_908b15bd-cc15-4b16-890a-e16377333101" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_OrthopedicSurgeryMember_90a2888a-8867-4aad-9011-2554af07e9ae" xlink:href="cnmd-20210331.xsd#cnmd_OrthopedicSurgeryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_908b15bd-cc15-4b16-890a-e16377333101" xlink:to="loc_cnmd_OrthopedicSurgeryMember_90a2888a-8867-4aad-9011-2554af07e9ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_GeneralSurgeryMember_502bf94c-9253-497f-8cbb-60316feb86ab" xlink:href="cnmd-20210331.xsd#cnmd_GeneralSurgeryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_908b15bd-cc15-4b16-890a-e16377333101" xlink:to="loc_cnmd_GeneralSurgeryMember_502bf94c-9253-497f-8cbb-60316feb86ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_dc75775f-8051-4f36-9fa4-6b51cd07b198" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2e0a1495-002b-496c-94c9-4b1929044ade" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_dc75775f-8051-4f36-9fa4-6b51cd07b198" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_dc75775f-8051-4f36-9fa4-6b51cd07b198_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_dc75775f-8051-4f36-9fa4-6b51cd07b198" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_dc75775f-8051-4f36-9fa4-6b51cd07b198_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_5a234ff9-979f-46e5-ae74-2515793760a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_dc75775f-8051-4f36-9fa4-6b51cd07b198" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_5a234ff9-979f-46e5-ae74-2515793760a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredAtPointInTimeMember_98144438-3570-45ac-9853-1066ce620a6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferredAtPointInTimeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_5a234ff9-979f-46e5-ae74-2515793760a9" xlink:to="loc_us-gaap_TransferredAtPointInTimeMember_98144438-3570-45ac-9853-1066ce620a6f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember_c624c55a-19c4-4884-a4f0-3d7d27c3149c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_5a234ff9-979f-46e5-ae74-2515793760a9" xlink:to="loc_us-gaap_TransferredOverTimeMember_c624c55a-19c4-4884-a4f0-3d7d27c3149c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.conmed.com/role/RevenuesCustomerLiabilityDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#RevenuesCustomerLiabilityDetails"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/RevenuesCustomerLiabilityDetails" xlink:type="extended" id="i55704c269be947c9aa07d587eaf02165_RevenuesCustomerLiabilityDetails"/>
  <link:roleRef roleURI="http://www.conmed.com/role/ComprehensiveIncomeLoss" xlink:type="simple" xlink:href="cnmd-20210331.xsd#ComprehensiveIncomeLoss"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/ComprehensiveIncomeLoss" xlink:type="extended" id="i2c3f566c4cc24784a1b80ff1a80237b4_ComprehensiveIncomeLoss"/>
  <link:roleRef roleURI="http://www.conmed.com/role/ComprehensiveIncomeLossTables" xlink:type="simple" xlink:href="cnmd-20210331.xsd#ComprehensiveIncomeLossTables"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/ComprehensiveIncomeLossTables" xlink:type="extended" id="i89563c2bb243414fbf123d0e6b73acf1_ComprehensiveIncomeLossTables"/>
  <link:roleRef roleURI="http://www.conmed.com/role/ComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#ComprehensiveIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/ComprehensiveIncomeLossDetails" xlink:type="extended" id="i36415f37566648c09b4cde31893e179c_ComprehensiveIncomeLossDetails"/>
  <link:roleRef roleURI="http://www.conmed.com/role/ComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#ComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/ComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended" id="i8f488d94a4fc4c7b983366ee24ac3401_ComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_dc8df07f-f4ac-40a2-9781-9bbdd14dbc3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_2e20304a-0570-40c1-b024-118a929d7cf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_dc8df07f-f4ac-40a2-9781-9bbdd14dbc3d" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_2e20304a-0570-40c1-b024-118a929d7cf5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6c83f1f6-48ad-4e40-8a97-1d05fb894d90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_2e20304a-0570-40c1-b024-118a929d7cf5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6c83f1f6-48ad-4e40-8a97-1d05fb894d90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_88749c5b-afd8-440b-a33d-ff8c2afed928" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_2e20304a-0570-40c1-b024-118a929d7cf5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_88749c5b-afd8-440b-a33d-ff8c2afed928" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_5f360b09-3c4f-4434-b23c-e40afd42f819" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_2e20304a-0570-40c1-b024-118a929d7cf5" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_5f360b09-3c4f-4434-b23c-e40afd42f819" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_1e366336-ae89-4068-85ca-5d96c04f994b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_2e20304a-0570-40c1-b024-118a929d7cf5" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_1e366336-ae89-4068-85ca-5d96c04f994b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a573415a-2927-4774-9131-814d558b13a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_2e20304a-0570-40c1-b024-118a929d7cf5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a573415a-2927-4774-9131-814d558b13a6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5e05fa1b-fa10-4007-aaad-2e3af65988d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ed29c358-d89f-4f28-a084-30c3a4f5ddea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_dc8df07f-f4ac-40a2-9781-9bbdd14dbc3d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ed29c358-d89f-4f28-a084-30c3a4f5ddea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_391c20b4-e081-4c38-b8da-1d4a0c1d0608" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ed29c358-d89f-4f28-a084-30c3a4f5ddea" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_391c20b4-e081-4c38-b8da-1d4a0c1d0608" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_391c20b4-e081-4c38-b8da-1d4a0c1d0608_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_391c20b4-e081-4c38-b8da-1d4a0c1d0608" xlink:to="loc_us-gaap_EquityComponentDomain_391c20b4-e081-4c38-b8da-1d4a0c1d0608_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3deb47e4-debf-4bfb-a650-1a3ef262991f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_391c20b4-e081-4c38-b8da-1d4a0c1d0608" xlink:to="loc_us-gaap_EquityComponentDomain_3deb47e4-debf-4bfb-a650-1a3ef262991f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_782df29d-9515-4352-9658-0db8d5915c50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3deb47e4-debf-4bfb-a650-1a3ef262991f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_782df29d-9515-4352-9658-0db8d5915c50" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_179cace5-c189-409b-b0f2-db761eeacd9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_782df29d-9515-4352-9658-0db8d5915c50" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_179cace5-c189-409b-b0f2-db761eeacd9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_3669c78c-95c0-482a-ab6d-4cdb11da7cd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_782df29d-9515-4352-9658-0db8d5915c50" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_3669c78c-95c0-482a-ab6d-4cdb11da7cd5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_f1969fc6-465f-49dc-a557-b9b902848142" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_782df29d-9515-4352-9658-0db8d5915c50" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_f1969fc6-465f-49dc-a557-b9b902848142" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.conmed.com/role/FairValueofFinancialInstruments" xlink:type="simple" xlink:href="cnmd-20210331.xsd#FairValueofFinancialInstruments"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/FairValueofFinancialInstruments" xlink:type="extended" id="icac6fca26e63455697073e4fd0bf79bf_FairValueofFinancialInstruments"/>
  <link:roleRef roleURI="http://www.conmed.com/role/FairValueofFinancialInstrumentsTables" xlink:type="simple" xlink:href="cnmd-20210331.xsd#FairValueofFinancialInstrumentsTables"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/FairValueofFinancialInstrumentsTables" xlink:type="extended" id="id1119352a7b64486915ad9d2eae74723_FairValueofFinancialInstrumentsTables"/>
  <link:roleRef roleURI="http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails" xlink:type="extended" id="i8b095d0badb34777a2566d983bf19e36_FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_85bbf873-cdf5-49ab-a8d2-99d1c3046315" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_99d64f3b-9aa5-4003-aa5d-b70fdeca3ae3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_85bbf873-cdf5-49ab-a8d2-99d1c3046315" xlink:to="loc_us-gaap_Revenues_99d64f3b-9aa5-4003-aa5d-b70fdeca3ae3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_050a2b1d-1721-4b09-9740-3f751bac3a58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_85bbf873-cdf5-49ab-a8d2-99d1c3046315" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_050a2b1d-1721-4b09-9740-3f751bac3a58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_afefed04-829a-48de-b12a-dc4e48d86aeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_85bbf873-cdf5-49ab-a8d2-99d1c3046315" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_afefed04-829a-48de-b12a-dc4e48d86aeb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_03538d7f-5355-44d7-889a-11c51e31a08f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_85bbf873-cdf5-49ab-a8d2-99d1c3046315" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_03538d7f-5355-44d7-889a-11c51e31a08f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_4aabb35d-b711-4fb0-b806-c6e0df63de52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_85bbf873-cdf5-49ab-a8d2-99d1c3046315" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_4aabb35d-b711-4fb0-b806-c6e0df63de52" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_7cf15ac6-88a7-40a0-82bf-1f9e9a471158" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_85bbf873-cdf5-49ab-a8d2-99d1c3046315" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_7cf15ac6-88a7-40a0-82bf-1f9e9a471158" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_aa34c91f-9bd0-4b5e-b2a9-f53a96a576b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_85bbf873-cdf5-49ab-a8d2-99d1c3046315" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_aa34c91f-9bd0-4b5e-b2a9-f53a96a576b2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_3686fa2a-9c58-4a55-94f1-c2f87b379c17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_85bbf873-cdf5-49ab-a8d2-99d1c3046315" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_3686fa2a-9c58-4a55-94f1-c2f87b379c17" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c1980f64-5a04-4d0c-9f27-59cb700d4849" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_85bbf873-cdf5-49ab-a8d2-99d1c3046315" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c1980f64-5a04-4d0c-9f27-59cb700d4849" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_9b70efdb-9484-43d4-bb4a-36db84553f55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c1980f64-5a04-4d0c-9f27-59cb700d4849" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_9b70efdb-9484-43d4-bb4a-36db84553f55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9b70efdb-9484-43d4-bb4a-36db84553f55_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9b70efdb-9484-43d4-bb4a-36db84553f55" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9b70efdb-9484-43d4-bb4a-36db84553f55_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_506daa12-bd4b-4a52-92a4-e9569f15d50e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9b70efdb-9484-43d4-bb4a-36db84553f55" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_506daa12-bd4b-4a52-92a4-e9569f15d50e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_RevenuesMember_a1a8fb55-b81b-4f6b-98e2-b0f65764a3fb" xlink:href="cnmd-20210331.xsd#cnmd_RevenuesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_506daa12-bd4b-4a52-92a4-e9569f15d50e" xlink:to="loc_cnmd_RevenuesMember_a1a8fb55-b81b-4f6b-98e2-b0f65764a3fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_0fab1b4d-0f24-4fd3-915d-5c9bd5c30c80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_506daa12-bd4b-4a52-92a4-e9569f15d50e" xlink:to="loc_us-gaap_CostOfSalesMember_0fab1b4d-0f24-4fd3-915d-5c9bd5c30c80" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails" xlink:type="extended" id="i99a073e3b0a747e3b5dcfde9cdb08baf_FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_bca1acb6-6d44-46df-93a4-1e652c30be64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_2cf98200-0e7f-48f1-ae12-a648dfad2387" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_bca1acb6-6d44-46df-93a4-1e652c30be64" xlink:to="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_2cf98200-0e7f-48f1-ae12-a648dfad2387" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_4116987b-d035-4778-9249-28a74c4ad26c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_bca1acb6-6d44-46df-93a4-1e652c30be64" xlink:to="loc_us-gaap_DerivativeNotionalAmount_4116987b-d035-4778-9249-28a74c4ad26c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_293fcc7d-a68e-4f06-86ed-f665d52e5375" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_bca1acb6-6d44-46df-93a4-1e652c30be64" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_293fcc7d-a68e-4f06-86ed-f665d52e5375" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_4c848820-5743-4aea-8b36-1b682c836e5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_bca1acb6-6d44-46df-93a4-1e652c30be64" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_4c848820-5743-4aea-8b36-1b682c836e5c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_ebc68bae-1757-4d70-b5b2-30d8a793df64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_bca1acb6-6d44-46df-93a4-1e652c30be64" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_ebc68bae-1757-4d70-b5b2-30d8a793df64" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract_edb3e7a1-5b2f-4041-a949-9fe08f99a17a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_bca1acb6-6d44-46df-93a4-1e652c30be64" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract_edb3e7a1-5b2f-4041-a949-9fe08f99a17a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_fd2122c4-74fb-48b8-a2bc-90d98ec81e89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract_edb3e7a1-5b2f-4041-a949-9fe08f99a17a" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_fd2122c4-74fb-48b8-a2bc-90d98ec81e89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_f805b5f0-7303-4064-b285-b93c3a5e7e75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract_edb3e7a1-5b2f-4041-a949-9fe08f99a17a" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_f805b5f0-7303-4064-b285-b93c3a5e7e75" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_af988383-4a6d-47cc-b38d-874c4fd209ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract_edb3e7a1-5b2f-4041-a949-9fe08f99a17a" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_af988383-4a6d-47cc-b38d-874c4fd209ce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_7f99522b-b87a-44e3-9a66-14d386fbda9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_bca1acb6-6d44-46df-93a4-1e652c30be64" xlink:to="loc_us-gaap_DerivativeTable_7f99522b-b87a-44e3-9a66-14d386fbda9c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f8ccf21c-8ede-43fd-aaf6-9b53a581451e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_7f99522b-b87a-44e3-9a66-14d386fbda9c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f8ccf21c-8ede-43fd-aaf6-9b53a581451e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f8ccf21c-8ede-43fd-aaf6-9b53a581451e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f8ccf21c-8ede-43fd-aaf6-9b53a581451e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f8ccf21c-8ede-43fd-aaf6-9b53a581451e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_26a26e54-2b2a-4b89-8684-1e7edd9e4bd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f8ccf21c-8ede-43fd-aaf6-9b53a581451e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_26a26e54-2b2a-4b89-8684-1e7edd9e4bd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_RevenuesMember_0692fec9-29c6-488a-9f59-4ef6e89cfe3f" xlink:href="cnmd-20210331.xsd#cnmd_RevenuesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_26a26e54-2b2a-4b89-8684-1e7edd9e4bd8" xlink:to="loc_cnmd_RevenuesMember_0692fec9-29c6-488a-9f59-4ef6e89cfe3f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_7a52341b-8c19-47b5-9b86-b923abab0fef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_26a26e54-2b2a-4b89-8684-1e7edd9e4bd8" xlink:to="loc_us-gaap_CostOfSalesMember_7a52341b-8c19-47b5-9b86-b923abab0fef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1b09d82d-9cd9-4447-94a1-b4ee733cc86c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_7f99522b-b87a-44e3-9a66-14d386fbda9c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1b09d82d-9cd9-4447-94a1-b4ee733cc86c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1b09d82d-9cd9-4447-94a1-b4ee733cc86c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1b09d82d-9cd9-4447-94a1-b4ee733cc86c" xlink:to="loc_us-gaap_EquityComponentDomain_1b09d82d-9cd9-4447-94a1-b4ee733cc86c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_37c869b8-7d4f-402c-8256-21d8606a2fea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1b09d82d-9cd9-4447-94a1-b4ee733cc86c" xlink:to="loc_us-gaap_EquityComponentDomain_37c869b8-7d4f-402c-8256-21d8606a2fea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_e88c4c8e-94a2-4955-8d89-3e664f6225b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_37c869b8-7d4f-402c-8256-21d8606a2fea" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_e88c4c8e-94a2-4955-8d89-3e664f6225b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_9cb94b47-cc9f-44b7-87af-0c72b18b7cd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_7f99522b-b87a-44e3-9a66-14d386fbda9c" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_9cb94b47-cc9f-44b7-87af-0c72b18b7cd8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_9cb94b47-cc9f-44b7-87af-0c72b18b7cd8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_9cb94b47-cc9f-44b7-87af-0c72b18b7cd8" xlink:to="loc_us-gaap_HedgingRelationshipDomain_9cb94b47-cc9f-44b7-87af-0c72b18b7cd8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_e8d0ac9f-5ed5-46ae-a712-c6270086dfc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_9cb94b47-cc9f-44b7-87af-0c72b18b7cd8" xlink:to="loc_us-gaap_HedgingRelationshipDomain_e8d0ac9f-5ed5-46ae-a712-c6270086dfc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_e18cd682-49cd-4e50-8e4a-eb2c4825074c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_e8d0ac9f-5ed5-46ae-a712-c6270086dfc1" xlink:to="loc_us-gaap_CashFlowHedgingMember_e18cd682-49cd-4e50-8e4a-eb2c4825074c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_a35278f4-d5f0-4799-bf0a-4c5a94d52b25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_e8d0ac9f-5ed5-46ae-a712-c6270086dfc1" xlink:to="loc_us-gaap_NondesignatedMember_a35278f4-d5f0-4799-bf0a-4c5a94d52b25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d6603c04-f2dc-4d8a-a50f-0db9867113e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_7f99522b-b87a-44e3-9a66-14d386fbda9c" xlink:to="loc_us-gaap_HedgingDesignationAxis_d6603c04-f2dc-4d8a-a50f-0db9867113e4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_d6603c04-f2dc-4d8a-a50f-0db9867113e4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_d6603c04-f2dc-4d8a-a50f-0db9867113e4" xlink:to="loc_us-gaap_HedgingDesignationDomain_d6603c04-f2dc-4d8a-a50f-0db9867113e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_fcb30431-8d48-46e7-aef7-9044b57043e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_d6603c04-f2dc-4d8a-a50f-0db9867113e4" xlink:to="loc_us-gaap_HedgingDesignationDomain_fcb30431-8d48-46e7-aef7-9044b57043e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fdb615f6-3483-469d-83f6-4ed0f41d1e7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_fcb30431-8d48-46e7-aef7-9044b57043e2" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fdb615f6-3483-469d-83f6-4ed0f41d1e7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_85cac718-8362-4dcb-a6bd-c575969b4cbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_fcb30431-8d48-46e7-aef7-9044b57043e2" xlink:to="loc_us-gaap_NondesignatedMember_85cac718-8362-4dcb-a6bd-c575969b4cbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f92854bd-f7e1-440f-af8b-59dcab16065c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_7f99522b-b87a-44e3-9a66-14d386fbda9c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f92854bd-f7e1-440f-af8b-59dcab16065c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f92854bd-f7e1-440f-af8b-59dcab16065c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f92854bd-f7e1-440f-af8b-59dcab16065c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f92854bd-f7e1-440f-af8b-59dcab16065c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6fcb8367-7667-4c10-8860-25877d9b9d1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f92854bd-f7e1-440f-af8b-59dcab16065c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6fcb8367-7667-4c10-8860-25877d9b9d1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_fdd75179-0e5b-4840-a6e3-7d8f9af5c9d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6fcb8367-7667-4c10-8860-25877d9b9d1c" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_fdd75179-0e5b-4840-a6e3-7d8f9af5c9d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_acb0de9a-aa59-4d5e-a0e0-4c43a356c2ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_7f99522b-b87a-44e3-9a66-14d386fbda9c" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_acb0de9a-aa59-4d5e-a0e0-4c43a356c2ca" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_acb0de9a-aa59-4d5e-a0e0-4c43a356c2ca_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_acb0de9a-aa59-4d5e-a0e0-4c43a356c2ca" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_acb0de9a-aa59-4d5e-a0e0-4c43a356c2ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_305de81e-f8dc-40d2-a6c3-fcdea9a943e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_acb0de9a-aa59-4d5e-a0e0-4c43a356c2ca" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_305de81e-f8dc-40d2-a6c3-fcdea9a943e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_856a8e91-7a0f-4a21-a95a-92f0b9965956" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_305de81e-f8dc-40d2-a6c3-fcdea9a943e8" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_856a8e91-7a0f-4a21-a95a-92f0b9965956" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_b4d26635-f50a-4b7e-bf35-13092d8bd4a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_305de81e-f8dc-40d2-a6c3-fcdea9a943e8" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_b4d26635-f50a-4b7e-bf35-13092d8bd4a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_0c767077-0ebe-408c-bc05-b45734927b6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_305de81e-f8dc-40d2-a6c3-fcdea9a943e8" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_0c767077-0ebe-408c-bc05-b45734927b6f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.conmed.com/role/Inventories" xlink:type="simple" xlink:href="cnmd-20210331.xsd#Inventories"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/Inventories" xlink:type="extended" id="i213ef29d11de4ddb95b58fddea670300_Inventories"/>
  <link:roleRef roleURI="http://www.conmed.com/role/InventoriesTables" xlink:type="simple" xlink:href="cnmd-20210331.xsd#InventoriesTables"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/InventoriesTables" xlink:type="extended" id="i6b43fd6c6e444a60992fd5cd22443d49_InventoriesTables"/>
  <link:roleRef roleURI="http://www.conmed.com/role/InventoriesDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#InventoriesDetails"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/InventoriesDetails" xlink:type="extended" id="idb1e1cbd550b4dac950a03704985b91b_InventoriesDetails"/>
  <link:roleRef roleURI="http://www.conmed.com/role/EarningsPerShare" xlink:type="simple" xlink:href="cnmd-20210331.xsd#EarningsPerShare"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/EarningsPerShare" xlink:type="extended" id="iad1b7a225a0e450b939a5830eb6f503b_EarningsPerShare"/>
  <link:roleRef roleURI="http://www.conmed.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="cnmd-20210331.xsd#EarningsPerShareTables"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/EarningsPerShareTables" xlink:type="extended" id="i1ac7c2c5f6eb4468b22d1900d2da2bc7_EarningsPerShareTables"/>
  <link:roleRef roleURI="http://www.conmed.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#EarningsPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/EarningsPerShareDetails" xlink:type="extended" id="i94f9a6a9b0c74160b943f5b3bf743326_EarningsPerShareDetails"/>
  <link:roleRef roleURI="http://www.conmed.com/role/EarningsPerShareConvertibleNotesDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#EarningsPerShareConvertibleNotesDetails"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/EarningsPerShareConvertibleNotesDetails" xlink:type="extended" id="i0a0e11aaeb7c43499b64707e0c31ec6c_EarningsPerShareConvertibleNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_56a04bd9-c96e-4516-9fa8-e714468fae45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_7a136b81-5559-4fe6-9d51-57b3c52c6234" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_56a04bd9-c96e-4516-9fa8-e714468fae45" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_7a136b81-5559-4fe6-9d51-57b3c52c6234" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_200a76aa-bec2-48a1-8486-fc61e44b3151" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_56a04bd9-c96e-4516-9fa8-e714468fae45" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_200a76aa-bec2-48a1-8486-fc61e44b3151" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_83c90652-3324-4348-a259-8345cb23f3d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityStrikePrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_56a04bd9-c96e-4516-9fa8-e714468fae45" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_83c90652-3324-4348-a259-8345cb23f3d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_43d77cc0-7e53-4083-aa35-59b309f64fb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_56a04bd9-c96e-4516-9fa8-e714468fae45" xlink:to="loc_us-gaap_DebtInstrumentTable_43d77cc0-7e53-4083-aa35-59b309f64fb1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_0de96bb8-68e7-46be-b54e-25253323d660" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_43d77cc0-7e53-4083-aa35-59b309f64fb1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_0de96bb8-68e7-46be-b54e-25253323d660" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0de96bb8-68e7-46be-b54e-25253323d660_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0de96bb8-68e7-46be-b54e-25253323d660" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0de96bb8-68e7-46be-b54e-25253323d660_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d28f55b0-9cbb-4f33-b376-c8f15f7a1d4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0de96bb8-68e7-46be-b54e-25253323d660" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d28f55b0-9cbb-4f33-b376-c8f15f7a1d4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_fdd5adcb-5297-447c-bfa2-4741308d6918" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d28f55b0-9cbb-4f33-b376-c8f15f7a1d4d" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_fdd5adcb-5297-447c-bfa2-4741308d6918" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cd49fdd4-f03b-44fd-86aa-7f3a517d02c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_43d77cc0-7e53-4083-aa35-59b309f64fb1" xlink:to="loc_us-gaap_DebtInstrumentAxis_cd49fdd4-f03b-44fd-86aa-7f3a517d02c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cd49fdd4-f03b-44fd-86aa-7f3a517d02c9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_cd49fdd4-f03b-44fd-86aa-7f3a517d02c9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cd49fdd4-f03b-44fd-86aa-7f3a517d02c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_499a4ed4-3818-46a8-824e-6a25f072a12c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_cd49fdd4-f03b-44fd-86aa-7f3a517d02c9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_499a4ed4-3818-46a8-824e-6a25f072a12c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_A2.625PercentConvertibleNotesDue2024Member_5509b5ec-c3f6-4642-a590-b35a8a99d0eb" xlink:href="cnmd-20210331.xsd#cnmd_A2.625PercentConvertibleNotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_499a4ed4-3818-46a8-824e-6a25f072a12c" xlink:to="loc_cnmd_A2.625PercentConvertibleNotesDue2024Member_5509b5ec-c3f6-4642-a590-b35a8a99d0eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_IndexedTransactionTypeAxis_25059adb-b1fa-4fb5-b458-0bef46b17272" xlink:href="cnmd-20210331.xsd#cnmd_IndexedTransactionTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_43d77cc0-7e53-4083-aa35-59b309f64fb1" xlink:to="loc_cnmd_IndexedTransactionTypeAxis_25059adb-b1fa-4fb5-b458-0bef46b17272" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_IndexedTransactionTypeDomain_25059adb-b1fa-4fb5-b458-0bef46b17272_default" xlink:href="cnmd-20210331.xsd#cnmd_IndexedTransactionTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cnmd_IndexedTransactionTypeAxis_25059adb-b1fa-4fb5-b458-0bef46b17272" xlink:to="loc_cnmd_IndexedTransactionTypeDomain_25059adb-b1fa-4fb5-b458-0bef46b17272_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_IndexedTransactionTypeDomain_08a5cb6a-e8ed-4ed5-84d1-e8ebf5e53b48" xlink:href="cnmd-20210331.xsd#cnmd_IndexedTransactionTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cnmd_IndexedTransactionTypeAxis_25059adb-b1fa-4fb5-b458-0bef46b17272" xlink:to="loc_cnmd_IndexedTransactionTypeDomain_08a5cb6a-e8ed-4ed5-84d1-e8ebf5e53b48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_HedgeTransactionsMember_c8021a93-1e75-4bce-a7e7-b15267af7080" xlink:href="cnmd-20210331.xsd#cnmd_HedgeTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cnmd_IndexedTransactionTypeDomain_08a5cb6a-e8ed-4ed5-84d1-e8ebf5e53b48" xlink:to="loc_cnmd_HedgeTransactionsMember_c8021a93-1e75-4bce-a7e7-b15267af7080" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_WarrantTransactionsMember_02170cfa-d821-45ea-bca0-11ceed66b132" xlink:href="cnmd-20210331.xsd#cnmd_WarrantTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cnmd_IndexedTransactionTypeDomain_08a5cb6a-e8ed-4ed5-84d1-e8ebf5e53b48" xlink:to="loc_cnmd_WarrantTransactionsMember_02170cfa-d821-45ea-bca0-11ceed66b132" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.conmed.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="cnmd-20210331.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended" id="icb186d14690e4929ab9fb1b7b8581e78_GoodwillandOtherIntangibleAssets"/>
  <link:roleRef roleURI="http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="simple" xlink:href="cnmd-20210331.xsd#GoodwillandOtherIntangibleAssetsTables"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="extended" id="i82468ffa6c9444c2ae054f2d9249f05b_GoodwillandOtherIntangibleAssetsTables"/>
  <link:roleRef roleURI="http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#GoodwillandOtherIntangibleAssetsGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails" xlink:type="extended" id="i8249aa925a93465897c047ec4c9eebfa_GoodwillandOtherIntangibleAssetsGoodwillDetails"/>
  <link:roleRef roleURI="http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails" xlink:type="extended" id="idce64ea35fd74d11bef4dcf09465c704_GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_b9353f0d-5cce-45d7-92ac-2ee9bc1214a2" xlink:href="cnmd-20210331.xsd#cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_f5117478-dbc8-4f8f-9510-1daefa0be2c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_b9353f0d-5cce-45d7-92ac-2ee9bc1214a2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_f5117478-dbc8-4f8f-9510-1daefa0be2c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_3f0aa4ba-e066-4faf-b264-16d80692cd45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_b9353f0d-5cce-45d7-92ac-2ee9bc1214a2" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_3f0aa4ba-e066-4faf-b264-16d80692cd45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1e380f6a-f281-456d-adcd-b42d1d7de06a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_b9353f0d-5cce-45d7-92ac-2ee9bc1214a2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1e380f6a-f281-456d-adcd-b42d1d7de06a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_fad07015-ddc5-40e9-ae3e-76c0d5749764" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_b9353f0d-5cce-45d7-92ac-2ee9bc1214a2" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_fad07015-ddc5-40e9-ae3e-76c0d5749764" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1ef1f423-ffab-46cf-8d9f-9c8c599b10e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_b9353f0d-5cce-45d7-92ac-2ee9bc1214a2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1ef1f423-ffab-46cf-8d9f-9c8c599b10e7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_d914954e-9ede-4eb1-aa64-48c48f916457" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_b9353f0d-5cce-45d7-92ac-2ee9bc1214a2" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_d914954e-9ede-4eb1-aa64-48c48f916457" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AssetAcquisitionContingentConsiderationLiability_472a2d21-4a16-4efb-8cc1-b7efdcdb4f60" xlink:href="cnmd-20210331.xsd#cnmd_AssetAcquisitionContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_b9353f0d-5cce-45d7-92ac-2ee9bc1214a2" xlink:to="loc_cnmd_AssetAcquisitionContingentConsiderationLiability_472a2d21-4a16-4efb-8cc1-b7efdcdb4f60" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_ccf3f040-8661-4abe-b45e-740d182a0fd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_b9353f0d-5cce-45d7-92ac-2ee9bc1214a2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_ccf3f040-8661-4abe-b45e-740d182a0fd2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_c703eb07-abbe-40a6-8f19-8a80fc86052d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_ccf3f040-8661-4abe-b45e-740d182a0fd2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_c703eb07-abbe-40a6-8f19-8a80fc86052d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_849a81eb-0947-45f9-8d74-1329bbf95f0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_ccf3f040-8661-4abe-b45e-740d182a0fd2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_849a81eb-0947-45f9-8d74-1329bbf95f0f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_ccd7b745-cb45-4522-bfeb-5bc450bbb9dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_ccf3f040-8661-4abe-b45e-740d182a0fd2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_ccd7b745-cb45-4522-bfeb-5bc450bbb9dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_046b5ac0-7c28-4846-8ca1-3a17a056ef9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_ccf3f040-8661-4abe-b45e-740d182a0fd2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_046b5ac0-7c28-4846-8ca1-3a17a056ef9d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_dcbed661-0113-405b-b185-85169861aa2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_ccf3f040-8661-4abe-b45e-740d182a0fd2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_dcbed661-0113-405b-b185-85169861aa2c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_023b610b-ab9d-4f7f-b275-9c78244674e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_ccf3f040-8661-4abe-b45e-740d182a0fd2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_023b610b-ab9d-4f7f-b275-9c78244674e4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable_e5562308-e8e0-47a0-b6ef-92df74854e1b" xlink:href="cnmd-20210331.xsd#cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_b9353f0d-5cce-45d7-92ac-2ee9bc1214a2" xlink:to="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable_e5562308-e8e0-47a0-b6ef-92df74854e1b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9d449cbe-3b73-44b0-bb11-9eaa61dcc426" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable_e5562308-e8e0-47a0-b6ef-92df74854e1b" xlink:to="loc_srt_RangeAxis_9d449cbe-3b73-44b0-bb11-9eaa61dcc426" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9d449cbe-3b73-44b0-bb11-9eaa61dcc426_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_9d449cbe-3b73-44b0-bb11-9eaa61dcc426" xlink:to="loc_srt_RangeMember_9d449cbe-3b73-44b0-bb11-9eaa61dcc426_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8cb1be3d-5c0d-41c6-a981-b71ebb160ff3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_9d449cbe-3b73-44b0-bb11-9eaa61dcc426" xlink:to="loc_srt_RangeMember_8cb1be3d-5c0d-41c6-a981-b71ebb160ff3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_eed44636-ce50-430a-9f1b-35d58847bd03" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8cb1be3d-5c0d-41c6-a981-b71ebb160ff3" xlink:to="loc_srt_WeightedAverageMember_eed44636-ce50-430a-9f1b-35d58847bd03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4b5e2dae-b1b7-4c0f-bf14-f99bcb58a5d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable_e5562308-e8e0-47a0-b6ef-92df74854e1b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4b5e2dae-b1b7-4c0f-bf14-f99bcb58a5d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4b5e2dae-b1b7-4c0f-bf14-f99bcb58a5d8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4b5e2dae-b1b7-4c0f-bf14-f99bcb58a5d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4b5e2dae-b1b7-4c0f-bf14-f99bcb58a5d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a806f469-2a88-4e75-9c9d-87fb13d6eafb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4b5e2dae-b1b7-4c0f-bf14-f99bcb58a5d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a806f469-2a88-4e75-9c9d-87fb13d6eafb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_CustomerandDistributorRelationshipsMember_2cc62a0d-8976-4cb3-b54c-f7d16b12a692" xlink:href="cnmd-20210331.xsd#cnmd_CustomerandDistributorRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a806f469-2a88-4e75-9c9d-87fb13d6eafb" xlink:to="loc_cnmd_CustomerandDistributorRelationshipsMember_2cc62a0d-8976-4cb3-b54c-f7d16b12a692" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_SalesrepresentationmarketingandpromotionalrightsMember_8c04eb99-e3e9-47b5-a587-fbb976e57131" xlink:href="cnmd-20210331.xsd#cnmd_SalesrepresentationmarketingandpromotionalrightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a806f469-2a88-4e75-9c9d-87fb13d6eafb" xlink:to="loc_cnmd_SalesrepresentationmarketingandpromotionalrightsMember_8c04eb99-e3e9-47b5-a587-fbb976e57131" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_PatentsAndOtherIntangibleAssetsMember_75be3a68-e263-4f67-a849-3b75b76a2812" xlink:href="cnmd-20210331.xsd#cnmd_PatentsAndOtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a806f469-2a88-4e75-9c9d-87fb13d6eafb" xlink:to="loc_cnmd_PatentsAndOtherIntangibleAssetsMember_75be3a68-e263-4f67-a849-3b75b76a2812" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_dd14b5f1-b9c6-420b-bcc2-f05c6ab9d9bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a806f469-2a88-4e75-9c9d-87fb13d6eafb" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_dd14b5f1-b9c6-420b-bcc2-f05c6ab9d9bb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_485b965a-8e6d-4f7e-bc4e-9f813b8c69fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable_e5562308-e8e0-47a0-b6ef-92df74854e1b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_485b965a-8e6d-4f7e-bc4e-9f813b8c69fa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_485b965a-8e6d-4f7e-bc4e-9f813b8c69fa_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_485b965a-8e6d-4f7e-bc4e-9f813b8c69fa" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_485b965a-8e6d-4f7e-bc4e-9f813b8c69fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_888193a7-e2ed-4e8c-a046-52e921734145" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_485b965a-8e6d-4f7e-bc4e-9f813b8c69fa" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_888193a7-e2ed-4e8c-a046-52e921734145" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_8f6cf15d-ae72-4b52-8bb0-9add9abbd493" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_888193a7-e2ed-4e8c-a046-52e921734145" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_8f6cf15d-ae72-4b52-8bb0-9add9abbd493" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_825a90d0-149f-4c65-b4fd-e9b8e17fba49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable_e5562308-e8e0-47a0-b6ef-92df74854e1b" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_825a90d0-149f-4c65-b4fd-e9b8e17fba49" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_825a90d0-149f-4c65-b4fd-e9b8e17fba49_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_825a90d0-149f-4c65-b4fd-e9b8e17fba49" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_825a90d0-149f-4c65-b4fd-e9b8e17fba49_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c5d6efe8-f425-4d3c-9823-2a446bca7a40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_825a90d0-149f-4c65-b4fd-e9b8e17fba49" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c5d6efe8-f425-4d3c-9823-2a446bca7a40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ExpenseMember_39878a9d-2d19-4b50-a6bd-585b0de02f01" xlink:href="cnmd-20210331.xsd#cnmd_ExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c5d6efe8-f425-4d3c-9823-2a446bca7a40" xlink:to="loc_cnmd_ExpenseMember_39878a9d-2d19-4b50-a6bd-585b0de02f01" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ReductionofRevenueMember_b07cc332-6db9-4c64-b6a7-1e88936020f8" xlink:href="cnmd-20210331.xsd#cnmd_ReductionofRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c5d6efe8-f425-4d3c-9823-2a446bca7a40" xlink:to="loc_cnmd_ReductionofRevenueMember_b07cc332-6db9-4c64-b6a7-1e88936020f8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.conmed.com/role/LongTermDebt" xlink:type="simple" xlink:href="cnmd-20210331.xsd#LongTermDebt"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/LongTermDebt" xlink:type="extended" id="ie88ad57a5bd74cb6b479e206fd010a9a_LongTermDebt"/>
  <link:roleRef roleURI="http://www.conmed.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="cnmd-20210331.xsd#LongTermDebtTables"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/LongTermDebtTables" xlink:type="extended" id="ia7a4abca31a54589808e92d61c540fbe_LongTermDebtTables"/>
  <link:roleRef roleURI="http://www.conmed.com/role/LongTermDebtDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#LongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/LongTermDebtDetails" xlink:type="extended" id="i0c70c49d630e463784624094cd80d1ff_LongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_7c9db74c-fbd4-4bed-bd61-6ec2c67b803e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_40eb519b-3d4e-4766-87e0-d63ce7bd8496" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7c9db74c-fbd4-4bed-bd61-6ec2c67b803e" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_40eb519b-3d4e-4766-87e0-d63ce7bd8496" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_d8388330-d7dd-4b1e-8bed-a3a8dfa0edb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7c9db74c-fbd4-4bed-bd61-6ec2c67b803e" xlink:to="loc_us-gaap_LongTermDebt_d8388330-d7dd-4b1e-8bed-a3a8dfa0edb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebt_ed79770f-86a0-460b-9c94-721b8f1db324" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7c9db74c-fbd4-4bed-bd61-6ec2c67b803e" xlink:to="loc_us-gaap_ConvertibleDebt_ed79770f-86a0-460b-9c94-721b8f1db324" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_5fdcdfb3-d28d-46cc-8e67-10f0658f6905" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7c9db74c-fbd4-4bed-bd61-6ec2c67b803e" xlink:to="loc_us-gaap_FinanceLeaseLiability_5fdcdfb3-d28d-46cc-8e67-10f0658f6905" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_58a3f238-ec6b-4c50-89f8-2648d42fd0e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7c9db74c-fbd4-4bed-bd61-6ec2c67b803e" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_58a3f238-ec6b-4c50-89f8-2648d42fd0e2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_7b96d3e0-2787-4313-b95a-d0891da0ba29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7c9db74c-fbd4-4bed-bd61-6ec2c67b803e" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_7b96d3e0-2787-4313-b95a-d0891da0ba29" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_63603c8f-477e-4e82-9b19-22288ff51329" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7c9db74c-fbd4-4bed-bd61-6ec2c67b803e" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_63603c8f-477e-4e82-9b19-22288ff51329" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_fa32f341-c87b-4094-9e90-798421995ec2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7c9db74c-fbd4-4bed-bd61-6ec2c67b803e" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_fa32f341-c87b-4094-9e90-798421995ec2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_955c44ba-63c1-4e7a-af84-b9b14aaaa1d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7c9db74c-fbd4-4bed-bd61-6ec2c67b803e" xlink:to="loc_us-gaap_DebtInstrumentTable_955c44ba-63c1-4e7a-af84-b9b14aaaa1d7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_03e88719-6c38-43bd-8d1a-79a8f1d6a6b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_955c44ba-63c1-4e7a-af84-b9b14aaaa1d7" xlink:to="loc_us-gaap_DebtInstrumentAxis_03e88719-6c38-43bd-8d1a-79a8f1d6a6b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_03e88719-6c38-43bd-8d1a-79a8f1d6a6b9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_03e88719-6c38-43bd-8d1a-79a8f1d6a6b9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_03e88719-6c38-43bd-8d1a-79a8f1d6a6b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d6cba1d6-41bf-4b97-8553-5a3f7eba9c9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_03e88719-6c38-43bd-8d1a-79a8f1d6a6b9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d6cba1d6-41bf-4b97-8553-5a3f7eba9c9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AmendedAndRestatedSeniorCreditAgreementMember_8431f597-3782-4462-b6a0-8ce652baf092" xlink:href="cnmd-20210331.xsd#cnmd_AmendedAndRestatedSeniorCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d6cba1d6-41bf-4b97-8553-5a3f7eba9c9e" xlink:to="loc_cnmd_AmendedAndRestatedSeniorCreditAgreementMember_8431f597-3782-4462-b6a0-8ce652baf092" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a20a8008-0196-4615-b7e0-b26c1ae9a016" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_955c44ba-63c1-4e7a-af84-b9b14aaaa1d7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a20a8008-0196-4615-b7e0-b26c1ae9a016" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a20a8008-0196-4615-b7e0-b26c1ae9a016_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a20a8008-0196-4615-b7e0-b26c1ae9a016" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a20a8008-0196-4615-b7e0-b26c1ae9a016_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a955ed58-95d2-4c50-86d5-b5e4be9a496f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a20a8008-0196-4615-b7e0-b26c1ae9a016" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a955ed58-95d2-4c50-86d5-b5e4be9a496f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_e5ba77cf-d3d2-4a4f-8608-2adfcb288579" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a955ed58-95d2-4c50-86d5-b5e4be9a496f" xlink:to="loc_us-gaap_LineOfCreditMember_e5ba77cf-d3d2-4a4f-8608-2adfcb288579" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_89d7e2a2-7209-43de-aa64-2ae6fdeb4d72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a955ed58-95d2-4c50-86d5-b5e4be9a496f" xlink:to="loc_us-gaap_LoansPayableMember_89d7e2a2-7209-43de-aa64-2ae6fdeb4d72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_1b78aa27-807f-401b-96c6-0b5e2bffad39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a955ed58-95d2-4c50-86d5-b5e4be9a496f" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_1b78aa27-807f-401b-96c6-0b5e2bffad39" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#LongTermDebtAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails" xlink:type="extended" id="i01342606322842c894c1a3aa431cc810_LongTermDebtAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_a463ea8f-cb6b-4f9b-b61f-00b4c94879f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_a463ea8f-cb6b-4f9b-b61f-00b4c94879f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_7456a9d7-da68-4907-bc1e-f0fdc8f713ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_7456a9d7-da68-4907-bc1e-f0fdc8f713ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_c544df93-e456-4f57-b93b-71881a8dd2cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_c544df93-e456-4f57-b93b-71881a8dd2cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_8f43a045-afe0-483d-9c1e-f5eac93da156" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_8f43a045-afe0-483d-9c1e-f5eac93da156" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_bdb083d6-c652-4849-a093-c9f396f4a79e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_bdb083d6-c652-4849-a093-c9f396f4a79e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_CreditAgreementExpirationTriggerRequirementConvertibleNoteOutstandingBalance_1ddcb474-2b2f-4d40-a32a-d05406715696" xlink:href="cnmd-20210331.xsd#cnmd_CreditAgreementExpirationTriggerRequirementConvertibleNoteOutstandingBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_cnmd_CreditAgreementExpirationTriggerRequirementConvertibleNoteOutstandingBalance_1ddcb474-2b2f-4d40-a32a-d05406715696" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_7f26dee2-6875-457b-b387-989dad176b90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_7f26dee2-6875-457b-b387-989dad176b90" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_c3779c54-b21e-4fd5-b180-6a8b1f241288" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_c3779c54-b21e-4fd5-b180-6a8b1f241288" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_1e6144fd-c4d7-4ece-a73f-7e49bd0d28f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_1e6144fd-c4d7-4ece-a73f-7e49bd0d28f3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_810b18a6-ab7b-414c-bded-5313535b8c2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_us-gaap_InterestExpenseDebt_810b18a6-ab7b-414c-bded-5313535b8c2f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_DebtInstrumentConvertibleGrossAmountofEquityComponent_092f98a0-9a43-4163-bc91-99e25f0efec0" xlink:href="cnmd-20210331.xsd#cnmd_DebtInstrumentConvertibleGrossAmountofEquityComponent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_cnmd_DebtInstrumentConvertibleGrossAmountofEquityComponent_092f98a0-9a43-4163-bc91-99e25f0efec0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_05c25038-e61d-403b-9ccf-c01d278ec6b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_05c25038-e61d-403b-9ccf-c01d278ec6b7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_a6f741b4-a639-4d60-92c6-1466bb1452b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_us-gaap_LongTermDebt_a6f741b4-a639-4d60-92c6-1466bb1452b2" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_ffcc9265-d2eb-4b87-b15a-957eaebf6fa4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_ffcc9265-d2eb-4b87-b15a-957eaebf6fa4" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_c40d53de-3b39-4759-a2f0-c3e20f90c8c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_c40d53de-3b39-4759-a2f0-c3e20f90c8c9" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_fa0e0faf-184c-4ef3-9db4-72e44f1bb935" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_fa0e0faf-184c-4ef3-9db4-72e44f1bb935" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_Hedgeandwarranttransactionsnetcashpaid_50af06d5-75e5-4f06-99bb-0d8cba792d4c" xlink:href="cnmd-20210331.xsd#cnmd_Hedgeandwarranttransactionsnetcashpaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_cnmd_Hedgeandwarranttransactionsnetcashpaid_50af06d5-75e5-4f06-99bb-0d8cba792d4c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_38d10590-ebdd-4fdb-9bad-0a63548f000a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityStrikePrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_38d10590-ebdd-4fdb-9bad-0a63548f000a" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_LIBORInterestRateFloor_5b9f7fef-d777-4386-8b65-85c64b264cf8" xlink:href="cnmd-20210331.xsd#cnmd_LIBORInterestRateFloor"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_cnmd_LIBORInterestRateFloor_5b9f7fef-d777-4386-8b65-85c64b264cf8" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_764b2f74-d217-4b06-a2c2-b871b2059eeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_764b2f74-d217-4b06-a2c2-b871b2059eeb" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b13b8073-729c-45c0-bf3c-7ffc50f03cc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_us-gaap_DebtInstrumentTable_b13b8073-729c-45c0-bf3c-7ffc50f03cc9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeAxis_a7cebdee-dd6b-43ae-be01-cd710346d836" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b13b8073-729c-45c0-bf3c-7ffc50f03cc9" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeAxis_a7cebdee-dd6b-43ae-be01-cd710346d836" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_a7cebdee-dd6b-43ae-be01-cd710346d836_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeAxis_a7cebdee-dd6b-43ae-be01-cd710346d836" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_a7cebdee-dd6b-43ae-be01-cd710346d836_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_3aa13307-2ed7-46d8-a507-0bbe4291e379" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeAxis_a7cebdee-dd6b-43ae-be01-cd710346d836" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_3aa13307-2ed7-46d8-a507-0bbe4291e379" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CallOptionMember_129041c4-7de7-4bca-9d6c-ca84ad499bf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CallOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_3aa13307-2ed7-46d8-a507-0bbe4291e379" xlink:to="loc_us-gaap_CallOptionMember_129041c4-7de7-4bca-9d6c-ca84ad499bf1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_VariableRateBasisAxis_8a134083-9a11-4ebf-8131-4203d9a20c08" xlink:href="cnmd-20210331.xsd#cnmd_VariableRateBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b13b8073-729c-45c0-bf3c-7ffc50f03cc9" xlink:to="loc_cnmd_VariableRateBasisAxis_8a134083-9a11-4ebf-8131-4203d9a20c08" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_VariableRateBasisDomain_8a134083-9a11-4ebf-8131-4203d9a20c08_default" xlink:href="cnmd-20210331.xsd#cnmd_VariableRateBasisDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cnmd_VariableRateBasisAxis_8a134083-9a11-4ebf-8131-4203d9a20c08" xlink:to="loc_cnmd_VariableRateBasisDomain_8a134083-9a11-4ebf-8131-4203d9a20c08_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_VariableRateBasisDomain_8cc28fdf-bb20-4d7a-a92c-d0da4a7d1370" xlink:href="cnmd-20210331.xsd#cnmd_VariableRateBasisDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cnmd_VariableRateBasisAxis_8a134083-9a11-4ebf-8131-4203d9a20c08" xlink:to="loc_cnmd_VariableRateBasisDomain_8cc28fdf-bb20-4d7a-a92c-d0da4a7d1370" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_c0485516-29c3-4852-9d7f-626304ce0201" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cnmd_VariableRateBasisDomain_8cc28fdf-bb20-4d7a-a92c-d0da4a7d1370" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_c0485516-29c3-4852-9d7f-626304ce0201" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_78ffbf6a-1ae8-45b4-af1e-7d6980e6d168" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cnmd_VariableRateBasisDomain_8cc28fdf-bb20-4d7a-a92c-d0da4a7d1370" xlink:to="loc_us-gaap_EurodollarMember_78ffbf6a-1ae8-45b4-af1e-7d6980e6d168" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_aeab7414-3d3c-4ccb-bcfc-f459e24b258c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cnmd_VariableRateBasisDomain_8cc28fdf-bb20-4d7a-a92c-d0da4a7d1370" xlink:to="loc_us-gaap_BaseRateMember_aeab7414-3d3c-4ccb-bcfc-f459e24b258c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5eb82b14-bb10-4907-b82e-6bc7a9d2151a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b13b8073-729c-45c0-bf3c-7ffc50f03cc9" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5eb82b14-bb10-4907-b82e-6bc7a9d2151a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5eb82b14-bb10-4907-b82e-6bc7a9d2151a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5eb82b14-bb10-4907-b82e-6bc7a9d2151a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5eb82b14-bb10-4907-b82e-6bc7a9d2151a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3af28c16-1090-4884-935a-b8e4ccbf4ddb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5eb82b14-bb10-4907-b82e-6bc7a9d2151a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3af28c16-1090-4884-935a-b8e4ccbf4ddb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_b714ea43-c257-49ea-b199-b8024b11caae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3af28c16-1090-4884-935a-b8e4ccbf4ddb" xlink:to="loc_us-gaap_LoansPayableMember_b714ea43-c257-49ea-b199-b8024b11caae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_85df9471-eb98-4a3a-89e4-8543ef0658ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3af28c16-1090-4884-935a-b8e4ccbf4ddb" xlink:to="loc_us-gaap_LineOfCreditMember_85df9471-eb98-4a3a-89e4-8543ef0658ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_6aa682e9-3d61-4980-9a12-0a68a0e42f4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3af28c16-1090-4884-935a-b8e4ccbf4ddb" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_6aa682e9-3d61-4980-9a12-0a68a0e42f4f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_e16aa461-f869-4117-bf2e-0d6109106e21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3af28c16-1090-4884-935a-b8e4ccbf4ddb" xlink:to="loc_us-gaap_LongTermDebtMember_e16aa461-f869-4117-bf2e-0d6109106e21" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_603481fe-3b5f-4f74-b573-9548f4c76e66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b13b8073-729c-45c0-bf3c-7ffc50f03cc9" xlink:to="loc_us-gaap_DebtInstrumentAxis_603481fe-3b5f-4f74-b573-9548f4c76e66" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_603481fe-3b5f-4f74-b573-9548f4c76e66_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_603481fe-3b5f-4f74-b573-9548f4c76e66" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_603481fe-3b5f-4f74-b573-9548f4c76e66_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b0f0b579-9069-4664-b8be-f5ae94914be9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_603481fe-3b5f-4f74-b573-9548f4c76e66" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b0f0b579-9069-4664-b8be-f5ae94914be9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AmendedAndRestatedSeniorCreditAgreementMember_9831220a-8a6b-45e8-9dde-e7ae38c3e8fa" xlink:href="cnmd-20210331.xsd#cnmd_AmendedAndRestatedSeniorCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b0f0b579-9069-4664-b8be-f5ae94914be9" xlink:to="loc_cnmd_AmendedAndRestatedSeniorCreditAgreementMember_9831220a-8a6b-45e8-9dde-e7ae38c3e8fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_A2.625PercentConvertibleNotesDue2024Member_352cf3b4-e3c3-41a5-a3a9-a3e88c9b9222" xlink:href="cnmd-20210331.xsd#cnmd_A2.625PercentConvertibleNotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b0f0b579-9069-4664-b8be-f5ae94914be9" xlink:to="loc_cnmd_A2.625PercentConvertibleNotesDue2024Member_352cf3b4-e3c3-41a5-a3a9-a3e88c9b9222" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_2919d7e0-2c3f-431f-ae55-77440d7b3efd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b13b8073-729c-45c0-bf3c-7ffc50f03cc9" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_2919d7e0-2c3f-431f-ae55-77440d7b3efd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_2919d7e0-2c3f-431f-ae55-77440d7b3efd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_2919d7e0-2c3f-431f-ae55-77440d7b3efd" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_2919d7e0-2c3f-431f-ae55-77440d7b3efd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_3d639c42-47af-4c81-8f6c-425545597cc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_2919d7e0-2c3f-431f-ae55-77440d7b3efd" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_3d639c42-47af-4c81-8f6c-425545597cc6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_IndexedTransactionTypeAxis_a4dc3543-e83d-4476-902a-70ee26c33363" xlink:href="cnmd-20210331.xsd#cnmd_IndexedTransactionTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b13b8073-729c-45c0-bf3c-7ffc50f03cc9" xlink:to="loc_cnmd_IndexedTransactionTypeAxis_a4dc3543-e83d-4476-902a-70ee26c33363" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_IndexedTransactionTypeDomain_a4dc3543-e83d-4476-902a-70ee26c33363_default" xlink:href="cnmd-20210331.xsd#cnmd_IndexedTransactionTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cnmd_IndexedTransactionTypeAxis_a4dc3543-e83d-4476-902a-70ee26c33363" xlink:to="loc_cnmd_IndexedTransactionTypeDomain_a4dc3543-e83d-4476-902a-70ee26c33363_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_IndexedTransactionTypeDomain_d07fb9fe-a7ce-41dd-a90b-99c7b01a258c" xlink:href="cnmd-20210331.xsd#cnmd_IndexedTransactionTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cnmd_IndexedTransactionTypeAxis_a4dc3543-e83d-4476-902a-70ee26c33363" xlink:to="loc_cnmd_IndexedTransactionTypeDomain_d07fb9fe-a7ce-41dd-a90b-99c7b01a258c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_HedgeTransactionsMember_f3af6e41-e808-4cdc-925d-22dc3062c52d" xlink:href="cnmd-20210331.xsd#cnmd_HedgeTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cnmd_IndexedTransactionTypeDomain_d07fb9fe-a7ce-41dd-a90b-99c7b01a258c" xlink:to="loc_cnmd_HedgeTransactionsMember_f3af6e41-e808-4cdc-925d-22dc3062c52d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.conmed.com/role/LongTermDebtMaturitiesofLongTermDebtDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#LongTermDebtMaturitiesofLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/LongTermDebtMaturitiesofLongTermDebtDetails" xlink:type="extended" id="i8a0498d286ed482ea048e966bc8c9db3_LongTermDebtMaturitiesofLongTermDebtDetails"/>
  <link:roleRef roleURI="http://www.conmed.com/role/Guarantees" xlink:type="simple" xlink:href="cnmd-20210331.xsd#Guarantees"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/Guarantees" xlink:type="extended" id="i05a3f611cf484f73b468cf97adb431f2_Guarantees"/>
  <link:roleRef roleURI="http://www.conmed.com/role/GuaranteesTables" xlink:type="simple" xlink:href="cnmd-20210331.xsd#GuaranteesTables"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/GuaranteesTables" xlink:type="extended" id="ica029cd03a77481ea2758a679644f8c2_GuaranteesTables"/>
  <link:roleRef roleURI="http://www.conmed.com/role/GuaranteesDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#GuaranteesDetails"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/GuaranteesDetails" xlink:type="extended" id="id7b5032f63de46ce8c4462e6f6fab7f2_GuaranteesDetails"/>
  <link:roleRef roleURI="http://www.conmed.com/role/PensionPlan" xlink:type="simple" xlink:href="cnmd-20210331.xsd#PensionPlan"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/PensionPlan" xlink:type="extended" id="i9e1485e40a00412db551c6e7254c90bf_PensionPlan"/>
  <link:roleRef roleURI="http://www.conmed.com/role/PensionPlanTables" xlink:type="simple" xlink:href="cnmd-20210331.xsd#PensionPlanTables"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/PensionPlanTables" xlink:type="extended" id="ie660662db7ad4645b4e8d4d33a77767c_PensionPlanTables"/>
  <link:roleRef roleURI="http://www.conmed.com/role/PensionPlanDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#PensionPlanDetails"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/PensionPlanDetails" xlink:type="extended" id="i9d504b8055f0429e932bac258d54cd84_PensionPlanDetails"/>
  <link:roleRef roleURI="http://www.conmed.com/role/AcquisitionandOtherExpense" xlink:type="simple" xlink:href="cnmd-20210331.xsd#AcquisitionandOtherExpense"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/AcquisitionandOtherExpense" xlink:type="extended" id="i426dc860b7f94f2ab42859ff5fbdf476_AcquisitionandOtherExpense"/>
  <link:roleRef roleURI="http://www.conmed.com/role/AcquisitionandOtherExpenseTables" xlink:type="simple" xlink:href="cnmd-20210331.xsd#AcquisitionandOtherExpenseTables"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/AcquisitionandOtherExpenseTables" xlink:type="extended" id="id61cd55baba349e583b1d14ea21c2ec6_AcquisitionandOtherExpenseTables"/>
  <link:roleRef roleURI="http://www.conmed.com/role/AcquisitionandOtherExpenseDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#AcquisitionandOtherExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/AcquisitionandOtherExpenseDetails" xlink:type="extended" id="ib91a4e1417b7451c8c6360da9457ec48_AcquisitionandOtherExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AcquisitionandOtherExpenseLineItems_a0ada9bb-d036-4a60-8cc2-c401ff1d30e6" xlink:href="cnmd-20210331.xsd#cnmd_AcquisitionandOtherExpenseLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_RestructuringAndRelatedCosts_3e2dbd90-a0c2-412e-a440-c55c38db1b29" xlink:href="cnmd-20210331.xsd#cnmd_RestructuringAndRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cnmd_AcquisitionandOtherExpenseLineItems_a0ada9bb-d036-4a60-8cc2-c401ff1d30e6" xlink:to="loc_cnmd_RestructuringAndRelatedCosts_3e2dbd90-a0c2-412e-a440-c55c38db1b29" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_Manufacturingconsolidationcosts_5876723b-425c-40b7-be6e-50e590afd43f" xlink:href="cnmd-20210331.xsd#cnmd_Manufacturingconsolidationcosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cnmd_AcquisitionandOtherExpenseLineItems_a0ada9bb-d036-4a60-8cc2-c401ff1d30e6" xlink:to="loc_cnmd_Manufacturingconsolidationcosts_5876723b-425c-40b7-be6e-50e590afd43f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_679d02a1-1dda-47b7-aeae-ad90f6f6c45d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cnmd_AcquisitionandOtherExpenseLineItems_a0ada9bb-d036-4a60-8cc2-c401ff1d30e6" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_679d02a1-1dda-47b7-aeae-ad90f6f6c45d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_a183c5d8-2e8b-4780-9731-b166d4ebf3d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cnmd_AcquisitionandOtherExpenseLineItems_a0ada9bb-d036-4a60-8cc2-c401ff1d30e6" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_a183c5d8-2e8b-4780-9731-b166d4ebf3d1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating_28a088ea-2db5-4f9c-9e38-f6254ecd343a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cnmd_AcquisitionandOtherExpenseLineItems_a0ada9bb-d036-4a60-8cc2-c401ff1d30e6" xlink:to="loc_us-gaap_OtherCostAndExpenseOperating_28a088ea-2db5-4f9c-9e38-f6254ecd343a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_OtherExpensesTable_c6540d6d-223d-4312-834e-124b947c6a4e" xlink:href="cnmd-20210331.xsd#cnmd_OtherExpensesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_cnmd_AcquisitionandOtherExpenseLineItems_a0ada9bb-d036-4a60-8cc2-c401ff1d30e6" xlink:to="loc_cnmd_OtherExpensesTable_c6540d6d-223d-4312-834e-124b947c6a4e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b4eb93b5-df28-485e-9c4b-f33c938f0900" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cnmd_OtherExpensesTable_c6540d6d-223d-4312-834e-124b947c6a4e" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b4eb93b5-df28-485e-9c4b-f33c938f0900" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b4eb93b5-df28-485e-9c4b-f33c938f0900_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b4eb93b5-df28-485e-9c4b-f33c938f0900" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b4eb93b5-df28-485e-9c4b-f33c938f0900_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_55db6a95-7236-493b-877a-be7bb7b2d292" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b4eb93b5-df28-485e-9c4b-f33c938f0900" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_55db6a95-7236-493b-877a-be7bb7b2d292" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_076ccc17-9c66-4ccf-bfd6-1353e5adbf2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_55db6a95-7236-493b-877a-be7bb7b2d292" xlink:to="loc_us-gaap_CostOfSalesMember_076ccc17-9c66-4ccf-bfd6-1353e5adbf2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_ea328e9b-7aac-4fcc-a1f6-cdedb6075a53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_55db6a95-7236-493b-877a-be7bb7b2d292" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_ea328e9b-7aac-4fcc-a1f6-cdedb6075a53" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.conmed.com/role/BusinessSegment" xlink:type="simple" xlink:href="cnmd-20210331.xsd#BusinessSegment"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/BusinessSegment" xlink:type="extended" id="i4b339e1e679446e699eb9c51b6f2e92c_BusinessSegment"/>
  <link:roleRef roleURI="http://www.conmed.com/role/BusinessSegmentTables" xlink:type="simple" xlink:href="cnmd-20210331.xsd#BusinessSegmentTables"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/BusinessSegmentTables" xlink:type="extended" id="ie2f1a9a2b6454b2d9861c610778118af_BusinessSegmentTables"/>
  <link:roleRef roleURI="http://www.conmed.com/role/BusinessSegmentDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#BusinessSegmentDetails"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/BusinessSegmentDetails" xlink:type="extended" id="i2ab79e0089c549fabacaf28698ad5a20_BusinessSegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_4f4e9df6-c951-4b7f-b55b-8023ad4a88b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_09156a6f-8d6b-436b-932f-d04f760ad2b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4f4e9df6-c951-4b7f-b55b-8023ad4a88b0" xlink:to="loc_us-gaap_Revenues_09156a6f-8d6b-436b-932f-d04f760ad2b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_81005f1e-c9d6-4d4f-86f2-8969f3de14fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4f4e9df6-c951-4b7f-b55b-8023ad4a88b0" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_81005f1e-c9d6-4d4f-86f2-8969f3de14fc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f1302799-7bc6-438b-b9b1-fb9b3b7877ac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_81005f1e-c9d6-4d4f-86f2-8969f3de14fc" xlink:to="loc_srt_ProductOrServiceAxis_f1302799-7bc6-438b-b9b1-fb9b3b7877ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f1302799-7bc6-438b-b9b1-fb9b3b7877ac_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_f1302799-7bc6-438b-b9b1-fb9b3b7877ac" xlink:to="loc_srt_ProductsAndServicesDomain_f1302799-7bc6-438b-b9b1-fb9b3b7877ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_dada22b6-48c5-4265-8cf0-535a53cad438" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_f1302799-7bc6-438b-b9b1-fb9b3b7877ac" xlink:to="loc_srt_ProductsAndServicesDomain_dada22b6-48c5-4265-8cf0-535a53cad438" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_OrthopedicSurgeryMember_38fe5058-1719-444f-a267-c5084970d939" xlink:href="cnmd-20210331.xsd#cnmd_OrthopedicSurgeryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_dada22b6-48c5-4265-8cf0-535a53cad438" xlink:to="loc_cnmd_OrthopedicSurgeryMember_38fe5058-1719-444f-a267-c5084970d939" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_GeneralSurgeryMember_fc30ec6e-4e7d-4876-b7e3-c935f6ce6f10" xlink:href="cnmd-20210331.xsd#cnmd_GeneralSurgeryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_dada22b6-48c5-4265-8cf0-535a53cad438" xlink:to="loc_cnmd_GeneralSurgeryMember_fc30ec6e-4e7d-4876-b7e3-c935f6ce6f10" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.conmed.com/role/LegalProceedings" xlink:type="simple" xlink:href="cnmd-20210331.xsd#LegalProceedings"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/LegalProceedings" xlink:type="extended" id="if6dc46be50d14d2798483dc3fabcc1d0_LegalProceedings"/>
  <link:roleRef roleURI="http://www.conmed.com/role/LegalProceedingsDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#LegalProceedingsDetails"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/LegalProceedingsDetails" xlink:type="extended" id="iab48761af1184493a070fdd55c043a14_LegalProceedingsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_acef9850-7fbc-442d-b333-35fe92266113" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident_86dfe24e-9375-4aac-b1ae-5d4f81cb72fc" xlink:href="cnmd-20210331.xsd#cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_acef9850-7fbc-442d-b333-35fe92266113" xlink:to="loc_cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident_86dfe24e-9375-4aac-b1ae-5d4f81cb72fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount_e519cf9a-78bd-480a-8342-5bd5941aea7a" xlink:href="cnmd-20210331.xsd#cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_acef9850-7fbc-442d-b333-35fe92266113" xlink:to="loc_cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount_e519cf9a-78bd-480a-8342-5bd5941aea7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_1a08df8b-a0ce-4ba9-9f6b-f63797fe7eab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_acef9850-7fbc-442d-b333-35fe92266113" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_1a08df8b-a0ce-4ba9-9f6b-f63797fe7eab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_08c3515c-7f44-45c9-86b9-58788838a272" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_acef9850-7fbc-442d-b333-35fe92266113" xlink:to="loc_us-gaap_LossContingenciesTable_08c3515c-7f44-45c9-86b9-58788838a272" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_a5124b51-c78d-469a-bcc5-9ccd7aa73192" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_08c3515c-7f44-45c9-86b9-58788838a272" xlink:to="loc_us-gaap_LitigationStatusAxis_a5124b51-c78d-469a-bcc5-9ccd7aa73192" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_a5124b51-c78d-469a-bcc5-9ccd7aa73192_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_a5124b51-c78d-469a-bcc5-9ccd7aa73192" xlink:to="loc_us-gaap_LitigationStatusDomain_a5124b51-c78d-469a-bcc5-9ccd7aa73192_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_5fb753df-7ec3-4d0f-93ed-24085e38f1fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_a5124b51-c78d-469a-bcc5-9ccd7aa73192" xlink:to="loc_us-gaap_LitigationStatusDomain_5fb753df-7ec3-4d0f-93ed-24085e38f1fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_777d8e3e-49f8-456a-9faf-be33a40f5f6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_5fb753df-7ec3-4d0f-93ed-24085e38f1fc" xlink:to="loc_us-gaap_PendingLitigationMember_777d8e3e-49f8-456a-9faf-be33a40f5f6d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_96b7146f-26f1-4c03-9b09-b55a6e07ad62" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_08c3515c-7f44-45c9-86b9-58788838a272" xlink:to="loc_srt_LitigationCaseAxis_96b7146f-26f1-4c03-9b09-b55a6e07ad62" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_96b7146f-26f1-4c03-9b09-b55a6e07ad62_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_96b7146f-26f1-4c03-9b09-b55a6e07ad62" xlink:to="loc_srt_LitigationCaseTypeDomain_96b7146f-26f1-4c03-9b09-b55a6e07ad62_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_378b657a-2dc5-4313-9d97-a9c6e36a866b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_96b7146f-26f1-4c03-9b09-b55a6e07ad62" xlink:to="loc_srt_LitigationCaseTypeDomain_378b657a-2dc5-4313-9d97-a9c6e36a866b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_EndoDynamixInc.Member_690de6e6-3d12-4daf-9ca7-fa0dd63ae3f5" xlink:href="cnmd-20210331.xsd#cnmd_EndoDynamixInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_378b657a-2dc5-4313-9d97-a9c6e36a866b" xlink:to="loc_cnmd_EndoDynamixInc.Member_690de6e6-3d12-4daf-9ca7-fa0dd63ae3f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_LitigationDamagesAxis_dce70eaa-26d0-499c-a794-88f427bcecc1" xlink:href="cnmd-20210331.xsd#cnmd_LitigationDamagesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_08c3515c-7f44-45c9-86b9-58788838a272" xlink:to="loc_cnmd_LitigationDamagesAxis_dce70eaa-26d0-499c-a794-88f427bcecc1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_LitigationDamagesDomain_dce70eaa-26d0-499c-a794-88f427bcecc1_default" xlink:href="cnmd-20210331.xsd#cnmd_LitigationDamagesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cnmd_LitigationDamagesAxis_dce70eaa-26d0-499c-a794-88f427bcecc1" xlink:to="loc_cnmd_LitigationDamagesDomain_dce70eaa-26d0-499c-a794-88f427bcecc1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_LitigationDamagesDomain_7e31ef03-9ffc-4519-9f30-e4674105c81e" xlink:href="cnmd-20210331.xsd#cnmd_LitigationDamagesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cnmd_LitigationDamagesAxis_dce70eaa-26d0-499c-a794-88f427bcecc1" xlink:to="loc_cnmd_LitigationDamagesDomain_7e31ef03-9ffc-4519-9f30-e4674105c81e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_LiquidatedDamagesMember_9d200068-78c6-417b-b014-51c68bfbfd27" xlink:href="cnmd-20210331.xsd#cnmd_LiquidatedDamagesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cnmd_LitigationDamagesDomain_7e31ef03-9ffc-4519-9f30-e4674105c81e" xlink:to="loc_cnmd_LiquidatedDamagesMember_9d200068-78c6-417b-b014-51c68bfbfd27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AdditionalDamagesMember_7b3842cc-52dc-43ed-9682-d39320a6ea2c" xlink:href="cnmd-20210331.xsd#cnmd_AdditionalDamagesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cnmd_LitigationDamagesDomain_7e31ef03-9ffc-4519-9f30-e4674105c81e" xlink:to="loc_cnmd_AdditionalDamagesMember_7b3842cc-52dc-43ed-9682-d39320a6ea2c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.conmed.com/role/NewAccountingPronouncements" xlink:type="simple" xlink:href="cnmd-20210331.xsd#NewAccountingPronouncements"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/NewAccountingPronouncements" xlink:type="extended" id="i06241bc334c14aec85ad962ba5f7ee3f_NewAccountingPronouncements"/>
  <link:roleRef roleURI="http://www.conmed.com/role/NewAccountingPronouncementsPolicies" xlink:type="simple" xlink:href="cnmd-20210331.xsd#NewAccountingPronouncementsPolicies"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/NewAccountingPronouncementsPolicies" xlink:type="extended" id="ia5e11a3e22d54b2391cb1dcb2ae7a4e8_NewAccountingPronouncementsPolicies"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>cnmd-20210331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:4a71bfc6-7922-4305-aa8d-7a5d2323cf49,g:a58de70d-c080-4226-99f2-d632a7268b2f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_DocumentType_7b7b595c-329d-4a41-912f-9a502375c0a3_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_0ba946ab-0b13-4bb6-8f35-c85da948d88c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in the carrying amount of service and product warranties</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Warranty Liability [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_c027ff83-943f-4e8a-afa7-e41bd85ab492_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_557e714c-a4d5-45cd-bcaa-bc6119bf6464_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_426dba05-cf07-4a89-955e-d7770902644a_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_13178062-56a3-475f-87eb-990e53860ecb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_7828a780-b786-4207-83a1-bf176fe18421_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future amortization expense [Abstract]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyDisclosureTextBlock_27eed6a0-a047-4e18-92cf-2d187397a86f_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:to="lab_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_EndoDynamixInc.Member_773960b5-71aa-4d42-bb36-064a4dd8deff_terseLabel_en-US" xlink:label="lab_cnmd_EndoDynamixInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EndoDynamix, Inc.</link:label>
    <link:label id="lab_cnmd_EndoDynamixInc.Member_label_en-US" xlink:label="lab_cnmd_EndoDynamixInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EndoDynamix, Inc. [Member]</link:label>
    <link:label id="lab_cnmd_EndoDynamixInc.Member_documentation_en-US" xlink:label="lab_cnmd_EndoDynamixInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EndoDynamix, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_EndoDynamixInc.Member" xlink:href="cnmd-20210331.xsd#cnmd_EndoDynamixInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_EndoDynamixInc.Member" xlink:to="lab_cnmd_EndoDynamixInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_9e9e4438-3c94-489f-94c9-85e209954a9c_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f41fe195-5dcc-4eb6-bc43-8815f11b134f_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_063502d7-333a-47eb-a2fd-009548751784_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_3e7f0e56-0929-4dda-88df-bb1ac18294dc_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_f40010e1-fe33-4ed7-a2c9-437b96702e01_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_cc03ec51-f73b-469b-93c8-fd18a6e5d7a1_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_15b674db-63cc-4ca5-91d9-a44446882645_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks &amp; tradenames</link:label>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:to="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CallOptionMember_5d9f06e4-7f69-4782-9a5e-3df509b4a840_terseLabel_en-US" xlink:label="lab_us-gaap_CallOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Call Option [Member]</link:label>
    <link:label id="lab_us-gaap_CallOptionMember_label_en-US" xlink:label="lab_us-gaap_CallOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Call Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CallOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CallOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CallOptionMember" xlink:to="lab_us-gaap_CallOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_877c23dd-becc-4432-85ba-f58082225d3e_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_da62ef5d-e578-4d89-a069-9555b21b40b9_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_IndexedTransactionTypeAxis_77c0a0ae-cb5e-4899-adda-fcaa6834b965_terseLabel_en-US" xlink:label="lab_cnmd_IndexedTransactionTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indexed transaction type [Axis]</link:label>
    <link:label id="lab_cnmd_IndexedTransactionTypeAxis_label_en-US" xlink:label="lab_cnmd_IndexedTransactionTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indexed transaction type [Axis]</link:label>
    <link:label id="lab_cnmd_IndexedTransactionTypeAxis_documentation_en-US" xlink:label="lab_cnmd_IndexedTransactionTypeAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indexed transaction type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_IndexedTransactionTypeAxis" xlink:href="cnmd-20210331.xsd#cnmd_IndexedTransactionTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_IndexedTransactionTypeAxis" xlink:to="lab_cnmd_IndexedTransactionTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_AcquisitionandOtherExpenseLineItems_9536bb14-9768-4ddc-879c-989ba3b08ed0_terseLabel_en-US" xlink:label="lab_cnmd_AcquisitionandOtherExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and Other Expense [Line Items]</link:label>
    <link:label id="lab_cnmd_AcquisitionandOtherExpenseLineItems_label_en-US" xlink:label="lab_cnmd_AcquisitionandOtherExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and Other Expense [Line Items]</link:label>
    <link:label id="lab_cnmd_AcquisitionandOtherExpenseLineItems_documentation_en-US" xlink:label="lab_cnmd_AcquisitionandOtherExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and Other Expense [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AcquisitionandOtherExpenseLineItems" xlink:href="cnmd-20210331.xsd#cnmd_AcquisitionandOtherExpenseLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_AcquisitionandOtherExpenseLineItems" xlink:to="lab_cnmd_AcquisitionandOtherExpenseLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_e32cad4d-9b23-4078-9d09-f1d27d5a662d_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset and Liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferredOverTimeMember_d3145d72-745d-4dab-ad37-ef4e894e669d_terseLabel_en-US" xlink:label="lab_us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services transferred over time</link:label>
    <link:label id="lab_us-gaap_TransferredOverTimeMember_label_en-US" xlink:label="lab_us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred over Time [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferredOverTimeMember" xlink:to="lab_us-gaap_TransferredOverTimeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6c4da86d-5202-49a0-959b-e00e3dd53081_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_4d3b3a2f-807f-4868-abfb-13f45cc927ef_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_6419ec0a-72a2-4498-92b2-2c77d0058642_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_VariableRateBasisDomain_8532de4a-9628-4e95-8b36-aabd29088d00_terseLabel_en-US" xlink:label="lab_cnmd_VariableRateBasisDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Basis [Domain]</link:label>
    <link:label id="lab_cnmd_VariableRateBasisDomain_label_en-US" xlink:label="lab_cnmd_VariableRateBasisDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Basis [Domain]</link:label>
    <link:label id="lab_cnmd_VariableRateBasisDomain_documentation_en-US" xlink:label="lab_cnmd_VariableRateBasisDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Basis [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_VariableRateBasisDomain" xlink:href="cnmd-20210331.xsd#cnmd_VariableRateBasisDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_VariableRateBasisDomain" xlink:to="lab_cnmd_VariableRateBasisDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_38609a3f-ab5b-43da-bf47-18df93e5d51e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under employee plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_5876f10b-6454-4b63-aa34-d7752f010ca9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_88864c30-8c7a-4429-b8a9-e58a72ffc280_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_043be447-da07-4162-88a0-6a46c270af27_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_3d23ccef-8c32-4a70-ada6-35529d7d6489_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableMember_47389bdd-09ae-483f-b578-7c09ed3dc1b7_verboseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable</link:label>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableMember_efd12011-3ddf-412e-92f9-7b13df50837e_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable [Member]</link:label>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleNotesPayableMember" xlink:to="lab_us-gaap_ConvertibleNotesPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_ae22782c-7005-4969-bcd6-dbb65205056d_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_4875ecb1-f438-4405-bbe3-41a2334cd75a_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_LitigationDamagesDomain_bf2ca1d8-eecd-4f5c-ab1f-c8686ff8cad0_terseLabel_en-US" xlink:label="lab_cnmd_LitigationDamagesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Damages [Domain]</link:label>
    <link:label id="lab_cnmd_LitigationDamagesDomain_label_en-US" xlink:label="lab_cnmd_LitigationDamagesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Damages [Domain]</link:label>
    <link:label id="lab_cnmd_LitigationDamagesDomain_documentation_en-US" xlink:label="lab_cnmd_LitigationDamagesDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Damages</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_LitigationDamagesDomain" xlink:href="cnmd-20210331.xsd#cnmd_LitigationDamagesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_LitigationDamagesDomain" xlink:to="lab_cnmd_LitigationDamagesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_73162f71-6230-4e6a-a122-2adbacc3ead8_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on revolving line of credit</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_a9d927dc-d21c-42a7-a0c2-34c674b0b560_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_60bde9ed-c278-442d-a829-3f0d53cfb5f6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_434d18d9-ebd1-4060-9796-d28c2a113407_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_a01da14f-4606-4f84-9a2d-422136fecac6_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_db792983-db2b-45fe-a6c2-c1742e653a74_terseLabel_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Proceedings</link:label>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Matters and Contingencies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:to="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a91b8be7-2b7f-42d2-bf98-4504dde795ef_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss) [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_RevenuesMember_e3626301-25e5-4f82-973d-afb339439b55_terseLabel_en-US" xlink:label="lab_cnmd_RevenuesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_cnmd_RevenuesMember_label_en-US" xlink:label="lab_cnmd_RevenuesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Member]</link:label>
    <link:label id="lab_cnmd_RevenuesMember_documentation_en-US" xlink:label="lab_cnmd_RevenuesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_RevenuesMember" xlink:href="cnmd-20210331.xsd#cnmd_RevenuesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_RevenuesMember" xlink:to="lab_cnmd_RevenuesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_8cd96c67-55c2-4832-8498-d39ca824f79e_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value $.01 per share; authorized 500,000 shares; none outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_c9f36d66-eeb9-49fd-a9db-9b80b0b8a80b_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_2e4e50f2-9e5f-4a99-8ad4-d4b0d19a1057_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160; Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_29d88250-8851-4631-b69f-3480cb126cb4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_0a35ab0a-61d1-4ce8-99d1-d12160d81ebf_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable_b9d0d860-1671-4338-8077-bcd7d8cebfab_terseLabel_en-US" xlink:label="lab_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived and Indefinite-Lived Assets [Table]</link:label>
    <link:label id="lab_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable_label_en-US" xlink:label="lab_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived and Indefinite-Lived Assets [Table]</link:label>
    <link:label id="lab_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable_documentation_en-US" xlink:label="lab_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived and Indefinite-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable" xlink:href="cnmd-20210331.xsd#cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable" xlink:to="lab_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_88e71c81-b9b9-490a-92fc-6716bf35e8ac_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_Hedgeandwarranttransactionsnetcashpaid_ddf92287-4a72-499d-bb6c-d1f3459174c5_terseLabel_en-US" xlink:label="lab_cnmd_Hedgeandwarranttransactionsnetcashpaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge and warrant transactions, net cash paid</link:label>
    <link:label id="lab_cnmd_Hedgeandwarranttransactionsnetcashpaid_label_en-US" xlink:label="lab_cnmd_Hedgeandwarranttransactionsnetcashpaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge and warrant transactions, net cash paid</link:label>
    <link:label id="lab_cnmd_Hedgeandwarranttransactionsnetcashpaid_documentation_en-US" xlink:label="lab_cnmd_Hedgeandwarranttransactionsnetcashpaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Up-front costs to purchase hedge instruments, net of cash received from sale of warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_Hedgeandwarranttransactionsnetcashpaid" xlink:href="cnmd-20210331.xsd#cnmd_Hedgeandwarranttransactionsnetcashpaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_Hedgeandwarranttransactionsnetcashpaid" xlink:to="lab_cnmd_Hedgeandwarranttransactionsnetcashpaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_391c2461-3e2a-4f2f-b073-3ab264627d16_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_ddd84b6d-2420-4d1b-8078-474b644ce724_verboseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_label_en-US" xlink:label="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:to="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_16f583e9-645d-400a-928d-a856ff8af7e8_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_f02b0367-745f-4580-b74a-c68ecb6da412_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_85566b24-64aa-4412-914a-76fc0ddec86a_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_617b923c-375b-4184-aab3-16c829f069eb_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_78782bc0-1b70-4395-80d3-4bcd21591c61_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_7c6bf039-ca4e-490f-b2c5-08f2d4741595_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_fab266b6-421f-48c6-bad4-2e818cb7a0a7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_GeneralSurgeryMember_49500985-f596-4a8e-9053-06691dfc4415_terseLabel_en-US" xlink:label="lab_cnmd_GeneralSurgeryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General Surgery</link:label>
    <link:label id="lab_cnmd_GeneralSurgeryMember_label_en-US" xlink:label="lab_cnmd_GeneralSurgeryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General Surgery [Member]</link:label>
    <link:label id="lab_cnmd_GeneralSurgeryMember_documentation_en-US" xlink:label="lab_cnmd_GeneralSurgeryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General Surgery [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_GeneralSurgeryMember" xlink:href="cnmd-20210331.xsd#cnmd_GeneralSurgeryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_GeneralSurgeryMember" xlink:to="lab_cnmd_GeneralSurgeryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_4a0d560e-c65f-43de-a27d-c5b0ec4aa29e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and integration costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_f243b05e-da87-4345-b090-fb4c4c2a9f00_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_206b42f6-d12f-4dcd-aee6-6fb89fc147c8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost on projected benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_64a71ad1-9961-4167-bc3d-353e22ac0134_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_WeightedAverageMember_cd7b8c7e-43e3-42e4-aa7c-50a75c4b6a82_terseLabel_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average</link:label>
    <link:label id="lab_srt_WeightedAverageMember_label_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_WeightedAverageMember" xlink:to="lab_srt_WeightedAverageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_b60df243-1e4e-498d-be5d-ef0d7e3d1cd8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_6b044c7d-dee1-4c74-8d39-417ab4d436fc_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fd571a1c-5c15-4f1d-bf1e-51fc2487da1a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_AssetAcquisitionContingentConsiderationLiability_86b695a4-cf76-4076-9ea1-537a2930e6b7_terseLabel_en-US" xlink:label="lab_cnmd_AssetAcquisitionContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset acquisition, contingent consideration liability</link:label>
    <link:label id="lab_cnmd_AssetAcquisitionContingentConsiderationLiability_label_en-US" xlink:label="lab_cnmd_AssetAcquisitionContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Contingent Consideration Liability</link:label>
    <link:label id="lab_cnmd_AssetAcquisitionContingentConsiderationLiability_documentation_en-US" xlink:label="lab_cnmd_AssetAcquisitionContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Contingent Consideration Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AssetAcquisitionContingentConsiderationLiability" xlink:href="cnmd-20210331.xsd#cnmd_AssetAcquisitionContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_AssetAcquisitionContingentConsiderationLiability" xlink:to="lab_cnmd_AssetAcquisitionContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_4f5c3aa3-9a2a-44a4-8210-bf34b75a11d6_terseLabel_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Debt Issuance Expense</link:label>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_label_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Debt Issuance Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:to="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_0ff64cc3-a42a-4d2f-be6c-d478cf7347a1_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Administrative Expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_cbe4ebb8-8a63-4adc-8107-a3088afddf9a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_fbcc2687-0ac1-4404-8dd4-50aef64756c1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value for Forward Foreign Exchange Contracts</link:label>
    <link:label id="lab_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Foreign Exchange Contracts, Statement of Financial Position [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_2c90544d-b5cd-49cc-b00d-ba23ea263806_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7750f485-7961-48cc-b00e-c90e90d157c7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of calculation of basic and diluted earnings per share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_18bd5dad-5ce3-4132-98ed-2af9a4a8ea82_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5860b9b2-0049-47fb-8889-a33ccf49f203_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_0bf56853-9881-4556-9b03-6b14d834ec4d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension liability, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_1b237d8a-7494-42d4-9f75-9fd5d2ebbcd2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_95c1e6e9-3df8-45ee-b206-e75faa11626d_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_2e9720ec-af89-427a-b10e-864c7007b29c_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident_0c78ba96-f33e-4668-84fe-4b47bd62a988_terseLabel_en-US" xlink:label="lab_cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability insurance, amount per incident</link:label>
    <link:label id="lab_cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident_label_en-US" xlink:label="lab_cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Contingency, Insurance, Amount per Incident</link:label>
    <link:label id="lab_cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident_documentation_en-US" xlink:label="lab_cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Contingency, Insurance, Amount per Incident</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident" xlink:href="cnmd-20210331.xsd#cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident" xlink:to="lab_cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_85ffafae-df17-4ac7-8551-7925ff6c9309_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_0135cf30-15ac-4a2c-a9fe-cbe015428568_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument Risk [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e2f65005-5ae2-4a62-bb40-25ed1f0de689_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_02323f85-ba0e-4075-b81d-6ca4acf72883_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_9a6079f8-411e-4db8-8f96-69a01d27f138_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_c4f39838-af91-4f8d-bdae-e2c92a0ae678_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_FairValueofFinancialInstrumentsAbstract_0f3f6767-3bfa-4c8e-b5c8-bb78bc387cc7_terseLabel_en-US" xlink:label="lab_cnmd_FairValueofFinancialInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments [Abstract]</link:label>
    <link:label id="lab_cnmd_FairValueofFinancialInstrumentsAbstract_label_en-US" xlink:label="lab_cnmd_FairValueofFinancialInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments [Abstract]</link:label>
    <link:label id="lab_cnmd_FairValueofFinancialInstrumentsAbstract_documentation_en-US" xlink:label="lab_cnmd_FairValueofFinancialInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_FairValueofFinancialInstrumentsAbstract" xlink:href="cnmd-20210331.xsd#cnmd_FairValueofFinancialInstrumentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_FairValueofFinancialInstrumentsAbstract" xlink:to="lab_cnmd_FairValueofFinancialInstrumentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_855d0b53-1382-495a-b6c2-baad78cb6c5c_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_595cff86-74ca-443b-aea0-af4f7800e1b5_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_22d16e63-56a1-4db1-b955-1687ba271462_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_4163340b-d5ad-4f5f-8fc3-ab738897b784_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_3d855c58-264f-43e9-bc32-6bcfe4804c2d_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive potential securities (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_ecfba964-cb68-4851-88bc-3ef6b9cac620_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of net sales information by product line</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_d451b8d1-d73a-42e5-bb52-5a59f5d6c4f9_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_bfb761df-ce0e-4999-a688-3f98cd732614_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_40a6a0ea-8333-43a9-82ca-cc5b514b4482_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_13f0d469-f171-4d2d-b897-9c288f995732_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8d6c090e-3ea7-4d56-af90-e17faf9b30db_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_dfad48d0-7781-4e25-a79a-39b5b77aa108_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and administrative expense</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_2b7e0945-0ef2-4cd3-9d6b-0946e430e75f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount of cash flow hedges</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_5ed3d91f-8e43-4089-9cb7-a6b54cf4dc40_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_25e0eb46-974e-4790-8b2b-dcdd01abd0c1_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation, Including Current Maturities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation, Including Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_DefinedBenefitPlanNonServiceCost_a7f46407-1c74-4bae-9133-56b1d63edf27_terseLabel_en-US" xlink:label="lab_cnmd_DefinedBenefitPlanNonServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Non-service cost</link:label>
    <link:label id="lab_cnmd_DefinedBenefitPlanNonServiceCost_label_en-US" xlink:label="lab_cnmd_DefinedBenefitPlanNonServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Non-Service Cost</link:label>
    <link:label id="lab_cnmd_DefinedBenefitPlanNonServiceCost_documentation_en-US" xlink:label="lab_cnmd_DefinedBenefitPlanNonServiceCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Non-Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_DefinedBenefitPlanNonServiceCost" xlink:href="cnmd-20210331.xsd#cnmd_DefinedBenefitPlanNonServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_DefinedBenefitPlanNonServiceCost" xlink:to="lab_cnmd_DefinedBenefitPlanNonServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_fc16a18a-e716-4a85-bb12-d2a10f756c19_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_90e0432f-13b5-4588-afa8-9c8c571fd002_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segment</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_d593fa7a-6fe7-4072-bf08-4940b7a86148_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_716f1d32-c2ab-4227-b9af-adf842aba46a_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_6db18835-ab6a-4700-8a5a-3c8aee54ed3f_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAmortizationOfDeferredCharges_b4882f71-3414-493c-9605-a82bfbc92b63_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAmortizationOfDeferredCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_OtherAmortizationOfDeferredCharges_label_en-US" xlink:label="lab_us-gaap_OtherAmortizationOfDeferredCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Other Deferred Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAmortizationOfDeferredCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAmortizationOfDeferredCharges" xlink:to="lab_us-gaap_OtherAmortizationOfDeferredCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_c2f9613b-03e6-452f-9f22-ebd57757fbf9_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_8ccac5aa-1258-4b6a-9758-15bc8d9b3e88_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_095b61c4-eaca-4d70-97ed-6549439069ee_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_b5d23185-dc2f-4ef9-8950-1eeb0d3acff5_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_2fbd0be3-55bd-4db7-b177-859b22601e41_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferredAtPointInTimeMember_c065b391-af14-49d7-920e-a69847799a36_terseLabel_en-US" xlink:label="lab_us-gaap_TransferredAtPointInTimeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goods transferred at a point in time</link:label>
    <link:label id="lab_us-gaap_TransferredAtPointInTimeMember_label_en-US" xlink:label="lab_us-gaap_TransferredAtPointInTimeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred at Point in Time [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredAtPointInTimeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferredAtPointInTimeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferredAtPointInTimeMember" xlink:to="lab_us-gaap_TransferredAtPointInTimeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_c8087dad-1520-4f75-a23f-6ea88430bc61_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_ac380f25-eb6e-42ab-8aaf-fc6f7f39fdff_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought, Value</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:to="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_537796b6-94e6-47ad-b483-0a5562bba751_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_e9b47671-2965-4f3f-8f8f-ad61e0a794e4_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6dc2c673-4fe8-4c35-9524-9ffd84430801_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_89b8d7c8-d5ec-4794-a6e4-647c09a72afe_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_2898977e-f5be-45de-8c71-f11927c02a4a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_0cbfa2b3-1e37-4402-a2ce-0842690de988_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_4689a54d-dfc3-447a-b63e-79308b391c21_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_f7ddf5ca-879f-4668-8241-14508d9352f6_terseLabel_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Length of Time Hedged in Cash Flow Hedge</link:label>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_label_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Length of Time Hedged in Cash Flow Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:to="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_3e099812-1bfb-4c9a-9fd0-b5f474d10990_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_7fc319f4-4b2e-4adf-9207-0c4969800716_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_4d712b9a-7612-4c55-8879-0ff9b8ef5f4f_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_ProductWarrantyAccrualTerm_c61d7255-b716-4759-bd67-f9a9117b98d2_terseLabel_en-US" xlink:label="lab_cnmd_ProductWarrantyAccrualTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard warranty period (in years)</link:label>
    <link:label id="lab_cnmd_ProductWarrantyAccrualTerm_label_en-US" xlink:label="lab_cnmd_ProductWarrantyAccrualTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Accrual Term</link:label>
    <link:label id="lab_cnmd_ProductWarrantyAccrualTerm_documentation_en-US" xlink:label="lab_cnmd_ProductWarrantyAccrualTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Accrual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ProductWarrantyAccrualTerm" xlink:href="cnmd-20210331.xsd#cnmd_ProductWarrantyAccrualTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_ProductWarrantyAccrualTerm" xlink:to="lab_cnmd_ProductWarrantyAccrualTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_7f731767-908f-43c7-98ca-2b76ecd2970e_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_52156137-7246-4f59-97ef-d28ce52a2dca_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_AmericasexcludingtheUnitedStatesMember_79fd4a84-6ef0-41ce-a206-3478dd9882c4_terseLabel_en-US" xlink:label="lab_cnmd_AmericasexcludingtheUnitedStatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas (excluding the United States)</link:label>
    <link:label id="lab_cnmd_AmericasexcludingtheUnitedStatesMember_label_en-US" xlink:label="lab_cnmd_AmericasexcludingtheUnitedStatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas (excluding the United States) [Member]</link:label>
    <link:label id="lab_cnmd_AmericasexcludingtheUnitedStatesMember_documentation_en-US" xlink:label="lab_cnmd_AmericasexcludingtheUnitedStatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas (excluding the United States) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AmericasexcludingtheUnitedStatesMember" xlink:href="cnmd-20210331.xsd#cnmd_AmericasexcludingtheUnitedStatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_AmericasexcludingtheUnitedStatesMember" xlink:to="lab_cnmd_AmericasexcludingtheUnitedStatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_1323b687-4510-48df-abd2-22dc7567b6a0_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_c5805e4c-8015-4cee-a0d0-5914b89ad40f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_1e45fd6c-bd0b-483b-88aa-abb06989b7a8_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at period start (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_30be769a-1294-4e5e-935c-bb8b49244b6c_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at period end (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_a30ed204-3791-4ab7-8d1d-52f74aba097d_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_7467b5d8-6f50-4986-a0e9-d69b49a243c4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and integration costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Integration Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_AdditionalDamagesMember_bfbf7abe-fb5d-4a2d-8f0a-ac48fb703efd_terseLabel_en-US" xlink:label="lab_cnmd_AdditionalDamagesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Damages</link:label>
    <link:label id="lab_cnmd_AdditionalDamagesMember_label_en-US" xlink:label="lab_cnmd_AdditionalDamagesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Damages [Member]</link:label>
    <link:label id="lab_cnmd_AdditionalDamagesMember_documentation_en-US" xlink:label="lab_cnmd_AdditionalDamagesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Damages</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AdditionalDamagesMember" xlink:href="cnmd-20210331.xsd#cnmd_AdditionalDamagesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_AdditionalDamagesMember" xlink:to="lab_cnmd_AdditionalDamagesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_2afac023-43cb-4dbb-a5da-d5976c7fd707_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_0ccd93fc-5c3c-49d9-a4af-ce344d528629_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_a780fa90-eadc-497b-992d-f4380c9a6d9a_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_AmendedAndRestatedSeniorCreditAgreementMember_0fc34121-425a-4451-9fda-b3b9d46f7cd8_terseLabel_en-US" xlink:label="lab_cnmd_AmendedAndRestatedSeniorCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended and Restated Senior Credit Agreement [Member]</link:label>
    <link:label id="lab_cnmd_AmendedAndRestatedSeniorCreditAgreementMember_label_en-US" xlink:label="lab_cnmd_AmendedAndRestatedSeniorCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended and Restated Senior Credit Agreement [Member]</link:label>
    <link:label id="lab_cnmd_AmendedAndRestatedSeniorCreditAgreementMember_documentation_en-US" xlink:label="lab_cnmd_AmendedAndRestatedSeniorCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended and Restated Senior Credit Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AmendedAndRestatedSeniorCreditAgreementMember" xlink:href="cnmd-20210331.xsd#cnmd_AmendedAndRestatedSeniorCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_AmendedAndRestatedSeniorCreditAgreementMember" xlink:to="lab_cnmd_AmendedAndRestatedSeniorCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_64456a40-c4d8-4f63-8c03-4f24c5c68a9d_periodStartLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance as of January 1,</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_dfbeeac7-ecd1-491f-81c6-f065a5eb9537_periodEndLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance as of March 31,</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrual" xlink:to="lab_us-gaap_StandardProductWarrantyAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_a27c9890-7aa9-4739-af9a-a9085738dca7_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1f2cd93e-3d93-49cc-a20d-f4817bfa2e48_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_4ed97dc7-abfa-4d95-89c8-7c52603c6e4f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyExpense_4c92aaf0-2cf6-4fe6-aaf9-1d628ae1a00c_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product extended warranty expense</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyExpense_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyExpense" xlink:to="lab_us-gaap_ProductWarrantyExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_445d3086-c00f-42be-a416-39abe2f871e1_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for warranties</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual, Increase for Warranties Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyAccrualWarrantiesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:to="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_c776f89b-10d7-47d4-90cf-1ad3ee3ca9ec_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension liability, net of income tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6408ee09-e2a2-4804-bb4c-ec679aa0371e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_PatentsAndOtherIntangibleAssetsMember_9da1f1ea-367b-4059-b03c-f76b21de3f73_terseLabel_en-US" xlink:label="lab_cnmd_PatentsAndOtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents and other intangible assets</link:label>
    <link:label id="lab_cnmd_PatentsAndOtherIntangibleAssetsMember_label_en-US" xlink:label="lab_cnmd_PatentsAndOtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents and Other Intangible Assets [Member]</link:label>
    <link:label id="lab_cnmd_PatentsAndOtherIntangibleAssetsMember_documentation_en-US" xlink:label="lab_cnmd_PatentsAndOtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents and Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_PatentsAndOtherIntangibleAssetsMember" xlink:href="cnmd-20210331.xsd#cnmd_PatentsAndOtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_PatentsAndOtherIntangibleAssetsMember" xlink:to="lab_cnmd_PatentsAndOtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_a88f5fba-5f58-4fd6-9352-a7d062e6aa10_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_fe475d32-e7f8-499b-846b-27d7916785e6_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_SalesrepresentationmarketingandpromotionalrightsMember_6153c220-f737-4524-9555-7c1258072971_terseLabel_en-US" xlink:label="lab_cnmd_SalesrepresentationmarketingandpromotionalrightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales representation, marketing and promotional rights</link:label>
    <link:label id="lab_cnmd_SalesrepresentationmarketingandpromotionalrightsMember_label_en-US" xlink:label="lab_cnmd_SalesrepresentationmarketingandpromotionalrightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales representation, marketing and promotional rights [Member]</link:label>
    <link:label id="lab_cnmd_SalesrepresentationmarketingandpromotionalrightsMember_documentation_en-US" xlink:label="lab_cnmd_SalesrepresentationmarketingandpromotionalrightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales representation, marketing and promotional rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_SalesrepresentationmarketingandpromotionalrightsMember" xlink:href="cnmd-20210331.xsd#cnmd_SalesrepresentationmarketingandpromotionalrightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_SalesrepresentationmarketingandpromotionalrightsMember" xlink:to="lab_cnmd_SalesrepresentationmarketingandpromotionalrightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_ae85df9c-41a5-42e6-aff4-c0bd58542892_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_b6adb3c5-d9c5-4698-8ca3-fb312bc22ce8_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_LIBORInterestRateFloor_6d7f1702-1218-4fef-9045-faae026989e4_terseLabel_en-US" xlink:label="lab_cnmd_LIBORInterestRateFloor" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR Interest Rate Floor</link:label>
    <link:label id="lab_cnmd_LIBORInterestRateFloor_label_en-US" xlink:label="lab_cnmd_LIBORInterestRateFloor" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR Interest Rate Floor</link:label>
    <link:label id="lab_cnmd_LIBORInterestRateFloor_documentation_en-US" xlink:label="lab_cnmd_LIBORInterestRateFloor" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR Interest Rate Floor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_LIBORInterestRateFloor" xlink:href="cnmd-20210331.xsd#cnmd_LIBORInterestRateFloor"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_LIBORInterestRateFloor" xlink:to="lab_cnmd_LIBORInterestRateFloor" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_2e6bd644-7b32-479c-abb2-d32d8f27e6fb_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7dd10f80-ba74-46ef-abff-44fef205b7f1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_8bbd39f5-f8d7-45fc-ae49-bbb2283b423e_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_75af6a37-ce7b-4a1d-b269-e1594eca81b2_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_23270345-5382-4475-b475-ee463885d6f8_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_f5fa6616-77a0-447c-966a-faf67f11051b_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_e2a002f0-b233-4b79-bdda-a5a4fdd5afa5_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_296a6038-0dd7-41ab-89ac-fa4d3aa649d2_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_a3eb2e5e-11cf-4cdb-aa65-5002fb315fa8_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard Product Warranty Accrual [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard Product Warranty Accrual [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInStandardProductWarrantyAccrualRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:to="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_692bb1fb-8288-4395-930e-4f8c0725b15a_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_e4619348-73ee-42a6-a5aa-b15f948aa51f_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain_989474f9-5c10-40ed-a615-b90d8c572f57_terseLabel_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain_label_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:to="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_1b3526ed-0c94-4c70-8598-dcc067416bc7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of inventory</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantiesDisclosuresAbstract_19475e8c-a62a-4646-bad6-6cd95d0abf84_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantiesDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranties Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_ProductWarrantiesDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ProductWarrantiesDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranties Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantiesDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantiesDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantiesDisclosuresAbstract" xlink:to="lab_us-gaap_ProductWarrantiesDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_7925dce1-1daf-47a3-afdf-13fac8a9de1e_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_49927a8f-fec4-47b6-99fd-ca341e35d865_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_ScheduleOfAcquisitionAndOtherOperatingExpenseTableTextBlock_39dc7479-8a01-4d24-aa8a-c4a188ef33aa_terseLabel_en-US" xlink:label="lab_cnmd_ScheduleOfAcquisitionAndOtherOperatingExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquisition and Other Operating Expense</link:label>
    <link:label id="lab_cnmd_ScheduleOfAcquisitionAndOtherOperatingExpenseTableTextBlock_label_en-US" xlink:label="lab_cnmd_ScheduleOfAcquisitionAndOtherOperatingExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquisition and Other Operating Expense [Table Text Block]</link:label>
    <link:label id="lab_cnmd_ScheduleOfAcquisitionAndOtherOperatingExpenseTableTextBlock_documentation_en-US" xlink:label="lab_cnmd_ScheduleOfAcquisitionAndOtherOperatingExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquisition and Other Operating Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ScheduleOfAcquisitionAndOtherOperatingExpenseTableTextBlock" xlink:href="cnmd-20210331.xsd#cnmd_ScheduleOfAcquisitionAndOtherOperatingExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_ScheduleOfAcquisitionAndOtherOperatingExpenseTableTextBlock" xlink:to="lab_cnmd_ScheduleOfAcquisitionAndOtherOperatingExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_d88ce739-3ee0-49f2-aa45-3f2c7c920f2b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining, 2021</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_547ec676-9b16-40a7-9472-9c3cfee513bf_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_27aa499c-28e0-43e4-9684-0e50748028a8_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated as hedged instruments:</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_378ddc1f-6fd4-465c-84b0-465d9581be96_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_bc86dcd9-0da8-42cf-90f4-c188d448b706_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_HedgeTransactionsMember_e4e842f0-a6e3-4175-bb43-a1ed5a1d9a6c_terseLabel_en-US" xlink:label="lab_cnmd_HedgeTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge transactions</link:label>
    <link:label id="lab_cnmd_HedgeTransactionsMember_label_en-US" xlink:label="lab_cnmd_HedgeTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge transactions [Member]</link:label>
    <link:label id="lab_cnmd_HedgeTransactionsMember_documentation_en-US" xlink:label="lab_cnmd_HedgeTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_HedgeTransactionsMember" xlink:href="cnmd-20210331.xsd#cnmd_HedgeTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_HedgeTransactionsMember" xlink:to="lab_cnmd_HedgeTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_ffced3b8-52c2-44b4-89d9-d75c66a7c76c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_67338731-14ef-4c17-9b3e-154267b258a7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_OtherExpensesTable_fefb0f9f-89e2-450b-9448-01ad308f9320_terseLabel_en-US" xlink:label="lab_cnmd_OtherExpensesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and Other Expenses [Table]</link:label>
    <link:label id="lab_cnmd_OtherExpensesTable_label_en-US" xlink:label="lab_cnmd_OtherExpensesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expenses [Table]</link:label>
    <link:label id="lab_cnmd_OtherExpensesTable_documentation_en-US" xlink:label="lab_cnmd_OtherExpensesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expenses [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_OtherExpensesTable" xlink:href="cnmd-20210331.xsd#cnmd_OtherExpensesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_OtherExpensesTable" xlink:to="lab_cnmd_OtherExpensesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_3a7841c7-4d36-4993-b38e-86fabc6e70ed_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansPayableMember_4cfc69fb-6a18-4180-aac2-9dadf6a784ac_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility [Member]</link:label>
    <link:label id="lab_us-gaap_LoansPayableMember_label_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayableMember" xlink:to="lab_us-gaap_LoansPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_6d622143-c21d-48d8-9244-72312f8220fd_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_96a60654-ee0f-47e1-8d69-0c1bd5c4fb7d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_6f3d9889-6bec-446a-a963-06d02567f66c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_5a29ba59-4e87-4478-a634-340780035318_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_CreditAgreementExpirationTriggerRequirementConvertibleNoteOutstandingBalance_146b4c5f-e19c-4d72-a10d-70a118f59edf_terseLabel_en-US" xlink:label="lab_cnmd_CreditAgreementExpirationTriggerRequirementConvertibleNoteOutstandingBalance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement Expiration Trigger Requirement, Convertible Note Outstanding Balance</link:label>
    <link:label id="lab_cnmd_CreditAgreementExpirationTriggerRequirementConvertibleNoteOutstandingBalance_label_en-US" xlink:label="lab_cnmd_CreditAgreementExpirationTriggerRequirementConvertibleNoteOutstandingBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement Expiration Trigger Requirement, Convertible Note Outstanding Balance</link:label>
    <link:label id="lab_cnmd_CreditAgreementExpirationTriggerRequirementConvertibleNoteOutstandingBalance_documentation_en-US" xlink:label="lab_cnmd_CreditAgreementExpirationTriggerRequirementConvertibleNoteOutstandingBalance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement Expiration Trigger Requirement, Convertible Note Outstanding Balance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_CreditAgreementExpirationTriggerRequirementConvertibleNoteOutstandingBalance" xlink:href="cnmd-20210331.xsd#cnmd_CreditAgreementExpirationTriggerRequirementConvertibleNoteOutstandingBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_CreditAgreementExpirationTriggerRequirementConvertibleNoteOutstandingBalance" xlink:to="lab_cnmd_CreditAgreementExpirationTriggerRequirementConvertibleNoteOutstandingBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_0b119ca6-1619-4f6e-8d5f-d77da2c4375f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedging gain, net of income tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_ea3ebf0d-68ab-4ea5-ad34-8b469365b048_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement, Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_172ba112-5eb8-4ee2-a7f3-efa90eb0da3f_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_04d3c5d1-7807-4b99-a2c7-ebb35e5f6fa5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_08145cfa-394f-493e-b469-7ab23a9a07e4_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_ad8d9377-4f13-42c4-936c-fae2159d9425_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net amortization and deferral</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_LiquidatedDamagesMember_13225558-ac22-4693-a287-94756704f670_terseLabel_en-US" xlink:label="lab_cnmd_LiquidatedDamagesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liquidated Damages</link:label>
    <link:label id="lab_cnmd_LiquidatedDamagesMember_label_en-US" xlink:label="lab_cnmd_LiquidatedDamagesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liquidated Damages [Member]</link:label>
    <link:label id="lab_cnmd_LiquidatedDamagesMember_documentation_en-US" xlink:label="lab_cnmd_LiquidatedDamagesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liquidated Damages</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_LiquidatedDamagesMember" xlink:href="cnmd-20210331.xsd#cnmd_LiquidatedDamagesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_LiquidatedDamagesMember" xlink:to="lab_cnmd_LiquidatedDamagesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_dc1931bc-c622-486d-8d4f-0fb3a2f1dce8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_89edd425-e631-444c-9500-439ffbc61fd1_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_84bfe64a-b5dc-479d-9724-1483ae50f6f7_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic pension cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_6e427f5d-a23c-4a2a-aa9a-ccfa184a7de6_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3d59f2fb-c11e-4716-8c90-0d3efd5e79e9_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_353124d5-cb4d-49e5-b3b0-b128181fa701_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0ee324e5-8b60-4bec-8348-f6bc899df9b5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining, 2021</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_Manufacturingconsolidationcosts_635bd0b4-2f40-442f-8d5a-4ea21334533d_terseLabel_en-US" xlink:label="lab_cnmd_Manufacturingconsolidationcosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing consolidation costs</link:label>
    <link:label id="lab_cnmd_Manufacturingconsolidationcosts_label_en-US" xlink:label="lab_cnmd_Manufacturingconsolidationcosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing consolidation costs</link:label>
    <link:label id="lab_cnmd_Manufacturingconsolidationcosts_documentation_en-US" xlink:label="lab_cnmd_Manufacturingconsolidationcosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing consolidation costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_Manufacturingconsolidationcosts" xlink:href="cnmd-20210331.xsd#cnmd_Manufacturingconsolidationcosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_Manufacturingconsolidationcosts" xlink:to="lab_cnmd_Manufacturingconsolidationcosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_d1c7d749-33ba-42a4-8e92-4396c5c4e90d_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_b4f6ca6d-b767-4b3c-9ff8-d09f74355cf2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_c971fd42-9a75-4239-879d-a4bad02571ae_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_14a6b66e-87f8-4e79-96ca-4d728ed9a099_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCostAndExpenseOperating_cf8a2562-cefc-47f1-b89b-9afed6c5b1a1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCostAndExpenseOperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and other expense</link:label>
    <link:label id="lab_us-gaap_OtherCostAndExpenseOperating_label_en-US" xlink:label="lab_us-gaap_OtherCostAndExpenseOperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Cost and Expense, Operating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCostAndExpenseOperating" xlink:to="lab_us-gaap_OtherCostAndExpenseOperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract_03b1e2ba-0c0d-4a81-bc72-6a6a1a6c53c6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Assets and Liabilities at Fair Value [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Assets (Liabilities), at Fair Value, Net, by Balance Sheet Classification [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract" xlink:to="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_ff5dd3cc-120f-4b42-bbc1-8bc038767244_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, Gross carrying amount</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_05983af5-c572-4748-a923-771cac6e3fbf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid on common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_e0f12153-b37f-42f6-996e-c2e510d1f5c1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_5b03132b-2136-4d98-b1b7-d40e71f53f15_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives not designated as hedging instruments:</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_325581eb-70ac-481c-9c2c-25079e331aee_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_71000788-83ca-4cb4-a455-ef6270a7c305_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_4fff3773-d401-4bea-af2e-2c574cad1840_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_RestructuringAndRelatedCosts_4f3e7e9b-024c-4d54-818c-da0dc771699e_terseLabel_en-US" xlink:label="lab_cnmd_RestructuringAndRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restucturing and related costs</link:label>
    <link:label id="lab_cnmd_RestructuringAndRelatedCosts_label_en-US" xlink:label="lab_cnmd_RestructuringAndRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and related costs</link:label>
    <link:label id="lab_cnmd_RestructuringAndRelatedCosts_documentation_en-US" xlink:label="lab_cnmd_RestructuringAndRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and related costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_RestructuringAndRelatedCosts" xlink:href="cnmd-20210331.xsd#cnmd_RestructuringAndRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_RestructuringAndRelatedCosts" xlink:to="lab_cnmd_RestructuringAndRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_4163e6d7-c4f3-4ecf-ab27-596f4c638130_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_39bf165f-24bb-45fb-99f9-51cf66a241f6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_OrthopedicSurgeryMember_447f1c21-9841-4b6e-85bd-a4d3fbc98528_terseLabel_en-US" xlink:label="lab_cnmd_OrthopedicSurgeryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orthopedic Surgery</link:label>
    <link:label id="lab_cnmd_OrthopedicSurgeryMember_label_en-US" xlink:label="lab_cnmd_OrthopedicSurgeryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orthopedic Surgery [Member]</link:label>
    <link:label id="lab_cnmd_OrthopedicSurgeryMember_documentation_en-US" xlink:label="lab_cnmd_OrthopedicSurgeryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orthopedic Surgery [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_OrthopedicSurgeryMember" xlink:href="cnmd-20210331.xsd#cnmd_OrthopedicSurgeryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_OrthopedicSurgeryMember" xlink:to="lab_cnmd_OrthopedicSurgeryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_1c6a5ddb-e3fb-432a-953f-cf937878e89d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_e28c727f-78e1-4908-86b7-4334dc88a06d_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_465a1563-e4ca-4e9a-b516-c60e734a8133_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_892db93b-cd00-4eae-ad32-1a9c7597c413_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_5a02181b-3fd1-497e-83e2-8e6d3c76e5da_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_a8b10995-187f-418e-82fc-bbf554d47a2c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_f87ed1ff-5f0a-4b61-b9ab-93dbb3243d37_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_10fd10b6-2f77-4659-962a-6bee6725b599_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_4eaa3be6-4a7b-44b5-9ec6-a2d4fba185c5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends per share of common stock (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_a6bd48b4-cf98-4445-bc11-7e02566b2e61_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_b16c0325-020e-4cf0-98ad-64f0f53e87f6_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_107a581d-5b9e-4ecb-b279-801342fd0629_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_543d5b32-2bba-4c66-a0f7-70c09dbe0b48_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EMEAMember_ff848c81-3394-431c-8f05-a153b56e52f4_terseLabel_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe, Middle East &amp; Africa</link:label>
    <link:label id="lab_us-gaap_EMEAMember_label_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EMEAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EMEAMember" xlink:to="lab_us-gaap_EMEAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaturitiesOfLongTermDebtAbstract_c8ec1b27-d99c-4328-9553-dbdef9751a6d_terseLabel_en-US" xlink:label="lab_us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Long-term Debt [Abstract]</link:label>
    <link:label id="lab_us-gaap_MaturitiesOfLongTermDebtAbstract_label_en-US" xlink:label="lab_us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Long-term Debt [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaturitiesOfLongTermDebtAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:to="lab_us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_654361fd-bcd4-4567-ae1d-3e4f5eb4884f_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_504e8840-37dd-4e84-9f57-0cf6fff79956_terseLabel_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityStrikePrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option indexed to issuer's equity, strike price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_label_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityStrikePrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity, Strike Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityStrikePrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1" xlink:to="lab_us-gaap_OptionIndexedToIssuersEquityStrikePrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_952dc8d8-87e0-4211-a1fa-f71a83246a38_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_d1d318d7-07e2-4f9a-ab1c-90d5a97b0b4c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Estimated Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_77e282aa-f523-474c-a5d9-353f1f27df7e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_5a26039d-4d56-4780-bb9b-07287d141c5f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract Type [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6cdc91d2-dd1c-45d3-a51f-3e620dc0a325_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cca37071-5f55-43d0-9b0d-ca3c88a27946_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted- weighted average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_681a9d83-7b99-4b41-951c-ea9b942bd8fc_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_7ea7f596-5639-446d-8b25-8c5942d61111_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_VariableRateBasisAxis_18af88d9-5e40-4aba-925f-ea8ea5687606_terseLabel_en-US" xlink:label="lab_cnmd_VariableRateBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Basis [Axis]</link:label>
    <link:label id="lab_cnmd_VariableRateBasisAxis_label_en-US" xlink:label="lab_cnmd_VariableRateBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Basis [Axis]</link:label>
    <link:label id="lab_cnmd_VariableRateBasisAxis_documentation_en-US" xlink:label="lab_cnmd_VariableRateBasisAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_VariableRateBasisAxis" xlink:href="cnmd-20210331.xsd#cnmd_VariableRateBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_VariableRateBasisAxis" xlink:to="lab_cnmd_VariableRateBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_9b2ac4a3-a920-4628-bfd9-2d5e1cc0abf8_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_6e60bedd-04be-4fd5-86e5-83e96ef872eb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_69b3b3dd-cd37-46e2-8f22-2d7977910f21_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_71eeca9c-d9fa-43c8-b830-56c30473055e_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_3ff5a1a7-f76e-4437-b192-2dde950f0974_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on term loan</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_d5b6ea53-1c7a-4207-9f45-c0fdba78078e_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_968643ad-7c9e-485f-a675-d8fe68191487_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_9fa810e1-445d-42fa-b254-59d8d5e1ccf6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $0.01 per share; 100,000,000 shares authorized; 31,299,194 shares issued in 2021 and 2020, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMember_89059e85-c776-4e9d-a7b5-5c4a33912bf2_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Member]</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMember_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMember" xlink:to="lab_us-gaap_LongTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a617ed29-8ca6-46f7-a61f-c2a8ebbe1d16_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_93354dda-ca24-451d-944a-506e48565e5d_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_1ca4ba37-2f1c-48ee-b724-88cec48e8ead_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_824ff541-b6ff-4d47-8701-9aaefb9f3e76_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_2adb3062-1e55-4dda-bba6-b4b90ccc1a25_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_a4e7fe39-c082-4559-a332-c0204ce6a2e8_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:to="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_4aae90a7-a672-4bba-9122-ab3c7cc84e7b_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_39751628-1238-438a-b908-2253027bb967_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_a9810148-2aac-468b-a94d-468ec1efb8be_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesAndFairValueTextBlock_00ea92c5-bb98-4a3b-9189-efa3ab30f3cc_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesAndFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesAndFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesAndFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives and Fair Value [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesAndFairValueTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesAndFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesAndFairValueTextBlock" xlink:to="lab_us-gaap_DerivativesAndFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_62e73f99-8640-4127-b2fa-f9307ac23c56_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e1d27d18-d8ac-40c0-b06b-904ee3f73b0a_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_90e57e4b-5875-4dc8-aa72-3558d9c4a3f4_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EurodollarMember_d58bdabd-c598-497a-839e-99236caaaf27_terseLabel_en-US" xlink:label="lab_us-gaap_EurodollarMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurodollar [Member]</link:label>
    <link:label id="lab_us-gaap_EurodollarMember_label_en-US" xlink:label="lab_us-gaap_EurodollarMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurodollar [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EurodollarMember" xlink:to="lab_us-gaap_EurodollarMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_DebtInstrumentConvertibleGrossAmountofEquityComponent_12b6c613-77a4-4ebb-b68f-b9a01108bc23_terseLabel_en-US" xlink:label="lab_cnmd_DebtInstrumentConvertibleGrossAmountofEquityComponent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Gross Amount of Equity Component</link:label>
    <link:label id="lab_cnmd_DebtInstrumentConvertibleGrossAmountofEquityComponent_label_en-US" xlink:label="lab_cnmd_DebtInstrumentConvertibleGrossAmountofEquityComponent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Gross Amount of Equity Component</link:label>
    <link:label id="lab_cnmd_DebtInstrumentConvertibleGrossAmountofEquityComponent_documentation_en-US" xlink:label="lab_cnmd_DebtInstrumentConvertibleGrossAmountofEquityComponent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Gross Amount of Equity Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_DebtInstrumentConvertibleGrossAmountofEquityComponent" xlink:href="cnmd-20210331.xsd#cnmd_DebtInstrumentConvertibleGrossAmountofEquityComponent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_DebtInstrumentConvertibleGrossAmountofEquityComponent" xlink:to="lab_cnmd_DebtInstrumentConvertibleGrossAmountofEquityComponent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_e4110ba9-7667-435d-a7d6-3f74016b659b_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Forward Contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_Paymentsrelatedtobusinessacquisitionsandassetacquisitions_54009392-36ae-40fd-9716-8c87020d0d9a_negatedTerseLabel_en-US" xlink:label="lab_cnmd_Paymentsrelatedtobusinessacquisitionsandassetacquisitions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments related to business and asset acquisitions, net of cash acquired</link:label>
    <link:label id="lab_cnmd_Paymentsrelatedtobusinessacquisitionsandassetacquisitions_label_en-US" xlink:label="lab_cnmd_Paymentsrelatedtobusinessacquisitionsandassetacquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments related to business acquisitions and asset acquisitions</link:label>
    <link:label id="lab_cnmd_Paymentsrelatedtobusinessacquisitionsandassetacquisitions_documentation_en-US" xlink:label="lab_cnmd_Paymentsrelatedtobusinessacquisitionsandassetacquisitions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments related to business acquisitions and asset acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_Paymentsrelatedtobusinessacquisitionsandassetacquisitions" xlink:href="cnmd-20210331.xsd#cnmd_Paymentsrelatedtobusinessacquisitionsandassetacquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_Paymentsrelatedtobusinessacquisitionsandassetacquisitions" xlink:to="lab_cnmd_Paymentsrelatedtobusinessacquisitionsandassetacquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_6666939e-f692-47c0-9355-a72ec290bdcc_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_ce6d6a5c-259a-4c41-8f40-6b137ee84a5e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_28260dec-8a5d-4fd1-9436-52a0c6f457ef_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_20a134cf-46bb-4daf-8cd5-367b260205fc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount_d5ece1e3-a1ec-4cd4-b7f3-136bd156ff15_terseLabel_en-US" xlink:label="lab_cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability insurance, aggregate annual amount</link:label>
    <link:label id="lab_cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount_label_en-US" xlink:label="lab_cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Contingency, Insurance, Aggregate Annual Amount</link:label>
    <link:label id="lab_cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount_documentation_en-US" xlink:label="lab_cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Contingency, Insurance, Aggregate Annual Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount" xlink:href="cnmd-20210331.xsd#cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount" xlink:to="lab_cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_d715bd24-620a-4496-9754-00ae0178a63e_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_c62283ce-6a77-406a-a2df-34825f14a841_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at period start</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_ac000568-9d83-4fb9-90b9-2d9d70c85ec2_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at period end</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2e453e42-6ad3-46fa-b952-4a7b459b4baf_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_7d5b2744-87c2-43b6-899b-d8acaba79ad6_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operations</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_268432a3-905d-4f23-91a8-9a49691f7011_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_14b1dee3-f841-4537-bb96-f284b456fec3_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1e5a17af-ddd5-4b3d-a6f7-cefbf4c4890e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_dd9a189e-aff3-4593-9df8-91facf503d6d_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_66f45149-eaa5-4572-a0d5-aaabe4b9c0ad_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_2fd9b688-a7f6-4f53-9fef-3a1170e22e06_totalLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Assets (Liabilities), at Fair Value, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:to="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_bb5db137-1c6e-45b8-a3df-f038382ae24d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedging gain, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_48acee26-89fe-4983-af97-24c5687b44be_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_ae36f215-04c4-48c2-ae6f-b2f85eac1d14_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_ReductionofRevenueMember_79ac5d55-09fb-43ef-9212-b87d758c0af3_terseLabel_en-US" xlink:label="lab_cnmd_ReductionofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization recorded as a reduction of revenue</link:label>
    <link:label id="lab_cnmd_ReductionofRevenueMember_label_en-US" xlink:label="lab_cnmd_ReductionofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction of Revenue [Member]</link:label>
    <link:label id="lab_cnmd_ReductionofRevenueMember_documentation_en-US" xlink:label="lab_cnmd_ReductionofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction of Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ReductionofRevenueMember" xlink:href="cnmd-20210331.xsd#cnmd_ReductionofRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_ReductionofRevenueMember" xlink:to="lab_cnmd_ReductionofRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_A2.625PercentConvertibleNotesDue2024Member_bd47ed7e-735c-4261-8e3f-a4ae01df2d21_terseLabel_en-US" xlink:label="lab_cnmd_A2.625PercentConvertibleNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.625 Percent Convertible Notes Due 2024 [Member]</link:label>
    <link:label id="lab_cnmd_A2.625PercentConvertibleNotesDue2024Member_label_en-US" xlink:label="lab_cnmd_A2.625PercentConvertibleNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.625 Percent Convertible Notes Due 2024 [Member]</link:label>
    <link:label id="lab_cnmd_A2.625PercentConvertibleNotesDue2024Member_documentation_en-US" xlink:label="lab_cnmd_A2.625PercentConvertibleNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.625 Percent Convertible Notes Due 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_A2.625PercentConvertibleNotesDue2024Member" xlink:href="cnmd-20210331.xsd#cnmd_A2.625PercentConvertibleNotesDue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_A2.625PercentConvertibleNotesDue2024Member" xlink:to="lab_cnmd_A2.625PercentConvertibleNotesDue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_31355e19-3584-4cf9-ab36-a297b4e82f2b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_c32c97f7-e712-40ad-a748-5ccdf361f279_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_9dbeff13-d1c0-42de-a491-c8021ae4b555_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_af470479-ee7e-44e5-afec-3cce4823b7ca_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_e3c7b1fd-9ed6-4c79-9ab2-d58223f6e68a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible asset useful life (in years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_952fc687-1dc9-4291-ac4b-076751529190_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_899c4c9d-c561-40fe-8146-23dbdc4e77cc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_9b662a14-2fea-494a-85ec-2e65adb4643d_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_951689e1-8766-4a1a-bfe0-6a218d5fc3ff_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_5d94cec6-6982-42a3-a5c0-17ad48ed79a3_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_baeabd89-ae41-4447-8c31-ad29a08e02a8_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_70812e90-1191-41ae-b06e-58b6635bbfd9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notional Amounts of Outstanding Derivative Positions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_34fd60a2-b7c5-4130-8e24-1661d975c17a_terseLabel_en-US" xlink:label="lab_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived and Indefinite-Lived Assets [Line Items]</link:label>
    <link:label id="lab_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_label_en-US" xlink:label="lab_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived and Indefinite-Lived Assets [Line Items]</link:label>
    <link:label id="lab_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_documentation_en-US" xlink:label="lab_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived and Indefinite-Lived Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems" xlink:href="cnmd-20210331.xsd#cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems" xlink:to="lab_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_803aaa97-9edb-4da1-b768-c947495bdc66_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_04718112-b9f8-48d3-88a5-7186e7bfc58f_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b44b7b06-9029-4f52-bb0a-567812610816_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in cash flows from changes in assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_dea04549-220b-4818-9956-195e4ce8aea0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_198850ba-f928-4344-b409-faccdb144e49_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Carrying Amount of Equity Component</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Carrying Amount of Equity Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:to="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_54523cbf-105b-4a42-995a-3f65b14f926a_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_f76517f2-7c64-4ed8-b895-ebff4a6a429b_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f306cdff-c884-44e0-a17c-9c7e43eecd3c_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net current-period other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_cd3287d0-782a-4c22-a18b-4be6230990ee_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_ecb18178-8879-47fb-9852-43d371d3b064_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_85cb48bc-1bc3-442b-aa37-54b71e90f09e_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_699ebded-f221-4ab3-af17-0950c094138e_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Per share data:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_3f0dec9f-ebaa-4e28-87e3-56220024e4fc_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_d6c6119e-213b-476f-ba0c-3216cf758ee9_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Liability</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_LitigationDamagesAxis_0a88b4f9-fcb5-4d28-987a-99955f45b58b_terseLabel_en-US" xlink:label="lab_cnmd_LitigationDamagesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Damages [Axis]</link:label>
    <link:label id="lab_cnmd_LitigationDamagesAxis_label_en-US" xlink:label="lab_cnmd_LitigationDamagesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Damages [Axis]</link:label>
    <link:label id="lab_cnmd_LitigationDamagesAxis_documentation_en-US" xlink:label="lab_cnmd_LitigationDamagesAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Damages</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_LitigationDamagesAxis" xlink:href="cnmd-20210331.xsd#cnmd_LitigationDamagesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_LitigationDamagesAxis" xlink:to="lab_cnmd_LitigationDamagesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_769f2ee9-c24b-415a-a490-c9a5b2351488_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_1a7608d4-0bda-4fe0-9727-cd97f24a86ae_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_bbd03278-dd20-489a-935d-963d1ccf373f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_83ef9326-3012-47a8-94f6-b6abb705e582_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebt_b9ab053b-46b5-42b7-8195-0781e87782a7_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebt" xlink:to="lab_us-gaap_ConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_48c7cfb4-bfb7-49e1-a582-4638c34240d7_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_4b284a4e-dd62-492d-9281-8c29c45b5e66_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_b6ec06e3-24da-45c6-952a-2a0f4c95bec5_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Translation Adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_fd9b2658-ecdf-441a-90e5-a80531e42bcc_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_ac51cedf-0180-4612-ba95-bc4bc9930a21_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_CustomerandDistributorRelationshipsMember_123e51ce-0400-406b-877b-c81cc8bf7724_verboseLabel_en-US" xlink:label="lab_cnmd_CustomerandDistributorRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer and distributor relationships</link:label>
    <link:label id="lab_cnmd_CustomerandDistributorRelationshipsMember_label_en-US" xlink:label="lab_cnmd_CustomerandDistributorRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer and Distributor Relationships [Member]</link:label>
    <link:label id="lab_cnmd_CustomerandDistributorRelationshipsMember_documentation_en-US" xlink:label="lab_cnmd_CustomerandDistributorRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer and Distributor Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_CustomerandDistributorRelationshipsMember" xlink:href="cnmd-20210331.xsd#cnmd_CustomerandDistributorRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_CustomerandDistributorRelationshipsMember" xlink:to="lab_cnmd_CustomerandDistributorRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_c033133f-a469-4a8a-97dd-f2926295f4e8_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_26bebe85-3d1e-4d20-b332-cb9a4e030bf7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized intangible assets, Gross carrying amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_IndexedTransactionTypeDomain_5893265e-ed16-4b38-adf2-435662221cb9_terseLabel_en-US" xlink:label="lab_cnmd_IndexedTransactionTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indexed transaction type [Domain]</link:label>
    <link:label id="lab_cnmd_IndexedTransactionTypeDomain_label_en-US" xlink:label="lab_cnmd_IndexedTransactionTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indexed transaction type [Domain]</link:label>
    <link:label id="lab_cnmd_IndexedTransactionTypeDomain_documentation_en-US" xlink:label="lab_cnmd_IndexedTransactionTypeDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indexed transaction type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_IndexedTransactionTypeDomain" xlink:href="cnmd-20210331.xsd#cnmd_IndexedTransactionTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_IndexedTransactionTypeDomain" xlink:to="lab_cnmd_IndexedTransactionTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_AcquisitionandOtherExpenseAbstract_f8c427fd-f1ec-4657-974c-989aace6c1af_terseLabel_en-US" xlink:label="lab_cnmd_AcquisitionandOtherExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and Other Expense [Abstract]</link:label>
    <link:label id="lab_cnmd_AcquisitionandOtherExpenseAbstract_label_en-US" xlink:label="lab_cnmd_AcquisitionandOtherExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and Other Expense [Abstract]</link:label>
    <link:label id="lab_cnmd_AcquisitionandOtherExpenseAbstract_documentation_en-US" xlink:label="lab_cnmd_AcquisitionandOtherExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and Other Expense [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AcquisitionandOtherExpenseAbstract" xlink:href="cnmd-20210331.xsd#cnmd_AcquisitionandOtherExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_AcquisitionandOtherExpenseAbstract" xlink:to="lab_cnmd_AcquisitionandOtherExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_ceace0f1-f450-4ae5-b58c-8865e0170992_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate, stated percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_68d6bd27-026e-4f5d-97da-69d049328ae0_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_9efe343e-c0ef-4c72-8c59-cfe277295f47_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_PaymentsForContingentConsideration_f6f39f67-d98f-40d3-828d-2adf29f00f80_negatedLabel_en-US" xlink:label="lab_cnmd_PaymentsForContingentConsideration" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments related to contingent consideration</link:label>
    <link:label id="lab_cnmd_PaymentsForContingentConsideration_label_en-US" xlink:label="lab_cnmd_PaymentsForContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Contingent Consideration</link:label>
    <link:label id="lab_cnmd_PaymentsForContingentConsideration_documentation_en-US" xlink:label="lab_cnmd_PaymentsForContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Contingent Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_PaymentsForContingentConsideration" xlink:href="cnmd-20210331.xsd#cnmd_PaymentsForContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_PaymentsForContingentConsideration" xlink:to="lab_cnmd_PaymentsForContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_df279287-0784-4fd0-8ac0-cc1df68c8edc_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0306b87e-6431-4e51-ac96-250508889632_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic-weighted average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_529108ac-fd6e-40e2-a562-09b2675dedb4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_9c10b844-40a6-4b8d-a297-6465c7616b3f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_966f9b82-80c5-4032-9a6e-5c550672aef8_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_f7980769-e740-4607-a25a-539a5a92b99a_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedge</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_6ebc64f5-409e-4f7f-97f1-beb9feff3437_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_02d13259-7111-4bcb-a4a9-fad4519f5f7d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_19b5c5cd-900e-45fb-a53b-0e79aee566d9_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends payable</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_b6f8cb22-c4c9-4095-bd2a-6784b60bd027_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interim Financial Information</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_5856fbf5-1349-48f1-83db-bd0702ee2ff9_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_970284a4-9061-4100-a2b9-5c5f21c9349e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_2fdf5aad-2f93-4698-b259-4ce52890c29a_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_76695f10-824d-4861-b003-d3fc5686f966_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_d16c0546-63d6-4300-b98d-a7fdb5aade9e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit from income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_72d439eb-45d6-4628-b24b-dff268b7af2c_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ce4388b1-d073-4d0e-8cb6-42f2b5abc089_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6ff724f3-3f43-4f4a-9362-a0681e80f998_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_5813956f-7fdf-4965-a585-7884c80e7e6a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_860c5d5b-f568-4aa6-b190-f4d7c9a219f1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4c0513cb-71df-460a-8372-2dd24756d3ff_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_caa232dd-f08a-4717-9c3e-406f345f312d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_2b5fa17c-445d-403f-8807-2532babee612_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_787b1e45-0c8f-4083-8499-b936a5105168_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from other accumulated comprehensive income (loss) before tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteesAbstract_17fbca7c-c649-4478-b4e7-206a882f9b61_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees [Abstract]</link:label>
    <link:label id="lab_us-gaap_GuaranteesAbstract_label_en-US" xlink:label="lab_us-gaap_GuaranteesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteesAbstract" xlink:to="lab_us-gaap_GuaranteesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_2f872114-5858-4fec-8429-e016f4d13615_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_16c25d24-7f88-4432-b55f-cb3dac632324_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_17f92558-e5df-4477-b476-0fc7e1d9e7e9_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_fd068c72-2407-4ff4-bade-980de2e82c4e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_ccb64dbd-4ec2-4565-a6b4-0a047612a498_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_fadb8bc4-95a9-40d4-a261-db8fbed64095_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_ca92bf4a-f531-4f4a-b05e-d833a1d15037_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_b6e680c5-d4d0-47a9-84c8-6ef8236d9242_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_ae1e11b6-033b-411c-86af-404a00383d15_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_806c2bdb-d991-4139-8dbf-fd05640ef6d8_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_dc1e38f5-d979-480d-b5b2-055eeaf9b068_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized intangible assets, Gross carrying amount</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_431facb9-27c5-43b9-acd8-9b56c5025cfd_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_bc27eabf-58c4-4f36-bbc0-c7cf7bdb33ea_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_AcquisitionandOtherExpenseTextBlock_1240d303-5da4-4f71-9bb2-be3da164e47f_terseLabel_en-US" xlink:label="lab_cnmd_AcquisitionandOtherExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and Other Expense</link:label>
    <link:label id="lab_cnmd_AcquisitionandOtherExpenseTextBlock_label_en-US" xlink:label="lab_cnmd_AcquisitionandOtherExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and Other Expense [Text Block]</link:label>
    <link:label id="lab_cnmd_AcquisitionandOtherExpenseTextBlock_documentation_en-US" xlink:label="lab_cnmd_AcquisitionandOtherExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and Other Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AcquisitionandOtherExpenseTextBlock" xlink:href="cnmd-20210331.xsd#cnmd_AcquisitionandOtherExpenseTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_AcquisitionandOtherExpenseTextBlock" xlink:to="lab_cnmd_AcquisitionandOtherExpenseTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_WarrantTransactionsMember_a498d000-0df3-4815-aa29-4ef097fb52b7_terseLabel_en-US" xlink:label="lab_cnmd_WarrantTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant transactions</link:label>
    <link:label id="lab_cnmd_WarrantTransactionsMember_label_en-US" xlink:label="lab_cnmd_WarrantTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant transactions [Member]</link:label>
    <link:label id="lab_cnmd_WarrantTransactionsMember_documentation_en-US" xlink:label="lab_cnmd_WarrantTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_WarrantTransactionsMember" xlink:href="cnmd-20210331.xsd#cnmd_WarrantTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_WarrantTransactionsMember" xlink:to="lab_cnmd_WarrantTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_8aaba952-2adb-43ab-a6a9-a56ab1494b2b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_478e3769-a9da-4fae-a94b-ee60c91c6e0b_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_24deaa62-dda2-4319-9cba-1aebef21e5ac_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, Accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_bc405feb-dab0-4a1f-92d0-3b4794f78a52_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_51e42d31-427d-43c2-8b50-bc5d7cb94b93_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_5e4d121c-9c61-4994-a5f9-1431bd1b397d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends on common stock ($0.20 per share)</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_7344e682-22c5-45e0-8834-8f44a525cc18_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_5606258e-f318-45d5-b6ca-e929fa22b69d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_49cc907c-5caa-47c1-b55d-3623095a185b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of net benefit cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_2e43c046-3a4f-4457-a33e-0fe6ecfce87a_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_48d751ae-9a84-4e31-8afa-69796ba054c8_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_ExpenseMember_bcc5df2f-1f89-42a1-800a-bb4c14c9a9d0_terseLabel_en-US" xlink:label="lab_cnmd_ExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization included in expense</link:label>
    <link:label id="lab_cnmd_ExpenseMember_label_en-US" xlink:label="lab_cnmd_ExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense [Member]</link:label>
    <link:label id="lab_cnmd_ExpenseMember_documentation_en-US" xlink:label="lab_cnmd_ExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ExpenseMember" xlink:href="cnmd-20210331.xsd#cnmd_ExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_ExpenseMember" xlink:to="lab_cnmd_ExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingExpense_30a04c3d-519e-4403-9189-a731f6377c02_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingExpense" xlink:to="lab_us-gaap_OtherNonoperatingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_43347a62-4852-44a7-b91c-66cf2810809e_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_1009f565-9573-4f90-af8c-a8ef93337ac7_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_05882808-45ae-477d-bc69-d85593d6e9c3_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualPayments_5920279e-7868-4464-874f-db61d20ac56f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims made</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualPayments_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual, Decrease for Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualPayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyAccrualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrualPayments" xlink:to="lab_us-gaap_StandardProductWarrantyAccrualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_6df917fe-90e1-439f-b9d8-6fc7a402b7e4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: 2,222,233 and 2,410,045 shares of common stock in treasury, at cost in 2021 and 2020, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_9a9f88bc-3da2-41ef-a89e-aa38b4e45ca7_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtendedProductWarrantyDisclosureAbstract_8a878eae-2322-42c7-80d9-3e4505a930e5_terseLabel_en-US" xlink:label="lab_us-gaap_ExtendedProductWarrantyDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Product Warranty Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_ExtendedProductWarrantyDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_ExtendedProductWarrantyDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Product Warranty Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtendedProductWarrantyDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtendedProductWarrantyDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtendedProductWarrantyDisclosureAbstract" xlink:to="lab_us-gaap_ExtendedProductWarrantyDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_976a8e56-be56-4f9c-a9bf-bbe1f6896aaa_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityTypeAxis_f9deac16-193a-49c6-a210-f3c99d8f09b5_terseLabel_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityTypeAxis_label_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:to="lab_us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_f8dd6f8f-ee74-44df-9579-89ee0c68b79a_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_e92cb61e-32b5-41ce-a1da-12648b50c0af_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_0516d334-7aaf-4447-a825-4efee2a5b0c1_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_299c47f7-2b0b-4d17-8a77-fdf0ee198f90_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_60999c84-b5f2-4a5d-a5ee-8944d9e99f6b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from revolving line of credit</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_f6576b83-0dec-476a-9499-30bf10384971_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>cnmd-20210331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:4a71bfc6-7922-4305-aa8d-7a5d2323cf49,g:a58de70d-c080-4226-99f2-d632a7268b2f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.conmed.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="cnmd-20210331.xsd#DocumentandEntityInformation"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/DocumentandEntityInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_41b43a70-9921-400a-8f45-ac228773c71f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_05af5172-3266-459f-9eb1-646df48f321e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41b43a70-9921-400a-8f45-ac228773c71f" xlink:to="loc_dei_EntityRegistrantName_05af5172-3266-459f-9eb1-646df48f321e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_8ae14b66-2649-4f65-8365-dc9b348d5f76" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41b43a70-9921-400a-8f45-ac228773c71f" xlink:to="loc_dei_DocumentQuarterlyReport_8ae14b66-2649-4f65-8365-dc9b348d5f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_8a020f25-0efd-4db3-bf94-3599413c9640" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41b43a70-9921-400a-8f45-ac228773c71f" xlink:to="loc_dei_DocumentType_8a020f25-0efd-4db3-bf94-3599413c9640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_4708fe34-c7d0-4376-88e8-be1273bde34e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41b43a70-9921-400a-8f45-ac228773c71f" xlink:to="loc_dei_DocumentPeriodEndDate_4708fe34-c7d0-4376-88e8-be1273bde34e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_dc727547-3adb-4eb4-bf1f-d3348f4215a5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41b43a70-9921-400a-8f45-ac228773c71f" xlink:to="loc_dei_CurrentFiscalYearEndDate_dc727547-3adb-4eb4-bf1f-d3348f4215a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_fb6902e6-7ea0-4ec4-ac5a-d46ab2aa131a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41b43a70-9921-400a-8f45-ac228773c71f" xlink:to="loc_dei_DocumentFiscalPeriodFocus_fb6902e6-7ea0-4ec4-ac5a-d46ab2aa131a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_4b8276ae-67be-4be5-8662-6c5b560b621a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41b43a70-9921-400a-8f45-ac228773c71f" xlink:to="loc_dei_DocumentFiscalYearFocus_4b8276ae-67be-4be5-8662-6c5b560b621a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_d40418ad-26e1-497a-ba40-ef3af9133ec9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41b43a70-9921-400a-8f45-ac228773c71f" xlink:to="loc_dei_EntityFileNumber_d40418ad-26e1-497a-ba40-ef3af9133ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_db55e967-dc7d-4d9a-b61a-6028647de68c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41b43a70-9921-400a-8f45-ac228773c71f" xlink:to="loc_dei_EntityIncorporationStateCountryCode_db55e967-dc7d-4d9a-b61a-6028647de68c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_33b06b4b-6683-4a17-bf01-228ee287114d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41b43a70-9921-400a-8f45-ac228773c71f" xlink:to="loc_dei_EntityTaxIdentificationNumber_33b06b4b-6683-4a17-bf01-228ee287114d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_153f0d4c-1b03-408f-b91f-8cb35e9e9093" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41b43a70-9921-400a-8f45-ac228773c71f" xlink:to="loc_dei_EntityAddressAddressLine1_153f0d4c-1b03-408f-b91f-8cb35e9e9093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_8c703a56-6308-4c11-9a60-918f913ae35b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41b43a70-9921-400a-8f45-ac228773c71f" xlink:to="loc_dei_EntityAddressCityOrTown_8c703a56-6308-4c11-9a60-918f913ae35b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_f386e297-4540-408e-9adf-08c25cbda260" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41b43a70-9921-400a-8f45-ac228773c71f" xlink:to="loc_dei_EntityAddressStateOrProvince_f386e297-4540-408e-9adf-08c25cbda260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_cd193e4a-0961-4f2a-b54d-08a0cb27bc63" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41b43a70-9921-400a-8f45-ac228773c71f" xlink:to="loc_dei_EntityAddressPostalZipCode_cd193e4a-0961-4f2a-b54d-08a0cb27bc63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_2fc02c2d-be37-458f-810c-68a74c25d39c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41b43a70-9921-400a-8f45-ac228773c71f" xlink:to="loc_dei_CityAreaCode_2fc02c2d-be37-458f-810c-68a74c25d39c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_41823592-b667-48c2-b66c-bdad34e7af82" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41b43a70-9921-400a-8f45-ac228773c71f" xlink:to="loc_dei_LocalPhoneNumber_41823592-b667-48c2-b66c-bdad34e7af82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_e6483aa1-25f0-4774-a11a-91316885efba" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41b43a70-9921-400a-8f45-ac228773c71f" xlink:to="loc_dei_EntityCentralIndexKey_e6483aa1-25f0-4774-a11a-91316885efba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_1003949e-5e47-412d-8b5b-85c93863daa9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41b43a70-9921-400a-8f45-ac228773c71f" xlink:to="loc_dei_Security12bTitle_1003949e-5e47-412d-8b5b-85c93863daa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_d9ad7a06-6c5f-495a-b867-765f1561ca71" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41b43a70-9921-400a-8f45-ac228773c71f" xlink:to="loc_dei_TradingSymbol_d9ad7a06-6c5f-495a-b867-765f1561ca71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_c13bb6f6-b4de-4b58-9bc7-d1fe3ae1d272" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41b43a70-9921-400a-8f45-ac228773c71f" xlink:to="loc_dei_SecurityExchangeName_c13bb6f6-b4de-4b58-9bc7-d1fe3ae1d272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_ae7c4b84-48cd-4a49-beb3-c9d5b76875e3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41b43a70-9921-400a-8f45-ac228773c71f" xlink:to="loc_dei_EntityCurrentReportingStatus_ae7c4b84-48cd-4a49-beb3-c9d5b76875e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_a34166af-ad46-4151-aa26-69115bdcfb6e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41b43a70-9921-400a-8f45-ac228773c71f" xlink:to="loc_dei_EntityInteractiveDataCurrent_a34166af-ad46-4151-aa26-69115bdcfb6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_6de85f84-f4a0-4f43-8c46-cf03a275f3ba" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41b43a70-9921-400a-8f45-ac228773c71f" xlink:to="loc_dei_EntityFilerCategory_6de85f84-f4a0-4f43-8c46-cf03a275f3ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_0b2dfbdb-e541-4ab9-8add-838d0c9cb42e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41b43a70-9921-400a-8f45-ac228773c71f" xlink:to="loc_dei_EntitySmallBusiness_0b2dfbdb-e541-4ab9-8add-838d0c9cb42e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_5be466fa-ab9e-42f5-83bb-9ea10d99284d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41b43a70-9921-400a-8f45-ac228773c71f" xlink:to="loc_dei_EntityEmergingGrowthCompany_5be466fa-ab9e-42f5-83bb-9ea10d99284d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_0be48612-f58e-4728-8f3a-a79ea4635fc4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41b43a70-9921-400a-8f45-ac228773c71f" xlink:to="loc_dei_DocumentTransitionReport_0be48612-f58e-4728-8f3a-a79ea4635fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_fd69ca04-0717-492a-ab09-dba0a0dff563" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41b43a70-9921-400a-8f45-ac228773c71f" xlink:to="loc_dei_EntityShellCompany_fd69ca04-0717-492a-ab09-dba0a0dff563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_55afd649-983d-4ea1-a99c-3d4dadfd7f84" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41b43a70-9921-400a-8f45-ac228773c71f" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_55afd649-983d-4ea1-a99c-3d4dadfd7f84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_2550f803-46be-4506-909c-6a3019eb26cc" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41b43a70-9921-400a-8f45-ac228773c71f" xlink:to="loc_dei_AmendmentFlag_2550f803-46be-4506-909c-6a3019eb26cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited" xlink:type="simple" xlink:href="cnmd-20210331.xsd#ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_01f28e2c-9f40-43db-ae75-cd1a399999cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_8684e460-1bf8-4671-8167-b860bc7af672" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_01f28e2c-9f40-43db-ae75-cd1a399999cd" xlink:to="loc_us-gaap_Revenues_8684e460-1bf8-4671-8167-b860bc7af672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_47f72b30-3248-4b3e-91cd-f90dc973ad56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_01f28e2c-9f40-43db-ae75-cd1a399999cd" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_47f72b30-3248-4b3e-91cd-f90dc973ad56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_149c0129-700f-452c-8a36-2bf2f6b09203" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_01f28e2c-9f40-43db-ae75-cd1a399999cd" xlink:to="loc_us-gaap_GrossProfit_149c0129-700f-452c-8a36-2bf2f6b09203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8642aae4-ee67-412f-a16f-c09798e183aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_01f28e2c-9f40-43db-ae75-cd1a399999cd" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8642aae4-ee67-412f-a16f-c09798e183aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_5567814f-a963-4581-830d-7a413ee92e84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_01f28e2c-9f40-43db-ae75-cd1a399999cd" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_5567814f-a963-4581-830d-7a413ee92e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_21b43534-f733-4bd6-9b57-5bd321dc16f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_01f28e2c-9f40-43db-ae75-cd1a399999cd" xlink:to="loc_us-gaap_OperatingExpenses_21b43534-f733-4bd6-9b57-5bd321dc16f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c099fc05-3a26-4df7-bda2-97acb3e902d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_01f28e2c-9f40-43db-ae75-cd1a399999cd" xlink:to="loc_us-gaap_OperatingIncomeLoss_c099fc05-3a26-4df7-bda2-97acb3e902d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_4533e3fa-15d7-49c7-b074-bf1cba46ef92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_01f28e2c-9f40-43db-ae75-cd1a399999cd" xlink:to="loc_us-gaap_InterestExpense_4533e3fa-15d7-49c7-b074-bf1cba46ef92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingExpense_94c73b23-2e96-47a2-9b54-141a2b3fdc5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_01f28e2c-9f40-43db-ae75-cd1a399999cd" xlink:to="loc_us-gaap_OtherNonoperatingExpense_94c73b23-2e96-47a2-9b54-141a2b3fdc5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_67b80bb8-3716-47e7-b4df-a02e550f0380" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_01f28e2c-9f40-43db-ae75-cd1a399999cd" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_67b80bb8-3716-47e7-b4df-a02e550f0380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_67ae18bb-f98d-4446-b5e6-cf92d3999d00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_01f28e2c-9f40-43db-ae75-cd1a399999cd" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_67ae18bb-f98d-4446-b5e6-cf92d3999d00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e0eec2fd-aa6a-4daa-be94-7b8462f8a69e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_01f28e2c-9f40-43db-ae75-cd1a399999cd" xlink:to="loc_us-gaap_NetIncomeLoss_e0eec2fd-aa6a-4daa-be94-7b8462f8a69e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_02daf669-a841-42eb-acc6-518cb12b5a9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_01f28e2c-9f40-43db-ae75-cd1a399999cd" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_02daf669-a841-42eb-acc6-518cb12b5a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_34468d57-3a87-43b3-8c55-61f44a742186" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_01f28e2c-9f40-43db-ae75-cd1a399999cd" xlink:to="loc_us-gaap_EarningsPerShareAbstract_34468d57-3a87-43b3-8c55-61f44a742186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_a074c046-76c9-46fb-8951-6ba2b3612003" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_34468d57-3a87-43b3-8c55-61f44a742186" xlink:to="loc_us-gaap_EarningsPerShareBasic_a074c046-76c9-46fb-8951-6ba2b3612003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_949af4eb-0788-40ad-9dbc-850cb68388cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_34468d57-3a87-43b3-8c55-61f44a742186" xlink:to="loc_us-gaap_EarningsPerShareDiluted_949af4eb-0788-40ad-9dbc-850cb68388cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_17c6911e-5a40-42ca-9192-e7f54e6fcbeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_01f28e2c-9f40-43db-ae75-cd1a399999cd" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_17c6911e-5a40-42ca-9192-e7f54e6fcbeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3bf12a1e-0d2c-4fb2-8d26-034feb8aa96a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_17c6911e-5a40-42ca-9192-e7f54e6fcbeb" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3bf12a1e-0d2c-4fb2-8d26-034feb8aa96a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ef705aa7-0824-4e9e-aa3c-963959ec2282" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_17c6911e-5a40-42ca-9192-e7f54e6fcbeb" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ef705aa7-0824-4e9e-aa3c-963959ec2282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="cnmd-20210331.xsd#ConsolidatedCondensedBalanceSheetsUnaudited"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_c51c7798-4b7c-456c-b95e-40d8fec1fb59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_e9b4ff33-8fd2-4950-9cef-1e71acef9439" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c51c7798-4b7c-456c-b95e-40d8fec1fb59" xlink:to="loc_us-gaap_AssetsAbstract_e9b4ff33-8fd2-4950-9cef-1e71acef9439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_a8d5e279-73ed-43fc-b694-7f71c2b0d244" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e9b4ff33-8fd2-4950-9cef-1e71acef9439" xlink:to="loc_us-gaap_AssetsCurrentAbstract_a8d5e279-73ed-43fc-b694-7f71c2b0d244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4424c328-1198-4dff-aaa6-a790331bc8b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a8d5e279-73ed-43fc-b694-7f71c2b0d244" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4424c328-1198-4dff-aaa6-a790331bc8b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_4c536da8-c828-42bf-ae45-9ad93094faa4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a8d5e279-73ed-43fc-b694-7f71c2b0d244" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_4c536da8-c828-42bf-ae45-9ad93094faa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_1943d904-c243-43b7-9051-85f652dbf1cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a8d5e279-73ed-43fc-b694-7f71c2b0d244" xlink:to="loc_us-gaap_InventoryNet_1943d904-c243-43b7-9051-85f652dbf1cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9d496040-b8f6-476d-a0d8-9774841aac9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a8d5e279-73ed-43fc-b694-7f71c2b0d244" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9d496040-b8f6-476d-a0d8-9774841aac9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c5fe01af-1589-4e22-996d-725b7ad4fa60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a8d5e279-73ed-43fc-b694-7f71c2b0d244" xlink:to="loc_us-gaap_AssetsCurrent_c5fe01af-1589-4e22-996d-725b7ad4fa60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_5fee0f82-abea-463e-8dcf-ad35b7e81da3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e9b4ff33-8fd2-4950-9cef-1e71acef9439" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_5fee0f82-abea-463e-8dcf-ad35b7e81da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6f30c090-a54e-4a05-9d56-2ee7a93cc8c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e9b4ff33-8fd2-4950-9cef-1e71acef9439" xlink:to="loc_us-gaap_Goodwill_6f30c090-a54e-4a05-9d56-2ee7a93cc8c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d39ad9b5-a609-4217-8552-f12a066d1d84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e9b4ff33-8fd2-4950-9cef-1e71acef9439" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d39ad9b5-a609-4217-8552-f12a066d1d84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_26ebb19c-3402-4da9-8c52-a40da5ab4f63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e9b4ff33-8fd2-4950-9cef-1e71acef9439" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_26ebb19c-3402-4da9-8c52-a40da5ab4f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_8b083f40-3a32-47f0-ad2a-7b10d6d73ffb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e9b4ff33-8fd2-4950-9cef-1e71acef9439" xlink:to="loc_us-gaap_Assets_8b083f40-3a32-47f0-ad2a-7b10d6d73ffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dca95d3f-bd10-4a17-ae7e-b2ccf3fa7734" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c51c7798-4b7c-456c-b95e-40d8fec1fb59" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dca95d3f-bd10-4a17-ae7e-b2ccf3fa7734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_b1d202c5-fee7-4de4-a88a-e34ae5673756" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dca95d3f-bd10-4a17-ae7e-b2ccf3fa7734" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_b1d202c5-fee7-4de4-a88a-e34ae5673756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_8bbd7c2c-20ab-44ea-a5a6-b73fa9f30d60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b1d202c5-fee7-4de4-a88a-e34ae5673756" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_8bbd7c2c-20ab-44ea-a5a6-b73fa9f30d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_016d4260-00af-43ef-aa5d-49dd30db3c9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b1d202c5-fee7-4de4-a88a-e34ae5673756" xlink:to="loc_us-gaap_AccountsPayableCurrent_016d4260-00af-43ef-aa5d-49dd30db3c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_df1bffd7-13d6-4f6d-85cb-0d2e3a5aaa32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b1d202c5-fee7-4de4-a88a-e34ae5673756" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_df1bffd7-13d6-4f6d-85cb-0d2e3a5aaa32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_f7eda035-534f-4004-84f7-b537883a7ed1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b1d202c5-fee7-4de4-a88a-e34ae5673756" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_f7eda035-534f-4004-84f7-b537883a7ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_ed85a8be-d7fc-4a8e-842b-ebc8064ddf0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b1d202c5-fee7-4de4-a88a-e34ae5673756" xlink:to="loc_us-gaap_LiabilitiesCurrent_ed85a8be-d7fc-4a8e-842b-ebc8064ddf0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_fd947efd-79f7-45c8-82a7-4e9ce7234de4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dca95d3f-bd10-4a17-ae7e-b2ccf3fa7734" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_fd947efd-79f7-45c8-82a7-4e9ce7234de4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_fdbd920b-ff3d-4570-89c3-1bd8783ed670" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dca95d3f-bd10-4a17-ae7e-b2ccf3fa7734" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_fdbd920b-ff3d-4570-89c3-1bd8783ed670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_d1571957-0441-496f-9c3d-6682b7b6ea5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dca95d3f-bd10-4a17-ae7e-b2ccf3fa7734" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_d1571957-0441-496f-9c3d-6682b7b6ea5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_6f191a39-9fae-4751-8598-c5ce2303d278" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dca95d3f-bd10-4a17-ae7e-b2ccf3fa7734" xlink:to="loc_us-gaap_Liabilities_6f191a39-9fae-4751-8598-c5ce2303d278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_697ed43b-393a-4e21-885b-c68cf6f0a24b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dca95d3f-bd10-4a17-ae7e-b2ccf3fa7734" xlink:to="loc_us-gaap_CommitmentsAndContingencies_697ed43b-393a-4e21-885b-c68cf6f0a24b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_9636ac7e-7991-42db-bd6c-6b454ca9849a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dca95d3f-bd10-4a17-ae7e-b2ccf3fa7734" xlink:to="loc_us-gaap_StockholdersEquityAbstract_9636ac7e-7991-42db-bd6c-6b454ca9849a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_666939b9-9136-4084-a584-76e64536223a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9636ac7e-7991-42db-bd6c-6b454ca9849a" xlink:to="loc_us-gaap_PreferredStockValue_666939b9-9136-4084-a584-76e64536223a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_7078103c-e688-4338-ad24-2fc8c1e54179" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9636ac7e-7991-42db-bd6c-6b454ca9849a" xlink:to="loc_us-gaap_CommonStockValue_7078103c-e688-4338-ad24-2fc8c1e54179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_063e3919-ea98-45d6-9907-29361960fd7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9636ac7e-7991-42db-bd6c-6b454ca9849a" xlink:to="loc_us-gaap_AdditionalPaidInCapital_063e3919-ea98-45d6-9907-29361960fd7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_fd5600f7-e102-4cee-a1c7-33d3d9dcb34e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9636ac7e-7991-42db-bd6c-6b454ca9849a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_fd5600f7-e102-4cee-a1c7-33d3d9dcb34e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_198ff692-bb96-4ed0-8efd-edc18fab3b4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9636ac7e-7991-42db-bd6c-6b454ca9849a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_198ff692-bb96-4ed0-8efd-edc18fab3b4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_e0cd2330-87c9-4c13-b848-4fc853167057" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9636ac7e-7991-42db-bd6c-6b454ca9849a" xlink:to="loc_us-gaap_TreasuryStockValue_e0cd2330-87c9-4c13-b848-4fc853167057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4684268c-ec55-4a77-be42-d47589169d78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9636ac7e-7991-42db-bd6c-6b454ca9849a" xlink:to="loc_us-gaap_StockholdersEquity_4684268c-ec55-4a77-be42-d47589169d78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_681c4a5f-b6c2-4f61-a41c-7a3dbea8d496" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dca95d3f-bd10-4a17-ae7e-b2ccf3fa7734" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_681c4a5f-b6c2-4f61-a41c-7a3dbea8d496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical" xlink:type="simple" xlink:href="cnmd-20210331.xsd#ConsolidatedCondensedBalanceSheetsUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_3a113948-fd4d-48a3-87e6-3e0d1044916f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5077e741-4186-4a16-9681-f3ffdc31ba71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3a113948-fd4d-48a3-87e6-3e0d1044916f" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5077e741-4186-4a16-9681-f3ffdc31ba71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_ddfd42d3-38d5-42a9-9489-2a40fae12c8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3a113948-fd4d-48a3-87e6-3e0d1044916f" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_ddfd42d3-38d5-42a9-9489-2a40fae12c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_01cbb325-f3b4-4810-982e-d43e85ba66d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3a113948-fd4d-48a3-87e6-3e0d1044916f" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_01cbb325-f3b4-4810-982e-d43e85ba66d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_51a0241a-9751-4b66-8915-b5a225ff07c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3a113948-fd4d-48a3-87e6-3e0d1044916f" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_51a0241a-9751-4b66-8915-b5a225ff07c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_6ba56386-e0b3-42d1-9cf3-b11ed86121c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3a113948-fd4d-48a3-87e6-3e0d1044916f" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_6ba56386-e0b3-42d1-9cf3-b11ed86121c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_db654173-a06b-49f3-9867-33f6be938671" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3a113948-fd4d-48a3-87e6-3e0d1044916f" xlink:to="loc_us-gaap_CommonStockSharesIssued_db654173-a06b-49f3-9867-33f6be938671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_19c09fd0-1993-4dfe-899a-c2354c9dc17f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3a113948-fd4d-48a3-87e6-3e0d1044916f" xlink:to="loc_us-gaap_TreasuryStockShares_19c09fd0-1993-4dfe-899a-c2354c9dc17f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited" xlink:type="simple" xlink:href="cnmd-20210331.xsd#ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_f5a711a6-3d6d-440f-9004-fbb28af72f7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f402893e-5c5a-462b-b4db-cd651192d594" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_f5a711a6-3d6d-440f-9004-fbb28af72f7f" xlink:to="loc_us-gaap_StatementTable_f402893e-5c5a-462b-b4db-cd651192d594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_89ff4660-88db-43d8-99fc-f7791551c3ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f402893e-5c5a-462b-b4db-cd651192d594" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_89ff4660-88db-43d8-99fc-f7791551c3ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_0c78ac35-7ab2-4647-a8b5-e1b23d2e95c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_89ff4660-88db-43d8-99fc-f7791551c3ab" xlink:to="loc_us-gaap_TypeOfAdoptionMember_0c78ac35-7ab2-4647-a8b5-e1b23d2e95c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_779b42e6-89f5-4138-8660-c5d446cc3502" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f402893e-5c5a-462b-b4db-cd651192d594" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_779b42e6-89f5-4138-8660-c5d446cc3502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e620911c-580d-48c1-8f2b-e5d79529cf07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_779b42e6-89f5-4138-8660-c5d446cc3502" xlink:to="loc_us-gaap_EquityComponentDomain_e620911c-580d-48c1-8f2b-e5d79529cf07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_772ef7e6-0f9d-4a52-a738-a2d2727e0924" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e620911c-580d-48c1-8f2b-e5d79529cf07" xlink:to="loc_us-gaap_CommonStockMember_772ef7e6-0f9d-4a52-a738-a2d2727e0924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_f7dc161a-cbb0-4022-bfc2-c61eb852ea6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e620911c-580d-48c1-8f2b-e5d79529cf07" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_f7dc161a-cbb0-4022-bfc2-c61eb852ea6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_746521d1-2dc6-4437-a266-7e5ca710f411" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e620911c-580d-48c1-8f2b-e5d79529cf07" xlink:to="loc_us-gaap_RetainedEarningsMember_746521d1-2dc6-4437-a266-7e5ca710f411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2cbd493d-066a-4ee7-835e-919e9827f72c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e620911c-580d-48c1-8f2b-e5d79529cf07" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2cbd493d-066a-4ee7-835e-919e9827f72c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_7703c5b6-1bcf-4d51-88a3-248599a10171" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e620911c-580d-48c1-8f2b-e5d79529cf07" xlink:to="loc_us-gaap_TreasuryStockMember_7703c5b6-1bcf-4d51-88a3-248599a10171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2c24b86d-c20b-41c9-8393-1168edbf4b16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f402893e-5c5a-462b-b4db-cd651192d594" xlink:to="loc_us-gaap_StatementLineItems_2c24b86d-c20b-41c9-8393-1168edbf4b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_57f61161-da97-49da-ad1f-dbe0207b3870" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2c24b86d-c20b-41c9-8393-1168edbf4b16" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_57f61161-da97-49da-ad1f-dbe0207b3870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_3d7b428f-6895-429a-94e0-427e3dfcf8ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_57f61161-da97-49da-ad1f-dbe0207b3870" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_3d7b428f-6895-429a-94e0-427e3dfcf8ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0d9961c6-2aa8-43c5-a9c2-84d3698ee0fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_57f61161-da97-49da-ad1f-dbe0207b3870" xlink:to="loc_us-gaap_StockholdersEquity_0d9961c6-2aa8-43c5-a9c2-84d3698ee0fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_099102d9-e7a0-4301-9cff-6d8263651d42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_57f61161-da97-49da-ad1f-dbe0207b3870" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_099102d9-e7a0-4301-9cff-6d8263651d42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_47ef6f86-8ea1-4859-87ad-5c66850b2ce4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_57f61161-da97-49da-ad1f-dbe0207b3870" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_47ef6f86-8ea1-4859-87ad-5c66850b2ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_470967b1-99fd-4062-937b-a1cc2dc4a5b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_57f61161-da97-49da-ad1f-dbe0207b3870" xlink:to="loc_us-gaap_DividendsCommonStockCash_470967b1-99fd-4062-937b-a1cc2dc4a5b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2513b942-cf09-48e7-83db-4909c442aabd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_57f61161-da97-49da-ad1f-dbe0207b3870" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2513b942-cf09-48e7-83db-4909c442aabd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_993aeadd-2bf8-45db-b7de-ccddd6a3ec09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2513b942-cf09-48e7-83db-4909c442aabd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_993aeadd-2bf8-45db-b7de-ccddd6a3ec09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_c3be278d-fbc3-48c0-93e1-d9b66247d710" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2513b942-cf09-48e7-83db-4909c442aabd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_c3be278d-fbc3-48c0-93e1-d9b66247d710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_04f2f0a6-4389-4043-af78-51d64694c193" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2513b942-cf09-48e7-83db-4909c442aabd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_04f2f0a6-4389-4043-af78-51d64694c193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_03e99b82-0c30-4acf-85f3-18dab8700a0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2513b942-cf09-48e7-83db-4909c442aabd" xlink:to="loc_us-gaap_NetIncomeLoss_03e99b82-0c30-4acf-85f3-18dab8700a0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e798053d-6eb9-4eee-b998-1e9e1a6bd983" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2513b942-cf09-48e7-83db-4909c442aabd" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e798053d-6eb9-4eee-b998-1e9e1a6bd983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_6660fea2-4fcc-4ef4-8d92-064196be8c70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_57f61161-da97-49da-ad1f-dbe0207b3870" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_6660fea2-4fcc-4ef4-8d92-064196be8c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_398ab99a-c250-4c97-9ce4-6d3aec3c99f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_57f61161-da97-49da-ad1f-dbe0207b3870" xlink:to="loc_us-gaap_StockholdersEquity_398ab99a-c250-4c97-9ce4-6d3aec3c99f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnauditedParenthetical" xlink:type="simple" xlink:href="cnmd-20210331.xsd#ConsolidatedCondensedStatementsofShareholdersEquityUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_89e1376d-3231-440e-bff3-fa4700b6e0b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ff8865af-b5a7-49af-9ba3-d01400f68df1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_89e1376d-3231-440e-bff3-fa4700b6e0b9" xlink:to="loc_us-gaap_StatementTable_ff8865af-b5a7-49af-9ba3-d01400f68df1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9586cc58-5040-4f9e-9835-96efd53b5e84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ff8865af-b5a7-49af-9ba3-d01400f68df1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9586cc58-5040-4f9e-9835-96efd53b5e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e0c818ef-5209-479f-9ee6-03b56ba762d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9586cc58-5040-4f9e-9835-96efd53b5e84" xlink:to="loc_us-gaap_EquityComponentDomain_e0c818ef-5209-479f-9ee6-03b56ba762d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_5aba9c0f-c9d8-4191-8edd-85b9af385328" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e0c818ef-5209-479f-9ee6-03b56ba762d8" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_5aba9c0f-c9d8-4191-8edd-85b9af385328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a2d2a3b5-ea1c-4263-b169-a92f6b1c094b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ff8865af-b5a7-49af-9ba3-d01400f68df1" xlink:to="loc_us-gaap_StatementLineItems_a2d2a3b5-ea1c-4263-b169-a92f6b1c094b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_b21bb05e-0777-4d95-968f-3d326d4f6fc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a2d2a3b5-ea1c-4263-b169-a92f6b1c094b" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_b21bb05e-0777-4d95-968f-3d326d4f6fc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="cnmd-20210331.xsd#ConsolidatedCondensedStatementsofCashFlowsUnaudited"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_40815ce5-a758-4afb-b42e-f0bcc22f06f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3e70ef5c-b293-4afb-985b-d85b02294856" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_40815ce5-a758-4afb-b42e-f0bcc22f06f9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3e70ef5c-b293-4afb-985b-d85b02294856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1ee26638-0ed1-418b-954f-33c190bc823d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3e70ef5c-b293-4afb-985b-d85b02294856" xlink:to="loc_us-gaap_NetIncomeLoss_1ee26638-0ed1-418b-954f-33c190bc823d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1614a791-bee2-43d9-98ab-90a17825a89a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3e70ef5c-b293-4afb-985b-d85b02294856" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1614a791-bee2-43d9-98ab-90a17825a89a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_ca3a2089-7b3c-4d8e-8dca-5db2f6f6db47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1614a791-bee2-43d9-98ab-90a17825a89a" xlink:to="loc_us-gaap_Depreciation_ca3a2089-7b3c-4d8e-8dca-5db2f6f6db47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_6dfff0be-eed3-4f4b-91e7-51f64317033f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1614a791-bee2-43d9-98ab-90a17825a89a" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_6dfff0be-eed3-4f4b-91e7-51f64317033f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_83f1a4dc-3a78-425e-beb6-0e5974209972" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1614a791-bee2-43d9-98ab-90a17825a89a" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_83f1a4dc-3a78-425e-beb6-0e5974209972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges_4799b1da-7f48-477f-ad78-3f40d3134d67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAmortizationOfDeferredCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1614a791-bee2-43d9-98ab-90a17825a89a" xlink:to="loc_us-gaap_OtherAmortizationOfDeferredCharges_4799b1da-7f48-477f-ad78-3f40d3134d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_6c4c0e9d-206e-45e3-b360-5d5dac2cb833" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1614a791-bee2-43d9-98ab-90a17825a89a" xlink:to="loc_us-gaap_ShareBasedCompensation_6c4c0e9d-206e-45e3-b360-5d5dac2cb833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9d07a04e-2484-4fe8-bffa-294fa67eca34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1614a791-bee2-43d9-98ab-90a17825a89a" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9d07a04e-2484-4fe8-bffa-294fa67eca34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cc970ddb-e678-4d87-a5d5-a3775148853c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1614a791-bee2-43d9-98ab-90a17825a89a" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cc970ddb-e678-4d87-a5d5-a3775148853c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_9fd34eb9-b4ce-499b-bdba-be093f5e5f25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cc970ddb-e678-4d87-a5d5-a3775148853c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_9fd34eb9-b4ce-499b-bdba-be093f5e5f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_767a66a3-bba8-4c3d-9ee9-a4bde88605dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cc970ddb-e678-4d87-a5d5-a3775148853c" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_767a66a3-bba8-4c3d-9ee9-a4bde88605dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_e10d5c38-ccbc-4e9d-a037-0b3643f962f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cc970ddb-e678-4d87-a5d5-a3775148853c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_e10d5c38-ccbc-4e9d-a037-0b3643f962f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_df31b992-7162-4e7f-b307-9cf4c09fde47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cc970ddb-e678-4d87-a5d5-a3775148853c" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_df31b992-7162-4e7f-b307-9cf4c09fde47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_cf20fe16-d8a5-488f-80f1-b842b15b240f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cc970ddb-e678-4d87-a5d5-a3775148853c" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_cf20fe16-d8a5-488f-80f1-b842b15b240f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_f7679512-e5cf-47b6-b2fc-b205053c6544" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cc970ddb-e678-4d87-a5d5-a3775148853c" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_f7679512-e5cf-47b6-b2fc-b205053c6544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a1a5cc48-6d42-4514-a456-80234b618353" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1614a791-bee2-43d9-98ab-90a17825a89a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a1a5cc48-6d42-4514-a456-80234b618353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2fb63d29-8023-45cf-9bca-63ff3f87d2e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_40815ce5-a758-4afb-b42e-f0bcc22f06f9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2fb63d29-8023-45cf-9bca-63ff3f87d2e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_15768d03-678d-4492-8608-312c0f2dfacd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2fb63d29-8023-45cf-9bca-63ff3f87d2e4" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_15768d03-678d-4492-8608-312c0f2dfacd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_Paymentsrelatedtobusinessacquisitionsandassetacquisitions_d434bfc6-c7ce-4bfb-8387-d4589c463cb1" xlink:href="cnmd-20210331.xsd#cnmd_Paymentsrelatedtobusinessacquisitionsandassetacquisitions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2fb63d29-8023-45cf-9bca-63ff3f87d2e4" xlink:to="loc_cnmd_Paymentsrelatedtobusinessacquisitionsandassetacquisitions_d434bfc6-c7ce-4bfb-8387-d4589c463cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_24cc1fa7-efb4-4888-830a-67904dd9f3f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2fb63d29-8023-45cf-9bca-63ff3f87d2e4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_24cc1fa7-efb4-4888-830a-67904dd9f3f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_09196fc4-9ef4-42ed-8204-511bb0ee60dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_40815ce5-a758-4afb-b42e-f0bcc22f06f9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_09196fc4-9ef4-42ed-8204-511bb0ee60dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_42d2ebac-6f42-4ebd-9064-2b62c223489b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_09196fc4-9ef4-42ed-8204-511bb0ee60dc" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_42d2ebac-6f42-4ebd-9064-2b62c223489b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_aa9c575a-adb7-4153-8523-7e3a6d7d5e35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_09196fc4-9ef4-42ed-8204-511bb0ee60dc" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_aa9c575a-adb7-4153-8523-7e3a6d7d5e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_d18c0634-bf92-4347-af4a-19a43cdb1f2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_09196fc4-9ef4-42ed-8204-511bb0ee60dc" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_d18c0634-bf92-4347-af4a-19a43cdb1f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_PaymentsForContingentConsideration_36e88a73-1728-4991-8b09-b846dcaafcfc" xlink:href="cnmd-20210331.xsd#cnmd_PaymentsForContingentConsideration"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_09196fc4-9ef4-42ed-8204-511bb0ee60dc" xlink:to="loc_cnmd_PaymentsForContingentConsideration_36e88a73-1728-4991-8b09-b846dcaafcfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_d8ebc4b4-7fc8-487c-be27-524bc35e98a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_09196fc4-9ef4-42ed-8204-511bb0ee60dc" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_d8ebc4b4-7fc8-487c-be27-524bc35e98a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_e3cbfa3b-0d1e-4928-960c-974a84094850" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_09196fc4-9ef4-42ed-8204-511bb0ee60dc" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_e3cbfa3b-0d1e-4928-960c-974a84094850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f0f81373-941f-4981-9c87-e682e68e5ad6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_09196fc4-9ef4-42ed-8204-511bb0ee60dc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f0f81373-941f-4981-9c87-e682e68e5ad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_25ccc611-75b3-4769-aaba-1990211f7b68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_40815ce5-a758-4afb-b42e-f0bcc22f06f9" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_25ccc611-75b3-4769-aaba-1990211f7b68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f03b4dce-a755-4b99-9fcd-66537179ddc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_40815ce5-a758-4afb-b42e-f0bcc22f06f9" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f03b4dce-a755-4b99-9fcd-66537179ddc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_10fe7d17-b5e4-4666-84fd-f16487cef122" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_40815ce5-a758-4afb-b42e-f0bcc22f06f9" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_10fe7d17-b5e4-4666-84fd-f16487cef122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_19d8d0b6-a658-4e6a-afe9-f7f625051670" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_40815ce5-a758-4afb-b42e-f0bcc22f06f9" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_19d8d0b6-a658-4e6a-afe9-f7f625051670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_b5c55c8f-9c8c-4e11-85eb-317e23af27ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_40815ce5-a758-4afb-b42e-f0bcc22f06f9" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_b5c55c8f-9c8c-4e11-85eb-317e23af27ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_162041a8-0cf3-4b8e-a3db-d1d426f0af63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_b5c55c8f-9c8c-4e11-85eb-317e23af27ae" xlink:to="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_162041a8-0cf3-4b8e-a3db-d1d426f0af63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/Operations" xlink:type="simple" xlink:href="cnmd-20210331.xsd#Operations"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/Operations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6a026339-602e-453a-81f9-7f504b0f4fd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_5020e41e-a588-48de-b13e-95d5acd2e1fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6a026339-602e-453a-81f9-7f504b0f4fd0" xlink:to="loc_us-gaap_NatureOfOperations_5020e41e-a588-48de-b13e-95d5acd2e1fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/InterimFinancialInformation" xlink:type="simple" xlink:href="cnmd-20210331.xsd#InterimFinancialInformation"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/InterimFinancialInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f2b4e5a8-2805-44ec-9b7b-73c77a9e034d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_a8036ef1-046b-429b-bf95-da5c39e39ba0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f2b4e5a8-2805-44ec-9b7b-73c77a9e034d" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_a8036ef1-046b-429b-bf95-da5c39e39ba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/InterimReportingPolicies" xlink:type="simple" xlink:href="cnmd-20210331.xsd#InterimReportingPolicies"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/InterimReportingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_a4e6d9d8-5920-49a3-b1bd-15c8230466cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_ca328036-d0fa-4012-8833-29cc8f8e4dbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_a4e6d9d8-5920-49a3-b1bd-15c8230466cf" xlink:to="loc_us-gaap_UseOfEstimates_ca328036-d0fa-4012-8833-29cc8f8e4dbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/Revenues" xlink:type="simple" xlink:href="cnmd-20210331.xsd#Revenues"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/Revenues" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2b823eb2-cc2c-4932-aba4-da0d3b2d5712" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_877b53c6-515e-43d7-b7d2-d855be36b973" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2b823eb2-cc2c-4932-aba4-da0d3b2d5712" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_877b53c6-515e-43d7-b7d2-d855be36b973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/RevenuesTables" xlink:type="simple" xlink:href="cnmd-20210331.xsd#RevenuesTables"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/RevenuesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_11b408d7-b959-467f-87e2-f86581de66a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_7342faac-8ab6-4943-a1dc-8ebe777af039" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_11b408d7-b959-467f-87e2-f86581de66a0" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_7342faac-8ab6-4943-a1dc-8ebe777af039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_3ddd96ca-9fcf-488a-bbce-68562ee93b47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_11b408d7-b959-467f-87e2-f86581de66a0" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_3ddd96ca-9fcf-488a-bbce-68562ee93b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#RevenuesDisaggregatedRevenuesDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_13c85945-988a-4cfb-b37c-50890673419e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_2e0a1495-002b-496c-94c9-4b1929044ade" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_13c85945-988a-4cfb-b37c-50890673419e" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_2e0a1495-002b-496c-94c9-4b1929044ade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_505b0e6e-f67a-4c51-8431-31de3b7e58be" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2e0a1495-002b-496c-94c9-4b1929044ade" xlink:to="loc_srt_StatementGeographicalAxis_505b0e6e-f67a-4c51-8431-31de3b7e58be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3921faff-b4d7-401b-814f-d96e3244931e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_505b0e6e-f67a-4c51-8431-31de3b7e58be" xlink:to="loc_srt_SegmentGeographicalDomain_3921faff-b4d7-401b-814f-d96e3244931e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_eca92f3f-4590-4aca-9441-1feb540bfd38" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3921faff-b4d7-401b-814f-d96e3244931e" xlink:to="loc_country_US_eca92f3f-4590-4aca-9441-1feb540bfd38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AmericasexcludingtheUnitedStatesMember_da58f81c-363d-4765-88a5-46e0ae3beec4" xlink:href="cnmd-20210331.xsd#cnmd_AmericasexcludingtheUnitedStatesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3921faff-b4d7-401b-814f-d96e3244931e" xlink:to="loc_cnmd_AmericasexcludingtheUnitedStatesMember_da58f81c-363d-4765-88a5-46e0ae3beec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_edc84081-df28-4705-a469-e6add8ab0186" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EMEAMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3921faff-b4d7-401b-814f-d96e3244931e" xlink:to="loc_us-gaap_EMEAMember_edc84081-df28-4705-a469-e6add8ab0186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_13402e14-8ed7-488c-b5d4-cb4572cb4fdb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3921faff-b4d7-401b-814f-d96e3244931e" xlink:to="loc_srt_AsiaPacificMember_13402e14-8ed7-488c-b5d4-cb4572cb4fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_bbb75cb8-f1e0-4e38-a6da-d34dc9be0748" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2e0a1495-002b-496c-94c9-4b1929044ade" xlink:to="loc_srt_ProductOrServiceAxis_bbb75cb8-f1e0-4e38-a6da-d34dc9be0748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_908b15bd-cc15-4b16-890a-e16377333101" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_bbb75cb8-f1e0-4e38-a6da-d34dc9be0748" xlink:to="loc_srt_ProductsAndServicesDomain_908b15bd-cc15-4b16-890a-e16377333101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_OrthopedicSurgeryMember_90a2888a-8867-4aad-9011-2554af07e9ae" xlink:href="cnmd-20210331.xsd#cnmd_OrthopedicSurgeryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_908b15bd-cc15-4b16-890a-e16377333101" xlink:to="loc_cnmd_OrthopedicSurgeryMember_90a2888a-8867-4aad-9011-2554af07e9ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_GeneralSurgeryMember_502bf94c-9253-497f-8cbb-60316feb86ab" xlink:href="cnmd-20210331.xsd#cnmd_GeneralSurgeryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_908b15bd-cc15-4b16-890a-e16377333101" xlink:to="loc_cnmd_GeneralSurgeryMember_502bf94c-9253-497f-8cbb-60316feb86ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_dc75775f-8051-4f36-9fa4-6b51cd07b198" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2e0a1495-002b-496c-94c9-4b1929044ade" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_dc75775f-8051-4f36-9fa4-6b51cd07b198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_5a234ff9-979f-46e5-ae74-2515793760a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_dc75775f-8051-4f36-9fa4-6b51cd07b198" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_5a234ff9-979f-46e5-ae74-2515793760a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredAtPointInTimeMember_98144438-3570-45ac-9853-1066ce620a6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferredAtPointInTimeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_5a234ff9-979f-46e5-ae74-2515793760a9" xlink:to="loc_us-gaap_TransferredAtPointInTimeMember_98144438-3570-45ac-9853-1066ce620a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember_c624c55a-19c4-4884-a4f0-3d7d27c3149c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_5a234ff9-979f-46e5-ae74-2515793760a9" xlink:to="loc_us-gaap_TransferredOverTimeMember_c624c55a-19c4-4884-a4f0-3d7d27c3149c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_1c7bc1ea-ef99-4ddc-8d9e-b312a31a4d74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2e0a1495-002b-496c-94c9-4b1929044ade" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_1c7bc1ea-ef99-4ddc-8d9e-b312a31a4d74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_cdbb9a60-687e-4686-b55b-c3eb3c708aa0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1c7bc1ea-ef99-4ddc-8d9e-b312a31a4d74" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_cdbb9a60-687e-4686-b55b-c3eb3c708aa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/RevenuesCustomerLiabilityDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#RevenuesCustomerLiabilityDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/RevenuesCustomerLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1b5677c3-f674-4337-aa63-624ee98ab2c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_0502af92-3d54-43c5-a975-0e772fa815ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1b5677c3-f674-4337-aa63-624ee98ab2c1" xlink:to="loc_us-gaap_ContractWithCustomerLiability_0502af92-3d54-43c5-a975-0e772fa815ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_324be346-75a8-462b-b1b7-f8d4c9a32a46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1b5677c3-f674-4337-aa63-624ee98ab2c1" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_324be346-75a8-462b-b1b7-f8d4c9a32a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/ComprehensiveIncomeLoss" xlink:type="simple" xlink:href="cnmd-20210331.xsd#ComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/ComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_abc81c78-8eae-4ba2-aa8a-0d62dcbc41c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_adb3bbf6-4872-4ae3-a963-394ba528b7c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_abc81c78-8eae-4ba2-aa8a-0d62dcbc41c6" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_adb3bbf6-4872-4ae3-a963-394ba528b7c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/ComprehensiveIncomeLossTables" xlink:type="simple" xlink:href="cnmd-20210331.xsd#ComprehensiveIncomeLossTables"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/ComprehensiveIncomeLossTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_ac6b71a9-ebaa-403b-bab9-968c64a9a0a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_3fa47ce7-8a66-4ccd-beef-55d3a91214a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ac6b71a9-ebaa-403b-bab9-968c64a9a0a7" xlink:to="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_3fa47ce7-8a66-4ccd-beef-55d3a91214a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_95cf812a-cc67-4453-babd-7115e9e4f49f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ac6b71a9-ebaa-403b-bab9-968c64a9a0a7" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_95cf812a-cc67-4453-babd-7115e9e4f49f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/ComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#ComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/ComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_4be096dc-33a1-413a-8c13-2f0eb3a6157f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f475c062-a656-4465-8a6d-96c9a70af1e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4be096dc-33a1-413a-8c13-2f0eb3a6157f" xlink:to="loc_us-gaap_NetIncomeLoss_f475c062-a656-4465-8a6d-96c9a70af1e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_c3bea271-0037-4eff-9d1e-86803d339571" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4be096dc-33a1-413a-8c13-2f0eb3a6157f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_c3bea271-0037-4eff-9d1e-86803d339571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_e2783578-1054-45c1-8c4a-16295989a58d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4be096dc-33a1-413a-8c13-2f0eb3a6157f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_e2783578-1054-45c1-8c4a-16295989a58d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_544738ec-04d8-4b44-b6b0-a6acb6c35ba5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4be096dc-33a1-413a-8c13-2f0eb3a6157f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_544738ec-04d8-4b44-b6b0-a6acb6c35ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_cd9161cc-863c-464e-98ab-ede10bedea08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4be096dc-33a1-413a-8c13-2f0eb3a6157f" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_cd9161cc-863c-464e-98ab-ede10bedea08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_e1cc73b3-6448-4e6a-a616-1e5abb8cfcaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4be096dc-33a1-413a-8c13-2f0eb3a6157f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_e1cc73b3-6448-4e6a-a616-1e5abb8cfcaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_c10c8dc6-5388-4189-8445-8962b1c7e1e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4be096dc-33a1-413a-8c13-2f0eb3a6157f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_c10c8dc6-5388-4189-8445-8962b1c7e1e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/ComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#ComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/ComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_5bbcb03a-b4bf-45e4-8341-6be2843f3205" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ed29c358-d89f-4f28-a084-30c3a4f5ddea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5bbcb03a-b4bf-45e4-8341-6be2843f3205" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ed29c358-d89f-4f28-a084-30c3a4f5ddea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_391c20b4-e081-4c38-b8da-1d4a0c1d0608" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ed29c358-d89f-4f28-a084-30c3a4f5ddea" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_391c20b4-e081-4c38-b8da-1d4a0c1d0608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3deb47e4-debf-4bfb-a650-1a3ef262991f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_391c20b4-e081-4c38-b8da-1d4a0c1d0608" xlink:to="loc_us-gaap_EquityComponentDomain_3deb47e4-debf-4bfb-a650-1a3ef262991f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_782df29d-9515-4352-9658-0db8d5915c50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3deb47e4-debf-4bfb-a650-1a3ef262991f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_782df29d-9515-4352-9658-0db8d5915c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_179cace5-c189-409b-b0f2-db761eeacd9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_782df29d-9515-4352-9658-0db8d5915c50" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_179cace5-c189-409b-b0f2-db761eeacd9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_3669c78c-95c0-482a-ab6d-4cdb11da7cd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_782df29d-9515-4352-9658-0db8d5915c50" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_3669c78c-95c0-482a-ab6d-4cdb11da7cd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_f1969fc6-465f-49dc-a557-b9b902848142" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_782df29d-9515-4352-9658-0db8d5915c50" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_f1969fc6-465f-49dc-a557-b9b902848142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_dc8df07f-f4ac-40a2-9781-9bbdd14dbc3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ed29c358-d89f-4f28-a084-30c3a4f5ddea" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_dc8df07f-f4ac-40a2-9781-9bbdd14dbc3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_2e20304a-0570-40c1-b024-118a929d7cf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_dc8df07f-f4ac-40a2-9781-9bbdd14dbc3d" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_2e20304a-0570-40c1-b024-118a929d7cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6c83f1f6-48ad-4e40-8a97-1d05fb894d90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_2e20304a-0570-40c1-b024-118a929d7cf5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6c83f1f6-48ad-4e40-8a97-1d05fb894d90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_88749c5b-afd8-440b-a33d-ff8c2afed928" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_2e20304a-0570-40c1-b024-118a929d7cf5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_88749c5b-afd8-440b-a33d-ff8c2afed928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_5f360b09-3c4f-4434-b23c-e40afd42f819" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_2e20304a-0570-40c1-b024-118a929d7cf5" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_5f360b09-3c4f-4434-b23c-e40afd42f819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_1e366336-ae89-4068-85ca-5d96c04f994b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_2e20304a-0570-40c1-b024-118a929d7cf5" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_1e366336-ae89-4068-85ca-5d96c04f994b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a573415a-2927-4774-9131-814d558b13a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_2e20304a-0570-40c1-b024-118a929d7cf5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a573415a-2927-4774-9131-814d558b13a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5e05fa1b-fa10-4007-aaad-2e3af65988d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_2e20304a-0570-40c1-b024-118a929d7cf5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5e05fa1b-fa10-4007-aaad-2e3af65988d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/FairValueofFinancialInstruments" xlink:type="simple" xlink:href="cnmd-20210331.xsd#FairValueofFinancialInstruments"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/FairValueofFinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_9bed6b3a-9e71-45fd-9e7a-c84a9fb869f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesAndFairValueTextBlock_aafce7c9-efa3-42ae-9394-9fb5ed8bb644" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesAndFairValueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9bed6b3a-9e71-45fd-9e7a-c84a9fb869f2" xlink:to="loc_us-gaap_DerivativesAndFairValueTextBlock_aafce7c9-efa3-42ae-9394-9fb5ed8bb644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/FairValueofFinancialInstrumentsTables" xlink:type="simple" xlink:href="cnmd-20210331.xsd#FairValueofFinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/FairValueofFinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_33f7f4af-2d44-4d8f-9bb4-1abc99fd52c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_25ce4f11-c223-4c11-9f1c-c4eacaceeede" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_33f7f4af-2d44-4d8f-9bb4-1abc99fd52c0" xlink:to="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_25ce4f11-c223-4c11-9f1c-c4eacaceeede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_8c9ece8d-5f41-4fa6-9e6b-46b20e311cd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_33f7f4af-2d44-4d8f-9bb4-1abc99fd52c0" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_8c9ece8d-5f41-4fa6-9e6b-46b20e311cd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_31eb2dc7-411e-41ed-ac40-97f13e76e9b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_33f7f4af-2d44-4d8f-9bb4-1abc99fd52c0" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_31eb2dc7-411e-41ed-ac40-97f13e76e9b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_26808b7f-b41b-4b8e-8f5b-10cd5b303321" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_33f7f4af-2d44-4d8f-9bb4-1abc99fd52c0" xlink:to="loc_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_26808b7f-b41b-4b8e-8f5b-10cd5b303321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_FairValueofFinancialInstrumentsAbstract_4c49989b-a04c-4dee-9fd6-d1cd9e2bc21c" xlink:href="cnmd-20210331.xsd#cnmd_FairValueofFinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c1980f64-5a04-4d0c-9f27-59cb700d4849" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_FairValueofFinancialInstrumentsAbstract_4c49989b-a04c-4dee-9fd6-d1cd9e2bc21c" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c1980f64-5a04-4d0c-9f27-59cb700d4849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_9b70efdb-9484-43d4-bb4a-36db84553f55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c1980f64-5a04-4d0c-9f27-59cb700d4849" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_9b70efdb-9484-43d4-bb4a-36db84553f55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_506daa12-bd4b-4a52-92a4-e9569f15d50e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9b70efdb-9484-43d4-bb4a-36db84553f55" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_506daa12-bd4b-4a52-92a4-e9569f15d50e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_RevenuesMember_a1a8fb55-b81b-4f6b-98e2-b0f65764a3fb" xlink:href="cnmd-20210331.xsd#cnmd_RevenuesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_506daa12-bd4b-4a52-92a4-e9569f15d50e" xlink:to="loc_cnmd_RevenuesMember_a1a8fb55-b81b-4f6b-98e2-b0f65764a3fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_0fab1b4d-0f24-4fd3-915d-5c9bd5c30c80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_506daa12-bd4b-4a52-92a4-e9569f15d50e" xlink:to="loc_us-gaap_CostOfSalesMember_0fab1b4d-0f24-4fd3-915d-5c9bd5c30c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_85bbf873-cdf5-49ab-a8d2-99d1c3046315" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c1980f64-5a04-4d0c-9f27-59cb700d4849" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_85bbf873-cdf5-49ab-a8d2-99d1c3046315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_99d64f3b-9aa5-4003-aa5d-b70fdeca3ae3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_85bbf873-cdf5-49ab-a8d2-99d1c3046315" xlink:to="loc_us-gaap_Revenues_99d64f3b-9aa5-4003-aa5d-b70fdeca3ae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_050a2b1d-1721-4b09-9740-3f751bac3a58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_85bbf873-cdf5-49ab-a8d2-99d1c3046315" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_050a2b1d-1721-4b09-9740-3f751bac3a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_afefed04-829a-48de-b12a-dc4e48d86aeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_85bbf873-cdf5-49ab-a8d2-99d1c3046315" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_afefed04-829a-48de-b12a-dc4e48d86aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_03538d7f-5355-44d7-889a-11c51e31a08f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_85bbf873-cdf5-49ab-a8d2-99d1c3046315" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_03538d7f-5355-44d7-889a-11c51e31a08f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_4aabb35d-b711-4fb0-b806-c6e0df63de52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_85bbf873-cdf5-49ab-a8d2-99d1c3046315" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_4aabb35d-b711-4fb0-b806-c6e0df63de52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_7cf15ac6-88a7-40a0-82bf-1f9e9a471158" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_85bbf873-cdf5-49ab-a8d2-99d1c3046315" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_7cf15ac6-88a7-40a0-82bf-1f9e9a471158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_aa34c91f-9bd0-4b5e-b2a9-f53a96a576b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_85bbf873-cdf5-49ab-a8d2-99d1c3046315" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_aa34c91f-9bd0-4b5e-b2a9-f53a96a576b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_3686fa2a-9c58-4a55-94f1-c2f87b379c17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_85bbf873-cdf5-49ab-a8d2-99d1c3046315" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_3686fa2a-9c58-4a55-94f1-c2f87b379c17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_cb20b43a-a6ba-4bde-a590-6e2dd05a4c28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_7f99522b-b87a-44e3-9a66-14d386fbda9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cb20b43a-a6ba-4bde-a590-6e2dd05a4c28" xlink:to="loc_us-gaap_DerivativeTable_7f99522b-b87a-44e3-9a66-14d386fbda9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f8ccf21c-8ede-43fd-aaf6-9b53a581451e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_7f99522b-b87a-44e3-9a66-14d386fbda9c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f8ccf21c-8ede-43fd-aaf6-9b53a581451e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_26a26e54-2b2a-4b89-8684-1e7edd9e4bd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f8ccf21c-8ede-43fd-aaf6-9b53a581451e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_26a26e54-2b2a-4b89-8684-1e7edd9e4bd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_RevenuesMember_0692fec9-29c6-488a-9f59-4ef6e89cfe3f" xlink:href="cnmd-20210331.xsd#cnmd_RevenuesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_26a26e54-2b2a-4b89-8684-1e7edd9e4bd8" xlink:to="loc_cnmd_RevenuesMember_0692fec9-29c6-488a-9f59-4ef6e89cfe3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_7a52341b-8c19-47b5-9b86-b923abab0fef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_26a26e54-2b2a-4b89-8684-1e7edd9e4bd8" xlink:to="loc_us-gaap_CostOfSalesMember_7a52341b-8c19-47b5-9b86-b923abab0fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1b09d82d-9cd9-4447-94a1-b4ee733cc86c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_7f99522b-b87a-44e3-9a66-14d386fbda9c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1b09d82d-9cd9-4447-94a1-b4ee733cc86c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_37c869b8-7d4f-402c-8256-21d8606a2fea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1b09d82d-9cd9-4447-94a1-b4ee733cc86c" xlink:to="loc_us-gaap_EquityComponentDomain_37c869b8-7d4f-402c-8256-21d8606a2fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_e88c4c8e-94a2-4955-8d89-3e664f6225b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_37c869b8-7d4f-402c-8256-21d8606a2fea" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_e88c4c8e-94a2-4955-8d89-3e664f6225b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_9cb94b47-cc9f-44b7-87af-0c72b18b7cd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_7f99522b-b87a-44e3-9a66-14d386fbda9c" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_9cb94b47-cc9f-44b7-87af-0c72b18b7cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_e8d0ac9f-5ed5-46ae-a712-c6270086dfc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_9cb94b47-cc9f-44b7-87af-0c72b18b7cd8" xlink:to="loc_us-gaap_HedgingRelationshipDomain_e8d0ac9f-5ed5-46ae-a712-c6270086dfc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_e18cd682-49cd-4e50-8e4a-eb2c4825074c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_e8d0ac9f-5ed5-46ae-a712-c6270086dfc1" xlink:to="loc_us-gaap_CashFlowHedgingMember_e18cd682-49cd-4e50-8e4a-eb2c4825074c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_a35278f4-d5f0-4799-bf0a-4c5a94d52b25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_e8d0ac9f-5ed5-46ae-a712-c6270086dfc1" xlink:to="loc_us-gaap_NondesignatedMember_a35278f4-d5f0-4799-bf0a-4c5a94d52b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d6603c04-f2dc-4d8a-a50f-0db9867113e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_7f99522b-b87a-44e3-9a66-14d386fbda9c" xlink:to="loc_us-gaap_HedgingDesignationAxis_d6603c04-f2dc-4d8a-a50f-0db9867113e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_fcb30431-8d48-46e7-aef7-9044b57043e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_d6603c04-f2dc-4d8a-a50f-0db9867113e4" xlink:to="loc_us-gaap_HedgingDesignationDomain_fcb30431-8d48-46e7-aef7-9044b57043e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fdb615f6-3483-469d-83f6-4ed0f41d1e7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_fcb30431-8d48-46e7-aef7-9044b57043e2" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fdb615f6-3483-469d-83f6-4ed0f41d1e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_85cac718-8362-4dcb-a6bd-c575969b4cbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_fcb30431-8d48-46e7-aef7-9044b57043e2" xlink:to="loc_us-gaap_NondesignatedMember_85cac718-8362-4dcb-a6bd-c575969b4cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f92854bd-f7e1-440f-af8b-59dcab16065c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_7f99522b-b87a-44e3-9a66-14d386fbda9c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f92854bd-f7e1-440f-af8b-59dcab16065c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6fcb8367-7667-4c10-8860-25877d9b9d1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f92854bd-f7e1-440f-af8b-59dcab16065c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6fcb8367-7667-4c10-8860-25877d9b9d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_fdd75179-0e5b-4840-a6e3-7d8f9af5c9d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6fcb8367-7667-4c10-8860-25877d9b9d1c" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_fdd75179-0e5b-4840-a6e3-7d8f9af5c9d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_acb0de9a-aa59-4d5e-a0e0-4c43a356c2ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_7f99522b-b87a-44e3-9a66-14d386fbda9c" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_acb0de9a-aa59-4d5e-a0e0-4c43a356c2ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_305de81e-f8dc-40d2-a6c3-fcdea9a943e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_acb0de9a-aa59-4d5e-a0e0-4c43a356c2ca" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_305de81e-f8dc-40d2-a6c3-fcdea9a943e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_856a8e91-7a0f-4a21-a95a-92f0b9965956" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_305de81e-f8dc-40d2-a6c3-fcdea9a943e8" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_856a8e91-7a0f-4a21-a95a-92f0b9965956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_b4d26635-f50a-4b7e-bf35-13092d8bd4a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_305de81e-f8dc-40d2-a6c3-fcdea9a943e8" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_b4d26635-f50a-4b7e-bf35-13092d8bd4a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_0c767077-0ebe-408c-bc05-b45734927b6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_305de81e-f8dc-40d2-a6c3-fcdea9a943e8" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_0c767077-0ebe-408c-bc05-b45734927b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_bca1acb6-6d44-46df-93a4-1e652c30be64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_7f99522b-b87a-44e3-9a66-14d386fbda9c" xlink:to="loc_us-gaap_DerivativeLineItems_bca1acb6-6d44-46df-93a4-1e652c30be64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_2cf98200-0e7f-48f1-ae12-a648dfad2387" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_bca1acb6-6d44-46df-93a4-1e652c30be64" xlink:to="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_2cf98200-0e7f-48f1-ae12-a648dfad2387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_4116987b-d035-4778-9249-28a74c4ad26c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_bca1acb6-6d44-46df-93a4-1e652c30be64" xlink:to="loc_us-gaap_DerivativeNotionalAmount_4116987b-d035-4778-9249-28a74c4ad26c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_293fcc7d-a68e-4f06-86ed-f665d52e5375" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_bca1acb6-6d44-46df-93a4-1e652c30be64" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_293fcc7d-a68e-4f06-86ed-f665d52e5375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_4c848820-5743-4aea-8b36-1b682c836e5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_bca1acb6-6d44-46df-93a4-1e652c30be64" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_4c848820-5743-4aea-8b36-1b682c836e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_ebc68bae-1757-4d70-b5b2-30d8a793df64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_bca1acb6-6d44-46df-93a4-1e652c30be64" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_ebc68bae-1757-4d70-b5b2-30d8a793df64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract_edb3e7a1-5b2f-4041-a949-9fe08f99a17a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_bca1acb6-6d44-46df-93a4-1e652c30be64" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract_edb3e7a1-5b2f-4041-a949-9fe08f99a17a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_fd2122c4-74fb-48b8-a2bc-90d98ec81e89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract_edb3e7a1-5b2f-4041-a949-9fe08f99a17a" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_fd2122c4-74fb-48b8-a2bc-90d98ec81e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_f805b5f0-7303-4064-b285-b93c3a5e7e75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract_edb3e7a1-5b2f-4041-a949-9fe08f99a17a" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_f805b5f0-7303-4064-b285-b93c3a5e7e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_af988383-4a6d-47cc-b38d-874c4fd209ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract_edb3e7a1-5b2f-4041-a949-9fe08f99a17a" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_af988383-4a6d-47cc-b38d-874c4fd209ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/Inventories" xlink:type="simple" xlink:href="cnmd-20210331.xsd#Inventories"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/Inventories" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_33cd63ff-5b13-4421-8b36-fe8b6cc2b825" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_caf82712-5c25-4b7e-b70d-5f1f34a1de04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_33cd63ff-5b13-4421-8b36-fe8b6cc2b825" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_caf82712-5c25-4b7e-b70d-5f1f34a1de04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/InventoriesTables" xlink:type="simple" xlink:href="cnmd-20210331.xsd#InventoriesTables"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/InventoriesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_c7ba4d96-1a2a-40b7-9fdf-b12e4313fb7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_af37f750-ca44-493e-b22b-198a88ea13d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_c7ba4d96-1a2a-40b7-9fdf-b12e4313fb7c" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_af37f750-ca44-493e-b22b-198a88ea13d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/InventoriesDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#InventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_6876349c-0f06-4185-b8cb-5c9576e10045" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_c0f3ba9e-70dd-48a9-9c22-3d81ea6ace72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_6876349c-0f06-4185-b8cb-5c9576e10045" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_c0f3ba9e-70dd-48a9-9c22-3d81ea6ace72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_1c8bab6f-9d73-48e3-956c-2d5876c4346c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_6876349c-0f06-4185-b8cb-5c9576e10045" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_1c8bab6f-9d73-48e3-956c-2d5876c4346c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_e39779e9-6e3b-4fa9-9b59-68d1503f40bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_6876349c-0f06-4185-b8cb-5c9576e10045" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_e39779e9-6e3b-4fa9-9b59-68d1503f40bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_50555fa2-ff4c-4b92-97ca-73758d2dbe19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_6876349c-0f06-4185-b8cb-5c9576e10045" xlink:to="loc_us-gaap_InventoryNet_50555fa2-ff4c-4b92-97ca-73758d2dbe19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/EarningsPerShare" xlink:type="simple" xlink:href="cnmd-20210331.xsd#EarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a76c0df0-bc0e-4849-a81c-3ebacbdbac90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_478d9d35-7aad-4809-a9bc-f84f0b6b277f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a76c0df0-bc0e-4849-a81c-3ebacbdbac90" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_478d9d35-7aad-4809-a9bc-f84f0b6b277f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="cnmd-20210331.xsd#EarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_dc79194e-3ce7-4e76-a438-686b2fd4d456" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_516c2c00-a426-4866-aa0c-9e59a19483f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_dc79194e-3ce7-4e76-a438-686b2fd4d456" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_516c2c00-a426-4866-aa0c-9e59a19483f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#EarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/EarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_4ce1b4e0-f840-4aed-a9e6-95e67cef3104" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_178bc2f5-0fe2-4df4-a0af-00d01ac4280e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4ce1b4e0-f840-4aed-a9e6-95e67cef3104" xlink:to="loc_us-gaap_NetIncomeLoss_178bc2f5-0fe2-4df4-a0af-00d01ac4280e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9e5fa1a5-e7ba-4d58-b11e-edfd27cb8af2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4ce1b4e0-f840-4aed-a9e6-95e67cef3104" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9e5fa1a5-e7ba-4d58-b11e-edfd27cb8af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_d9f2b6c8-c974-4542-a1db-620da08b60b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4ce1b4e0-f840-4aed-a9e6-95e67cef3104" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_d9f2b6c8-c974-4542-a1db-620da08b60b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_554a60fd-248f-42af-bf51-8ec59db2cf00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4ce1b4e0-f840-4aed-a9e6-95e67cef3104" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_554a60fd-248f-42af-bf51-8ec59db2cf00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_1d383840-b7ee-4b5c-9dc4-78a547162cf2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4ce1b4e0-f840-4aed-a9e6-95e67cef3104" xlink:to="loc_us-gaap_EarningsPerShareBasic_1d383840-b7ee-4b5c-9dc4-78a547162cf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_bca83aac-8867-4256-95eb-b407b6d9df83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4ce1b4e0-f840-4aed-a9e6-95e67cef3104" xlink:to="loc_us-gaap_EarningsPerShareDiluted_bca83aac-8867-4256-95eb-b407b6d9df83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3f2bd2e1-29a7-4311-90cb-177f4f5e7844" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4ce1b4e0-f840-4aed-a9e6-95e67cef3104" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3f2bd2e1-29a7-4311-90cb-177f4f5e7844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_d83559b6-d5e8-4d4e-b10d-acb26329b5ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4ce1b4e0-f840-4aed-a9e6-95e67cef3104" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_d83559b6-d5e8-4d4e-b10d-acb26329b5ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_48d0d132-c90b-43b7-87db-2de85f55c677" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4ce1b4e0-f840-4aed-a9e6-95e67cef3104" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_48d0d132-c90b-43b7-87db-2de85f55c677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/EarningsPerShareConvertibleNotesDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#EarningsPerShareConvertibleNotesDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/EarningsPerShareConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_33cba610-0da0-4f8c-97b0-04832c5276f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_43d77cc0-7e53-4083-aa35-59b309f64fb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_33cba610-0da0-4f8c-97b0-04832c5276f0" xlink:to="loc_us-gaap_DebtInstrumentTable_43d77cc0-7e53-4083-aa35-59b309f64fb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_0de96bb8-68e7-46be-b54e-25253323d660" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_43d77cc0-7e53-4083-aa35-59b309f64fb1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_0de96bb8-68e7-46be-b54e-25253323d660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d28f55b0-9cbb-4f33-b376-c8f15f7a1d4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0de96bb8-68e7-46be-b54e-25253323d660" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d28f55b0-9cbb-4f33-b376-c8f15f7a1d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_fdd5adcb-5297-447c-bfa2-4741308d6918" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d28f55b0-9cbb-4f33-b376-c8f15f7a1d4d" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_fdd5adcb-5297-447c-bfa2-4741308d6918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cd49fdd4-f03b-44fd-86aa-7f3a517d02c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_43d77cc0-7e53-4083-aa35-59b309f64fb1" xlink:to="loc_us-gaap_DebtInstrumentAxis_cd49fdd4-f03b-44fd-86aa-7f3a517d02c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_499a4ed4-3818-46a8-824e-6a25f072a12c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_cd49fdd4-f03b-44fd-86aa-7f3a517d02c9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_499a4ed4-3818-46a8-824e-6a25f072a12c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_A2.625PercentConvertibleNotesDue2024Member_5509b5ec-c3f6-4642-a590-b35a8a99d0eb" xlink:href="cnmd-20210331.xsd#cnmd_A2.625PercentConvertibleNotesDue2024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_499a4ed4-3818-46a8-824e-6a25f072a12c" xlink:to="loc_cnmd_A2.625PercentConvertibleNotesDue2024Member_5509b5ec-c3f6-4642-a590-b35a8a99d0eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_IndexedTransactionTypeAxis_25059adb-b1fa-4fb5-b458-0bef46b17272" xlink:href="cnmd-20210331.xsd#cnmd_IndexedTransactionTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_43d77cc0-7e53-4083-aa35-59b309f64fb1" xlink:to="loc_cnmd_IndexedTransactionTypeAxis_25059adb-b1fa-4fb5-b458-0bef46b17272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_IndexedTransactionTypeDomain_08a5cb6a-e8ed-4ed5-84d1-e8ebf5e53b48" xlink:href="cnmd-20210331.xsd#cnmd_IndexedTransactionTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_IndexedTransactionTypeAxis_25059adb-b1fa-4fb5-b458-0bef46b17272" xlink:to="loc_cnmd_IndexedTransactionTypeDomain_08a5cb6a-e8ed-4ed5-84d1-e8ebf5e53b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_HedgeTransactionsMember_c8021a93-1e75-4bce-a7e7-b15267af7080" xlink:href="cnmd-20210331.xsd#cnmd_HedgeTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_IndexedTransactionTypeDomain_08a5cb6a-e8ed-4ed5-84d1-e8ebf5e53b48" xlink:to="loc_cnmd_HedgeTransactionsMember_c8021a93-1e75-4bce-a7e7-b15267af7080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_WarrantTransactionsMember_02170cfa-d821-45ea-bca0-11ceed66b132" xlink:href="cnmd-20210331.xsd#cnmd_WarrantTransactionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_IndexedTransactionTypeDomain_08a5cb6a-e8ed-4ed5-84d1-e8ebf5e53b48" xlink:to="loc_cnmd_WarrantTransactionsMember_02170cfa-d821-45ea-bca0-11ceed66b132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_56a04bd9-c96e-4516-9fa8-e714468fae45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_43d77cc0-7e53-4083-aa35-59b309f64fb1" xlink:to="loc_us-gaap_DebtInstrumentLineItems_56a04bd9-c96e-4516-9fa8-e714468fae45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_7a136b81-5559-4fe6-9d51-57b3c52c6234" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_56a04bd9-c96e-4516-9fa8-e714468fae45" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_7a136b81-5559-4fe6-9d51-57b3c52c6234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_200a76aa-bec2-48a1-8486-fc61e44b3151" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_56a04bd9-c96e-4516-9fa8-e714468fae45" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_200a76aa-bec2-48a1-8486-fc61e44b3151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_83c90652-3324-4348-a259-8345cb23f3d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityStrikePrice1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_56a04bd9-c96e-4516-9fa8-e714468fae45" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_83c90652-3324-4348-a259-8345cb23f3d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="cnmd-20210331.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8b2a2fdc-4192-48f9-a39b-e1e451729699" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_bb9fbcae-41f4-4c5f-a560-408f2861771e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8b2a2fdc-4192-48f9-a39b-e1e451729699" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_bb9fbcae-41f4-4c5f-a560-408f2861771e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="simple" xlink:href="cnmd-20210331.xsd#GoodwillandOtherIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f67b5834-4e67-4008-8157-97b16f1238fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_d00c1414-6fef-4747-bf27-c63ced05e864" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f67b5834-4e67-4008-8157-97b16f1238fe" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_d00c1414-6fef-4747-bf27-c63ced05e864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_11f91a75-7754-4ab0-a910-da87489da75f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f67b5834-4e67-4008-8157-97b16f1238fe" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_11f91a75-7754-4ab0-a910-da87489da75f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_53942767-575d-476c-b2eb-55d064d5d5c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f67b5834-4e67-4008-8157-97b16f1238fe" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_53942767-575d-476c-b2eb-55d064d5d5c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_bc4ac59e-c564-450b-9659-f8755bd7345e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f67b5834-4e67-4008-8157-97b16f1238fe" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_bc4ac59e-c564-450b-9659-f8755bd7345e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#GoodwillandOtherIntangibleAssetsGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_88337097-d2f3-40b9-a7ad-dd2fbda1854a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_02e63b52-9094-49a9-a3d4-cb96786658a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_88337097-d2f3-40b9-a7ad-dd2fbda1854a" xlink:to="loc_us-gaap_GoodwillRollForward_02e63b52-9094-49a9-a3d4-cb96786658a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_148dd906-52d8-4cab-8c4f-0fb8a80f3c79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_02e63b52-9094-49a9-a3d4-cb96786658a0" xlink:to="loc_us-gaap_Goodwill_148dd906-52d8-4cab-8c4f-0fb8a80f3c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_9753c340-e415-40a3-b7ad-2e72ed199b35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_02e63b52-9094-49a9-a3d4-cb96786658a0" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_9753c340-e415-40a3-b7ad-2e72ed199b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f809dbe2-5597-4d41-8c8e-054162121dbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_02e63b52-9094-49a9-a3d4-cb96786658a0" xlink:to="loc_us-gaap_Goodwill_f809dbe2-5597-4d41-8c8e-054162121dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_75c92cf5-aa85-4b78-ab86-ed870deccfec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable_e5562308-e8e0-47a0-b6ef-92df74854e1b" xlink:href="cnmd-20210331.xsd#cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_75c92cf5-aa85-4b78-ab86-ed870deccfec" xlink:to="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable_e5562308-e8e0-47a0-b6ef-92df74854e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9d449cbe-3b73-44b0-bb11-9eaa61dcc426" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable_e5562308-e8e0-47a0-b6ef-92df74854e1b" xlink:to="loc_srt_RangeAxis_9d449cbe-3b73-44b0-bb11-9eaa61dcc426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8cb1be3d-5c0d-41c6-a981-b71ebb160ff3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_9d449cbe-3b73-44b0-bb11-9eaa61dcc426" xlink:to="loc_srt_RangeMember_8cb1be3d-5c0d-41c6-a981-b71ebb160ff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_eed44636-ce50-430a-9f1b-35d58847bd03" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8cb1be3d-5c0d-41c6-a981-b71ebb160ff3" xlink:to="loc_srt_WeightedAverageMember_eed44636-ce50-430a-9f1b-35d58847bd03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4b5e2dae-b1b7-4c0f-bf14-f99bcb58a5d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable_e5562308-e8e0-47a0-b6ef-92df74854e1b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4b5e2dae-b1b7-4c0f-bf14-f99bcb58a5d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a806f469-2a88-4e75-9c9d-87fb13d6eafb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4b5e2dae-b1b7-4c0f-bf14-f99bcb58a5d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a806f469-2a88-4e75-9c9d-87fb13d6eafb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_CustomerandDistributorRelationshipsMember_2cc62a0d-8976-4cb3-b54c-f7d16b12a692" xlink:href="cnmd-20210331.xsd#cnmd_CustomerandDistributorRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a806f469-2a88-4e75-9c9d-87fb13d6eafb" xlink:to="loc_cnmd_CustomerandDistributorRelationshipsMember_2cc62a0d-8976-4cb3-b54c-f7d16b12a692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_SalesrepresentationmarketingandpromotionalrightsMember_8c04eb99-e3e9-47b5-a587-fbb976e57131" xlink:href="cnmd-20210331.xsd#cnmd_SalesrepresentationmarketingandpromotionalrightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a806f469-2a88-4e75-9c9d-87fb13d6eafb" xlink:to="loc_cnmd_SalesrepresentationmarketingandpromotionalrightsMember_8c04eb99-e3e9-47b5-a587-fbb976e57131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_PatentsAndOtherIntangibleAssetsMember_75be3a68-e263-4f67-a849-3b75b76a2812" xlink:href="cnmd-20210331.xsd#cnmd_PatentsAndOtherIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a806f469-2a88-4e75-9c9d-87fb13d6eafb" xlink:to="loc_cnmd_PatentsAndOtherIntangibleAssetsMember_75be3a68-e263-4f67-a849-3b75b76a2812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_dd14b5f1-b9c6-420b-bcc2-f05c6ab9d9bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a806f469-2a88-4e75-9c9d-87fb13d6eafb" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_dd14b5f1-b9c6-420b-bcc2-f05c6ab9d9bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_485b965a-8e6d-4f7e-bc4e-9f813b8c69fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable_e5562308-e8e0-47a0-b6ef-92df74854e1b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_485b965a-8e6d-4f7e-bc4e-9f813b8c69fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_888193a7-e2ed-4e8c-a046-52e921734145" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_485b965a-8e6d-4f7e-bc4e-9f813b8c69fa" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_888193a7-e2ed-4e8c-a046-52e921734145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_8f6cf15d-ae72-4b52-8bb0-9add9abbd493" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_888193a7-e2ed-4e8c-a046-52e921734145" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_8f6cf15d-ae72-4b52-8bb0-9add9abbd493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_825a90d0-149f-4c65-b4fd-e9b8e17fba49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable_e5562308-e8e0-47a0-b6ef-92df74854e1b" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_825a90d0-149f-4c65-b4fd-e9b8e17fba49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c5d6efe8-f425-4d3c-9823-2a446bca7a40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_825a90d0-149f-4c65-b4fd-e9b8e17fba49" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c5d6efe8-f425-4d3c-9823-2a446bca7a40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ExpenseMember_39878a9d-2d19-4b50-a6bd-585b0de02f01" xlink:href="cnmd-20210331.xsd#cnmd_ExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c5d6efe8-f425-4d3c-9823-2a446bca7a40" xlink:to="loc_cnmd_ExpenseMember_39878a9d-2d19-4b50-a6bd-585b0de02f01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ReductionofRevenueMember_b07cc332-6db9-4c64-b6a7-1e88936020f8" xlink:href="cnmd-20210331.xsd#cnmd_ReductionofRevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c5d6efe8-f425-4d3c-9823-2a446bca7a40" xlink:to="loc_cnmd_ReductionofRevenueMember_b07cc332-6db9-4c64-b6a7-1e88936020f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_b9353f0d-5cce-45d7-92ac-2ee9bc1214a2" xlink:href="cnmd-20210331.xsd#cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable_e5562308-e8e0-47a0-b6ef-92df74854e1b" xlink:to="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_b9353f0d-5cce-45d7-92ac-2ee9bc1214a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_f5117478-dbc8-4f8f-9510-1daefa0be2c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_b9353f0d-5cce-45d7-92ac-2ee9bc1214a2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_f5117478-dbc8-4f8f-9510-1daefa0be2c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_3f0aa4ba-e066-4faf-b264-16d80692cd45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_b9353f0d-5cce-45d7-92ac-2ee9bc1214a2" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_3f0aa4ba-e066-4faf-b264-16d80692cd45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1e380f6a-f281-456d-adcd-b42d1d7de06a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_b9353f0d-5cce-45d7-92ac-2ee9bc1214a2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1e380f6a-f281-456d-adcd-b42d1d7de06a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_fad07015-ddc5-40e9-ae3e-76c0d5749764" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_b9353f0d-5cce-45d7-92ac-2ee9bc1214a2" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_fad07015-ddc5-40e9-ae3e-76c0d5749764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1ef1f423-ffab-46cf-8d9f-9c8c599b10e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_b9353f0d-5cce-45d7-92ac-2ee9bc1214a2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1ef1f423-ffab-46cf-8d9f-9c8c599b10e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_d914954e-9ede-4eb1-aa64-48c48f916457" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_b9353f0d-5cce-45d7-92ac-2ee9bc1214a2" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_d914954e-9ede-4eb1-aa64-48c48f916457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AssetAcquisitionContingentConsiderationLiability_472a2d21-4a16-4efb-8cc1-b7efdcdb4f60" xlink:href="cnmd-20210331.xsd#cnmd_AssetAcquisitionContingentConsiderationLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_b9353f0d-5cce-45d7-92ac-2ee9bc1214a2" xlink:to="loc_cnmd_AssetAcquisitionContingentConsiderationLiability_472a2d21-4a16-4efb-8cc1-b7efdcdb4f60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_ccf3f040-8661-4abe-b45e-740d182a0fd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_b9353f0d-5cce-45d7-92ac-2ee9bc1214a2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_ccf3f040-8661-4abe-b45e-740d182a0fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_c703eb07-abbe-40a6-8f19-8a80fc86052d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_ccf3f040-8661-4abe-b45e-740d182a0fd2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_c703eb07-abbe-40a6-8f19-8a80fc86052d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_849a81eb-0947-45f9-8d74-1329bbf95f0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_ccf3f040-8661-4abe-b45e-740d182a0fd2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_849a81eb-0947-45f9-8d74-1329bbf95f0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_ccd7b745-cb45-4522-bfeb-5bc450bbb9dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_ccf3f040-8661-4abe-b45e-740d182a0fd2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_ccd7b745-cb45-4522-bfeb-5bc450bbb9dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_046b5ac0-7c28-4846-8ca1-3a17a056ef9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_ccf3f040-8661-4abe-b45e-740d182a0fd2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_046b5ac0-7c28-4846-8ca1-3a17a056ef9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_dcbed661-0113-405b-b185-85169861aa2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_ccf3f040-8661-4abe-b45e-740d182a0fd2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_dcbed661-0113-405b-b185-85169861aa2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_023b610b-ab9d-4f7f-b275-9c78244674e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_ccf3f040-8661-4abe-b45e-740d182a0fd2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_023b610b-ab9d-4f7f-b275-9c78244674e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/LongTermDebt" xlink:type="simple" xlink:href="cnmd-20210331.xsd#LongTermDebt"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/LongTermDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_38ace4da-2cab-4717-912c-d5c247869084" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_6217ecef-bbca-400f-bd09-05e6c81b7d8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_38ace4da-2cab-4717-912c-d5c247869084" xlink:to="loc_us-gaap_LongTermDebtTextBlock_6217ecef-bbca-400f-bd09-05e6c81b7d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="cnmd-20210331.xsd#LongTermDebtTables"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/LongTermDebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ee8fc7c6-c12e-4473-8109-8d3106b2761c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_7685c821-362f-4d18-8cef-c6ac65d9662b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ee8fc7c6-c12e-4473-8109-8d3106b2761c" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_7685c821-362f-4d18-8cef-c6ac65d9662b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_d5286a2a-7e14-468a-96d3-bfeaef562f55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ee8fc7c6-c12e-4473-8109-8d3106b2761c" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_d5286a2a-7e14-468a-96d3-bfeaef562f55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/LongTermDebtDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#LongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/LongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b8d76439-a89d-42b1-ba61-d22425f2cc0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_955c44ba-63c1-4e7a-af84-b9b14aaaa1d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b8d76439-a89d-42b1-ba61-d22425f2cc0c" xlink:to="loc_us-gaap_DebtInstrumentTable_955c44ba-63c1-4e7a-af84-b9b14aaaa1d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_03e88719-6c38-43bd-8d1a-79a8f1d6a6b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_955c44ba-63c1-4e7a-af84-b9b14aaaa1d7" xlink:to="loc_us-gaap_DebtInstrumentAxis_03e88719-6c38-43bd-8d1a-79a8f1d6a6b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d6cba1d6-41bf-4b97-8553-5a3f7eba9c9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_03e88719-6c38-43bd-8d1a-79a8f1d6a6b9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d6cba1d6-41bf-4b97-8553-5a3f7eba9c9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AmendedAndRestatedSeniorCreditAgreementMember_8431f597-3782-4462-b6a0-8ce652baf092" xlink:href="cnmd-20210331.xsd#cnmd_AmendedAndRestatedSeniorCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d6cba1d6-41bf-4b97-8553-5a3f7eba9c9e" xlink:to="loc_cnmd_AmendedAndRestatedSeniorCreditAgreementMember_8431f597-3782-4462-b6a0-8ce652baf092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a20a8008-0196-4615-b7e0-b26c1ae9a016" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_955c44ba-63c1-4e7a-af84-b9b14aaaa1d7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a20a8008-0196-4615-b7e0-b26c1ae9a016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a955ed58-95d2-4c50-86d5-b5e4be9a496f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a20a8008-0196-4615-b7e0-b26c1ae9a016" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a955ed58-95d2-4c50-86d5-b5e4be9a496f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_e5ba77cf-d3d2-4a4f-8608-2adfcb288579" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a955ed58-95d2-4c50-86d5-b5e4be9a496f" xlink:to="loc_us-gaap_LineOfCreditMember_e5ba77cf-d3d2-4a4f-8608-2adfcb288579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_89d7e2a2-7209-43de-aa64-2ae6fdeb4d72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a955ed58-95d2-4c50-86d5-b5e4be9a496f" xlink:to="loc_us-gaap_LoansPayableMember_89d7e2a2-7209-43de-aa64-2ae6fdeb4d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_1b78aa27-807f-401b-96c6-0b5e2bffad39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a955ed58-95d2-4c50-86d5-b5e4be9a496f" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_1b78aa27-807f-401b-96c6-0b5e2bffad39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_7c9db74c-fbd4-4bed-bd61-6ec2c67b803e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_955c44ba-63c1-4e7a-af84-b9b14aaaa1d7" xlink:to="loc_us-gaap_DebtInstrumentLineItems_7c9db74c-fbd4-4bed-bd61-6ec2c67b803e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_40eb519b-3d4e-4766-87e0-d63ce7bd8496" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7c9db74c-fbd4-4bed-bd61-6ec2c67b803e" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_40eb519b-3d4e-4766-87e0-d63ce7bd8496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_d8388330-d7dd-4b1e-8bed-a3a8dfa0edb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7c9db74c-fbd4-4bed-bd61-6ec2c67b803e" xlink:to="loc_us-gaap_LongTermDebt_d8388330-d7dd-4b1e-8bed-a3a8dfa0edb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebt_ed79770f-86a0-460b-9c94-721b8f1db324" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7c9db74c-fbd4-4bed-bd61-6ec2c67b803e" xlink:to="loc_us-gaap_ConvertibleDebt_ed79770f-86a0-460b-9c94-721b8f1db324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_5fdcdfb3-d28d-46cc-8e67-10f0658f6905" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7c9db74c-fbd4-4bed-bd61-6ec2c67b803e" xlink:to="loc_us-gaap_FinanceLeaseLiability_5fdcdfb3-d28d-46cc-8e67-10f0658f6905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_58a3f238-ec6b-4c50-89f8-2648d42fd0e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7c9db74c-fbd4-4bed-bd61-6ec2c67b803e" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_58a3f238-ec6b-4c50-89f8-2648d42fd0e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_7b96d3e0-2787-4313-b95a-d0891da0ba29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7c9db74c-fbd4-4bed-bd61-6ec2c67b803e" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_7b96d3e0-2787-4313-b95a-d0891da0ba29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_63603c8f-477e-4e82-9b19-22288ff51329" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7c9db74c-fbd4-4bed-bd61-6ec2c67b803e" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_63603c8f-477e-4e82-9b19-22288ff51329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_fa32f341-c87b-4094-9e90-798421995ec2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7c9db74c-fbd4-4bed-bd61-6ec2c67b803e" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_fa32f341-c87b-4094-9e90-798421995ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#LongTermDebtAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_7bc54dfb-d771-4838-8b6c-138653483435" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b13b8073-729c-45c0-bf3c-7ffc50f03cc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_7bc54dfb-d771-4838-8b6c-138653483435" xlink:to="loc_us-gaap_DebtInstrumentTable_b13b8073-729c-45c0-bf3c-7ffc50f03cc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeAxis_a7cebdee-dd6b-43ae-be01-cd710346d836" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b13b8073-729c-45c0-bf3c-7ffc50f03cc9" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeAxis_a7cebdee-dd6b-43ae-be01-cd710346d836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_3aa13307-2ed7-46d8-a507-0bbe4291e379" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeAxis_a7cebdee-dd6b-43ae-be01-cd710346d836" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_3aa13307-2ed7-46d8-a507-0bbe4291e379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CallOptionMember_129041c4-7de7-4bca-9d6c-ca84ad499bf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CallOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_3aa13307-2ed7-46d8-a507-0bbe4291e379" xlink:to="loc_us-gaap_CallOptionMember_129041c4-7de7-4bca-9d6c-ca84ad499bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_VariableRateBasisAxis_8a134083-9a11-4ebf-8131-4203d9a20c08" xlink:href="cnmd-20210331.xsd#cnmd_VariableRateBasisAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b13b8073-729c-45c0-bf3c-7ffc50f03cc9" xlink:to="loc_cnmd_VariableRateBasisAxis_8a134083-9a11-4ebf-8131-4203d9a20c08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_VariableRateBasisDomain_8cc28fdf-bb20-4d7a-a92c-d0da4a7d1370" xlink:href="cnmd-20210331.xsd#cnmd_VariableRateBasisDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_VariableRateBasisAxis_8a134083-9a11-4ebf-8131-4203d9a20c08" xlink:to="loc_cnmd_VariableRateBasisDomain_8cc28fdf-bb20-4d7a-a92c-d0da4a7d1370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_c0485516-29c3-4852-9d7f-626304ce0201" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_VariableRateBasisDomain_8cc28fdf-bb20-4d7a-a92c-d0da4a7d1370" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_c0485516-29c3-4852-9d7f-626304ce0201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_78ffbf6a-1ae8-45b4-af1e-7d6980e6d168" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_VariableRateBasisDomain_8cc28fdf-bb20-4d7a-a92c-d0da4a7d1370" xlink:to="loc_us-gaap_EurodollarMember_78ffbf6a-1ae8-45b4-af1e-7d6980e6d168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_aeab7414-3d3c-4ccb-bcfc-f459e24b258c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_VariableRateBasisDomain_8cc28fdf-bb20-4d7a-a92c-d0da4a7d1370" xlink:to="loc_us-gaap_BaseRateMember_aeab7414-3d3c-4ccb-bcfc-f459e24b258c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5eb82b14-bb10-4907-b82e-6bc7a9d2151a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b13b8073-729c-45c0-bf3c-7ffc50f03cc9" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5eb82b14-bb10-4907-b82e-6bc7a9d2151a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3af28c16-1090-4884-935a-b8e4ccbf4ddb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5eb82b14-bb10-4907-b82e-6bc7a9d2151a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3af28c16-1090-4884-935a-b8e4ccbf4ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_b714ea43-c257-49ea-b199-b8024b11caae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3af28c16-1090-4884-935a-b8e4ccbf4ddb" xlink:to="loc_us-gaap_LoansPayableMember_b714ea43-c257-49ea-b199-b8024b11caae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_85df9471-eb98-4a3a-89e4-8543ef0658ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3af28c16-1090-4884-935a-b8e4ccbf4ddb" xlink:to="loc_us-gaap_LineOfCreditMember_85df9471-eb98-4a3a-89e4-8543ef0658ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_6aa682e9-3d61-4980-9a12-0a68a0e42f4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3af28c16-1090-4884-935a-b8e4ccbf4ddb" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_6aa682e9-3d61-4980-9a12-0a68a0e42f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_e16aa461-f869-4117-bf2e-0d6109106e21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3af28c16-1090-4884-935a-b8e4ccbf4ddb" xlink:to="loc_us-gaap_LongTermDebtMember_e16aa461-f869-4117-bf2e-0d6109106e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_603481fe-3b5f-4f74-b573-9548f4c76e66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b13b8073-729c-45c0-bf3c-7ffc50f03cc9" xlink:to="loc_us-gaap_DebtInstrumentAxis_603481fe-3b5f-4f74-b573-9548f4c76e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b0f0b579-9069-4664-b8be-f5ae94914be9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_603481fe-3b5f-4f74-b573-9548f4c76e66" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b0f0b579-9069-4664-b8be-f5ae94914be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AmendedAndRestatedSeniorCreditAgreementMember_9831220a-8a6b-45e8-9dde-e7ae38c3e8fa" xlink:href="cnmd-20210331.xsd#cnmd_AmendedAndRestatedSeniorCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b0f0b579-9069-4664-b8be-f5ae94914be9" xlink:to="loc_cnmd_AmendedAndRestatedSeniorCreditAgreementMember_9831220a-8a6b-45e8-9dde-e7ae38c3e8fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_A2.625PercentConvertibleNotesDue2024Member_352cf3b4-e3c3-41a5-a3a9-a3e88c9b9222" xlink:href="cnmd-20210331.xsd#cnmd_A2.625PercentConvertibleNotesDue2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b0f0b579-9069-4664-b8be-f5ae94914be9" xlink:to="loc_cnmd_A2.625PercentConvertibleNotesDue2024Member_352cf3b4-e3c3-41a5-a3a9-a3e88c9b9222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_2919d7e0-2c3f-431f-ae55-77440d7b3efd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b13b8073-729c-45c0-bf3c-7ffc50f03cc9" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_2919d7e0-2c3f-431f-ae55-77440d7b3efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_3d639c42-47af-4c81-8f6c-425545597cc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_2919d7e0-2c3f-431f-ae55-77440d7b3efd" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_3d639c42-47af-4c81-8f6c-425545597cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_IndexedTransactionTypeAxis_a4dc3543-e83d-4476-902a-70ee26c33363" xlink:href="cnmd-20210331.xsd#cnmd_IndexedTransactionTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b13b8073-729c-45c0-bf3c-7ffc50f03cc9" xlink:to="loc_cnmd_IndexedTransactionTypeAxis_a4dc3543-e83d-4476-902a-70ee26c33363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_IndexedTransactionTypeDomain_d07fb9fe-a7ce-41dd-a90b-99c7b01a258c" xlink:href="cnmd-20210331.xsd#cnmd_IndexedTransactionTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_IndexedTransactionTypeAxis_a4dc3543-e83d-4476-902a-70ee26c33363" xlink:to="loc_cnmd_IndexedTransactionTypeDomain_d07fb9fe-a7ce-41dd-a90b-99c7b01a258c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_HedgeTransactionsMember_f3af6e41-e808-4cdc-925d-22dc3062c52d" xlink:href="cnmd-20210331.xsd#cnmd_HedgeTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_IndexedTransactionTypeDomain_d07fb9fe-a7ce-41dd-a90b-99c7b01a258c" xlink:to="loc_cnmd_HedgeTransactionsMember_f3af6e41-e808-4cdc-925d-22dc3062c52d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b13b8073-729c-45c0-bf3c-7ffc50f03cc9" xlink:to="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_a463ea8f-cb6b-4f9b-b61f-00b4c94879f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_a463ea8f-cb6b-4f9b-b61f-00b4c94879f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_7456a9d7-da68-4907-bc1e-f0fdc8f713ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_7456a9d7-da68-4907-bc1e-f0fdc8f713ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_c544df93-e456-4f57-b93b-71881a8dd2cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_c544df93-e456-4f57-b93b-71881a8dd2cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_8f43a045-afe0-483d-9c1e-f5eac93da156" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_8f43a045-afe0-483d-9c1e-f5eac93da156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_bdb083d6-c652-4849-a093-c9f396f4a79e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_bdb083d6-c652-4849-a093-c9f396f4a79e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_CreditAgreementExpirationTriggerRequirementConvertibleNoteOutstandingBalance_1ddcb474-2b2f-4d40-a32a-d05406715696" xlink:href="cnmd-20210331.xsd#cnmd_CreditAgreementExpirationTriggerRequirementConvertibleNoteOutstandingBalance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_cnmd_CreditAgreementExpirationTriggerRequirementConvertibleNoteOutstandingBalance_1ddcb474-2b2f-4d40-a32a-d05406715696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_7f26dee2-6875-457b-b387-989dad176b90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_7f26dee2-6875-457b-b387-989dad176b90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_c3779c54-b21e-4fd5-b180-6a8b1f241288" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_c3779c54-b21e-4fd5-b180-6a8b1f241288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_1e6144fd-c4d7-4ece-a73f-7e49bd0d28f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_1e6144fd-c4d7-4ece-a73f-7e49bd0d28f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_810b18a6-ab7b-414c-bded-5313535b8c2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_us-gaap_InterestExpenseDebt_810b18a6-ab7b-414c-bded-5313535b8c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_DebtInstrumentConvertibleGrossAmountofEquityComponent_092f98a0-9a43-4163-bc91-99e25f0efec0" xlink:href="cnmd-20210331.xsd#cnmd_DebtInstrumentConvertibleGrossAmountofEquityComponent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_cnmd_DebtInstrumentConvertibleGrossAmountofEquityComponent_092f98a0-9a43-4163-bc91-99e25f0efec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_05c25038-e61d-403b-9ccf-c01d278ec6b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_05c25038-e61d-403b-9ccf-c01d278ec6b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_a6f741b4-a639-4d60-92c6-1466bb1452b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_us-gaap_LongTermDebt_a6f741b4-a639-4d60-92c6-1466bb1452b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_ffcc9265-d2eb-4b87-b15a-957eaebf6fa4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_ffcc9265-d2eb-4b87-b15a-957eaebf6fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_c40d53de-3b39-4759-a2f0-c3e20f90c8c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_c40d53de-3b39-4759-a2f0-c3e20f90c8c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_fa0e0faf-184c-4ef3-9db4-72e44f1bb935" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_fa0e0faf-184c-4ef3-9db4-72e44f1bb935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_Hedgeandwarranttransactionsnetcashpaid_50af06d5-75e5-4f06-99bb-0d8cba792d4c" xlink:href="cnmd-20210331.xsd#cnmd_Hedgeandwarranttransactionsnetcashpaid"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_cnmd_Hedgeandwarranttransactionsnetcashpaid_50af06d5-75e5-4f06-99bb-0d8cba792d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_38d10590-ebdd-4fdb-9bad-0a63548f000a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityStrikePrice1"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_38d10590-ebdd-4fdb-9bad-0a63548f000a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_LIBORInterestRateFloor_5b9f7fef-d777-4386-8b65-85c64b264cf8" xlink:href="cnmd-20210331.xsd#cnmd_LIBORInterestRateFloor"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_cnmd_LIBORInterestRateFloor_5b9f7fef-d777-4386-8b65-85c64b264cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_764b2f74-d217-4b06-a2c2-b871b2059eeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec1d1e6-562b-4863-9b65-858f3e303b87" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_764b2f74-d217-4b06-a2c2-b871b2059eeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/LongTermDebtMaturitiesofLongTermDebtDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#LongTermDebtMaturitiesofLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/LongTermDebtMaturitiesofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_025f5c68-3292-41be-bfae-c60532728395" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_26756bd6-a59d-46fd-8919-eee4ae774515" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaturitiesOfLongTermDebtAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_025f5c68-3292-41be-bfae-c60532728395" xlink:to="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_26756bd6-a59d-46fd-8919-eee4ae774515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_43d5aa73-8819-4ec0-934e-72e3266108e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_26756bd6-a59d-46fd-8919-eee4ae774515" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_43d5aa73-8819-4ec0-934e-72e3266108e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_6275eeb7-f293-4ce6-b943-d9690259f173" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_26756bd6-a59d-46fd-8919-eee4ae774515" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_6275eeb7-f293-4ce6-b943-d9690259f173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_e18cb4b8-3219-4066-b322-117d493629ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_26756bd6-a59d-46fd-8919-eee4ae774515" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_e18cb4b8-3219-4066-b322-117d493629ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_ceca74d1-30d4-40e8-9681-698a9050f40e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_26756bd6-a59d-46fd-8919-eee4ae774515" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_ceca74d1-30d4-40e8-9681-698a9050f40e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_d3f72351-77ba-440f-a204-71d3392d13a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_26756bd6-a59d-46fd-8919-eee4ae774515" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_d3f72351-77ba-440f-a204-71d3392d13a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/Guarantees" xlink:type="simple" xlink:href="cnmd-20210331.xsd#Guarantees"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/Guarantees" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesAbstract_f1bdbe87-7721-44a4-b073-32fbf30a7311" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyDisclosureTextBlock_29d8c0ff-288d-439b-a021-d917c7aefa18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteesAbstract_f1bdbe87-7721-44a4-b073-32fbf30a7311" xlink:to="loc_us-gaap_ProductWarrantyDisclosureTextBlock_29d8c0ff-288d-439b-a021-d917c7aefa18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/GuaranteesTables" xlink:type="simple" xlink:href="cnmd-20210331.xsd#GuaranteesTables"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/GuaranteesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesAbstract_af028027-17a8-496c-8cb1-dffa67065803" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_97f0e76e-f056-463c-ace5-c99ebf7da6a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteesAbstract_af028027-17a8-496c-8cb1-dffa67065803" xlink:to="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_97f0e76e-f056-463c-ace5-c99ebf7da6a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/GuaranteesDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#GuaranteesDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/GuaranteesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesAbstract_89de72a5-23b0-42c0-b18d-76a5d6087ff5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ProductWarrantyAccrualTerm_b1be2279-7a0d-486b-8803-8e0548f7e95d" xlink:href="cnmd-20210331.xsd#cnmd_ProductWarrantyAccrualTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteesAbstract_89de72a5-23b0-42c0-b18d-76a5d6087ff5" xlink:to="loc_cnmd_ProductWarrantyAccrualTerm_b1be2279-7a0d-486b-8803-8e0548f7e95d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_0f019c0e-5d57-459c-8b5d-1b35a454bf48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInStandardProductWarrantyAccrualRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteesAbstract_89de72a5-23b0-42c0-b18d-76a5d6087ff5" xlink:to="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_0f019c0e-5d57-459c-8b5d-1b35a454bf48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_e7339993-1195-46a2-a11f-56d597315325" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_0f019c0e-5d57-459c-8b5d-1b35a454bf48" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_e7339993-1195-46a2-a11f-56d597315325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_4e4fe8c5-7521-4439-a2cd-b4c26931d864" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyAccrualWarrantiesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_0f019c0e-5d57-459c-8b5d-1b35a454bf48" xlink:to="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_4e4fe8c5-7521-4439-a2cd-b4c26931d864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualPayments_f4d7537f-89e4-49b7-bc21-1870724de1a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyAccrualPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_0f019c0e-5d57-459c-8b5d-1b35a454bf48" xlink:to="loc_us-gaap_StandardProductWarrantyAccrualPayments_f4d7537f-89e4-49b7-bc21-1870724de1a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_9451dd2d-5039-429c-95ed-4015780195b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_0f019c0e-5d57-459c-8b5d-1b35a454bf48" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_9451dd2d-5039-429c-95ed-4015780195b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantiesDisclosuresAbstract_a74da5e2-0554-47ba-a1c9-1de9e88657b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantiesDisclosuresAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteesAbstract_89de72a5-23b0-42c0-b18d-76a5d6087ff5" xlink:to="loc_us-gaap_ProductWarrantiesDisclosuresAbstract_a74da5e2-0554-47ba-a1c9-1de9e88657b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtendedProductWarrantyDisclosureAbstract_3cb5c899-2da5-4d65-a5a9-3bc0bc9fc24a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtendedProductWarrantyDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductWarrantiesDisclosuresAbstract_a74da5e2-0554-47ba-a1c9-1de9e88657b2" xlink:to="loc_us-gaap_ExtendedProductWarrantyDisclosureAbstract_3cb5c899-2da5-4d65-a5a9-3bc0bc9fc24a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyExpense_4b2797d9-2b09-4535-95e4-dbc18547737a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtendedProductWarrantyDisclosureAbstract_3cb5c899-2da5-4d65-a5a9-3bc0bc9fc24a" xlink:to="loc_us-gaap_ProductWarrantyExpense_4b2797d9-2b09-4535-95e4-dbc18547737a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/PensionPlan" xlink:type="simple" xlink:href="cnmd-20210331.xsd#PensionPlan"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/PensionPlan" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a212d5ec-aa96-4599-b236-4b9fb3cdfb77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_e919c537-490c-44e7-9fef-c5eb257f7b79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a212d5ec-aa96-4599-b236-4b9fb3cdfb77" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_e919c537-490c-44e7-9fef-c5eb257f7b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/PensionPlanTables" xlink:type="simple" xlink:href="cnmd-20210331.xsd#PensionPlanTables"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/PensionPlanTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a7aaafff-1783-441e-a478-c98bc6b9d96f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_4e7082a4-d7b5-4925-8e64-ece8d3fca982" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a7aaafff-1783-441e-a478-c98bc6b9d96f" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_4e7082a4-d7b5-4925-8e64-ece8d3fca982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/PensionPlanDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#PensionPlanDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/PensionPlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_17aeec72-7573-42d9-950e-36747d689ace" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_f60d14ab-4021-484c-8c54-49e1621de50e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_17aeec72-7573-42d9-950e-36747d689ace" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_f60d14ab-4021-484c-8c54-49e1621de50e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_0eb61ba1-50d6-43e7-94e9-159e23167e3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_17aeec72-7573-42d9-950e-36747d689ace" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_0eb61ba1-50d6-43e7-94e9-159e23167e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_fd24a8b6-ae65-4645-855a-8344ac97863e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_17aeec72-7573-42d9-950e-36747d689ace" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_fd24a8b6-ae65-4645-855a-8344ac97863e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_5409a7c3-a58e-496d-8fdb-52636edca841" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_17aeec72-7573-42d9-950e-36747d689ace" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_5409a7c3-a58e-496d-8fdb-52636edca841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_60bbe55b-fad5-4048-a97e-8c963bb9a2df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_17aeec72-7573-42d9-950e-36747d689ace" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_60bbe55b-fad5-4048-a97e-8c963bb9a2df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_DefinedBenefitPlanNonServiceCost_98c5430a-2318-496e-b752-005bb429c535" xlink:href="cnmd-20210331.xsd#cnmd_DefinedBenefitPlanNonServiceCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_17aeec72-7573-42d9-950e-36747d689ace" xlink:to="loc_cnmd_DefinedBenefitPlanNonServiceCost_98c5430a-2318-496e-b752-005bb429c535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/AcquisitionandOtherExpense" xlink:type="simple" xlink:href="cnmd-20210331.xsd#AcquisitionandOtherExpense"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/AcquisitionandOtherExpense" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AcquisitionandOtherExpenseAbstract_c0f0d080-9200-4dca-bb06-1e0e89d97640" xlink:href="cnmd-20210331.xsd#cnmd_AcquisitionandOtherExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AcquisitionandOtherExpenseTextBlock_69ce6de8-ae4c-4749-ad42-784af0402721" xlink:href="cnmd-20210331.xsd#cnmd_AcquisitionandOtherExpenseTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_AcquisitionandOtherExpenseAbstract_c0f0d080-9200-4dca-bb06-1e0e89d97640" xlink:to="loc_cnmd_AcquisitionandOtherExpenseTextBlock_69ce6de8-ae4c-4749-ad42-784af0402721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/AcquisitionandOtherExpenseTables" xlink:type="simple" xlink:href="cnmd-20210331.xsd#AcquisitionandOtherExpenseTables"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/AcquisitionandOtherExpenseTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AcquisitionandOtherExpenseAbstract_7d4ca2b6-6f1f-4c9f-a877-e58480cb897d" xlink:href="cnmd-20210331.xsd#cnmd_AcquisitionandOtherExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ScheduleOfAcquisitionAndOtherOperatingExpenseTableTextBlock_e1a167bc-6fd7-4f6c-855c-f17f89e56048" xlink:href="cnmd-20210331.xsd#cnmd_ScheduleOfAcquisitionAndOtherOperatingExpenseTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_AcquisitionandOtherExpenseAbstract_7d4ca2b6-6f1f-4c9f-a877-e58480cb897d" xlink:to="loc_cnmd_ScheduleOfAcquisitionAndOtherOperatingExpenseTableTextBlock_e1a167bc-6fd7-4f6c-855c-f17f89e56048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/AcquisitionandOtherExpenseDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#AcquisitionandOtherExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/AcquisitionandOtherExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AcquisitionandOtherExpenseAbstract_d9229093-aa65-492c-8ba4-d71a4c39aa69" xlink:href="cnmd-20210331.xsd#cnmd_AcquisitionandOtherExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_OtherExpensesTable_c6540d6d-223d-4312-834e-124b947c6a4e" xlink:href="cnmd-20210331.xsd#cnmd_OtherExpensesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_AcquisitionandOtherExpenseAbstract_d9229093-aa65-492c-8ba4-d71a4c39aa69" xlink:to="loc_cnmd_OtherExpensesTable_c6540d6d-223d-4312-834e-124b947c6a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b4eb93b5-df28-485e-9c4b-f33c938f0900" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_OtherExpensesTable_c6540d6d-223d-4312-834e-124b947c6a4e" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b4eb93b5-df28-485e-9c4b-f33c938f0900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_55db6a95-7236-493b-877a-be7bb7b2d292" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b4eb93b5-df28-485e-9c4b-f33c938f0900" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_55db6a95-7236-493b-877a-be7bb7b2d292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_076ccc17-9c66-4ccf-bfd6-1353e5adbf2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_55db6a95-7236-493b-877a-be7bb7b2d292" xlink:to="loc_us-gaap_CostOfSalesMember_076ccc17-9c66-4ccf-bfd6-1353e5adbf2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_ea328e9b-7aac-4fcc-a1f6-cdedb6075a53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_55db6a95-7236-493b-877a-be7bb7b2d292" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_ea328e9b-7aac-4fcc-a1f6-cdedb6075a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AcquisitionandOtherExpenseLineItems_a0ada9bb-d036-4a60-8cc2-c401ff1d30e6" xlink:href="cnmd-20210331.xsd#cnmd_AcquisitionandOtherExpenseLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_OtherExpensesTable_c6540d6d-223d-4312-834e-124b947c6a4e" xlink:to="loc_cnmd_AcquisitionandOtherExpenseLineItems_a0ada9bb-d036-4a60-8cc2-c401ff1d30e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_RestructuringAndRelatedCosts_3e2dbd90-a0c2-412e-a440-c55c38db1b29" xlink:href="cnmd-20210331.xsd#cnmd_RestructuringAndRelatedCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_AcquisitionandOtherExpenseLineItems_a0ada9bb-d036-4a60-8cc2-c401ff1d30e6" xlink:to="loc_cnmd_RestructuringAndRelatedCosts_3e2dbd90-a0c2-412e-a440-c55c38db1b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_Manufacturingconsolidationcosts_5876723b-425c-40b7-be6e-50e590afd43f" xlink:href="cnmd-20210331.xsd#cnmd_Manufacturingconsolidationcosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_AcquisitionandOtherExpenseLineItems_a0ada9bb-d036-4a60-8cc2-c401ff1d30e6" xlink:to="loc_cnmd_Manufacturingconsolidationcosts_5876723b-425c-40b7-be6e-50e590afd43f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_679d02a1-1dda-47b7-aeae-ad90f6f6c45d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_AcquisitionandOtherExpenseLineItems_a0ada9bb-d036-4a60-8cc2-c401ff1d30e6" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_679d02a1-1dda-47b7-aeae-ad90f6f6c45d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_a183c5d8-2e8b-4780-9731-b166d4ebf3d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_AcquisitionandOtherExpenseLineItems_a0ada9bb-d036-4a60-8cc2-c401ff1d30e6" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_a183c5d8-2e8b-4780-9731-b166d4ebf3d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating_28a088ea-2db5-4f9c-9e38-f6254ecd343a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_AcquisitionandOtherExpenseLineItems_a0ada9bb-d036-4a60-8cc2-c401ff1d30e6" xlink:to="loc_us-gaap_OtherCostAndExpenseOperating_28a088ea-2db5-4f9c-9e38-f6254ecd343a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/BusinessSegment" xlink:type="simple" xlink:href="cnmd-20210331.xsd#BusinessSegment"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/BusinessSegment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_f92f7a3e-73ed-4c0a-86f1-72296e641099" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_34a81a79-f360-447d-ae21-0e881755e4e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f92f7a3e-73ed-4c0a-86f1-72296e641099" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_34a81a79-f360-447d-ae21-0e881755e4e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/BusinessSegmentTables" xlink:type="simple" xlink:href="cnmd-20210331.xsd#BusinessSegmentTables"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/BusinessSegmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_43179664-0063-4d73-a121-24b5f6c70e0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_11ddf665-e184-4cf6-88a3-aeb0062fae1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_43179664-0063-4d73-a121-24b5f6c70e0f" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_11ddf665-e184-4cf6-88a3-aeb0062fae1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/BusinessSegmentDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#BusinessSegmentDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/BusinessSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_cde501a5-31ba-41d6-a755-617ea7a27325" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_81005f1e-c9d6-4d4f-86f2-8969f3de14fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_cde501a5-31ba-41d6-a755-617ea7a27325" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_81005f1e-c9d6-4d4f-86f2-8969f3de14fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f1302799-7bc6-438b-b9b1-fb9b3b7877ac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_81005f1e-c9d6-4d4f-86f2-8969f3de14fc" xlink:to="loc_srt_ProductOrServiceAxis_f1302799-7bc6-438b-b9b1-fb9b3b7877ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_dada22b6-48c5-4265-8cf0-535a53cad438" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_f1302799-7bc6-438b-b9b1-fb9b3b7877ac" xlink:to="loc_srt_ProductsAndServicesDomain_dada22b6-48c5-4265-8cf0-535a53cad438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_OrthopedicSurgeryMember_38fe5058-1719-444f-a267-c5084970d939" xlink:href="cnmd-20210331.xsd#cnmd_OrthopedicSurgeryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_dada22b6-48c5-4265-8cf0-535a53cad438" xlink:to="loc_cnmd_OrthopedicSurgeryMember_38fe5058-1719-444f-a267-c5084970d939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_GeneralSurgeryMember_fc30ec6e-4e7d-4876-b7e3-c935f6ce6f10" xlink:href="cnmd-20210331.xsd#cnmd_GeneralSurgeryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_dada22b6-48c5-4265-8cf0-535a53cad438" xlink:to="loc_cnmd_GeneralSurgeryMember_fc30ec6e-4e7d-4876-b7e3-c935f6ce6f10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_4f4e9df6-c951-4b7f-b55b-8023ad4a88b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_81005f1e-c9d6-4d4f-86f2-8969f3de14fc" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_4f4e9df6-c951-4b7f-b55b-8023ad4a88b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_09156a6f-8d6b-436b-932f-d04f760ad2b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4f4e9df6-c951-4b7f-b55b-8023ad4a88b0" xlink:to="loc_us-gaap_Revenues_09156a6f-8d6b-436b-932f-d04f760ad2b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/LegalProceedings" xlink:type="simple" xlink:href="cnmd-20210331.xsd#LegalProceedings"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/LegalProceedings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_877a344e-8212-4b07-913c-3e97508eaf09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock_7135b4fc-2de1-4322-9928-66ced1bc2f66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_877a344e-8212-4b07-913c-3e97508eaf09" xlink:to="loc_us-gaap_LegalMattersAndContingenciesTextBlock_7135b4fc-2de1-4322-9928-66ced1bc2f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/LegalProceedingsDetails" xlink:type="simple" xlink:href="cnmd-20210331.xsd#LegalProceedingsDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/LegalProceedingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_002aef78-71fd-44c7-af0d-45272d175b27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_08c3515c-7f44-45c9-86b9-58788838a272" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_002aef78-71fd-44c7-af0d-45272d175b27" xlink:to="loc_us-gaap_LossContingenciesTable_08c3515c-7f44-45c9-86b9-58788838a272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_a5124b51-c78d-469a-bcc5-9ccd7aa73192" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_08c3515c-7f44-45c9-86b9-58788838a272" xlink:to="loc_us-gaap_LitigationStatusAxis_a5124b51-c78d-469a-bcc5-9ccd7aa73192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_5fb753df-7ec3-4d0f-93ed-24085e38f1fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_a5124b51-c78d-469a-bcc5-9ccd7aa73192" xlink:to="loc_us-gaap_LitigationStatusDomain_5fb753df-7ec3-4d0f-93ed-24085e38f1fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_777d8e3e-49f8-456a-9faf-be33a40f5f6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_5fb753df-7ec3-4d0f-93ed-24085e38f1fc" xlink:to="loc_us-gaap_PendingLitigationMember_777d8e3e-49f8-456a-9faf-be33a40f5f6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_96b7146f-26f1-4c03-9b09-b55a6e07ad62" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_08c3515c-7f44-45c9-86b9-58788838a272" xlink:to="loc_srt_LitigationCaseAxis_96b7146f-26f1-4c03-9b09-b55a6e07ad62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_378b657a-2dc5-4313-9d97-a9c6e36a866b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_96b7146f-26f1-4c03-9b09-b55a6e07ad62" xlink:to="loc_srt_LitigationCaseTypeDomain_378b657a-2dc5-4313-9d97-a9c6e36a866b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_EndoDynamixInc.Member_690de6e6-3d12-4daf-9ca7-fa0dd63ae3f5" xlink:href="cnmd-20210331.xsd#cnmd_EndoDynamixInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_378b657a-2dc5-4313-9d97-a9c6e36a866b" xlink:to="loc_cnmd_EndoDynamixInc.Member_690de6e6-3d12-4daf-9ca7-fa0dd63ae3f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_LitigationDamagesAxis_dce70eaa-26d0-499c-a794-88f427bcecc1" xlink:href="cnmd-20210331.xsd#cnmd_LitigationDamagesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_08c3515c-7f44-45c9-86b9-58788838a272" xlink:to="loc_cnmd_LitigationDamagesAxis_dce70eaa-26d0-499c-a794-88f427bcecc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_LitigationDamagesDomain_7e31ef03-9ffc-4519-9f30-e4674105c81e" xlink:href="cnmd-20210331.xsd#cnmd_LitigationDamagesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_LitigationDamagesAxis_dce70eaa-26d0-499c-a794-88f427bcecc1" xlink:to="loc_cnmd_LitigationDamagesDomain_7e31ef03-9ffc-4519-9f30-e4674105c81e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_LiquidatedDamagesMember_9d200068-78c6-417b-b014-51c68bfbfd27" xlink:href="cnmd-20210331.xsd#cnmd_LiquidatedDamagesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_LitigationDamagesDomain_7e31ef03-9ffc-4519-9f30-e4674105c81e" xlink:to="loc_cnmd_LiquidatedDamagesMember_9d200068-78c6-417b-b014-51c68bfbfd27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AdditionalDamagesMember_7b3842cc-52dc-43ed-9682-d39320a6ea2c" xlink:href="cnmd-20210331.xsd#cnmd_AdditionalDamagesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_LitigationDamagesDomain_7e31ef03-9ffc-4519-9f30-e4674105c81e" xlink:to="loc_cnmd_AdditionalDamagesMember_7b3842cc-52dc-43ed-9682-d39320a6ea2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_acef9850-7fbc-442d-b333-35fe92266113" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_08c3515c-7f44-45c9-86b9-58788838a272" xlink:to="loc_us-gaap_LossContingenciesLineItems_acef9850-7fbc-442d-b333-35fe92266113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident_86dfe24e-9375-4aac-b1ae-5d4f81cb72fc" xlink:href="cnmd-20210331.xsd#cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_acef9850-7fbc-442d-b333-35fe92266113" xlink:to="loc_cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident_86dfe24e-9375-4aac-b1ae-5d4f81cb72fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount_e519cf9a-78bd-480a-8342-5bd5941aea7a" xlink:href="cnmd-20210331.xsd#cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_acef9850-7fbc-442d-b333-35fe92266113" xlink:to="loc_cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount_e519cf9a-78bd-480a-8342-5bd5941aea7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_1a08df8b-a0ce-4ba9-9f6b-f63797fe7eab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_acef9850-7fbc-442d-b333-35fe92266113" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_1a08df8b-a0ce-4ba9-9f6b-f63797fe7eab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/NewAccountingPronouncements" xlink:type="simple" xlink:href="cnmd-20210331.xsd#NewAccountingPronouncements"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/NewAccountingPronouncements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_a364c2ed-4795-4f77-9707-4bdd1c79de71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_6c406dfc-9096-4f19-85be-11ba62568eb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_a364c2ed-4795-4f77-9707-4bdd1c79de71" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_6c406dfc-9096-4f19-85be-11ba62568eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/NewAccountingPronouncementsPolicies" xlink:type="simple" xlink:href="cnmd-20210331.xsd#NewAccountingPronouncementsPolicies"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/NewAccountingPronouncementsPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_8d4d9624-1009-400a-87c4-dcf9c188ffad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_5d78429c-c231-4466-8ace-9bd436a87769" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_8d4d9624-1009-400a-87c4-dcf9c188ffad" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_5d78429c-c231-4466-8ace-9bd436a87769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>cnmd-20210331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cnmd="http://www.conmed.com/20210331"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="cnmd-20210331.xsd" xlink:type="simple"/>
    <context id="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia8dfbbe9d1c145d5bb72b02ea4fac60c_I20210426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
        </entity>
        <period>
            <instant>2021-04-26</instant>
        </period>
    </context>
    <context id="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i46ba6599130f4eb1a4d6fe042999e135_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iae012f3fcd9f41fd9bc6e05669f51454_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib8d0268193f046989c7a7367bc639b32_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i27c15051984d44e6b5c9858e676ca33c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i151d90f96de242678881f597e8015d38_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2905d9021abd4b9ea314e60814616d57_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if3676449ae5744b184ad5f60ae92544f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie64010a164eb46af89de3193d71e8fba_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i96387733ca074ff7b4010cdd9df409b6_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if474f87feaa54dc0a8fcf5d08a768e3e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id31031a486b14a38af8dea7f3155fcb8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibac6966a355949378bb6c2fc42834ec1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib8f8f0e52b974b4e95f209ba842d8bb6_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i029f793cce2d4474856e032865f1f946_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i33ed66e8daf34fa8b10ccb54d98510cf_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5e2c39713f4b45bf83812220f02bcfce_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ieebf93936a0b4946a4cebd127f100d98_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6b008cae44884d848870e03a18000ab9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6cb501558a20431db8401ff4a527404c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iba78700e77d54679bf93d6b9acf74fae_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7e86d4601a4b4430ba15cc2ae32a9336_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icc2b6de697384224975fbf30994d9a87_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i72ed1085bea54a3ca02ccafd38fb3dca_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i44890b61b4e54cd6a45ec9fe485dffab_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i95bc22c9cff4438ba21e7d9b6141399c_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i1cc29bb8dbaa42239d37e7bb08963171_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="idc96afc7d3fb40a98303297d7f214b0e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i9cef9bc34cee464192cc0b9012143d3f_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i7ec34830172747ee92a710ad30795223_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i120ee47c2d2c46e08a15d763a7767f75_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i4c56f028fc084321a0e30cfeaea79a64_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ie62997345e524027a79ecf64d5ed0611_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3fd2671e438a474faa38d3e9a2c3f250_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4190bedf816e408ca9d02bfd966a3366_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ieb19adcd1a5d48da93ca6e4fe100bba2_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i775199af495945bf86d1df93013e716d_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i8caf0668d2a043b99300c2d015a59f5e_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i2d5cbd26c2e34fcca879ebd88ed26bbc_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3c4dbcab20b64473a815fafab7bb519b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iacc6728071cc42afac66a950fd77c7ec_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id693351de21b454f9ad10a807a5dd52f_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ibb2a8238876248f585425eb5051bb474_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i29730944e6d14730a59d95854830ef68_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i9bf13cfe5c8b4c3c98489e1e906361e1_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8985ce744656405e85a504c9d31badd8_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ifbade5dec7f741f6a1a4d181a6fd7c0a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibe2d2ede0d054d3ea31d7f38ad84c165_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ib4d5dfe5f1934d3982cae7661c4cf533_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ib4c14268949c4a94b1580a7aeb78ecbb_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i7bbfa0455ef7435a9f76aa8e63565ef5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cnmd:AmericasexcludingtheUnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i68905b6fbdec4d4cb2932ea45ef02924_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cnmd:AmericasexcludingtheUnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="idb1d2f66658942c69084f7e2616e914f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cnmd:AmericasexcludingtheUnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9c75aafd2b4c449c95acdba707112745_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cnmd:AmericasexcludingtheUnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i76d7ef8d98cb4ff19a021ad02e67da31_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cnmd:AmericasexcludingtheUnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i2cdefd0b0a3045d49ceeadee9e6bb36b_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cnmd:AmericasexcludingtheUnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ia86b4262c6984bb6ad658ce074db008e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id802a374e8af403cb3d3822bd10d7c08_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9557a8db05ee41ffaa88a992a0b82938_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i2a7ac877916a4014a3fb26b999be79af_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="if94e1dc3dd564aaebe0c764b728d2713_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="icfadd8f8b84b4fdf903364c77b8920f3_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5f20b36e15fb425494acd84a048f7177_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i11161ef39ae1485b8d27a2ae4c22875d_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i782cd02ea1ba4cd78b680a524b6ca850_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i1a74e7f2ffa04fa0814e8231216941c4_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ib20f23593d444604b32c771d7959b0ca_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5d4311b6e8044c8894a8f3e8bba1645c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4e128db3c81e4e588034d3c0247dee80_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7057925e589d42faa6a4fb3ddf23bbd6_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="if74b6b7e82ac4212bba27824114d47b4_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i12d7e0dffb5e4869af8c81221b0c0a7f_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i01ec3e073702455c9e537fe9a5385abb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0b7ea3f8782943fcbc4ba9d0d76b3ec1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1adb37865c4441248b72947844ddca28_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6d3af65fad6f44f0b3d057bbf55a6a78_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iad15f0679e6b4c0d9ac7119db78f9c33_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia1dc7178d7a640169fb15973f1266566_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8245a6aa10f94c0bbcc41d1b62a19629_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8c348cefc0004f5a84965d0ccc163ea3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i07bd77a73b3545aa8a2104efd8e434fd_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3fab3fd5ae6d4130a6074da5f6e613ae_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ide5c2d5254674b079e19ce03c1af6597_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3260d253c3314cdda5a4ade16ecbac96_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i539165515ff54031a19c7afae85ae40a_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ib283f3bae1b7414e9448c28a5baa9aff_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i2aa32ba1223944909a381ed581c46123_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i48e8d40f4b764e66a575ca1ee4752691_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ied165b7d8f6347aaa83ef46fd509ac16_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ib74665bfb6b541e48986d00dea4ca711_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i6c2b490080b54ee293093cabd55cf92f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2efe3e302ba4492a9b14126b56757fe7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icf6b5979fbd34dcbae2c42f8e0d6aed2_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iacdfcde17fac4a0eb431ce68961ed713_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib1e08f06254d472fa74789af8e1cd878_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i99806f4ebd244f5e87a9fa07d01115f6_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4e47fc121f8545dbb0463f80ac04eab2_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">cnmd:RevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iaa13b87841fb46f9971920ec855139e0_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">cnmd:RevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic4cfe412f15e40679fed8fb1ab50ff59_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if891372cb88f49d1ad8cf68161f49100_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="id18f74481683457cb6b00dae1d5691a4_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6331111f415a4d5ea9e8cd727632eeee_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i35307b95062445a3a39801d79634cee9_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6d3efa96f76c423a828baa29d94dcb15_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i67d105aa68f347b8a414ade6ce5542bc_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic235813d62984ee3b72d058a569b0a54_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9abfdfe4a61a4a60ab8b291e94a8244d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0a133038947642198d9059759b25062b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibd85c1ac785d48edbf3dd0030c518099_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic248ae873ff841ffbe0200170d941d8d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id748c1bbe2b3409b9e97ffd239dcc0f0_I20190129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2.625PercentConvertibleNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-29</instant>
        </period>
    </context>
    <context id="i4166a58e42b343bfb5ae40145fb70764_D20190129-20190129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2.625PercentConvertibleNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cnmd:IndexedTransactionTypeAxis">cnmd:HedgeTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-29</startDate>
            <endDate>2019-01-29</endDate>
        </period>
    </context>
    <context id="idf721ab99d84490dbfa3d3cec7d8e799_D20190129-20190129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2.625PercentConvertibleNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cnmd:IndexedTransactionTypeAxis">cnmd:WarrantTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-29</startDate>
            <endDate>2019-01-29</endDate>
        </period>
    </context>
    <context id="ieced3d585af14a18830b4dd4d45722c5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnmd:CustomerandDistributorRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i845a4163284f443481a7a9c2d614d09a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnmd:CustomerandDistributorRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2ee91ad444274cc2a46852ceb1cbe07b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnmd:CustomerandDistributorRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i764a3b1ff7c841b1ba858429acbdb036_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnmd:SalesrepresentationmarketingandpromotionalrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i67e28dd28d264c5ca16a46ab1364c8bc_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnmd:SalesrepresentationmarketingandpromotionalrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if46896d334d94c639ad7dd9fe363f7ff_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnmd:SalesrepresentationmarketingandpromotionalrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4827d1b693224030887c79b6d7a4ac8a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id22fbed2f4c849639e7b4e6618063e83_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if7cce587c6664fba92238d523270294d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic619fc4d993649a0aa3de013bce24ac7_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnmd:PatentsAndOtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9c573b67931c49ae94806ae92e81066f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnmd:PatentsAndOtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8660d403bca94922a95c5e1926714e31_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnmd:PatentsAndOtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2fbb390301fb48f0a30356e63cdebb22_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i16f265525a594e4196ee9d5387895783_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie71bc8ca5147459e9fc9a708d695e3d8_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9f228fccaaf945268b8dcbd31bed8868_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">cnmd:ExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9cfc55d543ed45c79d4721e64e912827_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">cnmd:ReductionofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i824ceb82e4874235bfdf7c0af561e38c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1d478e70dcec4899b2e2962f31e3f914_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3d8fccab0a15481582a37233de37abbf_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="idc48b5a1f090411da72a4fabcf8ba3c5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i99821198665d4c33ba7a5fc053af58b5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0b2868e4273945968f65bc7567ca9021_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ida498aa346244a73997d7daf728c9420_I20190207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:AmendedAndRestatedSeniorCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-07</instant>
        </period>
    </context>
    <context id="i7729e32eb8ce41c089d19b2205b89c39_I20190207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:AmendedAndRestatedSeniorCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-07</instant>
        </period>
    </context>
    <context id="i9eaf4f751cfe4066b7c97b065a34e247_I20190207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2.625PercentConvertibleNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-07</instant>
        </period>
    </context>
    <context id="i28142c61de0544568e9a171dfbb1187c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:AmendedAndRestatedSeniorCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cnmd:VariableRateBasisAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6e5c081b73e84195a5fcd7003f17de71_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:AmendedAndRestatedSeniorCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cnmd:VariableRateBasisAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ied43b21a44b44e51b34956e8f380ca38_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:AmendedAndRestatedSeniorCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib605253e0a9f4dfba2ff9d30ac708b49_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:AmendedAndRestatedSeniorCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cnmd:VariableRateBasisAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3d7a728e16414d51a3ab40885ff60574_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:AmendedAndRestatedSeniorCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iee99b7a3a16541f8b5be3bf158edab1d_D20190129-20190129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2.625PercentConvertibleNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-29</startDate>
            <endDate>2019-01-29</endDate>
        </period>
    </context>
    <context id="ie5c0fe7cdde24d5ab7b9a921af59a0d9_I20190129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2.625PercentConvertibleNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:CallOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-29</instant>
        </period>
    </context>
    <context id="ibf80fee48fa74ab4b9051fb83cdd995b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2.625PercentConvertibleNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i296a43d7781e4424a01be9d77422618e_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2.625PercentConvertibleNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i1c05d83ea1e6498489016ad7d59cf236_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7e04b4ea73e04184933b0223f3525651_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="id854f60e596745a88a6555bfb8baa9c8_D20170118-20170118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cnmd:EndoDynamixInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cnmd:LitigationDamagesAxis">cnmd:LiquidatedDamagesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-18</startDate>
            <endDate>2017-01-18</endDate>
        </period>
    </context>
    <context id="i82aee7908b334a16816b4969f87ddeaa_D20170118-20170118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cnmd:EndoDynamixInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cnmd:LitigationDamagesAxis">cnmd:AdditionalDamagesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-18</startDate>
            <endDate>2017-01-18</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80L2ZyYWc6ZTc0MTVmMTFkMDI3NGY1YWFjYmI4MDdiYWVmZmM3MzYvdGFibGU6ZTBhN2VlNzkxMjI2NDljODllOTBkOTMyODFhNzYyOGQvdGFibGVyYW5nZTplMGE3ZWU3OTEyMjY0OWM4OWU5MGQ5MzI4MWE3NjI4ZF8xLTEtMS0xLTA_283974ac-c3fb-404d-8e53-5af219b06b23">0000816956</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80L2ZyYWc6ZTc0MTVmMTFkMDI3NGY1YWFjYmI4MDdiYWVmZmM3MzYvdGFibGU6ZTBhN2VlNzkxMjI2NDljODllOTBkOTMyODFhNzYyOGQvdGFibGVyYW5nZTplMGE3ZWU3OTEyMjY0OWM4OWU5MGQ5MzI4MWE3NjI4ZF8yLTEtMS0xLTA_5a08a772-76bf-4136-82f3-bdf0425bc6d1">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80L2ZyYWc6ZTc0MTVmMTFkMDI3NGY1YWFjYmI4MDdiYWVmZmM3MzYvdGFibGU6ZTBhN2VlNzkxMjI2NDljODllOTBkOTMyODFhNzYyOGQvdGFibGVyYW5nZTplMGE3ZWU3OTEyMjY0OWM4OWU5MGQ5MzI4MWE3NjI4ZF8zLTEtMS0xLTA_764b1f00-458c-4c45-9b10-ffe1e0e3b2bd">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80L2ZyYWc6ZTc0MTVmMTFkMDI3NGY1YWFjYmI4MDdiYWVmZmM3MzYvdGFibGU6ZTBhN2VlNzkxMjI2NDljODllOTBkOTMyODFhNzYyOGQvdGFibGVyYW5nZTplMGE3ZWU3OTEyMjY0OWM4OWU5MGQ5MzI4MWE3NjI4ZF80LTEtMS0xLTA_606142de-ad57-46c6-8225-b03ce03a707c">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80L2ZyYWc6ZTc0MTVmMTFkMDI3NGY1YWFjYmI4MDdiYWVmZmM3MzYvdGFibGU6ZTBhN2VlNzkxMjI2NDljODllOTBkOTMyODFhNzYyOGQvdGFibGVyYW5nZTplMGE3ZWU3OTEyMjY0OWM4OWU5MGQ5MzI4MWE3NjI4ZF81LTEtMS0xLTA_7c60f7d6-1752-496d-b994-75e6d4836c07">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGV4dHJlZ2lvbjoyMWZiZTlmZWY1ZDc0ZmFmYWRiZmQ2YjMyNzViYTQ0ZF8yMTM4_a69dd2f9-c26b-447b-a0e6-8763d3d05c11">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGV4dHJlZ2lvbjoyMWZiZTlmZWY1ZDc0ZmFmYWRiZmQ2YjMyNzViYTQ0ZF8yMTQ2_97882b7b-8462-43f7-b944-462940621b85">true</dei:DocumentQuarterlyReport>
    <dei:DocumentTransitionReport
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGV4dHJlZ2lvbjoyMWZiZTlmZWY1ZDc0ZmFmYWRiZmQ2YjMyNzViYTQ0ZF8yMTM5_dfef0ffe-fe46-4cc2-82dd-bff5aaa36834">false</dei:DocumentTransitionReport>
    <dei:DocumentPeriodEndDate
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGFibGU6MmVkYmNiODdjNzFlNGEyNzhkNWFlNjlmN2JkZWFlMTIvdGFibGVyYW5nZToyZWRiY2I4N2M3MWU0YTI3OGQ1YWU2OWY3YmRlYWUxMl8xLTAtMS0xLTA_7b5cd5a5-b7b6-464c-9075-d406715d002f">2021-03-31</dei:DocumentPeriodEndDate>
    <dei:EntityFileNumber
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGFibGU6MmVkYmNiODdjNzFlNGEyNzhkNWFlNjlmN2JkZWFlMTIvdGFibGVyYW5nZToyZWRiY2I4N2M3MWU0YTI3OGQ1YWU2OWY3YmRlYWUxMl8xLTEtMS0xLTA_51a3fa38-eabf-4394-ad99-55fa746a72f2">001-39218</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGV4dHJlZ2lvbjoyMWZiZTlmZWY1ZDc0ZmFmYWRiZmQ2YjMyNzViYTQ0ZF8yMTQ3_841d157e-3c40-4814-a0f9-bf15fe188afc">CONMED CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGFibGU6MGFmNzNiM2NmYzkxNGM3N2I1MGJhMDhhOTQxZDc1ZjEvdGFibGVyYW5nZTowYWY3M2IzY2ZjOTE0Yzc3YjUwYmEwOGE5NDFkNzVmMV8wLTAtMS0xLTA_34c622ac-4154-43ea-9f89-b149c100ec48">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGFibGU6MGFmNzNiM2NmYzkxNGM3N2I1MGJhMDhhOTQxZDc1ZjEvdGFibGVyYW5nZTowYWY3M2IzY2ZjOTE0Yzc3YjUwYmEwOGE5NDFkNzVmMV8wLTMtMS0xLTA_865442e2-afcd-4f19-88a2-80af2daf2b8c">16-0977505</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGFibGU6MGFmNzNiM2NmYzkxNGM3N2I1MGJhMDhhOTQxZDc1ZjEvdGFibGVyYW5nZTowYWY3M2IzY2ZjOTE0Yzc3YjUwYmEwOGE5NDFkNzVmMV8zLTAtMS0xLTA_157963d2-d850-44cf-919a-d46d0ffb2370">11311 Concept Blvd</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGFibGU6MGFmNzNiM2NmYzkxNGM3N2I1MGJhMDhhOTQxZDc1ZjEvdGFibGVyYW5nZTowYWY3M2IzY2ZjOTE0Yzc3YjUwYmEwOGE5NDFkNzVmMV8zLTEtMS0xLTA_74a74e78-d7cb-4dd3-af81-3015dc259f05">Largo,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGFibGU6MGFmNzNiM2NmYzkxNGM3N2I1MGJhMDhhOTQxZDc1ZjEvdGFibGVyYW5nZTowYWY3M2IzY2ZjOTE0Yzc3YjUwYmEwOGE5NDFkNzVmMV8zLTItMS0xLTA_29587e19-77d5-4033-ad94-0364caef33f7">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGFibGU6MGFmNzNiM2NmYzkxNGM3N2I1MGJhMDhhOTQxZDc1ZjEvdGFibGVyYW5nZTowYWY3M2IzY2ZjOTE0Yzc3YjUwYmEwOGE5NDFkNzVmMV8zLTMtMS0xLTA_d4ea6799-9d85-40a3-894d-e8b67a692afc">33773</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGV4dHJlZ2lvbjoyMWZiZTlmZWY1ZDc0ZmFmYWRiZmQ2YjMyNzViYTQ0ZF8yMTQ4_05dd89dc-1da5-4e09-a774-c2e95c1a847c">727</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGV4dHJlZ2lvbjoyMWZiZTlmZWY1ZDc0ZmFmYWRiZmQ2YjMyNzViYTQ0ZF8yMTQw_c2c0a758-2dc8-468e-b650-ff7a19558705">392-6464</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGFibGU6YzliOGFlMjhmOGVjNGRjNWEwOWMwOTI1MjlhODEyNTAvdGFibGVyYW5nZTpjOWI4YWUyOGY4ZWM0ZGM1YTA5YzA5MjUyOWE4MTI1MF8xLTAtMS0xLTA_0b1ab7bc-9400-484a-8b8c-9e08686175ff">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGFibGU6YzliOGFlMjhmOGVjNGRjNWEwOWMwOTI1MjlhODEyNTAvdGFibGVyYW5nZTpjOWI4YWUyOGY4ZWM0ZGM1YTA5YzA5MjUyOWE4MTI1MF8xLTEtMS0xLTA_08766dba-b4ff-4347-9a34-83e62aa0b396">CNMD</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGFibGU6YzliOGFlMjhmOGVjNGRjNWEwOWMwOTI1MjlhODEyNTAvdGFibGVyYW5nZTpjOWI4YWUyOGY4ZWM0ZGM1YTA5YzA5MjUyOWE4MTI1MF8xLTItMS0xLTA_13dc3c57-c685-4ade-bcc4-57bd85445242">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGV4dHJlZ2lvbjoyMWZiZTlmZWY1ZDc0ZmFmYWRiZmQ2YjMyNzViYTQ0ZF8yMTQx_ccc1fcf3-5598-40a3-af47-7c2544f9eeb9">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGV4dHJlZ2lvbjoyMWZiZTlmZWY1ZDc0ZmFmYWRiZmQ2YjMyNzViYTQ0ZF8yMTM2_f8f558b3-e4cf-4c0a-8801-bfde58b1315f">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGV4dHJlZ2lvbjoyMWZiZTlmZWY1ZDc0ZmFmYWRiZmQ2YjMyNzViYTQ0ZF8yMTM3_8655cdc8-6b8a-438f-ab37-cc8f154cdad2">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGV4dHJlZ2lvbjoyMWZiZTlmZWY1ZDc0ZmFmYWRiZmQ2YjMyNzViYTQ0ZF8yMTQy_3a0b264f-1078-475b-8f3a-c491e920a7c4">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGV4dHJlZ2lvbjoyMWZiZTlmZWY1ZDc0ZmFmYWRiZmQ2YjMyNzViYTQ0ZF8yMTQz_39d2ae9f-3a62-48db-b9f6-53830dd55101">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGV4dHJlZ2lvbjoyMWZiZTlmZWY1ZDc0ZmFmYWRiZmQ2YjMyNzViYTQ0ZF8yMTQ1_d273ec38-3494-497f-9390-9253a407de99">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ia8dfbbe9d1c145d5bb72b02ea4fac60c_I20210426"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xL2ZyYWc6MjFmYmU5ZmVmNWQ3NGZhZmFkYmZkNmIzMjc1YmE0NGQvdGV4dHJlZ2lvbjoyMWZiZTlmZWY1ZDc0ZmFmYWRiZmQ2YjMyNzViYTQ0ZF8yMTI3_f962c370-52b7-4477-9265-43f07fcca8c0"
      unitRef="shares">29092141</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:Revenues
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMy0xLTEtMS0w_1f9028fe-ff19-4c21-b052-2faf7667e2a2"
      unitRef="usd">232677000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMy0zLTEtMS0w_08918b4b-d3fc-447b-b7d4-3c487e93d984"
      unitRef="usd">214010000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfNS0xLTEtMS0w_527b43f8-fa9c-4af1-accd-214bd9654a19"
      unitRef="usd">104228000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfNS0zLTEtMS0w_0efad7e6-1d98-40d6-b4d5-09b27be8cbdc"
      unitRef="usd">94851000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfNy0xLTEtMS0w_201eb49c-8eec-4856-87dd-7d63e0ef0035"
      unitRef="usd">128449000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfNy0zLTEtMS0w_acfbd39a-5fb8-430a-b233-7ab36519fc89"
      unitRef="usd">119159000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfOS0xLTEtMS0w_396e71f3-994a-4507-98a5-69c065075e38"
      unitRef="usd">98340000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfOS0zLTEtMS0w_c6ef80c7-c91e-4ab6-9424-7654bace8814"
      unitRef="usd">95867000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMTEtMS0xLTEtMA_0d54384c-a8bf-4fbd-8131-f0791a207f84"
      unitRef="usd">10027000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMTEtMy0xLTEtMA_f3a6287b-35b5-4d39-8b60-780e8cd2d612"
      unitRef="usd">10120000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingExpenses
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMTMtMS0xLTEtMA_df91f349-53cf-481e-8291-9a817b56b944"
      unitRef="usd">108367000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMTMtMy0xLTEtMA_3b877e2e-41c5-4155-9148-58fc5b190173"
      unitRef="usd">105987000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMTUtMS0xLTEtMA_eab0561b-f98d-4b09-b3ea-4428d55de910"
      unitRef="usd">20082000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMTUtMy0xLTEtMA_1ad5344e-4e6d-4af8-8044-d0754fc6f0a8"
      unitRef="usd">13172000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMTctMS0xLTEtMA_f352ff02-d347-4ebc-b122-0f2aa90bb84a"
      unitRef="usd">10351000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMTctMy0xLTEtMA_a8a41ab2-2dd6-4a32-a5d4-33e7b8eb07d8"
      unitRef="usd">9592000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingExpense
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMTktMS0xLTEtMA_4970c99f-37b2-49ba-a540-7f73307aedf9"
      unitRef="usd">0</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingExpense
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMTktMy0xLTEtMA_0823f6e2-a85a-4de4-8709-af8eaa0448e3"
      unitRef="usd">89000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMjEtMS0xLTEtMA_2f967235-4140-400c-9c76-e4832d29327b"
      unitRef="usd">9731000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMjEtMy0xLTEtMA_cf5b8a3a-2bc8-485e-86f1-f1ee71ff7c86"
      unitRef="usd">3491000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMjMtMS0xLTEtMA_2c7ef6b8-1216-45eb-a465-3803b546ba49"
      unitRef="usd">-129000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMjMtMy0xLTEtMA_cdace072-fa47-41e0-b611-7b1a4e6654a7"
      unitRef="usd">-2436000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMjUtMS0xLTEtMA_531667d9-77cd-4d45-bdda-e77cd158e532"
      unitRef="usd">9860000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMjUtMy0xLTEtMA_98893cad-29f8-4137-8fd3-04cc836b7e51"
      unitRef="usd">5927000</us-gaap:NetIncomeLoss>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMjctMS0xLTEtMA_63a3b3cc-0600-4722-a0c3-c1f87d0a43bb"
      unitRef="usd">10743000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMjctMy0xLTEtMA_db90a39b-37e1-4653-a2d9-6a4c79953f7a"
      unitRef="usd">-1121000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:EarningsPerShareBasic
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMzMtMS0xLTEtMA_0ed89bf5-3567-47c8-b679-0b511fb97af3"
      unitRef="usdPerShare">0.34</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMzMtMy0xLTEtMA_885470f5-180a-427a-a941-0fdfade38d8b"
      unitRef="usdPerShare">0.21</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMzQtMS0xLTEtMA_4aec4ddc-dd57-45f3-b212-6c92389816de"
      unitRef="usdPerShare">0.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMzQtMy0xLTEtMA_7c005e7d-0e4f-4726-9a74-1e8e3c9e9957"
      unitRef="usdPerShare">0.20</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMzctMS0xLTEtMA_5d3b43fc-9775-4685-bc06-32fdcede2797"
      unitRef="shares">28972000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMzctMy0xLTEtMA_08441aa9-8dcf-4d8f-9ee3-78bc03aeefc1"
      unitRef="shares">28478000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMzgtMS0xLTEtMA_06695938-77eb-409b-99af-ebe309777927"
      unitRef="shares">31378000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xNi9mcmFnOmVlMWE0NzJlNzVlODQ1YWVhYjJlZTNkY2M1MTgzYmRkL3RhYmxlOjdjMGQwZjRjMDcwYzQxYzA5YjgyNmQyZWM1NjgzYTZiL3RhYmxlcmFuZ2U6N2MwZDBmNGMwNzBjNDFjMDliODI2ZDJlYzU2ODNhNmJfMzgtMy0xLTEtMA_c7dfb1f3-1c19-4850-a621-c69704da79f3"
      unitRef="shares">29707000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMy0xLTEtMS0w_63f1bfce-4d53-49cd-af3d-898d0c946ef0"
      unitRef="usd">36769000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMy0zLTEtMS0w_f4d91063-bdd8-4e49-a6dd-f813ddcff3a8"
      unitRef="usd">27356000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfNC0xLTEtMS0w_5426556c-3b1b-4cb9-bdb9-95df9a2a5c33"
      unitRef="usd">163954000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfNC0zLTEtMS0w_f69e3df6-1ef8-43c5-883b-1b8df69e594f"
      unitRef="usd">177152000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfNS0xLTEtMS0w_a1ca8e74-b6f4-43e1-8047-6354719abffe"
      unitRef="usd">205797000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfNS0zLTEtMS0w_6a6e6df9-2675-4d90-971a-a481aa5a7c93"
      unitRef="usd">194868000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfNi0xLTEtMS0w_46818817-8438-4201-ad0b-1332f5e685db"
      unitRef="usd">17849000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfNi0zLTEtMS0w_f9f27dd9-e11c-41c9-80eb-efa0547e7b88"
      unitRef="usd">17278000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfNy0xLTEtMS0w_56883c1b-8ec2-48e1-be6d-60be85849a33"
      unitRef="usd">424369000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfNy0zLTEtMS0w_fbf93c65-eb30-4c1d-b9cf-71823c390574"
      unitRef="usd">416654000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfOC0xLTEtMS0w_f62b1dab-b53c-4659-a325-d8de7c29854d"
      unitRef="usd">109379000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfOC0zLTEtMS0w_ff9dbb88-7796-47dc-b002-c63c321dd5e0"
      unitRef="usd">111407000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfOS0xLTEtMS0w_48ff962f-b4b4-42ae-9604-f913a653cd46"
      unitRef="usd">618104000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfOS0zLTEtMS0w_ad5acd04-e5d4-489c-8457-78fa119c2c6d"
      unitRef="usd">618440000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMTAtMS0xLTEtMA_638ff893-eec2-45f4-811e-805baea991dc"
      unitRef="usd">493905000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMTAtMy0xLTEtMA_0a1851f8-f1ba-408c-a2d2-1728cfa3fc60"
      unitRef="usd">501537000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMTEtMS0xLTEtMA_e1d0962c-017d-4a45-8732-eb4d27e6572f"
      unitRef="usd">100855000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMTEtMy0xLTEtMA_41de55ad-e0e8-421d-ad5d-a14ad8f9cb25"
      unitRef="usd">103635000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMTItMS0xLTEtMA_c74b4d53-bf6a-4858-a41d-11dd1474a292"
      unitRef="usd">1746612000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMTItMy0xLTEtMA_7d2d3dce-be10-4f6b-b3e9-6f2209341470"
      unitRef="usd">1751673000</us-gaap:Assets>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMTktMS0xLTEtMA_31b7d62a-d9e9-4018-babd-a464efed8adb"
      unitRef="usd">20076000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMTktMy0xLTEtMA_f6910fa5-1bb7-4a66-909e-b1496f19deb2"
      unitRef="usd">18415000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMjAtMS0xLTEtMA_ec8052a4-8b68-4ef7-9084-92d823d3c3da"
      unitRef="usd">55780000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMjAtMy0xLTEtMA_f4578e49-e035-4d29-900f-f92d68e6a0b1"
      unitRef="usd">53310000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMjEtMS0xLTEtMA_c6612d23-b5ef-406c-a5d9-c9355599c9be"
      unitRef="usd">40908000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMjEtMy0xLTEtMA_6523420f-dce3-4d6c-88e8-a960f891cfcd"
      unitRef="usd">50171000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMjItMS0xLTEtMA_9cb7d58b-89f0-4d7d-9c64-c967101ebc2d"
      unitRef="usd">65391000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMjItMy0xLTEtMA_341fc990-e252-49d9-98d2-5ef129dbf417"
      unitRef="usd">68305000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMjMtMS0xLTEtMA_327d81bb-4040-46de-9aeb-6597b761ffe8"
      unitRef="usd">182155000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMjMtMy0xLTEtMA_d4762602-47b9-4011-b116-fafabb02db26"
      unitRef="usd">190201000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMjUtMS0xLTEtMA_802b2bfd-c102-4b94-a769-e8b1df2abd43"
      unitRef="usd">725320000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMjUtMy0xLTEtMA_500ddf7f-c938-4c81-92db-c7598b925491"
      unitRef="usd">735221000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMjYtMS0xLTEtMA_819ad34a-f404-4d84-9302-96b3e765dc0b"
      unitRef="usd">56593000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMjYtMy0xLTEtMA_9e536d12-8637-41fd-bacf-57a68006aac7"
      unitRef="usd">57875000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMjctMS0xLTEtMA_259bee1d-a536-4745-8f55-d6f6d8f84fba"
      unitRef="usd">56974000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMjctMy0xLTEtMA_e318d582-82b8-4564-b4cd-d6ed117c2699"
      unitRef="usd">59338000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMjgtMS0xLTEtMA_2ca5b9e7-6f3b-403c-857d-af5015bddc31"
      unitRef="usd">1021042000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMjgtMy0xLTEtMA_22b683ef-f28d-4c6d-a58f-89e1924fbbf8"
      unitRef="usd">1042635000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzAtMS0xLTEtMA_455f556a-c679-4936-ad88-73216076a84a"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzAtMy0xLTEtMA_a09df9c4-307a-43be-a647-4d5389dc5aeb"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmE5M2RkZmZhYjEwNjRjODFiOWYxNDhmY2FiZjUxNDBkXzMx_5ac8beb5-e818-490b-80af-05dea52442b0"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmE5M2RkZmZhYjEwNjRjODFiOWYxNDhmY2FiZjUxNDBkXzMx_9b9d731a-e755-4bef-9490-5af5183d9ea1"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmYzNTcxODE0MmMzNDQ3OGM5MTdjNThhMzQ4MTFjNzg2XzE1_0fc341c2-44f7-431b-b2b6-03f2b322e801"
      unitRef="shares">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmYzNTcxODE0MmMzNDQ3OGM5MTdjNThhMzQ4MTFjNzg2XzE1_b6b924f6-835a-42ed-ab27-d483e9ce3bf2"
      unitRef="shares">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmYzNTcxODE0MmMzNDQ3OGM5MTdjNThhMzQ4MTFjNzg2XzI2_0a6147cd-ef92-4f24-9f39-68bffddf9050"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmYzNTcxODE0MmMzNDQ3OGM5MTdjNThhMzQ4MTFjNzg2XzI2_728cf6cc-ed73-444c-a0c8-af155ff95728"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzQtMS0xLTEtMA_82951dee-7e81-4f2f-8c1f-73def463a9d6"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzQtMy0xLTEtMA_7d61d0c8-8974-4764-8ac1-c12f8e708ced"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjFjNDNhYzczMDU1ZDRlYzM5MjQyNzAxMzU4NTRiYTQ4XzI4_4b455b76-c1c8-4e57-a2f3-f80790d596f9"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjFjNDNhYzczMDU1ZDRlYzM5MjQyNzAxMzU4NTRiYTQ4XzI4_db6893bb-6e26-433b-93d4-584fadbb01ad"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjFjNDNhYzczMDU1ZDRlYzM5MjQyNzAxMzU4NTRiYTQ4XzQy_6a3e4577-13a2-43f3-9cbd-9630626c659d"
      unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjFjNDNhYzczMDU1ZDRlYzM5MjQyNzAxMzU4NTRiYTQ4XzQy_91608040-0d72-43d3-91d3-e440f3384b88"
      unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjFjNDNhYzczMDU1ZDRlYzM5MjQyNzAxMzU4NTRiYTQ4XzY0_513eeb1f-f367-47af-92f2-9b3d71811e4d"
      unitRef="shares">31299194</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjFjNDNhYzczMDU1ZDRlYzM5MjQyNzAxMzU4NTRiYTQ4XzY0_88240086-ecea-4785-9322-8ff61c5b199f"
      unitRef="shares">31299194</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzUtMS0xLTEtMA_76273220-bc55-43f6-b709-fdc5627ebde9"
      unitRef="usd">313000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzUtMy0xLTEtMA_1a56d710-caa5-4c89-a0e5-a4165bda91e2"
      unitRef="usd">313000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzYtMS0xLTEtMA_718f9986-e631-4a79-a358-0e0ce80bedce"
      unitRef="usd">388959000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzYtMy0xLTEtMA_90adca62-d635-4594-8e64-3bf88c1ce64f"
      unitRef="usd">382628000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzctMS0xLTEtMA_7ebbc5eb-7c45-466b-bd2a-645de7ec8ad7"
      unitRef="usd">461464000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzctMy0xLTEtMA_7ab39a61-a00a-4042-8f48-c434cd0267b6"
      unitRef="usd">457417000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzgtMS0xLTEtMA_954c7040-127d-4522-ab04-36ab557cc884"
      unitRef="usd">-62798000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzgtMy0xLTEtMA_a6615b53-65d2-4415-ad65-8d9e91b76d2c"
      unitRef="usd">-63681000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockShares
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzktMC0xLTEtMC90ZXh0cmVnaW9uOjdjZDY0NDU3Yjg1YjQ3M2I5YmRmNTIzMGY4MWI4MDk4XzEw_a6100a3c-706f-4f06-8f18-7537000304ac"
      unitRef="shares">2222233</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzktMC0xLTEtMC90ZXh0cmVnaW9uOjdjZDY0NDU3Yjg1YjQ3M2I5YmRmNTIzMGY4MWI4MDk4XzE3_0eea2ad4-0b6d-4472-8135-1f9f8f34cc28"
      unitRef="shares">2410045</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzktMS0xLTEtMA_8f2eff83-e12b-4969-8d8c-4e5b41a17216"
      unitRef="usd">62368000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfMzktMy0xLTEtMA_8bbf71b1-c26b-438e-9948-7246cc8f80cc"
      unitRef="usd">67639000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfNDAtMS0xLTEtMA_328881ea-3793-4601-9be4-b4980928fa86"
      unitRef="usd">725570000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfNDAtMy0xLTEtMA_53cbe7ab-17e8-47f0-b282-3ce9b09a1839"
      unitRef="usd">709038000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfNDEtMS0xLTEtMA_b359e4a8-077f-4dd9-927b-b83e65b953c0"
      unitRef="usd">1746612000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8xOS9mcmFnOjFhY2ExYTNlZTFiODQ0MGU5MjA0ODk5OTkzMjc2ZmRjL3RhYmxlOjMxNDRlN2MzNDkxMjQ4ZDBiMjY3MGIwZjNiN2JiOWRiL3RhYmxlcmFuZ2U6MzE0NGU3YzM0OTEyNDhkMGIyNjcwYjBmM2I3YmI5ZGJfNDEtMy0xLTEtMA_d4a3f045-030d-47f7-97dd-2274f5755da4"
      unitRef="usd">1751673000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="iae012f3fcd9f41fd9bc6e05669f51454_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMi0xLTEtMS0w_922c66b2-ba19-439c-b4aa-fc3fa6df3533"
      unitRef="shares">31299000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="iae012f3fcd9f41fd9bc6e05669f51454_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMi0yLTEtMS0w_347a464b-73e8-4251-864f-9198f536d9e4"
      unitRef="usd">313000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib8d0268193f046989c7a7367bc639b32_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMi0zLTEtMS0w_c633f2a3-f4ca-4bd2-aaf7-539e4154007e"
      unitRef="usd">382628000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i27c15051984d44e6b5c9858e676ca33c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMi00LTEtMS0w_d7539c50-715c-4c07-b56e-f69d380cb25f"
      unitRef="usd">457417000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i151d90f96de242678881f597e8015d38_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMi01LTEtMS0w_c6600e42-d9b8-424a-9736-0176a639efec"
      unitRef="usd">-63681000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2905d9021abd4b9ea314e60814616d57_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMi02LTEtMS0w_ecb55ae8-7253-4450-ae4f-bde112e1d764"
      unitRef="usd">-67639000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMi03LTEtMS0w_483612c8-3a58-4cd1-b404-103de33b3eca"
      unitRef="usd">709038000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="if3676449ae5744b184ad5f60ae92544f_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMy0zLTEtMS0w_80df5b52-022c-4c7f-9a2b-b68afd9fc9f2"
      unitRef="usd">2944000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ie64010a164eb46af89de3193d71e8fba_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMy02LTEtMS0w_18981237-e3ed-4b5f-8ad2-b7dbf4caa16f"
      unitRef="usd">5271000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMy03LTEtMS0w_6d575a2c-1464-4a3c-8ae5-b38fc4f9a18e"
      unitRef="usd">8215000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if3676449ae5744b184ad5f60ae92544f_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfNC0zLTEtMS0w_3948cd91-3d87-4d61-ad73-1b7bf1eca3c2"
      unitRef="usd">3387000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfNC03LTEtMS0w_9aa183d4-5ab7-4e60-bc35-4b9f6ec2fbef"
      unitRef="usd">3387000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfNS0wLTEtMS0wL3RleHRyZWdpb246MjVmM2RmNjk1ODc4NDJkOGFjMDQ0YmE2MjNmMzYyYzNfMzE_3872687a-beb6-48d6-b475-a441f5967129"
      unitRef="usdPerShare">0.20</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i96387733ca074ff7b4010cdd9df409b6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfNS00LTEtMS0w_836344cf-ad38-496d-a17d-8842cde1a6f8"
      unitRef="usd">5813000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfNS03LTEtMS0w_49d62c1d-6ebf-4928-a324-ab2040d7523e"
      unitRef="usd">5813000</us-gaap:DividendsCommonStockCash>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="if474f87feaa54dc0a8fcf5d08a768e3e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMTAtNS0xLTEtMTYxOQ_4d4ea368-ef73-46ea-9815-76d5eb8337b6"
      unitRef="usd">3926000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="if474f87feaa54dc0a8fcf5d08a768e3e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMTAtNS0xLTEtMA_0257a9e9-a247-470d-8234-177cd02fda93"
      unitRef="usd">-631000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="if474f87feaa54dc0a8fcf5d08a768e3e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMTEtNS0xLTEtMA_e2aec636-c26a-4753-969b-593414afadeb"
      unitRef="usd">-3674000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i96387733ca074ff7b4010cdd9df409b6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMTMtNC0xLTEtMA_7e0035ac-59cf-401b-a04b-fb37a4cd5e5e"
      unitRef="usd">9860000</us-gaap:NetIncomeLoss>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMTQtNy0xLTEtMA_fb35efe1-9844-41a0-845d-17eca7e6d295"
      unitRef="usd">10743000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="id31031a486b14a38af8dea7f3155fcb8_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMTUtMS0xLTEtMA_b41c486e-2431-47be-9252-760b276472e6"
      unitRef="shares">31299000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="id31031a486b14a38af8dea7f3155fcb8_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMTUtMi0xLTEtMA_43e1494e-ecc9-46c2-b39d-3b3a4f0385c2"
      unitRef="usd">313000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibac6966a355949378bb6c2fc42834ec1_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMTUtMy0xLTEtMA_d6d0a09f-a8fe-42ec-a075-e1cc32abaee1"
      unitRef="usd">388959000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib8f8f0e52b974b4e95f209ba842d8bb6_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMTUtNC0xLTEtMA_c013d483-2202-4e49-ad5c-a9fdb6f1b262"
      unitRef="usd">461464000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i029f793cce2d4474856e032865f1f946_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMTUtNS0xLTEtMA_6a394405-e5b8-4fbc-8ff6-af9f346a06bd"
      unitRef="usd">-62798000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i33ed66e8daf34fa8b10ccb54d98510cf_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMTUtNi0xLTEtMA_94900616-b3b1-4acf-a5f6-13eac8da48da"
      unitRef="usd">-62368000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjRiMGJkZmViNDFkNzQ1ZGU4OTM1YTE5MzNlNTE3ODc4L3RhYmxlcmFuZ2U6NGIwYmRmZWI0MWQ3NDVkZTg5MzVhMTkzM2U1MTc4NzhfMTUtNy0xLTEtMA_8e963bc8-c219-4cea-b94f-a8821e855538"
      unitRef="usd">725570000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i5e2c39713f4b45bf83812220f02bcfce_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMi0xLTEtMS0w_bffdd09c-a6ae-4dbf-b6bb-2a60b627e64c"
      unitRef="shares">31299000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i5e2c39713f4b45bf83812220f02bcfce_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMi0yLTEtMS0w_39608a8c-194a-4b81-9e60-125155e066ae"
      unitRef="usd">313000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ieebf93936a0b4946a4cebd127f100d98_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMi0zLTEtMS0w_2e71c061-2734-4163-ba67-d6a98e68de86"
      unitRef="usd">379324000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6b008cae44884d848870e03a18000ab9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMi00LTEtMS0w_d6c95a5b-b1d2-4e23-8154-2ec4becb7dc1"
      unitRef="usd">470844000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6cb501558a20431db8401ff4a527404c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMi01LTEtMS0w_72878d06-d3f1-4c64-8428-68054cdd4bb8"
      unitRef="usd">-59277000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iba78700e77d54679bf93d6b9acf74fae_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMi02LTEtMS0w_38314b01-90b2-4279-9896-b5ed0aa76b2f"
      unitRef="usd">-80737000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7e86d4601a4b4430ba15cc2ae32a9336_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMi03LTEtMS0w_355f0e58-88a9-412d-ab37-0eb781ee87a5"
      unitRef="usd">710467000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="icc2b6de697384224975fbf30994d9a87_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMy0zLTEtMS0w_cb8e3b77-aa45-4fe2-8e6e-b91217bf3bec"
      unitRef="usd">-7736000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i72ed1085bea54a3ca02ccafd38fb3dca_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMy02LTEtMS0w_32996bb3-ccef-4133-a695-d8392ff9cd98"
      unitRef="usd">2696000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMy03LTEtMS0w_f2a8bdd6-ba73-480d-8f45-20241535a423"
      unitRef="usd">-5040000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="icc2b6de697384224975fbf30994d9a87_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfNC0zLTEtMS0w_3ae4ffee-ea01-4455-aa2e-c5d47fb0e683"
      unitRef="usd">3032000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfNC03LTEtMS0w_9ac8c79a-4187-462d-8b43-9c5dac83ea25"
      unitRef="usd">3032000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfNS0wLTEtMS0wL3RleHRyZWdpb246YjcxMWMwZTVhNjE3NDBhMzkwYTdiOWFmOTQ0NDMxMDVfMzE_9d3b70c3-3546-41a4-92ba-cc25b02f112b"
      unitRef="usdPerShare">0.20</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i44890b61b4e54cd6a45ec9fe485dffab_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfNS00LTEtMS0w_9e79e860-fb6b-46b8-b878-1501222f3e17"
      unitRef="usd">5703000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfNS03LTEtMS0w_24f28d54-9d26-4878-9df1-d252eb58903a"
      unitRef="usd">5703000</us-gaap:DividendsCommonStockCash>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i95bc22c9cff4438ba21e7d9b6141399c_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfNy01LTEtMS0xNjM3_4dbcf823-04df-4a09-a2fd-59ede34301a3"
      unitRef="usd">2405000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i95bc22c9cff4438ba21e7d9b6141399c_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfOC01LTEtMS0xNjQw_9018268d-ae97-4594-813b-ac50d643e926"
      unitRef="usd">-535000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i95bc22c9cff4438ba21e7d9b6141399c_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMTAtNS0xLTEtMA_422c3c7a-c8b5-481f-aee7-5a24470ecc6e"
      unitRef="usd">-9988000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i44890b61b4e54cd6a45ec9fe485dffab_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMTMtNC0xLTEtMA_9cdab457-8b06-42fe-9348-8983ba7b999c"
      unitRef="usd">5927000</us-gaap:NetIncomeLoss>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMTQtNy0xLTEtMA_41705093-ea5b-4ec9-8b4b-9bc9c6aada26"
      unitRef="usd">-1121000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i1cc29bb8dbaa42239d37e7bb08963171_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMTYtMS0xLTEtMA_f81b583e-2187-4243-beb1-281be7c0f9f3"
      unitRef="shares">31299000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i1cc29bb8dbaa42239d37e7bb08963171_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMTYtMi0xLTEtMA_47381749-24db-45a9-824f-74787675d9da"
      unitRef="usd">313000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idc96afc7d3fb40a98303297d7f214b0e_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMTYtMy0xLTEtMA_bad5c2c5-fba1-4d4e-a9a5-86770f6898af"
      unitRef="usd">374620000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9cef9bc34cee464192cc0b9012143d3f_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMTYtNC0xLTEtMA_f7917abb-8709-46df-b468-a8e9b973be7e"
      unitRef="usd">471068000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7ec34830172747ee92a710ad30795223_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMTYtNS0xLTEtMA_a49e542e-a304-4196-affa-7b45a9b442a1"
      unitRef="usd">-66325000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i120ee47c2d2c46e08a15d763a7767f75_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMTYtNi0xLTEtMA_ff4b42d7-73bb-4cd8-aa2d-8d1b479dcbd6"
      unitRef="usd">-78041000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4c56f028fc084321a0e30cfeaea79a64_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yMi9mcmFnOjNkYzA2MTcxMTJjZjQ2ODY4YjQxZWMzMDcyZGYxOGVlL3RhYmxlOjdhZmJkNTQ1MjllMDQyMjk4MmI0YWVhY2YxYjk1NDk3L3RhYmxlcmFuZ2U6N2FmYmQ1NDUyOWUwNDIyOTgyYjRhZWFjZjFiOTU0OTdfMTYtNy0xLTEtMA_2cbfdeb8-7685-48bc-beac-c76c33a074a6"
      unitRef="usd">701635000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNC0xLTEtMS0w_e61f8bf8-b4c1-498d-be31-539883fe6c98"
      unitRef="usd">9860000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNC0zLTEtMS0w_618f0824-0fc3-413c-94a6-5e3e4aa1dd0d"
      unitRef="usd">5927000</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNi0xLTEtMS0w_8fe6d92b-dcc4-43d9-a706-3663313d747c"
      unitRef="usd">4757000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNi0zLTEtMS0w_9692ac0c-7b3e-408e-bcf4-9be196f3d884"
      unitRef="usd">4646000</us-gaap:Depreciation>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNy0xLTEtMS0w_df75bb64-92ff-4203-b85d-5ed9a637efe8"
      unitRef="usd">2503000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNy0zLTEtMS0w_1a4e994c-3e9e-49ff-8fd0-075c3ef60199"
      unitRef="usd">2264000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfOC0xLTEtMS0w_c2186d39-a4da-4ec4-8256-a2911ea6a61e"
      unitRef="usd">1058000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfOC0zLTEtMS0w_43b09bc4-9073-44db-b954-bc17c9657def"
      unitRef="usd">819000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:OtherAmortizationOfDeferredCharges
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfOS0xLTEtMS0w_63719d48-f2ca-4e2d-88e5-fac151b71383"
      unitRef="usd">13519000</us-gaap:OtherAmortizationOfDeferredCharges>
    <us-gaap:OtherAmortizationOfDeferredCharges
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfOS0zLTEtMS0w_b455ca26-834e-4a37-9d27-c9333a6de9a1"
      unitRef="usd">13776000</us-gaap:OtherAmortizationOfDeferredCharges>
    <us-gaap:ShareBasedCompensation
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMTAtMS0xLTEtMA_f6f360ad-1afd-4c3c-81a3-23dc5d6277b5"
      unitRef="usd">3387000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMTAtMy0xLTEtMA_c144293a-a0d2-4348-902e-8f8be6a02f4e"
      unitRef="usd">3032000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMTItMS0xLTEtMA_ebdb5ffd-a331-499b-81ec-32392d199dbf"
      unitRef="usd">-2688000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMTItMy0xLTEtMA_6042f334-c80e-4c08-bb55-bf4374b6c100"
      unitRef="usd">-2742000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMTUtMS0xLTEtMA_f1e36026-7bf7-49cb-8e2e-c13c0f2fd18e"
      unitRef="usd">-11957000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMTUtMy0xLTEtMA_09fb31c0-42d6-4f4c-aa96-07ef251a70d7"
      unitRef="usd">-19057000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMTYtMS0xLTEtMA_e3a62e0d-7248-4755-ba81-76a424aa4e46"
      unitRef="usd">11638000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMTYtMy0xLTEtMA_308c593b-4573-4093-b4c6-25e44ed5bc6b"
      unitRef="usd">12313000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMTctMS0xLTEtMA_50844257-dbe8-4b51-8c62-7313c426d704"
      unitRef="usd">2804000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMTctMy0xLTEtMA_37dc19b3-0f8c-4c6a-99af-f04f1aeaafb3"
      unitRef="usd">1705000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMTgtMS0xLTEtMA_cbc596ce-f0b6-47ed-b9a9-20a42ee4c42f"
      unitRef="usd">-8955000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMTgtMy0xLTEtMA_5938e52f-3fba-4b4e-a7f2-a1cc595e2cd8"
      unitRef="usd">-18397000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMTktMS0xLTEtMA_1cb08e62-a697-4aa2-802c-a6e6870a842d"
      unitRef="usd">6002000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMTktMy0xLTEtMA_ab7a630e-a9bc-4b54-8436-fccb72f81eb2"
      unitRef="usd">7260000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMjAtMS0xLTEtMA_b980b22f-8f05-4997-8301-b1d435b10eda"
      unitRef="usd">1782000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMjAtMy0xLTEtMA_86451596-8a43-4664-9f13-b0603ae3ee88"
      unitRef="usd">-6793000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMjItMS0xLTEtMA_9c4b667c-5fe7-427b-8470-8db26d27a9d7"
      unitRef="usd">22344000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMjItMy0xLTEtMA_c2333a52-09a9-4f02-94f2-67c47c4e3de3"
      unitRef="usd">3721000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMjYtMS0xLTEtMA_aa0ad3e5-9fc9-4c3a-9d57-76ee874582a5"
      unitRef="usd">3109000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMjYtMy0xLTEtMA_22d7ed1d-06ea-4c4e-8e44-4cc3fac169e0"
      unitRef="usd">2825000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <cnmd:Paymentsrelatedtobusinessacquisitionsandassetacquisitions
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMjctMS0xLTEtMA_a1bd0b0b-62ce-40e3-9443-5c257ffe652e"
      unitRef="usd">0</cnmd:Paymentsrelatedtobusinessacquisitionsandassetacquisitions>
    <cnmd:Paymentsrelatedtobusinessacquisitionsandassetacquisitions
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMjctMy0xLTEtMA_8e41ad81-4f28-4402-abda-ecfcd613e357"
      unitRef="usd">3852000</cnmd:Paymentsrelatedtobusinessacquisitionsandassetacquisitions>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMjgtMS0xLTEtMA_b68f4c0a-c791-4f2f-b58b-3cdee1eed681"
      unitRef="usd">-3109000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMjgtMy0xLTEtMA_05579990-47cc-4e69-8a79-212330703b3f"
      unitRef="usd">-6677000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMzEtMS0xLTEtMA_92121dc5-a157-4f89-9308-fb6915030004"
      unitRef="usd">3313000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMzEtMy0xLTEtMA_a557660f-71b1-4d2d-a559-ec6a6223f817"
      unitRef="usd">3313000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMzQtMS0xLTEtMA_94a72845-e399-49d8-97c4-e2558cb7b4aa"
      unitRef="usd">72000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMzQtMy0xLTEtMA_84eb4bd9-7395-4005-b8a7-12e356e4782b"
      unitRef="usd">41000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMzUtMS0xLTEtMA_e6287a5c-ba12-4489-8851-5b1c36c88c24"
      unitRef="usd">64000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMzUtMy0xLTEtMA_e95f7f0d-d7dd-4072-9aeb-ed81161ffaae"
      unitRef="usd">59000000</us-gaap:ProceedsFromLinesOfCredit>
    <cnmd:PaymentsForContingentConsideration
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMzctMS0xLTEtMA_c0e0a39d-9f0d-462d-a03f-7d2b0f667fc9"
      unitRef="usd">0</cnmd:PaymentsForContingentConsideration>
    <cnmd:PaymentsForContingentConsideration
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMzctMy0xLTEtMA_f98b1198-2993-49c1-9868-1f11451a31fc"
      unitRef="usd">1133000</cnmd:PaymentsForContingentConsideration>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMzktMS0xLTEtMA_eb291e8d-0bc0-4617-943a-13f0e176ba50"
      unitRef="usd">5775000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfMzktMy0xLTEtMA_dd840db3-cc7e-4d94-9524-c4a77567c878"
      unitRef="usd">5683000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNDItMS0xLTEtMA_d38854de-a4bc-4b6d-a554-aa376454cfb4"
      unitRef="usd">8216000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNDItMy0xLTEtMA_98051a94-8537-49b3-ae05-108641e3b085"
      unitRef="usd">-5132000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNDMtMS0xLTEtMA_4672aa22-545e-4467-8fc1-584fc15598cf"
      unitRef="usd">-8872000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNDMtMy0xLTEtMA_9421a34b-db7c-4ddf-8128-70a649b83e0d"
      unitRef="usd">2739000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNDUtMS0xLTEtMA_a875f7fc-9ce9-464a-b6a3-897874d6f98e"
      unitRef="usd">-950000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNDUtMy0xLTEtMA_a8729a41-6530-4d1e-baea-e541c9720db7"
      unitRef="usd">-1330000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNDctMS0xLTEtMA_636ad000-66a0-4a89-a811-92f99c32dcfd"
      unitRef="usd">9413000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNDctMy0xLTEtMA_7cfce18d-c4ad-4edd-8cc4-d71856749ef6"
      unitRef="usd">-1547000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNDktMS0xLTEtMA_a8c65645-86f4-482d-a044-889185e67236"
      unitRef="usd">27356000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7e86d4601a4b4430ba15cc2ae32a9336_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNDktMy0xLTEtMA_305c503b-1e1b-45e0-9240-a366b5cbaaa3"
      unitRef="usd">25856000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNTEtMS0xLTEtMA_1cead05f-f3c8-4587-8474-af3ba5bac8e2"
      unitRef="usd">36769000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4c56f028fc084321a0e30cfeaea79a64_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNTEtMy0xLTEtMA_dee1aa4a-57d1-4d51-a0c4-a1d740b8adcf"
      unitRef="usd">24309000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNTQtMS0xLTEtMA_e5a021aa-ff79-4035-bf56-b8dff1e718ce"
      unitRef="usd">5813000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="i4c56f028fc084321a0e30cfeaea79a64_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8yNS9mcmFnOjlkNzQ2N2U3YmM2MDQxMjc4N2FiMWQ1MDc0YzU5ZGZjL3RhYmxlOmFhMmM2ZWVlNzM0ZjRlZGFhNGE4NWQ0OWE0MmVlNDBiL3RhYmxlcmFuZ2U6YWEyYzZlZWU3MzRmNGVkYWE0YTg1ZDQ5YTQyZWU0MGJfNTQtMy0xLTEtMA_5fe156ae-7764-4900-997d-fe70e33d6001"
      unitRef="usd">5703000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:NatureOfOperations
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8zMS9mcmFnOjMxMTFmZTMyY2VkYzRmNmI4YjJlNDJmMGNiODVjZTcwL3RleHRyZWdpb246MzExMWZlMzJjZWRjNGY2YjhiMmU0MmYwY2I4NWNlNzBfMzk2_f44ddd58-b5d3-419e-8565-86456c6de7e2">OperationsCONMED Corporation (&#x201c;CONMED&#x201d;, the &#x201c;Company&#x201d;, &#x201c;we&#x201d; or &#x201c;us&#x201d;) is a medical technology company that provides surgical devices and equipment for minimally invasive procedures.&#160;&#160;The Company&#x2019;s products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology.</us-gaap:NatureOfOperations>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8zNC9mcmFnOjM5MGQzNGRhNmU2MTQ2NjE4ZjkwN2U1YzdhZjFkZGE5L3RleHRyZWdpb246MzkwZDM0ZGE2ZTYxNDY2MThmOTA3ZTVjN2FmMWRkYTlfMjEzOQ_74d4ae1c-0d73-4063-9193-e4a1c7c543ec">Interim Financial Information&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited consolidated condensed financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for annual financial statements.  The information herein reflects all normal recurring material adjustments, which are, in the opinion of management, necessary to fairly present the results for the periods presented.  The consolidated condensed financial statements herein consist of all wholly-owned domestic and foreign subsidiaries with all significant intercompany transactions eliminated.  Results for the period ended March&#160;31, 2021 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated condensed financial statements and notes thereto should be read in conjunction with the consolidated financial statements and notes for the year ended December&#160;31, 2020 included in our Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Preparation of the consolidated condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated condensed financial statements and the reported amounts of revenue and expenses during the reporting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due to the COVID-19 pandemic, there has been uncertainty and disruption in the global economy and financial markets. We are not aware of any specific event or circumstance that would require an update to our estimates or judgments or a revision of the carrying value of our assets or liabilities as of&#160;April&#160;29, 2021, the date of issuance of this Quarterly Report on Form 10-Q.  These estimates may change, as new events occur and additional information is obtained. Actual results could differ materially from these estimates under different assumptions or conditions.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF8zNC9mcmFnOjM5MGQzNGRhNmU2MTQ2NjE4ZjkwN2U1YzdhZjFkZGE5L3RleHRyZWdpb246MzkwZDM0ZGE2ZTYxNDY2MThmOTA3ZTVjN2FmMWRkYTlfMjE0MQ_7c91d408-89e4-4afd-bef5-61bd7607be3c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Preparation of the consolidated condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated condensed financial statements and the reported amounts of revenue and expenses during the reporting period.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RleHRyZWdpb246NWMzMDgwYmQ4M2RmNDU4ZWEwMjUxMjRiZTI0YjMxZjlfNTEz_4597fe73-8c69-49b1-97e6-24dab47afba6">Revenues&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present revenue disaggregated by primary geographic market where the products are sold, by product line and timing of revenue recognition: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Orthopedic Surgery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;General Surgery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Orthopedic Surgery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;General Surgery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Primary Geographic Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe, Middle East &amp;amp; Africa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas (excluding the United States)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total sales from contracts with customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Timing of Revenue Recognition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goods transferred at a point in time&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Services transferred over time&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total sales from contracts with customers&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liability balances related to the sale of extended warranties to customers are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.826%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue recognized during the three months ended March&#160;31, 2021 and March&#160;31, 2020 from amounts included in contract liabilities at the beginning of the period were $3.4 million and $3.0 million, respectively.  There were no material contract assets as of March&#160;31, 2021 and December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RleHRyZWdpb246NWMzMDgwYmQ4M2RmNDU4ZWEwMjUxMjRiZTI0YjMxZjlfNTE1_dd553447-a4c8-44ff-98d1-88178b8fb2fd">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present revenue disaggregated by primary geographic market where the products are sold, by product line and timing of revenue recognition: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Orthopedic Surgery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;General Surgery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Orthopedic Surgery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;General Surgery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Primary Geographic Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe, Middle East &amp;amp; Africa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas (excluding the United States)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total sales from contracts with customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Timing of Revenue Recognition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goods transferred at a point in time&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Services transferred over time&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total sales from contracts with customers&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie62997345e524027a79ecf64d5ed0611_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNC0xLTEtMS0w_e0695ac9-d494-4888-b97f-2b1fed4545a3"
      unitRef="usd">37131000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3fd2671e438a474faa38d3e9a2c3f250_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNC0zLTEtMS0w_0bcad251-9bd7-47cf-923b-8eb01e3ab3ca"
      unitRef="usd">86812000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4190bedf816e408ca9d02bfd966a3366_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNC01LTEtMS0w_b9d46602-3e8e-465d-b7ce-30faef35c20c"
      unitRef="usd">123943000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieb19adcd1a5d48da93ca6e4fe100bba2_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNC03LTEtMS0w_3375d9fc-6454-44cc-be8d-069428f9e325"
      unitRef="usd">37039000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i775199af495945bf86d1df93013e716d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNC05LTEtMS0w_a1d3d103-da52-46af-a5a2-5abc4f603c5f"
      unitRef="usd">81808000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8caf0668d2a043b99300c2d015a59f5e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNC0xMS0xLTEtMA_f17d902f-d8e1-4bd2-b013-941b3a1520b5"
      unitRef="usd">118847000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2d5cbd26c2e34fcca879ebd88ed26bbc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNS0xLTEtMS0xNTkx_a7a0065d-130e-4f5c-bb2f-9fe72aaac79f"
      unitRef="usd">26052000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3c4dbcab20b64473a815fafab7bb519b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNS0zLTEtMS0xNTkx_11b2d194-d98e-4b04-8775-253dad78bc5a"
      unitRef="usd">18544000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iacc6728071cc42afac66a950fd77c7ec_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNS01LTEtMS0xNTkx_40b020ba-3d08-4ec0-9b1f-b4b4536780cb"
      unitRef="usd">44596000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id693351de21b454f9ad10a807a5dd52f_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNS03LTEtMS0xNTkx_3df5c877-6da5-426c-a6b0-6f314142c84a"
      unitRef="usd">25907000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibb2a8238876248f585425eb5051bb474_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNS05LTEtMS0xNTkx_93e7d693-0de4-452c-912c-b0d0ecc2be8a"
      unitRef="usd">16615000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i29730944e6d14730a59d95854830ef68_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNS0xMS0xLTEtMTU5MQ_be6f3b4b-554f-4015-90a8-fbeb2c86f671"
      unitRef="usd">42522000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9bf13cfe5c8b4c3c98489e1e906361e1_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNS0xLTEtMS0w_4252253f-113d-4cd2-863f-0fefa39a2d06"
      unitRef="usd">26602000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8985ce744656405e85a504c9d31badd8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNS0zLTEtMS0w_6afc4c87-bb8d-4064-b8c7-77de3c1cb23b"
      unitRef="usd">12662000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifbade5dec7f741f6a1a4d181a6fd7c0a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNS01LTEtMS0w_49b3498a-447d-4fcc-b2cc-cb32132a0c3e"
      unitRef="usd">39264000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe2d2ede0d054d3ea31d7f38ad84c165_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNS03LTEtMS0w_9397b88c-cc61-4f01-88c5-142f899d4c65"
      unitRef="usd">20535000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib4d5dfe5f1934d3982cae7661c4cf533_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNS05LTEtMS0w_487efac1-a1d9-46c1-88b1-bf33f131dc02"
      unitRef="usd">8325000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib4c14268949c4a94b1580a7aeb78ecbb_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNS0xMS0xLTEtMA_6cd5dc4b-752b-416e-998b-26fdf0b1ce1f"
      unitRef="usd">28860000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7bbfa0455ef7435a9f76aa8e63565ef5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNy0xLTEtMS0w_c8cc3de9-58e5-4533-b9c5-985477cc4f74"
      unitRef="usd">17381000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i68905b6fbdec4d4cb2932ea45ef02924_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNy0zLTEtMS0w_64da8ad0-fef2-49b8-9b6f-408b3f47b910"
      unitRef="usd">7493000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idb1d2f66658942c69084f7e2616e914f_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNy01LTEtMS0w_f836649a-ec47-4a24-8a6b-eb23eb727d11"
      unitRef="usd">24874000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9c75aafd2b4c449c95acdba707112745_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNy03LTEtMS0w_fb1053a2-fb7c-410e-8b59-cd8ca8f3f736"
      unitRef="usd">15802000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i76d7ef8d98cb4ff19a021ad02e67da31_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNy05LTEtMS0w_6bf50ca6-7020-400a-a88a-8eca558ea1cf"
      unitRef="usd">7979000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2cdefd0b0a3045d49ceeadee9e6bb36b_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfNy0xMS0xLTEtMA_c530b156-1f2e-47df-b3d5-a5b39397dac2"
      unitRef="usd">23781000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia86b4262c6984bb6ad658ce074db008e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfOC0xLTEtMS0w_eda337a8-b8d1-4a1a-bbe2-df52684c8d3d"
      unitRef="usd">107166000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id802a374e8af403cb3d3822bd10d7c08_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfOC0zLTEtMS0w_1b597b1b-8bbb-49fa-ac71-059fffed260c"
      unitRef="usd">125511000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfOC01LTEtMS0w_96e19e1d-2546-4967-8161-d29370ca5949"
      unitRef="usd">232677000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9557a8db05ee41ffaa88a992a0b82938_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfOC03LTEtMS0w_0e2c0c87-a6af-4a6a-bcb9-a914063fc4e8"
      unitRef="usd">99283000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2a7ac877916a4014a3fb26b999be79af_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfOC05LTEtMS0w_9bbe9e98-7907-43d4-8bc6-257f06066179"
      unitRef="usd">114727000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfOC0xMS0xLTEtMA_1173c061-7ebe-4af5-838a-5806f935f280"
      unitRef="usd">214010000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if94e1dc3dd564aaebe0c764b728d2713_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfMTEtMS0xLTEtMA_f55b75a3-7448-4df2-96ff-c5a9c1d0dfaa"
      unitRef="usd">97690000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icfadd8f8b84b4fdf903364c77b8920f3_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfMTEtMy0xLTEtMA_e7c2cc7b-b099-438a-b960-630067fd9068"
      unitRef="usd">124394000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5f20b36e15fb425494acd84a048f7177_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfMTEtNS0xLTEtMA_eac9e0db-d788-4875-a77d-2c8ed9b78eb8"
      unitRef="usd">222084000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i11161ef39ae1485b8d27a2ae4c22875d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfMTEtNy0xLTEtMA_544582d2-04e3-4334-bc09-1be310058ffb"
      unitRef="usd">90553000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i782cd02ea1ba4cd78b680a524b6ca850_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfMTEtOS0xLTEtMA_2a7b348b-32d1-40b7-b87a-916c8a91872a"
      unitRef="usd">113901000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1a74e7f2ffa04fa0814e8231216941c4_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfMTEtMTEtMS0xLTA_eeb301bb-191e-4cd6-926c-9a281a60a53b"
      unitRef="usd">204454000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib20f23593d444604b32c771d7959b0ca_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfMTItMS0xLTEtMA_77eb4287-b7cf-4f69-ae0e-b0a407b0326e"
      unitRef="usd">9476000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5d4311b6e8044c8894a8f3e8bba1645c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfMTItMy0xLTEtMA_7586f0aa-85ee-4804-96f7-38f440cf89d0"
      unitRef="usd">1117000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e128db3c81e4e588034d3c0247dee80_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfMTItNS0xLTEtMA_adefd34c-6833-4454-93f8-1bcca9a0499e"
      unitRef="usd">10593000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7057925e589d42faa6a4fb3ddf23bbd6_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfMTItNy0xLTEtMA_a4313292-f842-447d-9b9e-7fd13e80cc41"
      unitRef="usd">8730000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if74b6b7e82ac4212bba27824114d47b4_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfMTItOS0xLTEtMA_6253eef3-1dca-4ba8-90e2-7e00fd7ab27a"
      unitRef="usd">826000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i12d7e0dffb5e4869af8c81221b0c0a7f_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfMTItMTEtMS0xLTA_31a6912d-ead8-4a2b-9b68-ae03858f8d11"
      unitRef="usd">9556000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia86b4262c6984bb6ad658ce074db008e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfMTMtMS0xLTEtMA_b917d1b8-81dd-422f-af4f-fa17d0e43f40"
      unitRef="usd">107166000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id802a374e8af403cb3d3822bd10d7c08_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfMTMtMy0xLTEtMA_d40c3cc2-9be1-49c6-b119-2b49775818c5"
      unitRef="usd">125511000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfMTMtNS0xLTEtMA_419c81d4-b5c4-498d-b092-5cf2e5587ad2"
      unitRef="usd">232677000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9557a8db05ee41ffaa88a992a0b82938_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfMTMtNy0xLTEtMA_4f329020-b9ae-48d9-b7fa-e6fe253ff19c"
      unitRef="usd">99283000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2a7ac877916a4014a3fb26b999be79af_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfMTMtOS0xLTEtMA_6d74c1e5-2dcd-4369-a2c6-75a8a44c1bdf"
      unitRef="usd">114727000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOmUxMTNiOTc4MzIyODQzMDVhYTYzNjdiZDI0YWY1ZWM2L3RhYmxlcmFuZ2U6ZTExM2I5NzgzMjI4NDMwNWFhNjM2N2JkMjRhZjVlYzZfMTMtMTEtMS0xLTA_b36da887-54ae-40bb-8383-49eaeb572e71"
      unitRef="usd">214010000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RleHRyZWdpb246NWMzMDgwYmQ4M2RmNDU4ZWEwMjUxMjRiZTI0YjMxZjlfNTIz_5fc2fec6-e35a-4c30-a8ea-4e8487eb5bd3">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liability balances related to the sale of extended warranties to customers are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.826%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOjhmMTUyMmI1OGVkODQzMTg5ZDhhMDdjZjhmM2NmYzRkL3RhYmxlcmFuZ2U6OGYxNTIyYjU4ZWQ4NDMxODlkOGEwN2NmOGYzY2ZjNGRfMi0xLTEtMS0w_02e7eecb-2952-41dc-860b-86e88722b434"
      unitRef="usd">15231000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RhYmxlOjhmMTUyMmI1OGVkODQzMTg5ZDhhMDdjZjhmM2NmYzRkL3RhYmxlcmFuZ2U6OGYxNTIyYjU4ZWQ4NDMxODlkOGEwN2NmOGYzY2ZjNGRfMi0zLTEtMS0w_7d82a2cf-6c00-43da-a08d-7e5be3fa92d1"
      unitRef="usd">13666000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RleHRyZWdpb246NWMzMDgwYmQ4M2RmNDU4ZWEwMjUxMjRiZTI0YjMxZjlfNDMw_986fe9e3-b20f-4d1a-8013-4b585de0c0b8"
      unitRef="usd">3400000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80MC9mcmFnOjVjMzA4MGJkODNkZjQ1OGVhMDI1MTI0YmUyNGIzMWY5L3RleHRyZWdpb246NWMzMDgwYmQ4M2RmNDU4ZWEwMjUxMjRiZTI0YjMxZjlfNDM3_3da55bbc-5f5b-4325-be67-fc49164a9543"
      unitRef="usd">3000000.0</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RleHRyZWdpb246ZjhhOTI2NTdlY2MyNDJjOTk4ZGQ2ZmQwMTllN2U1MTRfNDgw_5d46a1a8-8a45-4ae5-97fd-d68dd5abd294">Comprehensive Income (Loss)&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive income (loss) consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedging gain, net of income tax (income tax expense of $1,250 and $766 for the three months ended March 31, 2021 and 2020, respectively)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension liability, net of income tax (income tax expense of $201 and $170 for the three months ended March 31, 2021 and 2020, respectively)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,674)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,988)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive loss consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash Flow&lt;br/&gt;Hedging&lt;br/&gt;Gain (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;br/&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cumulative&lt;br/&gt;Translation&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,945)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,620)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63,681)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,674)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(949)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income (loss) before tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;a&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(383)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(201)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,674)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,989)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,790)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62,798)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash Flow&lt;br/&gt;Hedging&lt;br/&gt;Gain (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;br/&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cumulative&lt;br/&gt;Translation&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,691)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,079)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59,277)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,988)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,731)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income (loss) before tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;a&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,124)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(419)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,988)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,048)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,156)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,067)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66,325)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)  The cash flow hedging gain (loss) and pension liability accumulated other comprehensive income (loss) components are included in sales or cost of sales and as a component of net periodic pension cost, respectively.  Refer to Note 5 and Note 11, respectively, for further details.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RleHRyZWdpb246ZjhhOTI2NTdlY2MyNDJjOTk4ZGQ2ZmQwMTllN2U1MTRfNDU3_1e5e6280-f17f-4b96-be1f-94f7965c5a08">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive income (loss) consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedging gain, net of income tax (income tax expense of $1,250 and $766 for the three months ended March 31, 2021 and 2020, respectively)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension liability, net of income tax (income tax expense of $201 and $170 for the three months ended March 31, 2021 and 2020, respectively)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,674)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,988)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOmQ3NWQ0MzliM2I1NDQ0N2Q4MjllZjY4NGZhOTY1Zjk5L3RhYmxlcmFuZ2U6ZDc1ZDQzOWIzYjU0NDQ3ZDgyOWVmNjg0ZmE5NjVmOTlfMi0xLTEtMS0w_41305769-9f00-4fa4-9a6d-ca00cb8120f1"
      unitRef="usd">9860000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOmQ3NWQ0MzliM2I1NDQ0N2Q4MjllZjY4NGZhOTY1Zjk5L3RhYmxlcmFuZ2U6ZDc1ZDQzOWIzYjU0NDQ3ZDgyOWVmNjg0ZmE5NjVmOTlfMi0zLTEtMS0w_103d19d3-f2a5-46f0-a818-6517c155725d"
      unitRef="usd">5927000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOmQ3NWQ0MzliM2I1NDQ0N2Q4MjllZjY4NGZhOTY1Zjk5L3RhYmxlcmFuZ2U6ZDc1ZDQzOWIzYjU0NDQ3ZDgyOWVmNjg0ZmE5NjVmOTlfNS0wLTEtMS0xNjQ1L3RleHRyZWdpb246YmJhODNmYmE5YTMwNDRlNWFjNjAxNDdhMTMwZWYxZjRfODY_4a13dce7-a45a-439d-9166-52e15b74e6b6"
      unitRef="usd">-1250000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOmQ3NWQ0MzliM2I1NDQ0N2Q4MjllZjY4NGZhOTY1Zjk5L3RhYmxlcmFuZ2U6ZDc1ZDQzOWIzYjU0NDQ3ZDgyOWVmNjg0ZmE5NjVmOTlfNS0wLTEtMS0xNjQ1L3RleHRyZWdpb246YmJhODNmYmE5YTMwNDRlNWFjNjAxNDdhMTMwZWYxZjRfOTM_45dfcc09-5fc5-4bb6-8f83-97b4d87b77fc"
      unitRef="usd">-766000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOmQ3NWQ0MzliM2I1NDQ0N2Q4MjllZjY4NGZhOTY1Zjk5L3RhYmxlcmFuZ2U6ZDc1ZDQzOWIzYjU0NDQ3ZDgyOWVmNjg0ZmE5NjVmOTlfNS0xLTEtMS0xNjQ1_126eb743-cae8-4e68-bfbd-912fe30d5428"
      unitRef="usd">3926000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOmQ3NWQ0MzliM2I1NDQ0N2Q4MjllZjY4NGZhOTY1Zjk5L3RhYmxlcmFuZ2U6ZDc1ZDQzOWIzYjU0NDQ3ZDgyOWVmNjg0ZmE5NjVmOTlfNS0zLTEtMS0xNjQ1_ab05c4dc-5c8a-4f92-aedf-ff0c390aefa2"
      unitRef="usd">2405000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOmQ3NWQ0MzliM2I1NDQ0N2Q4MjllZjY4NGZhOTY1Zjk5L3RhYmxlcmFuZ2U6ZDc1ZDQzOWIzYjU0NDQ3ZDgyOWVmNjg0ZmE5NjVmOTlfNi0wLTEtMS0wL3RleHRyZWdpb246MmY0MThiMTQ1Y2ZiNDU5NzlhNWJiNTY3MWVjZWNlM2JfNjQ_9cf8cd84-bf37-4dd7-a4e5-42baaa0eb316"
      unitRef="usd">201000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOmQ3NWQ0MzliM2I1NDQ0N2Q4MjllZjY4NGZhOTY1Zjk5L3RhYmxlcmFuZ2U6ZDc1ZDQzOWIzYjU0NDQ3ZDgyOWVmNjg0ZmE5NjVmOTlfNi0wLTEtMS0wL3RleHRyZWdpb246MmY0MThiMTQ1Y2ZiNDU5NzlhNWJiNTY3MWVjZWNlM2JfNzE_b950b559-2fca-4454-be35-66b125416b29"
      unitRef="usd">170000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOmQ3NWQ0MzliM2I1NDQ0N2Q4MjllZjY4NGZhOTY1Zjk5L3RhYmxlcmFuZ2U6ZDc1ZDQzOWIzYjU0NDQ3ZDgyOWVmNjg0ZmE5NjVmOTlfNi0xLTEtMS0w_330d2b2f-c3f3-45f2-be00-ece95168a8d2"
      unitRef="usd">-631000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOmQ3NWQ0MzliM2I1NDQ0N2Q4MjllZjY4NGZhOTY1Zjk5L3RhYmxlcmFuZ2U6ZDc1ZDQzOWIzYjU0NDQ3ZDgyOWVmNjg0ZmE5NjVmOTlfNi0zLTEtMS0w_0a60f6c3-083d-4c3a-bbc0-153c0b31e676"
      unitRef="usd">-535000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOmQ3NWQ0MzliM2I1NDQ0N2Q4MjllZjY4NGZhOTY1Zjk5L3RhYmxlcmFuZ2U6ZDc1ZDQzOWIzYjU0NDQ3ZDgyOWVmNjg0ZmE5NjVmOTlfOC0xLTEtMS0xNDk4_890e3f3b-367e-443e-9fea-0c8803ab5bc5"
      unitRef="usd">-3674000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOmQ3NWQ0MzliM2I1NDQ0N2Q4MjllZjY4NGZhOTY1Zjk5L3RhYmxlcmFuZ2U6ZDc1ZDQzOWIzYjU0NDQ3ZDgyOWVmNjg0ZmE5NjVmOTlfOC0xLTEtMS0xNDk4_e0e45703-df24-46b3-a7a7-8143a062db3c"
      unitRef="usd">-3674000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOmQ3NWQ0MzliM2I1NDQ0N2Q4MjllZjY4NGZhOTY1Zjk5L3RhYmxlcmFuZ2U6ZDc1ZDQzOWIzYjU0NDQ3ZDgyOWVmNjg0ZmE5NjVmOTlfOC0zLTEtMS0xNTA0_af205491-1d5e-4780-9fd3-85b63eeabb93"
      unitRef="usd">-9988000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOmQ3NWQ0MzliM2I1NDQ0N2Q4MjllZjY4NGZhOTY1Zjk5L3RhYmxlcmFuZ2U6ZDc1ZDQzOWIzYjU0NDQ3ZDgyOWVmNjg0ZmE5NjVmOTlfOS0xLTEtMS0w_9365023c-1d04-45af-b0be-65eea173e5b2"
      unitRef="usd">10743000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOmQ3NWQ0MzliM2I1NDQ0N2Q4MjllZjY4NGZhOTY1Zjk5L3RhYmxlcmFuZ2U6ZDc1ZDQzOWIzYjU0NDQ3ZDgyOWVmNjg0ZmE5NjVmOTlfOS0zLTEtMS0w_969ed10b-3e4a-44b2-9f80-a7d62359a5d7"
      unitRef="usd">-1121000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RleHRyZWdpb246ZjhhOTI2NTdlY2MyNDJjOTk4ZGQ2ZmQwMTllN2U1MTRfNDUy_67f301d7-2294-47e3-9c68-a7bc784a1d97">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive loss consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash Flow&lt;br/&gt;Hedging&lt;br/&gt;Gain (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;br/&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cumulative&lt;br/&gt;Translation&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,945)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,620)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63,681)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,674)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(949)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income (loss) before tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;a&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(383)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(201)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,674)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,989)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,790)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62,798)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash Flow&lt;br/&gt;Hedging&lt;br/&gt;Gain (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;br/&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cumulative&lt;br/&gt;Translation&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,691)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,079)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59,277)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,988)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,731)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income (loss) before tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;a&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,124)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(419)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,988)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,048)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,156)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,067)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66,325)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)  The cash flow hedging gain (loss) and pension liability accumulated other comprehensive income (loss) components are included in sales or cost of sales and as a component of net periodic pension cost, respectively.  Refer to Note 5 and Note 11, respectively, for further details.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i01ec3e073702455c9e537fe9a5385abb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfMS0xLTEtMS0w_c6bc204e-f383-4710-b358-7f7426d0ad29"
      unitRef="usd">-5945000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i0b7ea3f8782943fcbc4ba9d0d76b3ec1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfMS0zLTEtMS0w_5c155b28-50d5-4d36-bc06-ab6e876180cd"
      unitRef="usd">-36620000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i1adb37865c4441248b72947844ddca28_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfMS01LTEtMS0w_75f842d2-a151-4941-b67b-ab2b66774cb6"
      unitRef="usd">-21116000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i151d90f96de242678881f597e8015d38_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfMS03LTEtMS0w_87a84f53-da1c-4886-9c27-ce3931c904ae"
      unitRef="usd">-63681000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i6d3af65fad6f44f0b3d057bbf55a6a78_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfMy0xLTEtMS0w_49b50a6c-0683-409a-ac9c-d842d7fd81de"
      unitRef="usd">2725000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="iad15f0679e6b4c0d9ac7119db78f9c33_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfMy0zLTEtMS0w_9cd5a6c1-4456-4c12-b839-70ebb5772bf2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ia1dc7178d7a640169fb15973f1266566_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfMy01LTEtMS0w_1086cf77-672e-42c4-a67f-32f181a78aba"
      unitRef="usd">-3674000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="if474f87feaa54dc0a8fcf5d08a768e3e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfMy03LTEtMS0w_d4db72e5-7afb-43e8-aa54-38681ab728fa"
      unitRef="usd">-949000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i6d3af65fad6f44f0b3d057bbf55a6a78_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNC0xLTEtMS0w_e5da9a35-d40d-4807-a614-2a0192f2d59f"
      unitRef="usd">-1584000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="iad15f0679e6b4c0d9ac7119db78f9c33_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNC0zLTEtMS0w_e2eaf120-37e1-465c-b2ed-24e267ffb15d"
      unitRef="usd">-832000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ia1dc7178d7a640169fb15973f1266566_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNC01LTEtMS0w_1846a0b4-0c4b-442c-8e88-61f74f76dd73"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="if474f87feaa54dc0a8fcf5d08a768e3e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNC03LTEtMS0w_7d609658-4f9f-4a30-a5c9-fcb8abb16924"
      unitRef="usd">-2416000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i6d3af65fad6f44f0b3d057bbf55a6a78_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNS0xLTEtMS0w_70cf523c-2a18-4116-879a-96bf775cf50b"
      unitRef="usd">-383000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="iad15f0679e6b4c0d9ac7119db78f9c33_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNS0zLTEtMS0w_f16d15a2-982e-4678-94e0-380e2007b043"
      unitRef="usd">-201000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ia1dc7178d7a640169fb15973f1266566_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNS01LTEtMS0w_0041e0de-12fd-486b-a42a-0ba79d882842"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="if474f87feaa54dc0a8fcf5d08a768e3e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNS03LTEtMS0w_e5bcbb4e-50a8-4b6f-8ff8-00d950e08250"
      unitRef="usd">-584000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6d3af65fad6f44f0b3d057bbf55a6a78_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNy0xLTEtMS0w_9bf094b1-fb34-4408-b295-358c28ef71b2"
      unitRef="usd">3926000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iad15f0679e6b4c0d9ac7119db78f9c33_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNy0zLTEtMS0w_b620c6de-a539-4c48-9a0a-ac72236be37f"
      unitRef="usd">631000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia1dc7178d7a640169fb15973f1266566_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNy01LTEtMS0w_faeea029-6e8a-4728-9649-b7a3d89526e5"
      unitRef="usd">-3674000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if474f87feaa54dc0a8fcf5d08a768e3e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNy03LTEtMS0w_2394f9a0-2499-4ccb-aef6-ccc5218cce03"
      unitRef="usd">883000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i8245a6aa10f94c0bbcc41d1b62a19629_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfOS0xLTEtMS0w_98658507-75ae-498e-a019-8cd6790feed5"
      unitRef="usd">-2019000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i8c348cefc0004f5a84965d0ccc163ea3_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfOS0zLTEtMS0w_584b7976-4bdc-48ae-80bf-dec885660ae3"
      unitRef="usd">-35989000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i07bd77a73b3545aa8a2104efd8e434fd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfOS01LTEtMS0w_cdafc7f2-5024-4456-b136-2b159b391930"
      unitRef="usd">-24790000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i029f793cce2d4474856e032865f1f946_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfOS03LTEtMS0w_91dbe9c5-6643-49a4-b060-dfa60155192a"
      unitRef="usd">-62798000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i3fab3fd5ae6d4130a6074da5f6e613ae_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfMS0xLTEtMS0w_63e10b35-1f66-4c80-ba8f-9f0eae28d856"
      unitRef="usd">493000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ide5c2d5254674b079e19ce03c1af6597_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfMS0zLTEtMS0w_07996af9-1d8a-4e20-9704-38cbd8c8167c"
      unitRef="usd">-31691000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i3260d253c3314cdda5a4ade16ecbac96_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfMS01LTEtMS0w_8d100270-f494-464e-a35c-e900dcfd816c"
      unitRef="usd">-28079000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6cb501558a20431db8401ff4a527404c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfMS03LTEtMS0w_d541b8ce-c129-4072-918e-96d6b569df25"
      unitRef="usd">-59277000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i539165515ff54031a19c7afae85ae40a_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfMy0xLTEtMS0w_76d137b2-77aa-4988-b814-5b350b8382c1"
      unitRef="usd">3257000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ib283f3bae1b7414e9448c28a5baa9aff_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfMy0zLTEtMS0w_72d1e703-cfea-495d-9ee9-ba6481cf6614"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i2aa32ba1223944909a381ed581c46123_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfMy01LTEtMS0w_707e08d9-7dd7-482c-8c1a-1ab3bc2752bc"
      unitRef="usd">-9988000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i95bc22c9cff4438ba21e7d9b6141399c_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfMy03LTEtMS0w_9e302967-624e-4d11-aab3-866ccceb3d2e"
      unitRef="usd">-6731000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i539165515ff54031a19c7afae85ae40a_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNC0xLTEtMS0w_767c56ac-23ad-4d12-b20f-2d598b83b31f"
      unitRef="usd">1124000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ib283f3bae1b7414e9448c28a5baa9aff_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNC0zLTEtMS0w_605e62c1-18c1-4300-86b4-c5e62ec335ce"
      unitRef="usd">-705000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i2aa32ba1223944909a381ed581c46123_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNC01LTEtMS0w_47619acf-92fc-44be-89a1-4a998a5d3dcf"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i95bc22c9cff4438ba21e7d9b6141399c_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNC03LTEtMS0w_8a1edb82-783b-40f1-9075-643fba61b055"
      unitRef="usd">419000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i539165515ff54031a19c7afae85ae40a_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNS0xLTEtMS0w_d5940b06-4aaa-461e-bc84-9f8a76abf7d8"
      unitRef="usd">272000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ib283f3bae1b7414e9448c28a5baa9aff_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNS0zLTEtMS0w_04f29630-9cd5-421a-8340-cabf287fa2db"
      unitRef="usd">-170000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i2aa32ba1223944909a381ed581c46123_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNS01LTEtMS0w_8e0833cf-d8a7-4266-a981-c35239ea585d"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i95bc22c9cff4438ba21e7d9b6141399c_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNS03LTEtMS0w_b1607e06-f358-44d7-b148-205e8bc91eda"
      unitRef="usd">102000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i539165515ff54031a19c7afae85ae40a_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNy0xLTEtMS0w_f57fb1e2-0af6-4fc9-91fd-f11a76557578"
      unitRef="usd">2405000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib283f3bae1b7414e9448c28a5baa9aff_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNy0zLTEtMS0w_46e9e850-d9e0-4f7d-8a5a-b0a257e96956"
      unitRef="usd">535000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2aa32ba1223944909a381ed581c46123_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNy01LTEtMS0w_dffb5009-f75f-4d5c-9595-24d5c0230630"
      unitRef="usd">-9988000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i95bc22c9cff4438ba21e7d9b6141399c_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNy03LTEtMS0w_d90c380a-4d04-4bd9-9e04-6f239ac22832"
      unitRef="usd">-7048000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i48e8d40f4b764e66a575ca1ee4752691_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfOS0xLTEtMS0w_8f3b785b-7a3a-41ef-a1ad-f13ae322d53a"
      unitRef="usd">2898000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ied165b7d8f6347aaa83ef46fd509ac16_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfOS0zLTEtMS0w_142a1119-d423-4084-b871-62ed5312f2c4"
      unitRef="usd">-31156000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib74665bfb6b541e48986d00dea4ca711_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfOS01LTEtMS0w_b6cc6856-ba54-45cb-a4a2-1d75862afb85"
      unitRef="usd">-38067000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i7ec34830172747ee92a710ad30795223_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfOS03LTEtMS0w_549725e2-e9d8-474d-9bb6-a93a78605d62"
      unitRef="usd">-66325000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DerivativesAndFairValueTextBlock
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RleHRyZWdpb246NzdiODQ5ODUwNmU1NGIyNDkzYzAxNTkwYjY3Nzk5ODVfNTYyNg_45be4c28-d24b-4153-9689-1a06f6b09c7b">Fair Value of Financial Instruments&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We enter into derivative instruments for risk management purposes only.  We operate internationally and, in the normal course of business, are exposed to fluctuations in interest rates, foreign exchange rates and commodity prices.  These fluctuations can increase the costs of financing, investing and operating the business.  We use forward contracts, a type of derivative instrument, to manage certain foreign currency exposures.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;By nature, all financial instruments involve market and credit risks.  We enter into forward contracts with major investment grade financial institutions and have policies to monitor the credit risk of those counterparties.  While there can be no assurance, we do not anticipate any material non-performance by any of these counterparties.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign Currency Forward Contracts.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We hedge forecasted intercompany sales denominated in foreign currencies through the use of forward contracts.&#160;&#160;We account for these forward contracts as cash flow hedges.&#160;&#160;To the extent these forward contracts meet hedge accounting criteria, changes in their fair value are not included in current earnings but are included in accumulated other comprehensive loss.&#160;&#160;These changes in fair value will be recognized into earnings as a component of sales or cost of sales when the forecasted transaction occurs.&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also enter into forward contracts to exchange foreign currencies for United States dollars in order to hedge our currency transaction exposures on intercompany receivables designated in foreign currencies.&#160;&#160;These forward contracts settle each month at month-end, at which time we enter into new forward contracts.&#160;&#160;We have not designated these forward contracts as hedges and have not applied hedge accounting to them.&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the notional contract amounts for forward contracts outstanding:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;FASB ASC Topic 815 Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The remaining time to maturity as of March&#160;31, 2021 is within two years for hedge designated foreign exchange contracts and approximately one month for non-hedge designated forward exchange contracts.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Statement of comprehensive income (loss) presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives designated as cash flow hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign exchange contracts designated as cash flow hedges had the following effects on accumulated other comprehensive income (loss) and net earnings on our consolidated condensed statements of comprehensive income (loss) and our consolidated condensed balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Recognized in AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated Condensed Statements  of Comprehensive Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="36" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Amount of Line Item Presented&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative Instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location of amount reclassified&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,849)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-tax gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(383)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,201)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2021, $2.3 million of net unrealized losses on forward contracts accounted for as cash flow hedges, and included in accumulated other comprehensive loss, are expected to be recognized in earnings in the next twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives not designated as cash flow hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net gains and losses from derivative instruments not accounted for as hedges and gains and losses on our intercompany receivables on our consolidated condensed statements of comprehensive income (loss) were:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.091%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative Instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Consolidated Condensed Statements of Comprehensive Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain (loss) on currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss on currency transaction exposures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,123)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(191)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Balance sheet presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record these forward foreign exchange contracts at fair value.  The following tables summarize the fair value for forward foreign exchange contracts outstanding at March&#160;31, 2021 and December&#160;31, 2020: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.514%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.033%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.944%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.944%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.950%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Consolidated Condensed Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedged instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,592)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,035)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(337)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,929)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,663)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,834)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.514%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.033%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.944%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.944%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.950%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Consolidated Condensed Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedged instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,826)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,326)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(535)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,361)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,838)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,511)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,963)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our forward foreign exchange contracts are subject to a master netting agreement and qualify for netting in the consolidated condensed balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value Disclosure.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  FASB guidance defines fair value and establishes a framework for measuring fair value and related disclosure requirements.  This guidance applies when fair value measurements are required or permitted.  The guidance indicates, among other things, that a fair value measurement assumes that the transaction to sell an asset or transfer a liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market for the asset or liability.  Fair value is defined based upon an exit price model.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Valuation Hierarchy. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; A valuation hierarchy was established for disclosure of the inputs to the valuations used to measure fair value.  This hierarchy prioritizes the inputs into three broad levels as follows.  Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities.  Level 2 inputs are quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in markets that are not active, inputs other than quoted prices that are observable for the asset or liability, including interest rates, yield curves and credit risks, or inputs that are derived principally from or corroborated by observable market data through correlation.  Level 3 inputs are unobservable inputs based on our own assumptions used to measure assets and liabilities at fair value.  A financial asset or liability&#x2019;s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement.  There have been no significant changes in the assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Valuation Techniques. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Assets and liabilities carried at fair value and measured on a recurring basis as of March&#160;31, 2021 consist of forward foreign exchange contracts.  The Company values its forward foreign exchange contracts using quoted prices for similar assets.  The most significant assumption is quoted currency rates.  The value of the forward foreign exchange contract assets and liabilities were valued using Level 2 inputs and are listed in the table above.&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;The carrying amounts reported in our consolidated condensed balance sheets for cash and cash equivalents, accounts receivable, accounts payable and long-term debt approximate fair value.</us-gaap:DerivativesAndFairValueTextBlock>
    <us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RleHRyZWdpb246NzdiODQ5ODUwNmU1NGIyNDkzYzAxNTkwYjY3Nzk5ODVfNTYzNg_864732d6-0c29-4d94-ac99-5a6e6769cfec">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the notional contract amounts for forward contracts outstanding:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;FASB ASC Topic 815 Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6c2b490080b54ee293093cabd55cf92f_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFkOTVhNjdjOTU1MjQ2ZjFiM2FkMTA3ZTBhOGU3NTBmL3RhYmxlcmFuZ2U6YWQ5NWE2N2M5NTUyNDZmMWIzYWQxMDdlMGE4ZTc1MGZfMi0zLTEtMS0w_faed0d11-27d0-440e-8f99-75e0d1b426d0"
      unitRef="usd">164562000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i2efe3e302ba4492a9b14126b56757fe7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFkOTVhNjdjOTU1MjQ2ZjFiM2FkMTA3ZTBhOGU3NTBmL3RhYmxlcmFuZ2U6YWQ5NWE2N2M5NTUyNDZmMWIzYWQxMDdlMGE4ZTc1MGZfMi01LTEtMS0w_076c49ab-a824-4ea4-b550-53932ca40e5f"
      unitRef="usd">154504000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="icf6b5979fbd34dcbae2c42f8e0d6aed2_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFkOTVhNjdjOTU1MjQ2ZjFiM2FkMTA3ZTBhOGU3NTBmL3RhYmxlcmFuZ2U6YWQ5NWE2N2M5NTUyNDZmMWIzYWQxMDdlMGE4ZTc1MGZfMy0zLTEtMS0w_da357639-61a9-45e7-a682-7fca38489ee1"
      unitRef="usd">45545000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iacdfcde17fac4a0eb431ce68961ed713_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFkOTVhNjdjOTU1MjQ2ZjFiM2FkMTA3ZTBhOGU3NTBmL3RhYmxlcmFuZ2U6YWQ5NWE2N2M5NTUyNDZmMWIzYWQxMDdlMGE4ZTc1MGZfMy01LTEtMS0w_786e4830-d227-4149-8709-33bfdbc0ac31"
      unitRef="usd">42380000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:MaximumLengthOfTimeHedgedInCashFlowHedge1
      contextRef="ib1e08f06254d472fa74789af8e1cd878_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RleHRyZWdpb246NzdiODQ5ODUwNmU1NGIyNDkzYzAxNTkwYjY3Nzk5ODVfMTk1Mw_0c1d9584-9898-4bb7-ac60-52c4223a4b25">P2Y</us-gaap:MaximumLengthOfTimeHedgedInCashFlowHedge1>
    <us-gaap:MaximumLengthOfTimeHedgedInCashFlowHedge1
      contextRef="i99806f4ebd244f5e87a9fa07d01115f6_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RleHRyZWdpb246NzdiODQ5ODUwNmU1NGIyNDkzYzAxNTkwYjY3Nzk5ODVfMjAyMg_06f51eac-3565-440e-ae21-d0919ed6d169">P1M</us-gaap:MaximumLengthOfTimeHedgedInCashFlowHedge1>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RleHRyZWdpb246NzdiODQ5ODUwNmU1NGIyNDkzYzAxNTkwYjY3Nzk5ODVfNTY0Ng_c361de3e-1f48-41b5-a444-7c4c9b1a174b">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign exchange contracts designated as cash flow hedges had the following effects on accumulated other comprehensive income (loss) and net earnings on our consolidated condensed statements of comprehensive income (loss) and our consolidated condensed balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Recognized in AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated Condensed Statements  of Comprehensive Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="36" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Amount of Line Item Presented&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative Instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location of amount reclassified&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,849)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-tax gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(383)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,201)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfNS0yLTEtMS0w_c0e9918b-f94b-4a43-a286-25a2dd1e0e70"
      unitRef="usd">3593000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfNS00LTEtMS0w_56d7f305-6294-469f-a0af-3e5c3bdb70e2"
      unitRef="usd">4295000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:Revenues
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfNS04LTEtMS0w_1f9028fe-ff19-4c21-b052-2faf7667e2a2"
      unitRef="usd">232677000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfNS05LTEtMS0w_08918b4b-d3fc-447b-b7d4-3c487e93d984"
      unitRef="usd">214010000</us-gaap:Revenues>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i4e47fc121f8545dbb0463f80ac04eab2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfNS0xMS0xLTEtMA_31149520-be77-4ac4-a8ae-48f17f032095"
      unitRef="usd">-1849000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="iaa13b87841fb46f9971920ec855139e0_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfNS0xMy0xLTEtMA_b2e1ddbc-1b30-4028-ac6b-41c242a08415"
      unitRef="usd">1201000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfNi04LTEtMS0w_527b43f8-fa9c-4af1-accd-214bd9654a19"
      unitRef="usd">104228000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfNi05LTEtMS0w_0efad7e6-1d98-40d6-b4d5-09b27be8cbdc"
      unitRef="usd">94851000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ic4cfe412f15e40679fed8fb1ab50ff59_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfNi0xMS0xLTEtMA_13fdf3c4-8817-447c-8c77-7eb6200cb519"
      unitRef="usd">265000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="if891372cb88f49d1ad8cf68161f49100_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfNi0xMy0xLTEtMA_48659db7-bf24-4bf2-899f-e540780790ec"
      unitRef="usd">-77000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfNy0yLTEtMS0w_01724a77-822b-454c-9f82-c392458d75d5"
      unitRef="usd">3593000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfNy00LTEtMS0w_b7eec16b-12d8-4e8d-81e6-6cb2276be004"
      unitRef="usd">4295000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfNy0xMS0xLTEtMA_54b66bef-78b2-4fbf-b82b-f4b7b93e3792"
      unitRef="usd">-1584000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfNy0xMy0xLTEtMA_fb396c0a-07ca-4ac4-a985-12c31536ade7"
      unitRef="usd">1124000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfOC0yLTEtMS0w_fd25959c-af3e-48b1-8825-2b4118c8dec5"
      unitRef="usd">868000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfOC00LTEtMS0w_a8761297-f222-4f3e-9423-af2271c1ff36"
      unitRef="usd">1038000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfOC0xMS0xLTEtMA_3d1a59ad-ec95-45b7-8c6a-ee4a0b8a5fce"
      unitRef="usd">-383000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfOC0xMy0xLTEtMA_4f3acd5d-e593-41ea-b12f-704959c0b765"
      unitRef="usd">272000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfOS0yLTEtMS0w_21a98419-e793-404a-80e0-91c417a47c5f"
      unitRef="usd">2725000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfOS00LTEtMS0w_31d1ccd9-1946-4292-82fd-32d111c93e60"
      unitRef="usd">3257000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfOS0xMS0xLTEtMA_823fac13-0436-4c2a-85a6-a30cf1326020"
      unitRef="usd">-1201000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOjlkZjY5OWQ0N2YxMTQ3ZGFiOGQ1OGVkMDYwMTIyNGYwL3RhYmxlcmFuZ2U6OWRmNjk5ZDQ3ZjExNDdkYWI4ZDU4ZWQwNjAxMjI0ZjBfOS0xMy0xLTEtMA_064fede4-cefe-44f7-bcc3-277d61eea219"
      unitRef="usd">852000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months
      contextRef="i6c2b490080b54ee293093cabd55cf92f_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RleHRyZWdpb246NzdiODQ5ODUwNmU1NGIyNDkzYzAxNTkwYjY3Nzk5ODVfMjQ2Mw_26493120-8272-40a1-9b18-e5f063542ee3"
      unitRef="usd">-2300000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months>
    <us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RleHRyZWdpb246NzdiODQ5ODUwNmU1NGIyNDkzYzAxNTkwYjY3Nzk5ODVfNTYyNw_66327c90-228f-4120-90ba-c681e5872611">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net gains and losses from derivative instruments not accounted for as hedges and gains and losses on our intercompany receivables on our consolidated condensed statements of comprehensive income (loss) were:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.091%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative Instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Consolidated Condensed Statements of Comprehensive Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain (loss) on currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss on currency transaction exposures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,123)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(191)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="id18f74481683457cb6b00dae1d5691a4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRjYTY5ZGM2Yzc4MzQ0YzZhNGRhZDI5N2M4NTcyYTU0L3RhYmxlcmFuZ2U6ZGNhNjlkYzZjNzgzNDRjNmE0ZGFkMjk3Yzg1NzJhNTRfMy00LTEtMS0w_3dbb85f4-9426-4b98-a5e9-73b28bee3a2b"
      unitRef="usd">458000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="i6331111f415a4d5ea9e8cd727632eeee_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRjYTY5ZGM2Yzc4MzQ0YzZhNGRhZDI5N2M4NTcyYTU0L3RhYmxlcmFuZ2U6ZGNhNjlkYzZjNzgzNDRjNmE0ZGFkMjk3Yzg1NzJhNTRfMy02LTEtMS0w_11580119-78c0-4acc-8815-df041ef65d58"
      unitRef="usd">-245000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRjYTY5ZGM2Yzc4MzQ0YzZhNGRhZDI5N2M4NTcyYTU0L3RhYmxlcmFuZ2U6ZGNhNjlkYzZjNzgzNDRjNmE0ZGFkMjk3Yzg1NzJhNTRfNC00LTEtMS0w_7271f7d8-9544-48ad-9c42-dcc5112c7587"
      unitRef="usd">-1123000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRjYTY5ZGM2Yzc4MzQ0YzZhNGRhZDI5N2M4NTcyYTU0L3RhYmxlcmFuZ2U6ZGNhNjlkYzZjNzgzNDRjNmE0ZGFkMjk3Yzg1NzJhNTRfNC02LTEtMS0w_e36a90a6-6a86-4489-b42e-5be025a17c18"
      unitRef="usd">-191000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RleHRyZWdpb246NzdiODQ5ODUwNmU1NGIyNDkzYzAxNTkwYjY3Nzk5ODVfNTYxOA_91ff426f-deb0-4f82-af6e-9aac55ecd7c7">The following tables summarize the fair value for forward foreign exchange contracts outstanding at March&#160;31, 2021 and December&#160;31, 2020: &lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.514%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.033%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.944%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.944%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.950%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Consolidated Condensed Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedged instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,592)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,035)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(337)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,929)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,663)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,834)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.514%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.033%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.944%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.944%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.950%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Consolidated Condensed Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedged instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,826)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,326)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(535)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,361)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,838)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,511)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,963)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i35307b95062445a3a39801d79634cee9_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFmMTZhYmY0ZmQ4MjQxYmJhYThhODgyNDVhMmM1MWU2L3RhYmxlcmFuZ2U6YWYxNmFiZjRmZDgyNDFiYmFhOGE4ODI0NWEyYzUxZTZfMi0yLTEtMS0w_b9380026-ed18-4712-84e1-7c36e74a797e"
      unitRef="usd">1557000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i35307b95062445a3a39801d79634cee9_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFmMTZhYmY0ZmQ4MjQxYmJhYThhODgyNDVhMmM1MWU2L3RhYmxlcmFuZ2U6YWYxNmFiZjRmZDgyNDFiYmFhOGE4ODI0NWEyYzUxZTZfMi00LTEtMS0w_6ec362ee-5f72-42e9-a9ff-017ced7cd5a2"
      unitRef="usd">4592000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="i35307b95062445a3a39801d79634cee9_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFmMTZhYmY0ZmQ4MjQxYmJhYThhODgyNDVhMmM1MWU2L3RhYmxlcmFuZ2U6YWYxNmFiZjRmZDgyNDFiYmFhOGE4ODI0NWEyYzUxZTZfMi02LTEtMS0w_238c9484-27d8-4907-8cdf-e0be7f9e41d2"
      unitRef="usd">-3035000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i6d3efa96f76c423a828baa29d94dcb15_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFmMTZhYmY0ZmQ4MjQxYmJhYThhODgyNDVhMmM1MWU2L3RhYmxlcmFuZ2U6YWYxNmFiZjRmZDgyNDFiYmFhOGE4ODI0NWEyYzUxZTZfMy0yLTEtMS0w_82cd3118-044d-475e-ae44-2dc84e29a142"
      unitRef="usd">709000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i6d3efa96f76c423a828baa29d94dcb15_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFmMTZhYmY0ZmQ4MjQxYmJhYThhODgyNDVhMmM1MWU2L3RhYmxlcmFuZ2U6YWYxNmFiZjRmZDgyNDFiYmFhOGE4ODI0NWEyYzUxZTZfMy00LTEtMS0w_06aa2881-795d-4b1d-8eae-16e4e27a66a1"
      unitRef="usd">337000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="i6d3efa96f76c423a828baa29d94dcb15_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFmMTZhYmY0ZmQ4MjQxYmJhYThhODgyNDVhMmM1MWU2L3RhYmxlcmFuZ2U6YWYxNmFiZjRmZDgyNDFiYmFhOGE4ODI0NWEyYzUxZTZfMy02LTEtMS0w_6c855029-4d90-40d7-b1b8-5c64a15534a4"
      unitRef="usd">372000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i67d105aa68f347b8a414ade6ce5542bc_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFmMTZhYmY0ZmQ4MjQxYmJhYThhODgyNDVhMmM1MWU2L3RhYmxlcmFuZ2U6YWYxNmFiZjRmZDgyNDFiYmFhOGE4ODI0NWEyYzUxZTZfNC0yLTEtMS0w_9dacdb0b-4b34-41c9-9e0b-d44d1ec9d3e6"
      unitRef="usd">2266000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i67d105aa68f347b8a414ade6ce5542bc_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFmMTZhYmY0ZmQ4MjQxYmJhYThhODgyNDVhMmM1MWU2L3RhYmxlcmFuZ2U6YWYxNmFiZjRmZDgyNDFiYmFhOGE4ODI0NWEyYzUxZTZfNC00LTEtMS0w_bd7251db-edfc-49b5-983f-269d7deade8a"
      unitRef="usd">4929000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="i67d105aa68f347b8a414ade6ce5542bc_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFmMTZhYmY0ZmQ4MjQxYmJhYThhODgyNDVhMmM1MWU2L3RhYmxlcmFuZ2U6YWYxNmFiZjRmZDgyNDFiYmFhOGE4ODI0NWEyYzUxZTZfNC02LTEtMS0w_7bbf3ebc-e40e-4b23-83c6-169a3e0ef7f0"
      unitRef="usd">-2663000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ic235813d62984ee3b72d058a569b0a54_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFmMTZhYmY0ZmQ4MjQxYmJhYThhODgyNDVhMmM1MWU2L3RhYmxlcmFuZ2U6YWYxNmFiZjRmZDgyNDFiYmFhOGE4ODI0NWEyYzUxZTZfNy0yLTEtMS0w_902b792b-92c3-4500-a824-4c8651861ca0"
      unitRef="usd">8000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ic235813d62984ee3b72d058a569b0a54_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFmMTZhYmY0ZmQ4MjQxYmJhYThhODgyNDVhMmM1MWU2L3RhYmxlcmFuZ2U6YWYxNmFiZjRmZDgyNDFiYmFhOGE4ODI0NWEyYzUxZTZfNy00LTEtMS0w_3bc8ed0e-1539-4b8a-b7e6-88d692e8261c"
      unitRef="usd">179000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="ic235813d62984ee3b72d058a569b0a54_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFmMTZhYmY0ZmQ4MjQxYmJhYThhODgyNDVhMmM1MWU2L3RhYmxlcmFuZ2U6YWYxNmFiZjRmZDgyNDFiYmFhOGE4ODI0NWEyYzUxZTZfNy02LTEtMS0w_1ccb5444-40e7-49da-a745-9057afad2a17"
      unitRef="usd">-171000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFmMTZhYmY0ZmQ4MjQxYmJhYThhODgyNDVhMmM1MWU2L3RhYmxlcmFuZ2U6YWYxNmFiZjRmZDgyNDFiYmFhOGE4ODI0NWEyYzUxZTZfOS0yLTEtMS0w_c3b2a859-0e7c-4207-80f5-fd5b5029d33f"
      unitRef="usd">2274000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFmMTZhYmY0ZmQ4MjQxYmJhYThhODgyNDVhMmM1MWU2L3RhYmxlcmFuZ2U6YWYxNmFiZjRmZDgyNDFiYmFhOGE4ODI0NWEyYzUxZTZfOS00LTEtMS0w_ad4afa43-7cd0-4412-b1aa-6cc6754bbf64"
      unitRef="usd">5108000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmFmMTZhYmY0ZmQ4MjQxYmJhYThhODgyNDVhMmM1MWU2L3RhYmxlcmFuZ2U6YWYxNmFiZjRmZDgyNDFiYmFhOGE4ODI0NWEyYzUxZTZfOS02LTEtMS0w_0d03f739-e660-47c4-9bff-6f5415392de0"
      unitRef="usd">-2834000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i9abfdfe4a61a4a60ab8b291e94a8244d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRkZjkzYjNmNGI1MTQ2ZTY5MmI4MzNhY2I5Y2UwYjg0L3RhYmxlcmFuZ2U6ZGRmOTNiM2Y0YjUxNDZlNjkyYjgzM2FjYjljZTBiODRfMi0yLTEtMS0w_c247d310-0e4e-423c-bbde-87f39a47416c"
      unitRef="usd">1500000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i9abfdfe4a61a4a60ab8b291e94a8244d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRkZjkzYjNmNGI1MTQ2ZTY5MmI4MzNhY2I5Y2UwYjg0L3RhYmxlcmFuZ2U6ZGRmOTNiM2Y0YjUxNDZlNjkyYjgzM2FjYjljZTBiODRfMi00LTEtMS0w_4a6c6697-7f21-4a09-855f-eacc663eec71"
      unitRef="usd">8826000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="i9abfdfe4a61a4a60ab8b291e94a8244d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRkZjkzYjNmNGI1MTQ2ZTY5MmI4MzNhY2I5Y2UwYjg0L3RhYmxlcmFuZ2U6ZGRmOTNiM2Y0YjUxNDZlNjkyYjgzM2FjYjljZTBiODRfMi02LTEtMS0w_16b418d5-976a-430a-a81b-92afc4fa1f91"
      unitRef="usd">-7326000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i0a133038947642198d9059759b25062b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRkZjkzYjNmNGI1MTQ2ZTY5MmI4MzNhY2I5Y2UwYjg0L3RhYmxlcmFuZ2U6ZGRmOTNiM2Y0YjUxNDZlNjkyYjgzM2FjYjljZTBiODRfMy0yLTEtMS0w_6fc4692c-6c4d-41b8-90ea-1136a5ec9bf6"
      unitRef="usd">23000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i0a133038947642198d9059759b25062b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRkZjkzYjNmNGI1MTQ2ZTY5MmI4MzNhY2I5Y2UwYjg0L3RhYmxlcmFuZ2U6ZGRmOTNiM2Y0YjUxNDZlNjkyYjgzM2FjYjljZTBiODRfMy00LTEtMS0w_f2ad0753-e1dd-4ed7-9930-538c2648016e"
      unitRef="usd">535000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="i0a133038947642198d9059759b25062b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRkZjkzYjNmNGI1MTQ2ZTY5MmI4MzNhY2I5Y2UwYjg0L3RhYmxlcmFuZ2U6ZGRmOTNiM2Y0YjUxNDZlNjkyYjgzM2FjYjljZTBiODRfMy02LTEtMS0w_91f57abd-d41b-4008-901b-4b61c99887a4"
      unitRef="usd">-512000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ibd85c1ac785d48edbf3dd0030c518099_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRkZjkzYjNmNGI1MTQ2ZTY5MmI4MzNhY2I5Y2UwYjg0L3RhYmxlcmFuZ2U6ZGRmOTNiM2Y0YjUxNDZlNjkyYjgzM2FjYjljZTBiODRfNC0yLTEtMS0w_29f441fe-c1c9-49be-ae77-55581c9f9181"
      unitRef="usd">1523000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ibd85c1ac785d48edbf3dd0030c518099_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRkZjkzYjNmNGI1MTQ2ZTY5MmI4MzNhY2I5Y2UwYjg0L3RhYmxlcmFuZ2U6ZGRmOTNiM2Y0YjUxNDZlNjkyYjgzM2FjYjljZTBiODRfNC00LTEtMS0w_f7adb3dd-3155-450a-8ab0-fcf2a70833ce"
      unitRef="usd">9361000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="ibd85c1ac785d48edbf3dd0030c518099_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRkZjkzYjNmNGI1MTQ2ZTY5MmI4MzNhY2I5Y2UwYjg0L3RhYmxlcmFuZ2U6ZGRmOTNiM2Y0YjUxNDZlNjkyYjgzM2FjYjljZTBiODRfNC02LTEtMS0w_16bae2e5-9fc2-41d7-bc56-cff3a6619db2"
      unitRef="usd">-7838000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ic248ae873ff841ffbe0200170d941d8d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRkZjkzYjNmNGI1MTQ2ZTY5MmI4MzNhY2I5Y2UwYjg0L3RhYmxlcmFuZ2U6ZGRmOTNiM2Y0YjUxNDZlNjkyYjgzM2FjYjljZTBiODRfNy0yLTEtMS0w_879bbac2-1c01-4cad-85a8-dc1f20647503"
      unitRef="usd">25000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ic248ae873ff841ffbe0200170d941d8d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRkZjkzYjNmNGI1MTQ2ZTY5MmI4MzNhY2I5Y2UwYjg0L3RhYmxlcmFuZ2U6ZGRmOTNiM2Y0YjUxNDZlNjkyYjgzM2FjYjljZTBiODRfNy00LTEtMS0w_7ac8280d-492e-4406-9fde-0dd4019ec7dd"
      unitRef="usd">150000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="ic248ae873ff841ffbe0200170d941d8d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRkZjkzYjNmNGI1MTQ2ZTY5MmI4MzNhY2I5Y2UwYjg0L3RhYmxlcmFuZ2U6ZGRmOTNiM2Y0YjUxNDZlNjkyYjgzM2FjYjljZTBiODRfNy02LTEtMS0w_d37346dc-1631-46a3-a2bd-5d454966121f"
      unitRef="usd">-125000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRkZjkzYjNmNGI1MTQ2ZTY5MmI4MzNhY2I5Y2UwYjg0L3RhYmxlcmFuZ2U6ZGRmOTNiM2Y0YjUxNDZlNjkyYjgzM2FjYjljZTBiODRfOS0yLTEtMS0w_68690ae8-e045-4026-b9cc-8003d7c18575"
      unitRef="usd">1548000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRkZjkzYjNmNGI1MTQ2ZTY5MmI4MzNhY2I5Y2UwYjg0L3RhYmxlcmFuZ2U6ZGRmOTNiM2Y0YjUxNDZlNjkyYjgzM2FjYjljZTBiODRfOS00LTEtMS0w_183dd3e9-36b8-418a-9c05-00496ff7684b"
      unitRef="usd">9511000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80Ni9mcmFnOjc3Yjg0OTg1MDZlNTRiMjQ5M2MwMTU5MGI2Nzc5OTg1L3RhYmxlOmRkZjkzYjNmNGI1MTQ2ZTY5MmI4MzNhY2I5Y2UwYjg0L3RhYmxlcmFuZ2U6ZGRmOTNiM2Y0YjUxNDZlNjkyYjgzM2FjYjljZTBiODRfOS02LTEtMS0w_6fb472a0-7f92-4602-8611-eb41513e5f34"
      unitRef="usd">-7963000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80OS9mcmFnOjNiNjdjMzBhZTFiNzQ2M2I4YjhjYzg2YTVjODMwYWIzL3RleHRyZWdpb246M2I2N2MzMGFlMWI3NDYzYjhiOGNjODZhNWM4MzBhYjNfODM_7cfb338c-d23e-45be-bf6f-998cf057ec50">Inventories&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.225%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80OS9mcmFnOjNiNjdjMzBhZTFiNzQ2M2I4YjhjYzg2YTVjODMwYWIzL3RleHRyZWdpb246M2I2N2MzMGFlMWI3NDYzYjhiOGNjODZhNWM4MzBhYjNfODc_73c8fa25-b907-49f5-9cdd-e575fd2f77c5">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.225%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80OS9mcmFnOjNiNjdjMzBhZTFiNzQ2M2I4YjhjYzg2YTVjODMwYWIzL3RhYmxlOmFjMDIxMTBlMWMwOTQzOThiMDk0MzVmYTJjYjJkMDgxL3RhYmxlcmFuZ2U6YWMwMjExMGUxYzA5NDM5OGIwOTQzNWZhMmNiMmQwODFfMS0xLTEtMS0w_05ee549a-a015-4038-a237-2bd3cf1e1081"
      unitRef="usd">73654000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80OS9mcmFnOjNiNjdjMzBhZTFiNzQ2M2I4YjhjYzg2YTVjODMwYWIzL3RhYmxlOmFjMDIxMTBlMWMwOTQzOThiMDk0MzVmYTJjYjJkMDgxL3RhYmxlcmFuZ2U6YWMwMjExMGUxYzA5NDM5OGIwOTQzNWZhMmNiMmQwODFfMS0zLTEtMS0w_e9d5a8be-b64b-47a6-9474-f299f939c7b1"
      unitRef="usd">71807000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80OS9mcmFnOjNiNjdjMzBhZTFiNzQ2M2I4YjhjYzg2YTVjODMwYWIzL3RhYmxlOmFjMDIxMTBlMWMwOTQzOThiMDk0MzVmYTJjYjJkMDgxL3RhYmxlcmFuZ2U6YWMwMjExMGUxYzA5NDM5OGIwOTQzNWZhMmNiMmQwODFfMi0xLTEtMS0w_df677fcd-4996-4a0c-bb68-ac7c15570636"
      unitRef="usd">18429000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80OS9mcmFnOjNiNjdjMzBhZTFiNzQ2M2I4YjhjYzg2YTVjODMwYWIzL3RhYmxlOmFjMDIxMTBlMWMwOTQzOThiMDk0MzVmYTJjYjJkMDgxL3RhYmxlcmFuZ2U6YWMwMjExMGUxYzA5NDM5OGIwOTQzNWZhMmNiMmQwODFfMi0zLTEtMS0w_72e88d8b-821d-4ae1-b282-ac9cc785547a"
      unitRef="usd">15864000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80OS9mcmFnOjNiNjdjMzBhZTFiNzQ2M2I4YjhjYzg2YTVjODMwYWIzL3RhYmxlOmFjMDIxMTBlMWMwOTQzOThiMDk0MzVmYTJjYjJkMDgxL3RhYmxlcmFuZ2U6YWMwMjExMGUxYzA5NDM5OGIwOTQzNWZhMmNiMmQwODFfMy0xLTEtMS0w_ca6c9543-f16f-4645-91f2-d4c1e517858b"
      unitRef="usd">113714000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80OS9mcmFnOjNiNjdjMzBhZTFiNzQ2M2I4YjhjYzg2YTVjODMwYWIzL3RhYmxlOmFjMDIxMTBlMWMwOTQzOThiMDk0MzVmYTJjYjJkMDgxL3RhYmxlcmFuZ2U6YWMwMjExMGUxYzA5NDM5OGIwOTQzNWZhMmNiMmQwODFfMy0zLTEtMS0w_702cdab0-c3bb-4aa0-b615-f3023b0be562"
      unitRef="usd">107197000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80OS9mcmFnOjNiNjdjMzBhZTFiNzQ2M2I4YjhjYzg2YTVjODMwYWIzL3RhYmxlOmFjMDIxMTBlMWMwOTQzOThiMDk0MzVmYTJjYjJkMDgxL3RhYmxlcmFuZ2U6YWMwMjExMGUxYzA5NDM5OGIwOTQzNWZhMmNiMmQwODFfNC0xLTEtMS0w_8ef49eee-9145-4f66-97e4-488d75921bfb"
      unitRef="usd">205797000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80OS9mcmFnOjNiNjdjMzBhZTFiNzQ2M2I4YjhjYzg2YTVjODMwYWIzL3RhYmxlOmFjMDIxMTBlMWMwOTQzOThiMDk0MzVmYTJjYjJkMDgxL3RhYmxlcmFuZ2U6YWMwMjExMGUxYzA5NDM5OGIwOTQzNWZhMmNiMmQwODFfNC0zLTEtMS0w_528737b7-bdd0-409c-8d77-25bdb72ec447"
      unitRef="usd">194868000</us-gaap:InventoryNet>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RleHRyZWdpb246N2MwZWEzOGVkODVjNDZmZTk2MGJlNDAxNzk3YjNjZGZfMjMyMA_ea51827f-e37d-4e71-86cd-c7cfa077942c">Earnings Per Share&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share (&#x201c;basic EPS&#x201d;) is computed by dividing net income by the weighted average number of common shares outstanding for the reporting period.  Diluted earnings per share (&#x201c;diluted EPS&#x201d;) gives effect to all dilutive potential shares outstanding resulting from employee stock options, restricted stock units, performance share units and stock appreciation rights ("SARs") as well as the Notes and related hedge transactions during the period.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted earnings per share for the three months ended March 31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic &#x2013; weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive potential securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted &#x2013; weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (per share)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The shares used in the calculation of diluted EPS exclude options and SARs to purchase shares where the exercise price was greater than the average market price of common shares for the period and the effect of the inclusion would be anti-dilutive.  Such shares aggregated approximately 0.3 million and 1.1 million for the three months ended March&#160;31, 2021 and 2020, respectively.  Our 2.625% convertible notes due in 2024 (the &#x201c;Notes&#x201d;) are convertible under certain circumstances, as defined in the indenture, into a combination of cash and CONMED common stock.&#160; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is intended to describe the impact of the Notes and related hedge transactions on the calculation of diluted EPS.  Additional shares to be issued pursuant to the terms of the Notes and related hedge transactions, if any, would occur at maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The calculation of diluted EPS includes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;potential diluted shares upon conversion of the Notes when the average market price per share of our common stock for the period is greater than the conversion price of the Notes of $88.80.  We intend to settle in cash the principal outstanding and use the treasury stock method when calculating their potential dilutive effect, if any.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2021 and 2020, our average share price exceeded the conversion price of the Notes and we included in our diluted share count 1.0&#160;million and 0.1&#160;million shares, respectively, assumed to be issued if the Notes were converted.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We previously entered into convertible notes hedge transactions to increase the effective conversion price of the Notes to $114.92.&#160; However, our convertible notes hedges are not included when calculating potential dilutive shares since their effect is always anti-dilutive.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Concurrently with entering into the hedge transactions, we also previously entered into warrant transactions under which we agreed to sell shares of our common stock at $114.92.  &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The calculation of diluted EPS also includes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;potential diluted shares to be issued under the warrants when the average market price per share of our common stock for the period is greater than $114.92.  During the three months ended March&#160;31, 2021, our average share price exceeded $114.92 and we therefore included in our diluted share count an additional 0.2&#160;million shares assumed to be issued under the warrants.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RleHRyZWdpb246N2MwZWEzOGVkODVjNDZmZTk2MGJlNDAxNzk3YjNjZGZfMjMwNQ_f57f1783-d744-4ab3-81f6-68a9bc10c483">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted earnings per share for the three months ended March 31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic &#x2013; weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive potential securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted &#x2013; weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (per share)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RhYmxlOjQyMGRkNmI3ZGFlNzQ0ZTBhMDg4ZDkzNjc5OThmZWI3L3RhYmxlcmFuZ2U6NDIwZGQ2YjdkYWU3NDRlMGEwODhkOTM2Nzk5OGZlYjdfMi0xLTEtMS0w_41305769-9f00-4fa4-9a6d-ca00cb8120f1"
      unitRef="usd">9860000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RhYmxlOjQyMGRkNmI3ZGFlNzQ0ZTBhMDg4ZDkzNjc5OThmZWI3L3RhYmxlcmFuZ2U6NDIwZGQ2YjdkYWU3NDRlMGEwODhkOTM2Nzk5OGZlYjdfMi0zLTEtMS0w_103d19d3-f2a5-46f0-a818-6517c155725d"
      unitRef="usd">5927000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RhYmxlOjQyMGRkNmI3ZGFlNzQ0ZTBhMDg4ZDkzNjc5OThmZWI3L3RhYmxlcmFuZ2U6NDIwZGQ2YjdkYWU3NDRlMGEwODhkOTM2Nzk5OGZlYjdfNC0xLTEtMS0w_5d3b43fc-9775-4685-bc06-32fdcede2797"
      unitRef="shares">28972000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RhYmxlOjQyMGRkNmI3ZGFlNzQ0ZTBhMDg4ZDkzNjc5OThmZWI3L3RhYmxlcmFuZ2U6NDIwZGQ2YjdkYWU3NDRlMGEwODhkOTM2Nzk5OGZlYjdfNC0zLTEtMS0w_08441aa9-8dcf-4d8f-9ee3-78bc03aeefc1"
      unitRef="shares">28478000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RhYmxlOjQyMGRkNmI3ZGFlNzQ0ZTBhMDg4ZDkzNjc5OThmZWI3L3RhYmxlcmFuZ2U6NDIwZGQ2YjdkYWU3NDRlMGEwODhkOTM2Nzk5OGZlYjdfNi0xLTEtMS0w_e46c40b9-ac64-4b4d-bb62-091cbb4d4537"
      unitRef="shares">2406000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RhYmxlOjQyMGRkNmI3ZGFlNzQ0ZTBhMDg4ZDkzNjc5OThmZWI3L3RhYmxlcmFuZ2U6NDIwZGQ2YjdkYWU3NDRlMGEwODhkOTM2Nzk5OGZlYjdfNi0zLTEtMS0w_5a2cfa00-30c5-4084-984a-b79b0faef41f"
      unitRef="shares">1229000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RhYmxlOjQyMGRkNmI3ZGFlNzQ0ZTBhMDg4ZDkzNjc5OThmZWI3L3RhYmxlcmFuZ2U6NDIwZGQ2YjdkYWU3NDRlMGEwODhkOTM2Nzk5OGZlYjdfOC0xLTEtMS0w_06695938-77eb-409b-99af-ebe309777927"
      unitRef="shares">31378000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RhYmxlOjQyMGRkNmI3ZGFlNzQ0ZTBhMDg4ZDkzNjc5OThmZWI3L3RhYmxlcmFuZ2U6NDIwZGQ2YjdkYWU3NDRlMGEwODhkOTM2Nzk5OGZlYjdfOC0zLTEtMS0w_c7dfb1f3-1c19-4850-a621-c69704da79f3"
      unitRef="shares">29707000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RhYmxlOjQyMGRkNmI3ZGFlNzQ0ZTBhMDg4ZDkzNjc5OThmZWI3L3RhYmxlcmFuZ2U6NDIwZGQ2YjdkYWU3NDRlMGEwODhkOTM2Nzk5OGZlYjdfMTEtMS0xLTEtMA_0ed89bf5-3567-47c8-b679-0b511fb97af3"
      unitRef="usdPerShare">0.34</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RhYmxlOjQyMGRkNmI3ZGFlNzQ0ZTBhMDg4ZDkzNjc5OThmZWI3L3RhYmxlcmFuZ2U6NDIwZGQ2YjdkYWU3NDRlMGEwODhkOTM2Nzk5OGZlYjdfMTEtMy0xLTEtMA_885470f5-180a-427a-a941-0fdfade38d8b"
      unitRef="usdPerShare">0.21</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RhYmxlOjQyMGRkNmI3ZGFlNzQ0ZTBhMDg4ZDkzNjc5OThmZWI3L3RhYmxlcmFuZ2U6NDIwZGQ2YjdkYWU3NDRlMGEwODhkOTM2Nzk5OGZlYjdfMTItMS0xLTEtMA_4aec4ddc-dd57-45f3-b212-6c92389816de"
      unitRef="usdPerShare">0.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RhYmxlOjQyMGRkNmI3ZGFlNzQ0ZTBhMDg4ZDkzNjc5OThmZWI3L3RhYmxlcmFuZ2U6NDIwZGQ2YjdkYWU3NDRlMGEwODhkOTM2Nzk5OGZlYjdfMTItMy0xLTEtMA_7c005e7d-0e4f-4726-9a74-1e8e3c9e9957"
      unitRef="usdPerShare">0.20</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RleHRyZWdpb246N2MwZWEzOGVkODVjNDZmZTk2MGJlNDAxNzk3YjNjZGZfODc0_09f080b9-1359-429c-8179-15f242b63819"
      unitRef="shares">300000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RleHRyZWdpb246N2MwZWEzOGVkODVjNDZmZTk2MGJlNDAxNzk3YjNjZGZfMTA5OTUxMTYzMDY4Nw_a2a78478-14f7-4219-aeb5-24ea78b8701c"
      unitRef="shares">1100000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id748c1bbe2b3409b9e97ffd239dcc0f0_I20190129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RleHRyZWdpb246N2MwZWEzOGVkODVjNDZmZTk2MGJlNDAxNzk3YjNjZGZfMTAzMw_4b151355-2264-482d-948e-413a8a1fdbe8"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="id748c1bbe2b3409b9e97ffd239dcc0f0_I20190129"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RleHRyZWdpb246N2MwZWEzOGVkODVjNDZmZTk2MGJlNDAxNzk3YjNjZGZfMTQzNQ_7488fc20-c2c5-4385-90e6-1dc3c601e0b8"
      unitRef="usdPerShare">88.80</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RleHRyZWdpb246N2MwZWEzOGVkODVjNDZmZTk2MGJlNDAxNzk3YjNjZGZfMTA5OTUxMTYzMDQ0OQ_cfed98f1-47f4-42ba-9997-b9e983f1173e"
      unitRef="shares">1000000.0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RleHRyZWdpb246N2MwZWEzOGVkODVjNDZmZTk2MGJlNDAxNzk3YjNjZGZfMTc5Nw_cd66234c-10d8-4074-b4c0-cebcedfd4e74"
      unitRef="shares">100000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:OptionIndexedToIssuersEquityStrikePrice1
      contextRef="i4166a58e42b343bfb5ae40145fb70764_D20190129-20190129"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RleHRyZWdpb246N2MwZWEzOGVkODVjNDZmZTk2MGJlNDAxNzk3YjNjZGZfMTA5OTUxMTYzNTUzMQ_9737693d-7ccb-4cb8-91e8-0843e0ad1652"
      unitRef="usdPerShare">114.92</us-gaap:OptionIndexedToIssuersEquityStrikePrice1>
    <us-gaap:OptionIndexedToIssuersEquityStrikePrice1
      contextRef="idf721ab99d84490dbfa3d3cec7d8e799_D20190129-20190129"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RleHRyZWdpb246N2MwZWEzOGVkODVjNDZmZTk2MGJlNDAxNzk3YjNjZGZfMTA5OTUxMTYzNTUzNQ_9253a793-70b2-423f-833e-7645b6b34251"
      unitRef="usdPerShare">114.92</us-gaap:OptionIndexedToIssuersEquityStrikePrice1>
    <us-gaap:OptionIndexedToIssuersEquityStrikePrice1
      contextRef="idf721ab99d84490dbfa3d3cec7d8e799_D20190129-20190129"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RleHRyZWdpb246N2MwZWEzOGVkODVjNDZmZTk2MGJlNDAxNzk3YjNjZGZfMTA5OTUxMTYzNTU0Mw_9253a793-70b2-423f-833e-7645b6b34251"
      unitRef="usdPerShare">114.92</us-gaap:OptionIndexedToIssuersEquityStrikePrice1>
    <us-gaap:OptionIndexedToIssuersEquityStrikePrice1
      contextRef="idf721ab99d84490dbfa3d3cec7d8e799_D20190129-20190129"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RleHRyZWdpb246N2MwZWEzOGVkODVjNDZmZTk2MGJlNDAxNzk3YjNjZGZfMTA5OTUxMTYzNTUzOQ_9253a793-70b2-423f-833e-7645b6b34251"
      unitRef="usdPerShare">114.92</us-gaap:OptionIndexedToIssuersEquityStrikePrice1>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81Mi9mcmFnOjdjMGVhMzhlZDg1YzQ2ZmU5NjBiZTQwMTc5N2IzY2RmL3RleHRyZWdpb246N2MwZWEzOGVkODVjNDZmZTk2MGJlNDAxNzk3YjNjZGZfMjE5OTAyMzI1OTk5NQ_9c0e4256-8fee-4fb2-ae40-0eabd94c7ad3"
      unitRef="shares">200000</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RleHRyZWdpb246MWIzNmViMjUwOTRkNDUzZGFlYjdjZDYzYjUyN2M2OWZfMTc3Nw_8e6f3f39-d07f-4bea-a791-c264376234c2">Goodwill and Other Intangible Assets&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the net carrying amount of goodwill for the three months ended March&#160;31, 2021 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;618,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(336)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;618,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities of acquired businesses are recorded at their estimated fair values as of the date of acquisition.&#160;&#160;Goodwill represents costs in excess of fair values assigned to the underlying net assets of acquired businesses.&#160; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other intangible assets consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:15.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.436%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.897%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.897%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.365%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Amortization Period (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible assets with definite lives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer and distributor relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(139,243)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(134,555)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales representation, marketing and promotional rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,705)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49,356)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48,882)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible assets with indefinite lives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and tradenames&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;759,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(265,457)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;758,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(257,142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer and distributor relationships, trademarks and tradenames, developed technology and patents and other intangible assets primarily represent allocations of purchase price to identifiable intangible assets of acquired businesses.  Sales representation, marketing and promotional rights represent intangible assets created under our agreement with Musculoskeletal Transplant Foundation (&#x201c;MTF&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense related to intangible assets which are subject to amortization totaled $8.3 million and $8.5 million in the three months ended March 31, 2021 and 2020, respectively, and is included as a reduction of revenue (for amortization related to our sales representation, marketing and promotional rights) and in selling and administrative expense (for all other intangible assets) in the consolidated condensed statements of comprehensive income (loss).  Included in developed technology is $6.0 million of earn-out consideration that is considered probable as of March&#160;31, 2021 associated with a prior asset acquisition.  This is recorded in other current and other long-term liabilities at March&#160;31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated intangible asset amortization expense remaining for the year ending December&#160;31, 2021 and for each of the five succeeding years is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.025%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortization included in expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortization recorded as a reduction of revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RleHRyZWdpb246MWIzNmViMjUwOTRkNDUzZGFlYjdjZDYzYjUyN2M2OWZfMTc2Nw_0cf0f43b-17d3-4fe7-b366-40899c27ad7a">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the net carrying amount of goodwill for the three months ended March&#160;31, 2021 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;618,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(336)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;618,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOmZmZGM0ZDA2OGNkYjQ4NDg4ZWM2ZmFiYjRiMzFkNWFmL3RhYmxlcmFuZ2U6ZmZkYzRkMDY4Y2RiNDg0ODhlYzZmYWJiNGIzMWQ1YWZfMC0xLTEtMS0w_9b84263e-4c78-4b05-8747-287ddd0fc363"
      unitRef="usd">618440000</us-gaap:Goodwill>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOmZmZGM0ZDA2OGNkYjQ4NDg4ZWM2ZmFiYjRiMzFkNWFmL3RhYmxlcmFuZ2U6ZmZkYzRkMDY4Y2RiNDg0ODhlYzZmYWJiNGIzMWQ1YWZfNC0xLTEtMS0w_8a444b98-c0b1-4cfe-85ed-917f2ce98ea8"
      unitRef="usd">-336000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOmZmZGM0ZDA2OGNkYjQ4NDg4ZWM2ZmFiYjRiMzFkNWFmL3RhYmxlcmFuZ2U6ZmZkYzRkMDY4Y2RiNDg0ODhlYzZmYWJiNGIzMWQ1YWZfNi0xLTEtMS0w_b2df201f-bc91-4849-983c-1c7fe36d1149"
      unitRef="usd">618104000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RleHRyZWdpb246MWIzNmViMjUwOTRkNDUzZGFlYjdjZDYzYjUyN2M2OWZfMTc2NA_d1eaf1dd-580c-4f95-be95-116c3dd77ebc">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other intangible assets consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:15.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.436%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.897%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.897%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.365%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Amortization Period (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible assets with definite lives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer and distributor relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(139,243)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(134,555)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales representation, marketing and promotional rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,705)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49,356)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48,882)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible assets with indefinite lives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and tradenames&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;759,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(265,457)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;758,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(257,142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RleHRyZWdpb246MWIzNmViMjUwOTRkNDUzZGFlYjdjZDYzYjUyN2M2OWZfMzI5ODUzNDg4NTY5MA_1b2372b6-3193-4a62-a0a1-72a2a4a40d46">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other intangible assets consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:15.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.436%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.897%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.897%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.365%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Amortization Period (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible assets with definite lives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer and distributor relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(139,243)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(134,555)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales representation, marketing and promotional rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,705)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49,356)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48,882)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible assets with indefinite lives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and tradenames&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;759,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(265,457)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;758,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(257,142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ieced3d585af14a18830b4dd4d45722c5_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfNC0xLTEtMS0w_45952025-ff4c-4915-b916-394cba6204c0">P24Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i845a4163284f443481a7a9c2d614d09a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfNC0yLTEtMS0w_ea226ccb-1304-47e3-b050-b847416c9a88"
      unitRef="usd">342531000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i845a4163284f443481a7a9c2d614d09a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfNC00LTEtMS0w_a4ab01cd-464a-45f4-8a34-879f063785c9"
      unitRef="usd">139243000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2ee91ad444274cc2a46852ceb1cbe07b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfNC02LTEtMS0w_6eaff69c-2eab-4040-a201-16f8741fa9cc"
      unitRef="usd">342639000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2ee91ad444274cc2a46852ceb1cbe07b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfNC04LTEtMS0w_c5c68b33-80d7-48b6-b412-e7dc3b720683"
      unitRef="usd">134555000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i764a3b1ff7c841b1ba858429acbdb036_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfNi0xLTEtMS0w_8ac6504e-f156-4696-b1f4-76b0d4a23a2d">P25Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i67e28dd28d264c5ca16a46ab1364c8bc_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfNi0yLTEtMS0w_37425b1e-7409-4d40-9413-25921a01cbf8"
      unitRef="usd">149376000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i67e28dd28d264c5ca16a46ab1364c8bc_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfNi00LTEtMS0w_713c1f97-3f46-4e98-ba7a-e5426005c2fc"
      unitRef="usd">55500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if46896d334d94c639ad7dd9fe363f7ff_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfNi02LTEtMS0w_609ab1c1-bfe8-4be8-8f73-44a4b69ce876"
      unitRef="usd">149376000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if46896d334d94c639ad7dd9fe363f7ff_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfNi04LTEtMS0w_2710c6e1-6244-4dd4-a1e1-6e13c3c43a91"
      unitRef="usd">54000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i4827d1b693224030887c79b6d7a4ac8a_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfOC0xLTEtMS0w_368be12e-fa78-4543-9d21-562958382b29">P16Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id22fbed2f4c849639e7b4e6618063e83_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfOC0yLTEtMS0w_599cf894-0ad1-490c-92f6-1e40966e0806"
      unitRef="usd">106604000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id22fbed2f4c849639e7b4e6618063e83_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfOC00LTEtMS0w_b7604673-f751-40d4-ac1b-e6c625230a96"
      unitRef="usd">21358000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if7cce587c6664fba92238d523270294d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfOC02LTEtMS0w_d9949dbf-6498-4bc2-a973-d8252d6e206c"
      unitRef="usd">106604000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if7cce587c6664fba92238d523270294d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfOC04LTEtMS0w_ab6b4d4f-8662-4d35-9d8f-787b31e65833"
      unitRef="usd">19705000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ic619fc4d993649a0aa3de013bce24ac7_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfMTAtMS0xLTEtMA_961f9369-f54a-4e69-ba74-733affa23767">P16Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9c573b67931c49ae94806ae92e81066f_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfMTAtMi0xLTEtMA_05cfd50d-9078-4fef-b02a-e5aa49b1f873"
      unitRef="usd">74307000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9c573b67931c49ae94806ae92e81066f_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfMTAtNC0xLTEtMA_02552650-4dd3-44be-9768-7c4d1b7e1d52"
      unitRef="usd">49356000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i8660d403bca94922a95c5e1926714e31_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfMTAtNi0xLTEtMA_590b0133-5af9-4949-a6d6-e65d3892f128"
      unitRef="usd">73516000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8660d403bca94922a95c5e1926714e31_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfMTAtOC0xLTEtMA_9e68a6de-3cc3-429c-a509-b3215854f329"
      unitRef="usd">48882000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i2fbb390301fb48f0a30356e63cdebb22_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfMTQtMi0xLTEtMA_6e647e0b-cd89-4103-90a4-29cb417aeee7"
      unitRef="usd">86544000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i16f265525a594e4196ee9d5387895783_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfMTQtNi0xLTEtMA_86a39316-8159-40a8-8dde-6af8c7ec7a03"
      unitRef="usd">86544000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ie71bc8ca5147459e9fc9a708d695e3d8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfMTYtMS0xLTEtMA_81604fc0-8192-4e48-bce1-4f1ef7a98a38">P22Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfMTYtMi0xLTEtMA_3ed955d7-fab7-40b8-9b86-dff519123cb0"
      unitRef="usd">759362000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfMTYtNC0xLTEtMA_8f0c0532-56ed-4351-9d08-552e94d228a9"
      unitRef="usd">265457000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfMTYtNi0xLTEtMA_db653d60-73f2-4f92-af90-23fc27f985db"
      unitRef="usd">758679000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjQ0MGQ1ZjgwODNkMjQ5ZGY5YTQwMTkxNmFmZGY5OWUwL3RhYmxlcmFuZ2U6NDQwZDVmODA4M2QyNDlkZjlhNDAxOTE2YWZkZjk5ZTBfMTYtOC0xLTEtMA_0cd25eed-1b9e-41b0-9a24-e4d89247348f"
      unitRef="usd">257142000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RleHRyZWdpb246MWIzNmViMjUwOTRkNDUzZGFlYjdjZDYzYjUyN2M2OWZfMTA1MQ_67e43ee1-8acb-4f21-9282-dc38b1b54b78"
      unitRef="usd">8300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RleHRyZWdpb246MWIzNmViMjUwOTRkNDUzZGFlYjdjZDYzYjUyN2M2OWZfMTA1OA_e6a72452-6261-431d-80ff-bcff041a0a87"
      unitRef="usd">8500000</us-gaap:AmortizationOfIntangibleAssets>
    <cnmd:AssetAcquisitionContingentConsiderationLiability
      contextRef="id22fbed2f4c849639e7b4e6618063e83_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RleHRyZWdpb246MWIzNmViMjUwOTRkNDUzZGFlYjdjZDYzYjUyN2M2OWZfMTQ0OA_f44bfe9a-ccbe-4351-afac-f8ee85e0533e"
      unitRef="usd">6000000.0</cnmd:AssetAcquisitionContingentConsiderationLiability>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RleHRyZWdpb246MWIzNmViMjUwOTRkNDUzZGFlYjdjZDYzYjUyN2M2OWZfMTc5Nw_0d97864c-b6d9-4f24-b6d4-9fcabfcdbbf1">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated intangible asset amortization expense remaining for the year ending December&#160;31, 2021 and for each of the five succeeding years is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.025%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortization included in expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortization recorded as a reduction of revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i9f228fccaaf945268b8dcbd31bed8868_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjMwNDI3ZDk3ZjgzYjQ0Nzk5NmJhMTJkNzRkYTk5ZTMyL3RhYmxlcmFuZ2U6MzA0MjdkOTdmODNiNDQ3OTk2YmExMmQ3NGRhOTllMzJfMS0xLTEtMS0w_a9a856ca-e9de-4f0b-9639-c83fc977351e"
      unitRef="usd">20620000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i9cfc55d543ed45c79d4721e64e912827_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjMwNDI3ZDk3ZjgzYjQ0Nzk5NmJhMTJkNzRkYTk5ZTMyL3RhYmxlcmFuZ2U6MzA0MjdkOTdmODNiNDQ3OTk2YmExMmQ3NGRhOTllMzJfMS0zLTEtMS0w_11b16ceb-350f-47de-82cc-9a84d21fc4e6"
      unitRef="usd">4500000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjMwNDI3ZDk3ZjgzYjQ0Nzk5NmJhMTJkNzRkYTk5ZTMyL3RhYmxlcmFuZ2U6MzA0MjdkOTdmODNiNDQ3OTk2YmExMmQ3NGRhOTllMzJfMS01LTEtMS0w_a50b27a1-8d9e-42ac-88c3-592eaa5a4b77"
      unitRef="usd">25120000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i9f228fccaaf945268b8dcbd31bed8868_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjMwNDI3ZDk3ZjgzYjQ0Nzk5NmJhMTJkNzRkYTk5ZTMyL3RhYmxlcmFuZ2U6MzA0MjdkOTdmODNiNDQ3OTk2YmExMmQ3NGRhOTllMzJfMi0xLTEtMS0w_8a705c38-df39-4cb0-b16a-70ad8fd60c04"
      unitRef="usd">26426000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i9cfc55d543ed45c79d4721e64e912827_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjMwNDI3ZDk3ZjgzYjQ0Nzk5NmJhMTJkNzRkYTk5ZTMyL3RhYmxlcmFuZ2U6MzA0MjdkOTdmODNiNDQ3OTk2YmExMmQ3NGRhOTllMzJfMi0zLTEtMS0w_56ffcb99-5e0e-455b-9e1c-43cb3d6def22"
      unitRef="usd">6000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjMwNDI3ZDk3ZjgzYjQ0Nzk5NmJhMTJkNzRkYTk5ZTMyL3RhYmxlcmFuZ2U6MzA0MjdkOTdmODNiNDQ3OTk2YmExMmQ3NGRhOTllMzJfMi01LTEtMS0w_fe8b0a86-43f1-45e2-a339-c5299bf0ccf9"
      unitRef="usd">32426000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i9f228fccaaf945268b8dcbd31bed8868_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjMwNDI3ZDk3ZjgzYjQ0Nzk5NmJhMTJkNzRkYTk5ZTMyL3RhYmxlcmFuZ2U6MzA0MjdkOTdmODNiNDQ3OTk2YmExMmQ3NGRhOTllMzJfMy0xLTEtMS0w_14672ee8-d2cc-4f19-a8bf-6019a8266db8"
      unitRef="usd">25646000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i9cfc55d543ed45c79d4721e64e912827_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjMwNDI3ZDk3ZjgzYjQ0Nzk5NmJhMTJkNzRkYTk5ZTMyL3RhYmxlcmFuZ2U6MzA0MjdkOTdmODNiNDQ3OTk2YmExMmQ3NGRhOTllMzJfMy0zLTEtMS0w_c6481f76-e217-49fd-8341-9ad6e91edd29"
      unitRef="usd">6000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjMwNDI3ZDk3ZjgzYjQ0Nzk5NmJhMTJkNzRkYTk5ZTMyL3RhYmxlcmFuZ2U6MzA0MjdkOTdmODNiNDQ3OTk2YmExMmQ3NGRhOTllMzJfMy01LTEtMS0w_0db53078-c296-4869-9cc4-ac43d12970bc"
      unitRef="usd">31646000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i9f228fccaaf945268b8dcbd31bed8868_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjMwNDI3ZDk3ZjgzYjQ0Nzk5NmJhMTJkNzRkYTk5ZTMyL3RhYmxlcmFuZ2U6MzA0MjdkOTdmODNiNDQ3OTk2YmExMmQ3NGRhOTllMzJfNC0xLTEtMS0w_8e6de201-5d45-4daf-984a-4b7fe6b7c1ee"
      unitRef="usd">24836000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i9cfc55d543ed45c79d4721e64e912827_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjMwNDI3ZDk3ZjgzYjQ0Nzk5NmJhMTJkNzRkYTk5ZTMyL3RhYmxlcmFuZ2U6MzA0MjdkOTdmODNiNDQ3OTk2YmExMmQ3NGRhOTllMzJfNC0zLTEtMS0w_227db3fc-0c44-425a-b5e3-0f444b2f8f2c"
      unitRef="usd">6000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjMwNDI3ZDk3ZjgzYjQ0Nzk5NmJhMTJkNzRkYTk5ZTMyL3RhYmxlcmFuZ2U6MzA0MjdkOTdmODNiNDQ3OTk2YmExMmQ3NGRhOTllMzJfNC01LTEtMS0w_8e31e9d6-0c4e-44cf-9893-4c4935b53082"
      unitRef="usd">30836000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i9f228fccaaf945268b8dcbd31bed8868_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjMwNDI3ZDk3ZjgzYjQ0Nzk5NmJhMTJkNzRkYTk5ZTMyL3RhYmxlcmFuZ2U6MzA0MjdkOTdmODNiNDQ3OTk2YmExMmQ3NGRhOTllMzJfNS0xLTEtMS0w_60963e8a-ce37-4931-aee1-ee7ff9a5d2b9"
      unitRef="usd">25058000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i9cfc55d543ed45c79d4721e64e912827_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjMwNDI3ZDk3ZjgzYjQ0Nzk5NmJhMTJkNzRkYTk5ZTMyL3RhYmxlcmFuZ2U6MzA0MjdkOTdmODNiNDQ3OTk2YmExMmQ3NGRhOTllMzJfNS0zLTEtMS0w_ae8b810d-66f1-4c1e-96ba-b73fd9fb864b"
      unitRef="usd">6000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjMwNDI3ZDk3ZjgzYjQ0Nzk5NmJhMTJkNzRkYTk5ZTMyL3RhYmxlcmFuZ2U6MzA0MjdkOTdmODNiNDQ3OTk2YmExMmQ3NGRhOTllMzJfNS01LTEtMS0w_2ba56bf6-1129-43dd-8cd7-d0617966bcb6"
      unitRef="usd">31058000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i9f228fccaaf945268b8dcbd31bed8868_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjMwNDI3ZDk3ZjgzYjQ0Nzk5NmJhMTJkNzRkYTk5ZTMyL3RhYmxlcmFuZ2U6MzA0MjdkOTdmODNiNDQ3OTk2YmExMmQ3NGRhOTllMzJfNi0xLTEtMS0w_074a3466-5fd3-468b-912c-a0097e034d9f"
      unitRef="usd">24529000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i9cfc55d543ed45c79d4721e64e912827_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjMwNDI3ZDk3ZjgzYjQ0Nzk5NmJhMTJkNzRkYTk5ZTMyL3RhYmxlcmFuZ2U6MzA0MjdkOTdmODNiNDQ3OTk2YmExMmQ3NGRhOTllMzJfNi0zLTEtMS0w_1daecece-43f0-4d3c-9a95-2ff42b195969"
      unitRef="usd">6000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81NS9mcmFnOjFiMzZlYjI1MDk0ZDQ1M2RhZWI3Y2Q2M2I1MjdjNjlmL3RhYmxlOjMwNDI3ZDk3ZjgzYjQ0Nzk5NmJhMTJkNzRkYTk5ZTMyL3RhYmxlcmFuZ2U6MzA0MjdkOTdmODNiNDQ3OTk2YmExMmQ3NGRhOTllMzJfNi01LTEtMS0w_19767385-998a-4036-91e8-3bfe67fb69bc"
      unitRef="usd">30529000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:LongTermDebtTextBlock
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfNjcxMQ_271f4461-2608-4d2d-b0e7-2d81e6162f0b">Long-Term Debt&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.360%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.804%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolving line of credit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term loan, net of deferred debt issuance costs of $1,520 and $1,668 in 2021 and 2020, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.625% convertible notes, net of deferred debt issuance costs of $5,031 and $5,475 in 2021 and 2020, respectively, and unamortized discount of $31,117 and $33,620 in 2021 and 2020, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;745,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:&#160;&#160;Current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;725,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February&#160;7, 2019 we entered into a sixth amended and restated senior credit agreement consisting of: (a) a $265.0 million term loan facility and (b) a $585.0 million revolving credit facility.   The revolving credit facility will terminate and the loans outstanding under the term loan facility will mature on the earlier of (i)&#160;February&#160;7, 2024 or (ii) 91 days prior to the earliest scheduled maturity date of the 2.625% convertible notes due in 2024 described below, (if, as of such date, more than $150.0 million in aggregate principal amount of such convertible notes (or any refinancing thereof) remains outstanding).  The term loan facility is payable in quarterly installments increasing over the term of the facility.  Proceeds from the term loan facility and borrowings under the revolving credit facility were used to repay the then existing senior credit agreement and in part to finance the acquisition of Buffalo Filter.  On April&#160;17, 2020, we amended our sixth amended and restated senior credit agreement to suspend our required leverage ratios for up to four quarters as a result of the potential impact from the COVID-19 pandemic.  On November&#160;20, 2020, we entered into a third amendment under our senior credit agreement to lower the applicable margin on the loans and lower the interest floor on Eurocurrency loans agreed upon in April 2020.  On April&#160;15, 2021, we terminated the suspension period, thus reinstating our required leverage ratios.  Interest rates are  adjusted so that the applicable margin for base rate loans is 2.00% per annum and for Eurocurrency rate loans is 3.00% per annum, and the applicable commitment fee rate for the revolving credit facility is 0.50%.  Following the suspension period, the applicable margin will depend upon CONMED&#x2019;s consolidated senior secured leverage ratio, using the pricing grid set forth in the amendment.  Interest rates were at LIBOR (subject to 0.50% floor) plus an interest rate margin of 3.00% (3.50% at March&#160;31, 2021).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were $238.5 million in borrowings outstanding on the term loan facility as of March&#160;31, 2021.  There were $199.0 million in borrowings outstanding under the revolving credit facility as of March&#160;31, 2021.  Our available borrowings on the revolving credit facility at March&#160;31, 2021 were $383.4 million with approximately $2.6 million of the facility set aside for outstanding letters of credit.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The sixth amended and restated senior credit agreement is collateralized by substantially all of our personal property and assets.  The sixth amended and restated senior credit agreement contains covenants and restrictions which, among other things, require the maintenance of certain financial ratios and restrict dividend payments and the incurrence of certain indebtedness and other activities, including acquisitions and dispositions.  We were in full compliance with these covenants and restrictions as of March&#160;31, 2021.  We are also required, under certain circumstances, to make mandatory prepayments from net cash proceeds from any issuance of equity and asset sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 29, 2019, we issued $345.0 million in 2.625% convertible notes due in 2024 (the "Notes").  Interest is payable semi-annually in arrears on February 1 and August 1 of each year, commencing August 1, 2019.  The Notes will mature on February 1, 2024, unless earlier repurchased or converted.  The Notes represent subordinated unsecured obligations and are convertible under certain circumstances, as defined in the indenture, into a combination of cash and CONMED common stock.&#160;&#160;The Notes may be converted at an initial conversion rate of 11.2608 shares of our common stock per $1,000 principal amount of Notes (equivalent to an initial conversion price of approximately $88.80 per share of common stock).  Holders of the Notes may convert the Notes at their option at any time on or after November 1, 2023 through the second scheduled trading day preceding the maturity date.  Holders of the Notes will also have the right to convert the Notes prior to November 1, 2023, but only upon the occurrence of specified events.  The conversion rate is subject to anti-dilution adjustments if certain events occur.  A portion of the net proceeds from the offering of the Notes were used as part of the financing for the Buffalo Filter acquisition &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and $21.0 million were used to pay the cost of certain convertible notes hedge transactions as further described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our effective borrowing rate for nonconvertible debt at the time of issuance of the Notes was estimated to be 6.14%, which resulted in $51.6 million of the $345.0 million aggregate principal amount of Notes issued, or $39.1 million after taxes, being attributable to equity.&#160;&#160;For the three months ended March 31, 2021 and 2020, we have recorded interest expense related to the amortization of debt discount on the Notes of $2.5 million and $2.3 million, respectively, at the effective interest rate of 6.14%.&#160;&#160;The debt discount on the Notes is being amortized through February 2024.&#160;&#160;For both the three months ended March 31, 2021 and 2020, we have recorded interest expense on the Notes of  $2.3 million at the contractual coupon rate of 2.625%.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the offering of the Notes, we entered into convertible note hedge transactions with a number of financial institutions (each, an &#x201c;option counterparty&#x201d;).  The convertible note hedge transactions cover, subject to anti-dilution adjustments substantially similar to those applicable to the Notes, the number of shares of our common stock underlying the Notes.  Concurrently with entering into the convertible note hedge transactions, we also entered into separate warrant transactions with each option counterparty whereby we sold to such option counterparty warrants to purchase, subject to customary anti-dilution adjustments, the same number of shares of our common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The convertible note hedge transactions are expected generally to reduce the potential dilution upon conversion of the Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted Notes, as the case may be, in the event that the market price per share of our common stock, as measured under the terms of the convertible note hedge transactions, is greater than the strike price ($114.92) of the convertible note hedge transactions, which initially corresponds to the conversion price of the Notes and is subject to anti-dilution adjustments substantially similar to those applicable to the conversion rate of the Notes.  If, however, the market price per share of our common stock, as measured under the terms of the warrant transactions, exceeds the strike price of the warrants, there would nevertheless be dilution to the extent that such market price exceeds the strike price of the warrants as noted in Note 7, unless we elect to settle the warrants in cash.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The scheduled&#160;maturities&#160;of&#160;long-term&#160;debt outstanding at March&#160;31, 2021 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;The above amounts exclude debt discount, deferred debt issuance costs and financing leases.&lt;/span&gt;&lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfNjcwNA_7cab6c70-b395-4211-853f-f3e24848ec46">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.360%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.804%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolving line of credit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term loan, net of deferred debt issuance costs of $1,520 and $1,668 in 2021 and 2020, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.625% convertible notes, net of deferred debt issuance costs of $5,031 and $5,475 in 2021 and 2020, respectively, and unamortized discount of $31,117 and $33,620 in 2021 and 2020, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;745,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:&#160;&#160;Current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;725,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i824ceb82e4874235bfdf7c0af561e38c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfMS0xLTEtMS0w_d6758f28-557d-4fc8-9e22-ce2bb68af9c7"
      unitRef="usd">199000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i1d478e70dcec4899b2e2962f31e3f914_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfMS0zLTEtMS0w_984d1ed9-c918-409a-b648-661de8c494d5"
      unitRef="usd">207000000</us-gaap:LongTermDebt>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i3d8fccab0a15481582a37233de37abbf_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfMi0wLTEtMS0wL3RleHRyZWdpb246NjI0MTM2NDQ2ZTIzNGE5MGE1NmU0NzI2MGRiZDY2NjdfNTQ_92be8098-ae6b-43a4-9f4e-3da201f79f8d"
      unitRef="usd">1520000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="idc48b5a1f090411da72a4fabcf8ba3c5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfMi0wLTEtMS0wL3RleHRyZWdpb246NjI0MTM2NDQ2ZTIzNGE5MGE1NmU0NzI2MGRiZDY2NjdfNjE_8db901c9-05e6-42bb-895d-a543bd3e4ff2"
      unitRef="usd">1668000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:LongTermDebt
      contextRef="i3d8fccab0a15481582a37233de37abbf_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfMi0xLTEtMS0w_6216b605-c515-4697-86e8-ccc6a2fb1433"
      unitRef="usd">236980000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="idc48b5a1f090411da72a4fabcf8ba3c5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfMi0zLTEtMS0w_295cbe8b-5236-4c5a-9ca3-40789bc13802"
      unitRef="usd">240145000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id748c1bbe2b3409b9e97ffd239dcc0f0_I20190129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfMy0wLTEtMS0wL3RleHRyZWdpb246ZTdjNTY0M2ZlMTVjNGQ0MmI0YjliN2Y2OWZhNmY2MjZfNA_4b151355-2264-482d-948e-413a8a1fdbe8"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i99821198665d4c33ba7a5fc053af58b5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfMy0wLTEtMS0wL3RleHRyZWdpb246ZTdjNTY0M2ZlMTVjNGQ0MmI0YjliN2Y2OWZhNmY2MjZfNjU_eb95ccce-9351-48d4-baa6-5f76e1e37dc3"
      unitRef="usd">5031000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i0b2868e4273945968f65bc7567ca9021_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfMy0wLTEtMS0wL3RleHRyZWdpb246ZTdjNTY0M2ZlMTVjNGQ0MmI0YjliN2Y2OWZhNmY2MjZfNzI_b3944a2a-5548-409f-b6f7-041e231d3a46"
      unitRef="usd">5475000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i99821198665d4c33ba7a5fc053af58b5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfMy0wLTEtMS0wL3RleHRyZWdpb246ZTdjNTY0M2ZlMTVjNGQ0MmI0YjliN2Y2OWZhNmY2MjZfMTMx_01efc9dc-0bd8-40e8-817a-86ec912570b8"
      unitRef="usd">31117000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i0b2868e4273945968f65bc7567ca9021_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfMy0wLTEtMS0wL3RleHRyZWdpb246ZTdjNTY0M2ZlMTVjNGQ0MmI0YjliN2Y2OWZhNmY2MjZfMTM4_8c8a049e-d3ad-4fa0-8f69-46f15065d183"
      unitRef="usd">33620000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:ConvertibleDebt
      contextRef="i99821198665d4c33ba7a5fc053af58b5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfMy0xLTEtMS0w_ce7fb3e7-8ba6-4565-99dd-5bc760db5979"
      unitRef="usd">308850000</us-gaap:ConvertibleDebt>
    <us-gaap:ConvertibleDebt
      contextRef="i0b2868e4273945968f65bc7567ca9021_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfMy0zLTEtMS0w_18e007b6-a9c8-4ee4-97cd-9ba20faf077d"
      unitRef="usd">305904000</us-gaap:ConvertibleDebt>
    <us-gaap:FinanceLeaseLiability
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfNC0xLTEtMS0w_bc21e3cb-ef95-4cbe-bdfb-ac53d513ad56"
      unitRef="usd">566000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfNC0zLTEtMS0w_6438ee1f-eb65-48ac-b21b-102d9dcf2d1f"
      unitRef="usd">587000</us-gaap:FinanceLeaseLiability>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfNS0xLTEtMS0w_79f50cc9-8ffb-43f0-a778-4d10142acd1e"
      unitRef="usd">745396000</us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfNS0zLTEtMS0w_7a126a21-26f3-4358-a7bd-d0931b357a55"
      unitRef="usd">753636000</us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfNi0xLTEtMS0w_4f6f13b5-d4f3-4de3-8199-5f0be8dc3e2a"
      unitRef="usd">20076000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfNi0zLTEtMS0w_3db1f42e-8143-47a0-a915-94a300d8bd64"
      unitRef="usd">18415000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfNy0xLTEtMS0w_360aa65c-c001-403d-9398-96144b846176"
      unitRef="usd">725320000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjFlMTgxZmQwNmFhYTQ5N2Q5NGE3YmJhOTlmNTMyYTY1L3RhYmxlcmFuZ2U6MWUxODFmZDA2YWFhNDk3ZDk0YTdiYmE5OWY1MzJhNjVfNy0zLTEtMS0w_9c033519-d075-4845-ad69-ec20fbaeb32e"
      unitRef="usd">735221000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ida498aa346244a73997d7daf728c9420_I20190207"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfMTg5_fb24c343-29c7-4a1b-b7c7-4d8138287d28"
      unitRef="usd">265000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i7729e32eb8ce41c089d19b2205b89c39_I20190207"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfMjIx_f76c9d53-af64-41b0-a20b-d597b82cf53f"
      unitRef="usd">585000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id748c1bbe2b3409b9e97ffd239dcc0f0_I20190129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfNDcz_4b151355-2264-482d-948e-413a8a1fdbe8"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <cnmd:CreditAgreementExpirationTriggerRequirementConvertibleNoteOutstandingBalance
      contextRef="i9eaf4f751cfe4066b7c97b065a34e247_I20190207"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfNTU1_624baf66-34b8-47b7-8000-3cbfe8283e42"
      unitRef="usd">150000000.0</cnmd:CreditAgreementExpirationTriggerRequirementConvertibleNoteOutstandingBalance>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i28142c61de0544568e9a171dfbb1187c_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfMTQxNQ_0d4a0bfa-efa5-4b4b-bd82-bcd4c4af08de"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i6e5c081b73e84195a5fcd7003f17de71_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfMTQ2Mw_48aea068-a17c-4cac-81d9-032f3589eb18"
      unitRef="number">0.0300</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="ied43b21a44b44e51b34956e8f380ca38_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfMTU1Mw_60194f48-3d74-466e-9dac-955ec7b8357a"
      unitRef="number">0.0050</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <cnmd:LIBORInterestRateFloor
      contextRef="ied43b21a44b44e51b34956e8f380ca38_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfMTc3Ng_3cd84ef4-94df-4abb-a67d-f92ed6c89b42"
      unitRef="number">0.0050</cnmd:LIBORInterestRateFloor>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ib605253e0a9f4dfba2ff9d30ac708b49_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfMTgxOA_ec0485a9-38c3-47bb-87f3-f0a19067e5c9"
      unitRef="number">0.0300</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i3d7a728e16414d51a3ab40885ff60574_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfMTgyMg_c50d1b19-2a67-4959-a431-d49409774b69"
      unitRef="number">0.0350</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3d8fccab0a15481582a37233de37abbf_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfMTg0NQ_1b616e2d-bb50-4762-9761-f008e5b1af64"
      unitRef="usd">238500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebt
      contextRef="i824ceb82e4874235bfdf7c0af561e38c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfMTkyMg_d6758f28-557d-4fc8-9e22-ce2bb68af9c7"
      unitRef="usd">199000000.0</us-gaap:LongTermDebt>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i824ceb82e4874235bfdf7c0af561e38c_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfMjA2Nw_fa28d650-85ab-43a0-a204-c18b3bb66eed"
      unitRef="usd">383400000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i824ceb82e4874235bfdf7c0af561e38c_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfMjA4OQ_d5fbcf9e-e99a-4ee1-95ab-7a60bae187a9"
      unitRef="usd">2600000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="id748c1bbe2b3409b9e97ffd239dcc0f0_I20190129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfMjg1Mg_f01c285b-cfa6-4cdb-9a14-d14738e2ce1c"
      unitRef="usd">345000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id748c1bbe2b3409b9e97ffd239dcc0f0_I20190129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfMjg1OA_4b151355-2264-482d-948e-413a8a1fdbe8"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="iee99b7a3a16541f8b5be3bf158edab1d_D20190129-20190129"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfMzM1Mg_3c52b533-4f32-4e39-bf70-cfb629057e12"
      unitRef="number">11.2608</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="id748c1bbe2b3409b9e97ffd239dcc0f0_I20190129"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfMzQ3NQ_7488fc20-c2c5-4385-90e6-1dc3c601e0b8"
      unitRef="usdPerShare">88.80</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <cnmd:Hedgeandwarranttransactionsnetcashpaid
      contextRef="ie5c0fe7cdde24d5ab7b9a921af59a0d9_I20190129"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfNDA0NA_96787fcf-bb5f-42f6-95cc-8081184de058"
      unitRef="usd">21000000.0</cnmd:Hedgeandwarranttransactionsnetcashpaid>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="id748c1bbe2b3409b9e97ffd239dcc0f0_I20190129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfNDI2MA_5ec888cf-349a-4203-8bf5-3911d38f5aa7"
      unitRef="number">0.0614</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <cnmd:DebtInstrumentConvertibleGrossAmountofEquityComponent
      contextRef="id748c1bbe2b3409b9e97ffd239dcc0f0_I20190129"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfNDI4Mg_dbcedafc-e6b5-4b37-bd82-33ec1aef9340"
      unitRef="usd">51600000</cnmd:DebtInstrumentConvertibleGrossAmountofEquityComponent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="id748c1bbe2b3409b9e97ffd239dcc0f0_I20190129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfNDI5Mg_f01c285b-cfa6-4cdb-9a14-d14738e2ce1c"
      unitRef="usd">345000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="id748c1bbe2b3409b9e97ffd239dcc0f0_I20190129"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfNDM0Mg_6650c33d-e643-461f-b3cb-6d6dae785a43"
      unitRef="usd">39100000</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="ibf80fee48fa74ab4b9051fb83cdd995b_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfNDQ5OQ_0fb106a8-1758-449b-b0be-c201f3981497"
      unitRef="usd">2500000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i296a43d7781e4424a01be9d77422618e_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfNDUwNg_ae154320-3949-4348-8d02-e25bb25c5e7e"
      unitRef="usd">2300000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="id748c1bbe2b3409b9e97ffd239dcc0f0_I20190129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfNDY5Nw_5ec888cf-349a-4203-8bf5-3911d38f5aa7"
      unitRef="number">0.0614</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:InterestExpenseDebt
      contextRef="ibf80fee48fa74ab4b9051fb83cdd995b_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfNDg0Nw_3c73347e-4a10-4e59-b4a8-df2dbaa2def3"
      unitRef="usd">2300000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i296a43d7781e4424a01be9d77422618e_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfNDg0Nw_559e6b73-8d70-48dc-ac93-ff6aeb9f9e51"
      unitRef="usd">2300000</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id748c1bbe2b3409b9e97ffd239dcc0f0_I20190129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfNDk3OA_4b151355-2264-482d-948e-413a8a1fdbe8"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:OptionIndexedToIssuersEquityStrikePrice1
      contextRef="i4166a58e42b343bfb5ae40145fb70764_D20190129-20190129"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfNjEwMw_d31c1a4c-81ef-4de2-b086-18a0a9401ebb"
      unitRef="usdPerShare">114.92</us-gaap:OptionIndexedToIssuersEquityStrikePrice1>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RleHRyZWdpb246OGNiODIwMmVhNjE2NDBjZGFiZjk0ZmEyYjg1NDM3MTlfNjcwMA_9ba8ca6d-7cb7-4d3c-ab8d-b347b9011737">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The scheduled&#160;maturities&#160;of&#160;long-term&#160;debt outstanding at March&#160;31, 2021 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;The above amounts exclude debt discount, deferred debt issuance costs and financing leases.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjY2NzE4YjFmYjFiYTQyNGNhNDA3NGExZDU2YWZlYmRmL3RhYmxlcmFuZ2U6NjY3MThiMWZiMWJhNDI0Y2E0MDc0YTFkNTZhZmViZGZfMC0xLTEtMS0w_377a2307-5ba7-4e64-8cd8-cab2af0aa54b"
      unitRef="usd">14906000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjY2NzE4YjFmYjFiYTQyNGNhNDA3NGExZDU2YWZlYmRmL3RhYmxlcmFuZ2U6NjY3MThiMWZiMWJhNDI0Y2E0MDc0YTFkNTZhZmViZGZfMS0xLTEtMS0w_e668b26e-9a75-421c-9a0b-754aacea178b"
      unitRef="usd">24844000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjY2NzE4YjFmYjFiYTQyNGNhNDA3NGExZDU2YWZlYmRmL3RhYmxlcmFuZ2U6NjY3MThiMWZiMWJhNDI0Y2E0MDc0YTFkNTZhZmViZGZfMi0xLTEtMS0w_eed5b040-e3a4-489c-8410-0fb889a54de4"
      unitRef="usd">397750000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjY2NzE4YjFmYjFiYTQyNGNhNDA3NGExZDU2YWZlYmRmL3RhYmxlcmFuZ2U6NjY3MThiMWZiMWJhNDI0Y2E0MDc0YTFkNTZhZmViZGZfMy0xLTEtMS0w_eb1e6448-7a1f-46e5-a8d1-2589c68a28ee"
      unitRef="usd">345000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF81OC9mcmFnOjhjYjgyMDJlYTYxNjQwY2RhYmY5NGZhMmI4NTQzNzE5L3RhYmxlOjY2NzE4YjFmYjFiYTQyNGNhNDA3NGExZDU2YWZlYmRmL3RhYmxlcmFuZ2U6NjY3MThiMWZiMWJhNDI0Y2E0MDc0YTFkNTZhZmViZGZfNC0xLTEtMS0w_6aa94137-4580-4b0b-8334-c3243ff55b1a"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:ProductWarrantyDisclosureTextBlock
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82MS9mcmFnOjBjNDg5NDdkMGNkMTRiNTU5MWVlODIwZDQ4OWIxNzA4L3RleHRyZWdpb246MGM0ODk0N2QwY2QxNGI1NTkxZWU4MjBkNDg5YjE3MDhfNjYy_01a38578-6d06-4747-9092-6f547b82b357">Guarantees&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We provide warranties on certain of our products at the time of sale and sell extended warranties.  The standard warranty period for our capital equipment is generally one year and our extended warranties typically vary from one to three years.  Liability under warranty policies is based upon a review of historical claim experience.  Adjustments are made to accruals as claim data and historical experience warrant.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the liability for standard warranties for the three months ended March 31, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.932%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.018%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1,&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for warranties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Claims made&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(206)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Costs associated with extended warranty repairs are recorded as incurred and amounted to $1.6 million and $1.5 million for the three months ended March 31, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ProductWarrantyDisclosureTextBlock>
    <cnmd:ProductWarrantyAccrualTerm
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82MS9mcmFnOjBjNDg5NDdkMGNkMTRiNTU5MWVlODIwZDQ4OWIxNzA4L3RleHRyZWdpb246MGM0ODk0N2QwY2QxNGI1NTkxZWU4MjBkNDg5YjE3MDhfMTk1_2113ed90-c865-4e95-8266-466d6e55294e">P1Y</cnmd:ProductWarrantyAccrualTerm>
    <us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82MS9mcmFnOjBjNDg5NDdkMGNkMTRiNTU5MWVlODIwZDQ4OWIxNzA4L3RleHRyZWdpb246MGM0ODk0N2QwY2QxNGI1NTkxZWU4MjBkNDg5YjE3MDhfNjY5_c9c60c64-ca37-4ad1-ac8d-b1827b7c0f77">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the liability for standard warranties for the three months ended March 31, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.932%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.018%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1,&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for warranties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Claims made&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(206)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="i46ba6599130f4eb1a4d6fe042999e135_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82MS9mcmFnOjBjNDg5NDdkMGNkMTRiNTU5MWVlODIwZDQ4OWIxNzA4L3RhYmxlOjI4OTViMGIxYmMyNTQyMWQ5YmMxOGQyYzdlM2EzZWVjL3RhYmxlcmFuZ2U6Mjg5NWIwYjFiYzI1NDIxZDliYzE4ZDJjN2UzYTNlZWNfMS0xLTEtMS0w_9d3b3f40-fd89-4314-b6ee-7a1386817b68"
      unitRef="usd">1826000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="i7e86d4601a4b4430ba15cc2ae32a9336_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82MS9mcmFnOjBjNDg5NDdkMGNkMTRiNTU5MWVlODIwZDQ4OWIxNzA4L3RhYmxlOjI4OTViMGIxYmMyNTQyMWQ5YmMxOGQyYzdlM2EzZWVjL3RhYmxlcmFuZ2U6Mjg5NWIwYjFiYzI1NDIxZDliYzE4ZDJjN2UzYTNlZWNfMS0zLTEtMS0w_c5b710c5-58fe-4fda-a318-b638821e8461"
      unitRef="usd">2186000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrualWarrantiesIssued
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82MS9mcmFnOjBjNDg5NDdkMGNkMTRiNTU5MWVlODIwZDQ4OWIxNzA4L3RhYmxlOjI4OTViMGIxYmMyNTQyMWQ5YmMxOGQyYzdlM2EzZWVjL3RhYmxlcmFuZ2U6Mjg5NWIwYjFiYzI1NDIxZDliYzE4ZDJjN2UzYTNlZWNfMy0xLTEtMS0w_9676ef6f-524f-4caf-823b-50dbbcb5f3c1"
      unitRef="usd">291000</us-gaap:StandardProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:StandardProductWarrantyAccrualWarrantiesIssued
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82MS9mcmFnOjBjNDg5NDdkMGNkMTRiNTU5MWVlODIwZDQ4OWIxNzA4L3RhYmxlOjI4OTViMGIxYmMyNTQyMWQ5YmMxOGQyYzdlM2EzZWVjL3RhYmxlcmFuZ2U6Mjg5NWIwYjFiYzI1NDIxZDliYzE4ZDJjN2UzYTNlZWNfMy0zLTEtMS0w_53e62340-2819-4355-af7c-940e8d39c3f9"
      unitRef="usd">355000</us-gaap:StandardProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:StandardProductWarrantyAccrualPayments
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82MS9mcmFnOjBjNDg5NDdkMGNkMTRiNTU5MWVlODIwZDQ4OWIxNzA4L3RhYmxlOjI4OTViMGIxYmMyNTQyMWQ5YmMxOGQyYzdlM2EzZWVjL3RhYmxlcmFuZ2U6Mjg5NWIwYjFiYzI1NDIxZDliYzE4ZDJjN2UzYTNlZWNfNC0xLTEtMS0w_1a1c30b3-85cb-46ed-942f-471ecb62c6b3"
      unitRef="usd">206000</us-gaap:StandardProductWarrantyAccrualPayments>
    <us-gaap:StandardProductWarrantyAccrualPayments
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82MS9mcmFnOjBjNDg5NDdkMGNkMTRiNTU5MWVlODIwZDQ4OWIxNzA4L3RhYmxlOjI4OTViMGIxYmMyNTQyMWQ5YmMxOGQyYzdlM2EzZWVjL3RhYmxlcmFuZ2U6Mjg5NWIwYjFiYzI1NDIxZDliYzE4ZDJjN2UzYTNlZWNfNC0zLTEtMS0w_b1814f32-4674-43e5-857b-113db1831a6f"
      unitRef="usd">363000</us-gaap:StandardProductWarrantyAccrualPayments>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82MS9mcmFnOjBjNDg5NDdkMGNkMTRiNTU5MWVlODIwZDQ4OWIxNzA4L3RhYmxlOjI4OTViMGIxYmMyNTQyMWQ5YmMxOGQyYzdlM2EzZWVjL3RhYmxlcmFuZ2U6Mjg5NWIwYjFiYzI1NDIxZDliYzE4ZDJjN2UzYTNlZWNfNi0xLTEtMS0w_0278ce44-fea5-40f5-b65c-bf0bc5bb08ca"
      unitRef="usd">1911000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="i4c56f028fc084321a0e30cfeaea79a64_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82MS9mcmFnOjBjNDg5NDdkMGNkMTRiNTU5MWVlODIwZDQ4OWIxNzA4L3RhYmxlOjI4OTViMGIxYmMyNTQyMWQ5YmMxOGQyYzdlM2EzZWVjL3RhYmxlcmFuZ2U6Mjg5NWIwYjFiYzI1NDIxZDliYzE4ZDJjN2UzYTNlZWNfNi0zLTEtMS0w_79f7f61d-2d06-4f66-a540-5afdcf66c884"
      unitRef="usd">2178000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:ProductWarrantyExpense
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82MS9mcmFnOjBjNDg5NDdkMGNkMTRiNTU5MWVlODIwZDQ4OWIxNzA4L3RleHRyZWdpb246MGM0ODk0N2QwY2QxNGI1NTkxZWU4MjBkNDg5YjE3MDhfNjE1_aaa64afb-732e-41f7-925c-ef1898de559f"
      unitRef="usd">1600000</us-gaap:ProductWarrantyExpense>
    <us-gaap:ProductWarrantyExpense
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82MS9mcmFnOjBjNDg5NDdkMGNkMTRiNTU5MWVlODIwZDQ4OWIxNzA4L3RleHRyZWdpb246MGM0ODk0N2QwY2QxNGI1NTkxZWU4MjBkNDg5YjE3MDhfNjIy_6f86f920-20ef-403e-824f-50fde9420e11"
      unitRef="usd">1500000</us-gaap:ProductWarrantyExpense>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82NC9mcmFnOjNmYjJmYzI3NjljNzQ1MTU4ZmZjNzljZTM3ZGE1MjZjL3RleHRyZWdpb246M2ZiMmZjMjc2OWM3NDUxNThmZmM3OWNlMzdkYTUyNmNfMzg4_e406ec6f-f076-40ec-a69f-ff1cd247cac6">Pension Plan&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net periodic pension cost consists of the following:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost on projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,289)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,255)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net amortization and deferral&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic pension cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;We do not expect to make any pension contributions during 2021.  Non-service cost of $0.1 million for the three months ended March&#160;31, 2020 is included in other expense in the consolidated condensed statements of comprehensive income (loss).  Non-service pension cost was immaterial for the three months ended March&#160;31, 2021.</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82NC9mcmFnOjNmYjJmYzI3NjljNzQ1MTU4ZmZjNzljZTM3ZGE1MjZjL3RleHRyZWdpb246M2ZiMmZjMjc2OWM3NDUxNThmZmM3OWNlMzdkYTUyNmNfMzg1_3f745c93-a837-4e40-9722-6c2fbc2d7d7a">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net periodic pension cost consists of the following:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost on projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,289)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,255)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net amortization and deferral&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic pension cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82NC9mcmFnOjNmYjJmYzI3NjljNzQ1MTU4ZmZjNzljZTM3ZGE1MjZjL3RhYmxlOjk1YThiMDU0MjllZjRkYjE5OWRiOWJhMmUyNzhlZDJmL3RhYmxlcmFuZ2U6OTVhOGIwNTQyOWVmNGRiMTk5ZGI5YmEyZTI3OGVkMmZfMi0xLTEtMS0w_a86b2ce1-7b5b-4f7b-8c0c-ca0a59e17fd1"
      unitRef="usd">248000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82NC9mcmFnOjNmYjJmYzI3NjljNzQ1MTU4ZmZjNzljZTM3ZGE1MjZjL3RhYmxlOjk1YThiMDU0MjllZjRkYjE5OWRiOWJhMmUyNzhlZDJmL3RhYmxlcmFuZ2U6OTVhOGIwNTQyOWVmNGRiMTk5ZGI5YmEyZTI3OGVkMmZfMi0zLTEtMS0w_a3ff53ce-aadd-4c22-af4b-b6a5ab316c38"
      unitRef="usd">179000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82NC9mcmFnOjNmYjJmYzI3NjljNzQ1MTU4ZmZjNzljZTM3ZGE1MjZjL3RhYmxlOjk1YThiMDU0MjllZjRkYjE5OWRiOWJhMmUyNzhlZDJmL3RhYmxlcmFuZ2U6OTVhOGIwNTQyOWVmNGRiMTk5ZGI5YmEyZTI3OGVkMmZfNC0xLTEtMS0w_975acdf2-92aa-4a2e-9009-d8a213269975"
      unitRef="usd">451000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82NC9mcmFnOjNmYjJmYzI3NjljNzQ1MTU4ZmZjNzljZTM3ZGE1MjZjL3RhYmxlOjk1YThiMDU0MjllZjRkYjE5OWRiOWJhMmUyNzhlZDJmL3RhYmxlcmFuZ2U6OTVhOGIwNTQyOWVmNGRiMTk5ZGI5YmEyZTI3OGVkMmZfNC0zLTEtMS0w_80f33fdf-b7ef-46d9-8840-5024318f5605"
      unitRef="usd">639000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82NC9mcmFnOjNmYjJmYzI3NjljNzQ1MTU4ZmZjNzljZTM3ZGE1MjZjL3RhYmxlOjk1YThiMDU0MjllZjRkYjE5OWRiOWJhMmUyNzhlZDJmL3RhYmxlcmFuZ2U6OTVhOGIwNTQyOWVmNGRiMTk5ZGI5YmEyZTI3OGVkMmZfNi0xLTEtMS0w_9f971663-8181-46db-9edc-818f980fd7f8"
      unitRef="usd">1289000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82NC9mcmFnOjNmYjJmYzI3NjljNzQ1MTU4ZmZjNzljZTM3ZGE1MjZjL3RhYmxlOjk1YThiMDU0MjllZjRkYjE5OWRiOWJhMmUyNzhlZDJmL3RhYmxlcmFuZ2U6OTVhOGIwNTQyOWVmNGRiMTk5ZGI5YmEyZTI3OGVkMmZfNi0zLTEtMS0w_060cd1ee-d40f-4561-a513-c2bad445d8d1"
      unitRef="usd">1255000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82NC9mcmFnOjNmYjJmYzI3NjljNzQ1MTU4ZmZjNzljZTM3ZGE1MjZjL3RhYmxlOjk1YThiMDU0MjllZjRkYjE5OWRiOWJhMmUyNzhlZDJmL3RhYmxlcmFuZ2U6OTVhOGIwNTQyOWVmNGRiMTk5ZGI5YmEyZTI3OGVkMmZfOC0xLTEtMS0w_d9f90f36-36c9-44bf-8f1b-7815ab9c4967"
      unitRef="usd">-832000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82NC9mcmFnOjNmYjJmYzI3NjljNzQ1MTU4ZmZjNzljZTM3ZGE1MjZjL3RhYmxlOjk1YThiMDU0MjllZjRkYjE5OWRiOWJhMmUyNzhlZDJmL3RhYmxlcmFuZ2U6OTVhOGIwNTQyOWVmNGRiMTk5ZGI5YmEyZTI3OGVkMmZfOC0zLTEtMS0w_ee646c38-d5e0-4b50-835d-719fdba02be2"
      unitRef="usd">-705000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82NC9mcmFnOjNmYjJmYzI3NjljNzQ1MTU4ZmZjNzljZTM3ZGE1MjZjL3RhYmxlOjk1YThiMDU0MjllZjRkYjE5OWRiOWJhMmUyNzhlZDJmL3RhYmxlcmFuZ2U6OTVhOGIwNTQyOWVmNGRiMTk5ZGI5YmEyZTI3OGVkMmZfMTAtMS0xLTEtMA_5927a122-9d86-4e87-b0df-2d6c9cd25d68"
      unitRef="usd">242000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82NC9mcmFnOjNmYjJmYzI3NjljNzQ1MTU4ZmZjNzljZTM3ZGE1MjZjL3RhYmxlOjk1YThiMDU0MjllZjRkYjE5OWRiOWJhMmUyNzhlZDJmL3RhYmxlcmFuZ2U6OTVhOGIwNTQyOWVmNGRiMTk5ZGI5YmEyZTI3OGVkMmZfMTAtMy0xLTEtMA_5304d9ba-dd03-4371-ac68-9ed3b25b9e65"
      unitRef="usd">268000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <cnmd:DefinedBenefitPlanNonServiceCost
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82NC9mcmFnOjNmYjJmYzI3NjljNzQ1MTU4ZmZjNzljZTM3ZGE1MjZjL3RleHRyZWdpb246M2ZiMmZjMjc2OWM3NDUxNThmZmM3OWNlMzdkYTUyNmNfMTc5_e96d5d2e-3e20-4fb0-8b62-3f3cfea68928"
      unitRef="usd">100000</cnmd:DefinedBenefitPlanNonServiceCost>
    <cnmd:AcquisitionandOtherExpenseTextBlock
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82Ny9mcmFnOmNjYmNmMDU0MjFiNTQ0YmZhMjIzMDAxZTBiMWEwYTJlL3RleHRyZWdpb246Y2NiY2YwNTQyMWI1NDRiZmEyMjMwMDFlMGIxYTBhMmVfMzk0Nw_408f17fb-784d-4e89-ae79-16b525b52d14">Acquisition and Other Expense&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Acquisition and other expense consist of the following, which are included in cost of sales or selling and administrative expense depending on the nature of the charge:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Manufacturing consolidation costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition and integration costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition and other expense included in cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and related costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition and integration costs &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition and other expense included in selling and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2020, we incurred $1.8&#160;million in costs related to the consolidation of certain manufacturing operations which were charged to cost of sales.  These costs related to winding down operations at certain locations and moving production lines to other facilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2020, we incurred costs for inventory step-up adjustments and other costs of $0.8 million related to a previous acquisition, which were charged to cost of sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2020, we incurred $0.8 million in severance and integration costs mainly related to the Buffalo Filter acquisition, which were included in selling and administrative expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2021, we recorded a charge of $0.4 million related to the restructuring of our sales force which was charged to selling and administrative expense.  The charges for sales force restructuring consisted &lt;/span&gt;&lt;/div&gt;primarily of termination payments to Orthopedic distributors made in exchange for ongoing assistance to transition to employee-based sales representatives and severance.</cnmd:AcquisitionandOtherExpenseTextBlock>
    <cnmd:ScheduleOfAcquisitionAndOtherOperatingExpenseTableTextBlock
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82Ny9mcmFnOmNjYmNmMDU0MjFiNTQ0YmZhMjIzMDAxZTBiMWEwYTJlL3RleHRyZWdpb246Y2NiY2YwNTQyMWI1NDRiZmEyMjMwMDFlMGIxYTBhMmVfMzk1NA_2ab5096f-0345-4aa4-9f01-2a1bed634828">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Acquisition and other expense consist of the following, which are included in cost of sales or selling and administrative expense depending on the nature of the charge:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Manufacturing consolidation costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition and integration costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition and other expense included in cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and related costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition and integration costs &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition and other expense included in selling and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cnmd:ScheduleOfAcquisitionAndOtherOperatingExpenseTableTextBlock>
    <cnmd:Manufacturingconsolidationcosts
      contextRef="ic4cfe412f15e40679fed8fb1ab50ff59_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82Ny9mcmFnOmNjYmNmMDU0MjFiNTQ0YmZhMjIzMDAxZTBiMWEwYTJlL3RhYmxlOjU4MWU5NWM0ZGEzODRhMjE4YTEzYjNiMjczYjgyMzk0L3RhYmxlcmFuZ2U6NTgxZTk1YzRkYTM4NGEyMThhMTNiM2IyNzNiODIzOTRfNy0xLTEtMS0w_016c0be1-c23e-4e52-aab7-0e4c5f539232"
      unitRef="usd">0</cnmd:Manufacturingconsolidationcosts>
    <cnmd:Manufacturingconsolidationcosts
      contextRef="if891372cb88f49d1ad8cf68161f49100_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82Ny9mcmFnOmNjYmNmMDU0MjFiNTQ0YmZhMjIzMDAxZTBiMWEwYTJlL3RhYmxlOjU4MWU5NWM0ZGEzODRhMjE4YTEzYjNiMjczYjgyMzk0L3RhYmxlcmFuZ2U6NTgxZTk1YzRkYTM4NGEyMThhMTNiM2IyNzNiODIzOTRfNy0zLTEtMS0w_1faf3101-f835-4cd6-a045-7a1703e0ff69"
      unitRef="usd">1785000</cnmd:Manufacturingconsolidationcosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ic4cfe412f15e40679fed8fb1ab50ff59_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82Ny9mcmFnOmNjYmNmMDU0MjFiNTQ0YmZhMjIzMDAxZTBiMWEwYTJlL3RhYmxlOjU4MWU5NWM0ZGEzODRhMjE4YTEzYjNiMjczYjgyMzk0L3RhYmxlcmFuZ2U6NTgxZTk1YzRkYTM4NGEyMThhMTNiM2IyNzNiODIzOTRfOC0xLTEtMS0w_8b7831a4-d4a2-439e-8216-7cdcfcc30dd4"
      unitRef="usd">0</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="if891372cb88f49d1ad8cf68161f49100_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82Ny9mcmFnOmNjYmNmMDU0MjFiNTQ0YmZhMjIzMDAxZTBiMWEwYTJlL3RhYmxlOjU4MWU5NWM0ZGEzODRhMjE4YTEzYjNiMjczYjgyMzk0L3RhYmxlcmFuZ2U6NTgxZTk1YzRkYTM4NGEyMThhMTNiM2IyNzNiODIzOTRfOC0zLTEtMS0w_2ee8c869-1906-4ea6-a2d9-24f9a09fc1af"
      unitRef="usd">805000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="ic4cfe412f15e40679fed8fb1ab50ff59_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82Ny9mcmFnOmNjYmNmMDU0MjFiNTQ0YmZhMjIzMDAxZTBiMWEwYTJlL3RhYmxlOjU4MWU5NWM0ZGEzODRhMjE4YTEzYjNiMjczYjgyMzk0L3RhYmxlcmFuZ2U6NTgxZTk1YzRkYTM4NGEyMThhMTNiM2IyNzNiODIzOTRfOS0xLTEtMS0w_c62fb990-d46c-4776-9539-b9ea96ac9285"
      unitRef="usd">0</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="if891372cb88f49d1ad8cf68161f49100_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82Ny9mcmFnOmNjYmNmMDU0MjFiNTQ0YmZhMjIzMDAxZTBiMWEwYTJlL3RhYmxlOjU4MWU5NWM0ZGEzODRhMjE4YTEzYjNiMjczYjgyMzk0L3RhYmxlcmFuZ2U6NTgxZTk1YzRkYTM4NGEyMThhMTNiM2IyNzNiODIzOTRfOS0zLTEtMS0w_f39e3e4d-a9e0-4a2d-96f2-e2ad47916a78"
      unitRef="usd">2590000</us-gaap:OtherCostAndExpenseOperating>
    <cnmd:RestructuringAndRelatedCosts
      contextRef="i1c05d83ea1e6498489016ad7d59cf236_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82Ny9mcmFnOmNjYmNmMDU0MjFiNTQ0YmZhMjIzMDAxZTBiMWEwYTJlL3RhYmxlOjU4MWU5NWM0ZGEzODRhMjE4YTEzYjNiMjczYjgyMzk0L3RhYmxlcmFuZ2U6NTgxZTk1YzRkYTM4NGEyMThhMTNiM2IyNzNiODIzOTRfMTItMS0xLTEtMA_30e9070a-797c-46fa-9917-3b844e0fae9f"
      unitRef="usd">414000</cnmd:RestructuringAndRelatedCosts>
    <cnmd:RestructuringAndRelatedCosts
      contextRef="i7e04b4ea73e04184933b0223f3525651_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82Ny9mcmFnOmNjYmNmMDU0MjFiNTQ0YmZhMjIzMDAxZTBiMWEwYTJlL3RhYmxlOjU4MWU5NWM0ZGEzODRhMjE4YTEzYjNiMjczYjgyMzk0L3RhYmxlcmFuZ2U6NTgxZTk1YzRkYTM4NGEyMThhMTNiM2IyNzNiODIzOTRfMTItMy0xLTEtMA_61abfb27-dd5d-4a68-8244-ee442ee754fa"
      unitRef="usd">0</cnmd:RestructuringAndRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i1c05d83ea1e6498489016ad7d59cf236_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82Ny9mcmFnOmNjYmNmMDU0MjFiNTQ0YmZhMjIzMDAxZTBiMWEwYTJlL3RhYmxlOjU4MWU5NWM0ZGEzODRhMjE4YTEzYjNiMjczYjgyMzk0L3RhYmxlcmFuZ2U6NTgxZTk1YzRkYTM4NGEyMThhMTNiM2IyNzNiODIzOTRfMTQtMS0xLTEtMA_b24e6308-c058-4366-be01-0e0f35230e2f"
      unitRef="usd">0</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i7e04b4ea73e04184933b0223f3525651_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82Ny9mcmFnOmNjYmNmMDU0MjFiNTQ0YmZhMjIzMDAxZTBiMWEwYTJlL3RhYmxlOjU4MWU5NWM0ZGEzODRhMjE4YTEzYjNiMjczYjgyMzk0L3RhYmxlcmFuZ2U6NTgxZTk1YzRkYTM4NGEyMThhMTNiM2IyNzNiODIzOTRfMTQtMy0xLTEtMA_8f836247-8ea7-4d99-a5db-a9815fc3aa18"
      unitRef="usd">754000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="i1c05d83ea1e6498489016ad7d59cf236_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82Ny9mcmFnOmNjYmNmMDU0MjFiNTQ0YmZhMjIzMDAxZTBiMWEwYTJlL3RhYmxlOjU4MWU5NWM0ZGEzODRhMjE4YTEzYjNiMjczYjgyMzk0L3RhYmxlcmFuZ2U6NTgxZTk1YzRkYTM4NGEyMThhMTNiM2IyNzNiODIzOTRfMTUtMS0xLTEtMA_b49dbcf3-c3d8-43bd-8ea6-b7428a1448f9"
      unitRef="usd">414000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="i7e04b4ea73e04184933b0223f3525651_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82Ny9mcmFnOmNjYmNmMDU0MjFiNTQ0YmZhMjIzMDAxZTBiMWEwYTJlL3RhYmxlOjU4MWU5NWM0ZGEzODRhMjE4YTEzYjNiMjczYjgyMzk0L3RhYmxlcmFuZ2U6NTgxZTk1YzRkYTM4NGEyMThhMTNiM2IyNzNiODIzOTRfMTUtMy0xLTEtMA_ce78d048-b5e0-4620-87d4-31bbaeddbfbd"
      unitRef="usd">754000</us-gaap:OtherCostAndExpenseOperating>
    <cnmd:Manufacturingconsolidationcosts
      contextRef="if891372cb88f49d1ad8cf68161f49100_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82Ny9mcmFnOmNjYmNmMDU0MjFiNTQ0YmZhMjIzMDAxZTBiMWEwYTJlL3RleHRyZWdpb246Y2NiY2YwNTQyMWI1NDRiZmEyMjMwMDFlMGIxYTBhMmVfMTA5OTUxMTYzODg0NQ_c495f97c-3305-439b-a894-0788224789af"
      unitRef="usd">1800000</cnmd:Manufacturingconsolidationcosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="if891372cb88f49d1ad8cf68161f49100_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82Ny9mcmFnOmNjYmNmMDU0MjFiNTQ0YmZhMjIzMDAxZTBiMWEwYTJlL3RleHRyZWdpb246Y2NiY2YwNTQyMWI1NDRiZmEyMjMwMDFlMGIxYTBhMmVfMTA5OTUxMTYzOTU4OA_0ce8baad-5285-4493-964d-706f559baf58"
      unitRef="usd">800000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i7e04b4ea73e04184933b0223f3525651_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82Ny9mcmFnOmNjYmNmMDU0MjFiNTQ0YmZhMjIzMDAxZTBiMWEwYTJlL3RleHRyZWdpb246Y2NiY2YwNTQyMWI1NDRiZmEyMjMwMDFlMGIxYTBhMmVfMTA5OTUxMTYzOTYwNQ_ff629d44-fd81-4c6a-868c-60d9dd9b542a"
      unitRef="usd">800000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <cnmd:RestructuringAndRelatedCosts
      contextRef="i1c05d83ea1e6498489016ad7d59cf236_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF82Ny9mcmFnOmNjYmNmMDU0MjFiNTQ0YmZhMjIzMDAxZTBiMWEwYTJlL3RleHRyZWdpb246Y2NiY2YwNTQyMWI1NDRiZmEyMjMwMDFlMGIxYTBhMmVfMjE5OTAyMzI4NzI4MQ_0f845c75-c764-4c55-a1a3-1bc9f4d410b7"
      unitRef="usd">400000</cnmd:RestructuringAndRelatedCosts>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF83MC9mcmFnOmZmNTc2N2Y0ZjRkYzQzNTBhZDk3MjRkNjY2OGMwNWQ4L3RleHRyZWdpb246ZmY1NzY3ZjRmNGRjNDM1MGFkOTcyNGQ2NjY4YzA1ZDhfMTI0Nw_dac0adee-72c5-42f9-88e2-1f1018728096">Business Segment&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are accounting and reporting for our business as a single operating segment entity engaged in the development, manufacturing and sale on a global basis of surgical devices and related equipment.  Our chief operating decision maker (the CEO) evaluates the various global product portfolios on a net sales basis and evaluates profitability, investment, cash flow metrics and allocates resources on a consolidated worldwide basis due to shared infrastructure and resources.  Our product lines consist of orthopedic surgery and general surgery.  Orthopedic surgery consists of sports medicine instrumentation and small bone, large bone and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures including 2DHD vision technologies and fees related to the sales representation, promotion and marketing of sports medicine allograft tissue.  General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.  These product lines' net sales are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Orthopedic surgery&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General surgery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF83MC9mcmFnOmZmNTc2N2Y0ZjRkYzQzNTBhZDk3MjRkNjY2OGMwNWQ4L3RleHRyZWdpb246ZmY1NzY3ZjRmNGRjNDM1MGFkOTcyNGQ2NjY4YzA1ZDhfMTI0NQ_4798febe-987f-4e03-85f9-df5c5dd3ee30">These product lines' net sales are as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Orthopedic surgery&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General surgery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock>
    <us-gaap:Revenues
      contextRef="ia86b4262c6984bb6ad658ce074db008e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF83MC9mcmFnOmZmNTc2N2Y0ZjRkYzQzNTBhZDk3MjRkNjY2OGMwNWQ4L3RhYmxlOjY0YjBmNTMwNTg3ZjQ3MjM5NjllNTgzZTNiZjk1YWU4L3RhYmxlcmFuZ2U6NjRiMGY1MzA1ODdmNDcyMzk2OWU1ODNlM2JmOTVhZThfMi0xLTEtMS0w_c78cb339-44db-4c4f-ab34-513784e5bea7"
      unitRef="usd">107166000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9557a8db05ee41ffaa88a992a0b82938_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF83MC9mcmFnOmZmNTc2N2Y0ZjRkYzQzNTBhZDk3MjRkNjY2OGMwNWQ4L3RhYmxlOjY0YjBmNTMwNTg3ZjQ3MjM5NjllNTgzZTNiZjk1YWU4L3RhYmxlcmFuZ2U6NjRiMGY1MzA1ODdmNDcyMzk2OWU1ODNlM2JmOTVhZThfMi0zLTEtMS0w_ea6cd1d3-9a21-4e24-8032-53dc699729df"
      unitRef="usd">99283000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id802a374e8af403cb3d3822bd10d7c08_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF83MC9mcmFnOmZmNTc2N2Y0ZjRkYzQzNTBhZDk3MjRkNjY2OGMwNWQ4L3RhYmxlOjY0YjBmNTMwNTg3ZjQ3MjM5NjllNTgzZTNiZjk1YWU4L3RhYmxlcmFuZ2U6NjRiMGY1MzA1ODdmNDcyMzk2OWU1ODNlM2JmOTVhZThfMy0xLTEtMS0w_5dcbfaf8-8b0d-4672-bd4b-009b9a6781e0"
      unitRef="usd">125511000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2a7ac877916a4014a3fb26b999be79af_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF83MC9mcmFnOmZmNTc2N2Y0ZjRkYzQzNTBhZDk3MjRkNjY2OGMwNWQ4L3RhYmxlOjY0YjBmNTMwNTg3ZjQ3MjM5NjllNTgzZTNiZjk1YWU4L3RhYmxlcmFuZ2U6NjRiMGY1MzA1ODdmNDcyMzk2OWU1ODNlM2JmOTVhZThfMy0zLTEtMS0w_bd6a029b-92a4-43e1-bf95-4fea556f6c9f"
      unitRef="usd">114727000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF83MC9mcmFnOmZmNTc2N2Y0ZjRkYzQzNTBhZDk3MjRkNjY2OGMwNWQ4L3RhYmxlOjY0YjBmNTMwNTg3ZjQ3MjM5NjllNTgzZTNiZjk1YWU4L3RhYmxlcmFuZ2U6NjRiMGY1MzA1ODdmNDcyMzk2OWU1ODNlM2JmOTVhZThfNC0xLTEtMS0w_6af0d646-a0c6-4e1a-adcd-bff49c5599c1"
      unitRef="usd">232677000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i584092c790a746ad8b01b344d9d7ed4d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF83MC9mcmFnOmZmNTc2N2Y0ZjRkYzQzNTBhZDk3MjRkNjY2OGMwNWQ4L3RhYmxlOjY0YjBmNTMwNTg3ZjQ3MjM5NjllNTgzZTNiZjk1YWU4L3RhYmxlcmFuZ2U6NjRiMGY1MzA1ODdmNDcyMzk2OWU1ODNlM2JmOTVhZThfNC0zLTEtMS0w_ba3c4551-8ebc-42af-adb5-67eff33cb5ad"
      unitRef="usd">214010000</us-gaap:Revenues>
    <us-gaap:LegalMattersAndContingenciesTextBlock
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF83My9mcmFnOjM3Nzg0ZWYzNTIwZDQ2OGM4MTA3YzI5MTg5NjZmMDMyL3RleHRyZWdpb246Mzc3ODRlZjM1MjBkNDY4YzgxMDdjMjkxODk2NmYwMzJfODA2OA_fe57294b-fd9b-4e4f-a44c-d406c2998681">Legal Proceedings&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company may receive an information request, subpoena or warrant from a government agency such as the Securities and Exchange Commission, Department of Justice, Equal Employment Opportunity Commission, the Occupational Safety and Health Administration, the United States Food and Drug Administration, the Department of Labor, the Treasury Department or other federal and state agencies or foreign governments or government agencies.  These information requests, subpoenas or warrants may or may not be routine inquiries, or may begin as routine inquiries and over time develop into enforcement actions of various types.  Likewise, if we receive reports of alleged misconduct from employees and third parties, we investigate as appropriate.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Manufacturers of medical devices have been the subject of various enforcement actions relating to interactions with health care providers domestically or internationally whereby companies are claimed to have provided health care providers with inappropriate incentives to purchase their products.  Similarly, the Foreign Corrupt Practices Act ("FCPA") imposes obligations on manufacturers with respect to interactions with health care providers who may be considered government officials based on their affiliation with public hospitals.  The FCPA also requires publicly listed manufacturers to maintain accurate books and records, and maintain internal accounting controls sufficient to provide assurance that transactions are accurately recorded, lawful and in accordance with management's authorization.  The FCPA poses unique challenges both because manufacturers operate in foreign cultures in which conduct illegal under the FCPA may not be illegal in local jurisdictions, and because, in some cases, a United States manufacturer may face risks under the FCPA based on the conduct of third parties over whom the manufacturer may not have complete control.  While CONMED has not experienced any material enforcement action to date, there can be no assurance that the Company will not be subject to a material enforcement action in the future, or that the Company will not incur costs including, in the form of fees for lawyers and other consultants, that are material to the Company&#x2019;s results of operations in the course of responding to a future inquiry or investigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Manufacturers of medical products may face exposure to significant product liability claims, as well as patent infringement and other claims incurred in the ordinary course of business.  To date, we have not experienced any claims that have been material to our financial statements or financial condition, but any such claims arising in the future could have a material adverse effect on our business, results of operations or cash flows.  We currently maintain commercial product liability insurance of $30 million per incident and $30 million in the aggregate annually, which we believe is adequate.  This coverage is on a claims-made basis.  There can be no assurance that claims will not exceed insurance coverage, that the carriers will be solvent or that such insurance will be available to us in the future at a reasonable cost.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our operations are subject, and in the past have been subject, to a number of environmental laws and regulations governing, among other things, air emissions; wastewater discharges; the use, handling and disposal of hazardous substances &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and wastes; soil and groundwater remediation and employee health and safety.  Likewise, the operations of our suppliers and sterilizers are subject to similar environmental laws and regulations.  In some jurisdictions, environmental requirements may be expected to become more stringent in the future.  In the United States, certain environmental laws can impose liability for the entire cost of site restoration upon each of the parties that may have contributed to conditions at the site regardless of fault or the lawfulness of the party&#x2019;s activities.  While we do not believe that the present costs of environmental compliance and remediation are material, there can be no assurance that future compliance or remedial obligations would not have a material adverse effect on our financial condition, results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2014, the Company acquired EndoDynamix, Inc.  The agreement governing the terms of the acquisition provides that, if various conditions are met, certain contingent payments relating to the first commercial sale of the products (the milestone payment), as well as royalties based on sales (the revenue based payments), are due to the seller.  In 2016, we notified the seller that there was a need to redesign the product, and that, as a consequence, the first commercial sale had been delayed.  Consequently, the payment of contingent milestone and revenue-based payments were delayed.  On January 18, 2017, the seller provided notice ("the Notice") seeking $12.7 million under a liquidated damages clause, which essentially represents the seller's view as to the sum of the projected contingent milestone and revenue-based payments on an accelerated basis.  CONMED responded to the Notice denying that there was any basis for acceleration of the payments due under the acquisition agreement.  On February 22, 2017, the representative of the former shareholders of EndoDynamix filed a complaint in Delaware Chancery Court claiming breach of contract with respect to the duty to commercialize the product and seeking the contingent payments on an accelerated basis.  We believe that there was a substantive contractual basis to support the Company's decision to redesign the product, such that there was no legitimate basis for seeking the liquidated damages.  In the third quarter of 2018, the Company decided to halt the development of the EndoDynamix clip applier.  We previously recorded a charge to write off assets and released a previously accrued contingent consideration liability.  In a pre-trial filing the Plaintiffs claim to seek liquidated damages, as well as additional damages up to $24.8&#160;million.  A non-jury trial in the Delaware Chancery Court commenced on March 18, 2021, and testimony concluded on April 7, 2021.  We expect the parties to submit post-trial briefs in the second quarter of 2021, with the Court to hear oral arguments at a hearing scheduled for July 22, 2021, and the Court to issue a ruling at some point thereafter.  The Company has not recorded any expense related to potential damages in connection with this matter because the Company does not believe any potential loss is probable.  We expect to defend the claims asserted by the sellers of EndoDynamix,  although there can be no assurance that we will prevail in the trial and/or any resulting appeals. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record reserves sufficient to cover probable and estimable losses associated with any such pending claims.  We do not expect that the resolution of any pending claims, investigations or reports of alleged misconduct will have a material adverse effect on our financial condition, results of operations or cash flows.  There can be no assurance, however, that future claims or investigations, or the costs associated with responding to such claims, investigations or reports of misconduct, especially claims and investigations not covered by insurance, will not have a material adverse effect on our financial condition, results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:LegalMattersAndContingenciesTextBlock>
    <cnmd:ProductLiabilityContingencyInsuranceAmountPerIncident
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF83My9mcmFnOjM3Nzg0ZWYzNTIwZDQ2OGM4MTA3YzI5MTg5NjZmMDMyL3RleHRyZWdpb246Mzc3ODRlZjM1MjBkNDY4YzgxMDdjMjkxODk2NmYwMzJfMjg4MQ_7e934365-0aca-4bd1-baea-15131b457b1e"
      unitRef="usd">30000000</cnmd:ProductLiabilityContingencyInsuranceAmountPerIncident>
    <cnmd:ProductLiabilityContingencyInsuranceAggregateAnnualAmount
      contextRef="ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF83My9mcmFnOjM3Nzg0ZWYzNTIwZDQ2OGM4MTA3YzI5MTg5NjZmMDMyL3RleHRyZWdpb246Mzc3ODRlZjM1MjBkNDY4YzgxMDdjMjkxODk2NmYwMzJfMjkwMQ_49f6fd9d-b7df-4ed2-981b-cb2294a3398d"
      unitRef="usd">30000000</cnmd:ProductLiabilityContingencyInsuranceAggregateAnnualAmount>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="id854f60e596745a88a6555bfb8baa9c8_D20170118-20170118"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF83My9mcmFnOjM3Nzg0ZWYzNTIwZDQ2OGM4MTA3YzI5MTg5NjZmMDMyL3RleHRyZWdpb246Mzc3ODRlZjM1MjBkNDY4YzgxMDdjMjkxODk2NmYwMzJfNDkzNA_ca8049a3-56fd-4185-8cc6-82ecd38b8699"
      unitRef="usd">12700000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="i82aee7908b334a16816b4969f87ddeaa_D20170118-20170118"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF83My9mcmFnOjM3Nzg0ZWYzNTIwZDQ2OGM4MTA3YzI5MTg5NjZmMDMyL3RleHRyZWdpb246Mzc3ODRlZjM1MjBkNDY4YzgxMDdjMjkxODk2NmYwMzJfMTA5OTUxMTYzNjA3Mw_4fdc6779-2d0f-4735-b85a-c9cf4c4903a5"
      unitRef="usd">24800000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF83Ni9mcmFnOjRiOTUyN2IyNGI2ZTQ3MmZiYzhlMDVlNmIwOGViMmVhL3RleHRyZWdpb246NGI5NTI3YjI0YjZlNDcyZmJjOGUwNWU2YjA4ZWIyZWFfNDU1MA_458366d5-5bc8-4039-82e5-6851c614abfb">New Accounting Pronouncements&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Standards, Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional guidance if certain criteria are met for entities that have contracts, hedging relationships, and other transactions that reference LIBOR or other reference rates expected to be discontinued as a result of reference rate reform.  This ASU is effective as of March 12, 2020 through December 31, 2022.  The Company has not adopted this ASU as of March&#160;31, 2021, however will continue to monitor the impact of reference rates and will elect to apply this guidance in our consolidated financial statements in the event that we are impacted by reference rate reform.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU 2020-06, Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity, which simplifies the accounting for convertible instruments by removing certain separation models requiring separate accounting for embedded conversion features which will result in more convertible debt instruments accounted for as a single liability.  The ASU eliminates certain settlement conditions that are required for equity classification to qualify for the derivative scope exception.  The ASU addresses how convertible instruments are accounted for in the calculation of diluted earnings per share by using the if-converted method.  The ASU is effective for fiscal years beginning after December 15, 2021, with early adoption permitted no earlier than fiscal years beginning after December 15, 2020.  The Company is currently assessing the impact of this guidance on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i77412df227934ab69ada8b55bfa24e54_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF83Ni9mcmFnOjRiOTUyN2IyNGI2ZTQ3MmZiYzhlMDVlNmIwOGViMmVhL3RleHRyZWdpb246NGI5NTI3YjI0YjZlNDcyZmJjOGUwNWU2YjA4ZWIyZWFfNDU1Mw_c5cd72dd-5f5f-4218-8f94-eb84852f6239">New Accounting Pronouncements&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Standards, Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional guidance if certain criteria are met for entities that have contracts, hedging relationships, and other transactions that reference LIBOR or other reference rates expected to be discontinued as a result of reference rate reform.  This ASU is effective as of March 12, 2020 through December 31, 2022.  The Company has not adopted this ASU as of March&#160;31, 2021, however will continue to monitor the impact of reference rates and will elect to apply this guidance in our consolidated financial statements in the event that we are impacted by reference rate reform.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU 2020-06, Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity, which simplifies the accounting for convertible instruments by removing certain separation models requiring separate accounting for embedded conversion features which will result in more convertible debt instruments accounted for as a single liability.  The ASU eliminates certain settlement conditions that are required for equity classification to qualify for the derivative scope exception.  The ASU addresses how convertible instruments are accounted for in the calculation of diluted earnings per share by using the if-converted method.  The ASU is effective for fiscal years beginning after December 15, 2021, with early adoption permitted no earlier than fiscal years beginning after December 15, 2020.  The Company is currently assessing the impact of this guidance on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNC0xLTEtMS0w_767c56ac-23ad-4d12-b20f-2d598b83b31f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNC0xLTEtMS0w_767c56ac-23ad-4d12-b20f-2d598b83b31f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNC0xLTEtMS0w_e5da9a35-d40d-4807-a614-2a0192f2d59f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNC0xLTEtMS0w_e5da9a35-d40d-4807-a614-2a0192f2d59f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNC03LTEtMS0w_8a1edb82-783b-40f1-9075-643fba61b055"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNC03LTEtMS0w_8a1edb82-783b-40f1-9075-643fba61b055"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNC03LTEtMS0w_7d609658-4f9f-4a30-a5c9-fcb8abb16924"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNC03LTEtMS0w_7d609658-4f9f-4a30-a5c9-fcb8abb16924"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNC0zLTEtMS0w_605e62c1-18c1-4300-86b4-c5e62ec335ce"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNC0zLTEtMS0w_605e62c1-18c1-4300-86b4-c5e62ec335ce"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNC0zLTEtMS0w_e2eaf120-37e1-465c-b2ed-24e267ffb15d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNC0zLTEtMS0w_e2eaf120-37e1-465c-b2ed-24e267ffb15d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNC01LTEtMS0w_1846a0b4-0c4b-442c-8e88-61f74f76dd73"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNC01LTEtMS0w_1846a0b4-0c4b-442c-8e88-61f74f76dd73"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNC01LTEtMS0w_47619acf-92fc-44be-89a1-4a998a5d3dcf"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNC01LTEtMS0w_47619acf-92fc-44be-89a1-4a998a5d3dcf"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RleHRyZWdpb246ZjhhOTI2NTdlY2MyNDJjOTk4ZGQ2ZmQwMTllN2U1MTRfNDg1_0cde947c-56e3-469d-922e-df5586b6f6bc" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RleHRyZWdpb246ZjhhOTI2NTdlY2MyNDJjOTk4ZGQ2ZmQwMTllN2U1MTRfNDg1_0cde947c-56e3-469d-922e-df5586b6f6bc" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The cash flow hedging gain (loss) and pension liability accumulated other comprehensive income (loss) components are included in sales or cost of sales and as a component of net periodic pension cost, respectively.  Refer to Note 5 and Note 11, respectively, for further details.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNC0xLTEtMS0w_767c56ac-23ad-4d12-b20f-2d598b83b31f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RleHRyZWdpb246ZjhhOTI2NTdlY2MyNDJjOTk4ZGQ2ZmQwMTllN2U1MTRfNDg1_0cde947c-56e3-469d-922e-df5586b6f6bc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNC0xLTEtMS0w_e5da9a35-d40d-4807-a614-2a0192f2d59f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RleHRyZWdpb246ZjhhOTI2NTdlY2MyNDJjOTk4ZGQ2ZmQwMTllN2U1MTRfNDg1_0cde947c-56e3-469d-922e-df5586b6f6bc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNC03LTEtMS0w_8a1edb82-783b-40f1-9075-643fba61b055"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RleHRyZWdpb246ZjhhOTI2NTdlY2MyNDJjOTk4ZGQ2ZmQwMTllN2U1MTRfNDg1_0cde947c-56e3-469d-922e-df5586b6f6bc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNC03LTEtMS0w_7d609658-4f9f-4a30-a5c9-fcb8abb16924"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RleHRyZWdpb246ZjhhOTI2NTdlY2MyNDJjOTk4ZGQ2ZmQwMTllN2U1MTRfNDg1_0cde947c-56e3-469d-922e-df5586b6f6bc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNC0zLTEtMS0w_605e62c1-18c1-4300-86b4-c5e62ec335ce"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RleHRyZWdpb246ZjhhOTI2NTdlY2MyNDJjOTk4ZGQ2ZmQwMTllN2U1MTRfNDg1_0cde947c-56e3-469d-922e-df5586b6f6bc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNC0zLTEtMS0w_e2eaf120-37e1-465c-b2ed-24e267ffb15d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RleHRyZWdpb246ZjhhOTI2NTdlY2MyNDJjOTk4ZGQ2ZmQwMTllN2U1MTRfNDg1_0cde947c-56e3-469d-922e-df5586b6f6bc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjliMTUzNzQzN2RiOTQ1MDNhNDY4YmExOWY4Y2Q4YTViL3RhYmxlcmFuZ2U6OWIxNTM3NDM3ZGI5NDUwM2E0NjhiYTE5ZjhjZDhhNWJfNC01LTEtMS0w_1846a0b4-0c4b-442c-8e88-61f74f76dd73"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RleHRyZWdpb246ZjhhOTI2NTdlY2MyNDJjOTk4ZGQ2ZmQwMTllN2U1MTRfNDg1_0cde947c-56e3-469d-922e-df5586b6f6bc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RhYmxlOjUxMjVlMjRhNjBkYjQ0NzM5YWI2MTI5NWRjZDkxY2MzL3RhYmxlcmFuZ2U6NTEyNWUyNGE2MGRiNDQ3MzlhYjYxMjk1ZGNkOTFjYzNfNC01LTEtMS0w_47619acf-92fc-44be-89a1-4a998a5d3dcf"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjYwZWE1NzVkNGFlNzQ1NmZhOWZmMDZlYzRmMzQ4OGUwL3NlYzo2MGVhNTc1ZDRhZTc0NTZmYTlmZjA2ZWM0ZjM0ODhlMF80My9mcmFnOmY4YTkyNjU3ZWNjMjQyYzk5OGRkNmZkMDE5ZTdlNTE0L3RleHRyZWdpb246ZjhhOTI2NTdlY2MyNDJjOTk4ZGQ2ZmQwMTllN2U1MTRfNDg1_0cde947c-56e3-469d-922e-df5586b6f6bc"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533619950296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Apr. 26, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CONMED CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">16-0977505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">11311 Concept Blvd<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Largo,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33773<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">392-6464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000816956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CNMD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,092,141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533624537800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Condensed Statements of Comprehensive Income (Loss) (Unaudited) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 232,677<span></span>
</td>
<td class="nump">$ 214,010<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">104,228<span></span>
</td>
<td class="nump">94,851<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">128,449<span></span>
</td>
<td class="nump">119,159<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling and administrative expense</a></td>
<td class="nump">98,340<span></span>
</td>
<td class="nump">95,867<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="nump">10,027<span></span>
</td>
<td class="nump">10,120<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">&#160; Operating expenses</a></td>
<td class="nump">108,367<span></span>
</td>
<td class="nump">105,987<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">20,082<span></span>
</td>
<td class="nump">13,172<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">10,351<span></span>
</td>
<td class="nump">9,592<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingExpense', window );">Other expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes</a></td>
<td class="nump">9,731<span></span>
</td>
<td class="nump">3,491<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Benefit from income taxes</a></td>
<td class="num">(129)<span></span>
</td>
<td class="num">(2,436)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">9,860<span></span>
</td>
<td class="nump">5,927<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income (loss)</a></td>
<td class="nump">$ 10,743<span></span>
</td>
<td class="num">$ (1,121)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Per share data:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 0.34<span></span>
</td>
<td class="nump">$ 0.21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 0.31<span></span>
</td>
<td class="nump">$ 0.20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average common shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (shares)</a></td>
<td class="nump">28,972<span></span>
</td>
<td class="nump">28,478<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (shares)</a></td>
<td class="nump">31,378<span></span>
</td>
<td class="nump">29,707<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533545403048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Condensed Balance Sheets (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 36,769<span></span>
</td>
<td class="nump">$ 27,356<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">163,954<span></span>
</td>
<td class="nump">177,152<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">205,797<span></span>
</td>
<td class="nump">194,868<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">17,849<span></span>
</td>
<td class="nump">17,278<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">424,369<span></span>
</td>
<td class="nump">416,654<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">109,379<span></span>
</td>
<td class="nump">111,407<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">618,104<span></span>
</td>
<td class="nump">618,440<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets, net</a></td>
<td class="nump">493,905<span></span>
</td>
<td class="nump">501,537<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">100,855<span></span>
</td>
<td class="nump">103,635<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,746,612<span></span>
</td>
<td class="nump">1,751,673<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">20,076<span></span>
</td>
<td class="nump">18,415<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">55,780<span></span>
</td>
<td class="nump">53,310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and benefits</a></td>
<td class="nump">40,908<span></span>
</td>
<td class="nump">50,171<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">65,391<span></span>
</td>
<td class="nump">68,305<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">182,155<span></span>
</td>
<td class="nump">190,201<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">725,320<span></span>
</td>
<td class="nump">735,221<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">56,593<span></span>
</td>
<td class="nump">57,875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">56,974<span></span>
</td>
<td class="nump">59,338<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">1,021,042<span></span>
</td>
<td class="nump">1,042,635<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $.01 per share; authorized 500,000 shares; none outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.01 per share; 100,000,000 shares authorized; 31,299,194 shares issued in 2021 and 2020, respectively</a></td>
<td class="nump">313<span></span>
</td>
<td class="nump">313<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Paid-in capital</a></td>
<td class="nump">388,959<span></span>
</td>
<td class="nump">382,628<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">461,464<span></span>
</td>
<td class="nump">457,417<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(62,798)<span></span>
</td>
<td class="num">(63,681)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Less: 2,222,233 and 2,410,045 shares of common stock in treasury, at cost in 2021 and 2020, respectively</a></td>
<td class="num">(62,368)<span></span>
</td>
<td class="num">(67,639)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">725,570<span></span>
</td>
<td class="nump">709,038<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">$ 1,746,612<span></span>
</td>
<td class="nump">$ 1,751,673<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533617549416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Condensed Balance Sheets (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">31,299,194<span></span>
</td>
<td class="nump">31,299,194<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="nump">2,222,233<span></span>
</td>
<td class="nump">2,410,045<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533545857672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Condensed Statements of Shareholders' Equity (Unaudited) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Paid-in Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Treasury Stock</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at period start (shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at period start at Dec. 31, 2019</a></td>
<td class="nump">$ 710,467<span></span>
</td>
<td class="nump">$ 313<span></span>
</td>
<td class="nump">$ 379,324<span></span>
</td>
<td class="nump">$ 470,844<span></span>
</td>
<td class="num">$ (59,277)<span></span>
</td>
<td class="num">$ (80,737)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Common stock issued under employee plans</a></td>
<td class="num">(5,040)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,736)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,696<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">3,032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends on common stock ($0.20 per share)</a></td>
<td class="num">(5,703)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,703)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Cash flow hedging gain, net of income tax</a></td>
<td class="nump">2,405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension liability, net of income tax</a></td>
<td class="nump">535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="num">(9,988)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,988)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">5,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income (loss)</a></td>
<td class="num">(1,121)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at period end (shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at period end at Mar. 31, 2020</a></td>
<td class="nump">701,635<span></span>
</td>
<td class="nump">$ 313<span></span>
</td>
<td class="nump">374,620<span></span>
</td>
<td class="nump">471,068<span></span>
</td>
<td class="num">(66,325)<span></span>
</td>
<td class="num">(78,041)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at period start (shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at period start at Dec. 31, 2020</a></td>
<td class="nump">709,038<span></span>
</td>
<td class="nump">$ 313<span></span>
</td>
<td class="nump">382,628<span></span>
</td>
<td class="nump">457,417<span></span>
</td>
<td class="num">(63,681)<span></span>
</td>
<td class="num">(67,639)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Common stock issued under employee plans</a></td>
<td class="nump">8,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,944<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,271<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">3,387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends on common stock ($0.20 per share)</a></td>
<td class="num">(5,813)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,813)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Cash flow hedging gain, net of income tax</a></td>
<td class="nump">3,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension liability, net of income tax</a></td>
<td class="nump">631<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">631<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="num">(3,674)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,674)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">9,860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income (loss)</a></td>
<td class="nump">10,743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at period end (shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at period end at Mar. 31, 2021</a></td>
<td class="nump">$ 725,570<span></span>
</td>
<td class="nump">$ 313<span></span>
</td>
<td class="nump">$ 388,959<span></span>
</td>
<td class="nump">$ 461,464<span></span>
</td>
<td class="num">$ (62,798)<span></span>
</td>
<td class="num">$ (62,368)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533541122280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Condensed Statements of Shareholders' Equity (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends per share of common stock (in dollars per share)</a></td>
<td class="nump">$ 0.20<span></span>
</td>
<td class="nump">$ 0.20<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533541960168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 9,860<span></span>
</td>
<td class="nump">$ 5,927<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">4,757<span></span>
</td>
<td class="nump">4,646<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="nump">2,503<span></span>
</td>
<td class="nump">2,264<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of deferred debt issuance costs</a></td>
<td class="nump">1,058<span></span>
</td>
<td class="nump">819<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAmortizationOfDeferredCharges', window );">Amortization</a></td>
<td class="nump">13,519<span></span>
</td>
<td class="nump">13,776<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">3,387<span></span>
</td>
<td class="nump">3,032<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(2,688)<span></span>
</td>
<td class="num">(2,742)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Increase (decrease) in cash flows from changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">11,957<span></span>
</td>
<td class="nump">19,057<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(11,638)<span></span>
</td>
<td class="num">(12,313)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">2,804<span></span>
</td>
<td class="nump">1,705<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued compensation and benefits</a></td>
<td class="num">(8,955)<span></span>
</td>
<td class="num">(18,397)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(6,002)<span></span>
</td>
<td class="num">(7,260)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="nump">1,782<span></span>
</td>
<td class="num">(6,793)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">22,344<span></span>
</td>
<td class="nump">3,721<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, plant and equipment</a></td>
<td class="num">(3,109)<span></span>
</td>
<td class="num">(2,825)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cnmd_Paymentsrelatedtobusinessacquisitionsandassetacquisitions', window );">Payments related to business and asset acquisitions, net of cash acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,852)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(3,109)<span></span>
</td>
<td class="num">(6,677)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Payments on term loan</a></td>
<td class="num">(3,313)<span></span>
</td>
<td class="num">(3,313)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Payments on revolving line of credit</a></td>
<td class="num">(72,000)<span></span>
</td>
<td class="num">(41,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from revolving line of credit</a></td>
<td class="nump">64,000<span></span>
</td>
<td class="nump">59,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cnmd_PaymentsForContingentConsideration', window );">Payments related to contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,133)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid on common stock</a></td>
<td class="num">(5,775)<span></span>
</td>
<td class="num">(5,683)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other, net</a></td>
<td class="nump">8,216<span></span>
</td>
<td class="num">(5,132)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="num">(8,872)<span></span>
</td>
<td class="nump">2,739<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="num">(950)<span></span>
</td>
<td class="num">(1,330)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="nump">9,413<span></span>
</td>
<td class="num">(1,547)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">27,356<span></span>
</td>
<td class="nump">25,856<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">36,769<span></span>
</td>
<td class="nump">24,309<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrentAndNoncurrent', window );">Dividends payable</a></td>
<td class="nump">$ 5,813<span></span>
</td>
<td class="nump">$ 5,703<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_PaymentsForContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for Contingent Consideration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_PaymentsForContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_Paymentsrelatedtobusinessacquisitionsandassetacquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments related to business acquisitions and asset acquisitions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_Paymentsrelatedtobusinessacquisitionsandassetacquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAmortizationOfDeferredCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization of other deferred costs recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAmortizationOfDeferredCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533541541528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operations<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Operations</a></td>
<td class="text">OperationsCONMED Corporation (&#8220;CONMED&#8221;, the &#8220;Company&#8221;, &#8220;we&#8221; or &#8220;us&#8221;) is a medical technology company that provides surgical devices and equipment for minimally invasive procedures.&#160;&#160;The Company&#8217;s products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533539491320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Interim Financial Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Interim Financial Information</a></td>
<td class="text">Interim Financial Information<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited consolidated condensed financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for annual financial statements.  The information herein reflects all normal recurring material adjustments, which are, in the opinion of management, necessary to fairly present the results for the periods presented.  The consolidated condensed financial statements herein consist of all wholly-owned domestic and foreign subsidiaries with all significant intercompany transactions eliminated.  Results for the period ended March&#160;31, 2021 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2021.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated condensed financial statements and notes thereto should be read in conjunction with the consolidated financial statements and notes for the year ended December&#160;31, 2020 included in our Annual Report on Form 10-K.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preparation of the consolidated condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated condensed financial statements and the reported amounts of revenue and expenses during the reporting period.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the COVID-19 pandemic, there has been uncertainty and disruption in the global economy and financial markets. We are not aware of any specific event or circumstance that would require an update to our estimates or judgments or a revision of the carrying value of our assets or liabilities as of&#160;April&#160;29, 2021, the date of issuance of this Quarterly Report on Form 10-Q.  These estimates may change, as new events occur and additional information is obtained. Actual results could differ materially from these estimates under different assumptions or conditions.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533541050392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenues</a></td>
<td class="text">Revenues<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present revenue disaggregated by primary geographic market where the products are sold, by product line and timing of revenue recognition: </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:33.458%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.316%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Orthopedic Surgery</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">General Surgery</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Orthopedic Surgery</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">General Surgery</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Primary Geographic Markets</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,943&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,808&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,847&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, Middle East &amp; Africa</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,052&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,544&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,596&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,907&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,615&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,522&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas (excluding the United States)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,381&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,493&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,874&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,802&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,979&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,781&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total sales from contracts with customers</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,166&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,511&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232,677&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,283&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,727&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,010&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Timing of Revenue Recognition</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goods transferred at a point in time</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,690&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,394&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222,084&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,553&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,901&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,454&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services transferred over time</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,730&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total sales from contracts with customers</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,166&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,511&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232,677&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,283&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,727&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,010&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.209%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.581%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liability balances related to the sale of extended warranties to customers are as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:58.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.401%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.826%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,231&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,666&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized during the three months ended March&#160;31, 2021 and March&#160;31, 2020 from amounts included in contract liabilities at the beginning of the period were $3.4 million and $3.0 million, respectively.  There were no material contract assets as of March&#160;31, 2021 and December&#160;31, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533539493816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Comprehensive Income (Loss)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Comprehensive Income (Loss)</a></td>
<td class="text">Comprehensive Income (Loss)<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) consists of the following:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.113%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,860&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,927&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedging gain, net of income tax (income tax expense of $1,250 and $766 for the three months ended March 31, 2021 and 2020, respectively)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension liability, net of income tax (income tax expense of $201 and $170 for the three months ended March 31, 2021 and 2020, respectively)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,674)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,988)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,743&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,121)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss consists of the following:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.526%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flow<br/>Hedging<br/>Gain (Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension<br/>Liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cumulative<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,945)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,620)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,116)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63,681)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,725&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,674)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(949)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss) before tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">a</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(383)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(201)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(584)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,674)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,019)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,989)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,790)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,798)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.526%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flow<br/>Hedging<br/>Gain (Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension<br/>Liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cumulative<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,691)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,079)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,277)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,988)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,731)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss) before tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">a</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,124)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(419)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,988)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,048)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,898&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,156)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,067)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66,325)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)  The cash flow hedging gain (loss) and pension liability accumulated other comprehensive income (loss) components are included in sales or cost of sales and as a component of net periodic pension cost, respectively.  Refer to Note 5 and Note 11, respectively, for further details.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533541640984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesAndFairValueTextBlock', window );">Fair Value of Financial Instruments</a></td>
<td class="text">Fair Value of Financial Instruments<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into derivative instruments for risk management purposes only.  We operate internationally and, in the normal course of business, are exposed to fluctuations in interest rates, foreign exchange rates and commodity prices.  These fluctuations can increase the costs of financing, investing and operating the business.  We use forward contracts, a type of derivative instrument, to manage certain foreign currency exposures.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By nature, all financial instruments involve market and credit risks.  We enter into forward contracts with major investment grade financial institutions and have policies to monitor the credit risk of those counterparties.  While there can be no assurance, we do not anticipate any material non-performance by any of these counterparties.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Forward Contracts.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hedge forecasted intercompany sales denominated in foreign currencies through the use of forward contracts.&#160;&#160;We account for these forward contracts as cash flow hedges.&#160;&#160;To the extent these forward contracts meet hedge accounting criteria, changes in their fair value are not included in current earnings but are included in accumulated other comprehensive loss.&#160;&#160;These changes in fair value will be recognized into earnings as a component of sales or cost of sales when the forecasted transaction occurs.&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also enter into forward contracts to exchange foreign currencies for United States dollars in order to hedge our currency transaction exposures on intercompany receivables designated in foreign currencies.&#160;&#160;These forward contracts settle each month at month-end, at which time we enter into new forward contracts.&#160;&#160;We have not designated these forward contracts as hedges and have not applied hedge accounting to them.&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the notional contract amounts for forward contracts outstanding:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:38.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.401%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.401%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,562&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,504&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,545&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining time to maturity as of March&#160;31, 2021 is within two years for hedge designated foreign exchange contracts and approximately one month for non-hedge designated forward exchange contracts.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Statement of comprehensive income (loss) presentation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives designated as cash flow hedges</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign exchange contracts designated as cash flow hedges had the following effects on accumulated other comprehensive income (loss) and net earnings on our consolidated condensed statements of comprehensive income (loss) and our consolidated condensed balance sheets:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:28.752%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.582%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in AOCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Condensed Statements  of Comprehensive Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Reclassified from AOCI</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="36" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="6" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Amount of Line Item Presented</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Instrument</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of amount reclassified</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232,677&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,010&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,849)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of Sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax gain (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,593&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,295&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,584)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,124&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax expense (benefit)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,038&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(383)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,725&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,257&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,201)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">852&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:28.752%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.582%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2021, $2.3 million of net unrealized losses on forward contracts accounted for as cash flow hedges, and included in accumulated other comprehensive loss, are expected to be recognized in earnings in the next twelve months.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives not designated as cash flow hedges</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains and losses from derivative instruments not accounted for as hedges and gains and losses on our intercompany receivables on our consolidated condensed statements of comprehensive income (loss) were:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.091%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Instrument</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Condensed Statements of Comprehensive Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(245)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss on currency transaction exposures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,123)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Balance sheet presentation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record these forward foreign exchange contracts at fair value.  The following tables summarize the fair value for forward foreign exchange contracts outstanding at March&#160;31, 2021 and December&#160;31, 2020: </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.514%"><tr><td style="width:1.0%"/><td style="width:33.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.033%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.399%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.944%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.944%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.950%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Condensed Balance Sheet</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net<br/>Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedged instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,592)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,035)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(337)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,266&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,929)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,663)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,274&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,108)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,834)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.514%"><tr><td style="width:1.0%"/><td style="width:33.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.033%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.399%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.944%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.944%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.950%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Condensed Balance Sheet</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net<br/>Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedged instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,826)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,326)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(535)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(512)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,523&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,361)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,838)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,548&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,511)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,963)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our forward foreign exchange contracts are subject to a master netting agreement and qualify for netting in the consolidated condensed balance sheets. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Disclosure.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  FASB guidance defines fair value and establishes a framework for measuring fair value and related disclosure requirements.  This guidance applies when fair value measurements are required or permitted.  The guidance indicates, among other things, that a fair value measurement assumes that the transaction to sell an asset or transfer a liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market for the asset or liability.  Fair value is defined based upon an exit price model.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Valuation Hierarchy. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A valuation hierarchy was established for disclosure of the inputs to the valuations used to measure fair value.  This hierarchy prioritizes the inputs into three broad levels as follows.  Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities.  Level 2 inputs are quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in markets that are not active, inputs other than quoted prices that are observable for the asset or liability, including interest rates, yield curves and credit risks, or inputs that are derived principally from or corroborated by observable market data through correlation.  Level 3 inputs are unobservable inputs based on our own assumptions used to measure assets and liabilities at fair value.  A financial asset or liability&#8217;s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement.  There have been no significant changes in the assumptions.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Valuation Techniques. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Assets and liabilities carried at fair value and measured on a recurring basis as of March&#160;31, 2021 consist of forward foreign exchange contracts.  The Company values its forward foreign exchange contracts using quoted prices for similar assets.  The most significant assumption is quoted currency rates.  The value of the forward foreign exchange contract assets and liabilities were valued using Level 2 inputs and are listed in the table above.&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div>The carrying amounts reported in our consolidated condensed balance sheets for cash and cash equivalents, accounts receivable, accounts payable and long-term debt approximate fair value.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesAndFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivatives and fair value of assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesAndFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533539606632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text">Inventories<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of the following:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:71.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.225%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,654&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,807&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,429&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,864&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,797&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,868&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533539506104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">Earnings Per Share<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share (&#8220;basic EPS&#8221;) is computed by dividing net income by the weighted average number of common shares outstanding for the reporting period.  Diluted earnings per share (&#8220;diluted EPS&#8221;) gives effect to all dilutive potential shares outstanding resulting from employee stock options, restricted stock units, performance share units and stock appreciation rights ("SARs") as well as the Notes and related hedge transactions during the period.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted earnings per share for the three months ended March 31, 2021 and 2020:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.113%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,860&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,927&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic &#8211; weighted average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive potential securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,406&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted &#8211; weighted average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,378&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,707&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (per share)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shares used in the calculation of diluted EPS exclude options and SARs to purchase shares where the exercise price was greater than the average market price of common shares for the period and the effect of the inclusion would be anti-dilutive.  Such shares aggregated approximately 0.3 million and 1.1 million for the three months ended March&#160;31, 2021 and 2020, respectively.  Our 2.625% convertible notes due in 2024 (the &#8220;Notes&#8221;) are convertible under certain circumstances, as defined in the indenture, into a combination of cash and CONMED common stock.&#160; </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is intended to describe the impact of the Notes and related hedge transactions on the calculation of diluted EPS.  Additional shares to be issued pursuant to the terms of the Notes and related hedge transactions, if any, would occur at maturity.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of diluted EPS includes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">potential diluted shares upon conversion of the Notes when the average market price per share of our common stock for the period is greater than the conversion price of the Notes of $88.80.  We intend to settle in cash the principal outstanding and use the treasury stock method when calculating their potential dilutive effect, if any.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2021 and 2020, our average share price exceeded the conversion price of the Notes and we included in our diluted share count 1.0&#160;million and 0.1&#160;million shares, respectively, assumed to be issued if the Notes were converted.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We previously entered into convertible notes hedge transactions to increase the effective conversion price of the Notes to $114.92.&#160; However, our convertible notes hedges are not included when calculating potential dilutive shares since their effect is always anti-dilutive.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concurrently with entering into the hedge transactions, we also previously entered into warrant transactions under which we agreed to sell shares of our common stock at $114.92.  </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of diluted EPS also includes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span>potential diluted shares to be issued under the warrants when the average market price per share of our common stock for the period is greater than $114.92.  During the three months ended March&#160;31, 2021, our average share price exceeded $114.92 and we therefore included in our diluted share count an additional 0.2&#160;million shares assumed to be issued under the warrants.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533541078728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Other Intangible Assets</a></td>
<td class="text">Goodwill and Other Intangible Assets<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the net carrying amount of goodwill for the three months ended March&#160;31, 2021 are as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(336)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618,104&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities of acquired businesses are recorded at their estimated fair values as of the date of acquisition.&#160;&#160;Goodwill represents costs in excess of fair values assigned to the underlying net assets of acquired businesses.&#160; </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets consist of the following:</span></div><div style="text-align:justify;text-indent:15.75pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:36.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.897%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.897%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.365%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Amortization Period (Years)</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets with definite lives:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer and distributor relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342,531&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139,243)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134,555)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales representation, marketing and promotional rights</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,358)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,705)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and other intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49,356)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,516&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48,882)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets with indefinite lives:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and tradenames</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">759,362&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(265,457)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">758,679&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(257,142)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer and distributor relationships, trademarks and tradenames, developed technology and patents and other intangible assets primarily represent allocations of purchase price to identifiable intangible assets of acquired businesses.  Sales representation, marketing and promotional rights represent intangible assets created under our agreement with Musculoskeletal Transplant Foundation (&#8220;MTF&#8221;).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense related to intangible assets which are subject to amortization totaled $8.3 million and $8.5 million in the three months ended March 31, 2021 and 2020, respectively, and is included as a reduction of revenue (for amortization related to our sales representation, marketing and promotional rights) and in selling and administrative expense (for all other intangible assets) in the consolidated condensed statements of comprehensive income (loss).  Included in developed technology is $6.0 million of earn-out consideration that is considered probable as of March&#160;31, 2021 associated with a prior asset acquisition.  This is recorded in other current and other long-term liabilities at March&#160;31, 2021. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated intangible asset amortization expense remaining for the year ending December&#160;31, 2021 and for each of the five succeeding years is as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:57.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization included in expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization recorded as a reduction of revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining, 2021</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,620&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,500&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,120&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,646&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,646&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,058&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,058&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,529&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533539553256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long Term Debt<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Long-term Debt</a></td>
<td class="text">Long-Term Debt<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consists of the following:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:72.360%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.804%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving line of credit</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,000&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,000&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan, net of deferred debt issuance costs of $1,520 and $1,668 in 2021 and 2020, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.625% convertible notes, net of deferred debt issuance costs of $5,031 and $5,475 in 2021 and 2020, respectively, and unamortized discount of $31,117 and $33,620 in 2021 and 2020, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305,904&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745,396&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753,636&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:&#160;&#160;Current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,076&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">725,320&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735,221&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;7, 2019 we entered into a sixth amended and restated senior credit agreement consisting of: (a) a $265.0 million term loan facility and (b) a $585.0 million revolving credit facility.   The revolving credit facility will terminate and the loans outstanding under the term loan facility will mature on the earlier of (i)&#160;February&#160;7, 2024 or (ii) 91 days prior to the earliest scheduled maturity date of the 2.625% convertible notes due in 2024 described below, (if, as of such date, more than $150.0 million in aggregate principal amount of such convertible notes (or any refinancing thereof) remains outstanding).  The term loan facility is payable in quarterly installments increasing over the term of the facility.  Proceeds from the term loan facility and borrowings under the revolving credit facility were used to repay the then existing senior credit agreement and in part to finance the acquisition of Buffalo Filter.  On April&#160;17, 2020, we amended our sixth amended and restated senior credit agreement to suspend our required leverage ratios for up to four quarters as a result of the potential impact from the COVID-19 pandemic.  On November&#160;20, 2020, we entered into a third amendment under our senior credit agreement to lower the applicable margin on the loans and lower the interest floor on Eurocurrency loans agreed upon in April 2020.  On April&#160;15, 2021, we terminated the suspension period, thus reinstating our required leverage ratios.  Interest rates are  adjusted so that the applicable margin for base rate loans is 2.00% per annum and for Eurocurrency rate loans is 3.00% per annum, and the applicable commitment fee rate for the revolving credit facility is 0.50%.  Following the suspension period, the applicable margin will depend upon CONMED&#8217;s consolidated senior secured leverage ratio, using the pricing grid set forth in the amendment.  Interest rates were at LIBOR (subject to 0.50% floor) plus an interest rate margin of 3.00% (3.50% at March&#160;31, 2021).</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were $238.5 million in borrowings outstanding on the term loan facility as of March&#160;31, 2021.  There were $199.0 million in borrowings outstanding under the revolving credit facility as of March&#160;31, 2021.  Our available borrowings on the revolving credit facility at March&#160;31, 2021 were $383.4 million with approximately $2.6 million of the facility set aside for outstanding letters of credit.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sixth amended and restated senior credit agreement is collateralized by substantially all of our personal property and assets.  The sixth amended and restated senior credit agreement contains covenants and restrictions which, among other things, require the maintenance of certain financial ratios and restrict dividend payments and the incurrence of certain indebtedness and other activities, including acquisitions and dispositions.  We were in full compliance with these covenants and restrictions as of March&#160;31, 2021.  We are also required, under certain circumstances, to make mandatory prepayments from net cash proceeds from any issuance of equity and asset sales.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 29, 2019, we issued $345.0 million in 2.625% convertible notes due in 2024 (the "Notes").  Interest is payable semi-annually in arrears on February 1 and August 1 of each year, commencing August 1, 2019.  The Notes will mature on February 1, 2024, unless earlier repurchased or converted.  The Notes represent subordinated unsecured obligations and are convertible under certain circumstances, as defined in the indenture, into a combination of cash and CONMED common stock.&#160;&#160;The Notes may be converted at an initial conversion rate of 11.2608 shares of our common stock per $1,000 principal amount of Notes (equivalent to an initial conversion price of approximately $88.80 per share of common stock).  Holders of the Notes may convert the Notes at their option at any time on or after November 1, 2023 through the second scheduled trading day preceding the maturity date.  Holders of the Notes will also have the right to convert the Notes prior to November 1, 2023, but only upon the occurrence of specified events.  The conversion rate is subject to anti-dilution adjustments if certain events occur.  A portion of the net proceeds from the offering of the Notes were used as part of the financing for the Buffalo Filter acquisition </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $21.0 million were used to pay the cost of certain convertible notes hedge transactions as further described below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective borrowing rate for nonconvertible debt at the time of issuance of the Notes was estimated to be 6.14%, which resulted in $51.6 million of the $345.0 million aggregate principal amount of Notes issued, or $39.1 million after taxes, being attributable to equity.&#160;&#160;For the three months ended March 31, 2021 and 2020, we have recorded interest expense related to the amortization of debt discount on the Notes of $2.5 million and $2.3 million, respectively, at the effective interest rate of 6.14%.&#160;&#160;The debt discount on the Notes is being amortized through February 2024.&#160;&#160;For both the three months ended March 31, 2021 and 2020, we have recorded interest expense on the Notes of  $2.3 million at the contractual coupon rate of 2.625%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the offering of the Notes, we entered into convertible note hedge transactions with a number of financial institutions (each, an &#8220;option counterparty&#8221;).  The convertible note hedge transactions cover, subject to anti-dilution adjustments substantially similar to those applicable to the Notes, the number of shares of our common stock underlying the Notes.  Concurrently with entering into the convertible note hedge transactions, we also entered into separate warrant transactions with each option counterparty whereby we sold to such option counterparty warrants to purchase, subject to customary anti-dilution adjustments, the same number of shares of our common stock.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The convertible note hedge transactions are expected generally to reduce the potential dilution upon conversion of the Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted Notes, as the case may be, in the event that the market price per share of our common stock, as measured under the terms of the convertible note hedge transactions, is greater than the strike price ($114.92) of the convertible note hedge transactions, which initially corresponds to the conversion price of the Notes and is subject to anti-dilution adjustments substantially similar to those applicable to the conversion rate of the Notes.  If, however, the market price per share of our common stock, as measured under the terms of the warrant transactions, exceeds the strike price of the warrants, there would nevertheless be dilution to the extent that such market price exceeds the strike price of the warrants as noted in Note 7, unless we elect to settle the warrants in cash.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scheduled&#160;maturities&#160;of&#160;long-term&#160;debt outstanding at March&#160;31, 2021 are as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:85.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,844&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The above amounts exclude debt discount, deferred debt issuance costs and financing leases.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533539617112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Guarantees<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteesAbstract', window );"><strong>Guarantees [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyDisclosureTextBlock', window );">Guarantees</a></td>
<td class="text">Guarantees<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide warranties on certain of our products at the time of sale and sell extended warranties.  The standard warranty period for our capital equipment is generally one year and our extended warranties typically vary from one to three years.  Liability under warranty policies is based upon a review of historical claim experience.  Adjustments are made to accruals as claim data and historical experience warrant.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the liability for standard warranties for the three months ended March 31, are as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:77.932%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.018%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1,</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,826&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,186&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for warranties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims made</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(206)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(363)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31,</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,911&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,178&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs associated with extended warranty repairs are recorded as incurred and amounted to $1.6 million and $1.5 million for the three months ended March 31, 2021 and 2020, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for standard and extended product warranties and other product guarantee contracts, including a tabular reconciliation of the changes in the guarantor's aggregate product warranty liability for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -URI http://asc.fasb.org/topic&amp;trid=2155896<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533539287912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Plan<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Pension Plan</a></td>
<td class="text">Pension Plan<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic pension cost consists of the following:&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.993%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.990%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on projected benefit obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,289)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,255)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amortization and deferral</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div>We do not expect to make any pension contributions during 2021.  Non-service cost of $0.1 million for the three months ended March&#160;31, 2020 is included in other expense in the consolidated condensed statements of comprehensive income (loss).  Non-service pension cost was immaterial for the three months ended March&#160;31, 2021.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533542236408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition and Other Expense<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cnmd_AcquisitionandOtherExpenseAbstract', window );"><strong>Acquisition and Other Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cnmd_AcquisitionandOtherExpenseTextBlock', window );">Acquisition and Other Expense</a></td>
<td class="text">Acquisition and Other Expense<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Acquisition and other expense consist of the following, which are included in cost of sales or selling and administrative expense depending on the nature of the charge:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:80.186%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing consolidation costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">805&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and other expense included in cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,590&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and related costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration costs </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and other expense included in selling and administrative expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2020, we incurred $1.8&#160;million in costs related to the consolidation of certain manufacturing operations which were charged to cost of sales.  These costs related to winding down operations at certain locations and moving production lines to other facilities. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2020, we incurred costs for inventory step-up adjustments and other costs of $0.8 million related to a previous acquisition, which were charged to cost of sales.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2020, we incurred $0.8 million in severance and integration costs mainly related to the Buffalo Filter acquisition, which were included in selling and administrative expense.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2021, we recorded a charge of $0.4 million related to the restructuring of our sales force which was charged to selling and administrative expense.  The charges for sales force restructuring consisted </span></div>primarily of termination payments to Orthopedic distributors made in exchange for ongoing assistance to transition to employee-based sales representatives and severance.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_AcquisitionandOtherExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquisition and Other Expense [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_AcquisitionandOtherExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_AcquisitionandOtherExpenseTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquisition and Other Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_AcquisitionandOtherExpenseTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533539599912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Business Segment</a></td>
<td class="text">Business Segment<div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are accounting and reporting for our business as a single operating segment entity engaged in the development, manufacturing and sale on a global basis of surgical devices and related equipment.  Our chief operating decision maker (the CEO) evaluates the various global product portfolios on a net sales basis and evaluates profitability, investment, cash flow metrics and allocates resources on a consolidated worldwide basis due to shared infrastructure and resources.  Our product lines consist of orthopedic surgery and general surgery.  Orthopedic surgery consists of sports medicine instrumentation and small bone, large bone and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures including 2DHD vision technologies and fees related to the sales representation, promotion and marketing of sports medicine allograft tissue.  General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.  These product lines' net sales are as follows:</span></div><div style="margin-top:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.113%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orthopedic surgery</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,166&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,283&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General surgery</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,511&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,727&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232,677&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,010&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533541218520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Legal Proceedings<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalMattersAndContingenciesTextBlock', window );">Legal Proceedings</a></td>
<td class="text">Legal Proceedings<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company may receive an information request, subpoena or warrant from a government agency such as the Securities and Exchange Commission, Department of Justice, Equal Employment Opportunity Commission, the Occupational Safety and Health Administration, the United States Food and Drug Administration, the Department of Labor, the Treasury Department or other federal and state agencies or foreign governments or government agencies.  These information requests, subpoenas or warrants may or may not be routine inquiries, or may begin as routine inquiries and over time develop into enforcement actions of various types.  Likewise, if we receive reports of alleged misconduct from employees and third parties, we investigate as appropriate.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturers of medical devices have been the subject of various enforcement actions relating to interactions with health care providers domestically or internationally whereby companies are claimed to have provided health care providers with inappropriate incentives to purchase their products.  Similarly, the Foreign Corrupt Practices Act ("FCPA") imposes obligations on manufacturers with respect to interactions with health care providers who may be considered government officials based on their affiliation with public hospitals.  The FCPA also requires publicly listed manufacturers to maintain accurate books and records, and maintain internal accounting controls sufficient to provide assurance that transactions are accurately recorded, lawful and in accordance with management's authorization.  The FCPA poses unique challenges both because manufacturers operate in foreign cultures in which conduct illegal under the FCPA may not be illegal in local jurisdictions, and because, in some cases, a United States manufacturer may face risks under the FCPA based on the conduct of third parties over whom the manufacturer may not have complete control.  While CONMED has not experienced any material enforcement action to date, there can be no assurance that the Company will not be subject to a material enforcement action in the future, or that the Company will not incur costs including, in the form of fees for lawyers and other consultants, that are material to the Company&#8217;s results of operations in the course of responding to a future inquiry or investigation.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturers of medical products may face exposure to significant product liability claims, as well as patent infringement and other claims incurred in the ordinary course of business.  To date, we have not experienced any claims that have been material to our financial statements or financial condition, but any such claims arising in the future could have a material adverse effect on our business, results of operations or cash flows.  We currently maintain commercial product liability insurance of $30 million per incident and $30 million in the aggregate annually, which we believe is adequate.  This coverage is on a claims-made basis.  There can be no assurance that claims will not exceed insurance coverage, that the carriers will be solvent or that such insurance will be available to us in the future at a reasonable cost.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations are subject, and in the past have been subject, to a number of environmental laws and regulations governing, among other things, air emissions; wastewater discharges; the use, handling and disposal of hazardous substances </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and wastes; soil and groundwater remediation and employee health and safety.  Likewise, the operations of our suppliers and sterilizers are subject to similar environmental laws and regulations.  In some jurisdictions, environmental requirements may be expected to become more stringent in the future.  In the United States, certain environmental laws can impose liability for the entire cost of site restoration upon each of the parties that may have contributed to conditions at the site regardless of fault or the lawfulness of the party&#8217;s activities.  While we do not believe that the present costs of environmental compliance and remediation are material, there can be no assurance that future compliance or remedial obligations would not have a material adverse effect on our financial condition, results of operations or cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2014, the Company acquired EndoDynamix, Inc.  The agreement governing the terms of the acquisition provides that, if various conditions are met, certain contingent payments relating to the first commercial sale of the products (the milestone payment), as well as royalties based on sales (the revenue based payments), are due to the seller.  In 2016, we notified the seller that there was a need to redesign the product, and that, as a consequence, the first commercial sale had been delayed.  Consequently, the payment of contingent milestone and revenue-based payments were delayed.  On January 18, 2017, the seller provided notice ("the Notice") seeking $12.7 million under a liquidated damages clause, which essentially represents the seller's view as to the sum of the projected contingent milestone and revenue-based payments on an accelerated basis.  CONMED responded to the Notice denying that there was any basis for acceleration of the payments due under the acquisition agreement.  On February 22, 2017, the representative of the former shareholders of EndoDynamix filed a complaint in Delaware Chancery Court claiming breach of contract with respect to the duty to commercialize the product and seeking the contingent payments on an accelerated basis.  We believe that there was a substantive contractual basis to support the Company's decision to redesign the product, such that there was no legitimate basis for seeking the liquidated damages.  In the third quarter of 2018, the Company decided to halt the development of the EndoDynamix clip applier.  We previously recorded a charge to write off assets and released a previously accrued contingent consideration liability.  In a pre-trial filing the Plaintiffs claim to seek liquidated damages, as well as additional damages up to $24.8&#160;million.  A non-jury trial in the Delaware Chancery Court commenced on March 18, 2021, and testimony concluded on April 7, 2021.  We expect the parties to submit post-trial briefs in the second quarter of 2021, with the Court to hear oral arguments at a hearing scheduled for July 22, 2021, and the Court to issue a ruling at some point thereafter.  The Company has not recorded any expense related to potential damages in connection with this matter because the Company does not believe any potential loss is probable.  We expect to defend the claims asserted by the sellers of EndoDynamix,  although there can be no assurance that we will prevail in the trial and/or any resulting appeals. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record reserves sufficient to cover probable and estimable losses associated with any such pending claims.  We do not expect that the resolution of any pending claims, investigations or reports of alleged misconduct will have a material adverse effect on our financial condition, results of operations or cash flows.  There can be no assurance, however, that future claims or investigations, or the costs associated with responding to such claims, investigations or reports of misconduct, especially claims and investigations not covered by insurance, will not have a material adverse effect on our financial condition, results of operations or cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalMattersAndContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalMattersAndContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533541111784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Pronouncements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">New Accounting Pronouncements</a></td>
<td class="text">New Accounting Pronouncements<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Standards, Not Yet Adopted</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional guidance if certain criteria are met for entities that have contracts, hedging relationships, and other transactions that reference LIBOR or other reference rates expected to be discontinued as a result of reference rate reform.  This ASU is effective as of March 12, 2020 through December 31, 2022.  The Company has not adopted this ASU as of March&#160;31, 2021, however will continue to monitor the impact of reference rates and will elect to apply this guidance in our consolidated financial statements in the event that we are impacted by reference rate reform.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity, which simplifies the accounting for convertible instruments by removing certain separation models requiring separate accounting for embedded conversion features which will result in more convertible debt instruments accounted for as a single liability.  The ASU eliminates certain settlement conditions that are required for equity classification to qualify for the derivative scope exception.  The ASU addresses how convertible instruments are accounted for in the calculation of diluted earnings per share by using the if-converted method.  The ASU is effective for fiscal years beginning after December 15, 2021, with early adoption permitted no earlier than fiscal years beginning after December 15, 2020.  The Company is currently assessing the impact of this guidance on our consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=113356391&amp;loc=SL49131195-203048<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=113356391&amp;loc=SL49131195-203048<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=112272810&amp;loc=SL108384541-122693<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=113356391&amp;loc=SL49131195-203048<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=113356391&amp;loc=SL49131195-203048<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=112272810&amp;loc=d3e31137-122693<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533540896264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Interim Reporting (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates, Policy</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preparation of the consolidated condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated condensed financial statements and the reported amounts of revenue and expenses during the reporting period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533540948600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Pronouncements (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements</a></td>
<td class="text">New Accounting Pronouncements<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Standards, Not Yet Adopted</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional guidance if certain criteria are met for entities that have contracts, hedging relationships, and other transactions that reference LIBOR or other reference rates expected to be discontinued as a result of reference rate reform.  This ASU is effective as of March 12, 2020 through December 31, 2022.  The Company has not adopted this ASU as of March&#160;31, 2021, however will continue to monitor the impact of reference rates and will elect to apply this guidance in our consolidated financial statements in the event that we are impacted by reference rate reform.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity, which simplifies the accounting for convertible instruments by removing certain separation models requiring separate accounting for embedded conversion features which will result in more convertible debt instruments accounted for as a single liability.  The ASU eliminates certain settlement conditions that are required for equity classification to qualify for the derivative scope exception.  The ASU addresses how convertible instruments are accounted for in the calculation of diluted earnings per share by using the if-converted method.  The ASU is effective for fiscal years beginning after December 15, 2021, with early adoption permitted no earlier than fiscal years beginning after December 15, 2020.  The Company is currently assessing the impact of this guidance on our consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533541658360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present revenue disaggregated by primary geographic market where the products are sold, by product line and timing of revenue recognition: </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:33.458%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.316%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Orthopedic Surgery</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">General Surgery</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Orthopedic Surgery</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">General Surgery</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Primary Geographic Markets</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,943&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,808&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,847&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, Middle East &amp; Africa</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,052&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,544&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,596&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,907&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,615&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,522&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas (excluding the United States)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,381&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,493&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,874&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,802&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,979&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,781&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total sales from contracts with customers</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,166&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,511&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232,677&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,283&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,727&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,010&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Timing of Revenue Recognition</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goods transferred at a point in time</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,690&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,394&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222,084&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,553&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,901&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,454&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services transferred over time</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,730&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total sales from contracts with customers</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,166&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,511&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232,677&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,283&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,727&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,010&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Contract with Customer, Asset and Liability</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liability balances related to the sale of extended warranties to customers are as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:58.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.401%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.826%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,231&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,666&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533540835608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Comprehensive Income (Loss) (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock', window );">Schedule of Comprehensive Income (Loss)</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) consists of the following:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.113%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,860&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,927&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedging gain, net of income tax (income tax expense of $1,250 and $766 for the three months ended March 31, 2021 and 2020, respectively)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension liability, net of income tax (income tax expense of $201 and $170 for the three months ended March 31, 2021 and 2020, respectively)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,674)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,988)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,743&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,121)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Loss</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss consists of the following:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.526%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flow<br/>Hedging<br/>Gain (Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension<br/>Liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cumulative<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,945)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,620)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,116)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63,681)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,725&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,674)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(949)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss) before tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">a</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(383)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(201)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(584)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,674)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,019)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,989)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,790)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,798)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.526%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flow<br/>Hedging<br/>Gain (Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension<br/>Liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cumulative<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,691)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,079)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,277)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,988)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,731)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss) before tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">a</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,124)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(419)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,988)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,048)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,898&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,156)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,067)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66,325)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)  The cash flow hedging gain (loss) and pension liability accumulated other comprehensive income (loss) components are included in sales or cost of sales and as a component of net periodic pension cost, respectively.  Refer to Note 5 and Note 11, respectively, for further details.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions  designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e526-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533539343160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock', window );">Schedule of Notional Amounts of Outstanding Derivative Positions</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the notional contract amounts for forward contracts outstanding:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:38.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.401%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.401%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,562&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,504&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,545&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign exchange contracts designated as cash flow hedges had the following effects on accumulated other comprehensive income (loss) and net earnings on our consolidated condensed statements of comprehensive income (loss) and our consolidated condensed balance sheets:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:28.752%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.582%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in AOCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Condensed Statements  of Comprehensive Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Reclassified from AOCI</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="36" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="6" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Amount of Line Item Presented</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Instrument</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of amount reclassified</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232,677&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,010&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,849)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of Sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax gain (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,593&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,295&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,584)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,124&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax expense (benefit)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,038&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(383)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,725&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,257&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,201)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">852&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Derivatives Not Designated as Hedging Instruments</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains and losses from derivative instruments not accounted for as hedges and gains and losses on our intercompany receivables on our consolidated condensed statements of comprehensive income (loss) were:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.091%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Instrument</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Condensed Statements of Comprehensive Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(245)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss on currency transaction exposures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,123)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock', window );">Schedule of Fair Value for Forward Foreign Exchange Contracts</a></td>
<td class="text">The following tables summarize the fair value for forward foreign exchange contracts outstanding at March&#160;31, 2021 and December&#160;31, 2020: <div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.514%"><tr><td style="width:1.0%"/><td style="width:33.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.033%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.399%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.944%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.944%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.950%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Condensed Balance Sheet</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net<br/>Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedged instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,592)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,035)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(337)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,266&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,929)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,663)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,274&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,108)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,834)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.514%"><tr><td style="width:1.0%"/><td style="width:33.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.033%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.399%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.944%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.944%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.950%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Condensed Balance Sheet</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net<br/>Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedged instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,826)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,326)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(535)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(512)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,523&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,361)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,838)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,548&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,511)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,963)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the presentation of foreign exchange contracts on the statement of financial position, including the fair value amounts and location of such amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the notional amounts of outstanding derivative positions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998890-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533540989288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of inventory</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of the following:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:71.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.225%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,654&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,807&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,429&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,864&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,797&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,868&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533539564664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of calculation of basic and diluted earnings per share</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted earnings per share for the three months ended March 31, 2021 and 2020:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.113%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,860&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,927&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic &#8211; weighted average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive potential securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,406&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted &#8211; weighted average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,378&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,707&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (per share)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533536799288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the net carrying amount of goodwill for the three months ended March&#160;31, 2021 are as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(336)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618,104&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets consist of the following:</span></div><div style="text-align:justify;text-indent:15.75pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:36.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.897%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.897%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.365%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Amortization Period (Years)</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets with definite lives:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer and distributor relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342,531&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139,243)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134,555)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales representation, marketing and promotional rights</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,358)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,705)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and other intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49,356)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,516&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48,882)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets with indefinite lives:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and tradenames</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">759,362&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(265,457)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">758,679&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(257,142)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Indefinite-Lived Intangible Assets</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets consist of the following:</span></div><div style="text-align:justify;text-indent:15.75pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:36.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.897%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.897%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.365%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Amortization Period (Years)</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets with definite lives:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer and distributor relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342,531&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139,243)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134,555)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales representation, marketing and promotional rights</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,358)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,705)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and other intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49,356)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,516&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48,882)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets with indefinite lives:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and tradenames</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">759,362&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(265,457)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">758,679&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(257,142)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Estimated Amortization Expense</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated intangible asset amortization expense remaining for the year ending December&#160;31, 2021 and for each of the five succeeding years is as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:57.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization included in expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization recorded as a reduction of revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining, 2021</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,620&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,500&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,120&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,646&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,646&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,058&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,058&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,529&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b),(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533541067304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long Term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-term Debt</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consists of the following:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:72.360%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.804%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving line of credit</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,000&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,000&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan, net of deferred debt issuance costs of $1,520 and $1,668 in 2021 and 2020, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.625% convertible notes, net of deferred debt issuance costs of $5,031 and $5,475 in 2021 and 2020, respectively, and unamortized discount of $31,117 and $33,620 in 2021 and 2020, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305,904&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745,396&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753,636&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:&#160;&#160;Current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,076&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">725,320&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735,221&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturities of Long-term Debt</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scheduled&#160;maturities&#160;of&#160;long-term&#160;debt outstanding at March&#160;31, 2021 are as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:85.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,844&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The above amounts exclude debt discount, deferred debt issuance costs and financing leases.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533540930040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Guarantees (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteesAbstract', window );"><strong>Guarantees [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock', window );">Changes in the carrying amount of service and product warranties</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the liability for standard warranties for the three months ended March 31, are as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:77.932%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.018%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1,</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,826&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,186&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for warranties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims made</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(206)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(363)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31,</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,911&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,178&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533541667608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Plan (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Schedule of net benefit cost</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic pension cost consists of the following:&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.993%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.990%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on projected benefit obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,289)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,255)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amortization and deferral</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533540848264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition and Other Expense (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cnmd_AcquisitionandOtherExpenseAbstract', window );"><strong>Acquisition and Other Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cnmd_ScheduleOfAcquisitionAndOtherOperatingExpenseTableTextBlock', window );">Schedule of Acquisition and Other Operating Expense</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Acquisition and other expense consist of the following, which are included in cost of sales or selling and administrative expense depending on the nature of the charge:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:80.186%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing consolidation costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">805&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and other expense included in cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,590&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and related costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration costs </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and other expense included in selling and administrative expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_AcquisitionandOtherExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquisition and Other Expense [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_AcquisitionandOtherExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_ScheduleOfAcquisitionAndOtherOperatingExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Acquisition and Other Operating Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_ScheduleOfAcquisitionAndOtherOperatingExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533545399736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock', window );">Schedule of net sales information by product line</a></td>
<td class="text">These product lines' net sales are as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.113%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orthopedic surgery</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,166&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,283&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General surgery</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,511&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,727&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232,677&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,010&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533618096824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues (Disaggregated Revenues) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">$ 232,677<span></span>
</td>
<td class="nump">$ 214,010<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember', window );">Goods transferred at a point in time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">222,084<span></span>
</td>
<td class="nump">204,454<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember', window );">Services transferred over time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">10,593<span></span>
</td>
<td class="nump">9,556<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cnmd_OrthopedicSurgeryMember', window );">Orthopedic Surgery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">107,166<span></span>
</td>
<td class="nump">99,283<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cnmd_OrthopedicSurgeryMember', window );">Orthopedic Surgery | Goods transferred at a point in time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">97,690<span></span>
</td>
<td class="nump">90,553<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cnmd_OrthopedicSurgeryMember', window );">Orthopedic Surgery | Services transferred over time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">9,476<span></span>
</td>
<td class="nump">8,730<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cnmd_GeneralSurgeryMember', window );">General Surgery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">125,511<span></span>
</td>
<td class="nump">114,727<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cnmd_GeneralSurgeryMember', window );">General Surgery | Goods transferred at a point in time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">124,394<span></span>
</td>
<td class="nump">113,901<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cnmd_GeneralSurgeryMember', window );">General Surgery | Services transferred over time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">1,117<span></span>
</td>
<td class="nump">826<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">123,943<span></span>
</td>
<td class="nump">118,847<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | Orthopedic Surgery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">37,131<span></span>
</td>
<td class="nump">37,039<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | General Surgery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">86,812<span></span>
</td>
<td class="nump">81,808<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=cnmd_AmericasexcludingtheUnitedStatesMember', window );">Americas (excluding the United States)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">24,874<span></span>
</td>
<td class="nump">23,781<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=cnmd_AmericasexcludingtheUnitedStatesMember', window );">Americas (excluding the United States) | Orthopedic Surgery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">17,381<span></span>
</td>
<td class="nump">15,802<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=cnmd_AmericasexcludingtheUnitedStatesMember', window );">Americas (excluding the United States) | General Surgery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">7,493<span></span>
</td>
<td class="nump">7,979<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember', window );">Europe, Middle East &amp; Africa</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">44,596<span></span>
</td>
<td class="nump">42,522<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember', window );">Europe, Middle East &amp; Africa | Orthopedic Surgery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">26,052<span></span>
</td>
<td class="nump">25,907<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember', window );">Europe, Middle East &amp; Africa | General Surgery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">18,544<span></span>
</td>
<td class="nump">16,615<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">39,264<span></span>
</td>
<td class="nump">28,860<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific | Orthopedic Surgery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">26,602<span></span>
</td>
<td class="nump">20,535<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific | General Surgery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">$ 12,662<span></span>
</td>
<td class="nump">$ 8,325<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cnmd_OrthopedicSurgeryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cnmd_OrthopedicSurgeryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cnmd_GeneralSurgeryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cnmd_GeneralSurgeryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=cnmd_AmericasexcludingtheUnitedStatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=cnmd_AmericasexcludingtheUnitedStatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_EMEAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533539363464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues (Customer Liability) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liability</a></td>
<td class="nump">$ 15,231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,666<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="nump">$ 3,400<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533546116696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Comprehensive Income (Loss) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 9,860<span></span>
</td>
<td class="nump">$ 5,927<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Cash flow hedging gain, net of income tax</a></td>
<td class="nump">3,926<span></span>
</td>
<td class="nump">2,405<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension liability, net of income tax</a></td>
<td class="nump">631<span></span>
</td>
<td class="nump">535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="num">(3,674)<span></span>
</td>
<td class="num">(9,988)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income (loss)</a></td>
<td class="nump">10,743<span></span>
</td>
<td class="num">(1,121)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax', window );">Pension liability, tax</a></td>
<td class="nump">201<span></span>
</td>
<td class="nump">170<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax', window );">Cash flow hedging gain, tax</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="nump">$ 766<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533541405576">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Comprehensive Income (Loss) (Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated other comprehensive income (loss) [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (63,681)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(62,798)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated other comprehensive income (loss) [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(63,681)<span></span>
</td>
<td class="num">$ (59,277)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(949)<span></span>
</td>
<td class="num">(6,731)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified from other accumulated comprehensive income (loss) before tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,416<span></span>
</td>
<td class="num">(419)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Reclassification from AOCI, Current Period, Tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(584)<span></span>
</td>
<td class="nump">102<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current-period other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">883<span></span>
</td>
<td class="num">(7,048)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(62,798)<span></span>
</td>
<td class="num">(66,325)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Cash Flow Hedging Gain (Loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated other comprehensive income (loss) [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(5,945)<span></span>
</td>
<td class="nump">493<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,725<span></span>
</td>
<td class="nump">3,257<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified from other accumulated comprehensive income (loss) before tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,584<span></span>
</td>
<td class="num">(1,124)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Reclassification from AOCI, Current Period, Tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(383)<span></span>
</td>
<td class="nump">272<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current-period other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,926<span></span>
</td>
<td class="nump">2,405<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,019)<span></span>
</td>
<td class="nump">2,898<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Pension Liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated other comprehensive income (loss) [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(36,620)<span></span>
</td>
<td class="num">(31,691)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified from other accumulated comprehensive income (loss) before tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">832<span></span>
</td>
<td class="nump">705<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Reclassification from AOCI, Current Period, Tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(201)<span></span>
</td>
<td class="num">(170)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current-period other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">631<span></span>
</td>
<td class="nump">535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(35,989)<span></span>
</td>
<td class="num">(31,156)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Cumulative Translation Adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated other comprehensive income (loss) [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(21,116)<span></span>
</td>
<td class="num">(28,079)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,674)<span></span>
</td>
<td class="num">(9,988)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified from other accumulated comprehensive income (loss) before tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Reclassification from AOCI, Current Period, Tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current-period other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,674)<span></span>
</td>
<td class="num">(9,988)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (24,790)<span></span>
</td>
<td class="num">$ (38,067)<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The cash flow hedging gain (loss) and pension liability accumulated other comprehensive income (loss) components are included in sales or cost of sales and as a component of net periodic pension cost, respectively.  Refer to Note 5 and Note 11, respectively, for further details.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724394-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533541935000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments (Amounts Recorded In and Reclassified From AOCI) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 232,677<span></span>
</td>
<td class="nump">$ 214,010<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">104,228<span></span>
</td>
<td class="nump">94,851<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="nump">3,593<span></span>
</td>
<td class="nump">4,295<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</a></td>
<td class="nump">868<span></span>
</td>
<td class="nump">1,038<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</a></td>
<td class="nump">2,725<span></span>
</td>
<td class="nump">3,257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</a></td>
<td class="num">(1,584)<span></span>
</td>
<td class="nump">1,124<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</a></td>
<td class="num">(383)<span></span>
</td>
<td class="nump">272<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</a></td>
<td class="num">(1,201)<span></span>
</td>
<td class="nump">852<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=cnmd_RevenuesMember', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</a></td>
<td class="num">(1,849)<span></span>
</td>
<td class="nump">1,201<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</a></td>
<td class="nump">$ 265<span></span>
</td>
<td class="num">$ (77)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=cnmd_RevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=cnmd_RevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533546388344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments (Foreign Currency Forward Contracts) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign Currency Transaction Gain (Loss), before Tax</a></td>
<td class="num">$ (1,123)<span></span>
</td>
<td class="num">$ (191)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract', window );"><strong>Derivative Assets and Liabilities at Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Asset Fair Value</a></td>
<td class="nump">2,274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,548<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Liabilities Fair Value</a></td>
<td class="num">(5,108)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,511)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Net Fair Value</a></td>
<td class="num">(2,834)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,963)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign Currency Forward Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments', window );">Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments</a></td>
<td class="nump">458<span></span>
</td>
<td class="num">$ (245)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated as hedged instruments: | Foreign Currency Forward Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract', window );"><strong>Derivative Assets and Liabilities at Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Asset Fair Value</a></td>
<td class="nump">2,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,523<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Liabilities Fair Value</a></td>
<td class="num">(4,929)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,361)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Net Fair Value</a></td>
<td class="num">(2,663)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,838)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated as hedged instruments: | Foreign Currency Forward Contracts | Other Noncurrent Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract', window );"><strong>Derivative Assets and Liabilities at Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Asset Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Liabilities Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(535)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Net Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(512)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated as hedged instruments: | Foreign Currency Forward Contracts | Other Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract', window );"><strong>Derivative Assets and Liabilities at Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Asset Fair Value</a></td>
<td class="nump">1,557<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Liabilities Fair Value</a></td>
<td class="num">(4,592)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,826)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Net Fair Value</a></td>
<td class="num">(3,035)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,326)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated as hedged instruments: | Foreign Currency Forward Contracts | Other Noncurrent Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract', window );"><strong>Derivative Assets and Liabilities at Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Asset Fair Value</a></td>
<td class="nump">709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Liabilities Fair Value</a></td>
<td class="num">(337)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Net Fair Value</a></td>
<td class="nump">$ 372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments: | Foreign Currency Forward Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1', window );">Maximum Length of Time Hedged in Cash Flow Hedge</a></td>
<td class="text">1 month<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of cash flow hedges</a></td>
<td class="nump">$ 45,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,380<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments: | Foreign Currency Forward Contracts | Other Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract', window );"><strong>Derivative Assets and Liabilities at Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Asset Fair Value</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Liabilities Fair Value</a></td>
<td class="num">(179)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(150)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Net Fair Value</a></td>
<td class="num">$ (171)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(125)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash flow hedge | Foreign Currency Forward Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1', window );">Maximum Length of Time Hedged in Cash Flow Hedge</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of cash flow hedges</a></td>
<td class="nump">$ 164,562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 154,504<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months', window );">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</a></td>
<td class="num">$ (2,300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=117331979&amp;loc=d3e41228-113958<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121605123&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in earnings in the period from the increase (decrease) in fair value of foreign currency derivatives not designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum length of time over which the entity is hedging its exposure to the variability in future cash flows for forecasted transactions, excluding those forecasted transactions related to the payment of variable interest on existing financial instruments, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533539328536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 73,654<span></span>
</td>
<td class="nump">$ 71,807<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">18,429<span></span>
</td>
<td class="nump">15,864<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">113,714<span></span>
</td>
<td class="nump">107,197<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventory</a></td>
<td class="nump">$ 205,797<span></span>
</td>
<td class="nump">$ 194,868<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533546111416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 9,860<span></span>
</td>
<td class="nump">$ 5,927<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic-weighted average shares outstanding (in shares)</a></td>
<td class="nump">28,972<span></span>
</td>
<td class="nump">28,478<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Effect of dilutive potential securities (in shares)</a></td>
<td class="nump">2,406<span></span>
</td>
<td class="nump">1,229<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted- weighted average shares outstanding (in shares)</a></td>
<td class="nump">31,378<span></span>
</td>
<td class="nump">29,707<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 0.34<span></span>
</td>
<td class="nump">$ 0.21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 0.31<span></span>
</td>
<td class="nump">$ 0.20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">300<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants', window );">Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants</a></td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1828-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1757-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1707-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2029-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533546076072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Earnings Per Share - Convertible Notes (Details) - Convertible Notes Payable - 2.625 Percent Convertible Notes Due 2024 [Member]<br></strong></div></th>
<th class="th">
<div>Jan. 29, 2019 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">2.625%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (in dollars per share)</a></td>
<td class="nump">$ 88.80<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Hedge transactions</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OptionIndexedToIssuersEquityStrikePrice1', window );">Option indexed to issuer's equity, strike price (in dollars per share)</a></td>
<td class="nump">114.92<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Warrant transactions</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OptionIndexedToIssuersEquityStrikePrice1', window );">Option indexed to issuer's equity, strike price (in dollars per share)</a></td>
<td class="nump">$ 114.92<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityStrikePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise or strike price stated in the contract for options indexed to the issuer's equity shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120519210&amp;loc=d3e90205-114008<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109262807&amp;loc=d3e22047-110879<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityStrikePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cnmd_A2.625PercentConvertibleNotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cnmd_A2.625PercentConvertibleNotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_IndexedTransactionTypeAxis=cnmd_HedgeTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_IndexedTransactionTypeAxis=cnmd_HedgeTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_IndexedTransactionTypeAxis=cnmd_WarrantTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_IndexedTransactionTypeAxis=cnmd_WarrantTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533539516440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Goodwill) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 618,440<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation</a></td>
<td class="num">(336)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 618,104<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533541754280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Intangible Assets) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems', window );"><strong>Schedule of Finite-Lived and Indefinite-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Gross carrying amount</a></td>
<td class="nump">$ 759,362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 758,679<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated amortization</a></td>
<td class="num">(265,457)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(257,142)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">8,300<span></span>
</td>
<td class="nump">$ 8,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Future amortization expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Remaining, 2021</a></td>
<td class="nump">25,120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2022</a></td>
<td class="nump">32,426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">31,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2024</a></td>
<td class="nump">30,836<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2025</a></td>
<td class="nump">31,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2026</a></td>
<td class="nump">30,529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=cnmd_ExpenseMember', window );">Amortization included in expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Future amortization expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Remaining, 2021</a></td>
<td class="nump">20,620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2022</a></td>
<td class="nump">26,426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">25,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2024</a></td>
<td class="nump">24,836<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2025</a></td>
<td class="nump">25,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2026</a></td>
<td class="nump">24,529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=cnmd_ReductionofRevenueMember', window );">Amortization recorded as a reduction of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Future amortization expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Remaining, 2021</a></td>
<td class="nump">4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2022</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2024</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2025</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2026</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember', window );">Trademarks &amp; tradenames</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems', window );"><strong>Schedule of Finite-Lived and Indefinite-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Unamortized intangible assets, Gross carrying amount</a></td>
<td class="nump">86,544<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86,544<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cnmd_CustomerandDistributorRelationshipsMember', window );">Customer and distributor relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems', window );"><strong>Schedule of Finite-Lived and Indefinite-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortized intangible assets, Gross carrying amount</a></td>
<td class="nump">342,531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">342,639<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated amortization</a></td>
<td class="num">(139,243)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(134,555)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cnmd_SalesrepresentationmarketingandpromotionalrightsMember', window );">Sales representation, marketing and promotional rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems', window );"><strong>Schedule of Finite-Lived and Indefinite-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortized intangible assets, Gross carrying amount</a></td>
<td class="nump">149,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149,376<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated amortization</a></td>
<td class="num">(55,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(54,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cnmd_PatentsAndOtherIntangibleAssetsMember', window );">Patents and other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems', window );"><strong>Schedule of Finite-Lived and Indefinite-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortized intangible assets, Gross carrying amount</a></td>
<td class="nump">74,307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,516<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated amortization</a></td>
<td class="num">(49,356)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(48,882)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems', window );"><strong>Schedule of Finite-Lived and Indefinite-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortized intangible assets, Gross carrying amount</a></td>
<td class="nump">106,604<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,604<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated amortization</a></td>
<td class="num">(21,358)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (19,705)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cnmd_AssetAcquisitionContingentConsiderationLiability', window );">Asset acquisition, contingent consideration liability</a></td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems', window );"><strong>Schedule of Finite-Lived and Indefinite-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset useful life (in years)</a></td>
<td class="text">22 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average | Customer and distributor relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems', window );"><strong>Schedule of Finite-Lived and Indefinite-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset useful life (in years)</a></td>
<td class="text">24 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average | Sales representation, marketing and promotional rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems', window );"><strong>Schedule of Finite-Lived and Indefinite-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset useful life (in years)</a></td>
<td class="text">25 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average | Patents and other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems', window );"><strong>Schedule of Finite-Lived and Indefinite-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset useful life (in years)</a></td>
<td class="text">16 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average | Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems', window );"><strong>Schedule of Finite-Lived and Indefinite-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset useful life (in years)</a></td>
<td class="text">16 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_AssetAcquisitionContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Contingent Consideration Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_AssetAcquisitionContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Finite-Lived and Indefinite-Lived Assets [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=cnmd_ExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=cnmd_ExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=cnmd_ReductionofRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=cnmd_ReductionofRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cnmd_CustomerandDistributorRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cnmd_CustomerandDistributorRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cnmd_SalesrepresentationmarketingandpromotionalrightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cnmd_SalesrepresentationmarketingandpromotionalrightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cnmd_PatentsAndOtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cnmd_PatentsAndOtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533545231576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long Term Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities', window );">Long-term Debt and Lease Obligation, Including Current Maturities</a></td>
<td class="nump">$ 745,396<span></span>
</td>
<td class="nump">$ 753,636<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance Lease, Liability</a></td>
<td class="nump">566<span></span>
</td>
<td class="nump">587<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">20,076<span></span>
</td>
<td class="nump">18,415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">725,320<span></span>
</td>
<td class="nump">735,221<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="nump">199,000<span></span>
</td>
<td class="nump">207,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Term Loan Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="nump">236,980<span></span>
</td>
<td class="nump">240,145<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized Debt Issuance Expense</a></td>
<td class="nump">1,520<span></span>
</td>
<td class="nump">1,668<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Convertible Debt</a></td>
<td class="nump">308,850<span></span>
</td>
<td class="nump">305,904<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt Instrument, Unamortized Discount</a></td>
<td class="nump">31,117<span></span>
</td>
<td class="nump">33,620<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized Debt Issuance Expense</a></td>
<td class="nump">$ 5,031<span></span>
</td>
<td class="nump">$ 5,475<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, including portion classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533647792600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long Term Debt Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 29, 2019 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 07, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,503,000<span></span>
</td>
<td class="nump">$ 2,264,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Term Loan Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term Debt, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">238,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">236,980,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 240,145,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Term Loan Facility [Member] | Amended and Restated Senior Credit Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 265,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">199,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 207,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Line of Credit Facility, Remaining Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">383,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of Credit Outstanding, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit [Member] | Amended and Restated Senior Credit Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">585,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes Payable [Member] | 2.625 Percent Convertible Notes Due 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="nump">$ 345,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent', window );">Debt Instrument, Convertible, Carrying Amount of Equity Component</a></td>
<td class="nump">$ 39,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">2.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cnmd_CreditAgreementExpirationTriggerRequirementConvertibleNoteOutstandingBalance', window );">Credit Agreement Expiration Trigger Requirement, Convertible Note Outstanding Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt Instrument, Interest Rate, Effective Percentage</a></td>
<td class="nump">6.14%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest Expense, Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cnmd_DebtInstrumentConvertibleGrossAmountofEquityComponent', window );">Debt Instrument, Convertible, Gross Amount of Equity Component</a></td>
<td class="nump">$ 51,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 88.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Debt Instrument, Convertible, Conversion Ratio</a></td>
<td class="nump">11.2608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes Payable [Member] | 2.625 Percent Convertible Notes Due 2024 [Member] | Hedge transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OptionIndexedToIssuersEquityStrikePrice1', window );">Option indexed to issuer's equity, strike price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 114.92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LongTermDebtMember', window );">Long-term Debt [Member] | Amended and Restated Senior Credit Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt Instrument, Interest Rate, Effective Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cnmd_LIBORInterestRateFloor', window );">LIBOR Interest Rate Floor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cnmd_VariableRateBasisAxis=us-gaap_LondonInterbankOfferedRateLIBORMember', window );">London Interbank Offered Rate (LIBOR) [Member] | Long-term Debt [Member] | Amended and Restated Senior Credit Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt Instrument, Basis Spread on Variable Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cnmd_VariableRateBasisAxis=us-gaap_EurodollarMember', window );">Eurodollar [Member] | Long-term Debt [Member] | Amended and Restated Senior Credit Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt Instrument, Basis Spread on Variable Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cnmd_VariableRateBasisAxis=us-gaap_BaseRateMember', window );">Base Rate [Member] | Long-term Debt [Member] | Amended and Restated Senior Credit Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt Instrument, Basis Spread on Variable Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OptionIndexedToIssuersEquityTypeAxis=us-gaap_CallOptionMember', window );">Call Option [Member] | Convertible Notes Payable [Member] | 2.625 Percent Convertible Notes Due 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cnmd_Hedgeandwarranttransactionsnetcashpaid', window );">Hedge and warrant transactions, net cash paid</a></td>
<td class="nump">$ 21,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_CreditAgreementExpirationTriggerRequirementConvertibleNoteOutstandingBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Credit Agreement Expiration Trigger Requirement, Convertible Note Outstanding Balance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_CreditAgreementExpirationTriggerRequirementConvertibleNoteOutstandingBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_DebtInstrumentConvertibleGrossAmountofEquityComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Gross Amount of Equity Component</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_DebtInstrumentConvertibleGrossAmountofEquityComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_Hedgeandwarranttransactionsnetcashpaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Up-front costs to purchase hedge instruments, net of cash received from sale of warrants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_Hedgeandwarranttransactionsnetcashpaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_LIBORInterestRateFloor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>LIBOR Interest Rate Floor</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_LIBORInterestRateFloor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityStrikePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise or strike price stated in the contract for options indexed to the issuer's equity shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120519210&amp;loc=d3e90205-114008<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109262807&amp;loc=d3e22047-110879<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityStrikePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cnmd_AmendedAndRestatedSeniorCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cnmd_AmendedAndRestatedSeniorCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cnmd_A2.625PercentConvertibleNotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cnmd_A2.625PercentConvertibleNotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_IndexedTransactionTypeAxis=cnmd_HedgeTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_IndexedTransactionTypeAxis=cnmd_HedgeTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_VariableRateBasisAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_VariableRateBasisAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_VariableRateBasisAxis=us-gaap_EurodollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_VariableRateBasisAxis=us-gaap_EurodollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_VariableRateBasisAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_VariableRateBasisAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityTypeAxis=us-gaap_CallOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityTypeAxis=us-gaap_CallOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533537576696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long Term Debt Maturities of Long Term Debt (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MaturitiesOfLongTermDebtAbstract', window );"><strong>Maturities of Long-term Debt [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">Remaining, 2021</a></td>
<td class="nump">$ 14,906<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2022</a></td>
<td class="nump">24,844<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2023</a></td>
<td class="nump">397,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2024</a></td>
<td class="nump">345,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2025</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaturitiesOfLongTermDebtAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaturitiesOfLongTermDebtAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533626541048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Guarantees (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteesAbstract', window );"><strong>Guarantees [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cnmd_ProductWarrantyAccrualTerm', window );">Standard warranty period (in years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInStandardProductWarrantyAccrualRollForward', window );"><strong>Movement in Standard Product Warranty Accrual [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrual', window );">Balance as of January 1,</a></td>
<td class="nump">$ 1,826<span></span>
</td>
<td class="nump">$ 2,186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued', window );">Provision for warranties</a></td>
<td class="nump">291<span></span>
</td>
<td class="nump">355<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualPayments', window );">Claims made</a></td>
<td class="num">(206)<span></span>
</td>
<td class="num">(363)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrual', window );">Balance as of March 31,</a></td>
<td class="nump">1,911<span></span>
</td>
<td class="nump">2,178<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtendedProductWarrantyDisclosureAbstract', window );"><strong>Extended Product Warranty Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyExpense', window );">Product extended warranty expense</a></td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_ProductWarrantyAccrualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product Warranty Accrual Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_ProductWarrantyAccrualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtendedProductWarrantyDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtendedProductWarrantyDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInStandardProductWarrantyAccrualRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInStandardProductWarrantyAccrualRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The expense charged against earnings for the period pertaining to standard and extended warranties on the entity's goods and services granted to customers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(3,4))<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1),(c)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the standard product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard product warranty. Excludes extended product warranties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in the standard product warranty accrual from warranties issued. Excludes extended product warranties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualWarrantiesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533541687624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Plan (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">$ 248<span></span>
</td>
<td class="nump">$ 179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost on projected benefit obligation</a></td>
<td class="nump">451<span></span>
</td>
<td class="nump">639<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(1,289)<span></span>
</td>
<td class="num">(1,255)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Net amortization and deferral</a></td>
<td class="nump">832<span></span>
</td>
<td class="nump">705<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic pension cost</a></td>
<td class="nump">$ 242<span></span>
</td>
<td class="nump">268<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cnmd_DefinedBenefitPlanNonServiceCost', window );">Defined Benefit Plan, Non-service cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_DefinedBenefitPlanNonServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Non-Service Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_DefinedBenefitPlanNonServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533545396744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition and Other Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cnmd_AcquisitionandOtherExpenseLineItems', window );"><strong>Acquisition and Other Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cnmd_Manufacturingconsolidationcosts', window );">Manufacturing consolidation costs</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,785<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition and integration costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">805<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCostAndExpenseOperating', window );">Acquisition and other expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,590<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling and Administrative Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cnmd_AcquisitionandOtherExpenseLineItems', window );"><strong>Acquisition and Other Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cnmd_RestructuringAndRelatedCosts', window );">Restucturing and related costs</a></td>
<td class="nump">414<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Acquisition and integration costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">754<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCostAndExpenseOperating', window );">Acquisition and other expense</a></td>
<td class="nump">$ 414<span></span>
</td>
<td class="nump">$ 754<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_AcquisitionandOtherExpenseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquisition and Other Expense [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_AcquisitionandOtherExpenseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_Manufacturingconsolidationcosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Manufacturing consolidation costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_Manufacturingconsolidationcosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_RestructuringAndRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring and related costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_RestructuringAndRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostAndExpenseOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostAndExpenseOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533627706472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 232,677<span></span>
</td>
<td class="nump">$ 214,010<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cnmd_OrthopedicSurgeryMember', window );">Orthopedic Surgery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">107,166<span></span>
</td>
<td class="nump">99,283<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cnmd_GeneralSurgeryMember', window );">General Surgery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 125,511<span></span>
</td>
<td class="nump">$ 114,727<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cnmd_OrthopedicSurgeryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cnmd_OrthopedicSurgeryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cnmd_GeneralSurgeryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cnmd_GeneralSurgeryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140533546144376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Legal Proceedings (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jan. 18, 2017</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident', window );">Product liability insurance, amount per incident</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount', window );">Product liability insurance, aggregate annual amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending Litigation | EndoDynamix, Inc. | Liquidated Damages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Loss Contingency, Damages Sought, Value</a></td>
<td class="nump">$ 12.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending Litigation | EndoDynamix, Inc. | Additional Damages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Loss Contingency, Damages Sought, Value</a></td>
<td class="nump">$ 24.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product Liability Contingency, Insurance, Aggregate Annual Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product Liability Contingency, Insurance, Amount per Incident</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cnmd_EndoDynamixInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cnmd_EndoDynamixInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_LitigationDamagesAxis=cnmd_LiquidatedDamagesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_LitigationDamagesAxis=cnmd_LiquidatedDamagesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_LitigationDamagesAxis=cnmd_AdditionalDamagesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_LitigationDamagesAxis=cnmd_AdditionalDamagesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>65
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M;&Y09XHEX3HGFJ:8W:#/Z!-RD<IA58U<#4Q&V4V;^ ]U_.!(_&]8=E'HWZ+
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M7RE$&@-XOA!"OT_,0=A^]R3_ 5!+ P04    "  "4IU2\*"*!^8%   ,&@
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MV7:**R&#O07U]V(0+HF7&P%8DB<S/VO003WILGHNF@ %Z!GROE;2-$NG348
M1F(:S>7$(*DT76PROLEF[7B/FB*@_-I>@PY22)>E<%R69S>XW1Q/?JK-_9@,
MH+)H6H<WHQ.$FJL[=["BD=MEM[^Z]T_[PYN/[LAB\OP3_G#='L$,T[0G0E^9
M@D#5J.)[F#)ZG\$RJ?:0I;TQ\NC.*7;2&%F[RP-G()P6 ._W4IK'&_N!_JCK
MZO]02P,$%     @  E*=4ERE*RKB @  'P8  !@   !X;"]W;W)K<VAE971S
M+W-H965T."YX;6R=5=MNVS ,_17" XH-*.+$22]H+D"3MM@>N@;M+@_#'A2)
ML87*DBO)2;.O'R4[7@:L1;&76")YR',HB9ELC7UT!:*'YU)I-TT*[ZN+-'6\
MP)*YGJE0DV=M;,D\;6V>NLHB$Q%4JC3K]T_3DDF=S";1MK2SB:F]DAJ7%EQ=
MELSNYJC,=IH,DKWA7N:%#X9T-JE8C@_HOU9+2[NTRR)DB=I)H\'B>II<#B[F
MHQ ? [Y)W+J#-00E*V,>P^:3F";]0 @5<A\R,/IL<(%*A41$XZG-F70E _!P
MO<]^$[63EA5SN##JNQ2^F";G"0A<LUKY>[/]B*V>DY"/&^7B+VS;V'X"O';>
ME"V8&)12-U_VW/;A+8"L!621=U,HLKQBGLTFUFS!AFC*%A91:D03.:G#H3QX
M2UY).#^[J]"RT!\W23WE"]:4M]AY@\U>P [AUFA?.+C6 L7?^)1X=&2R/9EY
M]FK"6V9[,!P<0];/!J_D&W;BAC'?\"5Q-F=:_HKZCF%!(HV2@C7700M86G2H
M?6,P:[B1FFDNF8(',B+=/>_@Q^7*>4NWY^<KC$8=HU%D-/JO=K\5N[C[?'M]
M18)L91H3O#]Z=YYE_7'CBIO!^!A\@;#WF+)B>M>Y6O,66PL8N[?5KK5] .F
M08E"<NJ*1UYHHTR^ ]YDHP+,0V7-1@IT]+1M'B,%;B0G0^@R/M6R"KT$FB'A
M#LN2*;4#J3?,T9,,<(ZBIL/H';T;G/;'S>\7XGY >G V=B%4U)Q.A5F$VJ&
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MV"M($XHXUF))EKPT9LTGU+)=%DDVLN?6:]AM#04!?- ON!_\Z2W<G)IL,R(
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MXSZ>S-NKM;+A%W;CV;280;VU3O=[94+0RV'\%X]['EXHE-%7%/A>@0?<HZ.
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M,BW@8FL("(,KV30*X4)8!]^)?O,CG*Z-K 7PG$49!SJ>I2FD*<NJ''C&JJB
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MG@Q^-Q@\WJO[O<;M%1)7M=$@2S"5@%(V>-WJ;G4!OU1*B$?" *:UJ(:\VI\
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M;Y6EY?%B0Z\5:N= ]Y52]J"X ./[M_H%4$L#!!0    (  )2G5)'M/00$P8
M +X/   9    >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;*5775/C-A3]*YJ4
M=MB9-'&< ($%9H"ELWW8769INP^=/BCV3:S!MEQ))N3?]US)=@P$=IF^V)9T
M=;_/D76ZUN;.9D1./!1Y:<\&F7/5R7ALDXP*:4>ZHA(K2VT*Z3 TJ[&M#,G4
M;RKR<1Q%A^-"JG)P?NKG;LSYJ:Y=KDJZ,<+612'-YI)RO3X;3 ;MQ%>URAQ/
MC,]/*[FB6W)_5C<&HW&G)54%E5;I4AA:G@TN)B>7,Y;W G\I6MO>M^!(%EK?
M\>#W]&P0L4.44^)8@\3KGJXHSUD1W/BWT3GH3/+&_G>K_3<?.V)92$M7.O^F
M4I>=#>8#D=)2UKG[JM<?J8GG@/4E.K?^*=9!=AH-1%);IXMF,SPH5!G>\J')
M0V_#_*4-<;,A]GX'0][+#]+)\U.CU\*P-+3QAP_5[X9SJN2BW#J#585][OQ:
MFE*5*RMNR(C;3!HZ'3OHY=5QTNBX##KB%W1,Q2==NLR*ZS*E]/'^,?SIG(I;
MIR[C5Q5^DF8DII.AB*-X\HJ^:1?DU.N;_G"0XN^+A74&/?'/*_IGG?Z9US_[
M7TE\50>#[\16,J&S =!ER=S38)?CE]*J1%"[4&'!^H7]7WZ:QW'T?N$%KF]N
M_7CR_IU05B2ZJ&I'J5AL1*KN58K-H@3F58DEXFF7D5C[)H:8O"<#3(JR+A:P
MH)>LH0"*O"TK &_K9.G5@!G\9D.5-HYGX)32Z4A\4+DW^HJW:2/2]W<%G%I!
MRR60*YP6,L^%E\.\J+2CTBF9[W(%8Z#1.V5T(:BH<KTA$H!1<B=TQ41@ARSF
MC$K8;EBI2^4P#_<\S94)-6[Z!0'MC:"L4)Q$2<\HAI-EQ?[@]N*K';P3TB*!
M\!5OSL=G>!KV&LHE&\LH14[1=J65GI2L2&O#[K)\F[4_\+W4.>C2K\A%#F\(
MAN";R[QH*&?P K4))6=+Z<L9;\OD,H.,% &QQ(@5P%N2=8#SBO 1G< 5ENVC
M^ZDLRXG/VT;:$\?#^6&$]\'P.#YJVI5+.YF\?]Y?.VH8SX?'1S&_9D=S<1VZ
M $'NZ@!*D#ZGH"$>SJ)#,1G&\7'7=F^QBH"F,!<?#X^BHWY ^UT&WS7![(EH
M-)WY%Q+0&L/<A&<B7[_&0FVQHLI0,YDG==[5K-?X@AZ2O$ZI;5!? .XI;OZJ
M1KYQ[+0JUQD9\@KI@4RBL%*AEX%=M-T*Y[(CKK,,1MN(<>#>(:8@^0S-;6N$
M#O3FO8$N]SQ"/O+:G\5K7>=@$FA'&7YMZS(2MS4ZHU$I5_!EY;N>,:,?%$Y0
MRC><)YQC>>Z/9!B:C";=^.TMZK%<D3_:\\U(?*F-B$>'\<'/"+%$\$XQ?$H/
MQ;3F*'C?3.RSG8:#/% []F&L]/?6L&]$@B%^<42B3%(7W#8)@3&0<_P"@,J[
M,BN(EZXV-,0GDQ?G>J'*KO")M)GW_^K+YT_7'[I2,+\\!3^8&TI"!J K)9L8
MM0CE5P5.BZXZ/T0V^GN=.!(7::IX8<NOL N+RMH:,NA&6Z/L/.LK1::P;_$!
M65E"9#-LND@G@+"0#AWJ&,N;D()7P.+[$)GH\4"[W**NPJY00MLHV+H'_+P"
MC2U=8I.&9_WJ/,6)V@&XGMD.;%OC&.S-YZ-Y-!+?J"DMIQ+T[G+?G+X[O V<
M"XFJ$%V?ICBY()60>]BVM=DTSA7D,CCEX^O2%XX699XFBWDTP+LM"$[K[5'T
M%@!REAX1:Q,X2(W(-^YWT\+*UM16UD.)M3XJ*U34Z+O)*'I$'U&//D+Y'U,"
M0Q07CH"?;1^K1RU!6\A3ZDN#4_Y>Z=J"L) VK*<!S<])90?,((=0N#K4XU%.
M^>MIP+Z]R60V.HY'XJ->$T2'31/NM&H]5V%BF[EGU=]1]P8E5O%O3NB.ANG1
MT#)?RXU]RNQ7N@1,#30A(6N%OQ"?%4]194,%N[".HLK<ZA?3N9;&>#;IIR\0
M[CI3Z#=6 (Q1@Y)\^]>W YY@D2Y_WR$1[U7')+NN ./>G:H@L_(W1QNZ,%RO
MNMGN<GH1[F1;\7"S!716"H'EM,36:'1T, C_CNW Z<K?T!;:X;[G/S-<L,FP
M -:7&E5L!FR@N[*?_P=02P,$%     @  E*=4J^H2C\O!@  %0\  !D   !X
M;"]W;W)K<VAE971S+W-H965T,34N>&ULK5=;;]LV%/XKA%<,-J#:NMM)DP!)
MLW9Y"!:TV8IAV ,M,1872G1)*D[VZ_<=RI;MW! 4>['%PW._\VBES:VMA'#L
MOE:-/1Y4SBT/)Q-;5*+F=JR7HL'-C38U=SB:Q<0NC>"E)ZK5) [#?%)SV0Q.
MCCSLRIP<Z=8IV8@KPVQ;U]P\G FE5\>#:+ !?)&+RA%@<G*TY OQ5;C?EU<&
MITG/I92U:*S4#3/BYGAP&AV>I83O$?Z08F5WOAE9,M?ZE@X7Y?$@)(6$$H4C
M#AQ_=^*C4(H808WO:YZ#7B01[GYON'_RML.6.;?BHU;?9.FJX\%LP$IQPUOE
MONC5KV)M3T;\"JVL_V6K#C=+!JQHK=/UFA@:U++I_OG]V@\[!+/P!8)X31![
MO3M!7LMS[OC)D=$K9@@;W.C#F^JIH9QL*"A?G<&M!)T[^:QUN9)*,=Z4[#=7
M"<,N&L>;A9PKP4ZM%<X>31PD$?ZD6',]Z[C&+W!-V*5N7&79+TTIRGWZ"33L
MU8PW:I[%KS*\Y&;,DBA@<1A'K_!+>K,3SR]YB]E/#&;GTA9*V]8(]M?IW#J#
MY/G[%;%I+S;U8M/_V=NO<J6Z/;1+7HCC 0K3"G,G!F\2Q:XKP8H*0&&9;!BP
M6(-&4'!C'F2S8+S6;>.8OF&+#3OT 8_G*B,$J[LP"PHS0Y"*JH\2X_ >MR!0
MJ'Q[R,ZXXDWA86!X+@I1SZ'5&C]D[U@>S8(T#1GJ#=74(/^-$4WQP!" QBKN
MZWB8)/GH$;-'DCM.49AN["0?*,GG4DDGA2?AQ?=6&F@];RW\"3SK-3:BT(:L
MX8[LE(8)ZR3*'Z ;CN,=5RWA>B[DB1)W/4<K2<DQZ]UOA(]) RT*;9WWL[@O
M()!H]CE:& TQ3GN^+9QJE(\#!85WICRO^G@=8KD-\1J_T&B@UFV4[:(!GH>/
MG?8T(-]\2X.<TSMAT*'9::V-D_]V<;@21NJ2#?\4W-@1^VPT3#HMBK9NE??6
M4\C%$^U6TE741&4CX42%!HU$^>C;'C2AL)50WLAYZY!W1G0Y8"NYM"Q.$>@D
MC8,LH9 /H^0@B--DM(;FR4$'38,LRT;L*U=P<A\.SRA *S6WPOE<A["ET;6F
M"X[ D?&0DK$H/0B2:<Z&619D83C: :1!2(!S<8?QMJ38B:)JM-*+!Q;E+ KS
M($<:#N,H2++9: N(#H)I"*VNX)AFG:'ZA1""T30-DG#*AB0X0_I/DR #>)C.
M@MDL'KWD6=D\]NVUX:4@HSN1CHX-K^&961YD:<I^_FD61_&'Q\<XAC.G&<3G
M]#6,\RQ(L^G(0V=!/O7.CK-I$*70YVTA##KYSZD3("N>\:D/TAM<MC0H62/5
MPS;@C"/SBTXX5<.R1?ICGA,N&@F*3D*VDS?H$V#TE.=+E?>#B;55[)FBQ7Y%
M!>-; -,M_+A NZT)VP?VLK5%BPEUB_7&@><U-<@E6J)#\P35NE52].+PP^7U
M)_\5?1B-]XM8W&.[LZ(+2]=ZGFJSJB0:!35'V\[_P3I%:'R7C=-0 N3O9N,$
M6XI2?N%J/"#K >L)\X;) 4KJ0 'TLDOA%S?U$'BXI Y:J-:W:"0!4,JVV_ 0
M((.D:5K!AC2F]E3<L9#\:7\H:*-.A89AK50;-%YB+Z,4YZ1G[]).!4R %W)T
MM/$'=6BM9.G5PZ$D\I)9*.4C[C.OT#54K6@;OJ/DQ!DBD $6(;W8. 0<GRT;
M..U=/@[[2( ANG;S'EMZ-R"09NM(5IA[TO90X=TPYYW>S\Q:&*,+Z77WF<FI
MGLAR,G)_)EY7%#R[';%0MW-.-^C=3DDKW2S>.V'JO;D-W?;%C_T*LYW0C[V\
MGP/;;*?G"L5OL\T\P!V4BP1[/ B[?"1,P2%Z,T@I#K8M"B$\%7'PUNVN/'NU
M)G>BM-'D=#]%-ZO'BWE]387&OFST[_<=U$KN5ZB4)A0!LB " -<QB_,@C7.6
MTZQB2>P/N$@(*4_[B\@?<)%BM :SI+\(_0$7&5&$V6Q+00=<Y$21Q0=;"CH\
MMS!/=IXJF \+_R"C=,.>V;U:>FC_YCOMGCI;].[!B$Q82/1R)6Y &HZGV: K
MT\W!Z:5_^,RUPS#RGQ7>K<(0 NYOM':; PGH7\(G_P%02P,$%     @  E*=
M4N/3Q"9N#   9B(  !D   !X;"]W;W)K<VAE971S+W-H965T,38N>&ULM5K;
MDMLV$OT5U.QX:Z:*UE#4=7RK\B6N>"N.78XW>=C:!XB$),0DP1#@7/;K]W0#
MI$B-)$]2NR\S$@4T^GKZ-*07MZ;^9K=*.7%7Y*5]>;9UKGIV=673K2JD'9E*
ME?AD;>I".KRM-U>VJI7,>%.17R5Q/+\JI"[/7KW@9Y_K5R],XW)=JL^UL$U1
MR/K^C<K-[<NS\5G[X(O>;!T]N'KUHI(;]8MR_ZP^UWAWU4G)=*%*JTTI:K5^
M>?9Z_.S-E-;S@E^UNK6]UX(L61GSC=Y\R%Z>Q:20RE7J2(+$OQOU5N4Y"8(:
M?P299]V1M+'_NI7^GFV'+2MIU5N3_Z8SMWUYMCP3F5K+)G=?S.V/*M@S(WFI
MR2W_%;=^;;(X$VECG2G"9FA0Z-+_EW?!#[T-R_C(AB1L2%AO?Q!K^4XZ^>I%
M;6Y%3:LAC5ZPJ;P;RNF2@O*+J_&IQC[WZB=3;L1751?BG5JY%U<.,NF3JS3L
M?^/W)T?V3\1'4[JM%3^4F<J&^Z^@2Z=0TBKT)CDI\*.L1V(RCD02)^,3\B:=
M@1.6-SDBC\P2[[1-<V.;6HE_O5Y95R,9_GU"^+03/F7ATQ/>>^I.>>\1^SOO
MBYVXC-ZF!KEOG15F+=Q6B;7)44.ZW#P3\%*Z[=R$W:DJ5JING\3BB[HQ^0W6
M"CJ3)*2URK03YV)\?1W%<8Q72;S@5ZQ!;F09B1(X@,7(:U5C@U=$6]O(,E70
M**AS/HYF.$66&;V<SY="EUX5>D0:1"A96RDNNOQ>))-Y=+V,13*-H_%T)I+1
M/)D](1-O5.WT*E>B-$[9QVLPB^*)/PXOIXO9=S2(^'E3RL+@O/^08"2%:4H^
M[1R.&X\77MQD$LUAW'<LFL3+:#F+\7\67<=3\5Z7T) ]K@ 35LSF<S%;+L17
MXV3NS5A,9]'D>BX6,QPQF8N?E+7/Q-L&AD*/BC0S=&H4+^9BO(RFXUG8G@]3
MXUPL$HA**(J+R2Q*H.>G4KQ7J[H!MHH%I<'X6MPJ <F*_*A+9X045M^YK9#
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M"T<CC+6"RE[X5I5"W85T/U81=!Z,JV ;;?<NX\V@&7\TVFHN9!CSIEFO96Z
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MJ$E39Z&M-V7;/\PJUQNY2R\*>]]A)V..Y,F(2C/Y"1F/2B +HI8.P?05G1H
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;+5:VX[<-A+]%6(VV$V
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M_S;SO&DTF8#)!!\8/[[860"M3G@K-)@!JES9DF>7KJ66.+N1B,B^+L,57^V
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M0FC";3.TR$DWIJV5*HR75+U%5Z9 ZBUG65NY5+'9SOJ$.?HG0"B9(KKD-#6
M]I71@+54<#/5;\$[;<A5&L79@L*2(1.M!953)PO>(O8-Z$AJ&2]M5-8C-5Q=
M?C4>=*A3<G$D<^_8 ( @2I=+<N*)*4][6$#/I6IZ _[24EC)T!3'&;9F)?.+
M_<%$QY,X-R&U6;3Q.V'LJ:?Y(FO?6B#^%($#'>O3LP?+&PE=".Y*7@ZYRWVG
M6_MIA:5%:E<U.#A5SHD#9#M4;*=PB(P@JHRM=0*!#*'C@#<//%UIX@&:Q7CC
M@]*N]RD)YL.?@-SZ$.?U!JQA)D2,K</7TC("!,!I9T9IWRP: ^_V8 8B=>I'
M*2MO]L!+-YC\;E2'$J!U.9A1GP!IQH]N_4Z: H01+0J!/BV8H(?=.X[-JC,I
M$^!UPZ9F;L JS][TG2QFZ\:KAZ[(I'6[&VI=)I8OX;6]*8]YB98VQG'6S*;0
M93-_'WR5 "_&WUL:#]-H^RCZ5:=^1@_'+NGL$6\!SQZNYA9/PS/= >A_?<27
MO\H#AME@S ?&]:NS]?'#J>JG24&#AP F=EFH#;K5'(M0CZ5PI.H/'B SR3#O
M3<[G,#L?@]<5KYMUF$(UM#.@O$^D^E=](.6%\YYI9!0KQVXBCQNY#TZQ/1@,
MMW7[E#9+'"#Y1(#P[226KIA8+I],T!T&J7FV3>DI07EA-EZBLE[/HS(Y2?-Z
M8I3.L0$2 \JSJ5U3YEY\1@. 6L.>-K$8&S[6FTN@8,=4N*C):Y[W@X//31/M
MW/BQ)@CS@YUOW$SP_') J9%Z,"(9A7:>"JD$9ZSD>?$&2=P9E'?F!O=/"9B[
M"_'&J"/O/U,X6-T'N?Z<$R5 59K"ACPDWIZ[TN-=.PZU :,VPM7*)<84\;EE
M-S$_U?(T&:/!]3&U:XCKHR6%4Z]RO+MJDM;YYG#,=WXUCVS1V)X7>.QUQ%=
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M>J55MQU$O1!G/6H!8AI=M!,#>7=#95NA]%:H)'R%(87=>AP#U\JW6Z!R.9L
M$X3R8M.]^PN^]&Z.CTH7**E=L(H-9J4CF!JJ&QTMT)YW:.52L6UN70CI*D1(
MDQ<0#Z9&J[FLJE4[)-(#;#2^Q:E[-WG$:%(+2IQ<;^T":;XVJ0Z=VYIE1H4
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M8H#WA7-Q?2,!^O\$SO\$4$L#!!0    (  )2G5*&8]&Z4P0  +T)   9
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MQ($_[BUURN!M]48"*UB]T@7I^@YJ5+46FT:65$CZB1I_UZ!&L(2ZT:K:EM:
M((%1;<4&32\%1PY$7X&5G;-,CAVL:2Q5W4OG[SD\-AKQ0U4<$U&:RV;,\\=M
M +]IV]#HJ8CEPU;72,1OL$<MVG'_J"SM_O/%N[W_-V_^WWK_#7PGYL3HP5*L
M#'R!*&-A%-(B3UD><EJ$/&)%' UG052XLY#E0>[.PISE<0;76TU$&-S*JFH1
MKH6Q\(/H-C_!<JUE*8"G+$@XT/4DCB&.65*DP!-6!!F$*4O#!&+.$LYA::2
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M>$AURPK_%0AE-^#[4F(L_8UU,/S/F/\-4$L#!!0    (  )2G5*3)\R7$@8
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MF%6OY<?MU<<-Z!YK'*$%7X&H_R:!4[RN/AA4%U9MW4OZ4EEXY7?+#6= 'C?
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M\F)-CQ9JYT#VM5)VK[@ PS.X^ M02P,$%     @  E*=4LH?2@#9 @  308
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M-.J/+P/0S?!J#E95?F!LE:7QX[<%S7O43H'N<T4); _.0?<'6?X"4$L#!!0
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M:K>!UN^4LAO!.>B_!:?_ E!+ P04    "  "4IU2_>EU#9\#   ["   &0
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M(6AR>44N-IW/NX73=?#66CMR:IA6]#2B\0%TOM':'18^0?_8SO\"4$L#!!0
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MY=#X -HOM'9[QR<8WLWT/U!+ P04    "  "4IU2C_&T]]$%  #K(0  &0
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M4$+GT'Z7:J/OGE&\!(N=7 OYS35C9)I%(XMKH 3Q '&Q15P?,M96MQL7ABC
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M83#P@AZI#<RP&V:7J9#QDA?@K7A:)KLHSM9 ;00X*L&92P:#)SRROR2&6V2
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M^^A!@2M2,[T0NR_8YN,$YH(I]PN[QG<T]""OE195"S8**LJ;+WENZ] #A.<
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MC_GY1$C,*O(DJO'-*WQH !\&'U@N5AS\D<<T;OM/9*Y-PN@IX3FR#OB!%*<
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M/D$8 WU_S;EZ'9@%ZGYV_A]02P,$%     @  E*=4J]XI_OA!0  TAT  !D
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M)NB3 EUD&5%_+RB7AZD7>L>-;VRW-W;#GTURLJ-K:I[S)X4KOXZ2LHP*S:0
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M/ R12)437+DP,G=#T$8:'*G<Y1ZG7JJL =[?2NSDU<(^H)ZC9_\ 4$L#!!0
M   (  )2G5)CK(=RK@(  )X'   9    >&PO=V]R:W-H965T<R]S:&5E=#0T
M+GAM;,55WT_;,!#^5T[1IH$$31KZ(T5MI4$WT6EL%6CC ?'@-M?6PK&#?6GA
MOY_MA*R3VFQ[F/82^^R[S]]]%Y^'6Z4?S1J1X#D3THR"-5%^'H9FL<:,F9;*
M4=J=I=(9(VOJ56ARC2SU09D(XRCJA1GC,A@/_=I,CX>J(,$ESC28(LN8?KE
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M![N_5+8W5H;KZ?63//X!4$L#!!0    (  )2G5+(\?!K5P(  &D%   9
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M1=!H?$:6==_8_<2JM6^FI;+4FG[8T%N(V@70_DHINYNX!,/K6KP"4$L#!!0
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M67Y<<F;J*=O ?#\70C\\6 6;RURG_P-02P,$%     @  E*=4IJJ*>^A P
MQPP  !D   !X;"]W;W)K<VAE971S+W-H965T-#<N>&ULM5?;;N,V$/T50MB'
M72 ;B;I[81OHV@T:P&F#S:9]*/I 2V.;6(ET22I.^O4E)462K0M2%'FQ16DN
M9XYF#D;S$Q<_Y % H><\8W)A'90Z?K%MF1P@)_*:'X'I)SLN<J+T4>QM>11
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M1O?$].Z53I]D14HU]:M""(/BCJA"4$5AD. J95BF-(/YM(S\P)N%<_NI2^2
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ML/*CRT&T.UNF6?'U7K>G3*(,=MK-N8YTR:+:FJN#XL=R\=QRI=?8\O*@OS1
M& /]?,=UK]<'L\LVWR[+?P%02P,$%     @  E*=4O]<+:6/!@  P"   !D
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M_Y=[+3A!=8"!]1><\?<,R"3HO$8R!0YKAHI\NU\IE#I#O[<$Z%8!NC9 ]TR
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MY_\GU>5\;[H^_K+\/CEZ>R\X!_B3X/$+4$L#!!0    (  )2G5(A7:<FS0$
M "0@   3    6T-O;G1E;G1?5'EP97-=+GAM;,W:R6[",!0%T%]!V5;$> @=
M!&S:;EL6_0$W>4!$$ENVH?#W=<(@M:*HB$J]&R)B^]T76SJ;9/2VM>1[F[IJ
M_#A9A& ?&//Y@FKM4V.IB2,SXVH=XE\W9U;G2STG)@:#(<M-$Z@)_=#62":C
M)YKI515ZSYMXVY>F&2>.*I_T'G<3VZQQHJVMRER'.,[63?$MI;]/2./*;HY?
ME-;?Q D).YG0COP<L%_WNB;GRH)Z4^W"BZ[C++:IF _;BGQZOL2)'LUL5N94
MF'Q5QR6IMXYTX1=$H:[27=&;\\DA[C#M?OG5^5V9<X%QYM09Z^.).;H\[G D
M[>J^C87(A?+\(QX38^FKGX_:TRZH^&5VW-X/XY;=>7C67:[?XZ]G?*Q_81\"
MI \)TH<"Z2,#Z6,(TL<M2!]W('W<@_3!!RB-H(C*44CE**9R%%0YBJH<A56.
MXBI'@96CR"I09!4HL@H4606*K )%5H$BJT"15:#(*E!D%2BR2A19)8JL$D56
MB2*K1)%5HL@J4625*+)*%%DEBJP*15:%(JM"D56AR*I09%4HLBH4616*K I%
M5H4B:X8B:X8B:X8B:X8B:_:?LKX;L_SK]];M-:UUV1SR6?=QP.034$L! A0#
M%     @  E*=4@=!36*!    L0   !               ( !     &1O8U!R
M;W!S+V%P<"YX;6Q02P$"% ,4    "  "4IU2M8[:5.\    K @  $0
M        @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    "  "4IU2
MF5R<(Q &  "<)P  $P              @ '- 0  >&PO=&AE;64O=&AE;64Q
M+GAM;%!+ 0(4 Q0    (  )2G5+M5M2K+@4  &<5   8              "
M@0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    "  "4IU2
M::6 =:($  "($   &               @(%R#0  >&PO=V]R:W-H965T<R]S
M:&5E=#(N>&UL4$L! A0#%     @  E*=4C (B=Q(!@  ;1@  !@
M     ("!2A(  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    (
M  )2G5(/ Q^IVP(   ,)   8              " @<@8  !X;"]W;W)K<VAE
M971S+W-H965T-"YX;6Q02P$"% ,4    "  "4IU2\*"*!^8%   ,&@  &
M            @('9&P  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#
M%     @  E*=4H?=QK4_ @  ^ 0  !@              ("!]2$  'AL+W=O
M<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    (  )2G5*_?1=?H 8  /8:
M   8              " @6HD  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q0
M2P$"% ,4    "  "4IU27*4K*N("   ?!@  &               @(% *P
M>&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @  E*=4ITA#"%6
M!0  _PP  !@              ("!6"X  'AL+W=O<FMS:&5E=',O<VAE970Y
M+GAM;%!+ 0(4 Q0    (  )2G5+XI9@RC 0   8*   9              "
M@>0S  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @  E*=
M4DSD._IK!   U@L  !D              ("!IS@  'AL+W=O<FMS:&5E=',O
M<VAE970Q,2YX;6Q02P$"% ,4    "  "4IU2>W.YY9<+  #((0  &0
M        @(%)/0  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0
M   (  )2G5(IUAR-8 (   L%   9              " @1=)  !X;"]W;W)K
M<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @  E*=4D>T]! 3!@  O@\
M !D              ("!KDL  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q0
M2P$"% ,4    "  "4IU2KZA*/R\&   5#P  &0              @('X40
M>&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    (  )2G5+CT\0F
M;@P  &8B   9              " @5Y8  !X;"]W;W)K<VAE971S+W-H965T
M,38N>&UL4$L! A0#%     @  E*=4E.$X^AH P  A@<  !D
M ("! V4  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    "  "
M4IU2G).]LX4"  !_!0  &0              @(&B:   >&PO=V]R:W-H965T
M<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    (  )2G5("#?FNN@,  (4*   9
M          " @5YK  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#
M%     @  E*=4H6]B*1F!   N@D  !D              ("!3V\  'AL+W=O
M<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    "  "4IU22-8_BM8,  !(
M(0  &0              @('L<P  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM
M;%!+ 0(4 Q0    (  )2G5+I*7P$)@4   H,   9              " @?F
M  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @  E*=4OJ#
M:W^J @  " 8  !D              ("!5H8  'AL+W=O<FMS:&5E=',O<VAE
M970R,RYX;6Q02P$"% ,4    "  "4IU2Q.AYAC %   5#   &0
M    @($WB0  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    (
M  )2G5*&8]&Z4P0  +T)   9              " @9Z.  !X;"]W;W)K<VAE
M971S+W-H965T,C4N>&UL4$L! A0#%     @  E*=4FMXL229!   <PP  !D
M             ("!*),  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"
M% ,4    "  "4IU2DR?,EQ(&  #!$0  &0              @('XEP  >&PO
M=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    (  )2G5+<4>JP<P(
M !(%   9              " @4&>  !X;"]W;W)K<VAE971S+W-H965T,C@N
M>&UL4$L! A0#%     @  E*=4LH?2@#9 @  308  !D              ("!
MZZ   'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    "  "4IU2
M4=*M*\L$   7#@  &0              @('[HP  >&PO=V]R:W-H965T<R]S
M:&5E=#,P+GAM;%!+ 0(4 Q0    (  )2G5+]Z74-GP,  #L(   9
M      " @?VH  !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%
M  @  E*=4ADE?6N+ @  > 4  !D              ("!TZP  'AL+W=O<FMS
M:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    "  "4IU2F0M[.YL"  "+!0
M&0              @(&5KP  >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+
M 0(4 Q0    (  )2G5*0*5<,R@(  ,H&   9              " @6>R  !X
M;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @  E*=4E6 =J-\
M @  0P4  !D              ("!:+4  'AL+W=O<FMS:&5E=',O<VAE970S
M-2YX;6Q02P$"% ,4    "  "4IU2C_&T]]$%  #K(0  &0
M@($;N   >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    (  )2
MG5)HP)'9< (  #(&   9              " @2.^  !X;"]W;W)K<VAE971S
M+W-H965T,S<N>&UL4$L! A0#%     @  E*=4OK>H_$4 P  #0D  !D
M         ("!RL   'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"% ,4
M    "  "4IU2E20,7@(&  "Y'P  &0              @($5Q   >&PO=V]R
M:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    (  )2G5*QHB9,O0,  -L.
M   9              " @4[*  !X;"]W;W)K<VAE971S+W-H965T-# N>&UL
M4$L! A0#%     @  E*=4J]XI_OA!0  TAT  !D              ("!0LX
M 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4    "  "4IU2<;"&
M<&P"   V!@  &0              @(%:U   >&PO=V]R:W-H965T<R]S:&5E
M=#0R+GAM;%!+ 0(4 Q0    (  )2G5+DF? GGP,  %,+   9
M  " @?W6  !X;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @
M E*=4F.LAW*N @  G@<  !D              ("!T]H  'AL+W=O<FMS:&5E
M=',O<VAE970T-"YX;6Q02P$"% ,4    "  "4IU2R/'P:U<"  !I!0  &0
M            @(&XW0  >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4
M Q0    (  )2G5+:P/),[@8  -@E   9              " @4;@  !X;"]W
M;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @  E*=4IJJ*>^A P
MQPP  !D              ("!:^<  'AL+W=O<FMS:&5E=',O<VAE970T-RYX
M;6Q02P$"% ,4    "  "4IU2_UPMI8\&  # (   &0              @(%#
MZP  >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    (  )2G5+Q
M-I+O-@(  )P%   9              " @0GR  !X;"]W;W)K<VAE971S+W-H
M965T-#DN>&UL4$L! A0#%     @  E*=4@(DVSP? P  '@D  !D
M     ("!=O0  'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q02P$"% ,4
M"  "4IU2>>"M]/4"   V"   &0              @(',]P  >&PO=V]R:W-H
M965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    (  )2G5)!\'+D\ (  *,)   9
M              " @?CZ  !X;"]W;W)K<VAE971S+W-H965T-3(N>&UL4$L!
M A0#%     @  E*=4N-WL#NG @  Q <  !D              ("!'_X  'AL
M+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"% ,4    "  "4IU2HF/N7KL"
M  #6!P  &0              @(']  $ >&PO=V]R:W-H965T<R]S:&5E=#4T
M+GAM;%!+ 0(4 Q0    (  )2G5(W.W@@( ,  ! 2   -              "
M >\# 0!X;"]S='EL97,N>&UL4$L! A0#%     @  E*=4I>*NQS     $P(
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9>&UL4$L%!@     ^ #X Z1   ,H0 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>155</ContextCount>
  <ElementCount>311</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>50</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/DocumentandEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Consolidated Condensed Statements of Comprehensive Income (Loss) (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited</Role>
      <ShortName>Consolidated Condensed Statements of Comprehensive Income (Loss) (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Consolidated Condensed Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited</Role>
      <ShortName>Consolidated Condensed Balance Sheets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Consolidated Condensed Balance Sheets (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical</Role>
      <ShortName>Consolidated Condensed Balance Sheets (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Consolidated Condensed Statements of Shareholders' Equity (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited</Role>
      <ShortName>Consolidated Condensed Statements of Shareholders' Equity (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Consolidated Condensed Statements of Shareholders' Equity (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnauditedParenthetical</Role>
      <ShortName>Consolidated Condensed Statements of Shareholders' Equity (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Consolidated Condensed Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited</Role>
      <ShortName>Consolidated Condensed Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/Operations</Role>
      <ShortName>Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2102102 - Disclosure - Interim Financial Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/InterimFinancialInformation</Role>
      <ShortName>Interim Financial Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2104103 - Disclosure - Revenues</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/Revenues</Role>
      <ShortName>Revenues</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2108104 - Disclosure - Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/ComprehensiveIncomeLoss</Role>
      <ShortName>Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2112105 - Disclosure - Fair Value of Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/FairValueofFinancialInstruments</Role>
      <ShortName>Fair Value of Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2116106 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/Inventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2119107 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2123108 - Disclosure - Goodwill and Other Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/GoodwillandOtherIntangibleAssets</Role>
      <ShortName>Goodwill and Other Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2127109 - Disclosure - Long Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/LongTermDebt</Role>
      <ShortName>Long Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2132110 - Disclosure - Guarantees</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/Guarantees</Role>
      <ShortName>Guarantees</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2135111 - Disclosure - Pension Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/PensionPlan</Role>
      <ShortName>Pension Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2138112 - Disclosure - Acquisition and Other Expense</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/AcquisitionandOtherExpense</Role>
      <ShortName>Acquisition and Other Expense</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2141113 - Disclosure - Business Segment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/BusinessSegment</Role>
      <ShortName>Business Segment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2144114 - Disclosure - Legal Proceedings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/LegalProceedings</Role>
      <ShortName>Legal Proceedings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2146115 - Disclosure - New Accounting Pronouncements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/NewAccountingPronouncements</Role>
      <ShortName>New Accounting Pronouncements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2203201 - Disclosure - Interim Reporting (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/InterimReportingPolicies</Role>
      <ShortName>Interim Reporting (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.conmed.com/role/NewAccountingPronouncements</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2247202 - Disclosure - New Accounting Pronouncements (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/NewAccountingPronouncementsPolicies</Role>
      <ShortName>New Accounting Pronouncements (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.conmed.com/role/NewAccountingPronouncements</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Revenues (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/RevenuesTables</Role>
      <ShortName>Revenues (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.conmed.com/role/Revenues</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2309302 - Disclosure - Comprehensive Income (Loss) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/ComprehensiveIncomeLossTables</Role>
      <ShortName>Comprehensive Income (Loss) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.conmed.com/role/ComprehensiveIncomeLoss</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2313303 - Disclosure - Fair Value of Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/FairValueofFinancialInstrumentsTables</Role>
      <ShortName>Fair Value of Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.conmed.com/role/FairValueofFinancialInstruments</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2317304 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.conmed.com/role/Inventories</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2320305 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.conmed.com/role/EarningsPerShare</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2324306 - Disclosure - Goodwill and Other Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Other Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.conmed.com/role/GoodwillandOtherIntangibleAssets</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2328307 - Disclosure - Long Term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/LongTermDebtTables</Role>
      <ShortName>Long Term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.conmed.com/role/LongTermDebt</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2333308 - Disclosure - Guarantees (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/GuaranteesTables</Role>
      <ShortName>Guarantees (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.conmed.com/role/Guarantees</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2336309 - Disclosure - Pension Plan (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/PensionPlanTables</Role>
      <ShortName>Pension Plan (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.conmed.com/role/PensionPlan</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2339310 - Disclosure - Acquisition and Other Expense (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/AcquisitionandOtherExpenseTables</Role>
      <ShortName>Acquisition and Other Expense (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.conmed.com/role/AcquisitionandOtherExpense</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2342311 - Disclosure - Business Segment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/BusinessSegmentTables</Role>
      <ShortName>Business Segment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.conmed.com/role/BusinessSegment</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2406401 - Disclosure - Revenues (Disaggregated Revenues) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails</Role>
      <ShortName>Revenues (Disaggregated Revenues) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.conmed.com/role/RevenuesTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2407402 - Disclosure - Revenues (Customer Liability) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/RevenuesCustomerLiabilityDetails</Role>
      <ShortName>Revenues (Customer Liability) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.conmed.com/role/RevenuesTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2410403 - Disclosure - Comprehensive Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/ComprehensiveIncomeLossDetails</Role>
      <ShortName>Comprehensive Income (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.conmed.com/role/ComprehensiveIncomeLossTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2411404 - Disclosure - Comprehensive Income (Loss) (Accumulated Other Comprehensive Income (Loss)) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/ComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Comprehensive Income (Loss) (Accumulated Other Comprehensive Income (Loss)) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.conmed.com/role/ComprehensiveIncomeLossTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2414405 - Disclosure - Fair Value of Financial Instruments (Amounts Recorded In and Reclassified From AOCI) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails</Role>
      <ShortName>Fair Value of Financial Instruments (Amounts Recorded In and Reclassified From AOCI) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.conmed.com/role/FairValueofFinancialInstrumentsTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2415406 - Disclosure - Fair Value of Financial Instruments (Foreign Currency Forward Contracts) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails</Role>
      <ShortName>Fair Value of Financial Instruments (Foreign Currency Forward Contracts) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.conmed.com/role/FairValueofFinancialInstrumentsTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2418407 - Disclosure - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/InventoriesDetails</Role>
      <ShortName>Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.conmed.com/role/InventoriesTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2421408 - Disclosure - Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/EarningsPerShareDetails</Role>
      <ShortName>Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.conmed.com/role/EarningsPerShareTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2422409 - Disclosure - Earnings Per Share - Convertible Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.conmed.com/role/EarningsPerShareConvertibleNotesDetails</Role>
      <ShortName>Earnings Per Share - Convertible Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2425410 - Disclosure - Goodwill and Other Intangible Assets (Goodwill) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Goodwill) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2426411 - Disclosure - Goodwill and Other Intangible Assets (Intangible Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Intangible Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2429412 - Disclosure - Long Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/LongTermDebtDetails</Role>
      <ShortName>Long Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.conmed.com/role/LongTermDebtTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2430413 - Disclosure - Long Term Debt Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails</Role>
      <ShortName>Long Term Debt Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2431414 - Disclosure - Long Term Debt Maturities of Long Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/LongTermDebtMaturitiesofLongTermDebtDetails</Role>
      <ShortName>Long Term Debt Maturities of Long Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2434415 - Disclosure - Guarantees (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/GuaranteesDetails</Role>
      <ShortName>Guarantees (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.conmed.com/role/GuaranteesTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2437416 - Disclosure - Pension Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/PensionPlanDetails</Role>
      <ShortName>Pension Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.conmed.com/role/PensionPlanTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2440417 - Disclosure - Acquisition and Other Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/AcquisitionandOtherExpenseDetails</Role>
      <ShortName>Acquisition and Other Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.conmed.com/role/AcquisitionandOtherExpenseTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2443418 - Disclosure - Business Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/BusinessSegmentDetails</Role>
      <ShortName>Business Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.conmed.com/role/BusinessSegmentTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="cnmd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2445419 - Disclosure - Legal Proceedings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/LegalProceedingsDetails</Role>
      <ShortName>Legal Proceedings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.conmed.com/role/LegalProceedings</ParentRole>
      <Position>54</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="cnmd-20210331.htm">cnmd-20210331.htm</File>
    <File>cnmd-20210331.xsd</File>
    <File>cnmd-20210331_cal.xml</File>
    <File>cnmd-20210331_def.xml</File>
    <File>cnmd-20210331_lab.xml</File>
    <File>cnmd-20210331_pre.xml</File>
    <File>cnmd33121ex311.htm</File>
    <File>cnmd33121ex312.htm</File>
    <File>cnmd33121ex321.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>70
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cnmd-20210331.htm": {
   "axisCustom": 3,
   "axisStandard": 17,
   "contextCount": 155,
   "dts": {
    "calculationLink": {
     "local": [
      "cnmd-20210331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cnmd-20210331_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "cnmd-20210331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cnmd-20210331_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cnmd-20210331_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "cnmd-20210331.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 401,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 5,
    "total": 5
   },
   "keyCustom": 15,
   "keyStandard": 296,
   "memberCustom": 16,
   "memberStandard": 34,
   "nsprefix": "cnmd",
   "nsuri": "http://www.conmed.com/20210331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Document and Entity Information",
     "role": "http://www.conmed.com/role/DocumentandEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2104103 - Disclosure - Revenues",
     "role": "http://www.conmed.com/role/Revenues",
     "shortName": "Revenues",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108104 - Disclosure - Comprehensive Income (Loss)",
     "role": "http://www.conmed.com/role/ComprehensiveIncomeLoss",
     "shortName": "Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativesAndFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2112105 - Disclosure - Fair Value of Financial Instruments",
     "role": "http://www.conmed.com/role/FairValueofFinancialInstruments",
     "shortName": "Fair Value of Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativesAndFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2116106 - Disclosure - Inventories",
     "role": "http://www.conmed.com/role/Inventories",
     "shortName": "Inventories",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2119107 - Disclosure - Earnings Per Share",
     "role": "http://www.conmed.com/role/EarningsPerShare",
     "shortName": "Earnings Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2123108 - Disclosure - Goodwill and Other Intangible Assets",
     "role": "http://www.conmed.com/role/GoodwillandOtherIntangibleAssets",
     "shortName": "Goodwill and Other Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2127109 - Disclosure - Long Term Debt",
     "role": "http://www.conmed.com/role/LongTermDebt",
     "shortName": "Long Term Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2132110 - Disclosure - Guarantees",
     "role": "http://www.conmed.com/role/Guarantees",
     "shortName": "Guarantees",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135111 - Disclosure - Pension Plan",
     "role": "http://www.conmed.com/role/PensionPlan",
     "shortName": "Pension Plan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cnmd:AcquisitionandOtherExpenseTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2138112 - Disclosure - Acquisition and Other Expense",
     "role": "http://www.conmed.com/role/AcquisitionandOtherExpense",
     "shortName": "Acquisition and Other Expense",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cnmd:AcquisitionandOtherExpenseTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Consolidated Condensed Statements of Comprehensive Income (Loss) (Unaudited)",
     "role": "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited",
     "shortName": "Consolidated Condensed Statements of Comprehensive Income (Loss) (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2141113 - Disclosure - Business Segment",
     "role": "http://www.conmed.com/role/BusinessSegment",
     "shortName": "Business Segment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2144114 - Disclosure - Legal Proceedings",
     "role": "http://www.conmed.com/role/LegalProceedings",
     "shortName": "Legal Proceedings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2146115 - Disclosure - New Accounting Pronouncements",
     "role": "http://www.conmed.com/role/NewAccountingPronouncements",
     "shortName": "New Accounting Pronouncements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UseOfEstimates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2203201 - Disclosure - Interim Reporting (Policies)",
     "role": "http://www.conmed.com/role/InterimReportingPolicies",
     "shortName": "Interim Reporting (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UseOfEstimates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2247202 - Disclosure - New Accounting Pronouncements (Policies)",
     "role": "http://www.conmed.com/role/NewAccountingPronouncementsPolicies",
     "shortName": "New Accounting Pronouncements (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Revenues (Tables)",
     "role": "http://www.conmed.com/role/RevenuesTables",
     "shortName": "Revenues (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2309302 - Disclosure - Comprehensive Income (Loss) (Tables)",
     "role": "http://www.conmed.com/role/ComprehensiveIncomeLossTables",
     "shortName": "Comprehensive Income (Loss) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2313303 - Disclosure - Fair Value of Financial Instruments (Tables)",
     "role": "http://www.conmed.com/role/FairValueofFinancialInstrumentsTables",
     "shortName": "Fair Value of Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2317304 - Disclosure - Inventories (Tables)",
     "role": "http://www.conmed.com/role/InventoriesTables",
     "shortName": "Inventories (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2320305 - Disclosure - Earnings Per Share (Tables)",
     "role": "http://www.conmed.com/role/EarningsPerShareTables",
     "shortName": "Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Consolidated Condensed Balance Sheets (Unaudited)",
     "role": "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited",
     "shortName": "Consolidated Condensed Balance Sheets (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2324306 - Disclosure - Goodwill and Other Intangible Assets (Tables)",
     "role": "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsTables",
     "shortName": "Goodwill and Other Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2328307 - Disclosure - Long Term Debt (Tables)",
     "role": "http://www.conmed.com/role/LongTermDebtTables",
     "shortName": "Long Term Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2333308 - Disclosure - Guarantees (Tables)",
     "role": "http://www.conmed.com/role/GuaranteesTables",
     "shortName": "Guarantees (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2336309 - Disclosure - Pension Plan (Tables)",
     "role": "http://www.conmed.com/role/PensionPlanTables",
     "shortName": "Pension Plan (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cnmd:ScheduleOfAcquisitionAndOtherOperatingExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2339310 - Disclosure - Acquisition and Other Expense (Tables)",
     "role": "http://www.conmed.com/role/AcquisitionandOtherExpenseTables",
     "shortName": "Acquisition and Other Expense (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cnmd:ScheduleOfAcquisitionAndOtherOperatingExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2342311 - Disclosure - Business Segment (Tables)",
     "role": "http://www.conmed.com/role/BusinessSegmentTables",
     "shortName": "Business Segment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406401 - Disclosure - Revenues (Disaggregated Revenues) (Details)",
     "role": "http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails",
     "shortName": "Revenues (Disaggregated Revenues) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407402 - Disclosure - Revenues (Customer Liability) (Details)",
     "role": "http://www.conmed.com/role/RevenuesCustomerLiabilityDetails",
     "shortName": "Revenues (Customer Liability) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410403 - Disclosure - Comprehensive Income (Loss) (Details)",
     "role": "http://www.conmed.com/role/ComprehensiveIncomeLossDetails",
     "shortName": "Comprehensive Income (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i46ba6599130f4eb1a4d6fe042999e135_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411404 - Disclosure - Comprehensive Income (Loss) (Accumulated Other Comprehensive Income (Loss)) (Details)",
     "role": "http://www.conmed.com/role/ComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails",
     "shortName": "Comprehensive Income (Loss) (Accumulated Other Comprehensive Income (Loss)) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i151d90f96de242678881f597e8015d38_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Consolidated Condensed Balance Sheets (Unaudited) (Parenthetical)",
     "role": "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical",
     "shortName": "Consolidated Condensed Balance Sheets (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414405 - Disclosure - Fair Value of Financial Instruments (Amounts Recorded In and Reclassified From AOCI) (Details)",
     "role": "http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails",
     "shortName": "Fair Value of Financial Instruments (Amounts Recorded In and Reclassified From AOCI) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415406 - Disclosure - Fair Value of Financial Instruments (Foreign Currency Forward Contracts) (Details)",
     "role": "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails",
     "shortName": "Fair Value of Financial Instruments (Foreign Currency Forward Contracts) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418407 - Disclosure - Inventories (Details)",
     "role": "http://www.conmed.com/role/InventoriesDetails",
     "shortName": "Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421408 - Disclosure - Earnings Per Share (Details)",
     "role": "http://www.conmed.com/role/EarningsPerShareDetails",
     "shortName": "Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "id748c1bbe2b3409b9e97ffd239dcc0f0_I20190129",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422409 - Disclosure - Earnings Per Share - Convertible Notes (Details)",
     "role": "http://www.conmed.com/role/EarningsPerShareConvertibleNotesDetails",
     "shortName": "Earnings Per Share - Convertible Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "idf721ab99d84490dbfa3d3cec7d8e799_D20190129-20190129",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:OptionIndexedToIssuersEquityStrikePrice1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i46ba6599130f4eb1a4d6fe042999e135_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425410 - Disclosure - Goodwill and Other Intangible Assets (Goodwill) (Details)",
     "role": "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails",
     "shortName": "Goodwill and Other Intangible Assets (Goodwill) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426411 - Disclosure - Goodwill and Other Intangible Assets (Intangible Assets) (Details)",
     "role": "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails",
     "shortName": "Goodwill and Other Intangible Assets (Intangible Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429412 - Disclosure - Long Term Debt (Details)",
     "role": "http://www.conmed.com/role/LongTermDebtDetails",
     "shortName": "Long Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfDebtDiscountPremium",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430413 - Disclosure - Long Term Debt Additional Information (Details)",
     "role": "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails",
     "shortName": "Long Term Debt Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i3d8fccab0a15481582a37233de37abbf_I20210331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431414 - Disclosure - Long Term Debt Maturities of Long Term Debt (Details)",
     "role": "http://www.conmed.com/role/LongTermDebtMaturitiesofLongTermDebtDetails",
     "shortName": "Long Term Debt Maturities of Long Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i5e2c39713f4b45bf83812220f02bcfce_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Consolidated Condensed Statements of Shareholders' Equity (Unaudited)",
     "role": "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited",
     "shortName": "Consolidated Condensed Statements of Shareholders' Equity (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i5e2c39713f4b45bf83812220f02bcfce_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cnmd:ProductWarrantyAccrualTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434415 - Disclosure - Guarantees (Details)",
     "role": "http://www.conmed.com/role/GuaranteesDetails",
     "shortName": "Guarantees (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cnmd:ProductWarrantyAccrualTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437416 - Disclosure - Pension Plan (Details)",
     "role": "http://www.conmed.com/role/PensionPlanDetails",
     "shortName": "Pension Plan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cnmd:ScheduleOfAcquisitionAndOtherOperatingExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "ic4cfe412f15e40679fed8fb1ab50ff59_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "cnmd:Manufacturingconsolidationcosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440417 - Disclosure - Acquisition and Other Expense (Details)",
     "role": "http://www.conmed.com/role/AcquisitionandOtherExpenseDetails",
     "shortName": "Acquisition and Other Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cnmd:ScheduleOfAcquisitionAndOtherOperatingExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "ic4cfe412f15e40679fed8fb1ab50ff59_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "cnmd:Manufacturingconsolidationcosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443418 - Disclosure - Business Segment (Details)",
     "role": "http://www.conmed.com/role/BusinessSegmentDetails",
     "shortName": "Business Segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "ia86b4262c6984bb6ad658ce074db008e_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cnmd:ProductLiabilityContingencyInsuranceAmountPerIncident",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445419 - Disclosure - Legal Proceedings (Details)",
     "role": "http://www.conmed.com/role/LegalProceedingsDetails",
     "shortName": "Legal Proceedings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "ice2c9150f3de4cb78aa6edbfabbcdeef_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cnmd:ProductLiabilityContingencyInsuranceAmountPerIncident",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Consolidated Condensed Statements of Shareholders' Equity (Unaudited) (Parenthetical)",
     "role": "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnauditedParenthetical",
     "shortName": "Consolidated Condensed Statements of Shareholders' Equity (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Consolidated Condensed Statements of Cash Flows (Unaudited)",
     "role": "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited",
     "shortName": "Consolidated Condensed Statements of Cash Flows (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Operations",
     "role": "http://www.conmed.com/role/Operations",
     "shortName": "Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2102102 - Disclosure - Interim Financial Information",
     "role": "http://www.conmed.com/role/InterimFinancialInformation",
     "shortName": "Interim Financial Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20210331.htm",
      "contextRef": "i77412df227934ab69ada8b55bfa24e54_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 50,
   "tag": {
    "cnmd_A2.625PercentConvertibleNotesDue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.625 Percent Convertible Notes Due 2024 [Member]",
        "label": "2.625 Percent Convertible Notes Due 2024 [Member]",
        "terseLabel": "2.625 Percent Convertible Notes Due 2024 [Member]"
       }
      }
     },
     "localname": "A2.625PercentConvertibleNotesDue2024Member",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/EarningsPerShareConvertibleNotesDetails",
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnmd_AcquisitionandOtherExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition and Other Expense [Abstract]",
        "label": "Acquisition and Other Expense [Abstract]",
        "terseLabel": "Acquisition and Other Expense [Abstract]"
       }
      }
     },
     "localname": "AcquisitionandOtherExpenseAbstract",
     "nsuri": "http://www.conmed.com/20210331",
     "xbrltype": "stringItemType"
    },
    "cnmd_AcquisitionandOtherExpenseLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition and Other Expense [Line Items]",
        "label": "Acquisition and Other Expense [Line Items]",
        "terseLabel": "Acquisition and Other Expense [Line Items]"
       }
      }
     },
     "localname": "AcquisitionandOtherExpenseLineItems",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/AcquisitionandOtherExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cnmd_AcquisitionandOtherExpenseTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition and Other Expense",
        "label": "Acquisition and Other Expense [Text Block]",
        "terseLabel": "Acquisition and Other Expense"
       }
      }
     },
     "localname": "AcquisitionandOtherExpenseTextBlock",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/AcquisitionandOtherExpense"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cnmd_AdditionalDamagesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional Damages",
        "label": "Additional Damages [Member]",
        "terseLabel": "Additional Damages"
       }
      }
     },
     "localname": "AdditionalDamagesMember",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnmd_AmendedAndRestatedSeniorCreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amended and Restated Senior Credit Agreement [Member]",
        "label": "Amended and Restated Senior Credit Agreement [Member]",
        "terseLabel": "Amended and Restated Senior Credit Agreement [Member]"
       }
      }
     },
     "localname": "AmendedAndRestatedSeniorCreditAgreementMember",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnmd_AmericasexcludingtheUnitedStatesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Americas (excluding the United States) [Member]",
        "label": "Americas (excluding the United States) [Member]",
        "terseLabel": "Americas (excluding the United States)"
       }
      }
     },
     "localname": "AmericasexcludingtheUnitedStatesMember",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnmd_AssetAcquisitionContingentConsiderationLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Contingent Consideration Liability",
        "label": "Asset Acquisition, Contingent Consideration Liability",
        "terseLabel": "Asset acquisition, contingent consideration liability"
       }
      }
     },
     "localname": "AssetAcquisitionContingentConsiderationLiability",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnmd_CreditAgreementExpirationTriggerRequirementConvertibleNoteOutstandingBalance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Agreement Expiration Trigger Requirement, Convertible Note Outstanding Balance",
        "label": "Credit Agreement Expiration Trigger Requirement, Convertible Note Outstanding Balance",
        "terseLabel": "Credit Agreement Expiration Trigger Requirement, Convertible Note Outstanding Balance"
       }
      }
     },
     "localname": "CreditAgreementExpirationTriggerRequirementConvertibleNoteOutstandingBalance",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnmd_CustomerandDistributorRelationshipsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer and Distributor Relationships [Member]",
        "label": "Customer and Distributor Relationships [Member]",
        "verboseLabel": "Customer and distributor relationships"
       }
      }
     },
     "localname": "CustomerandDistributorRelationshipsMember",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnmd_DebtInstrumentConvertibleGrossAmountofEquityComponent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Gross Amount of Equity Component",
        "label": "Debt Instrument, Convertible, Gross Amount of Equity Component",
        "terseLabel": "Debt Instrument, Convertible, Gross Amount of Equity Component"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleGrossAmountofEquityComponent",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnmd_DefinedBenefitPlanNonServiceCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Non-Service Cost",
        "label": "Defined Benefit Plan, Non-Service Cost",
        "terseLabel": "Defined Benefit Plan, Non-service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNonServiceCost",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/PensionPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnmd_EndoDynamixInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EndoDynamix, Inc. [Member]",
        "label": "EndoDynamix, Inc. [Member]",
        "terseLabel": "EndoDynamix, Inc."
       }
      }
     },
     "localname": "EndoDynamixInc.Member",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnmd_ExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expense [Member]",
        "label": "Expense [Member]",
        "terseLabel": "Amortization included in expense"
       }
      }
     },
     "localname": "ExpenseMember",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnmd_FairValueofFinancialInstrumentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value of Financial Instruments [Abstract]",
        "label": "Fair Value of Financial Instruments [Abstract]",
        "terseLabel": "Fair Value of Financial Instruments [Abstract]"
       }
      }
     },
     "localname": "FairValueofFinancialInstrumentsAbstract",
     "nsuri": "http://www.conmed.com/20210331",
     "xbrltype": "stringItemType"
    },
    "cnmd_GeneralSurgeryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "General Surgery [Member]",
        "label": "General Surgery [Member]",
        "terseLabel": "General Surgery"
       }
      }
     },
     "localname": "GeneralSurgeryMember",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/BusinessSegmentDetails",
      "http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnmd_HedgeTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge transactions",
        "label": "Hedge transactions [Member]",
        "terseLabel": "Hedge transactions"
       }
      }
     },
     "localname": "HedgeTransactionsMember",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/EarningsPerShareConvertibleNotesDetails",
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnmd_Hedgeandwarranttransactionsnetcashpaid": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Up-front costs to purchase hedge instruments, net of cash received from sale of warrants",
        "label": "Hedge and warrant transactions, net cash paid",
        "terseLabel": "Hedge and warrant transactions, net cash paid"
       }
      }
     },
     "localname": "Hedgeandwarranttransactionsnetcashpaid",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnmd_IndexedTransactionTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indexed transaction type",
        "label": "Indexed transaction type [Axis]",
        "terseLabel": "Indexed transaction type [Axis]"
       }
      }
     },
     "localname": "IndexedTransactionTypeAxis",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/EarningsPerShareConvertibleNotesDetails",
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cnmd_IndexedTransactionTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indexed transaction type [Domain]",
        "label": "Indexed transaction type [Domain]",
        "terseLabel": "Indexed transaction type [Domain]"
       }
      }
     },
     "localname": "IndexedTransactionTypeDomain",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/EarningsPerShareConvertibleNotesDetails",
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnmd_LIBORInterestRateFloor": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "LIBOR Interest Rate Floor",
        "label": "LIBOR Interest Rate Floor",
        "terseLabel": "LIBOR Interest Rate Floor"
       }
      }
     },
     "localname": "LIBORInterestRateFloor",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cnmd_LiquidatedDamagesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liquidated Damages",
        "label": "Liquidated Damages [Member]",
        "terseLabel": "Liquidated Damages"
       }
      }
     },
     "localname": "LiquidatedDamagesMember",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnmd_LitigationDamagesAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Damages",
        "label": "Litigation Damages [Axis]",
        "terseLabel": "Litigation Damages [Axis]"
       }
      }
     },
     "localname": "LitigationDamagesAxis",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cnmd_LitigationDamagesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Damages",
        "label": "Litigation Damages [Domain]",
        "terseLabel": "Litigation Damages [Domain]"
       }
      }
     },
     "localname": "LitigationDamagesDomain",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnmd_Manufacturingconsolidationcosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Manufacturing consolidation costs",
        "label": "Manufacturing consolidation costs",
        "terseLabel": "Manufacturing consolidation costs"
       }
      }
     },
     "localname": "Manufacturingconsolidationcosts",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/AcquisitionandOtherExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnmd_OrthopedicSurgeryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Orthopedic Surgery [Member]",
        "label": "Orthopedic Surgery [Member]",
        "terseLabel": "Orthopedic Surgery"
       }
      }
     },
     "localname": "OrthopedicSurgeryMember",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/BusinessSegmentDetails",
      "http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnmd_OtherExpensesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Expenses [Table]",
        "label": "Other Expenses [Table]",
        "terseLabel": "Acquisition and Other Expenses [Table]"
       }
      }
     },
     "localname": "OtherExpensesTable",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/AcquisitionandOtherExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cnmd_PatentsAndOtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patents and Other Intangible Assets [Member]",
        "label": "Patents and Other Intangible Assets [Member]",
        "terseLabel": "Patents and other intangible assets"
       }
      }
     },
     "localname": "PatentsAndOtherIntangibleAssetsMember",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnmd_PaymentsForContingentConsideration": {
     "auth_ref": [],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for Contingent Consideration",
        "label": "Payments for Contingent Consideration",
        "negatedLabel": "Payments related to contingent consideration"
       }
      }
     },
     "localname": "PaymentsForContingentConsideration",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnmd_Paymentsrelatedtobusinessacquisitionsandassetacquisitions": {
     "auth_ref": [],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments related to business acquisitions and asset acquisitions",
        "label": "Payments related to business acquisitions and asset acquisitions",
        "negatedTerseLabel": "Payments related to business and asset acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "Paymentsrelatedtobusinessacquisitionsandassetacquisitions",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product Liability Contingency, Insurance, Aggregate Annual Amount",
        "label": "Product Liability Contingency, Insurance, Aggregate Annual Amount",
        "terseLabel": "Product liability insurance, aggregate annual amount"
       }
      }
     },
     "localname": "ProductLiabilityContingencyInsuranceAggregateAnnualAmount",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product Liability Contingency, Insurance, Amount per Incident",
        "label": "Product Liability Contingency, Insurance, Amount per Incident",
        "terseLabel": "Product liability insurance, amount per incident"
       }
      }
     },
     "localname": "ProductLiabilityContingencyInsuranceAmountPerIncident",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnmd_ProductWarrantyAccrualTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product Warranty Accrual Term",
        "label": "Product Warranty Accrual Term",
        "terseLabel": "Standard warranty period (in years)"
       }
      }
     },
     "localname": "ProductWarrantyAccrualTerm",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/GuaranteesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cnmd_ReductionofRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reduction of Revenue [Member]",
        "label": "Reduction of Revenue [Member]",
        "terseLabel": "Amortization recorded as a reduction of revenue"
       }
      }
     },
     "localname": "ReductionofRevenueMember",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnmd_RestructuringAndRelatedCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and related costs",
        "label": "Restructuring and related costs",
        "terseLabel": "Restucturing and related costs"
       }
      }
     },
     "localname": "RestructuringAndRelatedCosts",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/AcquisitionandOtherExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnmd_RevenuesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenues [Member]",
        "label": "Revenues [Member]",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenuesMember",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails",
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnmd_SalesrepresentationmarketingandpromotionalrightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales representation, marketing and promotional rights [Member]",
        "label": "Sales representation, marketing and promotional rights [Member]",
        "terseLabel": "Sales representation, marketing and promotional rights"
       }
      }
     },
     "localname": "SalesrepresentationmarketingandpromotionalrightsMember",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnmd_ScheduleOfAcquisitionAndOtherOperatingExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Acquisition and Other Operating Expense",
        "label": "Schedule of Acquisition and Other Operating Expense [Table Text Block]",
        "terseLabel": "Schedule of Acquisition and Other Operating Expense"
       }
      }
     },
     "localname": "ScheduleOfAcquisitionAndOtherOperatingExpenseTableTextBlock",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/AcquisitionandOtherExpenseTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Finite-Lived and Indefinite-Lived Assets [Line Items]",
        "label": "Schedule of Finite-Lived and Indefinite-Lived Assets [Line Items]",
        "terseLabel": "Schedule of Finite-Lived and Indefinite-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Finite-Lived and Indefinite-Lived Assets [Table]",
        "label": "Schedule of Finite-Lived and Indefinite-Lived Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived and Indefinite-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cnmd_VariableRateBasisAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Rate Basis [Axis]",
        "label": "Variable Rate Basis [Axis]",
        "terseLabel": "Variable Rate Basis [Axis]"
       }
      }
     },
     "localname": "VariableRateBasisAxis",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cnmd_VariableRateBasisDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Rate Basis [Domain]",
        "label": "Variable Rate Basis [Domain]",
        "terseLabel": "Variable Rate Basis [Domain]"
       }
      }
     },
     "localname": "VariableRateBasisDomain",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnmd_WarrantTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant transactions",
        "label": "Warrant transactions [Member]",
        "terseLabel": "Warrant transactions"
       }
      }
     },
     "localname": "WarrantTransactionsMember",
     "nsuri": "http://www.conmed.com/20210331",
     "presentation": [
      "http://www.conmed.com/role/EarningsPerShareConvertibleNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia Pacific [Member]",
        "terseLabel": "Asia Pacific"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r175",
      "r266",
      "r270",
      "r420",
      "r458",
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/BusinessSegmentDetails",
      "http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r175",
      "r266",
      "r270",
      "r420",
      "r458",
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/BusinessSegmentDetails",
      "http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r285",
      "r309",
      "r310",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r419",
      "r459",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r285",
      "r309",
      "r310",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r419",
      "r459",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r176",
      "r177",
      "r266",
      "r271",
      "r461",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r176",
      "r177",
      "r266",
      "r271",
      "r461",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_WeightedAverageMember": {
     "auth_ref": [
      "r412",
      "r414",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average [Member]",
        "terseLabel": "Weighted Average"
       }
      }
     },
     "localname": "WeightedAverageMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "Accumulated other comprehensive income (loss) [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r3",
      "r17",
      "r181",
      "r182"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r53",
      "r59",
      "r62",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Pension Liability"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember": {
     "auth_ref": [
      "r52",
      "r59",
      "r62",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, attributable to the parent.",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]",
        "terseLabel": "Cash Flow Hedging Gain (Loss)"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r20",
      "r56",
      "r58",
      "r59",
      "r448",
      "r470",
      "r474"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "periodEndLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "periodStartLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r55",
      "r59",
      "r62",
      "r103",
      "r104",
      "r105",
      "r351",
      "r465",
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r51",
      "r59",
      "r62",
      "r351",
      "r399",
      "r400",
      "r401",
      "r402",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Cumulative Translation Adjustments"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r18",
      "r324"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r320",
      "r321",
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited",
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnauditedParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r108",
      "r109",
      "r110",
      "r112",
      "r185",
      "r186",
      "r187",
      "r188",
      "r191",
      "r192",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r324",
      "r332",
      "r333",
      "r334",
      "r335",
      "r422",
      "r423",
      "r424",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r312",
      "r313",
      "r325",
      "r326"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "auth_ref": [
      "r80",
      "r92",
      "r406"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.",
        "label": "Amortization of Debt Discount (Premium)",
        "terseLabel": "Amortization of debt discount"
       }
      }
     },
     "localname": "AmortizationOfDebtDiscountPremium",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited",
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r75",
      "r92",
      "r408"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of deferred debt issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r92",
      "r201",
      "r208"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r96",
      "r159",
      "r164",
      "r171",
      "r184",
      "r348",
      "r352",
      "r392",
      "r430",
      "r445"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r4",
      "r5",
      "r46",
      "r96",
      "r184",
      "r348",
      "r352",
      "r392"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r364",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Base Rate [Member]"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r344"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Acquisition and integration costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/AcquisitionandOtherExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationIntegrationRelatedCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.",
        "label": "Business Combination, Integration Related Costs",
        "terseLabel": "Acquisition and integration costs"
       }
      }
     },
     "localname": "BusinessCombinationIntegrationRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/AcquisitionandOtherExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CallOptionMember": {
     "auth_ref": [
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial contract between two parties, the buyer and the seller of the option, where the buyer has the right but not the obligation to buy an agreed quantity of a particular commodity or financial instrument (the underlying instrument) from the seller of the option for a certain price (the strike price). Seller is obligated to sell the asset to the buyer, if the buyer exercises the option.",
        "label": "Call Option [Member]",
        "terseLabel": "Call Option [Member]"
       }
      }
     },
     "localname": "CallOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r89",
      "r94",
      "r95"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited",
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r89",
      "r397"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash flow hedge"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Non-cash investing and financing activities:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r42",
      "r217",
      "r435",
      "r452"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends per share of common stock (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r103",
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r16",
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Balance at period end (shares)",
        "periodStartLabel": "Balance at period start (shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r16"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, par value $0.01 per share; 100,000,000 shares authorized; 31,299,194 shares issued in 2021 and 2020, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r65",
      "r67",
      "r73",
      "r347",
      "r354",
      "r438",
      "r455"
     ],
     "calculation": {
      "http://www.conmed.com/role/ComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Comprehensive income (loss)",
        "totalLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeLossDetails",
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited",
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r72",
      "r82",
      "r437",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeLoss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Contract with Customer, Asset and Liability"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/RevenuesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r255",
      "r256",
      "r267"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Contract liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/RevenuesCustomerLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r268"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Revenue recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/RevenuesCustomerLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebt": {
     "auth_ref": [
      "r13",
      "r433",
      "r447"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.",
        "label": "Convertible Debt",
        "terseLabel": "Convertible Debt"
       }
      }
     },
     "localname": "ConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleNotesPayableMember": {
     "auth_ref": [
      "r11",
      "r431",
      "r444",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder.",
        "label": "Convertible Notes Payable [Member]",
        "terseLabel": "Convertible Notes Payable [Member]",
        "verboseLabel": "Convertible Notes Payable"
       }
      }
     },
     "localname": "ConvertibleNotesPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/EarningsPerShareConvertibleNotesDetails",
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r77",
      "r420"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited",
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of Sales"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/AcquisitionandOtherExpenseDetails",
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails",
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r11",
      "r12",
      "r13",
      "r431",
      "r433",
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/EarningsPerShareConvertibleNotesDetails",
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Debt Instrument, Basis Spread on Variable Rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r13",
      "r238",
      "r433",
      "r444"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Long-term Debt, Gross"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent": {
     "auth_ref": [
      "r237"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.",
        "label": "Debt Instrument, Convertible, Carrying Amount of Equity Component",
        "terseLabel": "Debt Instrument, Convertible, Carrying Amount of Equity Component"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Conversion price (in dollars per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/EarningsPerShareConvertibleNotesDetails",
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r39",
      "r247",
      "r248",
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Debt Instrument, Convertible, Conversion Ratio"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r407",
      "r409"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt Instrument, Face Amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r38",
      "r241",
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Debt Instrument, Interest Rate, Effective Percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate, stated percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/EarningsPerShareConvertibleNotesDetails",
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/EarningsPerShareConvertibleNotesDetails",
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/EarningsPerShareConvertibleNotesDetails",
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r40",
      "r98",
      "r247",
      "r249",
      "r250",
      "r251",
      "r406",
      "r407",
      "r409",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/EarningsPerShareConvertibleNotesDetails",
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r406",
      "r409"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "terseLabel": "Debt Instrument, Unamortized Discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r92",
      "r97",
      "r331",
      "r340",
      "r341",
      "r342"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r328",
      "r329"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r282",
      "r292",
      "r303",
      "r304",
      "r305"
     ],
     "calculation": {
      "http://www.conmed.com/role/PensionPlanDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedTerseLabel": "Net amortization and deferral"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/PensionPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r282",
      "r291",
      "r302",
      "r304",
      "r305"
     ],
     "calculation": {
      "http://www.conmed.com/role/PensionPlanDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedTerseLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/PensionPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r282",
      "r284",
      "r290",
      "r301",
      "r304",
      "r305"
     ],
     "calculation": {
      "http://www.conmed.com/role/PensionPlanDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost on projected benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/PensionPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r288",
      "r299",
      "r304",
      "r305"
     ],
     "calculation": {
      "http://www.conmed.com/role/PensionPlanDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net periodic pension cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/PensionPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r283",
      "r289",
      "r300",
      "r304",
      "r305"
     ],
     "calculation": {
      "http://www.conmed.com/role/PensionPlanDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/PensionPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r92",
      "r214"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet": {
     "auth_ref": [
      "r356"
     ],
     "calculation": {
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments.",
        "label": "Derivative Assets (Liabilities), at Fair Value, Net",
        "totalLabel": "Net Fair Value"
       }
      }
     },
     "localname": "DerivativeAssetsLiabilitiesAtFairValueNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Assets (Liabilities), at Fair Value, Net, by Balance Sheet Classification [Abstract]",
        "terseLabel": "Derivative Assets and Liabilities at Fair Value [Abstract]"
       }
      }
     },
     "localname": "DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract Type [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r47",
      "r48",
      "r367",
      "r418"
     ],
     "calculation": {
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Asset Fair Value"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r47",
      "r48",
      "r367",
      "r418"
     ],
     "calculation": {
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "negatedTerseLabel": "Liabilities Fair Value"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r365",
      "r368",
      "r374",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument Risk [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r362",
      "r365",
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r362",
      "r365",
      "r374",
      "r376",
      "r377",
      "r380",
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r358",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional amount of cash flow hedges"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r357",
      "r359",
      "r360",
      "r362",
      "r363",
      "r370",
      "r374",
      "r378",
      "r379",
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesAndFairValueTextBlock": {
     "auth_ref": [
      "r390",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivatives and fair value of assets and liabilities.",
        "label": "Derivatives and Fair Value [Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "DerivativesAndFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives designated as hedged instruments:"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r266",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/RevenuesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r252"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedTerseLabel": "Dividends on common stock ($0.20 per share)"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r12",
      "r14",
      "r432",
      "r446"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.",
        "label": "Dividends Payable",
        "terseLabel": "Dividends payable"
       }
      }
     },
     "localname": "DividendsPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EMEAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regions of Europe, Middle East and Africa.",
        "label": "EMEA [Member]",
        "terseLabel": "Europe, Middle East &amp; Africa"
       }
      }
     },
     "localname": "EMEAMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Per share data:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r74",
      "r113",
      "r114",
      "r115",
      "r116",
      "r117",
      "r124",
      "r126",
      "r133",
      "r134",
      "r135",
      "r139",
      "r140",
      "r439",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited",
      "http://www.conmed.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r74",
      "r113",
      "r114",
      "r115",
      "r116",
      "r117",
      "r126",
      "r133",
      "r134",
      "r135",
      "r139",
      "r140",
      "r439",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited",
      "http://www.conmed.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r136",
      "r137",
      "r138",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": {
     "auth_ref": [
      "r397"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.",
        "label": "Effect of Exchange Rate on Cash and Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation and benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r109",
      "r118",
      "r120",
      "r142",
      "r188",
      "r246",
      "r252",
      "r320",
      "r321",
      "r322",
      "r334",
      "r335",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r404",
      "r465",
      "r466",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited",
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnauditedParenthetical",
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EurodollarMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate based on U.S. dollar denominated deposits at foreign banks or foreign branches of U.S. banks.",
        "label": "Eurodollar [Member]",
        "terseLabel": "Eurodollar [Member]"
       }
      }
     },
     "localname": "EurodollarMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtendedProductWarrantyDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extended Product Warranty Disclosure [Abstract]",
        "terseLabel": "Extended Product Warranty Disclosure [Abstract]"
       }
      }
     },
     "localname": "ExtendedProductWarrantyDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GuaranteesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r410",
      "r411"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Finance Lease, Liability"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Finite-lived intangible asset useful life (in years)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r207"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Intangible assets, Accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r209"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Remaining, 2021"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r209"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r209"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r209"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r209"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r202",
      "r204",
      "r207",
      "r211",
      "r421",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Future amortization expense [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r207",
      "r428"
     ],
     "calculation": {
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Amortized intangible assets, Gross carrying amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r202",
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months": {
     "auth_ref": [
      "r383"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months",
        "terseLabel": "Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months"
       }
      }
     },
     "localname": "ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r393",
      "r394",
      "r395",
      "r396"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), before Tax",
        "terseLabel": "Foreign Currency Transaction Gain (Loss), before Tax"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Foreign Currency Forward Contracts"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments": {
     "auth_ref": [
      "r365",
      "r373"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in earnings in the period from the increase (decrease) in fair value of foreign currency derivatives not designated as hedging instruments.",
        "label": "Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments",
        "verboseLabel": "Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments"
       }
      }
     },
     "localname": "GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r195",
      "r196",
      "r429"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited",
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r197"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r76",
      "r96",
      "r159",
      "r163",
      "r167",
      "r170",
      "r173",
      "r184",
      "r392"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Guarantees [Abstract]",
        "terseLabel": "Guarantees [Abstract]"
       }
      }
     },
     "localname": "GuaranteesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r362",
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r100",
      "r159",
      "r163",
      "r167",
      "r170",
      "r173"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/AcquisitionandOtherExpenseDetails",
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails",
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails",
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/AcquisitionandOtherExpenseDetails",
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails",
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails",
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r97",
      "r119",
      "r120",
      "r158",
      "r330",
      "r339",
      "r343",
      "r457"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Benefit from income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "terseLabel": "Accrued compensation and benefits"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Increase (decrease) in cash flows from changes in assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedTerseLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants": {
     "auth_ref": [
      "r127",
      "r128",
      "r129",
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants",
        "terseLabel": "Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToCallOptionsAndWarrants",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": {
     "auth_ref": [
      "r130",
      "r131",
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities",
        "terseLabel": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r203",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r210"
     ],
     "calculation": {
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Unamortized intangible assets, Gross carrying amount"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r203",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "totalLabel": "Intangible assets, Gross carrying amount"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r200",
      "r205"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Other intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r69",
      "r157",
      "r405",
      "r408",
      "r440"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r80",
      "r242"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest Expense, Debt"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r24",
      "r193"
     ],
     "calculation": {
      "http://www.conmed.com/role/InventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r2",
      "r45"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.conmed.com/role/InventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Total inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited",
      "http://www.conmed.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r26",
      "r193"
     ],
     "calculation": {
      "http://www.conmed.com/role/InventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r25",
      "r193"
     ],
     "calculation": {
      "http://www.conmed.com/role/InventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LegalMattersAndContingenciesTextBlock": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.",
        "label": "Legal Matters and Contingencies [Text Block]",
        "terseLabel": "Legal Proceedings"
       }
      }
     },
     "localname": "LegalMattersAndContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LegalProceedings"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of Credit Outstanding, Amount"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r35",
      "r96",
      "r165",
      "r184",
      "r349",
      "r352",
      "r353",
      "r392"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r23",
      "r96",
      "r184",
      "r392",
      "r434",
      "r450"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND SHAREHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r37",
      "r96",
      "r184",
      "r349",
      "r352",
      "r353",
      "r392"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "terseLabel": "Line of Credit Facility, Commitment Fee Percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r34"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r34"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Remaining Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit [Member]"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LoansPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing supported by a written promise to pay an obligation.",
        "label": "Loans Payable [Member]",
        "terseLabel": "Term Loan Facility [Member]"
       }
      }
     },
     "localname": "LoansPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "London Interbank Offered Rate (LIBOR) [Member]"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r13",
      "r239",
      "r433",
      "r447"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r13"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.conmed.com/role/LongTermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term Debt and Lease Obligation",
        "terseLabel": "Long-term debt",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited",
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.conmed.com/role/LongTermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-term Debt and Lease Obligation, Current",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited",
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities": {
     "auth_ref": [],
     "calculation": {
      "http://www.conmed.com/role/LongTermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, including portion classified as current.",
        "label": "Long-term Debt and Lease Obligation, Including Current Maturities",
        "totalLabel": "Long-term Debt and Lease Obligation, Including Current Maturities"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r102",
      "r235"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r102",
      "r235"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r102",
      "r235"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r102",
      "r235"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "auth_ref": [
      "r102"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.",
        "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year",
        "terseLabel": "Remaining, 2021"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.",
        "label": "Long-term Debt [Member]",
        "terseLabel": "Long-term Debt [Member]"
       }
      }
     },
     "localname": "LongTermDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-term Debt [Text Block]",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/EarningsPerShareConvertibleNotesDetails",
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r40",
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/EarningsPerShareConvertibleNotesDetails",
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r217",
      "r218",
      "r219",
      "r221",
      "r222",
      "r223",
      "r225",
      "r227",
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyDamagesSoughtValue": {
     "auth_ref": [
      "r217",
      "r220",
      "r224"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter.",
        "label": "Loss Contingency, Damages Sought, Value",
        "terseLabel": "Loss Contingency, Damages Sought, Value"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MaturitiesOfLongTermDebtAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturities of Long-term Debt [Abstract]",
        "terseLabel": "Maturities of Long-term Debt [Abstract]"
       }
      }
     },
     "localname": "MaturitiesOfLongTermDebtAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum length of time over which the entity is hedging its exposure to the variability in future cash flows for forecasted transactions, excluding those forecasted transactions related to the payment of variable interest on existing financial instruments, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Maximum Length of Time Hedged in Cash Flow Hedge",
        "terseLabel": "Maximum Length of Time Hedged in Cash Flow Hedge"
       }
      }
     },
     "localname": "MaximumLengthOfTimeHedgedInCashFlowHedge1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_MovementInStandardProductWarrantyAccrualRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Movement in Standard Product Warranty Accrual [Roll Forward]",
        "terseLabel": "Movement in Standard Product Warranty Accrual [Roll Forward]"
       }
      }
     },
     "localname": "MovementInStandardProductWarrantyAccrualRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GuaranteesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r143",
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "Operations"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/Operations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r89",
      "r90",
      "r93"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r0",
      "r63",
      "r66",
      "r71",
      "r93",
      "r96",
      "r108",
      "r113",
      "r114",
      "r115",
      "r116",
      "r119",
      "r120",
      "r132",
      "r159",
      "r163",
      "r167",
      "r170",
      "r173",
      "r184",
      "r392",
      "r436",
      "r453"
     ],
     "calculation": {
      "http://www.conmed.com/role/ComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeLossDetails",
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited",
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited",
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited",
      "http://www.conmed.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]",
        "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r106",
      "r107",
      "r110",
      "r111",
      "r121",
      "r122",
      "r123",
      "r189",
      "r190",
      "r277",
      "r278",
      "r279",
      "r280",
      "r323",
      "r336",
      "r337",
      "r338",
      "r425",
      "r426",
      "r427",
      "r469",
      "r470",
      "r471",
      "r472",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "terseLabel": "New Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/NewAccountingPronouncements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/NewAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives not designated as hedging instruments:"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r159",
      "r163",
      "r167",
      "r170",
      "r173"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OptionIndexedToIssuersEquityStrikePrice1": {
     "auth_ref": [
      "r244",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise or strike price stated in the contract for options indexed to the issuer's equity shares.",
        "label": "Option Indexed to Issuer's Equity, Strike Price",
        "terseLabel": "Option indexed to issuer's equity, strike price (in dollars per share)"
       }
      }
     },
     "localname": "OptionIndexedToIssuersEquityStrikePrice1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/EarningsPerShareConvertibleNotesDetails",
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_OptionIndexedToIssuersEquityTypeAxis": {
     "auth_ref": [
      "r245",
      "r385",
      "r386",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of freestanding contracts issued by an entity that are indexed to, and potentially settled in, an entity's own stock.",
        "label": "Option Indexed to Issuer's Equity, Type [Axis]",
        "terseLabel": "Option Indexed to Issuer's Equity, Type [Axis]"
       }
      }
     },
     "localname": "OptionIndexedToIssuersEquityTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OptionIndexedToIssuersEquityTypeDomain": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the type of freestanding contract issued by a Company that is indexed to, and potentially settled in, a Company's own stock. Specifically, the pertinent rights and privileges of the securities outstanding.",
        "label": "Option Indexed to Issuer's Equity, Type [Domain]",
        "terseLabel": "Option Indexed to Issuer's Equity, Type [Domain]"
       }
      }
     },
     "localname": "OptionIndexedToIssuersEquityTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r1",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Interim Financial Information"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/InterimFinancialInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAmortizationOfDeferredCharges": {
     "auth_ref": [
      "r78",
      "r92"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization of other deferred costs recognized in the income statement.",
        "label": "Amortization of Other Deferred Charges",
        "terseLabel": "Amortization"
       }
      }
     },
     "localname": "OtherAmortizationOfDeferredCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r59",
      "r68",
      "r398",
      "r400",
      "r404"
     ],
     "calculation": {
      "http://www.conmed.com/role/ComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r52",
      "r56"
     ],
     "calculation": {
      "http://www.conmed.com/role/ComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Cash flow hedging gain, net of income tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeLossDetails",
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": {
     "auth_ref": [
      "r57"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax",
        "negatedTerseLabel": "Cash flow hedging gain, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r52",
      "r56"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r52",
      "r56",
      "r366",
      "r371",
      "r381"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax": {
     "auth_ref": [
      "r57"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r56",
      "r60"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r56",
      "r60",
      "r372"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax": {
     "auth_ref": [
      "r57"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) for reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.conmed.com/role/ComprehensiveIncomeLossDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeLossDetails",
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r64",
      "r67",
      "r68",
      "r72",
      "r246",
      "r398",
      "r403",
      "r404",
      "r437",
      "r454"
     ],
     "calculation": {
      "http://www.conmed.com/role/ComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Net current-period other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Comprehensive income (loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r54",
      "r56"
     ],
     "calculation": {
      "http://www.conmed.com/role/ComprehensiveIncomeLossDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedLabel": "Pension liability, net of income tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeLossDetails",
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax": {
     "auth_ref": [
      "r54",
      "r57",
      "r347"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax",
        "terseLabel": "Pension liability, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCostAndExpenseOperating": {
     "auth_ref": [
      "r78"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.",
        "label": "Other Cost and Expense, Operating",
        "terseLabel": "Acquisition and other expense"
       }
      }
     },
     "localname": "OtherCostAndExpenseOperating",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/AcquisitionandOtherExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other Current Liabilities [Member]"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r36"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other Noncurrent Assets [Member]"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other Noncurrent Liabilities [Member]"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingExpense": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Expense",
        "terseLabel": "Other expense"
       }
      }
     },
     "localname": "OtherNonoperatingExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedTerseLabel": "Dividends paid on common stock"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchases of property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending Litigation"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r285",
      "r286",
      "r287",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r304",
      "r306",
      "r307",
      "r308",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Pension Plan"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/PensionPlan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, par value $.01 per share; authorized 500,000 shares; none outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r4",
      "r30",
      "r31"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r84",
      "r99"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Proceeds from revolving line of credit"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r85",
      "r88",
      "r101"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantiesDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product Warranties Disclosures [Abstract]",
        "terseLabel": "Product Warranties Disclosures [Abstract]"
       }
      }
     },
     "localname": "ProductWarrantiesDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GuaranteesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProductWarrantyDisclosureTextBlock": {
     "auth_ref": [
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for standard and extended product warranties and other product guarantee contracts, including a tabular reconciliation of the changes in the guarantor's aggregate product warranty liability for the reporting period.",
        "label": "Product Warranty Disclosure [Text Block]",
        "terseLabel": "Guarantees"
       }
      }
     },
     "localname": "ProductWarrantyDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/Guarantees"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProductWarrantyExpense": {
     "auth_ref": [
      "r91",
      "r231"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The expense charged against earnings for the period pertaining to standard and extended warranties on the entity's goods and services granted to customers.",
        "label": "Product Warranty Expense",
        "terseLabel": "Product extended warranty expense"
       }
      }
     },
     "localname": "ProductWarrantyExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GuaranteesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r9",
      "r10",
      "r215",
      "r451"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_QuarterlyFinancialInformationDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Quarterly Financial Information Disclosure [Abstract]"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": {
     "auth_ref": [
      "r59",
      "r62",
      "r398",
      "r402",
      "r404"
     ],
     "calculation": {
      "http://www.conmed.com/role/ComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax",
        "negatedTerseLabel": "Amounts reclassified from other accumulated comprehensive income (loss) before tax"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodTax": {
     "auth_ref": [
      "r57",
      "r61"
     ],
     "calculation": {
      "http://www.conmed.com/role/ComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Reclassification from AOCI, Current Period, Tax",
        "terseLabel": "Reclassification from AOCI, Current Period, Tax"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r87",
      "r99"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "negatedLabel": "Payments on revolving line of credit"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedLabel": "Payments on term loan"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r327",
      "r492"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r19",
      "r252",
      "r324",
      "r449",
      "r469",
      "r474"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r109",
      "r118",
      "r120",
      "r188",
      "r320",
      "r321",
      "r322",
      "r334",
      "r335",
      "r465",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r155",
      "r156",
      "r162",
      "r168",
      "r169",
      "r175",
      "r176",
      "r179",
      "r265",
      "r266",
      "r420"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net Sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r269",
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/Revenues"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r70",
      "r96",
      "r155",
      "r156",
      "r162",
      "r168",
      "r169",
      "r175",
      "r176",
      "r179",
      "r184",
      "r392",
      "r441"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Net sales"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/BusinessSegmentDetails",
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited",
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r59",
      "r403",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions  designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.",
        "label": "Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r40",
      "r98",
      "r247",
      "r249",
      "r250",
      "r251",
      "r406",
      "r407",
      "r409",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of calculation of basic and diluted earnings per share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": {
     "auth_ref": [
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table Text Block]",
        "terseLabel": "Schedule of net sales information by product line"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/BusinessSegmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r202",
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock": {
     "auth_ref": [
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the presentation of foreign exchange contracts on the statement of financial position, including the fair value amounts and location of such amounts.",
        "label": "Schedule of Foreign Exchange Contracts, Statement of Financial Position [Table Text Block]",
        "terseLabel": "Schedule of Fair Value for Forward Foreign Exchange Contracts"
       }
      }
     },
     "localname": "ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r198",
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r210",
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r8",
      "r27",
      "r28",
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of inventory"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Schedule of Maturities of Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Schedule of net benefit cost"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/PensionPlanTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions.",
        "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]",
        "terseLabel": "Schedule of Notional Amounts of Outstanding Derivative Positions"
       }
      }
     },
     "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r373",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.",
        "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]",
        "terseLabel": "Derivatives Not Designated as Hedging Instruments"
       }
      }
     },
     "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.",
        "label": "Schedule of Product Warranty Liability [Table Text Block]",
        "terseLabel": "Changes in the carrying amount of service and product warranties"
       }
      }
     },
     "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GuaranteesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r159",
      "r160",
      "r166",
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/BusinessSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Estimated Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r152",
      "r153",
      "r154",
      "r159",
      "r161",
      "r167",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r178",
      "r179",
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Business Segment"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/BusinessSegment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/BusinessSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling and administrative expense"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling and Administrative Expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/AcquisitionandOtherExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyAccrual": {
     "auth_ref": [
      "r232"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.",
        "label": "Standard Product Warranty Accrual",
        "periodEndLabel": "Balance as of March 31,",
        "periodStartLabel": "Balance as of January 1,"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrual",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GuaranteesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyAccrualPayments": {
     "auth_ref": [
      "r229"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the standard product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard product warranty. Excludes extended product warranties.",
        "label": "Standard Product Warranty Accrual, Decrease for Payments",
        "negatedTerseLabel": "Claims made"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrualPayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GuaranteesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyAccrualWarrantiesIssued": {
     "auth_ref": [
      "r230"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in the standard product warranty accrual from warranties issued. Excludes extended product warranties.",
        "label": "Standard Product Warranty Accrual, Increase for Warranties Issued",
        "terseLabel": "Provision for warranties"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrualWarrantiesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GuaranteesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r44",
      "r103",
      "r104",
      "r105",
      "r109",
      "r118",
      "r120",
      "r142",
      "r188",
      "r246",
      "r252",
      "r320",
      "r321",
      "r322",
      "r334",
      "r335",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r404",
      "r465",
      "r466",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Statement, Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited",
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnauditedParenthetical",
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited",
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnauditedParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r142",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited",
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnauditedParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r15",
      "r16",
      "r252",
      "r314",
      "r315"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Common stock issued under employee plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r16",
      "r21",
      "r22",
      "r96",
      "r183",
      "r184",
      "r392"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance at period end",
        "periodStartLabel": "Balance at period start",
        "totalLabel": "Total shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited",
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Developed technology"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceAxis": {
     "auth_ref": [
      "r266",
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by timing of transfer of good or service to customer.",
        "label": "Timing of Transfer of Good or Service [Axis]",
        "terseLabel": "Timing of Transfer of Good or Service [Axis]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceDomain": {
     "auth_ref": [
      "r266",
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.",
        "label": "Timing of Transfer of Good or Service [Domain]",
        "terseLabel": "Timing of Transfer of Good or Service [Domain]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksAndTradeNamesMember": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trademarks and Trade Names [Member]",
        "terseLabel": "Trademarks &amp; tradenames"
       }
      }
     },
     "localname": "TrademarksAndTradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferredAtPointInTimeMember": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred at point in time.",
        "label": "Transferred at Point in Time [Member]",
        "terseLabel": "Goods transferred at a point in time"
       }
      }
     },
     "localname": "TransferredAtPointInTimeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferredOverTimeMember": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred over time.",
        "label": "Transferred over Time [Member]",
        "terseLabel": "Services transferred over time"
       }
      }
     },
     "localname": "TransferredOverTimeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r43",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r43",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock, shares (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r43",
      "r253",
      "r254"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Less: 2,222,233 and 2,410,045 shares of common stock in treasury, at cost in 2021 and 2020, respectively"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r108",
      "r109",
      "r110",
      "r112",
      "r185",
      "r186",
      "r187",
      "r188",
      "r191",
      "r192",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r324",
      "r332",
      "r333",
      "r334",
      "r335",
      "r422",
      "r423",
      "r424",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnamortizedDebtIssuanceExpense": {
     "auth_ref": [
      "r32"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.",
        "label": "Unamortized Debt Issuance Expense",
        "terseLabel": "Unamortized Debt Issuance Expense"
       }
      }
     },
     "localname": "UnamortizedDebtIssuanceExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates, Policy"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/InterimReportingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r135"
     ],
     "calculation": {
      "http://www.conmed.com/role/EarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "terseLabel": "Effect of dilutive potential securities (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r125",
      "r135"
     ],
     "calculation": {
      "http://www.conmed.com/role/EarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (shares)",
        "totalLabel": "Diluted- weighted average shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited",
      "http://www.conmed.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average common shares:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r124",
      "r135"
     ],
     "calculation": {
      "http://www.conmed.com/role/EarningsPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (shares)",
        "verboseLabel": "Basic-weighted average shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeLossUnaudited",
      "http://www.conmed.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 4
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04.(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=112272810&loc=d3e31137-122693"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=112272810&loc=SL108384541-122693"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1828-109256"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1930-109256"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2029-109256"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(2))",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(3))",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(3,4))",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1),(c)(5)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "460",
   "URI": "http://asc.fasb.org/topic&trid=2155896"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031898-161870"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=109262807&loc=d3e22047-110879"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "63",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=117411753&loc=d3e23176-110880"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=SL108413299-114919"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4587-114921"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e1043-128460"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5227-128473"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=117331979&loc=d3e41228-113958"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998890-113959"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41641-113959"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=120519210&loc=d3e90193-114008"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=120519210&loc=d3e90198-114008"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=120519210&loc=d3e90205-114008"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=120519210&loc=d3e90205-114008"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=120519491&loc=d3e90476-114009"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "820",
   "URI": "http://asc.fasb.org/topic&trid=2155941"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=121605123&loc=d3e30226-110892"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30690-110894"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611282-123010"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611282-123010"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611282-123010"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column E)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611282-123010"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column F)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611282-123010"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611282-123010"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e526-108580"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r493": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r494": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r495": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r496": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r497": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r498": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e640-108580"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6904-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e689-108580"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724391-108580"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>71
<FILENAME>0000816956-21-000008-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000816956-21-000008-xbrl.zip
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M-+$2O F/JU!=I!9[%VF@,40<L."!Y>),026F;=#<$RDJ8NV?K:V8C4?!@PB
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M<%2$.)IR'YVFD6O%*1-YXX?RV"8A262Z D'X'V=_O.[T8SN]',9PT4;I24)
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M,*QE2!L>4-1.*BL-+8+$C"G%GH\/=\Y7V5\[&H(6[!S9;B.>1'^<2R3 S^#
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M\=;:>FL;/FWOP _-]=;.=J/]"GYOOME:_P<N;;Y?!R:%[^N-WUZWM[=_O_L
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M_;'M[W=R&9K)JDN]OV36(&'SDB23T"OX*^LGOGN<9[562;^R[6UG]7J%5\D
M0VC#4"R6743B2!,2D<;"V6C!I 2_L,(-6S18E&A-N,[MJ!Z$J&7Y,63Y6MU[
M2[0@2:-$G$4<:X\L#1011;5/EB4O\<**P&11L#(5<WT.$8<)P'AX+L=\*Z$G
M !37\LE:@[ZO5W)_0>NL7T<0D01L)/4($Q40MUP@K1A%T?% 591"T;S3#>-%
M+1Z,(.H@1'F%]PD01"V\4Q'>*\C 28A"V( BCCFSFP1D@X"_"+=!)^,=%5EX
MV:)D91+>:>Y J4Y*Z.WPX7%75DLW%7>O173O\<^-*GZRM-=:]]Y+]VY>!TY>
M<5?41W-)VGSTAD86]#$B) 3"%;?44-"]BXK+14FF522@*KDCM5:KM=JL\GMK
MK79?K7:%*%6@@04?D8L$(YZD0XY%@V2B%!O&0;/A0JL)LB@5JXI6.P><%QVY
M/.M@<G+!3(MO,QA2&!SG5:L2EPB_:R^G,M%WC?I7O8VR<66IVZ@YZ_Z<-2<Q
M^=O/:7B]N?KWYNO-G<WU[<9J:ZVQ_<_JUOH_[==KZUO;_VJLOWVWN;/[D%,<
MRB8-E0@X/O/#&+H=ZSK=SK@3Y_Y$AOGDO2K7P[M@PJ/!L/#%!JG1'?3WT3@.
M>^!1N6]2H>I*YW/J:C]! /$U<-8.,-8:\-5J/[RT1_EHQM?1CF+;P605QR[6
M6VU_R2/_=#W.R(A305*+@@$_G&.BD;,N(,LECRD&;7/U'HH7L2I3;?/Z,(9:
M1<TX&EBKJ$=545=!PR0-P<D*1)Q3B%LID<$F(D>XD8D8P!YY*40O<C*OJ]"E
M!X>7QR\<V=-<);Q.BR_!L0MO)K2H5= OJ*##&XGPT6LLJ.5(.YE/@$D*5)#F
MR-"@*0O,LV 75H185/K!FW/J//CR"N\3GKA0"^_#A/<:?N!"Z7QH4\0L%U*F
M!H07)Y1 >J6.TF)'0'C9(B-E$MYG%5P"KA\>QSS07J[M66#GHGZ0B_V8.G5:
M_$P!Q7KOJ#LXC7$K=NTXAM=78>A:/?V*>KJ1(N^E)#10AIR("7$L/;(B&.0-
M$P)LC3<N+JQPO B(HT3N39TA7SUL4<OQU.7X"F9(01FG@"N"CPQ@!LBQUE$C
M:R1.VA"??,@;[!:)(B62XV<5IFC?.)GAVG)J':^8]:Z[6AD]4!G=2!\W0*D@
MM$/:) S*2 5DO.0 *J0BF$3G:2XG(A:9>; RJ@,6Y97>I]IV5TOOPZ7W"DHP
M3I(W!J-(!47<@#=@=* (' 1"#2A?3A1(KUYDI2J[\;R/8G@HFJA+M#]%7DFM
MIQZFIYHWDD>H"IHXASCF@#)DB,C8Z!!8'.64)"G%?&2,IHMD:KO[2[-%K3Z6
MH2( I9;YA\O\%38)7$DJ,< 2Y8J$,8(<(1(8*>MI3(.C,A]+B1>!;%61^;+M
M_KC3@&>=O7W_3L[7OI';==_K'^9$U^'NTB41U\;@7L;@W74 J#%UU"7@7)(M
M@C,<624-BMJ1D*AU@;.%%47%(J-EJEI;+UY5$,;5TOPHTGP%[03&(225\M*S
M1MQKDA/<'/)*&.T,%=P0D&8F%BF=PR6L4L.*M9@B^"ZAT>G[02\VQO:D7K6:
M*;JXH,AF09 =>W+-SZP/SKFO(MJ] 2N(L8%QBQ+''/&0,VT9  PC'8M*BN"Q
M6U@1<E&8:=4(J5>O2BC%3X J:BF>LA1?P0D3!9.!4*0E4X@3<!. CQ,2RDJ-
ML;36*Y!BM:C5'*YBE1I-3/)@KK9O3VGM:KZUT0PR8>HZMK^HB/QU.$&%<3'F
MZK6@D!!7N0AU$@*!,9%!)\V3LP6<,*H^"&N.!7@&R3"U /^Z %\AB<B(#D(#
MDJ!.(RXD1X[[  (< R'*4VD,"+!99*Q,*?+/LP[UE+)JG_&:^-/FP=2*Z5Z*
M:?\&LO!6.!,5DHGE+!CFD18*@$82F @7@@<:K9!%(-<BV)FJU#.M3_B>,UA2
MB_L#Q/T*AU#JI&8QH41U0-S+[%+HA#30R5!P(US2A;AS.HTC,9Y*W,M6*/;Q
MLE]FVLGGL$SU<M#K=<:]F$O!Y.W;6=%!WV/?_P@._H*->1PT=3+J+/<[W;\6
MQL/C^+42O3:VO/Y\?62U4KV/4CV[45N%"Y&$D!9YJ<S_8^]-F]I*EG7AOZ+@
M[/?>[@@57?/@/D$$;;"W]VT)#[A]\!='C2 L)(XD;,.O?[.6!!*3C4# $E3L
MW1BD-=243SZ9E96)N&$2V: U4HP"6BII-;=9A"Y@Z:,G+9U_)<ZCZ,M*?*B5
M.%7O%IN0C.>(86419RXB*[E"N0Z+-L$+&]VU*[%N2K36SW@.JO##GAW$O7X7
M6,+P_S;B_QYU1L<E:_/3R=I\X\47.M].GSUY!,K7OR"ZFH+'&)6W@]-PHN&H
M[[\V&X=VT/AFNT>Q\:^?*;2W<5 MZX4XK-ZT7UU4;&?M^I";]=8.M@8?1CE5
MQ3^Y;=.W3W0<+CKN!CJN-6J]G.BXEP9__I\][ _^Z=E/YFCK8%.TZ/NOGV%,
M=O8WO[?WW^]O;4#[/^U V_8.=NBKSN?]C_#[7U__YZ3UXXNP7KOH!(J::.!J
MV"&-;4)8A&@%Y9PZ_'-*=,T*NIT/I*R@I5M!QIF@&+$H*B$0=S$A ^L("9L$
MT2R8:,G*&EZ]XNS0I0\:AQ'X5I[/*< #V-:,ZY1Z'/=*[6JH7>W1:*\_@!M"
MXUHHK);M<'$H>&-7\'F K-!PN'[6X *,<P'CNY\ X\X)]/7'UL8F;AWD=KQC
M6Z];HK4=]MO;>WMY;%K;K_;;)[OT?TXVR1></./$4\1Y I.3$8<<=1)AEJAC
ME$:-R4]4ZY7KZ0Z\K*RG)5]/3KJ\)2&19L(B3F- UE&% M<L&A^92S2G(\--
M ,,;Z-KQ OMS3D1;S H$(/9Y%7[O#\(P]FZR!+>.1L.1[65]4-;@HZS!-_0+
MMI)PY0.*R0"P)<J12<P@J5U*(22#Q<_,A7O4D65%+>>*4E3[)+U'$:P(4)7<
M(XN]1C81(5(R BY868/5%&\ :?WIC/["?GCV)S$6$Y)T$@?]8(=[/Q>WRE(O
M^QCSBMC,\2EJ!(%902IJDF$W(>U)0@HF+W')K DRVVZ:$OIGC4Y>E/-3M8PL
M*E)[CU([6QM=DI!UF3:*(ZXD1]IZ@CRA24>%M0=SJH926[93JJB7?F\Q>RD+
M\X2/&U7<X(L3UX_7\]A]X*@;[;V=$W_2VOB8^PQC #QV_]UQ^V3]!]S+V]OO
M.SO;[SCP6/Z%.RZ$4Q*DV^>"0D(A2Q-#26-E<!!&)G.KC92%;<65Y5/CY1.<
MU(8YAV2D$G'&'#(L<"0T3S8XAXD-=]Y%J2'0UL_].2,FQ?=9"_%X=_Q%6A:Y
M4 H19BF(!P"K\2X@(QF65'K0K^%Q_$YE,2W=8C) K'7.;XN#RHLIP&(B\"-R
M#LC"-'<Z!_V/'>ES.=,;TXW"Q_&KS[D:WPR'1V4E/M)*W,%?!&$1D">AQ*0"
M"]$F9&BBR#@6%-&$1+X<L%86TN,N)*TI\"LM4?31PD+2 N@CI4BG)(D7CAB3
M5M88:<(J:!)S.2G"=8A6>P+9J59>H]-K9'RLCJCD]=UL0.,/(_3E6^P>WV$S
MX%GD4;C]9L"UN%"\A[<"A*G/7TFJ0(0Q<C['U;$DD5/8H!2\@*^B"]%DD;YS
MOK22X*2^@GE[?W\1S,4*YM2M3ZR0P,XP\M:*G%35((NC0)83*5RPAD1:-\%\
M5C4!W]I.0$ (_#BA<,FI^HAI2=9A_'(S;#?/RIO>),ESP9^Y\.=<+E4P#),Q
MF>M+1A"W"O"'"8UPQ#YJ[&+P$?!'ZZ81ID;;BB48H#;DH(CO0XOO3!)5;(.W
MDJ(@&= '83C247+$7-+:$P^_9U-=TZ:D=\Y]5K^H@.6@$._CR,*'H1'MH >M
M+TE4'Y-$G,[&YF0RUKT_.CBJ*IYOQ-3QG9*+<3Y .I=,5468*1$=4IX#($GI
MD O4(LE%B"IZ;8-:6>.2-+DLV52?L"0_ )\HDKQX29X).+2.&2L)LAC;7,(S
M;P!PC3QGW =,I7(2)%FH)B>J1I+\K+P3,TN^T:^RMOO^P>$@[L7>L/,M-KK]
MX7,K _/;@]"-(?03?IO'^IE.594&^N7L1(WK2_P-L]6.HZVT;7\4Z)H+NL[E
M736">Y5C,@A5 :PB2I%U&*PB:9T0RGNM^<J:I$UE+AM%OQ=WQE,0[=OSCR+:
MM1/MF21L4A+A!$-2A'P8G@AD@Q1(!Q,-<4H&ZD&T65/JR\&MCR+:Y0#$VM]Q
M.'Q1PQ"V[4&TPZ/!\4SL48DZFDLVO_XDZBCL?][8P>T->-;^+MG9?\?@7K%S
M\/Z@O?WFI/5ZA[<^O>&MC:_\?TXVOX-DPV*QS".%94(\80GV!M%(":9@>3+,
M+4@V;5(*_['+^Z%5M$[]HMO*&JO-&F-?<(R6VL 1=A*((5=@T\(\(Y),T@GL
M6I_/AU.P:'$3\\L9ND\C<_LIVUEGA[H:]0]LZS5&DX78;-@1M'XX*F%NCV4\
MW@X\2JS-K;!CYN![HK L-4.14(>XD09HH_;Y?)WCQ!)%B:S,0B;O8A86KW2-
MA?8!W-)%:.\NM%.#3SN7%'$$>2I!:)F.R!@.M)!RZ;U.&OML\*FF9)?C4QY%
M:)]G7:_A3#[K*@N!^G.2U;J4^:KK5GB%4),YVZSFJB#5'$C5WCA7J8)1K36)
M%C%E&.(2$V1<S+4(C<:&ZF0UT M%15.HRZ< :UK\I]3Z>F*;YD7F[R[S4W8B
MF'=168>(BAIQE3!R5%/$?#0.&TLT,R#SV#3QW6N//G#!KX4$YRT/@9DI3%IY
M1&Y.:&Y8"VS<QQ<,1B;TCUPWGDW:W1"O=N/YKT<<H">C"AZVRNMZ+Q3%<$?%
ML#E+!AT3)G*K$58J(1Z"088JAYQF40IG0''@7 M2<=F4Y,ZE7Q<N2(_LL2J0
M6B!U&=EU@=1%0^J4:P=N6<)<(,QPR%Q;(:-"0)0JGH02(EA>0:H@3:D6=6#V
M\2&UHN-_C"R\](H=QIEG^0B+??#P<DBGM5X^Q-CH]4?PV%$_"U\U&E5T*OP1
M8F\(OZ5.S_9\)_L,<]+ JD[EZK4[J).7<#JV(P[[P^H,V8M![-J\4?GG]TX8
M[9V"P<R-DQG#TUNL@^8<C:Z_I2YC22_LO<[\S*VM@$/B:&'1@U!$Q85,UJ2$
M9?0\,:YUQ%\H73F]:>^L[N2AW8W(#:+]BFR"#KZPW>_V>+CRQ[EQ..CTT(5Q
MOSADUPY,2G<;F.J)+_*YP([_Y5"-)0FPN#^PU12#_,9!O@I::6O<NL;>(*ND
M__KU-"JP3[/HYYB#7,HU2\M__V'7KEHB-UC*:__M!G^L72MM#R\!ZDH)>+G5
M;FUN-%YNO7^[]7Y]^\U6>QF:_&'K[S<;Z]M5PT%YM3_ ;Q^VX8/69GO[0V/K
M5>/#O]??;_Y[Z^^-S?<?_F]C\]W'-]L[M>_9;Q][]BAT ,6;.69DM-<_@L>%
M82/^\!&4VEF&T(8]  TZ&OY^;9<.[& 7P&6"S?(\ZS[K9*7KICA>Z5?H;-<>
M#N.+TU_^#)WA8=<>O^CTJB97-UW4I*"5)]!ES*K"*J/7Q+,U>?P$V%8K8+M
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MFB 3)4:$"B)$Q!)@Z1YR4A7P*>#SL. 3HTN&&28M=MQP:;F/+A"J$CPJ&+T
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MV^ZYE7B<A$@.LUPT.L/A40P@HC#&C7APV.T?Q]@X[,(+[E+P<6;2KD@F]9/
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M!X,8QM2C,QP>5?6V?7^88X*+(Z-N!.35^!1$;_=EGJ&"5G.@U=;LQJ2G1,O
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MAS/J,>O$ _L54/QT0"N<L,/AT<'AA(!DK+?CC'9C'9"%/Y. L>.MTF[#89Q
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MG,T8(UNM#DEN@ST3&RVX;F_8V,Q[$#<X"OELA^/9+I-JJ[)QNF_XK)?(N:'
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MX_2ZK5$_VL'U[?UF??LSV:&[S<;&-]$X;^TWOO^WV=B&E?S^UP&\3ZM._YL
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MCOE\>B75S9I&-S[XU_PXL\M)UL/%SBS5_0(."P4.H].M[;?XATT4"VX((D&
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MOPE?]F&EL_P96YPV+/N=C%Z)Q<Q#8]/]!<,/V'PD4"M9=WS<RBT5;C!QOP*
MHR>@UZ<UXK]Z>)635MQ*C<Y !Q^VD-A*6R?]7A_>'EYO9.K_.73]]2H7RBNV
M]<_!UM>2*T:#1-CGQL3!<&2],4A8&:62QJ?HK]ONBX$_VQ4PMT#:5<1=N<M
M9O0JO79@F@VHY9)E:G;8>J1R;-_@I\Z(F-[, (_O ';0N/>:[8NC+'GUD/O2
M$3UXK4OG=G7ZY3-$'O?BFXM??@_-WG'+GKUIMJMEJFZZ?L;5[QP/_;G&K"FL
MLDMW&,X_''[H[5VKO+W73N0&WS&]9JBY]6N\1F[][E?#$KW&\>VW_FK87W\G
M&"N3Q?<;]H[\CBF23F9YJ;EQZ820D &WO%!<Q US9M#D*/M=KIQNSWY]%V,E
M/K[]^J[V]NO[VG;G&)0#341M8ZC; #K?6O;E02MSKZRFQ5BV*QE(Y![+-+/2
M2<NSAAN@_A\YT+\G)G(]-*'MH0LT=X%K%QZ62P/M4A6Z#[DM_?*\O^I,><R:
M/#):\NZU7.Y(R7N\_WQ'24X1)"D]==Q@K+$3/$9J&#;,6Q>$\,G05 5)DD<E
M$(XLY:OV]-P$03[05!X$01Y]/-S:AF<=A(.M[6\$KJ>[!Q^;=?KQL+[]ENUN
MO]N'>;'&]KNCZT&0.]\_B\;W#[1!ZZ*Q_0U,:WB?[YOG\/G/^D9HU3]]X#!W
M4O^TF^K-L=289&/ N?\H50$CSG%$.H&1K42$CQVG,N"5=2+YJI"SJJ,Y#<XN
M0$1XP;C7@W$TILAR\UYG.3<T1V5P0J434@F5HAH$@A-:,.[%,6Z4\X*5]-Q8
MAZRF'/%H.7)"8"288=1;P#R1NW,*P#A\LS_GG&+<<W=D7@(U?P%7H-%IH]%Y
MRBS>^I5U>9L"VWT"'#?*)!<8#][92#VG28,B)$%+HD5_G1-L'R]Q&2P32C*#
M)+$&<1$5LC(W=$O>,LVUB9&LK'.Q*GCIS+K$S&M]2#Y$HI+UW.+H.",^2FTD
MB4$15A2SN6'>D6*FM(PYK1(%2A7BA!ND%3:(,9>"\]AZEIF7KC)]LY'2RS'O
MA"R[Z_'@3W'L.M_GV=UX9)OMZCP[!Y!4H;3]DVZ55U9%\E;' H--NS@;J#4'
M09C-]B^S*1R)6"<LJ>"!*YJLXDH;"Y*9^*"5GAB(,<;6\%K^33CIGH).WHOM
MZWQ=MS^;1R='?\3V7G]_*^65^4]VFX;-=G:D?FQU3JN_R6*R]X/#,.K;AZ0.
MUI,GP8C<G5 ;C;AS(&&]!.LI:T>46>ZH6%GOGW9J9]%V;Z1&5!$+@X">L<"@
M&Q'C8[%!.4OP^+C;@5V!:UMGOZ0-8S26B4<7*.=)1*VL21:K@ DA(LE"&T]#
M&P=OS^I[/V#I!8G6(R:D&'@/06LF*&!#3 PR$&E6UCOM.(@TFT@;.9!Y$GW<
M8OE=BV2>F*CYV,C%UYC#J6_/X2SIF/,VNZ=)QYR8MW9G'MJUO#6<"';,$V$E
MZ'-$61TEQ\HHST4@UL]EWMJO"*&*[CT:AEO_*B%^&,%W-3CDZ8*IGVZAIJ+2
M'*MPF:DZ#N$3@OH7*V3WBH#O;0Z#_C?;]RS0\MI#>'%C[X=GDH3((B*)@^Y(
MG$ Y_14!&'@ $DL4=XL9POOQ=@7VUSQ0V[=AF)EQ$0 <4XI5%._=Z217$2>K
MRKE\QF5^2,[LR+D&G79UX% - W_ 8N5,SMX%DO7N@K(JP?+V@=R@V'2MMQ]C
MO[?L$<><B(=$'%,-J@]]DFA;,?-H6[4FE"QSG7T4,UV@R3Y\89=ENQ9LKOI^
M\/*,\?'F>C#N$++I@L?C#CS]66Q^JLIH_5&)R2_C>9JUMUOO-V<1%$[HDB[B
M^W%MXOVE-O%UI)8,K-1QO61SJ)?\\<M.JX5";Z?081/R[%3K=HYN4NES9L_(
M2;'ZB[[RV_O=&&OU[.#LU3ZT<V+X90K$BZWTW0O]P,R*,LCC![D'&RP:#W3Z
MME4;8= ?<$5M$V"]]N? *W:_X*5EV-P'#W)/>%@,@A@Y!<?JICU3RMR"\<X]
ML^1>Y\K<Z&!65B:OS!\=/SBC :P=E ;(%4,N5;VR:(]@M"5ZW<(]!7$?1S.3
M6[P2\:L>K_<Q[9[)R"F/?$7C+-LC7T/?VMO/45\B:_T5)&TN9U[F@P(_'I@'
M\*N@CRLQ(]D1FS]\%W.XZ\@5.U#=W[;#/+7O>53RP$'K</=@1VQ]_XP;=.=G
M??LSV_WTL;GUZ3/9^O3787UC!^[=/&M\VCF]GCRP]?W+4>/@4.QNP#T''WXV
M-L+ASO=-OKOQC>]^_WS:.'C[LWZP"7-]EQI?\=EE\H#'T1BB'4HFEX*WG"%+
MM4146!H"B3@JO++.5H5A,\KI7*#4] )D\_1N4P"9T!P;ZI7!5G%I@W:8.,9Y
M,$'%P$,%9/@"R![7CKL V0L"&1[U(9-!)88%DM3PW HJ(8MM0BP*SUQP"D>Z
MLLY7J7ET!N/\ =FRZK6-V*]]S:68BQI;T'\NU=@O\>_8/HF] MS3 3<?M15/
M!E.=(DJ)&,0])<AA01%--BDI5:06@)LRNBK5S6:Z+PK=!4&6%$&>4W\L"/(P
M!!&CRD0Z6[!@O@:6/.)<.>14X(AYKE4T+!C- 4$(7X4=FR\$*7K,:T.A:1IF
M\\A5\H22I 47P3G,)4L:6X]YM([>0Y&9OG/VU/;L=4MV8-\68W9J1/L):/:S
M0K6W/Q@AW B*44X11=QZCJRV$7&=B$J846S$RCI9U=P\OJMV ;,"9D]>6L@2
MYK32G"3'93)&$4-Q]%H(PDS$+^J2*Q V,P@[NX0P1R,)P7D$JC-&'(R\7/(D
M]YOUE%.+@10J"*.8S)%2]MB*D ]RS2WQ& M1(FTRN<W1DLV=5'L_;)3W<.]L
M*<HWA^[,O*U;Z5.G$W*_]*^Q^W=N-_RUTPI%$DXC"9MC#DY!E>-@M@$A&0^J
M?"(@!WU E' 7C!3<$@-R$/-52O4<%>@K3/A"'L'"A+-BPC$?84P6=DHB$G+]
M/1PD<CP(A(T#]HS:N^!7U@U?U>+1VFBI<#N_?.RY3Q'D:2(B<BR523'HY(AU
M J<DS#V$:;$UYX.YQ]UEA*60F.=(:Z+R$8!'VBN%5'02T-@[D64LE:5Z]:+Q
M]C3^\J0-88IZIW7B)A 0TSY)322!/V&X>PCI2W]YX?)YX?*11XEK*4QP"KF4
M6Y# 3Z2-20B,(*PT!N4L@A"?$"5P?X_XK M<+WGBP9_=7/OK9VVOJI;1NF=Y
MD=)#JO206B2O2 GQ?3$!<#:6JX")HMR"5J<I=8@+[I%)FB+/#.5"!R6"F&VN
M0NFQ5_!QGEY\3AU6!1]?$!]'*1!.Q>B)= @$HT8\ZH TB1))[T!,2A<QYK--
M@5@4?"QCS'Z,(G->A\R9Q@$S Z6\!"PNCN@9]\ *[B2(F(24=A3QY!)R&M3T
MQ)URAD6F#,W1/J"7/#Y@<5'D3L'(UX&1RZ*7%V2<&3*.O-;),2,]M@@K;X>A
MW$8+T-(](X(!#425D9'0TC9[CG@:J+X6?Q[GZMJU?[K8CJG9?YAS^W4?X#VO
M^O@DCHD"@-,!X-;[,:]M"E0883RRB>7\%4>0UE0@ZC@AVFO8/[&RKN6\AKX5
MSEYVK:<P_8R8?N2*M%I)0HU" .;9&@3.-YPRP   =^))2DQFG0>S96;[,D:!
MTOEVLLW87BR8.35F7DGZ#<0*V$X4O1&("Z>0]M*B&+G%3EN1?%Q99_KF\?:+
M!#@5UIX_+:DP],LS]%C 8F+6!P$,+0Q#G$2+'*$)*<RS282=DF#[4$7G2 EZ
M#6&+N:[<?(0L#ONF,=BLT#G)G5<OWKZ<#<QL@99&0"QBT&/JQVX1(U.*D?$2
MS918HSDQ**HL1#"W2..(D2&>$V6Y\B*!$%E5=,9A/3-@O<4X?RT@7$!XJ7V9
M!80?!L(CAR8C@7@?#"*&2\2IH4C3%!"C@1#B#8NRJI-/Q:QJE"X-")<Q7BSX
ML@BV5R_8EC]\LPBWAPFW<<^SIBQ93QC"G,E<A!ML#&$EL@S[1!B5H,C<5JOM
MH=&;BR_9"@H7%)Y'\Z( [)P [.@D $N>8H@<^9@BXCPIY+QGB"H5)(G1TER@
M1(M'GP3,#<96YPB_]2T\%/X-S;_7+UZM<7($7.37_UU]6%UQ^3Z#6<&[M.QQ
M+[ZY^.7WT.P=M^S9FV:[8J[JINO/AW?Y_;09^OMOC%GC1&2^&QYD#(<??$O6
M*I:\MI2#[ZA>4X+>^C5>(P_\3C#QH#M_-5FU)I0L<YWY7 E=H,D^?&&79;L6
M;*[Z?O!RQSGL!2 "GL9?J[6OX\HY6:XYF4:Y<OZO+*12KBQ$5:Z<_RL+494K
M"U&5*^?_RD)4Y<I"5.7*^;^R$%6Y\JF(ZN*2X1$DJPZM)X\R19!2N;1<.O'2
M"2=]\./BEK%3PX.37K^9S@8'B<UVB&T@3ED-E!^T_F_7_6W]\J3SX0-=W.&?
M_G2?9E?_VWZM;KM^?W!4R\AJ+8='K=;^SQ3'_M)3QPW&&CO!8Z2&8<.\=4$(
MGPQ-/S8GAER)E0>$7'WL=&'Z[?<GW6YL^[.)00#;G7=C8<0Q;)QT8>,;,%]"
MZS#Q_=[*13B 7,QP@%;\SY>SW>_AV%$N&^>AN;7Q66QM?#MM''TCC4^;9XV-
MP_.=\[<_&]N'ISL'.ZQQ?@C?_Y5@3!CQ!Y7<,"  I*FBB&-+D'%$HR@2EDQP
M&B-;6:=K-[-U:T"#K4P/G51KQSZ013<"89_'4,OY:$"8\!WLYJGMAHI*\HV]
MFO6^<P(D$_)W-=NK>=BX6H*=J^WGK>NMUFP[U)IMWSH),?^2;SDY.FG9?%,G
MQX' <&.!(-7CX*YNK$H=^7Q9OU-SL=:-OK/7KJ8$PT3;;</N]_+O, I,^F>_
MUC^-+1CBJ"*&M2G8]J'L_G3<78WXIMF'Q_E[\/L&#/2W[<,"]FKM3A_X,?-@
MM<@3=F4V*W,E=*+V^+#-JXCPU<-<3UIQ*U710F,OV.CT-RY?[VTO8P10PF:[
MU^_"7-K]WM<^?%/]MI4^-MNV[9NV]6?L5FC4]O%M.XP^[O2:F0/^Z%RD%X/,
MV(87>=?J^,-7!B.-[9VSQND/*1E5WF!$J4Z(9T QV%GDI291:$4E@>V*@+7'
MF6:Z)UG;6PBQ>)%EVZM@:8ALJ=LY H:YH"] E$M*JGCI!L@-F*@:XL9@&4)/
MNC!&/W8SL-GV64:N"(,#85U^#]Q2Q3=5' I_A%S4+1^]7U!N!N*KP-BL0N2&
M^<&UT]B-;V:.<$>V"[QT$:,EKP9W^IA?*NOM3Q ?13!>PX/ Q&D#I+A:(_QA
M<1%W15O<_M"'1ELPNH:U6I#)JL6:J[GW?!;)=)X#<^J!EYH;ETX(&1^@R@N%
M1JO)=3;WNS'6!B9%[4,[*ZZ5,54#.^H>A1F>9=<78R5'6EMMI)_=8PD?0(6+
ML2 7:F;6 ]Z/ZP#O+W6 KU=T@"M1\K7-H0[PQSUKA$R3\#>*OJ9W15_/^2)G
MD^(^!53N\\:O;N7PDR/<"Z#FK>6)9D8#3UF!L$SR62>Y"'EMDU-PEI-5%[^:
M5Y;V?NC:ONE%?8I:7\NZL%]C"S[<JSPN-APUVTW0*@<*YK R_DM43GL%>;'+
MF=D:B$Z*<TVD9EPH[Z3#.-A(@I"&V.G+^U^<56VUKYUHC2RA,4?UG9[LE:7(
M;SWZ<K"SO2-V/]7ISKGG, ^\<[Z[W_@$S]W8% U:YS"/LYWM;_AZ?NONI\9^
MXZ!U"-<?-,[WSAL;7PX:1Q_P[J>/A_6#0[9SO@?O_%]XCR^I/MYYD 7GM$@\
M%_F6B#NCD171(,4<U2Y&9JE;6>?BT<6^)X/H/-< *&@U3^\V3344"?@#_R5.
MA.5!1&NB]D%1)1F-\-\]$O%OJ;-=<.M%<8M>XA8A0F-" *BTQ[DUDT=:$X%"
MPIS$)$40&NQT?K.PXM1%3YX.LI; Z%C ]E#9Z,CFQA5K [3C=F^(+* A=WHG
MW?@PB^,)6BHLPJH^D<5QQVI.<&XOMJA>4HG\(O7)KHGH[1&+7ZVYN30%<IY)
M$#?&^P6!5D62"AH9P3GBV@9D/*<H>"\(H5X)/>R1>/_>%W/4XJ( S&( S QJ
M;]VB\A<4>3(4&:GSD4D+6R>1M%HBSK5!CM.(A(N8"DN4)Z#.$W/_&H:O3FO_
M=<&N_'=FF&;[I#I8GTD8W)!;.5U3 CCZ>!@C^J8;6Y7F-XI9^Y^KD8_#P#D\
MNL6Z7J=UTK_]EDD!=B\1&FFNKL;XS_WNB/CV(G+=: ^1S27XWMC6J3WKK?QV
M-8JPV4;7EO#ZV]_ZCBD]8]ST@&T +3O=BGC>@/R,W7P5S-+.\>QJ^]TL'?[1
ME#A:H43@-BHN9+(F)2RCYXEQK2/^H7+;X!RN6<62 'VU\X&379^TV]=8:0#U
M.!'LF"?"2L(-459'R;$RRG,1B/4#>07WQ/ V*Z]4<4QB)$H3#+]AN%X3KP.+
M42;J^5VAPB]"_K\BA'>VE8/&:[W]" ;V,9C/L(;55<^08# O@=/?!_D7W9"3
M+7KQ\A S#90(,(7]OFWOQ?'<D'XMV6:W]K=MG<2U6NW9\@6&BLV'X93>7\SH
M,K!J/"M@B-.O/>S_Y];;'X:DQ*E,P <.(YXT!9"7$1EKO1#1!^75=6Y7VA/C
M@DJ81PX&DP&V3X8+YQ7Q@!/7TP2V]S/MM%J=T^Q3Z0]BXGLG1T>V"]189?*,
MB*:*M[\'I75.^KV^;8?*33,Q\:WRWFQ$'X]<[%[Y"K^IW=0I'LV>MZ3+W$37
M.]=O3L+SC5H3A#\D.I^Q-<$>5K[TKCAZQIX@-IT9,_/)ZC7#^5/$T?-7/U=Q
MOTR"AT=5OZ #9'*,YF4H>NV><:Z+%8)ZCPCI"XWL:];(7G,T^=M>#U32CUE@
M_I4%YFM>BS^:UC5;H,S!D&5%AN>!E1J25Z/ZY>:*O(98S/'4Z*MIT54>9QC/
M]WSSF.C!IXN GF&PY^N+@"[+699S'I;S-82@?+S52)]%D,0BK,#6H*1)=:C6
MK[5&2LD31HG<:^$6^W3W?J\XW\>^4YSZ,L&P<F#<2LJYL,PRHS$)RDC& 2G-
M+:67V!1!)".U*.N'E6JXE48?5J;%DIS[?CRJ;^_"[SMX]^@SA^M_[AS]=W]G
M>W]_:V/OK+'QUW[]J$[JW[_1Z^>^.]]W?C:./C9W#[X<[5;7?FSN''W<W_KT
M@6]M;.+&]P]G.^???NYN[Z9Z<ZQ#MC-,8TPEBH%HQ!6A2/-(D/),1L6M,BKF
MZ!'Q^.:LDT%R#F)+"BPM!"Q-$XWR\KAT8>:?%6R:#IM&D6TR @C1&)%(N4H<
MC0;E8V.$B?(Q*!^$I2OK?%68FZW?[A]D7F"IP-+\P]+TP;?75*3>F-_Q;?\2
MLAI%>9H6H$9!<Y1I;[CFB.;X6VZP0MJ'A")V4243.0DT=[;'[#%9,#,$J-?@
M1IVQ:;^ *S P[5N=]A[JQ^Y1S5;\_Z0N,SK="DZ46O,'[=-D/ 86DS4R*>DY
M9593[:RE)A@>O"/B=F0OUN[3 O;9F+6KJ0^,@*&+.0]@[8J(;.2 W\&#U4N-
M)1P 6V&S?,G62\ZJ4V4G/P^O%@OP@?PZL@"QA'W1FB!E!/"K(P'I:",B,@*[
M*BNE):!@L9N^J3E*,BZL.D=2M=A",V75D2TDO18"4X-X,!AQ'!1RQ&DDO.26
M",&XY<"JZJ:KYN5$ZV-/.E^Z2MQ#'4ACI]?DEZ?72^I=NO_[+P^2JD"PL%;J
MQ+ARVG+";8C21R$X=;X<U,T?OC;>CYDN)E@?'':@!3&../$&F0A_!K!D2/0&
M)*5<6:>K5,H9'=3=FTOFW%U>T&XYT&XJ$^_%X:Y8?P^$O)'UYX*B@@2'8D@>
M<>,$,IHE1*4)*D383VWS^9^A-_TU4[O7"]H5M)NG%W\>M"O'BG.#>R-36CF7
M6'0>18XCZ'N4(<V\1$0:RR*.226<53TI[U_1Y^5P;W)C52)^T5GU6:I(O_08
M]UKX,LDGF>1K"''_=:?%_4$IU,?G%,VI2VPA/.&/R&4I2U:6[!E3?!8P"J;$
M <TVQ:<<6M[3&O.4"4U8D-1H'B-SB@8LM!72.&P%+Z% +V5DC8<"&4R=,M0A
M0SU#7&",K*8<<:^E(%H2;\'(6L*N"TO.J-/X39Z)4XLK^('<.M8EQ7D= XZ(
M"&80=]HBIZ)$6@=I:-04^'5EG:C'.((+JRXEJ]Y25;CX,9^(:<=:A'CO!,]%
MR7%4B)M@D55<((.%LLD&:DFN3*[N7U/X.:*!'N>HG%-WR(QZ4<[8!U@F.7-'
MY5R;J;=T,>_T;0M ^])=^=+%71[:KVRXO<.JEPQV.'1.<HG+UW#\^J UF&_]
M9!KU)%)OB,")A<B]4]I:&8-+UCD?8&%*>-W\Z2I;7\?< 9XY:K4P"%05CSC-
MJ9PX"92"<#FL.3"6JO ZQ6?D$IB*4^:\4V-!ON5"OJDLLQ>'ON)?>2#\C?PK
M-G"PR#A#R@>,."<4.6(MDMY+);AS2?*5=;%*\$V/Z-3&6D&^@GRO&_E*V-W<
M8.#(784#9DDQ@Z*4@('*<V1<2D@FP;/;F898A=UI=E,%G$\,G-"6:@;-7TIS
MAUB:.\32W.%5-W>XZ%%ST=\!E_X.K[B"?^GO4/H[E/X.I;]#J:!?EO/U+.>K
M2RFY/:2Z5MHFE+8)K[P0\!2>0V-="BER*XF%']@Z[:@AT? <@\Q#Y3G$A);C
MXOOX"K\<[AX<GN\<-(X:GS9)??LSW=W>$?6C35X_;^SOT$VQ0[^=YG&O^PIW
M/WTYVMIN-.MT!^\<?/O9R,\\.#R#:\_K]./!SD'K8'?[77-KX\O5M@F><A48
MP0A''A&GS"/G0D1:)68L5YQ(7[5-P+BT32BPM"@G&B^/2\MVEOMLV#0ZRX6-
M\U(:A52B!'&+#=)")!2MA\]9C%Z1E76]JNG-2E&E;<(\L6Z!I<?"4CEHG1N
M&LL+D(X3'00R2EK$&;;(:I(S\6SR/%F2# "46F7S E"OP3M9TJ6OMTTH"=//
M9 UC2QC#3!NN)*?$Z&"P,$H81W.G''<[O!>3]VE1>SQA6@(V2T,]DC[W3LBU
MG0V.%A'"I!71&Y=R =*;):E*QO1\<^HTFM@SL6JQ A_(KB,K,%$;L!(,11*
M76-0R!B&D6#:4\DU)C*NK(M'=:8JK+J4K%HRII^7:4>6D2%)*.L""B!?$=!
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M2AZFUX3=L=V+03)XC8UR\]FK$\883>7F@## Q:P'N .SR,'$@U%7+R9W@5!
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M<@=3W>/]YSN0:IK<ODB](0(G%B+W3FEK92X-9IWS 1:EBJ,:JG /C""]U/"
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M_2+T3"%7E@C]>XF=7\LI !9'>*7193:T004&*6WS/,^ALIQ"JW6=F/UUO!Y
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M3#BU/I"X\EYQL<K,HOI\W9F77I #X@WCP_WUD0H?EA0?)EJ-LH1*2W.=E,0
M'X0&?' !!6P8<4PH*P3@@V"K\N$]/)X*'Q;DZRB>K<JJ4,NL ?T9^_UWY5:4
M/T?\43O.(;%NIW*#++WJ,]JQ"L?FP;'II&^>9"+,"11XQK$0&=+$&"02=E$'
MSR*U^53>*E:5\^05<_32*"L51]^+HR>:"0N.)$XC\#$'CE86+!? :F2X91@'
M[8+D*^^)7N7D+>>$/Y_+I76AQ-<]E<!152X&JQVZPYP'/)[^PRRNI5NS^]9
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MKG[HZ=;W.FML?/O9V#YHPPS9UO=&JWX6CG:VOYTVVHU4/]OG>Y%G$I,)):S
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M[^:TI6M3DAY0</WZ4\2OV/"^^_N_&D'S1,ICD5>9Q<MZ)XRR*L^S+"N!,X_
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M+7Q$%-THR.CJTTO"B+(8D>@$7+R1=LU;4CQ=D6'--_$B+.=PA\ 7TR3/]+8
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M711A?@_G$2;Y2Z;=WD(U$5/"-&^3/J[&)-2ANUM!Y3,AG3L<1HQ=W"Y!?BL
M5XZG8XRJBAS21"29X,?KL)A>4TC9[==[@U:K+1K8)&O0[A_UA[VNXT@A2A;S
M)"9AHQW/^=?CUJ?;O]M#QS[J=OO5IE,?5MO=5J<ZZ'5$U>[;P[;=[M=;HO/B
MIV;[KIY\@'K'<#G]ZE<,]6+D4PKC0AJ'M(H\<X [7)"/)1[L$D.R&GI@QX%/
MU7%52QYX]7@"FK+5Y3?YMK'RFE<+D>X,QBZ6=(YB=1T&H2N'J4DWDB@YYXD!
M=:A! LL4 =>)=$""_AU0H%IXK8L3HR48'U!98E5;UB%B]&OB:;:1[L4<CHH
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M.?,%W.5_4Y,2VDBJDJ*RM6$D9\VNIY%NW)%[-FD7.W1OVD*L1+PJRG/T69'
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MC>79@5RKD'X5#Z^9#A:L2<O4L<BM>N64Y_9$=RCE_V27E*76_X1*3N8V\+P
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M2V@6]:%L<"J\+:TQ!%+:=:[/-NFE('-Q:6UDO1C=-J;,"M>_$9'+W:UMZ:"
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M.VTX/.SYB>@AGFKUKG9VY:GNX*DVF_L><G@(EL_'CV/:5*6[K0/=?:-#'@-
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M3D<SC#2*P\"_ADT"NX'7!#,B8%(@0BK!=P0G/PH\')/=<K@L&K-(>N/ OF0
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MZHW:V?G5/I'9__?N\J-UYG.] >LTL!.*%:ZJ4@/J=T?_[@22THTP<POCJ%3
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M-]3LIJ[::W@K(:NM=Z]9=S;M^U=?EE<=SI&.O%&6*@S)./<X]3+N2=#4$03
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M-RSZ/A.Q,+]=T,?ZIOFT/)]>?9CA^TJXW_ %[7]7^'(ZG_]C M=YO*C@#U=
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M,GXVR33240@*$')F,A:R=0T-([J,+*6<LP6%B8=3T_3009R>L*<FT0$<;LJ
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MB_?/K^>+Z17.?OQX<W?JV7R.]/_E]?Z4(QFREC-+TX%IZRV+QD26%$:5'/<
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MQI'Y;( 68D^[K.#6IGH)&FQIPIJ]L$Z?(M) E_=NA0^FB 8I(;?0O?H-9[>
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M42V-!U&OX4?.HN>6)8L\%ZLRFB9QGX''\2=K!];UB=/\M@YG<R!?<E]=*L)
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M&4!(%K..U=2@K4""9AB,#>3(9<.;Y$4^ DL>R,9^')(<(O^A*Z>OCR5O<I5
M@"^1;,WH!4$IEH;K4=9T2DN^D095NI79OOO<T]OZ TI\.HRXFIWEOH7+SX!X
M@2BBSHP7220M6;% PV$FD;]KR+A+ODG6_#TDYZ#Q8<1\BNJ2#R33_#2=X?AB
MLKHYGC[=7"U>M]WM4^5LF!>W3FPZ9OR;G;T#U*Q!%3DX[>B_)J>2,:0<N8_P
M8!)A1PA#.>U?G+V8:)%*T3*;-5'5YL*"(N(+M*:V*8]HVW3[OH^E[W+W,WP<
M7UU?O<3:(.Y5J=5>E[&4_&)R)[8B1C*5X"4G7.@*T[X(!DB3'ZSVN4"6RC<)
MCG5&^)C!K^.XL;DHME%&BZ[=GP?^R[2*&"Y7N84C+80-WD66N3*U\(&G+4$'
M)CU-\:0)F&U2H7D7H*^?$X.(NH'[L['X;@W$OIM^C[<33'^XGHTG%[_0-B#D
MS[1,OY^/9% E)9>)N1YIU^>6>8N9%6O)?I!HE&L2P!D&_M=/KT=08X-\I372
M5Y.-\6P-BM%$^G(1[MG\)C)VZQ=&.GGM:7UEQFE%EBT"\U%9)J+U,GEET319
MQ@8>Q]=/S\=4;(-<I8U!+&\XD:E**KF;L%(/JS F2U8P,N&,8SH[SJ*)DBF>
M:84/*I<V1N8!&+]^?K522(-DH2]#?S:?XV*^KNP_QOFSQ6=/Z1=<?/_I>[@D
M9PG?OD=</+][%!KG2^=HA#DJ=" 8C8 ,2*[)@ QD/82"W!?RS(1K4MYHT%%\
M_?Q[/*4V2!'Z,IC/R%^5C1&.2I9"RJ29TR62YQ(] QD3"SP'C\D+](U/IG>#
M>TP^G5S_.YDXD/(:^!P/8/S<ZV14/#?1%,Z<XJJ6;ZR50+UA,:AZWP,=MO$J
MN@+\DV@#*[&!3]%98B,HP7OEJSU9JQBXE%A4/C-?_7":,CRD)F=]G1'^2;>A
MU=C -_@"=)5DX6A@1LK(HG? M$;% EAR5716WI:8H4VSLPT<I\^S&MJR.ER<
M7T/F4_$I%2D2\YB1:54R RB6A6CJC4:AC3AE@L'3R'PZ0M4'I"<=(O*3)YQT
M ?=G>M)QNCPH\^0819R<+=+6VBU&,QDE39'H _/6UY758<X!=<Q-K@M]7>E)
M[4ARB/P;IR=Q&V3!%)@,M9Z2]T!VE0E,8['DSJ6":N."[E>9GG20Q/>D)QTB
MKI.D)SDP4FD1F4^"8+AHB)_>DILD%42(O&"3"]9//CWI&(T/(^8&R_G^FK8B
M\I"]S"RD3."T=BQH\I>B1G1*I>3;'+L_R:+A0YJ#PXF]081B>^W:+J#^K M^
MJ/8Z%8(^1O2GJPONZ/6T9#&7:W<D+LFLD<8R*;*WG-;*TJ:AQ==2%WQX.APB
M\;8E=(\O XS>)YT\5EE(IH,QS&?:215:JXN5TL0F=<N^SOK. _"@12WG0Y38
M-%NPZ\VTU>60%(..- U3JOT\='2,-O#">'(R"A]=:N.C'@?W'*R=$RBJ0>!\
M"ZSU3;$.P%J:0CN1/8XY= KU3EOJIL$FN1L@^LRA8C.8#=,6D($3DB4K'>?>
MYI+$&9#F 9OI27'F$)4TX,KMO94 KC=7X5.VONZKJ?9L-IQYU, PRJ1IG^=.
M-_&]MZ(YO<DSD+8VXR^]1=W COEE.LF?C:[U;45EI/-%LUPS%;0+@<7":>--
M!H+.1D;9)--D"Y9ST7U?,;?;)=8F]_I\(%O+5>*:%9D3T]D# \-+;700O'5"
M*&R2HKL=SCE8H ,(ND'J[7U4-S3O@NL$!N8]8(]C7PZAO ?YT$/R)UD8UJ?
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M-SF^W0?J,6^C]%7?]NO#_67?P-"\?:_F3E8KI,@S!J@ML@+90089<.0T=*U
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M+R:_$<3I;'Q<G_;;?]Z[Q.U.+!N%:J506"0Y@B*CSCD&$XTG]PZ!1*LX'^U
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MFR<-A^P$39S"$=<V&J@YIDGZ6CN;UO4$Q!D0#KBQ6,(3V,$_X_V3AH-JM$%
MY7#8/TVO9Z.<8LV!$D0547.=34V2](9Y(VSP5@"TN>=Q'-P_:3BD/@>,T/1
M3;\[XE)%*W@D*S=DIHNKYW7.L)"<EUI;I]OTF3P.[I\L'%*? T9\#@]'K"Y\
MH#%6*NYKEFEMO@J<15JO69"Y..V-1M'M8M/A[VY=-N51(H2-5?#8Y5;FL\7H
M36V'LNH$GK4.M.HR%9VJG< )>12"!02P(J>D99=J\?306^L6?=I<L^Z\]=37
MI4ZBUFE?\0X8 /D,XB:)O N, VY)=]?V\"GZ#U^<ZJ&!31WV$%]#;?H41415
M5S9:WK1(ED'P]41"8*RMLDKITC7J:6AQQZ6HX95XB-0&5MX_<7SQOB;=_(8S
M^ P(D49EE64)#:TNB@,+142F3#;>:Q<S'TR-6Q&<SA+LI8OID()LD'RYQ\K\
M_M//\+^GL^>7,)\OB:RC09F!;%@1:S<S3J9E$9J50#9)-!Y,;E*UY@",Y[PY
MMU;9::/$7X#>ONC? 6[+@B@'XGV<.BG-]-^=9X,I[[3G9EMA@^>V:!N8!.^9
MQJ6O7!MWNQ*%RA:A-&F0_22X]D 5EJ=*M4-T-O3][^?7\\7TBK;P2?YA/%_,
MQO&:?OL-7B[#,?/WXP_KVZ\R)2N!; 0?G"6)1%6KVB567!8V"@DV=+O2T_F5
M3RH\UE]ST^9B'_HN^5NXQ/D,/\QP7FNE5VA7,/L5:Y86(?] \IO6'\+EK!J#
MGYNN):XQAL!082!S(!H&QCM68J0QH'%"B4Y,.>[]9TR;$RADZ 7F-2P(ZOS9
MCBN+-PB=(1\$+%F0TI)76:QCX'6H3J:)SH+THMOBTNEU9\R0X<7=P)!^A^G]
M9'HYO?CT/<RW2&0%,F=!NW A5S204ZHECRRF)%GA)MEZ'A!B$U.F$[KSI% [
M!37(F'C@PLM]DZYV";,&F$>[/$LBXR[5%/3BA8H^V5":W(P[$.<?P>EOJ;K3
M,VV[_]@!<DOG_PC,CQ, :,J%PW@WF"(;! *.@>Z]%T&!HVU^60/))P9<6V8D
M!BF<TJ+5)?,GPKT' @)/G7J'Z*\!Y=[-(&/U+ZHYN?Q0L7UV*HI-19C, )UD
M9 A(YF,M<PXY!X@QZ]#ES.1P\VP?JM.;9<WUNFF:#::4)L4OTO1JU6%MV53G
MIG'S<O+X6I>(9\Z$#H7I9&OMQ)(9ANA1D%$*NDEM^#V8_ABFUC J:9!IN@/:
M>I)T -?6@-J#[K%,I8%TV8TC/131Q #:!S(9\F@+>E:T-$QGE5CP4I'SJ[6-
M"1SH)LVI'H$E#QHUCT&20^0_=(CQ)FGT9@M4P3L/(;/:L+EN@9R!C9D9,MYX
M1BX+[Q9]OO/8QS L!I/W=!!A#7VZ\(:VP65]U6EY@[_AY'H-*G*7DE*2V1Q#
M9:FF[8ZL)8'>!V5I(I9N=:5WO>%LE#F("$]1JK;V1GIWTQOI[GN[U7F\\_>]
MBS?N1K-1D9&D!=DX,#$[G:*-V@64W);,!8< HUVXCI7-\65DMSQE4#EU* ];
M>0I$5R7 :..#YY[\F6Q%,IJ7B*/]&(^568_RH=L>,ZC4.O5J3XXG';)5'+55
MSFLK-0\Z9<^S*&6T[8%M^K*[%')T]729/$7:#L@[C:0_9C')9%WT7&$+*ZI1
M7_;;@B,/ZSE\&"_@\B7"'%_%R_'%ZK"=UN959:SGU[,9O?YG6%S/2.LX'VF.
MT8@0F<H:R?&REGE'+ACI*J&+V>O0)27_8'GT!?[8W6Z.8]2V7H@G4U^#:,AM
M_*/LE?=*T<M=SB0(@<Q7:8 "GPMPI(VZ-97.CQ8'B;5M8\PE',PN.,=+[>7%
MF;8\UD-7S9P4T1>1HY)-[A]NX#@/1?<1;IOT7Y@D7*X_7VI2F5IYJD3%LO2Y
MEK]+]72 +&U>N#6^V,";G+%L17,>>N\OZ 9GP-TVHYL]:&0\J"*59YAL)/^+
M_&H?BF?2:I^U)/\!FU3[.@CE>;"EG6(:A+SO"N ?$UC=?<::!9JFUP30Q6"S
M(B-%.N^85D*Q& RPS'T0&7@$>8(6NEN0G0=;AE5 @\('MR%5K//Y=5T,;\)V
M(ZLL5\D7LF9=+9SI)0M1!":E]+X44PLFM:#'?ECGP8T!1=^@^F2W=6Y40,FB
MM&#).UK@.-E' 0-G+G@M10B&!/%X.\]Y$*6!*AK4A]S6D308DW3M9T >L*A)
MH<"@>$TK7!0:Z'\B-RF'O 5+ZX(5I]M%#A?M8Q>>V#Z.Y1$AC=I[1\N:360E
M:14S\UD D1:JCV7!MHE3W(?RE#KY'J3<O60Y6,@-HA8[6U-WP=4RY^*T3=L?
M2K?HJ[BN7=N/D?HI69%MBD1PR[2(9/W$X)@W1C%#KI3#""&%$YP*/'*NZ*G(
M<(BPATZD>':U/)<BD^8-SNM9=7Z+D_%T]GR&>;QX=C'#Y?:SSC4DWZ@8PJ<<
MF<):6UG/F,F?3FB-C%!XQPNA![WVL2W(8U4U/8F<&YUB+-:'MNM&V" Y>,X]
MS=I X[?"U"+\O#;'2@(P !?-#L8VP9R+G=!;T UBWIN8UG?+.J!J:2=LA_4X
M5D)_M3W @QXR;V E[$)'S,=L/ LFRYNXJLT$T2"Y5@%TL$T*M)^2"0]8""<C
MP@&B;D$ \J!?E=56M:[Z9"(XEPK+JB("78_H:,P2<DE1>F]<F[/M>U!.;QT,
MH:1-O?>3<!,; ";SU_"I[G%KJR1DAQ(D<Y(',GXSKCHX24!;,D:=7:,XXR:4
M\]!Y/PFW36WX9;K #7 B.@\@R>+ECFQ?+B(+-EG&:]V<6 IDU63*[T5U%DP8
M3NX[[<%&B;W/<AZOJH^\F)3I[&J5XCQ,=N;>9P^:LME]%)MYG$)I:;E54GHM
MDP^:=G@%0.Y;2E[P4>>WM$GNE)A$%FB9L3(R[:UB(=I:T=T7A8JKZ$\0^W\Y
M5'+GW<?^!*G6+J\'N*"M0O"%U81MIDN(Y"^+PCB/.@7M72A-,G)V 7KLB,5Q
M#-@?L#I2W U,D[NX;BV>SV$V^S2>7*Q@OBKOWN./_[H>+SX]GUY]F$YJ,HC3
MQ@+MLBS76C@Z<,=B$L@*+SGYXH2")CTK>F ^1S*U4UH#L^AN8]-E2OY-YLCK
M&5Z-KZ]&R6B=2U ,"2E-"$, @XK,">\%^)QE:N(*/XCL/+@SK ):Q,QNN6^T
M3BZS%W^&C^.KZZOOI[/9]/>:JPX?Z%\6GT:^: 5<&P:E7NWV*K.P9+-!2$%E
M$*9-(/4 D.?!FV9J:9!L>G?\+R;D8N!\\086JRN$^37.4BT >(&CF",G>)8E
M:V3M%A48<.)^"D61EZ'!G>)P;A_$\Z!/(Y4,F&.Z*BQZ]PCIQX\?QJLNRN]F
MXXL+G+U!VDYGN+'M5D?SU?5BOH!)O4GS/5S6Q+>1R#E%[32349*SF35GH&1-
MA32:6T=S8//ZTZZ2KP.B^KKI]+A*:I"O>E<XW\-\/'_[88:07TW^&V;C&KJH
MDT2,7)$V(TIFO:O]%1WY"<H[%GS(D(6S,32IT- 5X-?-JZ;J:)'-NF4W)AO_
M:KQ8NI>(M];3I)P+9-2Q*&D+UJ4&TH3GS(*/HD@MI&_2J>$ C.=!GE9*:9[<
M>GL[_K$43(OQ;[?!DCR$KH5.DB;'46-"!DX5YE"'F'F6OE.;G@&-I"THSX-#
M[11SGT6^?TVA%;R;%/_E+4,O.!$9+(-8L[:%3BQFS,PHH8PRT2?9Q'W?@N4\
M&-%7R/?U'GJ9R#N#3W^?3>?S5>1I6C;#3CS($CS44GI:$6*20$Q!L!!0FL*1
MN,T[V<)'O?[K9L*)Q+XEVC=T>/E.>'+$39*&U\N$5F2F:>PLI%18XB)+Y^L5
MPQ.<J-P%]74S97"Q;^'$("E0GPL0@"U.BZ@96!7(_;)$59DL$]K:&(4VY):U
MOF]U'CH_6JQ;=-PDB/L&JVRJZWTO7EA*2D'20+-$&C>-DJQA RP8AX"QV )-
MZCX<!O-,>-).-5N8U+]P "[(_IFO$=^*X-PL9TGS;&IVCXJ5ZLX$!K)PEA1*
M7@)//K7)GGL V)FP94CQ;^''P"4!;I^%+K^MJ:>O9^.$8E3+V? "A0E/]K+&
M0F+(L=8_0?*A1*QMMD][7+V!\#P8TT8A6ZAS=.QU:4__%^8+)";_3L813!8+
M^C*'93'(^007">;O/\ XCPR'PFONF3-HF*;OR7:.D?'L4P079-:ID]_2[7U?
M-P5:"7:+\GM'4%]]J)!JU?"/F-]-:[4"(N?*?WJ[F(U_Q1N6*I\%-X$SC+5$
M5LED+D?(C)-I9;0OG/,F?6^Z ORZ*=-4'5MX<W3D=,GMER^^?_7F=E#NI\OI
M=#8R,117L+#L7*UYXBWSJX$GJZ.T.G6LN+O]^5^WAH<2W!9E]@Y@=MBKWM23
M13%R%0_Y5&0&"T(::;D"F22C 8LHB9"(3;JI=4;X=9.DK4*V4.?H&.AVI*OK
MB[&VL>%.D043R* QB;-85&*.G"C#"U>IC2OR!,N##$>"PT7[5,J#[-O3OMQP
M<XEV,D26<\W_5;5G,I**4W:T.6B;O6J2P=8%W%.Z&GP0 0XP+HY21(/$V(<P
MKJ_&=$#9\NIP-YB/<Y5X>#4?R*,>.GH\1BD H11W3&(]0R9T# Q]Y#&BED&@
M:G/[]#&9],!5Y*="I$-4T^(*(^W\*Z3KVW,R<"V29BYCM;D2L)!M8@F\AJS)
M?R^B!54V@9S>UFVAL,V+BWVD/71SF=O);LLLN%7_(QJ=YIY,.1"U/$<LS LE
M:N]BE0-(GG@W/W?KX[]V:V,@P0UXI6([HG5?L@Z8MEL2797Z&+; 4$K8J],>
M$ARZYM1.;"E)7W)AD9QAIG.MI!-D8IEGT."R4*Y;OLU)M;IC7SZI4@\07)OZ
M,+EN- N<19C\^JH4G&&N()<AM)NM(7'MC1&6T>JDR+LVDK8&5YB55G&=D+;1
M)AMQ)W2GVYV'4^3]7(J!M=#@ZNZ/U[-IGEY>PNP&C_.EQ&*!"4!/FU9-_R@"
MR7ZPP7.T6=@FB=Z;0,Z  +UDVV!9H'$MQW>#!A"BTT(S59O=Z90BBZDD5K0)
M*'64QC>Y>7T7QAGHN8=<3U N;KG#&8Q>1L(4H^ W%[:]1&9C<A"R%$8T.7]\
MZK4"^P0$>PNZ48>4+;5PNJ#Z0]<*/$AMW4K$'2/ST]4*5%"D3V1V"![JY6JO
M65 &""+6%:OHG)L<13[U6H$-B'"(J)L0X%Y5L^B$QIK+GZ1Q-$@D,"($0L1I
M?Q(B 32YK_Z$Z\8=I*2'Z\8=(N$6M0+O5R_T)I>@G6 8 ]F>H(#Y@)IYHQ4N
MNW=!FPG_=.M#]M)Y/PF?O%:@!;"TC@4R2JT@0OIZFT?(FO'D@:.613>Y4?=U
MU KLPX3AY-[(&5C?YUB7,16$21.8XFU@6@C:X0KM<)P \B"X1=DJ[+,!Y2S4
MWU/"S0O7+*T:RY7VHM3\>E.8KAE/T9#7$VJRHT[.HFV2'_*T&\KT<?YZ"GG
MDC/;$=UJD= %UQ^ZH<Q!BNO:0^08J3>P"G;BBT1P A18X'61LI;P^5BK:P$&
M'42MD?OUL^'PAC)-R'"(L(<^W#NLT4GP2DC)R72%FI!BT+.0,S)T@,HGA;YL
M! K/K*',0:HZOJ',(7(>.B_CF?R+E>:F LBF^?K#-9(R]0U,960J*FJ&JIY.
M"3"UJWN@+^A]"C%(V;&_4.=WG@47VDBX^?[P!C->+=.'"/MXFI<KH@RB5L'G
M3"95:C/>P@"-8<YIS;.+Y-SF]CO%-FCG:4SV5D+S"G.;"&^F2Q>,IS,TMX-\
M"D9G?P4?Q)\>VCGY@K-VR+-5(6G)M /"FKQ@OEB:5M(8;4QP*9W 7STE@PXR
M5!^'0(<H96@C=ITT^^4>\)<4:IV3,EHQK!6"M7:6MFL)S'%$:9-2RJI.)LKN
M=WSM^\R0(ARP#N4>6.M+$!V '91>NN]MCY!C.I1.'M9S#X&>9BZO^WER5V(H
MM01A0C*'<V80>&0A)!>Y@/M)24]&T_OR3D^NZ$/D.+2"E\4;;L&:W[@Z14&Q
MJ 6-E'O:0')B01I2GB0)<"N3D;F3;G>\X,2I9,/)_U[EBY["VQDP:-1TZF=8
M7,_H>3B?EML_'ZCOU$./'[3UU$%CV>@^Y8'KX+/T%K/V$NFCQV!MK/6+<E2C
M(T=UB%[^?@VU8@KB46*_]=>]I;H+R6;+KMJJV0J1BO:Z.!6U]:D$!SE6(U:.
MMF,Z3B9+&ZJG9&Z>,:!\MJ':D%("3O9>Y@K(GO<"03KCP;I@M2X^W9;2?7S'
MR:K'[+W_D &EU64FDK]CN)+%JHS:)O2I]NQ&6RO-17>'5#WGV^O5]O_Z$B;'
M2.KVG_>6T4XL&]()*+0WJ#EPKH7,T1B1+#II=*)-JHQVH#I2+L=/NOL/&5)&
M':8=6LNM)0G1<J1MS=A'GW56=1HZZ])H+\(CY=5CXFUYRI 2ZS+U0C9<DXMJ
M3.%:!@Q*1DAD[V1B5_9ZM!_C(3)[EOYU/9ZO>CA.\JO%>YS=%+@^1G9[GM9;
MAEV1;LA22YN3MYR6K*"+A*BE-Z$44V(NY"F,NF$>1J;'3^,'G]E0OATF>;8B
M96,B1% ZH/$JBESS-Z5($M,^*?>;\[N?VV,)>/BA#:7=98&(08"F'4BXZ#1M
M/#Y997F&H(W#I/T><?=KSKHZFMOY\)>?ZPX!!X(3(R-[RS(-EK-Z/X@ES44I
M(BN.W7HN=7A9+T^[GC3/KE-U)"87RY/GRWKP_'PZ7\Q'"FG?RH$SX(2=]GER
M1K7F+!F3E,]11!DZC6+?6T[L<P^MO3NN]V#2'/K _F>87!>X 4:3<3Z]'.=E
MLZJTQ&8\V2)2Q1J*3TS3=L$B6F2&HPD<2M:J=-+T R\Z)V4/*=,6=S6OYS3&
M^?SY]"J.)TM<M\1QAYGD!&8N03"1,S!-JRH#!*(GL97\'9NT:7(^WQWBF?"F
ML6X:I']O05KOHU^L.MW=00K"JV2R9Q(]D=[51'6G!(O"VEQ+(JC<)"V\.\3S
M9]$0NFF04+X<>T5">^*-"%Y]P(IS<C&2'KCW"*R&$6KK\<0"*L^*E49CRDJK
M-I6-]X Z,Z8,)O\!L\Z7 [\]U%78<92LT3S;>BY13[.4D,PKC4Q('8-VR9+I
MW\D4N?_LUM5(V]L</>6US<QXC)*D+\A$NEJUW%W6:ZU_4/503S,C+4=!$1-S
MD;Z6,T$6DHZL*)6"\H4'WJ3#Z!Y,I\[>&$35]_JW#2/R!I;J#FCK%-H.X%KF
M!.Y%]SC)@(/ILAM'>BCBY&PQ)D<+P3#RO&AE);S,.P?D>;D87919AB:-O!Z!
M)0\D_#T.20Z1?Y,KS//%J_(6+G&=]<"=32D)1P.TMM;2*2R6;%GM4(D&<KU7
MV8(0]Y"<_E;"@)JZ=V.YCY@;E"MXBY?T3Q=_QPE9M9=DY3[+5R3?^:+:N+_A
M>AM=7Z\%)3V&R!Q (HLW)0:B6)8RDDRX,V":-!(^".4Y\:6=>G:N(0,F*JW]
M[+<WQN\11RJ;C^A]@+(7T^898%0JH$#K@M86;0BT^B<CHJ5)&60:[4'70T['
MG_9M?]#0,NMR>"^+@  R6FTT43QX*Y(5W#DOA(>R*;E^AWD;#^MQ@K?C24-+
ML,M9G83H G+N:YOY4"!"JK42;/"0#4B^*<)^!W1?%IR+U3V$#]-9#7*\F)3I
M[ INQGOCA>NB,>2ZL 0CF(Z.]BQC:%GC4D'6X'ULXFEV ==W0WR#O^'D&N<C
M'H2Q8 OSJ_KP]"4H65CFNCC+(<O8)"J[!G#Z;6QPW6_N9D?)MH71D]YCOKY$
MLL1V#_G[3[?7IMJRG9M:,30%LLYTU@2>M@'F@PU%912TW3;A_.%83]4[J#E?
M6NOIL:-Z\]EB]'HVS==I\6KV%F>_C=/J8D(1BDL7 G,QV=I7+;(8HF"%OJKH
MJOG8A6ST_%M$HT^;)-L%X+%N7357^'1 P0_HA=_",R<C_P;1ND!N%U '!/(.
M8<5]-*<-W VCJ/M:'TC*)Z- A@R2K&FF?3),UW[>/A7.C*H^7:*%5'4I#?X4
M5;\C&G="S1\BW*$O;+V:+=Y//V >I[?7LPN<?5K7IO %#3>>"2<"TYI6-9#6
ML62XU\'Q'%2W#+(=+SB==3F@[*<#"V[H9+&;,,U=0"4ICLDBT^@R#=-9%ATJ
MVJZ4*3:A+:);)X]M3__JU=A;9*>(8[W$"[BDP2<DODTNCKM5M_F,_E?G]J+:
MB"84FY.VD:9&%CK3^NFU5SFI C$ED?EH'[X^LNIS$7''HP:77)=P#,3*0P%%
M"*]U4, =+SD;D[A6(/0] 0X3CWDYK6E*DVH"XR2-<?[%LX*$)7C#F2LQT4HG
M,XM**49S!(.4U@K1)!B_&U*OQ?-F<7E)DAY?CA>?OKSBTXO)_'H&$S( KJ;7
MD\5KG+V@%V=R 4;>YH)2(PO*T<)3X]Y1 #)#?H 7*3JYZ9;O6%V/>OUCE%$=
MA ]WUN#VDA]ZH^V$^.)B1E-R@<\FDVNX7 U@A$:$5 (PYV/=6FH9.*4E,S&;
MH D_N&Y%]HZ&\ ?B3&\--*G)?UL8GWZ *[C ^=OI]<7[Q7_#Y36.!'"?"[D5
MP&O]@ B!A6(C*U:YX HZ;%2N_2%D7SUSVNB@2>WNC7&O0DW<)V6$J15_M*X%
M@ +S-@9FO//>*P_2-<F1V0[G5&'>DY#@*!D_=OSV\U!([A?+V&3- ;A>=38$
M4[,+C6#)>5KG+*UX9&H;%E+*#L IT2:A:AN8QXKG#J'C>]T?>LJZQ9ZR@6E=
M\:D#JJ:MG[;">J363[W5]@ />LC\=(PP)3JC<F$.:\79S M9STCFI>;>H/)%
MM#E$/"43'FK]="(B'"+J!@1XC9,:!?@";MV'TKGL49%-$TKM0VF!#!LH+*)2
MH'DQQ3:Y,;@#SR.8E .H:SJ\K ?T4&ND] N6YS!?G5L$6SM3V<*D+8+IQ!4+
MD8=Z&@X6N8-LN]@#G8YP[K_^#"R  >0ZH*MP'\VM$G1=, U]8KL+S.D/;/LJ
M::>^>TIXX-/:G=B4\]$:5^\%UL,0)0A;#HY!2!:5!6]MEP#"$]3ZGK/:4RC]
M$,$.?5#[XR1/?_@T@:OQQQ>3])=UC[' ,UJT3&4A:=NBW24D<*P S]DJ0%5,
MIW#BUL>?]G1O&+%/!Y79T('C+V.\"3HMB9H3.HY  [2Y=AX-B8$+FGE?M'0Q
M84JBDQ:W/OX,MMZ!9#?@!?GMB-:GT1TP'52[>L>+'J%L]0!*V*O3'A(<>L7=
MA<VA$ECJ9E)*+<,N:FQ8<8;:.BVX25YTN^=^4JWN*U%](J4>(KCAE?FOZUKD
M!_,-IG4SIBPYY]8SYVLVEW"112XTJU4Q?2RQ9.DZ*G/K"TY<CV(0T4\'EMO0
MF^BSG%=5&B[O8G)1>2U38H8,!;(3R'T/UDN655"2D\D'LMM9_(X7?.VZ'$)N
MITAW^@5_?Y92/:PET^'U;#JA;]/RQ.2H-)Y]C^N=RM,9ZV;I:RNUB$DIG80&
M3-Y #E9&,,4A6:"CCJ@'DNOKZ>6XFF@#R_?S8UO*>3OVS?0I@T* 0BESO1"H
M@DA1Y!0EH .-?I^\;X_BAN;U2R0OY3__[?\"4$L#!!0    (  )2G5(0J[;"
M$K(  .5S!P 5    8VYM9"TR,#(Q,#,S,5]L86(N>&ULW+WI<N0XEB[XOY^"
MDSUV.]),J.0"DD#U<DVQ56DF,J0;H>RZ;6EC;E@E=KK<5205$:JG'X"+N\L7
M.@ NXDQ;6Y9"<N*<\\'Q\0 XR[_]SQ\/2^^;R(MLO?KWGX(_^3]Y8L76/%O=
M_?M/O]U^!.BG__D?__1/__9_ /"_WW[YY+U?LZ<'L2J]=[D@I>#>]ZR\]_[&
M1?&')_/U@_>W=?Y']HT \!_50^_6C\]Y=G=?>J$?!OM_S?\,21I0R1*0XC $
M,/)C0 CB("4Q#Z,P8A+BB[L_DQAQD?H<,!_Y (9A C"6(>!)%)(T3! -937H
M,EO]\6?]'TH*X2GC5D7USW__Z;XL'__\RR_?OW__TP^:+_^TSN]^"7T_^J7]
M]$_-QW\<?/Y[5'TZP!C_4OUU\]$B._9!-6SPR__^]=-7=B\>",A614E63 LH
MLC\7U2\_K1DI*\S/ZN6=_(3^%V@_!O2O0!""*/C3CX+_]!__Y'DU'/EZ*;X(
MZ>G__>W+U4F1^!?]B5]6XD[/[(W(LS7_6I*\_$2H6"KMJ]'*YT?Q[S\5V</C
M4K2_N\^%/#[L,L]?C*JUQ%K+(-%:_O,I8;_T4'\@?<M#70=0KC+W\U Z=F'Z
M>3!U;Q4_B/$5WA'36^7Z"_5AQ:?Z[FY$]59]?(V'^EJL2[*<X&NQ%;.C\E+_
MXI/ZJ1&C!^H@TTI.0]T[JHH?I5AQ4;/EBZ&]C/_[3^JG!1?9HGWKW:J'%BE-
M:8QC!J(0<P )#  .U.L'D]@/HS1F/HD6Y>:[O! K\-O75FPU]O&!?[*PI#RQ
M(G-1K)]RMGV7/2R/O:#4NTF_S= O*_(@BD?2/*"TTZ_]6N'_V+SJM7+_]LM6
M?0NLEJ,AL)R#\6OV0H&E?JFO\WU+U^RDI=O%42@E*S,+P?YTM_[VBWI$F1OZ
M^@>@?P!^T+S;__E@N%\.YN0R;W4C.3L#:/.)7]A:>2F/)7B!K?;JNHTHU]W3
M68.CA/SDK7,N<N5G'E%X\R5Z*L =(8\+[3WQIZ6XEC?YFC^Q\F\DS\FJ?/Z4
M$9HML_+YEM"EN%5K^*U2[X^%3PF&":' IT$$(*4)0#** 4,Q5W]!'"%FLC!=
M%9C; GYWK_XE"B];>>6]\)C2_EGY]1YY6#^I;_9:>H7(OV5,>&3%O<?:1N][
M;60F"K,U[SQ=W=PPQ22,S"&MZAKI1GFOU=[;J._]7AG@:0N\RH3_IS_?]$7O
MQ4N[0DZ2@E:F-T/7W"269='^9I^DG'68A,SZ(M227N]QW,CQ\F&=E]D_JCWD
MM7PO:/D^*YA>US>Y>,B>'A;,#U,I400PC"2  A% )$F!@ 'E*"84XM"&#<]*
MG!O][2JLER!7*GN\T=F.V\ZC;49F@V(X,GOMPZ>U]5IUO3>-PC\/QU7&X Q)
M3N>%3LI&QACLTX_Y@VY\<YL+4CSESU]+Q5V_B@<J\D4<IR(-( ,$\AC F'%
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MAB2#D[(F981S%N_3PMG/.P;#J;<DT0="30^,8A$**&)?JGV,B"6 !&. "(>
M0^KS )/ C]/%MK7]^4"G?0E6;+"1,]XW_'_\<Y#X_^IM]-RTQ+$,(SM THP#
M>N$S\N+?8O+A'";VD5>G[!XT=NI R+313Z=L/(A?.OG!X6-<VP.1NN2I^GVN
M;Z7>B_I_-ST40LP1"F,?(!0' "91 &B")8@@\AD-PH11JVNC_BK-S8UX=_JP
M]L_#A: :3I<AV4PZ"6.ST_E T]TCW1&Z:0P'YU0!HX9:S29&U Y%F[!0RY'=
MVW^M5]5.[H;DUWE5.[8N,ZWD5I6F%SZ)8D)] I) !V0Q@0#&ZB<>A,HQX2@0
MU+H-V!F9,V323>W[W7.<-WR]7)*\V)[EV)>@.(N_&7,.C.K(U-@ VAS>*(5U
MH>A:Y?HHQU-*UP7OAVT=9@C1T"W$SHF=O)68(0['6HJ9/NIP>?65W0O^M!37
M\F.VRDKQ23$BOUPI]N-"[ORF:I!4=6]>4,P5!R4^"))4L5,4(=VN,-4E<5*.
MF.(F8G1&Y"A_;DS56J"]BMH&4*E<Q<5LS6A^V3;RJDRQN3%RF"B#R[5QX1^9
MTN:+O,5]WK@S,-&=WR@S87<]Z(YCYQ6BP[#373.ZV_SB*K+',#W.(CYEA&;+
MJBKG9V7KILN!2 .& D!Q=0&AG& <2@;4JR:A,HH%(LSZC.&HJ+F]1^J]ZW(3
MWKW<*NUP=' <78LC@=Z83;+5W]%2;>TW>@Z\G^_$8O!]^G%IT^^_.ZT^NJ_N
M?L+!.ZT2--4[Y#O13;?*JJR_VH+K0/F5*!DI[G6S[@7G$H<A2G79\%"1!N:
MTH2I_;*,8(R#%#+SD"LSF7-CCTKKZG7;Z.WM*G[A*=4]K;NGE;=P?@QGP,#5
M'![7">XY7Q%2"Q]R>&@G\AM_>P2*?!2R;%THC[!<>X]JZ'N=SG1?H9]MLB,;
MP'6E&HUY+IBHG$E-7EY!:M^S 6"H0DQVN';ZD89#3><[VMGVPE^T?-3-1[Q:
M?5.SOLZ?_[;._[A:57DZS1'M%U&(_)LH%A$.6 @3]1H5(0%0AA)0/XU 1&B8
MP"1,>6"5,V\@<VZ\KS4%V0H\UKK:>8HF&)NYC ,C-S*S;[2]\+2^BF6\1N/-
M_5"K]7">I 5$0[J4)F(G]2TM<-AW,FT>=6R_U10#N5[M]<EY+_+LFWH;ZONB
MS2OI\[ILHV_T]K@)R-GY@/),.8(T46\$J&8'\H#JLU($8*I^"R$3:0CM,KX'
MUM!F54Z3&KY3^$=7JCOH0+6U<Z?,1:&+:7M;4SU2>&V<VLZG+)N!#?QE,*/2
M5YS@D6GW56;6O@'9./@/VJ5L8!6G;64V#KX'_<Y&$N.8#LO_^ZDHJY%NUY><
M9]I;)LL;Y2=?K9I2 -5='MWO,OU%_/TI*[)2?%7OMXR).CCABV#KNU4U2IUB
M$"0R1I' NFDT!]"OSDV1KB$5ZZK.1*8"6>70CJSPW/SHZH*UZ?3.=JRQ3*H=
M>YK-7B%SFKR1WRF7-U?O+NJPA6;VFC*WWJ7>G-Z)N@A6&\SCR;6.#RM*;\>F
M 9-Y)P)^T S@L76>-FUXHADXR#6>2F[/TQ2U65I(/Z1^E*0@A3J>/T8^H"DD
M@"5(,+59(3 (G8Y-U.!SX_56-^M;M!>(H3A.$AI"]78ENO=Z$ (<*,321#*?
M<\%00FPR()P1FR#YX5;+\+)6PQZH61X=66(QW1F14FR$8Z =<T<Y[]'CO\[!
MSHYE)T]P=C_C6N6_2J#^J/30%6QT:.[?LO+^G:+A]8/(/_Q@RR>=OJO#%M3_
M<UV(.0E2BL.(@2B-*8 !@H 0&H$@82C$TD^PL$IO=-!A;@2ISSN_DJ4M/;J@
M;\8'(V,Z,FTTVM?74JW^WG=E@-=:<.%M;/!:(X8M8=T#PF';#-BK,7$# F><
M#EL3N ]EQW]%7BZ^BCOM:OY%K.]R\GB?,;)LLHQ3E**0,A\$-/4!C' ,D,\C
M "GC81#C@"6!"<-U2ID;A^UJ:)FVW8UF-V,-AM'8YZY6\!BSC9'Y'7RBGM_A
M$O6O?1[I%C )4QC9V'*!V8>'*""_TPVW_K'0&TF]G0P6*4NH]",,&(%"1U!*
M0$,6 Q_)D,,4*A(P"H:RECPW5CBHA+ZC>_L/K;U7J=^GLGS7=)@Y/:. /#*M
M#(1OSY+S!EB-5WJ^2_@KEJ WP*2[%+W) &X\5J4O:1&?LI6X4C\6"ZFC=1*:
M !@&$D#$$D!U>8E0H  QFA*?6)6?/Q0Q-V;::.C]KG7T*B4MZ\P< =*,:OK!
M,S*G6")CS1VGC1^2)(Y(F90-3ENYO^P[/ND0KOT7L1(Y67Y]RN]$_MS4-H0X
M]GV,8B!CK-8X00)@/XZ GR0XX))!Y9$8!V<?DS"WU=WHZ#5*6D0&'\6O>U4/
M@LKH^X\7@+C4RSR*C$6$=%^$)HJ'MD;*+IZY"X7.Z.6C#TX7J]RE]XO(Y,X/
MNCDL;Y\*W6FR>+=^H%E=9NN2U3=VU>5=5:M;WR@7"TA\'B>^ "S1]VH1%X"$
M*0<LIKY@D)#0KN*FN>BY4>".FE4"1;8JQ5U>EXJK0OWM?!V+.3#S@<9!=F0:
M;97V=K2^\':A;A2O AP&C(BS1VM(9\I"^J1.ECTJ^\Z7PP@]-UUU=KH,843]
M6 !.=,Y<!&- ?>P#22&#+"18^E;M:5\./S<NVME2V*3^G\#.<H\UNY()QF"X
M;ZV.)-</O*V:,,^^V[J3VZDALN3?Z^1[P=\JGT9FY8V:QROU&E7?AE)SPB+T
M$PI#F>BJ4,K;X(P#(D0"$DD1EBR *;.*^.P6-[=5W>I6N1,ZFOPQ7_^W8/KM
M1VL+O/7YAF@NN)L>Z Z%YNBGN)6B7J.IIU75\9(-O%K;(8]N35 9]KRV4^+$
MA[0FUA^>S!H]97^)_$6'QU[^R(I% DD:$!X C), P"#1Q9PB#J(X$F%(F!]$
M1H4]7XPZ-\;0W)P5974)^JL@Q5/>O BULA:WQ5O8NIG &8P)7  ''*RNA0_L
M[GL-O!UPLFO? QMVKWD/_VB__OXFLKM[G6[R3>3D3C2'6HRG%+%4*+]<1 "&
M0H>HI0S$/DEC!FE"D%%P[DD)<UN7K9)>HZ7Y2CP.X/E5V1N6D5?H/B(#'@.>
M-;_O0CT^^&2+MM.VW07<_<'A2VR_(\7]Q^7Z>U4[H<U-^R+8DA1%)A49:S_U
MK9#K7.A029KX7&_302"J( [$ 14Q!T+Z/!41#QBW<NZ'4VUN]&%0\ED;Z&D+
MJ\11<>'M)*)>>/N67J@-A+:U,R1S[/DWVV2\SJR.S'ZO,Z&#%OIVPWZJ@M^6
MVLVF\+<;JC8%P!TEV+TMN,@6'U9E5CY_?2#+97L(O$BH#R%+.>!"Z*+?*02(
M1UAMQU)"(8=1(HTJ'YX8?VZ\7:OH53IZK9)F?'L*P6[2' "7D9G/#A)CQCIC
M^)9VBI9W"L'^=+?^]HMZLJ8<]<,^TYP:=1*Z.&-2N^;/?<PUE_)E8X"KNCKW
M_7JIQB@^_/U)R?NRTSU9\C@-2*"V<"S0#6$#Y<O)0( XD"R$*.4D(';IEE;R
MY[;P-ZG8;UH#?M8%F'9M^!>OMJ)7@VO;:3)SN48$?V1V&0%WA^1')_2&S8^T
M4V'B%$HG? ZS+-V&<0CYJXI"[]Q:Z^2G;'57QQ 7&1=UU$=;&?9Y@1*:X)A
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MQB$=L1&@']1/&U*_:=VX$9 ]\/+&D&$?4'*I!' MY..2W"U"AOT80@YHS#B
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MW[%ERK":SHV/=V,A5J+T"K)4JS_;FJHC[!\W91=6[FU4!IYQP\WT'.9Q]./
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M]RG$\*G^Z4G5!?MCIEMH"E*(:[K,[BJIQ=6*+9_T 7>39+G-)%B$L? %A0G
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MGMEKVQV2D1>E!1K6K^+C1@_YUMV3,.D+]KAU^^_2$Y]RN,[4;V)QFY-5H0A
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MH&G&V/TP&IE9*^6\1KL1XC1.&S]LGLN!E(DS5TY9>9B+<O*3_5/X%@E/PC"
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MA)4W%UP#(B8?7+0U*"=<B_B8%ZY>'YH!*Y:*K=0[U?Y[V\=D]54)-?W95(U
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MR-8F2@TE+)Q)T]WNV&BT<3SK/-^7G\\:WS/C?&:]#V$(C]%PH-8T&"<FVY'
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M@+3, 6$B!T(44E=$$"6]NAMY61_;+*]Q*GO3M$#S;7_N!WM>YA4GM0(5*@N
M%"X $[0"$.<X)X30JH1NM1C)@1^F)*-Q"_S1!9&Q-HJV&]TJ6^S\S]Y,Y]D
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M8V.;Y.W[:F<@<I-O(JW.P'2U>C;.JTQ8WSW5M/H@=V.U6$"F/E$YPK"5:-A
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MM(-'C^UU/TBYF,ZMBD\[.5'>1<"'$/:_[[<!D_@5WY;P^A><'6+@4606C,5
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M.9(F^-Z_(B;[=2P#^U*GJ_LH%(ILG5&&5)*RLWM>>+ 87*RD2!5)5TCUZ\=
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M]"O^&M;ADJU)D(H;$PJ$K SM?II#"((,HN=<QYQ*-,/E\VZG83>@=']X.8"
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MF=-'OA,+$TZV/GNF( DEZXFE!<\T!Z>+T2+7#,0FY[JWB1BW:FMXL!PLX [
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MTBG";G>A93S%*(6F%1(528J\$N\$DG\JT>D8C,F-&FL\2=?8)[ C8.Q0K70
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MAJ76*G_R;GT?^7< GCLE%;4>8IZF,[S#TL?%OM+DAJM@*8"))(S:P-!#O:H
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MA+."-G,+42/MD,88<*ID*-S4*  +%TTJ&(ZB>EP'N4^<[Z7)(\>:D 26ZQ[
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M\H^PS!.!@DFF K!-[QL*$<DA$0HX=\'3JK>IM-FR=Z>Q>^?R"+#<1V8CS?4
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M#VO\L*X-42\][W"&$QNX--%QT+H. BWUUC9K^M9&F;1(1LA&P[YV);&GX.=
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MNR+1:4[[=PY8 HLH4I,^&3\B[+DD#AZ(C-VORO=74P>PV\K$Q43<Z?SLNJJ
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MTN_[7["%^^5EJVPGF765,W;9V9G:)U8#:"BLD4@/227QO]\&15D41<J\'.A
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MCR$R!Y#(>$^)@2B6);(2H^7.@&DR2>DD*L<M"6B'M7:B&GL+SV&#\\/WW2'
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M4%RZ$)B+J?8K^\ABB((5^E5%5S.BQR".GK^%-OK=+M(.$3 RC%I+?#X@^_N
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MN5S_1\;V![?#J[=7_8OAU<TU@//VXR\7UT,RO-E[RS\.^L[F3CLD-V_)\-V
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MBJP/;CDC%JD?>OA"8KG^@:N(HR 0,_3G[)\3\;XC.]H?9!\U#X\VD?U@4ML
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M4(V1:+X^#<\7E)VG TI.$I%#V!%!JS#7 9%@#L5ZK5SD"=",(Q2XCF7)H$V
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MO#LLPO2&KBO8.G8:9<&R%,.85U8#3 IAJMA86BIX$"MA*@V9H+FR75<<)$D
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M+3(P,C$P,S,Q+FAT;5!+ 0(4 Q0    (  )2G5*J=I-E5PT   Z,   1
M          "  1MX 0!C;FUD+3(P,C$P,S,Q+GAS9%!+ 0(4 Q0    (  )2
MG5(6$5%X<1L  -(5 0 5              "  :&% 0!C;FUD+3(P,C$P,S,Q
M7V-A;"YX;6Q02P$"% ,4    "  "4IU2!K!B@U5!   ,J@( %0
M    @ %%H0$ 8VYM9"TR,#(Q,#,S,5]D968N>&UL4$L! A0#%     @  E*=
M4A"KML(2L@  Y7,' !4              ( !S>(! &-N;60M,C R,3 S,S%?
M;&%B+GAM;%!+ 0(4 Q0    (  )2G5(=0'1I VT  'K+!  5
M  "  1*5 @!C;FUD+3(P,C$P,S,Q7W!R92YX;6Q02P$"% ,4    "  "4IU2
MYM_E!/X'  #J*   $@              @ %( @, 8VYM9#,S,3(Q97@S,3$N
M:'1M4$L! A0#%     @  E*=4I?-HY'Y!P  &BH  !(              ( !
M=@H# &-N;60S,S$R,65X,S$R+FAT;5!+ 0(4 Q0    (  )2G5(ST6Z&$04
M (X@   2              "  9\2 P!C;FUD,S,Q,C%E>#,R,2YH=&U02P4&
2      D "0!* @  X!<#

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
